Annual Report 2013-2014 Report Annual
CIN : U25193KL1966GOI002621 HLL’s Corporate Headquarters at Thiruvananthapuram, Kerala ¥…π…™… - ∫…⁄S…“ CONTENTS
x…n‰˘∂…EÚ ®…∆b˜±… Board of Directors
+v™…I… EÚ… ¶……π…h… Chairman's Speech
+∆∂…v…… Æ˙™……Â EÚ…‰ ∫…⁄S…x…… Notice to Shareholders
x…n‰˘∂…EÚ…Â EÚ“ Æ˙{……‰]«ı Directors’ Report
EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…Æ˙ Æ˙{……‰]«ı Report on Corporate Governance
|…§…∆v…x… EÚ“ S…S……« +…ËÆ˙ ¥…∂±…‰π…h… Management Discussion and Analysis
±…‰J……{…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«ı Auditors' Report
¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ EÚ“ Comments of the Comptroller and Auditor ]ı{{… h…™……ƒ General of India
¥…π…« 2013-14 E‰Ú ±…B i…÷±…x…-{…j… Balance Sheet and Statement of i…l…… ±……¶…-Ω˛… x… ±…‰J…… Profit & Loss for the year 2013-14
±…‰J…… EÚ…‰ ]ı{{… h…™……ƒ Notes to Accounts
∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… Report on the Consolidated {…Æ˙ Æ˙{……‰]«ı Financial Statement
∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… Consolidated Financial Statements
∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… Notes to Consolidated Financial EÚ“ ]ı{{… h…™……ƒ Statements ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 2 ¸ÉÒ VÉMÉiÉ |ÉEòÉ¶É xÉd÷É Shri Jagat Prakash Nadda ∫…®®……x…x…“™… ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ∫…∆P… EËÚ §…x…]ı ®…∆j…“ Hon'ble Union Cabinet Minister for Health & Family Welfare
¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 2 3 ¸ÉÒ ¸ÉÒ{Énù ªÉɺÉÉä xÉÉ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 4 ¸ÉÒ ¸ÉÒ{Énù ªÉɺÉÉä xÉÉ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 4 5 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 6 x…n‰˘∂…EÚ ®…∆b˜±… Board of Directors b÷Éì. B¨É. +ªªÉ{{ÉxÉ Dr. M. Ayyappan +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ ¸ÉÒ MÉÉèiÉ¨É MÉÖ½þÉ Chairman & Managing Director ¸ÉÒ BxÉ.¤ÉÒ. vÉÉ±É Shri Gautam Guha Shri N.B. Dhal +{É®ú ºÉÊSÉ´É & B¡ò.B, º´ÉɺlªÉ B´ÉÆ {ÉÊ®ú´ÉÉ®ú Eò±ªÉÉhÉ ¨ÉÆjÉɱɪÉ, ºÉƪÉÖHò ºÉÊSÉ´É, º´ÉɺlªÉ B´ÉÆ {ÉÊ®ú´ÉÉ®ú Eò±ªÉÉhÉ ¨ÉÆjÉɱɪÉ, ¦ÉÉ®úiÉ ºÉ®úEòÉ® ¦ÉÉ®úiÉ ºÉ®úEòÉ®ú Addl. Secretary & F.A, Ministry of Health & Family Welfare, Joint Secretary, Ministry of Health & Family Welfare, Government of India Government of India b÷Éìì. ¤ÉɤÉÖ iÉÉä¨ÉºÉ ¸ÉÒ ®úÉEäò¶É |ɺÉÉnù JÉhbä÷±É´ÉÉ±É b÷Éì. Eäò.+É®.úBºÉ. EÞò¹hÉxÉ Dr. Babu Thomas Shri Rakesh Prasad Khandelwal Dr. K.R.S. Krishnan x…n‰˘∂…EÚ ( ¥…{…h…x…) x…n‰˘∂…EÚ ( ¥…k…) x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) Director (Marketing) Director (Finance) Director (Technical & Operations) ¸ÉÒ Eäò. ¨ÉÉä½þxÉnùÉºÉ ¸ÉÒ ºÉÆVÉÒ´É Eò{ÉÚ®ú b÷Éì. +É®úiÉÒ Ê´ÉVÉ Shri K. Mohandas Shri Sanjiv Kapoor Dr. Aarti Vij M…ËÆ˙-∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ x…n‰˘∂…EÚ M…ËÆ˙-∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ x…n‰˘∂…EÚ M…ËÆ˙-∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ x…n‰˘∂…EÚ Non-Official Part-time Director Non-Official Part-time Director Non-Official Part-time Director ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 6 7 ∏…“ ±…¥… ¥…®……«, +…<« B B∫…, ∫… S…¥…, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ x…‰ 28 +M…∫i… 2014 EÚ…‰ BS…B±…B±… E‰Ú x…M… ®…i…ı ®…÷J™……±…™…, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… x…®……«h… EÚÆ˙ Æ˙Ω‰˛ x…B ®…EÚ…x… EÚ… +…v……Æ˙ ∂…±…… b˜…±……˛* Mr. Lov Verma, I.A.S, Secretary, Ministry of Health and Family Welfare, Government of India laid the foundation stone of the new building constructing at HLL’s Corporate Head Office in Thiruvananthapuram, Kerala on 28 August, 2014. b˜…Ï. Ω˛π…« ¥…v…«x…, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ∫…∆P… ®…∆j…“, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ x…‰ 19 ∫…i…∆§…Æ˙ 2014 EÚ…‰ BS…B±…B±… +…CE÷Ú±…®… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®…, E‰ÚÆ˙±… ®… n˘…ËÆ˙… EÚ™……* Dr. Harsh Vardhan, Minister for Health and Family Welfare, Government of India made his visit to HLL Akkulam Factory in Thiruvananthapuram, Kerala on 19 September 2014. ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 8 ∏…“ ±…¥… ¥…®……«, ∫… S…¥…, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ +…ËÆ˙ BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, b˜…Ï.B®…. +™™…{{…x… 21 ®……S…« 2014 EÚ…‰ EÂÚp˘“™… ∫……¥…«V… x…EÚ =t®… E‰Ú ∫…∂…HÚ“EÚÆ˙h… ∫…÷EÚÆ˙ §…x……x…‰ +…ËÆ˙ x…π{……n˘x… ∫i…Æ˙ §…g¯…x…‰ E‰Ú ±…B ∫…®…Z……Ëi…… Y……{…x… EÚ… +…n˘…x… |…n˘…x… EÚÆ˙i…‰ Ω˲∆* Mr. Lov Verma, Secretary, Ministry of Health & Family Welfare, Government of India, and HLL C&MD Dr. M. Ayyappan exchange Memorandum of Understanding to facilitate empowerment and enhance performance levels of Central Public Sector Enterprises on 21 March 2014. ∏…“ ±…¥… ¥…®……«, +…<« B B∫…, ∫… S…¥…, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ x…‰ 28 +M…∫i… 2014 EÚ…‰ BS…B±…B±… E‰Ú x…M… ®…i…ı ®…÷J™……±…™…, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… x…®……«h… EÚÆ˙ Æ˙Ω‰˛ x…B ®…EÚ…x… EÚ… +…v……Æ˙ ∂…±…… b˜…±……˛* Mr. Lov Verma, I.A.S, Secretary, Ministry of Health and Family Welfare, Government of BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, b˜…Ï.B®….+™™…{{…x…, Æ˙∫……™…x… B¥…∆ =¥…«Æ˙EÚ ∫…∆P… ®…∆j…“, ∏…“ +…x…∆i… E÷Ú®……Æ˙ EÚ“ ={…Œ∫l… i… ®… Æ˙∫……™…x… B¥…∆ India laid the foundation stone of the new building constructing at HLL’s Corporate =¥…«Æ˙EÚ Æ˙…V™… ®…∆j…“, ∏…“ x…Ω˛…±…S…∆n˘ ®…‰P…¥……±… ∫…‰ |……Ët…‰ M…EÚ“ x…¥……S……Æ˙ E‰Ú Head Office in Thiruvananthapuram, Kerala on 28 August, 2014. ±…B Æ˙…π]≈ı“™… {…÷Æ˙∫EÚ…Æ˙ |……{i… EÚÆ˙i…‰ ΩÈ˛* {…÷Æ˙∫EÚ…Æ˙ ∫…®……Æ˙…‰Ω˛ 17 V…÷±……<« 2014 EÚ…‰ x…<« n˘±±…“ ®… +…™……‰ V…i… EÚ“ M…<«* HLL Chairman and Managing Director Dr. M. Ayyappan receives the National Award for Technology Innovation from Minister of State for Chemicals and Fertilizers, Mr. Nihalchand Meghwal, in the presence of Union Minister for Chemicals & Fertilizers Mr. Ananth Kumar. The award function was held on 17 July 2014 in New Delhi. ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ∫…∆v… ®…∆j…“, b˜…Ï. Ω˛π…« ¥…v…«x… x…‰ 19 ∫…i…∆§…Æ˙ 2014 EÚ…‰ BS…B±…B±… {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®…, E‰ÚÆ˙±… EÚ… ∫…∆n˘∂…«x… EÚ™……* Union Minister for Health and Family Welfare, b˜…Ï. Ω˛π…« ¥…v…«x…, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ∫…∆P… ®…∆j…“, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ x…‰ 19 ∫…i…∆§…Æ˙ 2014 EÚ…‰ BS…B±…B±… +…CE÷Ú±…®… °ËÚC]ıÆ˙“, Dr. Harsh Vardhan visited HLL Peroorkkada i…Ø˚¥…x…∆i…{…÷Æ˙®…, E‰ÚÆ˙±… ®… n˘…ËÆ˙… EÚ™……* Factory in Thiruvananthapuram, Kerala on 19 September 2014. Dr. Harsh Vardhan, Minister for Health and Family Welfare, Government of India made his visit to HLL Akkulam Factory in Thiruvananthapuram, Kerala on 19 September 2014. ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 8 9 i… ®…±…x……b÷˜ ∫…Æ˙EÚ…Æ˙ x…‰ i… ®…±…x……b÷˜ ®… x…<« {… Æ˙™……‰V…x……+… EÚ“ ∫l……{…x…… E‰Ú ±…B 16 E∆Ú{… x…™…… ®… ∫…‰ BEÚ E‰Ú ∞¸{… ®… BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb ˜(BS… §…“ B±…) EÚ…‰ S…÷x… ±…™…… Ω˲* =∫…“ E‰Ú ±…B BEÚ ∫…®…Z……Ëi…… Y……{…x… i… ®…±…x……b÷˜ ®…÷J™…®…∆j…“, b˜…Ï. V…‰. V…™…±… ±…i…… E‰Ú ∫…®…I… Ω˛∫i……I…Æ˙ EÚ™…… l……˛* Government of Tamil Nadu has chosen HLL Biotech Ltd (HBL) as one of the 16 companies to set up new projects in Tamil Nadu. A MoU for the same was inked in the presence of Tamil Nadu Chief Minister Dr J. Jayalalitha. BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, b˜…Ï. B®…. +™™…{{…x… 25 +M…∫i…, 2013 EÚ…‰ {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… B±… Bx… V…“ ∫]ı…‰Æ‰˙V… +…ËÆ˙ Æ˙-M…Ë ∫… °ÚE‰Ú∂…x… ∫…÷ ¥…v…… E‰Ú ±…B +…v……Æ˙ ∂…±…… EÚ… +x……¥…Æ˙h… EÚÆ˙ Æ˙Ω‰˛ ΩÈ˛* HLL C&MD Dr. M. Ayyappan unveiling the foundation stone for LNG storage and re-gasification facility at its Peroorkada Factory in Thiruvananthapuram on 25 August, 2013. ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±…, x…n‰˘∂…EÚ ( ¥…k…), <∆ b˜™…x… <∆Œ∫]ı]ı⁄]ı +…Ï°Ú <∆V…“ x…™…ÀÆ˙M… (+…<« +…<« +…<« <«) u˘…Æ˙… M……‰±b˜ ∏…‰h…“ ®… ±…M……™…‰ M…™…‰ =iEfiÚπ]ı x…π{……n˘x…" B¥……b«˜ 2012 |……{i… EÚÆ˙ Æ˙Ω‰˛ ΩÈ˛* Shri R.P. Khandelwal, Director (Finance) receiving “Performance Excellence Award 2012” instituted by Indian Institute of Industrial Engineering (IIIE) in the Gold Category. ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 10 b˜…Ï. E‰Ú.+…Æ˙.B∫… EfiÚπh…x…, x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…), BS…B±…B±… E‰Ú ∫…“ B∫… +…Æ˙ EÚ…™…«GÚ®… E‰Ú ¶……M… E‰Ú ∞¸{… ®… 22 ®……S…« EÚ…‰ |……l… ®…EÚ ∫¥……∫l™… EÂÚp˘, EÚÆ˙E÷Ú±…®… M……ƒ¥…, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… +…™……‰ V…i… x…:∂…÷±EÚ ®…‰ b˜EÚ±… EÈÚ{… EÚ… =n¬˘P……]ıx… EÚÆ˙ Æ˙Ω‰˛ ΩÈ˛* Dr. K.R.S Krishnan, Director (Technical & Operations) inaugurating the free medical camp organised by HLL as part of its CSR programme at the Primary Health Centre in Karakulam village in Thiruvananthapuram on 22 March. i… ®…±…x……b÷˜ ∫…Æ˙EÚ…Æ˙ x…‰ i… ®…±…x……b÷˜ ®… x…<« {… Æ˙™……‰V…x……+… EÚ“ ∫l……{…x…… E‰Ú ±…B 16 E∆Ú{… x…™…… ®… ∫…‰ BEÚ E‰Ú ∞¸{… ®… BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb ˜(BS… §…“ B±…) EÚ…‰ S…÷x… ±…™…… Ω˲* =∫…“ E‰Ú ±…B BEÚ ∫…®…Z……Ëi…… Y……{…x… i… ®…±…x……b÷˜ ®…÷J™…®…∆j…“, b˜…Ï. V…‰. V…™…±… ±…i…… E‰Ú ∫…®…I… Ω˛∫i……I…Æ˙ EÚ™…… l……˛* Government of Tamil Nadu has chosen HLL Biotech Ltd (HBL) as one of the 16 companies to set up new projects b˜…Ï. {…⁄h…«À±…M…®…, ¶…⁄i…{…⁄¥…« +…<« B B∫… + v…EÚ…Æ˙“ +…ËÆ˙ BS…B±…B±… E‰Ú in Tamil Nadu. A MoU for the same was inked in the presence +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, b˜…Ï. B®…. +™™…{{…x… n˘…‰x…… x…‰ ∫…∆™…÷HÚ ∞¸{… of Tamil Nadu Chief Minister Dr J. Jayalalitha. ∫…‰ BS…B±…B±… +EÚ…n˘®…“ u˘…Æ˙… +…™……‰ V…i… |……{…h… |…§…∆v…x… {…Æ˙ +∆i…Æ˙…«π]≈ı“™… |… ∂…I…h… EÚ…™…«GÚ®… EÚ… =n¬˘P……]ıx… EÚ™……* Dr. Poornalingam, former IAS Officer and HLL C&MD Dr. M Ayyappan jointly inaugurated the International Training Programme on Procurement Management organised by HLL Academy. BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, b˜…Ï. B®…. +™™…{{…x… 25 +M…∫i…, 2013 EÚ…‰ {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… B±… Bx… V…“ ∫]ı…‰Æ‰˙V… +…ËÆ˙ Æ˙-M…Ë ∫… °ÚE‰Ú∂…x… ∫…÷ ¥…v…… E‰Ú ±…B +…v……Æ˙ ∂…±…… EÚ… +x……¥…Æ˙h… EÚÆ˙ Æ˙Ω‰˛ ΩÈ˛* HLL C&MD Dr. M. Ayyappan unveiling the foundation stone for LNG storage and re-gasification facility at its Peroorkada Factory in Thiruvananthapuram on 25 August, 2013. ∏…“ M…÷±……®… x…§…“ +…W……n˘, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j…“, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ 02 ®……S…« 2014 EÚ…‰ + J…±… ¶……Æ˙i…“™… +…™…÷Ã¥…Y……x… ∫…∆∫l…… (B +…<« +…<« B®… B∫…), x…<« n˘±±…“ ®… BS…B±…B±… ±……<°ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ u˘…Æ˙… ∫…∆∫l…… {…i… x…:∂…÷±EÚ ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±…, x…n‰˘∂…EÚ ( ¥…k…), <∆ b˜™…x… <∆Œ∫]ı]ı⁄]ı +…Ï°Ú V…‰x… Æ˙EÚ °Ú…®…«∫…“ EÚ… =n¬˘P……]ıx… EÚÆ˙ Æ˙Ω‰˛ ΩÈ˛* <∆V…“ x…™…ÀÆ˙M… (+…<« +…<« +…<« <«) u˘…Æ˙… M……‰±b˜ ∏…‰h…“ ®… ±…M……™…‰ M…™…‰ =iEfiÚπ]ı x…π{……n˘x…" B¥……b«˜ 2012 |……{i… EÚÆ˙ Æ˙Ω‰˛ ΩÈ˛* Mr. Ghulam Nabi Azad, Minister for Health and Family Welfare, Government of India Shri R.P. Khandelwal, Director (Finance) receiving inaugurating the Free Generic Pharmacy “Performance Excellence Award 2012” instituted by set up by HLL Lifecare Ltd at All India Indian Institute of Industrial Engineering (IIIE) in the Gold Institute of Medical Sciences (AIIMS), New Category. Delhi on 02 March, 2014. ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 10 11 E‰ÚÆ˙±… E‰Ú ∫…®®……x…x…“™… Æ˙…V™…{……±…, ∏…“ x… J…±… E÷Ú®……Æ˙ 08 +H⁄Ú§…Æ˙ 2013 EÚ…‰ BS…B±…B±… {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… BS…B±…B±… ÀΩ˛n˘“ {…J…¥……c˜… ∫…®……Æ˙…‰Ω˛ EÚ… =n¬˘P……]ıx… EÚÆ˙i…‰ ΩÈ˛* Mr. Nikhil Kumar, Kerala Governor inaugurates HLL Hindi fortnight celebrations at HLL Peroorkada Factory in Thiruvananthapuram on 08 October 2013 b˜…Ï. B®…. +™™…{{…x…, BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ x…‰ 27 x…¥…∆§…Æ˙ 2013 EÚ…‰ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ®… +…B ®…Ë∫…∫…« ∫……®™……∆M…, EÚ…‰ Æ˙™…… E‰Ú |… i… x… v…™…… ∫…‰ BS…B±…B±… E‰Ú <«-]Âıb˜ÀÆ˙M… {……‰]«ı±…, +…Ïx…±…… 2013. ∫…“ B∫… +…Æ˙ E‰Ú ¶……M… E‰Ú ∞¸{… ®…Â, BS…B±…B±… x…‰ 25 +M…∫i… 2013 EÚ…‰ EÚ¥… b˜™……Æ˙, i…Ø˚¥…x…∆i…{…÷Æ˙®…, E‰ÚÆ˙±… ®… ®……<« ∫…]ı“ x……®…EÚ +{…x…“ BEÚ“EfiÚi… `ˆ…‰∫… +{… ∂…π]ı |…§…∆v…x… {… Æ˙™……‰V…x…… EÚ…‰ ±……∆S… EÚ™……* As part of CSR, HLL launched its integrated solid waste management project called MY CITY at Kowdiar ward in Thiruvananthapuram, Kerala on 25 August 2013 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 12 BS…B±…B±… x…‰ M……‰¥…… Æ˙…V™… E‰Ú ∫¥…… ®…i¥… ¥……±…“ ∫……¥…«V… x…EÚ =t®… E∆Ú{…x…“, M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… E‰ÚÆ˙±… E‰Ú ∫…®®……x…x…“™… Æ˙…V™…{……±…, ∏…“ x… J…±… +…hb˜ °Ú…®…«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ (V…“ B {…“ B±…) E÷Ú®……Æ˙ 08 +H⁄Ú§…Æ˙ 2013 EÚ…‰ BS…B±…B±… {…‰∞¸Æ˙EÚc˜… EÚ“ 74% <ŒC¥…]ı“ |……{i… EÚÆ˙E‰Ú <∫…EÚ…‰ + v…EÚ…Æ˙ ®… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… BS…B±…B±… ÀΩ˛n˘“ ±…™…… Ω˲* BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, {…J…¥……c˜… ∫…®……Æ˙…‰Ω˛ EÚ… =n¬˘P……]ıx… EÚÆ˙i…‰ ΩÈ˛* b˜…Ï. B®…. +™™…{{…x… +…ËÆ˙ ∏…“ B∫….{…“.¶…^ı, B®… b˜“, <« b˜“ ∫…“ ±… ®…]‰ıb˜ 19 ®……S…« 2014 EÚ…‰ + v…O…Ω˛h… Mr. Nikhil Kumar, Kerala Governor {…Æ˙ ∂…‰™…Æ˙ GÚ™… +…ËÆ˙ ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ… EÚÆ˙…Æ˙ EÚ… inaugurates HLL Hindi fortnight ¥… x…®…™… EÚÆ˙i…‰ ΩË∆˛* celebrations at HLL Peroorkada HLL took over Goa Antibiotics and Factory in Thiruvananthapuram on 08 Pharmaceuticals Ltd (GAPL),Goa October 2013 state owned Public Sector Company, by acquiring 74% of its equity. HLL C&MD Dr. M. Ayyappan and Mr. S.P. Bhat, MD, EDC Ltd, exchange Share Purchase & Shareholders’ Agreement on the acquisition on 19 March 2014. BS…B±…B±… °ËÚC]ıÆ˙“ n˘¥…∫… 05.04.2014 EÚ…‰ BS…B±…B±… E‰Ú |…l…®… +v™…I…, ∏…“ EfiÚ{…… x…ÆË˙x…, +…<« B B∫… (∫…‰¥…… x…¥…fik…¬) EÚ“ ={…Œ∫l… i… ®… BS…B±…B±… {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰Ú {……∫… ∫…M…«®… +…Ï b˜]ı…‰ Æ˙™…®… ®… ®…x……™…… M…™……* HLL Factory Day was celebrated on 05.04.2014 at Sargam Auditorium near HLL Peroorkada Factory in Thiruvananthapuram in the presence of HLL’s First Chairman b˜…Ï. B®…. +™™…{{…x…, BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ x…‰ 27 x…¥…∆§…Æ˙ 2013 EÚ…‰ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ®… +…B ®…Ë∫…∫…« ∫……®™……∆M…, EÚ…‰ Æ˙™…… E‰Ú |… i… x… v…™…… ∫…‰ Mr. Kripa Narain, IAS (Rtd). BS…B±…B±… E‰Ú <«-]Âıb˜ÀÆ˙M… {……‰]«ı±…, +…Ïx…±…… 2013. ıb˜…Ï. E‰Ú.+…Æ˙.B∫…. EfiÚπh…x…, x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) BS…B±…B±… +EÚ…n˘®…“ u˘…Æ˙… ±…‰E¬ÚS…Æ˙˙ ∫…“Æ˙“∫… E‰Ú +v…“x… 1 °ÚÆ˙¥…Æ˙“ 2014 EÚ…‰ +…™……‰ V…i… "Àl…EÚ ]ÈıEÚ", "¶… ¥…π™… |……Ët…‰ M…EÚ“" {…Æ ¶……π…h… n‰˘ Æ˙Ω‰˛ ΩÈ˛* Dr. KRS Krishnan, Director (Technical ∫…“ B∫… +…Æ˙ E‰Ú ¶……M… E‰Ú ∞¸{… ®…Â, BS…B±…B±… x…‰ & Operation) delivering talk on 25 +M…∫i… 2013 EÚ…‰ EÚ¥… b˜™……Æ˙, i…Ø˚¥…x…∆i…{…÷Æ˙®…, “Future Technology” organised on E‰ÚÆ˙±… ®… ®……<« ∫…]ı“ x……®…EÚ +{…x…“ BEÚ“EfiÚi… `ˆ…‰∫… +{… ∂…π]ı |…§…∆v…x… {… Æ˙™……‰V…x…… EÚ…‰ ±……∆S… EÚ™……* 1st February 2014 by HLL Academy as a part of “Think Tank” Lecture As part of CSR, HLL launched its series. integrated solid waste management project called MY CITY at Kowdiar ward in Thiruvananthapuram, Kerala on 25 August 2013 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 12 13 nfiŒπ]ıEÚ…‰h…˘/n˘…Ëi™… i…l…… =q‰˘∂™… nfiŒπ]ıEÚ…‰h…˘ x…Æ∆˙i…Æ˙ x…¥……S……Æ˙ E‰Ú W… Æ˙B ∫…∫i…“ B¥…∆ M…÷h…¥…k……¥……±…‰ ∫¥……∫l™… Æ˙I…… ∫…®……v……x… |…n˘…x… EÚÆ˙E‰Ú ∫…®… ¥…Œπ]ı {…Æ˙ ∫…∆EÂÚ p˘i… ¥…∑…∫i…Æ˙“™… ∫…®®…… x…i… ∫…∆M…`ˆx… §…x… V……x……* n˘…Ëi™… EÚ…Ï{……ÊƉ˙]ı o˘Œπ]ıEÚ…‰h… {…⁄Æ˙… EÚÆ˙x…‰ EÚ“ +…‰Æ˙, BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…‰ x…®x… ±… J…i… n˘…Ëi™… =Œ±±… J…i… EÚ™…… Ω˲ V……‰ |…®…÷J… I…‰j…… {…Æ˙ ∫…∆EÂÚ p˘i… ΩÈ˛ : • +∆i…Æ˙…«π]≈ı“™… ®……x…EÚ {…⁄Æ˙… EÚÆ˙x…‰ ¥……±…‰ M…÷h…¥…k……¥……±…‰ =i{……n˘ +…ËÆ˙ ∫…‰¥……Bƒ |…n˘…x… EÚÆ˙x……* • =k…®… |……Ët…‰ M… EÚ™…… +…ËÆ˙ {…r˘ i…™…… EÚ…‰ +{…x……x…‰ ∫…‰ x…Æ∆˙i…Æ˙ ∫…÷v……Æ˙ E‰Ú u˘…Æ˙… =iEfiÚπ]ıi……* • x…¥……S……Æ˙, +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫…, ±……M…i… |…§…∆v…x… +…ËÆ˙ ={…¶……‰HÚ… Æ˙I…… E‰Ú u˘…Æ˙… ={…¶……‰HÚ… +…x…∆n˘ +…ËÆ˙ ®…⁄±™… ∫…fiV…x…* • S…÷x……Ëi…“{…⁄h…« ¥™…¥…∫……™… ¥……i……¥…Æ˙h… EÚ“ +…¥…∂™…EÚi……+… EÚ“ {…⁄i…‘ E‰Ú ±…B ®……x…¥… ∫…∆∫……v…x… ¥…EÚ…∫… {…Æ˙ EÂÚ p˘i… EÚÆ˙x……* • EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… +…ËÆ˙ EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… E‰Ú =SS…i…®… ®……x…EÚ §…x……B Æ˙J…x…‰ E‰Ú u˘…Æ˙… ∫……®…… V…EÚ ∞¸{… ∫…‰ |… i…§…r˘ EÚ…Ï{……ÊƉ˙]ı §…x… V……x……* • Ω˛Æ˙“˙ {…Ω˛±… +…ËÆ˙ v……Æ˙h…“™… ¥…EÚ…∫… E‰Ú |……‰z…®…x… E‰Ú W… Æ˙B {…fil¥…“ ®……ƒ EÚ“ ¶…±……<« +…ËÆ˙ ¶… ¥…π™… {…“ f¯™…… E‰Ú ±…B |… i…§…r˘ Æ˙Ω˛x……* =n‰∂™… • =SS… M…÷h…¥…k…… ±……M…i… |… i…™……‰M…“ E‰Ú ∫……l… |…S……±…x… EÚ“ i¥… Æ˙i… ¥…fi r˘ +…ËÆ˙ M±……‰§…±… ∫i…Æ˙ Ω˛… ∫…±… EÚÆ˙x…… +…ËÆ˙ |…i™…‰EÚ ®…÷J™… =i{……n˘ ∏…‰h…“ ®… ®…÷J™… i…“x… J…±…… b˜™…… ®… BEÚ §…x… V……x……* • +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… {…Ω˛±… E‰Ú W… Æ˙B x…Æ∆˙i…Æ˙˙ x…¥……S……Æ˙ EÚ“ ∫…∆∫EfiÚ i… §…x……x……* • 90% ∫…‰ + v…EÚ EÚ®…«S……Æ˙“ ∫…∆i…÷Œπ]ı ∫i…Æ˙ E‰Ú ∫……l… ¶……Æ˙i… ®… ¥…EÚ±{… E‰Ú x…™……‰HÚ… Æ˙Ω˛x…‰ E‰Ú ±…B |…™……∫… EÚÆ˙x……* • ∫…®……V… EÚ…‰ |… i…§…r˘i…… E‰Ú ∫……l… {…÷x…Ø˚i{……n˘x… B¥…∆ ®… Ω˛±…… ∫¥……∫l™… Æ˙I…… E‰Ú I…‰j… ®… +O…h…“ ∫……®…… V…EÚ ∫…∆M…`ˆx… E‰Ú ∞¸{… ®… ®……x™…i…… |……{i… EÚÆ˙x…… - ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 14 nfiŒπ]ıEÚ…‰h…˘/n˘…Ëi™… i…l…… =q‰˘∂™… VISION/MISSION & OBJECTIVES nfiŒπ]ıEÚ…‰h…˘ VISION x…Æ∆˙i…Æ˙ x…¥……S……Æ˙ E‰Ú W… Æ˙B ∫…∫i…“ B¥…∆ M…÷h…¥…k……¥……±…‰ ∫¥……∫l™… Æ˙I…… ∫…®……v……x… |…n˘…x… EÚÆ˙E‰Ú ∫…®… ¥…Œπ]ı {…Æ˙ ∫…∆EÂÚ p˘i… ¥…∑…∫i…Æ˙“™… ∫…®®…… x…i… ∫…∆M…`ˆx… §…x… V……x……* To be a globally respected organisation, focusing on inclusiveness by providing affordable and quality healthcare solutions through continuous innovation. n˘…Ëi™… MISSION EÚ…Ï{……ÊƉ˙]ı o˘Œπ]ıEÚ…‰h… {…⁄Æ˙… EÚÆ˙x…‰ EÚ“ +…‰Æ˙, BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…‰ x…®x… ±… J…i… n˘…Ëi™… =Œ±±… J…i… EÚ™…… Ω˲ V……‰ |…®…÷J… I…‰j…… {…Æ˙ To accomplish the Corporate Vision, HLL Lifecare Ltd has outlined following Mission which focus on six key areas: ∫…∆EÂÚ p˘i… ΩÈ˛ : • Provide quality products and services meeting international standards. • +∆i…Æ˙…«π]≈ı“™… ®……x…EÚ {…⁄Æ˙… EÚÆ˙x…‰ ¥……±…‰ M…÷h…¥…k……¥……±…‰ =i{……n˘ +…ËÆ˙ ∫…‰¥……Bƒ |…n˘…x… EÚÆ˙x……* • Excellence through continual improvement by adoption of best technologies and practices. • =k…®… |……Ët…‰ M… EÚ™…… +…ËÆ˙ {…r˘ i…™…… EÚ…‰ +{…x……x…‰ ∫…‰ x…Æ∆˙i…Æ˙ ∫…÷v……Æ˙ E‰Ú u˘…Æ˙… =iEfiÚπ]ıi……* • Customer delight and value creation through innovation, R & D, cost management and customer • x…¥……S……Æ˙, +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫…, ±……M…i… |…§…∆v…x… +…ËÆ˙ ={…¶……‰HÚ… Æ˙I…… E‰Ú u˘…Æ˙… ={…¶……‰HÚ… +…x…∆n˘ +…ËÆ˙ ®…⁄±™… ∫…fiV…x…* care. • S…÷x……Ëi…“{…⁄h…« ¥™…¥…∫……™… ¥……i……¥…Æ˙h… EÚ“ +…¥…∂™…EÚi……+… EÚ“ {…⁄i…‘ E‰Ú ±…B ®……x…¥… ∫…∆∫……v…x… ¥…EÚ…∫… {…Æ˙ EÂÚ p˘i… EÚÆ˙x……* • Focusing on human resource development to meet the needs of challenging business environment. • EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… +…ËÆ˙ EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… E‰Ú =SS…i…®… ®……x…EÚ §…x……B Æ˙J…x…‰ E‰Ú u˘…Æ˙… ∫……®…… V…EÚ ∞¸{… ∫…‰ • Be a socially committed corporate by maintaining highest standards of corporate governance and |… i…§…r˘ EÚ…Ï{……ÊƉ˙]ı §…x… V……x……* corporate social responsibility. • • Ω˛Æ˙“˙ {…Ω˛±… +…ËÆ˙ v……Æ˙h…“™… ¥…EÚ…∫… E‰Ú |……‰z…®…x… E‰Ú W… Æ˙B {…fil¥…“ ®……ƒ EÚ“ ¶…±……<« +…ËÆ˙ ¶… ¥…π™… {…“ f¯™…… E‰Ú ±…B |… i…§…r˘ Æ˙Ω˛x……* Committed to the well-being of mother earth and future generations through green initiatives and promotion of sustainable development. =n‰∂™… OBJECTIVES • =SS… M…÷h…¥…k…… ±……M…i… |… i…™……‰M…“ E‰Ú ∫……l… |…S……±…x… EÚ“ i¥… Æ˙i… ¥…fi r˘ +…ËÆ˙ M±……‰§…±… ∫i…Æ˙ Ω˛… ∫…±… EÚÆ˙x…… +…ËÆ˙ |…i™…‰EÚ ®…÷J™… =i{……n˘ The company will strive to fulfill its vision/mission by ∏…‰h…“ ®… ®…÷J™… i…“x… J…±…… b˜™…… ®… BEÚ §…x… V……x……* • Attaining rapid growth and global levels of operations with high quality cost competitiveness and be • +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… {…Ω˛±… E‰Ú W… Æ˙B x…Æ∆˙i…Æ˙˙ x…¥……S……Æ˙ EÚ“ ∫…∆∫EfiÚ i… §…x……x……* among the top three players in each main product category. • Create a culture of continuous innovation through R& D initiatives. • 90% ∫…‰ + v…EÚ EÚ®…«S……Æ˙“ ∫…∆i…÷Œπ]ı ∫i…Æ˙ E‰Ú ∫……l… ¶……Æ˙i… ®… ¥…EÚ±{… E‰Ú x…™……‰HÚ… Æ˙Ω˛x…‰ E‰Ú ±…B |…™……∫… EÚÆ˙x……* • • ∫…®……V… EÚ…‰ |… i…§…r˘i…… E‰Ú ∫……l… {…÷x…Ø˚i{……n˘x… B¥…∆ ®… Ω˛±…… ∫¥……∫l™… Æ˙I…… E‰Ú I…‰j… ®… +O…h…“ ∫……®…… V…EÚ ∫…∆M…`ˆx… E‰Ú ∞¸{… ®… ®……x™…i…… Strive to be the employer of choice in India with employee satisfaction levels of over 90%. |……{i… EÚÆ˙x…… - ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 14 15 M…÷h…¥…k…… x…“ i… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ |… i…§…r˘ Ω˲ : • ±……‰M…… EÚ…‰ ∫¥…∫l… B¥…∆ ∫…÷J…“ V…“¥…x… ∫…®…l…« EÚÆ˙x…‰, +∆i…Æ˙…«π]≈ı“™… ®……x…EÚ E‰Ú +x…÷∞¸{… ∫…®… ¥…Œπ]ı {…Æ˙ ∫…∆E‰ÚŒxp˘i… EÚ°Ú…™…i…“ ∫¥……∫l™… Æ˙I…… ∫…®……v……x… |…n˘…x… EÚÆ˙x……* • ∫…¶…“ I…‰j…… ®… =k…®… |……Ët…‰ M…EÚ“ +…ËÆ˙ {…r˘ i…™……ƒ +{…x……x…‰ u˘…Æ˙… ±…M……i……Æ˙ =z… i… E‰Ú W… Æ˙B ∫…∆M…`ˆx……i®…EÚ ∏…‰π`ˆi…… ={…±…§v… EÚÆ˙x……* • x…¥……x¥…‰π…h…, M…÷h…¥…k…… i…l…… +x…÷∫…∆v……x… ¥… ¥…EÚ…∫…, ±……M…i… |…§…∆v…x… i…l…… O……Ω˛EÚ ∫…∆§…∆v… |…§…∆v…x… {…Æ˙ °Ú…‰EÚ∫… EÚÆ˙E‰Ú O……Ω˛EÚ…Â E‰Ú ±…B ∫……¥…«¶……Ë ®…EÚ i……ËÆ˙ {…Æ˙ n‰˘x…‰ ¥……±…‰ =SS… ®…⁄±™…¥……±…‰ =i{……n˘ ¥… ∫…‰¥……Bƒ ¥…{…h…x… EÚÆ˙x……* • ∫……®…⁄ Ω˛EÚ + ¶…∂……∫…x… i…l…… ∫……®…⁄ Ω˛EÚ ∫……®…… V…EÚ n˘… ™…i¥… ∫…‰ ™…÷HÚ =SS…i…®… ®……x…EÚ…Â EÚ…‰ {…⁄Æ˙… EÚÆ˙x…‰¥……±…‰ ∫…∆M…`ˆx… §…x…x……* ∫…÷Æ˙I……, ∫¥……∫l™… B¥…∆ {…™……«¥…Æ˙h… x…“ i… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…®x… ±… J…i… E‰Ú W… Æ˙B {…™……«¥…Æ˙h… E‰Ú ∫…∆Æ˙I…h… EÚÆ˙x…‰, ¥™…¥…∫…… ™…EÚ V……‰ J…®…… EÚ…‰ n⁄˘Æ˙ EÚÆ˙x…‰ +…ËÆ˙ EÚ®…«S…… Æ˙™…… +…ËÆ˙ ={… ∫…∆ ¥…n˘…EÚ…Æ˙… EÚ“ ∫…÷Æ˙I…… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B |… i…§…r˘ Ω˲& • +x…¥…Æ˙i… +…v……Æ˙ {…Æ˙ <∫…E‰Ú EÚ…™…«EÚ±……{……Â, =i{……n˘… +…ËÆ˙ ∫…‰¥……+… E‰Ú |…¶……¥… EÚ… +x…÷¥…“I…h… B¥…∆ x…™…∆j…h… EÚÆ˙x……* • ={…™…÷HÚ ¥… v…EÚ B¥…∆ +x™… +{…‰I……+… EÚ… +x…÷{……±…x… EÚÆ˙x……* • ∫……®…… V…EÚ V…¥……§…n‰˘Ω˛“ {…Æ˙ W……‰Æ˙ n‰˘EÚÆ˙ ∫…÷Æ˙ I…i… |…S……±…x… |…l……+… EÚ…‰ +{…x……x……* • EÚ®…«S……Æ˙“ |… ∂…I…h… +…ËÆ˙ =x…E‰Ú O…∫i…i…… ∫…÷∫……v™… §…x……x……* • =ii…®… {…r˘ i…™……ƒ +{…x……x…‰ u˘…Æ˙… |…n⁄˘π…h… EÚ®… EÚÆ˙x……* • ®……±…, >V……« ∫…∆Æ˙ I…i… Æ˙J…x…… +…ËÆ˙ Æ˙ q˘™…… EÚ…‰ "ª……‰i… {…Æ˙ EÚ®… EÚÆ˙x…… +…ËÆ˙ x…¥…“EÚÆ˙h…“™… >V……«"ª……‰i…… E‰Ú |…™……‰M… §…f¯…x……* • ∫…÷Æ˙I……, ∫¥……∫l™… B¥…∆ {…™……«¥…Æ˙h… |…§…∆v…x… |…h……±…“ EÚ“ +…¥… v…EÚ ∫…®…“I……* |…™……‰M…∂……±…… M…÷h…¥…k…… x…“ i… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ |… i…§…r˘ Ω˲ : • Æ˙…π]≈ı“™…/+∆i…Æ˙…«π]≈ı“™… ®……x…EÚ…Â EÚ“ V……ƒS… |…h……±…“ EÚ… +x…÷{……±…x… EÚÆ˙E‰Ú i…l…… +SU‰Ù ¥™……¥…∫…… ™…EÚ +…S…Æ˙h…… E‰Ú |…™……‰M… u˘…Æ˙… ¥…∑…∫…x…“™…, ∫…÷∫…∆M…i… i…l…… +x…÷®……M…«h…“™… V……ƒS… {… Æ˙h……®… ∫…÷ x…Œ∂S…i… EÚÆ˙x…… * • M…÷h…¥…k…… |…S……±…x… ®… ∫…Œ®®… ±…i… ∫…¶…“ Eڅî…EÚ…Â EÚ…‰ +…<« B∫… +…‰/+…<« <« ∫…“ 17025 : 2005 E‰Ú +x…÷∞¸{… |…§…∆v…x… |…h……±…“ EÚ“ x…“ i…™…… +…ËÆ˙ EÚ…™…« ¥… v…™…… E‰Ú ∫……l… ∫…÷{… Æ˙ S…i… §…x……x……, ∫…÷ x…Œ∂S…i… EÚÆ˙x…… i…l…… =∫…EÚ…‰ =x…E‰Ú EÚ…™…« ®… EÚ…™……«Œx¥…i… EÚÆ˙x……* • |…§…∆v…x… |…h……±…“ E‰Ú |…¶…… ¥…i… x…Æ∆˙i…Æ˙ ∫…÷v……Æ˙x…… * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 16 M…÷h…¥…k…… x…“ i… QUALITY POLICY BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ |… i…§…r˘ Ω˲ : HLL Lifecare Limited is committed to: • Provide affordable healthcare solutions focussing on inclusiveness, conforming to international • ±……‰M…… EÚ…‰ ∫¥…∫l… B¥…∆ ∫…÷J…“ V…“¥…x… ∫…®…l…« EÚÆ˙x…‰, +∆i…Æ˙…«π]≈ı“™… ®……x…EÚ E‰Ú +x…÷∞¸{… ∫…®… ¥…Œπ]ı {…Æ˙ ∫…∆E‰ÚŒxp˘i… EÚ°Ú…™…i…“ ∫¥……∫l™… Æ˙I…… ∫…®……v……x… |…n˘…x… standards, enabling people to lead healthy and happy lives; EÚÆ˙x……* • Achieve organisational excellence through continual improvement by adoption of best technologies • ∫…¶…“ I…‰j…… ®… =k…®… |……Ët…‰ M…EÚ“ +…ËÆ˙ {…r˘ i…™……ƒ +{…x……x…‰ u˘…Æ˙… ±…M……i……Æ˙ =z… i… E‰Ú W… Æ˙B ∫…∆M…`ˆx……i®…EÚ ∏…‰π`ˆi…… ={…±…§v… EÚÆ˙x……* and practices in all areas; • Market products and services globally delivering highest value for customers through focus on innovation, • x…¥……x¥…‰π…h…, M…÷h…¥…k…… i…l…… +x…÷∫…∆v……x… ¥… ¥…EÚ…∫…, ±……M…i… |…§…∆v…x… i…l…… O……Ω˛EÚ ∫…∆§…∆v… |…§…∆v…x… {…Æ˙ °Ú…‰EÚ∫… EÚÆ˙E‰Ú O……Ω˛EÚ…Â E‰Ú ±…B quality, R&D, cost management and customer relationship management; ∫……¥…«¶……Ë ®…EÚ i……ËÆ˙ {…Æ˙ n‰˘x…‰ ¥……±…‰ =SS… ®…⁄±™…¥……±…‰ =i{……n˘ ¥… ∫…‰¥……Bƒ ¥…{…h…x… EÚÆ˙x……* • Be an organisation meeting highest standards in Corporate Governance and Corporate Social • ∫……®…⁄ Ω˛EÚ + ¶…∂……∫…x… i…l…… ∫……®…⁄ Ω˛EÚ ∫……®…… V…EÚ n˘… ™…i¥… ∫…‰ ™…÷HÚ =SS…i…®… ®……x…EÚ…Â EÚ…‰ {…⁄Æ˙… EÚÆ˙x…‰¥……±…‰ ∫…∆M…`ˆx… §…x…x……* Responsibility. SHE POLICY ∫…÷Æ˙I……, ∫¥……∫l™… B¥…∆ {…™……«¥…Æ˙h… x…“ i… HLL Lifecare Limited is committed to protect environment, eliminate occupational hazards and ensure BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…®x… ±… J…i… E‰Ú W… Æ˙B {…™……«¥…Æ˙h… E‰Ú ∫…∆Æ˙I…h… EÚÆ˙x…‰, ¥™…¥…∫…… ™…EÚ V……‰ J…®…… EÚ…‰ n⁄˘Æ˙ EÚÆ˙x…‰ +…ËÆ˙ EÚ®…«S…… Æ˙™…… safety of employees & subcontractors through: +…ËÆ˙ ={… ∫…∆ ¥…n˘…EÚ…Æ˙… EÚ“ ∫…÷Æ˙I…… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B |… i…§…r˘ Ω˲& • Monitoring and control of the impact of its activities, products and services on a continual basis; • +x…¥…Æ˙i… +…v……Æ˙ {…Æ˙ <∫…E‰Ú EÚ…™…«EÚ±……{……Â, =i{……n˘… +…ËÆ˙ ∫…‰¥……+… E‰Ú |…¶……¥… EÚ… +x…÷¥…“I…h… B¥…∆ x…™…∆j…h… EÚÆ˙x……* • Compliance of applicable legal and other requirements; • ={…™…÷HÚ ¥… v…EÚ B¥…∆ +x™… +{…‰I……+… EÚ… +x…÷{……±…x… EÚÆ˙x……* • Adopting safe operating practices with an emphasis on social accountability. • ∫……®…… V…EÚ V…¥……§…n‰˘Ω˛“ {…Æ˙ W……‰Æ˙ n‰˘EÚÆ˙ ∫…÷Æ˙ I…i… |…S……±…x… |…l……+… EÚ…‰ +{…x……x……* • Facilitating employee training and their involvement; • EÚ®…«S……Æ˙“ |… ∂…I…h… +…ËÆ˙ =x…E‰Ú O…∫i…i…… ∫…÷∫……v™… §…x……x……* • Pollution mitigation through adoption of best practices; • • =ii…®… {…r˘ i…™……ƒ +{…x……x…‰ u˘…Æ˙… |…n⁄˘π…h… EÚ®… EÚÆ˙x……* Conserving materials, energy and reducing waste at source, and/ encouraging usage of renewable energy sources; • ®……±…, >V……« ∫…∆Æ˙ I…i… Æ˙J…x…… +…ËÆ˙ Æ˙ q˘™…… EÚ…‰ "ª……‰i… {…Æ˙ EÚ®… EÚÆ˙x…… +…ËÆ˙ x…¥…“EÚÆ˙h…“™… >V……«"ª……‰i…… E‰Ú |…™……‰M… §…f¯…x……* • Periodic review of safety, health and environment management system. • ∫…÷Æ˙I……, ∫¥……∫l™… B¥…∆ {…™……«¥…Æ˙h… |…§…∆v…x… |…h……±…“ EÚ“ +…¥… v…EÚ ∫…®…“I……* LAB QUALITY POLICY |…™……‰M…∂……±…… M…÷h…¥…k…… x…“ i… HLL Lifecare Limited is committed to: BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ |… i…§…r˘ Ω˲ : • Ensure reliable, consistent and traceable results of testing by using test methods complying to national / international standards and by following good professional practices. • Æ˙…π]≈ı“™…/+∆i…Æ˙…«π]≈ı“™… ®……x…EÚ…Â EÚ“ V……ƒS… |…h……±…“ EÚ… +x…÷{……±…x… EÚÆ˙E‰Ú i…l…… +SU‰Ù ¥™……¥…∫…… ™…EÚ +…S…Æ˙h…… E‰Ú |…™……‰M… u˘…Æ˙… ¥…∑…∫…x…“™…, ∫…÷∫…∆M…i… i…l…… • +x…÷®……M…«h…“™… V……ƒS… {… Æ˙h……®… ∫…÷ x…Œ∂S…i… EÚÆ˙x…… * Ensure that all personnel involved in the testing operations familiarize with the policies and procedures of the management system conforming to ISO/IEC 17025 : 2005 and implement the same in their works. • M…÷h…¥…k…… |…S……±…x… ®… ∫…Œ®®… ±…i… ∫…¶…“ Eڅî…EÚ…Â EÚ…‰ +…<« B∫… +…‰/+…<« <« ∫…“ 17025 : 2005 E‰Ú +x…÷∞¸{… |…§…∆v…x… |…h……±…“ EÚ“ x…“ i…™…… +…ËÆ˙ • Continually improve the effectiveness of the management system. EÚ…™…« ¥… v…™…… E‰Ú ∫……l… ∫…÷{… Æ˙ S…i… §…x……x……, ∫…÷ x…Œ∂S…i… EÚÆ˙x…… i…l…… =∫…EÚ…‰ =x…E‰Ú EÚ…™…« ®… EÚ…™……«Œx¥…i… EÚÆ˙x……* • |…§…∆v…x… |…h……±…“ E‰Ú |…¶…… ¥…i… x…Æ∆˙i…Æ˙ ∫…÷v……Æ˙x…… * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 Annual Report 2013-2014 16 17 +v™…I… EÚ… ¶……π…h… |…™… ∂…‰™…Æ˙v……Æ˙EÚ…‰∆, ®…È ¥…π…« 2013-14 E‰Ú ±…B BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú 48¥…” ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ ®… +…{…EÚ… ∫¥……M…i… EÚÆ˙i…… Ω⁄ƒ˛ * +…{…EÚ“ +x…÷®… i… ∫…‰, ®…È +…{…E‰Ú ∫…®…I… ¥……Ãπ…EÚ Æ˙{……‰]«ı 2013-14 |…∫i…÷i… EÚÆ˙i…… Ω⁄ƒ˛, V……‰ S…÷x……Ë i…™…… +…ËÆ˙ +¥…∫…Æ˙… E‰Ú ∫……l…-∫……l… +…{…EÚ“ E∆Ú{…x…“ E‰Ú x…π{……n˘x… E‰Ú §…Ω÷˛i… ¥™……{…EÚ +…ËÆ˙ ¥…∫i…fii… ¥…∂±…‰π…h… +…{…EÚ…‰ n‰˘i…… Ω˲ * ¥…k…“™… ¥…π…« 2013-14 §…Ω÷˛i… S…÷x……Ëi…“{…⁄h…« ¥…k… ¥…π…« Æ˙Ω˛… Ω˲ * ¥…π…« E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ u˘…Æ˙… ∫…∆¶……±…‰ E÷Ú±… ¥™……{……Æ˙ `1590 EÚÆ˙…‰c˜ Ω˲ * n‰˘∂… E‰Ú ∫……v……Æ˙h… +…Ãl…EÚ ¥…EÚ…∫… E‰Ú §……¥…V…⁄n˘, +…{…EÚ“ E∆Ú{…x…“ +{…x…“ |…M… i… E‰Ú ±…I™… ®…Â, {…UÙ±…‰ ¥…π…« ®… |……{i… ` 832.94 E‰Ú ¥™……{……Æ˙…¥…k…« EÚ“ i…÷±…x…… ®… ` 941.68 EÚÆ˙…‰c˜ E‰Ú ¥™……{……Æ˙…¥…k…« ®… 13% ¥…fi r˘ |……{i… EÚÆ˙x…‰ ®… ∫…I…®… §…x… M…™…“ l…“ * <∫…E‰Ú + i… Æ˙HÚ, +…{…EÚ“ E∆Ú{…x…“ ` 36.21 EÚÆ˙…‰c˜ E‰Ú EÚÆ˙ E‰Ú {…⁄¥…« ®…Ω˛i¥…{…⁄h…« ±……¶… {……‰∫]ı EÚÆ˙x…‰ ®… EÚ…®…™……§… §…x… M…™…“ * §……‰b«˜ x…‰ ` 65.79 ±……J… E‰Ú ±……¶……∆∂… ¥…i…Æ˙h… EÚÆ˙ ∫… Ω˛i… ` 452.86 ±……J… E‰Ú ∫…®……x… ±……¶……∆∂… ¶…÷M…i……x… EÚ… +x…÷Æ˙I…h… EÚÆ˙E‰Ú ¥…k…“™… ¥…π…« E‰Ú ±…B E∆Ú{…x…“ E‰Ú |…n˘k… <ŒC¥…]ı“ ∂…‰™…Æ˙ {…⁄ƒV…“ {…Æ˙ ` 20.00 E‰Ú ±……¶……∆∂… EÚ“ ∫…°Ú… Æ˙∂… EÚ“ Ω˲ * +…{…EÚ“ E∆Ú{…x…“ E‰Ú ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… EÚ“ ®…÷J™… ={…±…Œ§v…™……ƒ ΩÈ˛ :- • ®……S…« 2014 EÚ…‰ ®…‰∫…∫…« M……‰¥…… B∆ ]ı§……™……‰ ]ıC∫… Bhb˜ °Ú…®…«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ (V…“ B {…“ B±…), M……‰¥…… ∫…Æ˙EÚ…Æ˙ EÚ… =t®…, E‰Ú 74% <ŒC¥…]ı“ ∂…‰™…Æ˙ EÚ… + v…O…Ω˛h… * • 11.5 ®…±™…x… +n˘n˘ ∫…‰ 12.5 ®…±™…x… +n˘n˘ i…EÚ §±…b˜ §…ËM… =i{……n˘x… I…®…i…… EÚ… ∫…∆¥…v…«x… +…ËÆ˙ ∫…Â]ıGÚ…‰®…‰x… =i{……n˘x… 1500 EÚ.O……®… i…EÚ ∫…∆¥…v…«x… EÚ™…… M…™…… * • B‰Æ˙…{…⁄Æ˙®…, EÚ…‰ŒSS…-E‰ÚÆ˙±… ®… ` 28 EÚÆ˙…‰c˜ E‰Ú E÷Ú±… x…¥…‰∂… E‰Ú ∫……l… 300 ®…±™…x… +n˘n˘ i…EÚ E∆Úb˜…‰®… ¥… x…®……«h… I…®…i…… EÚ… ∫…∆¥…v…«x… * • EÚx…M…±…… °ËÚC]ıÆ˙“, §…‰±…M……®… ®… ` 5.6 EÚÆ˙…‰c˜ {… Æ˙™……‰V…x…… ±……M…i… E‰Ú ∫……l… 120 ®…±™…x… +n˘n˘ i…EÚ E∆Úb˜…‰®… ¥… x…®……«h… I…®…i…… EÚ… ∫…∆¥…v…«x… * • 200 ®…±™…x… +n˘n˘ ∫…‰ 400 ®…±™…x… +n˘n˘ i…EÚ ∫…Ë x…]ıÆ˙“ x…Ë{… EÚx… =i{……n˘x… I…®…i…… EÚ… ∫…∆¥…v…«x… * • §……±…Æ˙…®…{…÷Æ˙®…, E‰ÚÆ˙±… ®… {…ËÀEÚM… +…ËÆ˙ ¶…∆b˜…Æ˙h… ∫…÷ ¥…v……+… EÚ… EÚ®…“∂…Àx…M… * • +…CE÷Ú±…®… °ËÚC]ıÆ˙“, E‰ÚÆ˙±… ®… °ËÚC]ıÆ˙“ ®…EÚ…x… EÚ… x…®……«h… * • BS…B±…B±…-{…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… B±… Bx… V…“ ¶…∆b˜…Æ˙h… +…ËÆ˙ {…÷x…& M…Ë∫…“EÚÆ˙h… ∫…÷ ¥…v…… EÚ… x…®……«h… * • ` 221.46 EÚÆ˙…‰c˜ E‰Ú V…{®…‰Æ˙ °‰Ú∫… IV {… Æ˙™……‰V…x……, ¶……Æ˙i…“™… ∫…⁄S…x…… |……Ë t M…EÚ“ +…ËÆ˙ |…§…∆v…x… ∫…∆∫l……x… E‰ÚÆ˙±… E‰Ú ±…B EËÚ®{…∫… E‰Ú ¥…EÚ…∫… EÚ“ +…‰Æ˙ `1600.00 EÚÆ˙…‰c˜ EÚ“ ±……M…i…, `143.20 EÚÆ˙…‰c˜ E‰Ú ±…B EÚ…‰ŒSS… EÚ…‰ ®…‰ b˜EÚ±… Eڅϱ…‰V… {… Æ˙™……‰V…x……, {…k…x…®… i…^ı…, E‰ÚÆ˙±… EÚ… x…®……«h…, ` 81.05 EÚÆ˙…‰c˜ E‰Ú ±…B {…“ B®… B∫… B∫… ¥……<« n⁄˘∫…Æ˙… S…Æ˙h… E‰Ú +v…“x… i… ®…±…x……b÷˜ ®… ®…l…÷ÆË˙ ®…‰ b˜EÚ±… Eڅϱ…‰V… {… Æ˙™……‰V…x…… EÚ… =z…™…x…, V…Ë∫…“ {… Æ˙™……‰V…x……+… EÚ“ |……Œ{i… * • ®…… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 18 CHAIRMAN’S SPEECH Dear Shareholders, ` I welcome you to the 48th Annual General Meeting of HLL Lifecare Limited for the year 2013-14. With your permission, I present before you the Annual Report 2013-14 that gives you very comprehensive and detailed analysis of your Company’s performance along with the challenges and opportunities. Financial year 2013-14 has been a very challenging fiscal. The total business handled by the Company during the year stood at `1590 Cr. Despite the mediocre economic growth of the country, your company in its pursuit of progress, was able to attain 13% growth in turnover in view of ` 941.68 Cr. turnover achieved as compared with ` 832.94 in the previous year. Moreover, your company managed to post significant Profit Before Tax of ` 36.21 Cr. The Board has recommended a dividend of ` 20.00 per share on the paid-up equity share capital of the Company for the financial year maintaining the same dividend pay out of ` 452.86 lakh inclusive of dividend distribution tax of ` 65.79 lakh. Major achievements of your company during the year 2013-14 include: • Acquisition of 74% equity stake of M/s Goa Antibiotics & Pharmaceuticals Ltd.(GAPL), a Government of Goa undertaking, in March 2014. • Augmentation of Blood Bag production capacity from 11.5 million pieces to 12.5 million pieces &augmented the Centchroman production to 1500 Kg. • Augmentation of Condom production capacity to 300 million pieces at Irapuram, Kochi- Kerala with a total investment of ` 28 Cr. • Augmentation of Condom manufacturing capacity by 120 million pieces at Kanagala Factory, Belgaum involving project cost of ` 5.6 Cr. • Augmentaion of Sanitary napkins production capacity from 200 million pieces to 400 million pieces • Commissioning of packing and storage facilities at Balaramapuram, Kerala • Construction of factory building at Akkulam Factory, Kerala. • Construction of LNG Storage and re-gasification facility at HLL Peroorkada Factory, Thiruvananthapuram • Obtaining projects viz. JIPMER Phase IV project for ` 221.46 Cr.; Project Management consultancy for Development of campus for Indian Institute of Information Technology and Management, Kerala costing `160.00 Cr.; Construction of Konni Medical College project at Pathanamthitta, Kerala for `143.20 Cr.,Upgradation of Madurai Medical College project in Tamil Nadu under PMSSY 2nd phase for `81.05 Cr. • Launched Sutures in foreign territories namely Micronesia, Zambia, Malaysia and Rwanda • Launched MOODS Condoms in countries viz. Algeria, Benin and Zambia. • Development and launch of new products /product variants namely Female and Male condoms branded, “Velvet” and “Feel” respectively; ‘Tatkal 72’- non hormonal emergency contraceptive pill, ‘Hinglact Rapidsorb’ – Sutures, ‘MEDIGARD‘– Disinfectants, ‘Silver- Intra Uterine Device’. • Established Lifecare Centre in three medical college hospitals at VSS Medical College-Burla, MKCG Medical College, Berhampur and SCB Medical College, Cuttack. Lifecare Centres were also set up at Koyilandi in Kerala and at NIMHANS, Bangalore in Karnataka. Annual Report 2013-2014 19 +…{…EÚ“ E∆Ú{…x…“ x…‰ BS…B±…B±… +…ËÆ˙ ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú §…“S… Ω˛∫i……I… Æ˙i… B®… +…‰ ™…÷ E‰Ú ∫…∆§…∆v… ®… 2009-10 ∫…‰ ±…M……i……Æ˙ "=iEfiÚπ]ı' x…π{……n˘x… §…x……™…… Æ˙J…… Ω˲ * +…{…EÚ“ E∆Ú{…x…“ x…π{……n˘x… ∫…⁄S…EÚ…Â EÚ…‰ n‰˘J…i…‰ Ω÷˛B ¥…π…« 2013-14 E‰Ú ±…B '=iEfiÚπ`ˆ' Ɖ˙À]ıM… |……{i… EÚÆ˙x…‰ EÚ“ =®®…“n˘ EÚÆ˙i…“ Ω˲* +…{…EÚ“ E∆Ú{…x…“ x…‰ ∫……¥…«V… x…EÚ =t®… ¥…¶……M… u˘…Æ˙… V……Æ˙“ EÚ™…‰ EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… ®……M…« x…nÊ˘∂…… EÚ… +x…÷{……±…x… EÚ™…… l…… * ®…È ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú ¥… ¥…v… ¥…¶……M……Â, ¥…∂…‰π…i…& ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™… ∫…‰ |……{i… ±…M……i……Æ˙ ∫…®…l…«x… B¥…∆ ∫…Ω˛…™…i…… E‰Ú ±…B EfiÚi…Y…i…… +n˘… EÚÆ˙i…… Ω⁄ƒ˛ * ∫…v…x™…¥……n˘, b˜…Ï. B®…. +™™…{{…x… +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 20 • Set up one of the largest generic drug stores, capable of handling 4000 out patients per day at All India Institute of Medical Sciences (AIMS), New Delhi in March 2014. Your company maintained “Excellent” performance rating consecutively since 2009-10 regarding the MoU signed between HLL and Government of India. The company expects to obtain “Excellent” rating for year 2013-14 also in view of the performance indicators. Your company had complied with Corporate Governance Guidelines issued by Department of Public Enterprises. I gratefully acknowledge the continued support and help received from various departments of Government of India, particularly from the Ministry of Health & Family Welfare. Thank you. Dr. M. AYYAPPAN Chairman and Managing Director HLL Lifecare Ltd Annual Report 2013-2014 21 ∫…∆. BS…B±…B±…/∫…“B∫…/2-338/2014 31 V…÷±……<«, 2014 ∫…⁄S…x…… Bi…n¬˘u˘…Æ˙… ∫…⁄S…x…… n˘“ V……i…“ Ω˲ EÚ x…®x… ±… J…i… EÚ…™…« x…§……Ω˛x…‰ E‰Ú ±…B BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ“ 48 ¥…” ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ {…∆V…“EfiÚi… EÚ…™……«±…™…, BS…B±…B±… ¶…¥…x…, {…⁄V…{{…÷Æ˙…, i…Ø˚¥…x…∆i…{…÷Æ˙®… - 695 012 ®… M…÷Ø˚¥……Æ˙, 28 +M…∫i…, 2014 +{…Æ˙…ºx… 3.30 §…V…‰ EÚ…‰ +…™……‰ V…i… EÚ“ V……BM…“* ∫……®……x™… EÚ…™…«: 1. 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… Ω÷˛B ¥…π…« E‰Ú ±…B ±…‰J…… {…Æ˙“ I…i… ¥…k…“™… ¥…¥…Æ˙h…, =∫… {…Æ˙ x…n‰˘∂…EÚ…Â, ∫……∆ ¥… v…EÚ ±…‰J…… {…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«ı E‰Ú ∫……l… ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛…±…‰J…… {…Æ˙“I…EÚ (∫…“ & B V…“) EÚ“ ]ı{{…h…“ {…Æ˙ ¥…S……Æ˙ EÚÆ˙x…… +…ËÆ˙ +∆M…“EÚ…Æ˙ EÚÆ˙x……* 2. 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…k…“™… ¥…π…« E‰Ú ±…B E∆Ú{…x…“ E‰Ú <ŒC¥…]ı“ ∂…‰™…Æ˙ {…Æ˙ ±……¶……∆∂… P……‰ π…i… EÚÆ˙x……* 3. ¥…π…« 2014-15 E‰Ú ±…B E∆Ú{…x…“ E‰Ú ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â EÚ…‰ n‰˘™… {…… Æ˙∏… ®…EÚ i…™… EÚÆ˙x…‰ E‰Ú ±…B x…n‰˘∂…EÚ ®…∆b˜±… EÚ…‰ |…… v…EfiÚi… EÚÆ˙x……* x…®x… ±… J…i… ∫…∆EÚ±{…… EÚ…‰ ∫……v……Æ˙h… ∫…∆EÚ±{… E‰Ú ∞¸{… ®… ∫…∆∂……‰v…˘x… E‰Ú ∫……l… ™…… ∫…∆∂……‰v…˘x… E‰Ú §…x…… ¥…S……Æ˙ EÚÆ˙x…… +…ËÆ˙ ™……‰M™… ∫…®…Z…… V……™… i……‰ {…… Æ˙i… EÚÆ˙x……* ""∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 142(1) E‰Ú +{…‰I…… E‰Ú +x…÷∫……Æ˙ ®… ¥…π…« 2014-15 E‰Ú ±…B ¶……Æ˙i… E‰Ú x…™…∆j…EÚ +…ËÆ˙ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ u˘…Æ˙… x…™…÷HÚ ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú {…… Æ˙∏… ®…EÚ i…™… EÚÆ˙x…‰ E‰Ú ±…B E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ®…∆b˜±… EÚ…‰ Bi…n¬˘u˘…Æ˙… |…… v…EfiÚi… EÚ™…… V……i…… Ω˲*'' ¥…∂…‰π… EÚ…™…« 4. E∆Ú{…x…“ E‰Ú |…i™…‰EÚ ` 1000/- E‰Ú +∆ EÚi… ®…⁄±™… E‰Ú <ŒC¥…]ı“ ∂…‰™…Æ˙… EÚ…‰ |…i™…‰EÚ ` 10/- E‰Ú +∆ EÚi… ®…⁄±™… E‰Ú ∂…‰™…Æ˙… ®… ={… ¥…¶…… V…i… (∂…‰™…Æ˙ - ¥…¶……V…x…) EÚÆ˙x……* x…®x… ±… J…i… ∫…∆EÚ±{…… EÚ…‰ ∫……v……Æ˙h… ∫…∆EÚ±{… E‰Ú ∞¸{… ®… ∫…∆∂……‰v…x… E‰Ú ∫……l… ™…… ∫…∆∂……‰v…x… E‰Ú §…x…… ¥…S……Æ˙ EÚÆ˙x…… +…ËÆ˙ ™……‰M™… ∫…®…Z…… V……™… i……‰ {…… Æ˙i… EÚÆ˙x……* ˆ""∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 61 (b˜“) +…ËÆ˙ E∆Ú{…x…“ + v… x…™…®… 2013 E‰Ú ™… n˘ EÚ…‰<« +x™… |…™……‰V™… |……¥…v……x… E‰Ú +x…÷∫…Æ˙h… ®…Â, E∆Ú{…x…“ E‰Ú <ŒC¥…]ı“ ∂…‰™…Æ˙ E‰Ú ={… ¥…¶……V…x… E‰Ú ±…B ∂…‰‰™…Æ˙v……Æ˙EÚ…Â EÚ“ ∫…Ω˛®… i… Bi…n¬˘u˘…Æ˙… |…n˘…x… EÚ“ V……i…“ Ω˲, V……‰ EÚ |…i™…‰EÚ ` 1000/- (BEÚ Ω˛W……Æ˙ Ø˚{…B ®……j…) E‰Ú +∆ EÚi… ®…⁄±™… E‰Ú |…i™…‰EÚ <ŒC¥…]ı“ ∂…‰™…Æ˙ EÚ…‰ |…i™…‰E Ú` 10/- (n˘∫… Ø˚{…B ®……j…) E‰Ú +∆ EÚi… ®…⁄±™… E‰Ú 100 (∫……Ë) <ŒC¥…]ı“ ∂…‰™…Æ˙… ®… ={… ¥…¶…… V…i… EÚÆ˙x……* '' ""+…M…‰ ∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ E‰Ú <ŒC¥…]ı“ ∂…‰™…Æ˙… E‰Ú ={… ¥…¶……V…x…/E‰Ú +x…÷∫…Æ˙h… ®…Â, |…i™…‰EÚ `1000/- (BEÚ Ω˛W……Æ˙ Ø˚{…B ®……j…) E‰Ú +∆ EÚi… ®…⁄±™… E‰Ú |…… v…EfiÚi…, V……Æ˙“ EÚB, + ¶…n˘k… +…ËÆ˙ |…n˘k… <ŒC¥…]ı“ ∂…‰‰™…Æ˙ {…⁄ƒV…“ |…i™…‰EÚ ` 10/- (n˘∫… Ø˚{…B ®……j…) E‰Ú +∆ EÚi… ®…⁄±™… E‰Ú 100 (∫……Ë) <ŒC¥…]ı“ ∂…‰™…Æ˙… ®… ={… ¥…¶…… V…i… EÚ™…… V……BM……* '' ""+…M…‰ ∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ ={…™…÷«HÚ E‰Ú ∞¸{… ®… <ŒC¥…]ı“ ∂…‰‰™…Æ˙… E‰Ú ={… - ¥…¶……V…x… {…Æ˙ ™…Ω˛ ∫…®…Z…… V……BM…… EÚ ®……ËV…⁄n˘ ∂…‰™…Æ˙ |…®……h…{…j… ∫¥…S…… ±…i… ∞¸{… ∫…‰ Æ˙q˘ EÚÆ˙ n˘™…… M…™…… Ω˲ +…ËÆ˙ E∆Ú{…x…“ {…÷Æ˙…x…‰ ∂…‰‰™…Æ˙ |…®……h…-{…j… E‰Ú +¶™…{…«h… E‰Ú +{…‰I…… E‰Ú §…x……, B‰∫…‰ {…÷Æ˙…x…‰ ∂…‰™…Æ˙ |…®……h… - {…j…… E‰Ú ∫l……x… {…Æ˙ E∆Ú{…x…“ E‰Ú x…B ∂…‰™…Æ˙ |…®……h… - {…j… V……Æ˙“ EÚÆ˙i…… Ω˲*'' ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 22 No.HLL/CS/2-338/2014 31 July 2014 N O T I C E NOTICE is hereby given that the 48th Annual General Meeting of the shareholders of HLL Lifecare Ltd. will be held at Thiruvananthapuram on Thursday, the 28th August 2014 at 3.30 p.m. at the Registered Office, HLL Bhavan, Poojappura, Thiruvananthapuram – 695 012 to transact the following business: ORDINARY BUSINESS: 1. To consider and adopt the Audited Financial Statements for the year ended 31st March 2014 along with the Report of the Directors, Statutory Auditors together with comments of the Comptroller & Auditor General of India (C&AG). 2. To declare dividend on the equity shares of the Company for the financial year ended 31st March 2014. 3. To authorize the Board of Directors to fix remuneration payable to the Statutory Auditors of the Company for the year 2014-15. To consider and, if thought fit, to pass the following resolution, with or without modification as an ordinary resolution: “RESOLVED THAT pursuant to the requirement of Section 142 (1) of the Companies Act, 2013, the Board of Directors of the Company be and are hereby authorised to fix the remuneration to the Statutory Auditors as appointed by the Comptroller and Auditor General of India for the year 2014-15”. SPECIAL BUSINESS 4. To sub-divide (Stock-split) equity shares of the Company having face value of `1000/- each into shares of face value of `10/- each. To consider and, if thought fit, to pass the following resolutions, with or without modification as an ordinary resolution: “RESOLVED THAT, pursuant to section 61(d) of the Companies Act, 2013, and other applicable provisions, if any, of the Companies Act, 2013, the consent of shareholders be and is hereby accorded for sub- dividing the equity share of the Company such that each equity share having nominal value of `1000/- (Rupees Thousand only) each be sub-divided into 100 (Hundred) equity shares having nominal value of `10/- (Rupees Ten only) each fully paid-up.” “RESOLVED FURTHER THAT pursuant to the sub-division of equity shares of the Company, the Authorised, Issued, Subscribed and Paid-up equity share capital of nominal value of `1000/- (Rupees Thousand only) each, shall stands sub-divided into 100 (Hundred) equity shares of nominal value of `10/- (Rupees Ten only) each”. “RESOLVED FURTHER THAT upon sub-division of equity shares as aforesaid, the existing share certificates shall be deemed to have been automatically cancelled and the Company may without requiring surrender of the old share certificates, issue the new share certificates of the Company in lieu of such old share certificates”. Annual Report 2013-2014 23 5. ∫…∆∫l…… E‰Ú Y……{…x… EÚ… +x…÷SU‰Ùn˘ V EÚ… {… Æ˙¥…i…«x… x…®x… ±… J…i… ∫…∆EÚ±{…… EÚ…‰ ∫……v……Æ˙h… ∫…∆EÚ±{… E‰Ú ∞¸{… ®… ∫…∆∂……‰v…x… E‰Ú ∫……l… ™…… ∫…∆∂……‰v…x… E‰Ú §…x…… ¥…S……Æ˙ EÚÆ˙x…… +…ËÆ˙ ™……‰M™… ∫…®…Z…… V……™… i……‰ {…… Æ˙i… EÚÆ˙x……* ""∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 13 E‰Ú |……¥…v……x……‰∆ E‰Ú +x…÷∫…Æ˙h… ®…Â, ∫…∆∫l…… E‰Ú Y……{…x… E‰Ú {… Æ˙¥…i…«x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ“ ∫…Ω˛®… i… Bi…n¬˘u˘…Æ˙… |…n˘…x… EÚ“ V……i…“ Ω˲*'' ""+…M…‰ ∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ E‰Ú ∫…∆∫l…… E‰Ú Y……{…x… EÚ… ®……ËV…⁄n˘… +x…÷SU‰Ùn˘ 5 Bi…n¬˘u˘…Æ˙… x…EÚ…±…… V……i…… Ω˲ +…ËÆ˙ x…®x… ±… J…i… ®…n˘… E‰Ú ∫……l… |… i…∫l…… {…i… EÚ™…… V……i…… Ω˲* "" ""V. E∆Ú{…x…“ EÚ“ |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ ` 300,00,00,000/-(Ø˚{…B i…“x… ∫……Ë EÚÆ˙…‰b˜ ®……j…) Ω˲ V……‰ B‰∫…“ Æ˙… ∂… EÚ…‰ E∆Ú{…x…“ EÚ“ ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®…… ®… ™…l…… x…v……« Æ˙i… EÚB V……x…‰¥……±…‰ + v…EÚ…Æ˙, ¥…∂…‰π…… v…EÚ…Æ˙ +…ËÆ˙ =∫…∫…‰ ∫…∆±…Mx… ∂…i……Á +l…¥…… =∫…EÚ“ ∂…i…Á ∫… Ω˛i…, ¥… ¶…z… ∏…‰ h…™…… ®… {…⁄ƒV…“ §…f¯…x…‰, ={… ¥…¶…… V…i…, ∫…®…‰ EÚi… EÚÆ˙x…‰ +l…¥…… P…]ıx…… EÚ“ ∂… HÚ™…… E‰Ú ∫……l… |…i™…‰EÚ ` 10/- (n˘∫… Ø˚{…B ®……j…) ¥……±…‰ ` 30,00,00,000/- (Ø˚{…B i…“∫… EÚÆ˙…‰b˜ ®……j…) <ŒC¥…]ı“ ∂…‰™…Æ˙… ®… ¥…¶…… V…i… Ω˲* "" 6. ∫…∆∫l…… E‰Ú Y……{…x… EÚ… +x…÷SU‰Ùn˘ 4 EÚ… {… Æ˙¥…i…«x… x…®x… ±… J…i… ∫…∆EÚ±{…… EÚ…‰ ¥…∂…‰π… ∫…∆EÚ±{… E‰Ú ∞¸{… ®… ∫…∆∂……‰‰v…x… E‰Ú ∫……l… ™…… ∫…∆∂……‰‰v…x… E‰Ú §…x…… ¥…S……Æ˙ EÚÆ˙x…… +…ËÆ˙ ™……‰M™… ∫…®…Z…… V……™… i……‰ {…… Æ˙i… EÚÆ˙x……* ˆ""∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 14 E‰Ú |……¥…v……x……‰∆ E‰Ú +x…÷∫…Æ˙h… ®…Â, ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… EÚ…‰ {… Æ˙¥…i…«x… E‰Ú ±…B ∂…‰‰™…Æ˙v……Æ˙EÚ…Â EÚ“ ∫…Ω˛®… i… Bi…n¬˘u˘…Æ˙… n˘“ V……i…“ Ω˲*'' ""+…M…‰ ∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ E∆Ú{…x…“ E‰Ú ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… EÚ… ®……ËV…⁄n˘… +x…÷SU‰Ùn˘ 4 Bi…n¬˘u˘…Æ˙… x…EÚ…±…… V……i…… Ω˲ +…ËÆ˙ x…®x… ±… J…i… ®…n˘… E‰Ú ∫……l… |… i…∫l…… {…i… EÚ™…… V……i…… Ω˲*'' ""4. {…⁄ƒV…“: E∆Ú{…x…“ EÚ“ |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ V……‰ ` 300,00,00,000/- (Ø˚{…B i…“x… ∫……Ë EÚÆ˙…‰b˜ ®……j…) Ω˲ ` 10/- (Ø˚{…B n˘∫… ®……j…) ¥……±…‰ ` 30,00,00,000/- (Ø˚{…B i…“∫… EÚÆ˙…‰b˜ ®……j…) <ŒC¥…]ı“ ∂…‰™…Æ˙… ®… ¥…¶…… V…i… Ω˲ §…∂…«i… EÚ E∆Ú{…x…“ +{…x…‰ Y……{…x… EÚ“ ∂…i……Á ®… {… Æ˙¥…i…«x… EÚÆÂ˙ i…… EÚ B‰∫…“ Æ˙… ∂…, V…Ë∫…… EÚ E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 61 ®… n˘B M…B i…Æ˙“E‰Ú E‰Ú x…B ∂…‰™…Æ˙ V……Æ˙“ EÚÆ˙x…… ±……¶…|…n˘ ∫…®…Z…‰, ∫…‰ <∫…EÚ“ ∂…‰™…Æ˙ {…⁄ƒV…“ ®… ¥…fi r˘ Ω˛…‰*'' ""+…M…‰ ∫…∆EÚ±{… EÚ™…… V……i…… Ω˲ EÚ B‰∫…‰ ∫…¶…“ EÚ…™…«, EÚ®…«, ®……®…±…‰ +…ËÆ˙ §……i……Â, V……‰ =HÚ ∫…∆EÚ±{…… EÚ…‰ ±……M…⁄ EÚÆ˙x…‰ E‰Ú ±…B +…¥…∂™…EÚ, ∫…®…“S…“x…, ∫……®……x™… ™…… = S…i… ∫…®…Z…‰, EÚ…‰ EÚÆ˙x…‰, {……±…x… EÚÆ˙x…‰ +…ËÆ˙ x…π{…… n˘i… EÚÆ˙x…‰ E‰Ú ±…B E∆Ú{…x…“ E‰Ú E∆Ú{…x…“ ∫… S…¥… B¥…∆ ={……v™…I… ( ¥…k…) EÚ…‰ Bi…n¬˘u˘…Æ˙… |…… v…EfiÚi… EÚ™…… V……i…… ΩË*˛'' §……‰b«˜ E‰Ú +…n‰˘∂……x…÷∫……Æ˙ {…“.∏…“E÷Ú®……Æ˙ E∆Ú{…x…“ ∫… S…¥… B¥…∆ ={……v™…I… ( ¥…k…) ]ı{{… h…™……ƒ: 1. §…Ë`ˆEÚ ®… ¶……M… ±…‰x…‰ +…ËÆ˙ ®…i…n˘…x… EÚÆ˙x…‰ E‰Ú ±…B Ω˛EÚn˘…Æ˙ ∫…n˘∫™… EÚ…‰, ¶……M… ±…‰x…‰ +…ËÆ˙ S…÷x……¥…… ®… J…÷n˘ E‰Ú §…V……™… ¥……‰]ı EÚÆ˙x…‰ E‰Ú ±…B BEÚ |……ÏC∫…“ EÚ…‰ x…™…÷HÚ EÚÆ˙x…‰ EÚ… + v…EÚ…Æ˙ Ω˲ +…ËÆ˙ B‰∫…‰ |……ÏC∫…“ E∆Ú{…x…“ E‰Ú ∫…n˘∫™… Ω˛…‰x…‰ EÚ“ V…∞¸Æ˙i… x…Ω˛” Ω˲* |……ÏŒC∫…™…… EÚ…‰, ¥…Ëv… B¥…∆ |…¶……¥…“ Ω˛…‰x…‰ EÚ“ +…‰Æ˙, §…Ë`ˆEÚ |……Æ∆˙¶… Ω˛…‰x…‰ E‰Ú EÚ®… ∫…‰ EÚ®… 48 P…h]‰ı {…Ω˛±…‰ E∆Ú{…x…“ E‰Ú {…∆V…“EfiÚi… EÚ…™……«±…™… ®… n˘V…« EÚÆ˙x…… S…… Ω˛B* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 24 5. To alter Clause V of Memorandum of Association To consider and, if thought fit, to pass the following resolutions, with or without modification as an special resolution: “RESOLVED THAT pursuant to the provisions of Section 13 of the Companies Act, 2013, the consent of the shareholders be and is hereby accorded to alter the Memorandum of Association”. “RESOLVED FURTHER THAT, the existing Clause V of the Memorandum of Association of the Company be and is hereby deleted and substituted with the following: “V. The authorized share capital of the company is ` 300,00,00,000/- (Rupees Three hundred Crore only) divided into 30,00,00,000 (Thirty crore only) equity shares of `10/- (Rupees Ten only) each with power to increase, subdivide, consolidate or reduce into several classes with the rights, privileges and conditions attaching thereto as are or may be prescribed by the Articles of Association of the Company or the conditions thereof.” 6. To alter Article 4 of Articles of Association To consider and, if thought fit, to pass the following resolutions, with or without modification as a special resolution: “RESOLVED THAT pursuant to the provisions of Section 14 of the Companies Act, 2013, the consent of the shareholders be and is hereby accorded to alter the Articles of Association”. “RESOLVED FURTHER THAT the existing Article 4 of the Articles of Association of the Company be and is hereby deleted and substituted with the following: “4. Capital: The authorized share capital of the company is `300,00,00,000/- (Rupees Three hundred Crore only) divided into 30,00,00,000 (Thirty Core only) equity shares of `10/- (Rupees Ten only) each provided that the company may alter the conditions of its Memorandum so as to increase its Share Capital by such amounts as it think expedient by issuing new shares in the manner prescribed in Section 61 of the Companies Act, 2013.” “RESOLVED FURTHER THAT the Company Secretary & Vice President (Finance) of the Company be and is hereby authorised to do, perform and execute all such acts, deeds, matters and things as it may consider necessary, expedient, usual or proper to give effect to aforesaid resolutions”. By the order of the Board P. SREEKUMAR COMPANY SECRETARY & VP (F) Notes: 1. A member entitled to attend and vote at the meeting is entitled to appoint a proxy to attend and on a poll to vote instead of himself/herself and such proxy need not be a member of the Company. Proxies, in order to be valid and effective, must be lodged with the registered office of the company not less than 48 hours before the commencement of the meeting. Annual Report 2013-2014 25 2. E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 139 (5) E‰Ú +x…÷∫…Æ˙h… ®…Â, ∫…Æ˙EÚ…Æ˙“ E∆Ú{…x…“ E‰Ú ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â EÚ…‰ ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ (∫…“ & B V…“ ) u˘…Æ˙… x…™…÷HÚ EÚB V……i…‰ ΩÈ˛* E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 142(1) E‰Ú +x…÷∫……Æ˙, ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú {…… Æ˙∏… ®…EÚ E∆Ú{…x…“ u˘…Æ˙… ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ ®… i…™… EÚ™…… V……x…… Ω˲ ™…… B‰∫…‰ f∆¯M… ∫…‰ ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ ®… E∆Ú{…x…“ x…v……« Æ˙i… EÚÆ˙ ∫…EÚi…“ Ω˲* ¥…k…“™… ¥…π…« 2014-15 E‰Ú ±…B ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â EÚ…‰ x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ u˘…Æ˙… x…™…÷HÚ EÚ™…… V……x…… Ω˲* x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ u˘…Æ˙… E∆Ú{…x…“ E‰Ú ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â EÚ…‰ x…™…÷HÚ EÚÆ˙x…‰ {…Æ˙, ¥…k…“™… ¥…π…« 2014 -15 E‰Ú ±…B =x…E‰Ú {…… Æ˙∏… ®…EÚ x…™…i… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ x…n‰˘∂…EÚ ®…∆b˜±… EÚ…‰ |…… v…EfiÚi… EÚÆ˙x…‰ E‰Ú ±…B +…¥…∂™…EÚ ∫…∆EÚ±{… ∫…n˘∫™…… E‰Ú ∫…I…®… Æ˙J…… M…™…… Ω˲* 3. E∆Ú{…x…“ (|…§…∆v…x… B¥…∆ |…∂……∫…x…) x…™…®…, 2014 E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 102 E‰Ú +x…÷∫…Æ˙h… ®…Â, ¥…∂…‰π… EÚ…™…« ∫…‰ ∫…∆§…∆ v…i… i…l™…… ®… Æ˙J…‰ ¥™……J™……i®…EÚ ¥…¥…Æ˙h… ∫…∆±…Mx… Ω˲* ∫…‰¥…… ®… ∂…‰™…Æ˙v……Æ˙EÚ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 26 2. Pursuant to Section 139 (5) of the Companies Act, 2013, the Statutory Auditors of a Government Company are appointed by the Comptroller and Auditor General of India (C&AG). In terms of Section 142(1) of the Companies Act, 2013 the remuneration of auditors has to be fixed by the company in the annual general meeting or in such manner as the company in annual general meeting may determine. The Statutory Auditors for the financial year 2014-15 are yet to be appointed by the C&AG. Necessary resolution has been placed before the Members for authorising the Board of directors to fix up the remuneration to the Statutory Auditors of the Company for the financial year 2014-15 as and when the appointment is made by the C&AG. 3. Explanatory Statement pursuant to Section 102 of the Companies Act, 2013, read with Companies (Management and Administration) Rules, 2014, setting out the material facts in respect of Special Business is annexed. To The Shareholders Annual Report 2013-2014 27 ∫{…π]ı“EÚÆ˙h… ¥…¥…Æ˙h… (E∆Ú{…x…“ + v… ®…™…®…, 2013 EÚ“ v……Æ˙… 102 E‰Ú +x…÷∫……Æ˙) E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 102 E‰Ú +x…÷∫……Æ˙ ∫…∆±…Mx… x……‰]ı“∫… ®… =Œ±±… J…i… ¥…∂…‰π… ¥™…¥…∫……™… E‰Ú ∫…∆§…∆ v…i… ®……®…±…… EÚ…‰ x…®x……∆ EÚi… ∫{…π]ı“EÚÆ˙h… ¥…¥…Æ˙h… x…Ãn˘π]ı EÚÆ˙i…‰ ΩÈ˛* ®…n˘ ∫…∆. 4 E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ®…∆b˜±… E‰Ú 8 x…¥…∆§…Æ˙, 2013 EÚ…‰ +…™……‰ V…i… +{…x…‰ 242¥…” §…Ë`ˆEÚ ®…Â, ∫…Æ˙EÚ…Æ˙ +…ËÆ˙ ∫…n˘∫™…… E‰Ú +x…÷®……‰n˘x… E‰Ú +x…÷∫……Æ˙ `1000/- (Ω˛W……Æ˙ Ø˚{…B ®……j…) E‰Ú ¥…i…«®……x… |…i™…I… ®…⁄±™… E‰Ú |…i™…‰EÚ <ŒC¥…]ı“ ∂…‰™…Æ˙… EÚ… +∆ EÚi… ®…⁄±™… |…i™…‰EÚ ` 10/- E‰Ú 100 (∫……Ë) <ŒC¥…]ı“ ∂…‰™…Æ˙… ®… ¥…¶…… V…i… EÚÆ˙x…‰ EÚ“ ∫…°Ú… Æ˙∂… EÚ“ Ω˲* EfiÚ{…™…… ∫…n˘∫™… ™…Ω˛ x……‰]ı EÚÆ˙ ±…™…… V……™… EÚ +§… E∆Ú{…x…“ E‰Ú |…i™…‰EÚ <ŒC¥…]ı“ ∂…‰™…Æ˙ E‰Ú +∆ EÚi… ®…⁄±™… |… i… ∂…‰™…Æ˙ E‰Ú ±…B ` 1000/- (BEÚ Ω˛W……Æ˙ Ø˚{…B ®……j…) Ω˲ +…ËÆ˙ ={… ¥…¶……V…x… E‰Ú {… Æ˙h……®…∫¥…∞¸{… ™…Ω˛ |…i™…‰EÚ ` 10/- (n˘∫… ∞¸{…B ®……j…) E‰Ú 100 (∫……Ë) <ŒC¥…]ı“ ∂…‰™…Æ˙… ®… ¥…¶…… V…i… EÚ™…… V…… Æ˙Ω˛… Ω˲* ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ x…‰ n˘x……∆EÚ 12 ®……S…«, 2014 E‰Ú EÚ…™……«±…™… Y……{…x… ∫…∆.B°Ú.x…∆.B-45013/77/ 2010-BS…B±…B±… E‰Ú u˘…Æ˙… E∆Ú{…x…“ E‰Ú <ŒC¥…]ı“ ∂…‰™…Æ˙… EÚ…‰ |…i™…‰EÚ ` 1000/- (BEÚ Ω˛W……Æ˙ Ø˚{…B ®……j…) ∫…‰ |…i™…‰EÚ ` 10/- (n˘∫… Ø˚{…B ®……j…) ®… ={… ¥…¶…… V…i… (∫]ı…ÏEÚ ®… §……ƒ]ıx…) EÚÆ˙x…‰ E‰Ú |…∫i……¥… EÚ…‰ +x…÷®……‰n˘x… n˘™…… Ω˲* E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 61 E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙, ∂…‰™…Æ˙… E‰Ú ={… ¥…¶……V…x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ… +x…÷®……‰n˘x… +{…‰ I…i… Ω˲* <∫… ±…B, =HÚ |…∫i……¥… +x…÷®……‰n˘x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â E‰Ú ∫…®…I… |…∫i…÷i… EÚ™…… V…… Æ˙Ω˛… Ω˲* +…{…E‰Ú x…n‰˘∂…EÚ…Â x…‰ +{…E‰Ú +x…÷®……‰n˘x… E‰Ú ±…B ={…™…÷«HÚ |…∫i……¥… EÚ“ ∫…°Ú… Æ˙∂… EÚ“ Ω˲* E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ™…… ®…÷J™… |…§…∆v…EÚ“™… Eڅî…EÚ ™…… =x…E‰Ú Æ˙∂i…‰n˘…Æ˙ ={…™…÷«HÚ ∫…∆n˘Ã¶…i… ∫…∆EÚ±{… ®… ¥… k…™… ™…… +x™… ∞¸{… ∫…‰ EÚ∫…“ ¶…“ i…Æ˙Ω˛ ∫…∆§…∆ v…i… ™…… Ø˚ S… x…Ω˛” Æ˙J…i…‰ ΩÈ˛* ®…n˘ ∫…∆. 5 ∫…∆∫l…… E‰Ú Y……{…x… E‰Ú ¥…t®……x… +x…÷SU‰Ùn˘ V E∆Ú{…x…“ EÚ“ ¥…i…«®……x… |…… v…EfiÚi… ∂…‰Æ˙ {…⁄ƒV…“ EÚ… ¥…¥…Æ˙h… n‰˘i…… Ω˲* <ŒC¥…]ı“ ∂…‰™…Æ˙… E‰Ú x…… ®…i… ®…⁄±™… |… i… ∂…‰™…Æ˙ `1000/- (BEÚ Ω˛W……Æ˙ Ø˚{…B ®……j…) ∫…‰ |… i… ∂…‰™…Æ˙ ` 10/- (n˘∫… Ø˚{…B ®……j…) E‰Ú ={…- ¥…¶……V…x… EÚ“ o˘Œπ]ı ®…Â, ∫…∆∫l…… E‰Ú Y……{…x… E‰Ú ¥…t®……x… +x…÷SU‰Ùn˘ V <ŒC¥…]ı“ ∂…‰™…Æ˙… E‰Ú ={… J…∆b˜ EÚ…‰ |… i…À§… §…i… EÚÆ˙x…‰ E‰Ú ±…B §…n˘±… n˘™…… V……x…… +{…‰ I…i… Ω˲* E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 13 E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙, E∆Ú{…x…“ E‰Ú ∫…∆∫l…… E‰Ú Y……{…x… E‰Ú ∫…∆∂……‰v…x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ… +x…÷®……‰n˘x… +{…‰ I…i… Ω˲* i…n˘x…÷∫……Æ˙, ™…Ω˛ ∫…∆EÚ±{… +x…÷®……‰n˘x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â E‰Ú ∫…®…I… |…∫i…÷i… EÚ™…… V…… Æ˙Ω˛… Ω˲* +…{…E‰Ú x…n‰˘∂…EÚ…Â x…‰ +{…E‰Ú +x…÷®……‰n˘x… E‰Ú ±…B ={…™…÷«HÚ |…∫i……¥… EÚ“ ∫…°Ú… Æ˙∂… EÚ“ Ω˲* E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ™…… ®…÷J™… |…§…∆v…EÚ“™… Eڅî…EÚ ™…… =x…E‰Ú Æ˙∂i…‰n˘…Æ˙ ∫…∆n˘Ã¶…i… ∫…∆EÚ±{… ®… ¥…k…“™… ™…… +x™… ∞¸{… ∫…‰ EÚ∫…“ ¶…“ i…Æ˙Ω˛ ∫…∆§…∆ v…i… ™…… Ø˚ S… x…Ω˛” Æ˙J…i…‰ ΩÈ˛* ®…n˘˛ ∫…∆. 6 ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… E‰Ú ¥…t®……x… +∆i…Ãx…™…®… 4 E∆Ú{…x…“ EÚ“ ¥…i…«®……x… |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ EÚ… ¥…¥…Æ˙h… n‰˘i…… Ω˲* <ŒC¥…]ı“ ∂…‰™…Æ˙… E‰Ú x…… ®…EÚ ®…⁄±™… |… i… ∂…‰™…Æ ` 1000/- (BEÚ Ω˛W……Æ˙ Ø˚{…B ®……j…) ∫…‰ |… i… ∂…‰™…Æ˙ ` 10/- (n˘∫…˙ Ø˚{…B ®……j…)˙E‰Ú ={…- ¥…¶……V…x… EÚ“ o˘Œπ]ı ®…Â, ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… E‰Ú ¥…t®……x… +∆i…Ãx…™…®… 4 <ŒC¥…]ı“ ∂…‰™…Æ˙… E‰Ú ={… J…∆b˜ EÚ…‰ |… i…À§… §…i… EÚÆ˙x…‰ E‰Ú ±…B §…n˘±… n˘™…… V……x…… +{…‰ I…i… Ω˲* E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 14 E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙, E∆Ú{…x…“ E‰Ú ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… E‰Ú ∫…∆∂……‰v…x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ… +x…÷®……‰n˘x… +{…‰ I…i… Ω˲* i…n˘x…÷∫……Æ˙, ™…Ω˛ ∫…∆EÚ±{… +x…÷®……‰n˘x… E‰Ú ±…B ∂…‰™…Æ˙v……Æ˙EÚ…Â E‰Ú ∫…®…I… |…∫i…÷i… EÚ™…… V…… Æ˙Ω˛… Ω˲* +…{…E‰Ú x…n‰˘∂…EÚ…Â x…‰ +…{…E‰Ú +x…÷®……‰n˘x… E‰Ú ±…B ={…™…÷«HÚ |…∫i……¥… EÚ“ ∫…°Ú… Æ˙∂… EÚ“ ΩÈ˛* E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ™…… ®…÷J™… |…§…∆v…EÚ“™… Eڅî…EÚ ™…… =x…E‰Ú Æ˙∂i…‰n˘…Æ˙ ={…™…÷«HÚ ∫…∆n˘Ã¶…i… ∫…∆EÚ±{… ®… ¥…k…“™… ™…… +x™… ∞¸{… ∫…‰ EÚ∫…“ ¶…“ i…Æ˙Ω˛ ∫…∆§…∆ v…i… ™…… Ø˚ S… x…Ω˛” Æ˙J…i…‰ ΩÈ˛* §……‰b«˜ E‰Ú +…n‰˘∂……x…÷∫……Æ˙ {…“. ∏…“E÷Ú®……Æ˙ E∆Ú{…x…“ ∫… S…¥… B¥…∆ ={……v™…I… ( ¥…k…) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 28 EXPLANATORY STATEMENT (Pursuant to Section 102 of the Companies Act, 2013) As required under Section 102 of the Companies Act, 2013, the following explanatory statement sets out the matters in relation to the Special Business mentioned in the accompanying notice: Item No. 4 The Board of Directors of the Company at its 242nd meeting held on 8th November 2013 has recommended to sub- divide (split) the nominal value of each equity share having a present face value of `1000/- (Rupees Thousand only) each into 100 (Hundred) equity shares of `10 each, subject to the approval of the Government and Members. The Members may please note that presently the nominal value of each equity share of the Company is `1000/- (Rupees Thousand only) per share and consequent upon the sub-division it is being divided into 100 (Hundred) equity shares of `10/- (Rupees Ten only) each. The Ministry of Health & Family Welfare, Government of India, vide O.M. No. F.No.A-45013/77/2010-HLL dated 12th March 2014, have approved the proposal for sub-division (stock split) of equity shares of the Company for `1000/- (Rupees Thousand only) each to be `10/- (Rupees Ten only) each. As per the provisions of Section 61 of the Companies Act 2013, approval of the shareholders is required for sub- division of shares. Therefore, the said resolution is being put up before the shareholders for approval. Your Directors recommend the above resolution for your approval. None of the Directors or Key Managerial Personnel of the Company or their relative is in any way concerned or interested, financially or otherwise in the above referred resolution. Item No. 5 The existing Clause V of Memorandum of Association specifies the present Authorised Share Capital of the Company. In view of sub-division in the nominal value of the equity shares from `1000/- (Rupees Thousand only) per share to `10/- (Rupees Ten only) per share, the present Clause V of the Memorandum of Association is required to be altered to reflect the sub-division of the equity shares. As per the provisions of Section 13 of the Companies Act 2013, approval of the shareholders is required for amending the Memorandum of Association of the Company. Accordingly, this resolution is being put up before the shareholders for approval. Your Directors recommend the above resolution for your approval. None of the Directors or Key Managerial Personnel of the Company or their relative is in any way concerned or interested, financially or otherwise in the above referred resolution. Item No. 6 The existing Article 4 of the Articles of Association specifies the present Authorised Share Capital of the Company. In view of sub-division in the nominal value of the equity shares from `1000/- (Rupees Thousand only) per share to `10/- (Rupees Ten only) per share, the present Article 4 of the Articles of Association is required to be altered to reflect the sub-division of the equity shares. As per the provisions of Section 14 of the Companies Act 2013, approval of the shareholders is required for amending the Articles of Association of the Company. Accordingly, this resolution is being put up before the shareholders for approval. Your Directors recommend the above resolution for your approval. None of the Directors or Key Managerial Personnel of the Company or their relative is in any way concerned or interested, financially or otherwise in the above referred resolution. By the order of the Board P. SREEKUMAR COMPANY SECRETARY & VP (F) Annual Report 2013-2014 29 I. x…n‰˘∂…EÚ…Â EÚ“ Æ˙{……‰]«ı (2013-14) ∫…n˘∫™… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…n‰˘∂…EÚ ®…∆b˜±… EÚ…‰ 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…B ±…‰J……{…Æ˙“ I…i… ¥…k…“™… ¥…¥…Æ˙h……‰∆ E‰Ú ∫……l… E∆Ú{…x…“ EÚ“ +`ˆi……±…“∫…¥…“∆ (48 ¥…“∆) ¥……Ãπ…EÚ Æ˙{……‰]«ı +…ËÆ˙ ±…‰J……{…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«ı +…ËÆ˙ =∫…{…Æ˙ ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ EÚ“ Æ˙{……‰]«ı |…∫i…÷i… EÚÆ˙x…‰ ®… J…÷∂…“ Ω˲ * 1. ¥…k…“™… x…π{……n˘x… 1.1. ¥…π…« 2013-14 ∫…®…“I…… n÷˘ x…™…… ¶…Æ˙ EÚ“ +l…«¥™…¥…∫l……+… E‰Ú ±…B, ¥…k…“™… ¥…π…« 2013-14 §…Ω÷˛i… S…÷x……Ëi…“{…⁄h…« Æ˙Ω˛… Ω˲ * +∆i…Æ˙…«π]≈ı“™… +…Ãl…EÚ x… v… E‰Ú x…¥…“x…i…®… ¥…∑… +…Ãl…EÚ +…=]ı±…÷EÚ (+…<« B®… B°Ú) E‰Ú +x…÷∫……Æ˙, 2013 EÚ“ |…l…®… UÙ®……Ω˛“ EÚ“ i…÷±…x…… ®…Â, u˘i…“™… UÙ®……Ω˛“ E‰Ú n˘…ËÆ˙…x… ¥…Ë ∑…EÚ +…Ãl…EÚ M… i… ¥… v…™…… EÚ…‰ ®…W…§…⁄i… EÚ™…… M…™…… +…ËÆ˙ ®……‰]‰ı i……ËÆ˙ {…Æ˙ =z…i… +l…«¥™…¥…∫l……+… ®… ¥…∫…⁄±…“˙ E‰Ú EÚ…Æ˙h… 2014-15 ®… +…ËÆ˙ ∫…÷v……Æ˙ EÚ“ |…i…“I…… EÚ“ V……i…“ Ω˲ * ¥…Ë ∑…EÚ ¥…fi r˘ +§… 2014 ®… EÚÆ˙“§… 3.6 |… i…∂…i… Ω˛…‰x…‰ EÚ… +x…÷®……x… Ω˲ +…ËÆ˙ 2015 ®… 3.9 |… i…∂…i… EÚ“ ¥…fi r˘ EÚ“ =®®…“n˘ EÚ“ V……i…“ Ω˲ * ¥…Ë ∑…EÚ ¥…EÚ…∫… +…ËÆ˙ P…Ɖ˙±…⁄ §……v……+… EÚ…‰ n˘∂……«i…‰ Ω÷˛B P…Ɖ˙±…⁄ §……W……Æ˙ ®…Â, M…i… i…“x… ¥…k…“™… ¥…π……Á E‰Ú ¶……Æ˙i… EÚ“ ¥…fi r˘ ∫…∆™…®… n‰˘J…… Ω˲ * EÂÚp˘“™… ∫……∆ŒJ™…EÚ“ ∫…∆M…`ˆx… (∫…“ B∫… +…‰) E‰Ú x…¥…“x…i…®… {…⁄¥……«x…÷®……x… E‰Ú +x…÷∫……Æ˙ 2013-14 E‰Ú ±…B V…“ b˜“ {…“ ¥…fi r˘ 2012-13 EÚ“ 4.5 |… i…∂…i… EÚ“ i…÷±…x…… ®… 4.9 |… i…∂…i… EÚ… +x…÷®……x… EÚ™…… V……i…… Ω˲ * ¶……Æ˙i…“™… +l…«¥™…¥…∫l…… ®…∆n˘i…… EÚ“ ∫……I…“ Ω˛…‰x…‰ E‰Ú §……¥…V…⁄n˘ ¶…“, +…{…EÚ“ E∆Ú{…x…“ x…‰ ¥…fi r˘ EÚ“ M… i… EÚ…‰ §…x……™…‰ Æ˙J…˛… +…ËÆ˙ |…S……±…x… ∫…‰ Æ˙…V…∫¥… ®… 13% ¥…fi r˘ |……{i… EÚ“ * +…{…EÚ“ E∆Ú{…x…“ x…‰ |…S……±…x… ∫…‰ {…UÙ±…‰ ¥…π…« E‰Ú ` 832.94 EÚÆ˙…‰c˜ ∫…‰ 2013-14 E‰Ú n˘…ËÆ˙…x… ` 941.68 EÚÆ˙…‰c˜ E‰Ú ∫…¥……« v…EÚ Æ˙…V…∫¥… Ω˛… ∫…±… EÚ™…… * §™……V… E‰Ú {…⁄¥…« +V…«x…, EÚÆ˙ ®…⁄±™…ø…∫… B¥…∆ {… Æ˙∂……‰v…x… (<« §…“ +…<« ]ı“ b˜“ B) {…UÙ±…‰ ¥…π…« 2012-13 E‰Ú ` 72.69 EÚÆ˙…‰c˜ EÚ“ +…‰Æ˙ 8% §…g¯…EÚÆ˙ ` 78.40 EÚÆ˙…‰c˜ i…EÚ +…™……* EÚÆ˙ E‰Ú {…⁄¥…« ±……¶… ({…“ §…“ ]ı“) {…UÙ±…‰ ¥…π…« E‰Ú ` 37.81 EÚÆ˙…‰c˜ EÚ“ i…÷±…x…… ®… ` 36.24 EÚÆ˙…‰c˜ l…… * EÚÆ˙ E‰Ú §……n˘ ±……¶… ({…“ B ]ı“) {…UÙ±…‰ ¥…π…« 2012-13 E‰Ú ` 30.07 EÚÆ˙…‰c˜ EÚ“ i…÷±…x…… ®… ` 24.83 EÚÆ˙…‰c˜ l…… * x…¥…±… ®…⁄±™… 31/3/2014 EÚ…‰ ` 403.05 EÚÆ˙…‰c˜ i…EÚ §…g¯ M…™……, V……‰ {…UÙ±…‰ ¥…k…“™… ¥…π…« <∫…“ i……Æ˙“J… E‰Ú ` 378.21 EÚÆ˙…‰c˜ ∫…‰ 7% + v…EÚ Ω˲ * ¶……Æ˙i…“™… Ø˚{…™…‰ E‰Ú |… i… ™…÷ B∫… $ E‰Ú + v…®…⁄±™…x… E‰Ú EÚ…Æ˙h… ` 10.87 EÚÆ˙…‰c˜ Ø˚{…B EÚ“ ¥…n‰˘∂…“ ®…÷p˘… ®…Â Ω˛… x… EÚ“ ¥…V…Ω˛ ∫…‰ ¥…π…« 2013-14 E‰Ú ±…B E∆Ú{…x…“ E‰Ú ±……¶… {…Æ˙ |… i…E⁄Ú±… |…¶……¥… {…c˜… l……* ±……¶…|…n˘i…… {…Æ˙ |…¶…… ¥…i… +x™… ®…÷J™… {…Ω˛±…⁄ Ω˲ {…UÙ±…‰ n˘…‰ ¥…k… ¥…π…« E‰Ú n˘…ËÆ˙…x… ∫…Æ˙EÚ…Æ˙“ +…{…⁄Ãi… ®…⁄±™… (E∆Úb˜…‰®…, +…‰ ∫…“ {…“, |…‰Mx…‰x∫…“ ]‰ı∫]ı EÚ]ı) {…Æ˙ Ω÷˛<« M…ËÆ˙-∫…∆∂……‰v…x… * Ω˛…±……∆ EÚ, ±……¶…|…n˘i…… {…Æ˙ |… i…E⁄Ú±… |…¶……¥… E∆Ú{…x…“ u˘…Æ˙… ±…™…‰ M…™…‰ EÚ<« {…Ω˛±…… ∫…‰ +…∆ ∂…EÚ ∞¸{… ∫…‰ {…⁄Æ˙… EÚ™…… M…™…… * |……{…h… B¥…∆ {…Æ˙…®…∂…« ¥™…¥…∫……™… O…⁄{… +…ËÆ˙ +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… ¥™…¥…∫……™… O…⁄{… u˘…Æ˙… ∫…∆¶……±…‰ ±…‰x…n‰˘x…… E‰Ú ®…⁄±™… {…Æ˙ ¥…S……Æ˙ EÚÆ˙i…‰ Ω÷˛B 2013-14 E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ u˘…Æ˙… ∫…∆¶……±…‰ E÷Ú±… ¥™…¥…∫……™… {…UÙ±…‰ ¥…π…« E‰Ú ` 1376 EÚÆ˙…‰c˜ EÚ“ i…÷±…x…… ®… `1590 Ω˲ * 1.2. §…g¯i…‰ EÚn˘®… +…{…EÚ“ E∆Ú{…x…“ ¥…EÚ…∫… E‰Ú BEÚ =k…‰V…EÚ S…Æ˙h… ∫…r˘ EÚÆ˙i…“ Ω˲ +…ËÆ˙ BEÚ n˘“P…«EÚ… ±…EÚ ∫]≈ı…]‰ı V…EÚ ™……‰V…x…… " ¥…W…x… 2020' {…Æ˙ EÚ…®… EÚÆ˙i…“ Ω˲, V……‰ E∆Ú{…x…“ EÚ…‰ +{…x…‰ ∫]≈ı…]‰ı V…EÚ =q‰˘∂™…… EÚ…‰ {…⁄Æ˙… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ ®……M…« n˘J……i…… Ω˲ * ={…™…÷«HÚ EÚ…‰ v™……x… ®… Æ˙J…i…‰ Ω÷˛B, +…{…EÚ“ E∆Ú{…x…“ x…‰ §……W……Æ˙ |…¥…‰∂… ®… §…g¯i…“ i…x……¥… E‰Ú ∫……l… ¥™……¥…∫…… ™…EÚ M… i… ¥… v…™…… E‰Ú ¥… ¥…v…“EÚÆ˙h… ∫…‰ +±…M… Ω˛…‰EÚÆ˙ =i{……n˘x… I…®…i…… +…ËÆ˙ =i{……n˘ ±…… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 30 I. DIRECTORS’ REPORT (2013-14) The Members HLL Lifecare Ltd. The Board of Directors have pleasure in presenting the Forty-eighth (48th) Annual Report of the Company together with Audited Financial Statements for the year ended 31st March, 2014 and Auditors’ Report and the Report thereon by the Comptroller & Auditor General of India. 1. FINANCIAL PERFORMANCE 1.1. Year 2013-14 - Review For economies across the globe, financial year 2013-14 has been a very challenging one. As per the latest World Economic Outlook of International Monetary Fund (IMF), compared to the first half of 2013, the global economic activity strengthened during the second half and is expected to improve further in 2014-15, largely on account of recovery in the advanced economies. Global growth is now projected to be at around 3.6 percent in 2014, and expected to rise to 3.9 percent in 2015. On the domestic front, India’s growth has seen moderation in the last three financial years, reflecting global developments and domestic constraints. As per the latest forecast of Central Statistical Organization (CSO), the GDP growth for 2013-14 is estimated at 4.9 percent compared to 4.5 percent in 2012-13. Despite the Indian economy witnessing a slowdown, your Company continued to maintain the momentum of growth and achieved 13% growth in revenue from operations. Your Company achieved the highest ever revenue from operations of `941.68 crore during 2013-14 from `832.94 crore in the previous year. Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) increased by 8% to `78.40 crore against `72.69 crore in previous year 2012-13. Profit before Tax (PBT) was `36.24 crore vis-a-vis `37.81 crore in the previous year. Profit after Tax (PAT) was `24.83 crore vis-a-vis `30.07 crore in the previous year 2012-13. Networth increased to `403.05 crore as on 31/03/2014, 7% higher than `378.21 crore in the previous financial year corresponding date. The profit of the Company for the year 2013-14 was affected adversely, mainly due to foreign exchange loss to the tune of `10.87 crore due to US $ appreciating against Indian Rupee. Another key factor affecting the profitability has been non-revision of Government supply prices (Condoms, OCP, Pregnancy Test Kits) during last two fiscals. However, the adverse impact on profitability was partially offset by several initiatives taken by the Company. Considering the value of transactions handled by the Procurement & Consultancy Business Group and Infrastructure Development Business Group, the total business handled by the Company during 2013-14 is `1590 crore compared to `1,376 crore in the previous year. 1.2. The Way Forward Your Company is witnessing an exciting phase of growth and is working on a long term strategic plan” Vision 2020" which will steer the Company towards meeting its strategic objectives. Keeping in view the above, your Company has initiated various steps for augmenting production capacity and product line apart from diversifying business activities with enhanced stress on market penetration. Through detailed study and analysis considering the unique position of HLL in the emerging healthcare opportunities, the Company will widen product and service portfolio, increase customer base, reinforce R&D and technical capabilities, add physical infrastructure and strengthen marketing and distribution. The Company’s strategy to expand the product, service and market share could be seen as a vital step for achievement of the above objectives which is already underway through product development, service diversification and geographical expansion. The Company has made its presence in new geographies including Russia, Latin America, Africa and SAARC countries recently. Annual Report 2013-2014 31 E∆Ú{…x…“ u˘…Æ˙… +{…x…‰ °Ú…®…«∫™…⁄ ]ıEÚ±… ¥™…¥…∫……™… E‰Ú ±…B ∫¥…“EÚ…Æ˙ EÚ“ M…™…“ |…®…÷J… EÚ…™…«x…“ i…™…… ®… BEÚ Ω˲ +V…Ë ¥…EÚ ¥…EÚ…∫… * ®……S…«, 2014 E‰Ú n˘…ËÆ˙…x… ®…Ë∫…‰∫…« M……‰¥…… B∆ ]ı§……™……‰ ]ıC∫… B¥…∆ °Ú…®…«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ (V…“ B {…“ B±…), M……‰¥…… ∫…Æ˙EÚ…Æ˙ EÚ… =t®… E‰Ú 74% <ŒC¥…]ı“ ∂…‰™…Æ˙… EÚ… +V…«x… <∫… n˘∂…… EÚ“ +…‰Æ˙ EÚ… EÚn˘®… l…… * ∫…‰¥…… ¥™…¥…∫……™…… EÚ…‰ ∫…∂…HÚ EÚÆ˙x…‰ E‰Ú ±…B, +…{…EÚ“ E∆Ú{…x…“ x…‰ +|…˱…, 2014 EÚ…‰ BEÚ 100% ∫…®…x…÷π…∆M…“ E∆Ú{…x…“ BS…B±…B±… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 32 One of the key strategies adopted by the Company for its Pharmaceutical business is inorganic growth. Acquisition of 74% equity stake of M/s Goa Antibiotics & Pharmaceuticals Ltd.(GAPL), a Government of Goa undertaking, during March 2014 was a step towards this direction. For bolstering the services business, your Company has promoted a 100% subsidiary company by name HLL Infra Tech Services Ltd. [HITES] in April 2014. The subsidiary company will carry on the business of providing services namely, infrastructure Development Facilities, Management Procurement Consultancy and allied services, highlighting the intended diversification strategy. Keeping in mind its strategy to launch new products to existing customers, HLL has entered into MOUs and agreements with various domestic and global players to enhance the Research and Development capabilities. The plans for technology acquisition, modernisation, expansion, have been prepared in line with the overall strategy (Vision 2020) and are being implemented 2. DIVIDEND The Directors are pleased to recommend a dividend of `20.00 per share on the paid-up equity share capital of the Company for the financial year 2013-14, same as in last year. The total outgo on account of dividend, inclusive of dividend tax, for 2013-14 is `452.86 lakh, which represents a pay-out of 18.5% of the Company’s Profit after Tax (PAT) against the pay-out of 15% in 2012-13. 3. RATING OF HLL vis-à-vis MoU Targets Your Company’s performance has been rated as “Excellent” in terms of MoU signed with the Government of India for the year 2012-13. The Company has been getting Excellent rating consecutively since 2009-10. Based on the self-assessment, your Company is likely to achieve “Excellent” rating for the year 2013-14 as well. The Company’s MoU with Government of India for the year 2014-15 targets higher turnover and gross margin along with thrust on inclusive growth encompassing customer orientation, Human Resource Management, R&D, adoption of innovative practises, Corporate Social Responsibility and Sustainability. 4. DIVERSIFICATION/EXPANSION 4.1. MRI Scan Centres Your Company proposes to set up Diagnostic facilities and Lifecare Centre at Government Medical College, Kozhikode, Kerala, and MRI Scan facilities at Government Medical College, Trivandrum, Kerala involving an investment of `9.13 Cr. and ` 6.15 Cr. respectively. 4.2. Lifecare Centre Lifecare Centres are comprehensive medical retail outlets offering surgical implants, surgical consumables, essential life saving drugs, ophthalmic medicines and ophthalmic accessories such as lenses and frames. During the year, the Company has established Lifecare Centre in three medical college hospitals viz. VSS Medical College-Burla, MKCG Medical College, Berhampur and SCB Medical College, Cuttack. Lifecare Centres were also set up at Koyilandi in Kerala and at NIMHANS, Bangalore in Karnataka. With these Centres, the total number of Lifecare Centres has risen to 14 and gained foothold for the Company in four States. 4.3. Generic Drug Stores HLL set up a generic drug store at All India Institute of Medical Sciences, New Delhi in March 2014. This is one of the largest of its kind in the country with an ability to handle over 4000 out patients per day. 4.4. Blood Bag capacity augmentation Augmented capacity of Blood Bag production from 11.5 Mpcs to 12.5 MPcs. 4.5. Centchroman Your company augmented the Centchroman production to 1500 Kg 4.6. Design Office The Company has established a Design office for Infrastructure Development Division. Annual Report 2013-2014 33 4.7 ÀΩ˛n˘±…˧… ∫…∆S…™…x… EÂÚp˘ +…{…EÚ“ E∆Ú{…x…“ x…‰ ÀΩ˛n˘±…˧… |…™……‰M…∂……±……+… E‰Ú ±…B n˘…‰ x…B ∫…∆S…™…x… EÂÚp˘ V……‰b˜ n˘™……* 4.8. §……±…Æ˙…®…{…÷Æ˙®… {… Æ˙™……‰V…x…… ¥…π…« E‰Ú n˘…ËÆ˙…x…, BS…B±…B±… x…‰ §……±…Æ˙…®…{…÷Æ˙®… ®… {…È EÚM… +…ËÆ˙ ¶…∆b˜…Æ˙h… ∫…÷ ¥…v……+… EÚ… EÚ®…“∂…x… EÚ™……* 4.9 +…CE÷Ú±…®… °ËÚC]ıÆ˙“ ®…EÚ…x… +…{…EÚ“ E∆Ú{…x…“ x…‰ +…CE÷Ú±…®… °ËÚC]ıÆ˙“ ®… °ËÚC]ıÆ˙“ §…œ±b˜M… EÚ… x…®……«h… ∫…°Ú±…i……{…⁄¥…«EÚ {…⁄Æ˙… EÚ™……* 4.10 ¶……ËM……‰ ±…EÚ ¥…∫i……Æ˙h… • ¥…π…« E‰Ú n˘…ËÆ˙…x…, +…{…EÚ“ E∆Ú{…x…“ x…‰ ®…… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 34 4.7. Hindlab Collection Centre Your company added two new collection centres for Hindlabs laboratories. 4.8.Balaramapuram Project During the year, HLL commissioned packing and storage facilities at Balaramapuram 4.9. Akkulam Factory Building Your company has successfully completed construction of factory building at Akkulam Factory 4.10. Geographic expansion • During the year, your company expanded its market for Sutures to new territories including Micronesia, Zambia, Malaysia and Rwanda. • During the year, your company expanded its market for MOODS Condoms to new territories including Algeria, Benin and Zambia. 4.11. New Projects • The manufacturing plant for augmenting Condom capacity by 300 M.Pcs at Irapuram near Kochi in Kerala involving an investment of `28 crore will begin commercial production by July, 2014. • The project for augmenting condom manufacturing capacity at Kanagala Factory, Belgaum by 120 M.Pcs. at a project cost of `5.6 crore is expected to be completed by July, 2014. • Augmentation of manufacturing capacity for sanitary napkins at Kanagala Factory, Belgaum from 200 Million pieces to 400 Million pieces is expected to be commissioned by August 2014. • Pre-engineered building at Akkulam, Thiruvananthapuram for storage of Medical devices is expected to be completed by July 2014. 4.12. Construction of Regional Office building at Mumbai Construction of Regional Office building at Kharghar, Navi Mumbai in the land owned by the Company, involving an investment of `11.10 crore is nearing completion. 4.13. LNG Storage and Re-gasification facility at Peroorkada Factory, Thiruvananthapuram The LNG Storage and re-gasification facility being set up by the company near the Condom manufacturing facility at Peroorkada, Thiruvananthapuram in Kerala is progressing and the facility will be commissioned by end of July 2014. 4.14. Medipark The Medipark project proposed to be established in Chengalpattu near Chennai at the revised project cost of `123.55 crore is expected to get clearance from Government soon. 4.15. Purchase of land at Chennai Based on the request from the Company, Government of Tamilnadu has allotted 30 cents of Government land in Velacherry, Chennai for construction of an office building for the Company. 4.16. New Products The Brands newly launched by the Company includes: • HLL Manufactured and launched ‘Velvet’ - Female condom • ‘Feel’ – Male condom • ‘Tatkal 72’- A non hormonal emergency contraceptive pill • ‘Hinglact Rapidsorb’ - Sutures • ‘MEDIGARD‘ – Disinfectants Annual Report 2013-2014 35 • |……Æ∆˙ ¶…i… "˜ ∫…±…¥…Æ˙ - <∆]≈ı… ™…⁄]‰ı Æ˙x… b˜¥……<∫…˜' • +x…EÚ]ı ∂…“]ı ∫]‰ıV… ∫…‰ |…‰Mx…‰x∫…“ ]‰ı∫]ı EÚ]ı E‰Ú ¥… x…®……«h… E‰Ú ±…B ¥…EÚ ∫…i… |……Ët…‰ M…EÚ“* 5. ∫…‰¥…… ∫…∆ ¥…n˘… ∫…®…“I……v…“x… EÚ…±… E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ E‰Ú +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… O…⁄{… u˘…Æ˙… |……{i… ®…÷J™… ∫…‰¥…… ∫…∆ ¥…n˘… ®… x…®x… ±… J…i… ∂…… ®…±… ΩÈ˛* - • BS…B±…B±… EÚ…‰ ` 221.46 EÚÆ˙…‰c˜ EÚ“ Æ˙EÚ®… E‰Ú V…{®…‰Æ˙ °‰ÚW… - IV {… Æ˙™……‰V…x…… |…n˘…x… EÚÆ˙x……* • ¶……Æ˙i…“™… ∫…⁄S…x…… |……ˉt…‰ M…EÚ“ B¥…∆ |…§…∆v…x… ∫…∆∫l……x… - E‰ÚÆ˙±… E‰Ú ±…B EÈÚ{…∫… ¥…EÚ…∫… E‰Ú ±…B {… Æ˙™……‰V…x…… |…§…∆v…x… {…Æ˙…®…∂…«* E÷Ú±… {… Æ˙™……‰V…x…… ±……M…i… ` 160.00 EÚÆ˙…‰c˜ Ω˲* • ` 143.20 EÚÆ˙…‰c˜ EÚ“ Æ˙EÚ®… E‰Ú {…k…x…®… i…^ı…, EÚ…‰ŒSS… ®…‰ b˜EÚ±… Eڅϱ…‰V… {… Æ˙™……‰V…x…… EÚ… x…®……«h…* • {…“ B®… B∫… B∫… ¥……<« - 2 °‰ÚW… E‰Ú +v…“x… 24.2.2014 EÚ…‰ ` 81.05 EÚÆ˙…‰c E‰Ú ±…B ®…v…÷ÆË˙ ®…‰ b˜EÚ±… Eڅϱ…‰V… {… Æ˙™……‰V…x…… EÚ… =z…™…x…* 6. BS…B±…B±… +EÚ…n˘®…“ BS…B±…B±… +EÚ…n˘®…“ ¶……M…“n˘…Æ˙ ∫…∆∫l…… E‰Ú ∞¸{… ®… ¥…∑… §…ÈEÚ u˘…Æ˙… |……{…h… |…§…∆v…x… ®… |…∫i……¥… EÚB n˘…‰ EÚ…™…«GÚ®… +…™……‰ V…i… EÚÆ˙x…‰ EÚ… |…∫i……¥… n‰˘i…… Ω˲* ∫…®…“I……v…“x… +¥… v… ®… +EÚ…n˘®…“ u˘…Æ˙… +…™……‰ V…i… ®…÷J™… EÚ…™…«GÚ®… ∂…… ®…±… Ω˲ : • ∫¥……∫l™… ®…∆j……±…™… +…ËÆ˙ ¥…∑… §…ÈEÚ EÚ“ ∫…Ω˛¶…… M…i…… ∫…‰ "|……{…h… ®… x…¥……S……Æ˙ |… GÚ™……' ®… +∆i…Æ˙…«π]≈ı“™… |… ∂…I…h… EÚ…™…«GÚ®…* • ¥™…¥…∫……™… |…§…∆v…x… ∫E⁄Ú±…, E‰ÚÆ˙±… ¥…∑… ¥…t…±…™… EÚ“ ∫…Ω˛¶…… M…i…… ®… "∫……®…… V…EÚ ¥…{…h…x… - ∂…I…… ¥…n˘…Â, ∫…Æ˙EÚ…Æ˙, ∫……¥…«V… x…EÚ I…‰j… +…ËÆ˙ Bx… V…“ +…‰' EÚ“ ¶…⁄ ®…EÚ… {…Æ˙ Æ˙…π]≈ı“™… ∫…‰ ®…x……Æ˙* 7. {…÷x…& ¥…M…‘EÚÆ˙h… E‰Ú ±…B |…∫i……¥… ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ x…‰ +x…÷∫…⁄S…“ "§…“' ∫…‰ "B' ∫…“ {…“ B∫… <« EÚ“ +…‰Æ˙ BS…B±…B±… EÚ… {…÷x…& ¥…M…‘EÚÆ˙h… +…ËÆ˙ =z…™…x… E‰Ú ±…B ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ EÚ…‰ |…∫i……¥… |…∫i…÷i… EÚ™…… Ω˲ +…ËÆ˙ ™…Ω˛ |…∫i……¥… +§… ∫…Æ˙EÚ…Æ˙ E‰Ú ∫… GÚ™… ¥…S……Æ˙…v…“x… Ω˲* 8. ∂…‰™…Æ˙ {…⁄ƒV…“ 31 ®……S…«, 2014 i…EÚ E∆Ú{…x…“ EÚ“ ∂…‰™…Æ˙ {…⁄ƒV…“ `193.53 EÚÆ˙…‰c˜ Ω˲, ˛ 31 ®……S…«, 2013 EÚ…‰ ™…Ω˛ =∫…“ ∫i…Æ˙ {…Æ˙ l……* E∆Ú{…x…“, ∫…n˘∫™…… ∫…‰ +…¥…∂™…EÚ +x…÷®……‰n˘x… |……{i… EÚÆ˙x…‰ E‰Ú §……n˘ |…i™…‰EÚ `1000/- E‰Ú <ŒC¥…]ı“ ∂…™…Æ˙… EÚ…‰ 100:1 +x…÷{……i… ®… |…i™…‰EÚ ` 10/- E‰Ú +∆ EÚi… ®…⁄±™… ®… ¥…¶…… V…i… EÚÆ˙x…‰ EÚ… |…∫i……¥… n‰˘i…“ Ω˲* ∫…Æ˙EÚ…Æ˙ x…‰ {…Ω˛±…‰ Ω˛“ <∫… |…∫i……¥… EÚ…‰ +x…÷®……‰n˘x… n˘™…… Ω˲* 9. M…÷h…¥…k…… |…§…∆v…x… |…h……±…“ 9.1 M…÷h…¥…k…… |…®……h…x… E∆Ú{…x…“ E‰Ú ¥… x…®……«h… ™…⁄ x…]ı/|…¶……M…, x…“S…‰ =Œ±±… J…i… |…®……h…x… |……{i… EÚÆ˙x…… V……Æ˙“ Æ˙J…… Ω˲* • +…CE÷Ú±…®…, {…‰∞¸Æ˙EÚc˜…, EÚx…M…±……, ®…x…‰∫…Æ˙, EÚ…‰ŒSS… E‰Ú ¥… x…®……«h… ™…⁄ x…]ı… +…ËÆ˙ x……‰Bb˜… E‰Ú |……{…h… B¥…∆ {…Æ˙…®…∂…« |…¶……M… E‰Ú ±…B +…<« B∫… +…‰ 9001 : 2008 |…®……h…x…* • +…CE÷Ú±…®…, {…‰∞¸Æ˙EÚc˜…, EÚx…M…±…… +…ËÆ˙ EÚ…‰ŒSS… ®… ¥… x…®……«h… ™…⁄ x…]ı… E‰Ú ±…B +…<« B∫… +…‰ 13485 : 2003 |…®……h…x…* • +…CE÷Ú±…®…, {…‰∞¸Æ˙EÚc˜…, EÚx…M…±…… +…ËÆ˙ EÚ…‰ŒSS… E‰Ú ¥… x…®……«h… ™…⁄ x…]ı… EÚ…‰ |…¶……¥…“ {…™……«¥…Æ˙h… |…§…∆v…x… |…h……±…“ E‰Ú ±…B +…<« B∫… +…‰ 14001:2004 |…®……h…x… * • +…CE÷Ú±…®…, {…‰∞¸Æ˙EÚc˜…, EÚx…M…±…… +…ËÆ˙ EÚ…‰ŒSS… E‰Ú ™…⁄ x…]ı… EÚ…‰ ¥™……¥…∫…… ™…EÚ ∫¥……∫l™… B¥…∆ ∫…÷Æ˙I…… E‰Ú ±…B +…‰ BS… B∫… B B∫… 18001 : 2007 |…®……h…x…* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 36 • Introduced ‘Silver- Intra Uterine Device’ • Developed technology for manufacturing Pregnancy Test Kit from uncut sheet stage 5. SERVICE CONTRACTS The major service contracts received by the Infrastructure Development Group of Company during the period under review include the following: • Award of JIPMER Phase IV project to HLL for an amount of `221.46 Crores • Project Management consultancy for Development of campus for Indian Institute of Information Technology and Management – Kerala. The total project cost is `160.00 Crores. • Construction of Konni Medical College project at Pathanamthitta for an amount of `143.20 Crores • Upgradation of Madurai Medical College project under PMSSY 2nd phase for `81.05 Crores on 24.02.2014. 6. HLL ACADEMY HLL Academy proposes to conduct two programmes offered by the World Bank in procurement management as a partner institute. The major programmes conducted by the Academy during the period under review include: • International training programmes in association with Union Ministry of Health and World bank on innovation processes in procurement • National conference on “Social marketing- Role of Academics, Government, Public Sector and NGO” in association with the School of business Management, University of Kerala 7. PROPOSAL FOR RE-CATEGORIZATON During the year under review, the Company submitted proposal to Government of India for re-categorization and upgradation of HLL from Schedule ‘B’ to ‘A’ CPSE and the proposal is now under active consideration of the Government. 8. SHARE CAPITAL The share capital of the Company stood at `193.53 crore as at 31st March 2014, at the same level as it was as at 31 March, 2013. The Company proposes to split the equity shares of face value of `1,000/- each into face value of `10/- each in the ratio of 100:1 after obtaining necessary approval from Members. The Government has already approved this proposal. 9. QUALITY MANAGEMENT SYSTEMS 9.1. Quality certifications The company’s manufacturing units/divisions continue to possess the certifications mentioned below: • ISO 9001:2008 certification for manufacturing units at Akkulam, Peroorkada, Kanagala, Manesar, Kochi and Procurement & Consultancy Division at Noida. • ISO 13485:2003 certification for manufacturing units at Akkulam, Peroorkada, Kanagala and Kochi. • ISO 14001:2004 certification for manufacturing units at Akkulam, Peroorkada, Kanagala and Kochi for efficient environment management systems. • OHSAS 18001:2007 certification for units at Akkulam, Peroorkada, Kanagala and Kochi for Occupational Health and Safety. Annual Report 2013-2014 37 • +…<« B∫… +…‰ 17025 : 2005 E‰Ú +x…÷∫……Æ˙ {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… i…Ë™……Æ˙ =i{……n˘ {…Æ˙“I…h… |…™……‰M…∂……±…… E‰Ú ±…B Bx… B §…“ B±… |…i™……™…x…* • +…<« B∫… +…‰ 15189 : 2012 E‰Ú +x…÷∫……Æ˙ ÀΩ˛n˘±…˧∫…, x…<« n˘±±…“ EÚ…‰ S… EÚi∫…… {…Æ˙“I…h… E‰Ú ±…B Bx… B §…“ B±… |…i™……™…x…* • {…‰∞¸Æ˙EÚc˜… +…ËÆ˙ EÚ…‰ŒSS… ™…⁄ x…]ı… ®… ¥… x…î…i… {…÷Ø˚π… E∆Úb˜…‰®… E‰Ú ±…B ∫…“ <« ®……E«Ú • EÚ…‰ŒSS… ™…⁄ x…]ı ®… ¥… x…î…i… ®… Ω˛±…… E∆Úb˜…‰®… E‰Ú ±…B ∫…“ <« ®……E«Ú • +…CE÷Ú±…®… ™…⁄ x…]ı ®… ¥… x…î…i… §±…b˜ §…ËM… +…ËÆ˙ ∫…ÃV…EÚ±… ∫™…⁄S…‰∫…« E‰Ú ±…B ∫…“ <« ®……E«Ú* • |…‰Mx…‰x∫…“ ]‰ı∫]ı EÚ…b«˜ ({…“ ]ı“ ∫…“) E‰Ú ±…B ∫…“ <« ®……E«Ú ¥…fi k…EÚ ={…™……‰M…, ¥…fi k…EÚ ={…™……‰M… E‰Ú ±…B ®…±…‰ Æ˙™…… {…“ B°Ú EÚ…b«˜, ¥…fi k…EÚ ={…™……‰M… E‰Ú ±…B ®…±…‰ Æ˙™…… {…“ B°Ú + {…“ ¥…“ EÚ…b«˜, ¥…fi k…EÚ ={…™……‰M… E‰Ú ±…B ®…±…‰ Æ˙™…… {……x… + {…“ B°Ú EÚ…b«˜, ¥…fi k…EÚ ={…™……‰M… E‰Ú ±…B B±… BS… EÚ…b«˜, ∫¥…™…∆ {…Æ˙“I…h… E‰Ú ±…B |…‰M…x…‰x∫…“ ]‰ı∫]ı EÚ…b«˜ +…ËÆ˙ ∫¥…™…∆ {…Æ˙“I…h… E‰Ú ±…B ®…x…‰∫…Æ˙ ™…⁄ x…]ı ®… ¥… x…î…i… |…‰M…x…‰x∫…“ ]‰ı∫]ı ®…b˜∫]≈ı“®… EÚ…b«˜ * • {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“ b˜Œ§±…™…÷ BS… +…‰ 2010, +…<« B∫… +…‰ 4074 - 2002, B∫… B Bx… B∫… +…<« B∫… +…‰ 4074, B B∫… ]ı“ B®… b˜“ 3492 +…ËÆ˙ V…“ +…‰ B∫… ]ı“ - 4645 - 81 V…Ë∫…‰ +∆i…Æ˙…«π]≈ı“™… M…÷h…¥…k…… ¥… x…nÊ˘∂… +…ËÆ˙ ®……x…EÚ EÚ“ ¥™……{…EÚ ∏…‰h…“ {…⁄Æ˙… EÚÆ˙x…‰ E‰Ú +±……¥…… EÚ…<]ı ®……E«Ú, ∫…“ B®… b˜“ ∫…“ B B∫…, Bx… B°Ú ®……E«Ú =i{……n˘ |…®……h…x… |……{i… EÚÆ˙x…… V……Æ˙“ Æ˙J…“ ΩË* 9.2. M…÷h…¥…k…… ∫…÷v……Æ˙ {…Ω˛±…÷Bƒ ¥…π…« E‰Ú n˘…ËÆ˙…x…, x…®x……∆ EÚi… M…÷h…¥…k…… ∫…÷v……Æ˙ {…Ω˛±…÷Bƒ ±…™…‰ M…™…‰, • {…‰∞¸Æ˙EÚc˜…, +…CE÷Ú±…®… +…ËÆ˙ EÚx…M…±…… E‰Ú ¥… x…®……«h… ™…⁄ x…]ı… ®… ∫…C∫…˛ ∫…M®…… §±……EÚ §…‰±]ı {… Æ˙™……‰V…x……B∆* • {…‰∞¸Æ˙EÚc˜… E‰Ú ∫…C∫…˛ ∫…M®…… §±……EÚ §…‰±]ı {… Æ˙™……‰V…x……+… EÚ…‰ b≈˜M∫… Bhb˜ °Ú…®…«∫™…⁄ ]ıEÚ±∫… ∏…‰h…“ E‰Ú +v…“x… ¶……Æ˙i…“™… M…÷h…¥…k…… {… Æ˙π…n¬˘ u˘…Æ˙… "C™…÷∫…“ +…<« b˜“ B±… ∂…… EÚ®®…‰x…b‰˜∂…x… B¥……b«˜' ∫…‰ {…÷Æ˙∫EfiÚi… EÚ™…… M…™…… * 10. {…÷Æ˙∫EÚ…Æ˙ B¥…∆ ∫…®®……x… E∆Ú{…x…“ E‰Ú x…π{……n˘x… E‰Ú ∫…±… ∫…±…‰ ®… ®……x™…i…… |……{i… ¥… ¶…z… ∫…∆∫l……+… ∫…‰ {…÷Æ˙∫EÚ…Æ˙ B¥…∆ ∫…®®……x… Ω˛… ∫…±… EÚ™…‰ M…™…‰ * ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… +…{…EÚ“ E∆Ú{…x…“ u˘…Æ˙… Ω˛… ∫…±… EÚ™…‰ M…B E÷ÚUÙ {…÷Æ˙∫EÚ…Æ˙… E‰Ú ¥…¥…Æ˙h… x…“S…‰ n˘™…‰ V……i…‰ ΩÈ˛ * • Æ˙…V…¶……π…… x…“ i… E‰Ú =iEfiÚπ`ˆ EÚ…™……«x¥…™…x… E‰Ú ±…B <∆ n˘Æ˙… M……ƒv…“ Æ˙…π]≈ı“™… {…÷Æ˙∫EÚ…Æ˙ (|…l…®… {…÷Æ˙∫EÚ…Æ˙)* ™…Ω˛ {…÷Æ˙∫EÚ…Æ˙ ÀΩ˛n˘“ n˘¥…∫… E‰Ú +¥…∫…Æ˙ {…Æ˙ +…™……‰ V…i… BEÚ ∫…®……Æ˙…‰Ω˛ ®… ¶……Æ˙i… E‰Ú ∫…®®……x…x…“™… Æ˙…π]≈ı{… i… ∏…“ |…x…§… ®…÷J…V…‘ u˘…Æ˙… |…n˘…x… EÚ™…‰ M…™…‰ * • B°Ú B®… ∫…“ V…“ I…‰j… ®… "•……∆b˜ =iEfiÚπ]ıi…… {…÷Æ˙∫EÚ…Æ'˙-®…⁄b¬˜∫… • °Ú…®…«∫™…⁄ ]ıEÚ±… I…‰j… ®… "•……∆b˜ =iEfiÚπ]ıi…… {…÷Æ˙∫EÚ…Æ˙' - ∫…Ω‰˛±…“ • + J…±… ¶……Æ˙i…“™… Æ˙§…c˜ <∆b˜∫]≈ı“∫… B∫……‰ ∫…™…‰∂…x… ∫…‰ "=SS… x…™……«i… {…÷Æ˙∫EÚ…Æ˙-+∫{…i……±… +…ËÆ˙ ∫¥…SUÙ =i{……n˘' • b˜…Ï.B®….+™™…{{…x…, +v™…I… B¥…∆ |…§…∆v…EÚ x…n‰˘∂…EÚ, BS…B±…B±… x…‰ b˜“ ∫…“ §…÷C∫… u˘…Æ˙… ∫…∆∫l…… {…i… '¥™……¥…∫…… ™…EÚ x…‰i…fii¥… {…÷Æ˙∫EÚ…Æ˙' Ω˛… ∫…±… EÚ™……* • ]≈ı…¥…x…EÚ…‰Æ˙ |…§…∆v…x… B∫……‰ ∫…™…‰∂…x… u˘…Æ˙… ∫…∆∫l…… {…i… "®…Ëx…‰V…Æ˙ +…Ï°Ú n˘ <™…Æ˙ 2014˙' {…÷Æ˙∫EÚ…Æ b˜…Ï.B®….+™™…{{…x… EÚ…‰ |……{i… Ω÷˛+… * • Æ˙…π]≈ı“™… ∫…∆Æ˙I…… {… Æ˙π…n¬˘, EÚx……«]ıEÚ… S…Ë{]ıÆ˙ u˘…Æ˙… §…b‰˜ =t…‰M… EÚ“ ∏…‰h…“ ®… ∫…∆∫l…… {…i… 2012-2013 E‰Ú ±…B =z…i… ∫…÷Æ˙I…… {…÷Æ˙∫EÚ…Æ˙ BS…B±…B±…-E‰Ú B°Ú §…“ x…‰ V…“i… ±…™…… * • |… i…Œπ`ˆi… B∫… B {…“ B ∫…“ <« ¥…∂…‰π… ®……x™…i…… {…÷Æ˙∫EÚ…Æ˙ * • E‰ÚÆ˙±… |…§…∆v…x… B∫……‰ ∫…™…‰∂…x… ∫…‰ +…<« ]ı“ ™…⁄∫…Æ˙ +…Ï°Ú n˘ <™…Æ˙ B¥……b«˜ * • i…Ø˚¥…x…∆i…{…÷Æ˙®… |…§…∆v…x… B∫……‰ ∫…™…‰∂…x…, i…Ø˚¥…x…∆i…{…÷Æ˙®… ∂…Ω˛Æ˙ u˘…Æ˙… ∫…∆∫l…… {…i… ]ı“ B®… B x…¥……S……Æ˙ E‰Ú ±…B {…÷Æ˙∫EÚ…Æ˙ * • E‰ÚÆ˙±… |…n⁄˘π…h… x…™…∆j…h… §……‰b«˜ u˘…Æ˙… ∫…∆∫l…… {…i… §…c‰˜ =t…‰M… ∏…‰h…“ ®… |…n⁄˘π…h… x…™…∆j…h… EÚ…™…«EÚ±……{…… E‰Ú ¥…π…« 2013 E‰Ú |…l…®… {…÷Æ˙∫EÚ…Æ˙ E‰Ú ±…B BS…B±…B±…-{…“ B°Ú ]ı“ Ω˛EÚn˘…Æ˙ §…x… M…™…… * • M……‰±b˜ı ∏…‰h…“ ®… ¶……Æ˙i…“™… +…Ët…‰ M…EÚ <∆V…“ x…™…ÀÆ˙M… ∫…∆∫l…… u˘…Æ˙… ∫…∆∫l…… {…i… '=iEfiÚπ]ı x…π{……n˘x… {…÷Æ˙∫EÚ…Æ˙-2012' |…n˘k… EÚ™…… M…™…… * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 38 • NABL accreditation for finished products testing laboratory at Peroorkada Factory, Thiruvananthapuram in accordance with ISO 17025:2005. • NABL accreditation for medical testing at HINDLABS, New Delhi in accordance with ISO 15189:2012. • CE mark for Male Condoms produced at Peroorkada and Kochi Units • CE mark for Female Condoms produced at Kochi Unit • CE mark for Blood Bags and Surgical Sutures produced at Akkulam Unit. • CE mark for Pregnancy Test Cards (PTC)- professional use, Malaria Pf Card for Professional Use, Malaria Pf+Pv Card for Professional Use, Malaria Pan+Pf Card for Professional Use, LH Card for Professional Use, Pregnancy Test Card for Self Testing and Pregnancy Test Midstream Card for Self Testing produced at Manesar Unit. • Peroorkada Factory continues to possess product certifications KITE mark, CMD CAS, NF mark besides meeting a wide range of international quality specifications and standards such as WHO 2010, ISO 4074-2002, SANS ISO 4074, ASTM D 3492 and GOST-4645-81. 9.2. Quality Improvement Initiatives During the year, following quality improvement initiatives were under taken: • Six Sigma Black Belt Projects for manufacturing Units at Peroorkada, Akkulam and Kanagala. • Six Sigma Black Belt project of Peroorkada was awarded with “QCI DL SHAH COMMENDATION AWARD” by Quality Council of India under the category of Drugs & Pharmaceuticals. 10. AWARDS & RECOGNITIONS The Awards and Recognitions received from various organizations of repute speak volumes about the Company’s performance. Some of the Awards won by your Company during the year 2013-14 are mentioned below: • Indira Gandhi National Award (1st prize) for excellent implementation of Official Language Policy. The award was presented by Shri Pranab Mukherjee, Hon’ble President of India at a function organized on the occasion of Hindi Divas • Brand excellence award in the FMCG sector – MOODS • Brand excellence award in the pharmaceutical sector- Saheli • “Top export awards- Hospital and Hygienic products” from all India Rubber Industries Association • Dr. M. Ayyappan, C&MD HLL bagged the “Professional Leadership Award” instituted by DC Books • Manager of the Year 2014 Award to Dr.M.Ayyappan, C&MD instituted by Travancore Management Association • HLL- KFB won the Unnatha Suraksha Praskara for 2012-2013 in large scale industry instituted by National Safety Council, Karnataka chapter • Prestigious SAP ACE special recognition award • IT user of the year award from the Kerala Management Association • TMA award for Innovation instituted by the Trivandrum Management Association Thiruvananthapuram city • HLL- PFT bagged the first prize for pollution control activities in the category of large scale industries, instituted by Kerala State Pollution Control Board for the year 2013 • Conferred the “Performance Excellence Award 2012” instituted by the Indian Institute of Industrial engineering in the Gold category. Annual Report 2013-2014 39 11. ∫…⁄S…x…… |……Ët…‰ M…EÚ“ <« +…Æ˙ {…“ EÚ…™……«x¥…™…x… E‰Ú +…M…‰ (§…c˜“ {… Æ˙™……‰V…x…… E‰Ú ±…B +SUÙ…) 27 x…¥…∆§…Æ˙, 2013 EÚ…‰ |……Æ∆˙ ¶…i… |…l…®… x… ¥…n˘… E‰Ú ∫……l… +…{…EÚ“ E∆Ú{…x…“ x…‰ <«- x… ¥…n˘… (B∫… B {…“-B∫… +…Æ˙ B®… 7.0.2) ±……<¥… EÚ™…… Ω˲ * EÚ®…«S……Æ˙“ ∫¥…™…∆-∫…‰¥…… (<« B∫… B∫…) +…ËÆ˙ |…§…∆v…EÚ ∫¥…™…∆-∫…‰¥…… (B®… B∫… B∫…) V…Ë∫…‰ ®……Ïb˜¨⁄±∫…, EÚ“ {…Ω÷ƒ˛S… EÚ∫…“ ¶…“ V…M…Ω˛ EÚ∫…“ ∫…®…™… <∆]ıÆ˙x…‰]ı E‰Ú ®……v™…®… ∫…‰ EÚÆ˙x…‰ EÚ…‰ {… Æ˙ x…™……‰ V…i… EÚ“ M…™…” * B‰Æ˙…{…÷Æ˙®… EÚ“ x…<« °ËÚC]ıÆ˙“ ®… B∫… B {…“ ∫……‰±™…⁄∂…x… ¶…“ ¥…∫i……Æ˙ EÚ™…… M…™……* BS…B±…B±… B∫… B {…“ ¥……Ãπ…EÚ O……Ω˛EÚ =iEfiÚπ]ıi…… {…÷Æ˙∫EÚ…Æ˙ 2013 - ±……‰EÚ ∫…‰¥…… +…ËÆ˙ Æ˙…π]≈ı x…®……«h… ®… B∫… B {…“ ∫……‰±™…⁄∂…x… E‰Ú ±……¶… E‰Ú ±…B ¥…∂…‰π… ®……x™…i…… {…÷Æ˙∫EÚ…Æ˙ E‰Ú ±…B Ω˛EÚn˘…Æ˙ §…x… M…™…… * BS…B±…B±… x…‰ BEÚ =t®… E‰Ú ∞¸{… ®… E‰Ú B®… B-x……∫…EÚ…‰®… +…<« ]ı“ ™…⁄∫…Æ˙ B¥……b«˜ 2013 |……{i… EÚ™……, =x…EÚ“ O……Ω˛EÚ…Â +…ËÆ˙ Ω˛i…v……Æ˙EÚ…Â EÚ…‰ ®…Ω˛i¥…{…⁄h…« ¥™…¥…∫……™… ®…⁄±™… EÚ…‰ |…‰ π…i… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ ∫…⁄S…x…… |……Ët…‰ M…EÚ“ EÚ…‰ ∫…°Ú±…i……{…⁄¥…«EÚ ±……¶… =`ˆ…™…… * 12. ®……x…¥… ∫…∆∫……v…x… 12.1. ®……x…¥… ∫…∆∫……v…x… ¥…EÚ…∫… +…{…EÚ“ E∆Ú{…x…“ +{…x…“ i……EÚi… E‰Ú ∞¸{… ®… +{…x…‰ EÚ®…«S…… Æ˙™…… EÚ…‰ ®……x…i…“ Ω˲ +…ËÆ˙ EÚ®…«S…… Æ˙™…… E‰Ú |… ∂…I…h… +…ËÆ˙ ¥…EÚ…∫… EÚ…‰ =SS… |……l… ®…EÚi…… n‰˘i…“ Ω˲ * ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ x…‰ EÚ…™…«{……±…EÚ…Â E‰Ú ±…B 1243.5 EÚ…™…« n˘¥…∫… +…ËÆ˙ EÚ…®…M……Æ˙… E‰Ú ±…B 2224 EÚ…™…« n˘¥…∫… EÚ…‰ ∂…… ®…±… EÚÆ˙E‰Ú ¥… ¥…v… |… ∂…I…h… EÚ…™…«GÚ®… +…™……‰ V…i… EÚ™…‰ l…‰ * 12.2. +…Ët…‰ M…EÚ ∫…∆{…E«Ú ¥…π…« 2013-14 ®… {…UÙ±…‰ ¥…π…« E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ ®… ∫……ËΩ˛…n«˘{…⁄h…« +…Ët…‰ M…EÚ ∫…∆§…∆v… ∫l…… {…i… EÚ™…… M…™…… * 12.3 +x…÷∫…⁄ S…i… V…… i…/+x…÷∫…⁄ S…i… V…x…V…… i…/+x™… {…UÙc˜… ¥…M…« +…ËÆ˙ ∂……Æ˙“ Æ˙EÚ i……ËÆ˙ {…Æ˙ ¥…EÚ±……∆M… ¥™… HÚ™…… E‰Ú ±…B +…Æ˙I…h… +…{…EÚ“ E∆Ú{…x…“ +x…÷∫…⁄ S…i… V…… i…, +x…÷∫…⁄ S…i… V…x…V…… i… +…ËÆ˙ +x™… {…UÙc‰˜ ¥…M…« E‰Ú +…Æ˙I…h… ∫…‰ ∫…∆§…∆ v…i… ∫…®…™…-∫…®…™… {…Æ˙ ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… V……Æ˙“ EÚ™…‰ Æ˙…π]≈ı{… i… E‰Ú x…nÊ˘∂…… +…ËÆ˙ ®……M…« x…nÊ˘˘∂…… EÚ… +I…Æ˙∂…& +x…÷∫…Æ˙h… EÚ™…… V…… Æ˙Ω˛… Ω˲* 1.4.2014 i…EÚ E‰Ú E÷Ú±… EÚ®…«S……Æ˙“ ∂… HÚ E‰Ú +x…÷∫…⁄ S…i… V…… i…/ +x…÷∫…⁄ S…i… V…x…V…… i…/+x™… {…UÙc˜… ¥…M…«/∂……Æ˙“ Æ˙EÚ i……ËÆ˙ {…Æ˙ ¥…EÚ±……∆M… ¥™… HÚ™…… E‰Ú |… i… x… v…i¥… x…“S…‰ n˘™…‰ V……i…‰ ΩÈ˛ * ¥…¥…Æ˙h… EÚ®…«S…… Æ˙™…… EÚ“ ∫…∆J™…… |… i… x… v…i¥… : +x…÷∫…⁄ S…i… V…… i… 288 +x…÷∫…⁄ S…i… V…x…V…… i… 74 +x™… {…UÙc˜… ¥…M…« 424 ∂……Æ˙“ Æ˙EÚ ∞¸{… ∫…‰ ¥…EÚ±……∆M… 37 +x™… ¥…M…« 1008 EÚ®…«S…… Æ˙™…… EÚ“ E÷Ú±… ∫…∆J™…… 1831 12.4. EÚ®…«S…… Æ˙™…… E‰Ú ¥…¥…Æ˙h… ¥…k…“™… ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ (EÚ®…«S…… Æ˙™…… E‰Ú ¥…¥…Æ˙h…) ∫…∆∂……‰v…x… x…™…®…, 2011 E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙…˜ 217 (2 B) E‰Ú +v…“x… x…v……« Æ˙i… Æ˙EÚ®… E‰Ú + i… Æ˙HÚ {…… Æ˙∏… ®…EÚ EÚ“ |……Œ{i… ®… E∆Ú{…x…“ E‰Ú EÚ…‰<« EÚ®…«S……Æ˙“ x…Ω˛” Ω˲ * 12.5. EÚ…™…«∫l…±… ®… ±…È M…EÚ =i{…“c˜x… E‰Ú Æ˙…‰EÚl……®… +…ËÆ˙ x…π…‰v… {…Æ˙ x…“ i… BS…B±…B±… À±…M… ¶…‰n˘¶……¥… E‰Ú §…x…… ∫…¶…“ EÚ…‰ ∫…®……x… +¥…∫…Æ˙ |…n˘…x… EÚÆ˙x…‰ E‰Ú BEÚ |… i…§…r˘ x…™……‰HÚ… Ω˲ +…ËÆ˙ <∫…E‰Ú ∫…®…l…«x… EÚÆ˙x…‰ E‰Ú ∫…±… ∫…±…‰ ®…Â, E∆Ú{…x…“ =i{…“c˜x… +…ËÆ˙ ¶…‰n˘¶……¥… Æ˙ Ω˛i… EÚ…™…«∫l…±… i…Ë™……Æ˙ EÚÆ˙x…‰ E‰Ú ±…B o˘g¯i…… ∫…‰ |… i…§…r˘ Ω˲ * E∆Ú{…x…“ EÚ…‰ EÚ∫…“ i…Æ˙Ω˛ E‰Ú ±…È M…EÚ =i{…“c˜x… E‰Ú |… i… ∂…⁄⁄x™… ∫… Ω˛πh…÷i…… o˘Œπ]ıEÚ…‰h… Ω˲ * x…™…‰ |…EÚ…Æ˙ ∫…‰ |……∞¸ {…i… "EÚ…™…«∫l…±… {…Æ˙ ®… Ω˛±……+… EÚ… ±…È M…EÚ =i{…“c˜x…' (Æ˙…‰EÚl……®…, x…π…‰v… +…ËÆ˙ x…¥……Æ˙h… + v… x…™…®… B¥…∆ x…™…®…, 2013) E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ x…‰ +{…x…“ ±…È M…EÚ =i{…c˜“x… E‰Ú Æ˙…‰EÚl……®… EÚ“ x…“ i… ∫…∆∂……‰ v…i… EÚ“ * ™…Ω˛ x…“ i… EÚ…™…«∫l…±… {…Æ˙ ®… Ω˛±……+… E‰Ú ±…È M…EÚ =i{…“c˜x… +…ËÆ˙ B‰∫…“ ∂…EÚ…™…i…… E‰Ú Æ˙…‰EÚl……®… +…ËÆ˙ x…¥……Æ˙h… E‰Ú |… i… ∫…÷Æ˙I…… |…n˘…x… EÚÆ˙i…“ Ω˲ * E∆Ú{…x…“ x…‰ ={…™…÷«HÚ + v… x…™…®…… E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙ ∫…¶…“ ™…⁄ x…]ı… ®… ∫… ®… i…™……ƒ ∫…∆∫l…… {…i… EÚ“ ΩÈ˛ * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 40 11. INFORMATION TECHNOLOGY In continuation to the ERP implementation (Good to Great Project) your Company has gone live in e-tendering (SAP-SRM 7.0.2) with the first tender floated on 27th November 2013. Modules like Employee Self- Service (ESS) and Manager Self-service (MSS) were deployed over internet for anytime, anywhere access to the system. SAP solution has also been extended to the new factory at Irapuram. HLL won the SAP Annual Customer Excellence award 2013-Special Recognition Award for leveraging SAP Solutions in Public Service and Nation Building. HLL has also won the KMA-NASSCOM IT user award 2013 as an enterprise which has successfully leveraged Information Technology to deliver significant business value to their customers and stakeholders. 12. HUMAN RESOURCES 12.1. Human Resources Development Your Company regards its employees as its strength and accords high priority to training and development of employees. During the year under review, the Company had organized various training programmes involving 1243.5 man days for Executives and 2224 man days for workmen. 12.2. Industrial Relations The year 2013-14 witnessed harmonious industrial relations in the company as in the previous years. 12.3. Reservation for SC/ST/OBC and physically challenged Your Company has been following the Presidential Directives and Guidelines issued by the Government of India from time to time regarding the reservation of SCs, STs and OBCs, in letter and spirit. The representation of SC/ ST/OBC/Physically Challenged categories in the total employee strength as on 01.04.2014 is given below: Description No. of employees Representation of : SC 288 ST 74 OBC 424 Physically challenged 37 Other categories 1008 Total strength of employees 1831 12.4. Particulars of Employees During the financial year 2013-14, no employee of the Company was in receipt of remuneration in excess of the sum prescribed under Section 217 (2A) of the Companies Act, 1956, read with the Companies (Particulars of Employees) Amendment Rules, 2011. 12.5. Policy on Prevention & Prohibition of Sexual Harassment at Workplace HLL is a committed employer, giving equal opportunity to all without gender discrimination and in order to support this, the Company is strongly committed to creating a harassment and discrimination free workplace. The Company has a ‘zero-tolerance’ approach towards any act of sexual harassment. In line with the newly drafted ‘Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal Act and Rules’, 2013, the Company revised its policy for the prevention of sexual harassment. The Policy provides for protection against sexual harassment of women at workplace and for prevention and redressal of such complaints. The Company has constituted committees in all Units in line with the provisions of the above Act. These Committees are chaired by female employees and female employees comprise fifty percent of the total strength of the Committee. The Company has also incorporated provisions relating to redressal of sexual harassment at workplace in the Conduct, Discipline and Appeal Rules, 1979 followed by the Company and in the certified Standing Orders. No complaints have been received during the year under report. Annual Report 2013-2014 41 12.6. 31.03.2014 i…EÚ ¥…EÚ±……∆M… ¥™… HÚ™…… E‰Ú ±…B +…Æ˙ I…i… {…n˘… E‰Ú EÚ…™……«x¥…™…x… EÚ“ Œ∫l… i… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ¥…EÚ±……∆M… ¥™… HÚ™…… E‰Ú ±…B +…Æ˙ I…i… ¥…i…«®……x… ®… ¥…EÚ±……∆M… ¥™… HÚ™…… E‰Ú {…n˘… EÚ“ Œ∫l… i… ±…B Æ˙J…‰ {…n˘… EÚ“ Œ∫l… i… {…Ω˛S……x… EÚ“ M…™…“ E÷Ú±… {…n˘… EÚ“ +∆v……{…x… J…Æ˙…§… ±……‰EÚ…‰®……‰]ıÆ˙ +∆v……{…x… J…Æ˙…§… ±……‰EÚ…‰®……‰]ıÆ˙ ∫…∆J™…… ™…… +±{… ∫…÷x…¥……<« ¥…EÚ±……∆M…i…… ™…… +±{… ∫…÷x…¥……<« ¥…EÚ±……∆M…i…… o˘Œπ]ı ™…… ®…Œ∫i…πEÚ o˘Œπ]ı ™…… ®…Œ∫i…πEÚ {…I……P……i… {…I……P……i… 1377 13 14 14 3 9 26 13. EÚ…Ï{……ÊƉ˙]ı ∫…∆S……Æ˙ +…{…EÚ“ E∆Ú{…x…“ x…‰ +{…x…‰ +…{…EÚ…‰ Æ˙…π]≈ı x…®……«h… EÚ…‰ ∫¥……∫l™…Æ˙I…… =i{……n˘ B¥…∆ ∫…‰¥……+… E‰Ú |…n˘…™…EÚ E‰Ú ∞¸{… ®… ®……ËV…⁄n˘ Æ˙J…x…‰ EÚ“ +…‰Æ˙ §…Ω÷˛i… ∫…‰ ∫…∆S……Æ˙ Ω˛∫i…I…‰{… +{…x……™…“ Ω˲ * P……‰π…h……, +ti…x…, ={…±…Œ§v…™……ƒ, ¥…fi r˘, |…S……±…x……i®…EÚ +…ËÆ˙ ¥…k…“™… ®……‰S…Ê {…Æ˙ Ω˛…±… Ω˛“ E‰Ú ¥…EÚ…∫… ∫…∆§…∆ v…i… ∫…⁄S…x…… +…ËÆ˙ §……i…S…“i… ∫…¶…“ Ω˛i…v……Æ˙EÚ…Â E‰Ú ∫……l…˙ ∫…÷EÚÆ˙˙Ú|…∫……Æ §…x……x…‰ EÚ“ o˘Œπ]ı ∫…‰ ¥…‰§…∫……<]ı {…Æ˙Ú +ti…x… EÚÆ˙x…‰ E‰Ú + i… Æ˙HÚ +…{…EÚ“ E∆Ú{…x…“ u˘…Æ˙… x…™… ®…i… |…‰∫… ¥…Y…Œ{i…™……ƒ V……Æ˙“ EÚ“ M…<« Ω˲∆ +…ËÆ˙ EÚ®…«S…… Æ˙™…… E‰Ú ∫……l… |…§…∆v… E‰Ú + ¶…®…÷J… §……i…S…“i… EÚ… ¶…“ +…™……‰V…x… EÚ™…… M…™…… Ω˲* E∆Ú{…x…“ E‰Ú EÚ®…«S…… Æ˙™…… EÚ…‰ E∆Ú{…x…“ E‰Ú o˘Œπ]ıEÚ…‰h…, ±…I™… +…ËÆ˙ EÚ…™…«x…“ i…™…… E‰Ú §……Ɖ˙ ®… ∫…®…Z…x…‰ +…ËÆ˙ O…Ω˛h… EÚÆ˙x…‰ EÚ…‰ ∫…I…®… §…x……x…‰ ®… +…∆i… Æ˙EÚ ∫…∆S……Æ˙ ®…÷J™… ¶…⁄ ®…EÚ… x…¶……i…… Ω˲* <∫… =q‰˘∂™… EÚ“ +…‰Æ˙ +…{…EÚ“ E∆Ú{…x…“ x…‰ ±…M……i……Æ˙ ®…… ∫…EÚ x™…⁄W…±…‰]ıÆ˙, ∫…“ B®… b˜“ EÚ“ ¥…Y…Œ{i…, ¥…EÚ…∫…, ={…±…Œ§v…™……ƒ +…ËÆ˙ P…]ıx……Bƒ, |…§…∆v… E‰Ú o˘Œπ]ıEÚ…‰h… EÚ®…«S…… Æ˙™…… EÚ…‰ +¥…M…i… EÚÆ˙…x…‰ ¥……±…“ M…fiΩ˛ {… j…EÚ…Bƒ, V…Ë∫…‰ ∫…∆S……Æ˙ ={…EÚÆ˙h…… EÚ…‰ ±…M……i……Æ˙ °ËÚ±……™…… Ω˲ +…ËÆ˙ EÚ®…«S…… Æ˙™…… EÚ…‰ BS…B±…B±… E‰Ú ∫……l… ¶……M… ±…‰x…‰ +…ËÆ˙ ∫…Ω˛™……‰M… EÚÆ˙x…‰ ®… M…¥…« ®…Ω˛∫…⁄∫… EÚÆ˙x…‰ E‰Ú ±…B BEÚ ®…∆S… ¶…“ |…n˘…x… EÚÆ˙i…… Ω˲* +…{…∫…‰ Ω˛…=∫… ∫…j… ¶…“ x…™… ®…i… ∞¸{… ∫…‰ +…™……‰ V…i… EÚ™…… V……i…… Ω˲, V…Ω˛…ƒ +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ +…ËÆ˙ x…n‰˘∂…EÚ EÚ®…«S…… Æ˙™…… E‰Ú ∫……l… §……i…S…“i… EÚÆ˙i…‰ ΩÈ˛* ∫…⁄S…x…… EÚ… ™…Ω˛ ∂…‰™…ÀÆ˙M… ∫…∆§…xv… +…ËÆ˙ +…{…∫…“ ¥…∑……∫… EÚ“ ¶……¥…x…… |…n˘…x… EÚÆ˙i…… Ω˲ * 14. ∫…®…x…÷π…∆M…“ E∆Ú{… x…™……ƒ +…{…EÚ“ E∆Ú{…x…“ EÚ…‰ <∫…“ i……Æ˙“J… {…Æ˙ i…“x… ∫…®…x…÷π…∆M…“ E∆Ú{… x…™……ƒ ΩÈ˛ * 14.1. BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ (BS… §…“ B±…) BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ (BS… §…“ B±…), ®……S…«, 2012 EÚ…‰ |……Æ∆˙ ¶…i… 100% ∫…®…x…÷π…∆M…“ E∆Ú{…x…“, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú ¥…Ë ∑…EÚ ]ı“EÚ…EÚÆ˙h… EÚ…™…«GÚ®… (™…÷ +…<« {…“) E‰Ú ±…B +{…‰ I…i… ¥…ËŒC∫…x…… +…ËÆ˙ x…¥……Æ˙h…“™… §…“®…… Æ˙™…… E‰Ú |… i… +x™… x…™…“ {…“g¯“ ¥…ËŒC∫…x…… E‰Ú ¥… x…®……«h… E‰Ú ±…B ` 594 EÚÆ˙…‰c˜ EÚ“ {… Æ˙™……‰V…x…… ±……M…i… {…Æ˙ S…‰z…Ë E‰Ú {……∫… S…ÂM…±…{…‰^ı ®… +…i™……v…÷ x…EÚ ∫…÷ ¥…v……¥……±…‰ BEÚ <∆]ıO…‰]ıb˜ ¥…ËC∫…“x… EÚ…Ï®{±…‰C∫… (+…<« ¥…“ ∫…“) EÚ…‰ ∫…∆∫l…… {…i… EÚÆ˙ Æ˙Ω˛“ Ω˲ * ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… Æ˙…π]≈ı“™… ®…Ω˛i¥… EÚ“ {… Æ˙™……‰V…x…… E‰Ú ∞¸{… ®… P……‰ π…i… <∫… +…<« ¥…“ ∫…“ EÚ… x…®……«h… {…⁄Ɖ˙ V……‰Æ˙… {…Æ˙ §…g¯ Æ˙Ω˛… Ω˲ * 14.2. M……‰¥…… B∆ ]ı§……™……‰ ]ıC∫… Bhb˜ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ (V…“ B {…“ B±…) ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, +…{…EÚ“ E∆Ú{…x…“ x…‰ °Ú…®……« I…‰j… ®… BS…B±…B±… u˘…Æ˙… ±… I…i… ¥…fi r˘ E‰Ú +x…÷∫……Æ˙ BS…B±…B±… EÚ“ °Ú…®……« ¥… x…®……«h… I…®…i……+… EÚ…‰ §…g¯…x…‰ E‰Ú ±…B ®…Ë∫…‰∫…« M……‰¥…… B∆ ]ı§……™……‰ ]ıC∫… Bhb˜ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ (V…“ B {…“ B±…), M……‰¥…… ∫…Æ˙EÚ…Æ˙ EÚ… BEÚ ∫……¥…«V… x…EÚ =t®… E‰Ú 74 |… i…∂…i… |…n˘k… ∂…‰‰™…Æ˙ {…⁄ƒV…“ EÚ…‰ + v…O…Ω˛h… EÚ™…… Ω˲ * V…“ B {…“ B±… EÚ…‰ ]ı⁄B®…-{…‰x…Ê®…, M……‰¥…… ®… ¥… x…®……«h… ∫…∆™…∆j… Ω˲* E∆Ú{…x…“ b≈˜…<« {……=b˜Æ˙, <∆V…‰C]ı §…±∫…, E‰Ú{∫™…⁄⁄±∫…, M……‰ ±…™……ƒ +…ËÆ˙ +…‰Æ˙±… ±…ŒC¥…b˜ ®… °Ú…®…«∫™…⁄ ]ıEÚ±… ∫…⁄j…“EÚÆ˙h… EÚ… ¥… x…®…«…h… EÚÆ˙i…“ Ω˲ * BS…B±…B±… u˘…Æ˙… 74% ∫……®™…… ∂…‰™…Æ˙… E‰Ú + v…O…Ω˛h… E‰Ú §……n˘ V…“ B {…“ B±… E‰Ú §……‰b«˜ ®… BS…B±…B±… E‰Ú S……Æ˙ x…… ®…i… x…n‰˘∂…EÚ…Â EÚ…‰ ∂…… ®…±… EÚ™…… M…™…… +…ËÆ˙ BS…B±…B±… E‰Ú +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ, b˜…Ï.B®….+™™…{{…x… EÚ…‰ V…“ B {…“ B±… E‰Ú +v™…I… E‰Ú ∞¸{… ®… i…Ëx……i… EÚ™…… M…™……* V…“ B {…“ B±… EÚ…‰ + v…EÚ…Æ˙ ®… ±…‰x…‰ ∫…‰ BS…B±…B±… EÚ…‰ x…®x……∆ EÚi… °Ú…™…n‰˘ |……{i… Ω˛…ÂM…‰ * • +±{……¥… v… ®… ®…÷J™… {…⁄ƒV…“ x…¥…‰∂… E‰Ú §…x…… BEÚ ∫…∆{…⁄h…« °Ú…®……« ∫…÷ ¥…v…… * • §…Ω÷˛i… ∫…‰ =i{……n˘… EÚ“ ={…±…§v…i…… * • V…“ B {…“ B±… EÚ…‰ BEÚ ∫l…… {…i… °Ú…®……« ¥… x…®……«h… ∫…÷ ¥…v…… Ω˲, +i…& x…EÚ]ı ¶… ¥…π™… E‰Ú ±…B BS…B±…B±… EÚ“ °Ú…®……« +{…‰I……+… EÚ…‰ {…⁄Æ˙… EÚÆ˙x…‰ EÚ“ |…i…“I…… Ω˲ * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 42 12.6. Status of implementation of posts reserved for persons with disabilities in HLL Lifecare Limited as on 31.03.2014 HLL LIFECARE LIMITED No. of post reserved for PwDs No. of post currently held by PwDs Total number of posts Blindness Hearing Locomotor Blindness Hearing Locomotor identified or low impared disability or or low impaired disability or] vision cerebral vision or cerebral palsy palsy 1377 13 14 14 3 9 26 13. CORPORATE COMMUNICATIONS Your Company has adopted a number of communication interventions to present itself as a provider of healthcare products and services contributing to nation building. In order to facilitate dissemination of information and interaction with all stakeholders regarding announcements, updates, achievements, growth, recent developments on operational and financial front, besides updates on website, regular press communiqué have been issued by your Company and face interaction of the management with employees is also arranged. Internal communications play a key role in enabling employees across the Company in understanding and embracing the Company’s mission, goals and strategies. Towards this objective, your Company has continuously deployed communication tools such as monthly newsletters, C&MD’s communiqué, house journals to apprise the employees of the developments, achievements & events, viewpoints of the management and also provide a platform to employees to participate and take pride in being associated with HLL. Open house sessions are also regularly organised where C&MD and Directors of your Company interact with all the employees. This sharing of information contributes towards a sense of belonging and mutual trust. 14. SUBSIDIARY COMPANIES Your Company has three subsidiary companies as on date. 14.1. HLL Biotech Limited (HBL) HLL Biotech Limited (HBL), the 100% subsidiary company incorporated in March 2012, is setting up a state-of-the- art Integrated Vaccine Complex (IVC) at Chengalpattu near Chennai to manufacture vaccines required for Universal Immunization Programme (UIP) of Government of India and other new generation vaccines against preventable diseases at a project cost of `594 crore. The construction of IVC which is declared as a ‘Project of National Importance’ by Government of India is going on in full swing. 14.2. Goa Antibiotics & Pharmaceuticals Ltd. (GAPL) During the year under review, your Company has acquired 74% of paid-up share capital of M/s.Goa Antibiotics & Pharmaceuticals Ltd. (GAPL), a Public Sector Undertaking of Government of Goa, for enhancing the Pharma manufacturing capabilities of HLL in line with the growth targeted by HLL in Pharma sector. GAPL has manufacturing plant at Tuem-Pernem, Goa. Company manufactures pharmaceutical formulations in Dry powder Injectables, Capsules, Tablets and liquid oral. Post- acquisition of 74% equity shares by HLL, four Nominee Directors of HLL were inducted on the Board of GAPL and Dr M. Ayyappan, C & MD of HLL was appointed as the Chairman of GAPL. The following are the advantages that HLL would gain by taking over GAPL: • A full-fledged Pharma facility without major capital investments envisaged in short term. • Availability of a basket of products. • GAPL is an established Pharma manufacturing facility; hence expected to fulfill HLL’s Pharma requirements for the near future. Annual Report 2013-2014 43 • BS…B±…B±… EÚ“ +{…‰I……+… E‰Ú +x…÷∫……Æ˙ x…EÚ]ı ¶… ¥…π™… ®…Â Ω‰˛§∫…« Bhb˜ §…‰Æ˙“∫… E‰Ú =i{……n˘… E‰Ú ±…B +…™…÷¥…Ên˘ =i{……n˘x… ∫…÷ ¥…v……+… EÚ“ ={…±…§v…i…… EÚ…‰ ={…™……‰M… EÚ™…… V…… ∫…EÚi…… Ω˲ * • +SU“ +¥…∫…∆Æ˙S…x…… (∫…∆™…∆j… +…ËÆ˙ <®……Æ˙i…) EÚ“ ={…±…§v…i…… EÚ®… ±……M…i… {…Æ˙ x…¥…“EÚÆ˙h… +…ËÆ˙ =z…™…x… E‰Ú ±…B EÚ…™…«I…‰j…˙ |…n˘…x… EÚÆ˙i…… Ω˲ * • V…“ B {…“ B±… E‰Ú ®…Ω˛i¥…{…⁄h…« ∫…∆ S…i… x…÷C∫……x… E‰Ú EÚ…Æ˙h… + v…O…Ω˛h… {…Æ˙ EÚ…‰<« EÚÆ˙ n‰˘™…i…… x…Ω˛” * • + v…O…Ω˛h… E‰Ú §……n˘, ¥…k…n˘…i…… E‰Ú ∞¸{… ®… |…®……‰]ıÆ˙ (<« b˜“ ∫…“ B±…, M……‰¥……) ∫…‰ ∫…Ω˛…™…i…… * 31 ®……S…«, 2014 i…EÚ V…“ B {…“ B±… EÚ“ |…… v…EfiÚi… +…ËÆ˙ |…n˘k… ∂…‰™…Æ˙ {…⁄ƒV…“ GÚ®…∂…& ` 25 EÚÆ˙…‰c˜ +…ËÆ˙ ` 19.02 EÚÆ˙…‰c˜ Ω˲ * V…“ B {…“ B±… ®… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ (v……Æ˙EÚ E∆Ú{…x…“) EÚ… ∂…‰™…Æ˙v……Æ˙h… 74% Ω˲ +…ËÆ˙ ∂…‰π… 26% <« b˜“ ∫…“ ±… ®…]‰ıb˜ (M……‰¥…… Æ˙…V™… ¥…k… x…M…®…) u˘…Æ˙… Æ˙J…… M…™…… Ω˲˲ * ¥…k…“™… ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… V…“ B {…“ B±… E‰Ú |…S……±…x… +…ËÆ˙ x…¥…±… ±……¶… ∫…‰ E÷Ú±… Æ˙…V…∫¥… {…UÙ±…‰ ¥…π…« 2012- 13 EÚ“ <∫… +¥… v… E‰Ú ` 35.61 EÚÆ˙…‰c˜ +…ËÆ˙ ` 19.90 ±……J… E‰Ú |… i… GÚ®…∂…& ` 40.59 EÚÆ˙…‰c˜ +…ËÆ˙ ` 2.99 EÚÆ˙…‰c˜ l…… * 14.3. BS…B±…B±… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 44 • Availability of Ayurveda production facilities can be utilized for Herbs & berries range of products in future as per HLL requirements. • Availability of good infrastructure (Plant & buildings), providing scope for renovation and up-gradation at lesser cost. • No tax liability on acquisition due to GAPL’s significant accumulated losses. • Support from the Promoter (EDCL, Goa) as Financer, post-acquisition. The authorized and paid up share capital of GAPL is `25 crore and `19.02 crore respectively as on 31st March 2014. The shareholding of HLL Lifecare Limited (holding company) in GAPL is 74% and balance 26% is held by EDC Limited (State Finance Corporation of Goa). The gross revenue from operations and net profit of GAPL during the financial year 2013-14 was `40.59 crore and `2.99 crore respectively as against `35.61 crore and `19.90 lakh in the corresponding period in the previous year 2012-13. 14.3. HLL Infra Tech Services Ltd. (HITES) In April 2014, your Company formed a 100% subsidiary Company by name HLL Infra Tech Services Ltd. [HITES] to carry on the business of providing services namely Infrastructure Development, Facilities Management, Procurement Consultancy and allied services. 15. JOINT VENTURE COMPANY The business income of LifeSpring Hospitals (P) Ltd. [LSH], the 50:50 joint venture between HLL Lifecare and Acumen Fund, had grown by 47.66% as compared with business income for year 2012-13. LSH has facilitated delivery of 6635 babies during the year under review. As the performance of LSH is on an upward trend, LSH proposes to add one more cluster of 10 to 12 hospitals in addition to the existing cluster of 12 hospitals. HLL and Acumen has received a term sheet from CDC & M/s. Rainbow Children’s Medicare Pvt. Ltd, Hyderabad [Rainbow] offering to invest equity of `8 Cr. and `10 Cr. respectively totaling `18.00 Cr. in the JV for funding the cost of setting up a cluster of 10 LifeSpring hospitals (`12.00 Cr.) apart from prepaying the outstanding bank loan of LifeSpring (approx. `4.50 Cr.). 16. OFFICIAL LANUGUAGE POLICY (RAJBHASHA) IMPLEMENTATION Your Company is committed to the implementation of Official Language Policy of the Government of India. Various steps have been taken to propagate Hindi in all the Units/Divisions of the Company. Several programmes such as Official Language Conference, Hindi Workshops and Hindi Training Programmes are organised on a regular basis to time to encourage more and more employees to do their Official work in Hindi. Incentive Scheme for doing work in Hindi is in place to popularise the use of Hindi. The Company is bringing out various publications for popularizing Hindi as the Official Language. The Company has published two issues of house Magazine “Samanvaya” apart from publishing bi-monthly Newsletter “Corporate News” in Hindi and monthly Photo Newsletter ‘Moments’ in bilingual. The Units also published newsletters in Hindi by name” Anmol, Pragathi, Dharpan and Mathrujyothi. Your Company also conducted Hindi Mela and Hindi Music Night for the employees as well as their children. The overall performance of the Company in the field of official language implementation during the year 2013-14 has been excellent and it has been lauded by the Government. Your Company has been conferred with the “Indira Gandhi National Award” (1st prize) for excellent implementation of Official Language Policy and progressive use of Hindi for the undertakings situated in ‘C’ Region. The award was presented by Shri Pranab Mukherjee, Hon’ble President of India at a function organised on the occasion of Hindi Divas at New Delhi. Your company has also bagged TOLIC awards (first prize) for excellent implementation of the Official Language Policy and Hindi Magazine Samanvaya. 17. VIGILANCE The Vigilance Department of the Company has been focusing on preventive and proactive vigilance activities to facilitate a conducive environment for enabling people to work with integrity, impartiality and efficiency, in a fair and transparent manner, upholding highest ethical standards to enhance reputation and create value for the organization. The Department conducts investigations/enquiries, periodic and surprise checks. The competent authority is kept appraised of Vigilance findings from time to time, to ensure for appropriate corrective actions. Annual Report 2013-2014 45 +…{…EÚ“ E∆Ú{…x…“ ∫…i…E«Úi…… ∫…∆§…∆v…“ x…n‰˘∂…… EÚ…‰ EÚ…™……«Œx¥…i… EÚÆ˙x…‰ E‰Ú ±…B EÂÚp˘“™… ∫…i…E«Úi…… +…™……‰M… +…ËÆ˙ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… E‰Ú ∫…i…E«Úi…… EÚI… E‰Ú ∫……l… ∫…∆§…∆v… Æ˙J…i…“ Ω˲ * ¥…¶……M… ∫…∆M…`ˆx… E‰Ú ¥… ¶…z… ™…⁄ x…]ı/EÚ…™……«±…™… E‰Ú §…“S… ∫…i…E«Úi…… ∫…∆§…∆v…“ EÚ…™…«EÚ±……{…… EÚ… ∫…®…x¥…™…x… EÚÆ˙E‰Ú E∆Ú{…x…“ E‰Ú EÚ®…«S…… Æ˙™…… E‰Ú §…“S… ∫…i…E«Úi…… V……M…∞¸EÚi…… ®… ∫…÷v……Æ˙ ±……x…‰ EÚ… ±…I™… EÚÆ˙i…… Ω˲ * 18. x…n‰˘∂…EÚ…Â E‰Ú =k…Æ˙n˘… ™…i¥… ¥…¥…Æ˙h… E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 217(2 B B) E‰Ú +{…‰I……+… E‰Ú +x…÷∫……Æ˙, x…n‰˘∂…EÚ {…÷Œπ]ı EÚÆ˙i…‰ ΩÈ˛ EÚÚ: EÚ) ¥……Ãπ…EÚ ±…‰J…… EÚ“ i…Ë™……Æ˙“ ®…Â, ={…™…÷HÚ ±…‰J…… ®……x…EÚ…Â E‰Ú {……±…x… EÚ™…‰ M…™…‰ ΩË∆˛ +…ËÆ˙ ¥…Ω˛…ƒ EÚ…‰<« ®……±… ¥…S…±…x… x…Ω˛” Ω˲˛ * J…) =xΩ˛…Âx…‰ B‰∫…“ ±…‰J…… x…“ i…™…… EÚ… S…™…x… EÚ™…… Ω˲ i…l…… ∫…÷∫…∆M…i… ∞¸{… ∫…‰ =x…EÚ…‰ |…™…÷HÚ EÚ™…… M…™……* M…) ±…M……i……Æ˙ ¥…¥…‰EÚ“ B¥…∆ ∫…®…Z…n˘…Æ˙ x…h…«™… B¥…∆ +…EÚ±…x… §…x……B M…B i…… EÚ ¥…k… ¥…π…« E‰Ú +∆i… ®… E∆Ú{…x…“ E‰Ú ®……®…±…… EÚ“ n˘∂…… EÚ“ o˘Œπ]ı ∫…Ω˛“ B¥…∆ ∫……°Ú ¥…¥…Æ˙h… +…ËÆ˙ =∫… +¥… v… E‰Ú ±…B E∆Ú{…x…“ E‰Ú ±……¶… n‰˘ ∫…EÂÚ˛* P…) E∆Ú{…x…“ EÚ“ {… Æ˙∫…∆{… k…™……‰∆ EÚ…‰ ∫…÷Æ˙ I…i… Æ˙J…x…‰ +…ËÆ˙ EÚ{…]ı i…l…… +x™… + x…™… ®…i…i……+… EÚ…‰ Æ˙…‰EÚx…‰ B¥…∆ {…i…… ±…M……x…‰ E‰Ú ±…B E∆Ú{…x…“ + v… x…™…®…, 1956 E‰Ú |……¥…v……x……‰∆ E‰Ú +x…÷∫……Æ˙ {…™……«{i… ±…‰J…… E‰Ú + ¶…±…‰J…… E‰Ú +x…÷Æ˙I…h… E‰Ú ±…B ™……‰M™…i…… EÚ“ +…‰Æ˙ = S…i… +…ËÆ˙ {…™……«{i… v™……x… n˘™…… Ω˲˛ * RÛ) =xΩ˛…Âx…‰ ±……¶…EÚ…Æ˙“ EÚ…Æ˙…‰§……Æ˙¥……±…… E‰Ú +…v……Æ {…Æ ¥……Ãπ…EÚ ±…‰J…… i…Ë™……Æ EÚ™…… Ω˲ * 19. ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… ∫…∆™…÷HÚ =t®… E∆Ú{…x…“ (±……<¢Úœ∫|…M… +∫{…i……±… ({…“) ±… ®…]‰ıb˜) ∫…‰ |……{i… =∫…E‰Ú x…n‰˘∂…EÚ ®…∆b˜±… u˘…Æ˙… +x…÷®……‰ n˘i… ¥…k…“™… ¥…¥…Æ˙h… {…Æ˙ +…v…… Æ˙i… ±…‰J…… {…Æ˙“ I…i… ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… ±…‰J…… ®……x…EÚ 27 (B B∫… - 27) - "∫…∆™…÷HÚ =t®…' ®…Â Ω˛i…… E‰Ú ¥…k…“™… Æ˙{……‰Õ]ıM… - E‰Ú +x…÷∫……Æ˙ i…Ë™……Æ˙ EÚ™…… M…™…… Ω˲* E∆Ú{…x…“ + v… x…™…®… 1956 E‰Ú +v…“x… +{…‰ I…i… V…Ë∫…‰, E∆Ú{…x…“ x…‰ ±…‰J…… ®……x…EÚ 21 (B B∫…-21) +…ËÆ˙ ˙¥……Ãπ…EÚ Æ˙{……‰]«ı B¥…∆ J……i…‰ E‰Ú Ω˛∫∫…‰ E‰Ú +x…÷∫……Æ E∆Ú{…x…“ +…ËÆ˙ <∫…E‰Ú ∫…®…x…÷π…∆M…“ E‰Ú ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h…˙ i…Ë™……Æ˙ EÚ™…… Ω˲ * E∆Ú{…x…“ E‰Ú {…∆V…“EfiÚi… EÚ…™……«±…™… E‰Ú x…Æ˙“I…h… E‰Ú ±…B ∫…®…x…÷π…∆M…“ E∆Ú{…x…“ E‰Ú ¥……Ãπ…EÚ ±…‰J…… ∫…‰ ∫…∆§…∆ v…i… ∫…⁄S…x…… ∫… Ω˛i… ={…±…§v… Ω˲ * 20. x…n‰˘∂…EÚ ®…∆b˜±… E∆Ú{…x…“ E‰Ú x…n‰˘∂…x… ®… x…®x……∆ EÚi… §…n˘±……¥… ±……™…… M…™…… Ω˲* x…™…÷ HÚ ∏…“ M……Ëi…®… M…÷Ω˛…, +{…Æ˙ ∫… S…¥… B¥…∆ ¥…k…“™… ∫…±……Ω˛EÚ…Æ˙ (B B∫… & B°Ú B), ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ EÚ…‰ 12/ 03/2014 E‰Ú |…¶……¥… ∫…‰ +∆∂…EÚ… ±…EÚ ∫…Æ˙EÚ…Æ˙“ x…n‰˘∂…EÚ E‰Ú ∞¸{… ®… x…™…÷HÚ EÚ™…… M…™…… Ω˲* ∫…®……Œ{i… ∏…“ B∫….E‰Ú ∏…“¥……∫i…¥…, {…⁄¥…« +{…Æ˙ ∫… S…¥… B¥…∆ ¥…k…“™… ∫…±……Ω˛EÚ…Æ˙, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ EÚ…‰ +{…x…“ i…Ëx……i…“ n˘±±…“ ∫…Æ˙EÚ…Æ˙ E‰Ú ®…÷J™… ∫… S…¥… E‰Ú ∞¸{… ®…Â Ω˛…‰x…‰ {…Æ˙ 12/03/2014 E‰Ú |…¶……¥… ∫…‰ x…n‰˘∂…EÚ {…n˘ EÚ…‰ ∫…®……{i… EÚ™…… Ω˲* ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙π… E÷Ú®……Æ˙, x…n‰˘∂…EÚ ( ¥…{…h…x…), ÀΩ˛n÷˘∫i……x… x™…⁄W…À|…]ı ±… ®…]‰ıb˜ (BS… Bx… B±…) ®… |…§…∆v… x…n‰˘∂…EÚ E‰Ú ∞¸{… ®… ¶…i…‘ ±…‰x…‰ E‰Ú ±…B E∆Ú{…x…“ EÚ“ ∫…‰¥…… ∫…‰ =x…EÚ“ <∫i…“°Ú… E‰Ú {… Æ˙h……®…∫¥…∞¸{… 11/12/2013 E‰Ú |…¶……¥… ∫…‰ x…n‰˘∂…EÚ {…n˘ ∫…®……{i… Ω˛…‰M……* x…n‰˘∂…EÚ ®…∆b˜±… x…‰ {…n˘®…÷HÚ x…n‰˘∂…EÚ…Â u˘…Æ˙… n˘“ M…™…“ +®…⁄±™… ∫…‰¥……+… EÚ“ J…⁄§… ∫…Æ˙…Ω˛x…… EÚ“* 21. ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ x…‰ ®…Ë∫…∫…« +•…Ω˛…®… & V……‰∫…, ∫…x…n˘“ ±…‰J……EÚ…Æ˙, u˘i…“™… i…±…, ∫…]ı“ EÂÚp˘, 618/2, B®… ∫…“ Æ˙…‰c˜, S…∆M…x……SS…‰Æ˙“ - 686 101, EÚ…‰^ı™…®… V…±……, E‰ÚÆ˙±… EÚ…‰ ¥…k…“™… ¥…π…« 2013-14 E‰Ú ±…B E∆Ú{…x…“ E‰Ú ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ E‰Ú ∞¸{… ®… x…™…÷HÚ EÚ™…… Ω˲* 22. ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ¶……M… E‰Ú ∞¸{… ®… ¥™……J™……i®…EÚ/∫{…π]ı“EÚÆ˙h… ]ı{{… h…™…… E‰Ú +v…“x… ∫…∆M…i… ]ı{{…h…“ E‰Ú ∫……l… ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«ı ®… {… `ˆi… |… i…§…∆v…/+¥…±……‰EÚx… ∫¥…i…& ¥™……J™……i®…EÚ Ω˲ +…ËÆ˙ +…M…‰ EÚ…‰<« ∫{…π]ı“EÚÆ˙h… +{…‰ I…i… x…Ω˛” Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 46 Your Company interacts with Central Vigilance Commission and the Vigilance Wing of Ministry of Health and Family Welfare to implement vigilance related directives. The Department aims at improving the vigilance awareness among employees of the Company by co-ordinating vigilance related activities across the different units/offices of the organization. 18. DIRECTORS’ RESPONSIBILITY STATEMENT Pursuant to Section 217 (2 AA) of the Companies Act, 1956, the Directors confirm: a) that in the preparation of the annual accounts, the applicable accounting standards have been followed and that there are no material departures; b) that they have selected such accounting policies and applied them c) consistently and made judgments and estimates that are reasonable and prudent, so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profits of the Company for that period; d) that they have taken proper and sufficient care, to the best of their knowledge and ability, for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956, for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; and, e) that they have prepared the annual accounts on a going concern basis 19. CONSOLIDATED FINANCIAL STATEMENTS The Audited Consolidated Financial Statements based on the financial statements received from the Joint Venture Company (LifeSpring Hospitals (P) Ltd), as approved by its Board of directors, has been prepared in accordance with Accounting Standard 27 (AS-27) – Financial Reporting of Interests in Joint Ventures. As required under the Companies Act, 1956, the Company has prepared the Consolidated Financial Statements of the Company and its Subsidiaries as per Accounting Standard 21(AS -21) and form part of the Annual Report and Accounts. The Annual Accounts of the Subsidiary Companies, along with related information are available for inspection at the Registered Office of the Company. 20. BOARD OF DIRECTORS The following changes took place in the Directorship of the Company: Appointment Shri Gautam Guha, Additional Secretary & Financial Advisor (AS&FA), Ministry of Health & Family Welfare, Government of India has been appointed as Part-time Official Director with effect from 12/03/2014. Cessation Shri S.K.Srivastava, former Additional Secretary & Financial Advisor, Ministry of Health & Family Welfare, Government of India ceased to Director up on his posting as Chief Secretary to Delhi Government with effect from 12/03/2014. Shri K.K.Sureshkumar, Director (Marketing) ceased to be Director with effect from 11/12/2013 consequent on his resignation from the service of the Company to join Hindustan Newsprint Ltd. (HNL) as its Managing Director. The Board of Directors place on record their deep appreciation of the valuable services rendered by the outgoing Directors. 21. STATUTORY AUDITORS The Comptroller and Auditor General of India appointed M/s Abraham & Jose, Chartered Accountants, Second Floor, City Centre, 618/2, M.C. Road, Changanasserry–686101, Kottayam District, Kerala, as Statutory Auditors of the Company for the financial year 2013-14. 22. AUDITOR’S REPORT The qualifications/observations of Statutory Auditors in their report read with the relevant notes under Explanatory/ Clarificatory Notes forming part of the financial statements are self-explanatory and do not require further explanation. Annual Report 2013-2014 47 23. ±……M…i… ±…‰J……{…Æ˙“I…… ±……M…i… ±…‰J……{…Æ˙“I…… x…™…®…, 2011 E‰Ú +v…“x… x…v……« Æ˙i… ¥… ¥…v… =i{……n˘… E‰Ú ∫…∆§…∆v… ®… E∆Ú{…x…“ u˘…Æ˙… +x…÷Æ˙ I…i… ±…‰J…‰ EÚ“ ±……M…i… ±…‰J……{…Æ˙“I…… +…™……‰ V…i… EÚÆ˙x…‰ EÚ…‰ ¥…k…“™… ¥…π…« 2013-14 E‰Ú ±…B ®…Ë∫…∫…« B.V…“.+ x…±…ÀJ…n˘“ & E∆Ú{…x…“, ±……M…i… ±…‰J……EÚ…Æ˙, EÚ…‰±Ω˛…{…÷Æ˙, ®…Ω˛…Æ˙…π]≈ı…, ®…Ë∫…∫…« V…÷M…±….E‰Ú.{…÷Æ˙“ & B∫……‰ ∫…™…‰]¬ı∫…, ±……M…i… ±…‰J……EÚÆ˙ x…™…… M…÷b˜M……¥… +…ËÆ˙ ®…Ë∫…∫…« B∫….x……™…Æ˙ B¥…∆ B∫……‰ ∫…™…‰]¬ı∫…, ±……M…i… ±…‰J……EÚÆ˙, i…Ø˚¥…x…∆i…{…÷Æ˙®… EÚ…‰ ±……M…i… ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ∞¸{… ®… x…™…÷HÚ EÚB M…B* ¥…k…“™… ¥…π…« 2012-13 E‰Ú ±…B ±……M…i… ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı 26/09/2013 EÚ…‰ x…M… ®…i… EÚ…™…« ®…∆j……±…™… (B®… ∫…“ B), ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú ∫……l… °Ú…<±… EÚ“ M…™…“* ¥…k…“™… ¥…π…« 2013-14 EÚ“ ±……M…i… ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı 27 ∫…i…∆§…Æ˙, 2014 EÚ…‰ ™…… {…Ω˛±…‰ B®… ∫…“ B E‰Ú ∫……l… °Ú…<±… EÚ“ V……x…“ Ω˲ +…ËÆ˙ =∫…EÚ…‰ x…™…i… ∫…®…™… {…Æ˙ °Ú…<±… EÚƉ˙M…“* 24. ∫…⁄S…x…… + v…EÚ…Æ˙ + v… x…™…®…, 2005 +…{…EÚ“ E∆Ú{…x…“ x…‰ ∫…⁄S…x…… + v…EÚ…Æ˙ (+…Æ˙ ]ı“ +…<«) + v… x…™…®…, 2005 EÚ…‰ EÚ…™……«Œx¥…i… EÚ™…… Ω˲, V……‰ =k…Æ˙n˘… ™…i¥… +…ËÆ˙ {……Æ˙n˘Ã∂…i…… EÚ…‰ §…x……B Æ˙J…x…‰ E‰Ú ∫…±… ∫…±…‰ ®… ∫…⁄S…x…… |…n˘…x… EÚÆ˙E‰Ú +…®… V…x…i…… EÚ…‰ ∂… HÚ n‰˘i…… Ω˲* E∆Ú{…x…“ x…‰ Ω˛®…‰∂…… ™…Ω˛ ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B |…™……∫… EÚ™…… Ω˲ EÚ +…Æ˙ ]ı“ +…<« + v… x…™…®… 2005 ∫…‰˙ ¥… ¥…v… ∫…I…®… |……¥…v……x…… EÚ…‰ {…⁄h…«i…: EÚ…™……«Œx¥…i… EÚ™…… M…™…… Ω˲* ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… |……{i… +…ËÆ˙ x…{…]ı…x… EÚ“ M…<« +…Æ˙ ]ı“ +…<« +…¥…‰n˘x… EÚ“ ∫…∆J™…… x…“S…‰ n˘“ V……i…“ ΩÈ˛: 1 +|…˱… 2013 E‰Ú n˘…ËÆ˙…x… ±…∆ §…i… +…Æ˙ ]ı“ +…<« +…¥…‰n˘x… 5 ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… |……{i… +…Æ˙ ]ı“ +…<« +…¥…‰n˘x… 82 ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… x…{…]ı…x… EÚB +…Æ˙ ]ı“ +…<« +…¥…‰n˘x… 82 31 ®……S…«, 2014 i…EÚ ±…∆ §…i… +…Æ˙ ]ı“ +…<« +…¥…‰n˘x… 5 +…Æ˙ ]ı“ +…<« +…¥…‰n˘x…… E‰Ú + i… Æ˙HÚ, E∆Ú{…x…“ EÚ…‰ ∫…“ {…“ +…<« +…‰ EÚ“ x…h…«™… EÚ“ +…‰Æ˙ 15 +{…“±… ¶…“ |……{i… Ω÷˛<« Ω˲, V…x…EÚ…‰ ¶…“ B°Ú B B u˘…Æ˙… ¥… v…¥…i…¬ v™……x… n˘™…… +…ËÆ˙ = S…i… ∞¸{… ∫…‰ x…{…]ı…x… EÚB M…B* 25. B®…B∫…B®…<«B∫… ∫…‰ ®……±…… EÚ… |……{…h… ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ x…‰ ∫…⁄I®…, ±…P…÷ +…ËÆ˙ ®…v™…®… =t®… (B®…B∫…B®…<«B∫…) ∫…‰ Ø˚. 3769 ±……J… ®…⁄±™… E‰Ú ®……±… EÚ… |……{…h… EÚÆ˙x…‰ EÚ“ ™……‰V…x…… §…x……™…“ l…“* i…l…… {…, ¥…π…« E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ ¥……∫i…¥… ®… Ø˚. 2255.00 ±……J… ®…⁄±™… E‰Ú ®……±… |……{…h… EÚÆ {……™…“* 26. >V……« ∫…∆Æ˙I…h…, i…EÚx…“EÚ“ +…®…‰±…x…, ¥…n‰˘∂…“ ®…÷p˘… +V…«x…/¥™…™… ™…l…… ∫…∆∂……‰ v…i… E∆Ú{…x…“ x…™…®… 1988 ( x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ Æ˙{……‰]«ı ®… ¥…¥…Æ˙h…… E‰Ú |…EÚ]ı“EÚÆ˙h…) E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®…, 1956 EÚ“ v……Æ˙… 217 EÚ“ ={… v……Æ˙… 1(<«) E‰Ú +v…“x… x…v……« Æ˙i… >V……« ∫…∆Æ˙I…h…, i…EÚx…“EÚ“ +…®…‰±…x…, ¥…n‰˘∂…“ ®…÷p˘… +V…«x… +…ËÆ˙ ¥™…™… ∫…‰ ∫…∆§…∆ v…i… ¥…¥…Æ˙h… +x…÷§…∆v… - B E‰Ú ∞¸{… ®… n˘B V……i…‰ ΩÈ˛, V……‰ <∫… Æ˙{……‰]«ı EÚ… ¶……M… Ω˲* 27. EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… +…ËÆ˙ Œ∫l…Æ˙i…… 27.1 E∆Ú{…x…“ x…‰ EÂÚp˘“™… ∫……¥…«V… x…EÚ =t®…… E‰Ú ±…B 1 +|…˱…, 2013 E‰Ú |…¶……¥… ∫…‰ ∫……¥…«V… x…EÚ =t®… ¥…¶……M… (b˜“ {…“ <«) u˘…Æ˙… V……Æ˙“ EÚB EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… +…ËÆ˙ Œ∫l…Æ˙i…… ¥…EÚ…∫… {…Æ˙ ®……M…« x…nÊ˘∂…… {…Æ˙ +…v…… Æ˙i… EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… +…ËÆ˙ Œ∫l…Æ˙i…… {…Æ˙ BEÚ x…“ i… |…∫i…÷i… EÚ“ Ω˲* E∆Ú{…x…“ x…‰ ∫…“ B∫… +…Æ˙ E‰Ú ±…B BEÚ EÚ…Ï{……ÊƉ˙]ı ∫…∆S……Æ˙ EÚ…™…«x…“ i… +…ËÆ˙ E∆Ú{…x…“ E‰Ú ±…B Œ∫l…Æ˙i…… {…Ω˛±…… EÚ…‰ ¶…“ |…∫i…÷i… EÚ™…… Ω˲* 27.2. |…i…“I…… °Ú…=∆b‰˜∂…x… EÚ… M…`ˆx… +…{…EÚ“ E∆Ú{…x…“ x…‰ j……¥…x…EÚ…‰Æ˙, EÚ…‰ŒSS…x… ∫……I…Æ˙i……, ¥…ËY…… x…EÚ +…ËÆ˙ v…®……«l…« ∫… ®… i… {…∆V…“EÚÆ˙h… + v… x…™…®… 1955 E‰Ú +v…“x… x…®x……∆ EÚi… ±…I™…… E‰Ú ∫……l… BS…B±…B±… |…i…“I…… v…®……«l…« ∫… ®… i… E‰Ú x……®… ∫…‰˙ BEÚ v…®…«…l…« ∫… ®… i… EÚ… M…`ˆx… EÚ™…… Ω˲* i. ∫… ®… i… E‰Ú ∫…n˘∫™…… E‰Ú §…SS…… EÚ…‰ UÙ…‰b˜EÚÆ˙ +…Ãl…EÚ ∞¸{… ∫…‰ {…UÙb‰˜ ¥™… HÚ™…… +…ËÆ˙ ™…… ∂……Æ˙“ Æ˙EÚ ∞¸{… ∫…‰ ¥…EÚ±……∆M… ¥™… HÚ™…… EÚ…‰ ®…‰ Æ˙]ı E‰Ú +…v……Æ˙ {…Æ˙ ∂…I…… E‰Ú ±…B UÙ…j…¥…fi k…, +x…÷n˘…x… +…ËÆ˙ +x™… ∫…Ω˛…™…i…… E‰Ú ®……v™…®… ∫…‰ ∫…÷ ¥…v……Bƒ +…ËÆ˙ x… v…EÚÆ˙h… E‰Ú |……‰z…®…x… EÚÆ˙x…… +…ËÆ˙ §…g¯…¥…… n‰˘x……* ii. ∫… ®… i… E‰Ú ∫…n˘∫™…… EÚ…‰ ®…‰ b˜EÚ±… +…ËÆ˙ EÚ±™……h… ∫…÷ ¥…v……Bƒ B¥…∆ +x™… ∫…÷J…∫…÷ ¥…v……Bƒ |…n˘…x… EÚÆ˙x……* ∫… ®… i… x…‰ |……Æ∆˙¶… ®… n˘…‰ ™……‰V…x……Bƒ ±……ƒS… EÚ“ ΩÈ˛ V…Ë∫…‰ (i) +…Ãl…EÚ ∞¸{… ∫…‰ {…UÙb‰˜ Æ˙Ω‰˛ ¥…t…Ãl…™…… EÚ“ ∂…I…… E‰Ú ±…B ¥…k…“™… ∫…Ω˛…™…i…… +…ËÆ˙ (ii) E∆Ú{…x…“ ∫…‰ ∫…‰¥…… x…¥…fik… EÚ®…«S…… Æ˙™…… EÚ“ ∫¥……∫l™… Æ˙I…… +…¥…∂™…EÚi……+… E‰Ú ±…B ¥…k…“™… ∫…Ω˛…™…i……* E∆Ú{…x…“ E‰Ú ∫…®…“I……v…“x… ¥…π…« E‰Ú EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… +…ËÆ˙ Œ∫l…Æ˙i…… {…Ω˛±…… EÚ“ Æ˙{……‰]«ı +x…÷§…∆v… J…, E‰Ú ∞¸{… ®… n˘“ V……i…“ Ω˲, V……‰ <∫… Æ˙{……‰]«ı EÚ… ¶……M… Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 48 23. COST AUDIT M/s. A.G.Anilkhindi & Co., Cost Accountants, Kolhapur, Maharashtra, M/s. Jugal K Puri & Associates, Cost Accountants, New Gurgaon and M/s. S Nair & Associates, Cost Accountants, Thiruvananthapuram were appointed as Cost Auditors for the financial year 2013- 14 to conduct cost audit of the accounts maintained by the Company in respect of the various products prescribed under Cost Audit Rules, 2011. The Cost Audit Report for the financial year 2012-13 was filed with the Ministry of Corporate Affairs (MCA), Government of India on 26/09/2013. The Cost Audit Report for the financial year 2013-14 is due to be filed with MCA on or before September 27, 2014 and the same would be filed as per timeline. 24. RIGHT TO INFORMATION ACT, 2005 Your Company has implemented Right to Information (RTI) Act, 2005, which empowers the common citizen by providing access to information with a view to maintain accountability and transparency. The Company has always endeavoured to ensure that various enabling provisions of the RTI Act, 2005 are implemented in letter and spirit. The number of RTI applications received and disposed off during year 2013-14 are given below: No. of RTI applications pending as on 1st April 2013 5 No. of RTI applications received during year 2013-14 82 No. of RTI applications disposed off during year 2013-14 82 No. of RTI applications pending as on 31st March 2014 5 Apart from RTI applications, the Company also received 15 appeals against the decision of CPIO, which too were duly attended to and appropriately disposed off by the FAA. 25. PROCUREMENT OF GOODS FROM MSMEs During the year 2013-14, the company had planned to procure goods of value Rs.3769 lakh from Micro, Small and Medium Enterprises (MSMEs). However, the company could actually procure goods of value Rs.2255.00 lakh only during the year. 26. CONSERVATION OF ENERGY, TECHNICAL ABSORPTION, FOREIGN EXCHANGE EARNINGS/OUTGO The particulars regarding Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo, as prescribed under sub-section 1(e) of Section 217 of the Companies Act, 1956 read with the Companies (Disclosure of Particulars in the Report of Board of Directors) Rules, 1988 as amended, are given as Annexure-A, which forms part of this report. 27. CORPORATE SOCIAL RESPONSIBILITY & SUSTAINABILTY 27.1 The Company has laid down a Policy on Corporate Social Responsibility and Sustainability modelled on the Guidelines on Corporate Social Responsibility and Sustainability Development issued by the Department of Public Enterprises (DPE) for Central Public Sector Enterprises applicable with effect from 1st April 2013. The Company has also laid down a Corporate Communication Strategy for CSR& Sustainability initiatives for the Company. 27.2. Formation of Pratheeksha Foundation Your Company has formed a Charitable Society by name HLL Pratheeksha Charitable Society under the Travancore Cochin Literacy, Scientific and Charitable Societies Registration Act, 1955 with the objectives given below: i. To promote and encourage facilities and funding through scholarships, grants and other assistance for education to the economically backward persons and or physically challenged persons on merit basis, excluding children of the members of the Society. ii. To provide medical and welfare facilities and other amenities to the members of the Society. To start with the Society has launched two schemes viz. (i) financial assistance for education of economically backward students and (ii) financial assistance for healthcare needs of the retired employees of the Company. A report on the Corporate Social Responsibility & Sustainability initiatives of the Company during the year under review is given as Annexure B, forming part of this report. Annual Report 2013-2014 49 28. EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… +…{…EÚ“ E∆Ú{…x…“ +SU‰Ù EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… E‰Ú =SS…i…®… ®……x…EÚ…Â E‰Ú +x…÷Æ˙I…h… ®… |… i…§…r˘ Ω˲ +…ËÆ˙ ∫……¥…«V… x…EÚ =t®… ¥…¶……M… u˘…Æ˙… n˘x……∆EÚ 14- 05-2010 E‰Ú b˜“ {…“ <« EÚ….Y…….∫…∆.18(8)/2005 - V…“ B®… ®… x…v……« Æ˙i… ∫…¶…“ +x…÷§…∆v…… E‰Ú {……±…x… EÚÆ˙x…‰ E‰Ú ±…B {…™……«{i… EÚn˘®… =`ˆ…™…“ Ω˲* EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… E‰Ú ∂…i……Á E‰Ú +x…÷{……±…x… EÚ“ {…÷Œπ]ı EÚÆ˙i…‰ Ω÷˛B ∫…x…n˘“ ±…‰J……EÚ…Æ˙ ®…Ë∫…∫…« B•…Ω˛…®… +…ËÆ˙ V……‰∫… E‰Ú |…®……h…-{…j… ∫… Ω˛i… EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…Æ˙ Æ˙{……‰]«ı <∫… Æ˙{……‰]«ı EÚ… ¶……M… §…x…i…… Ω˲* 29. |…§…∆v… S…S……« +…ËÆ˙ ¥…∂±…‰π…h… Æ˙{……‰]«ı <∫… Æ˙{……‰]«ı E‰Ú ¶……M… E‰Ú ∞¸{… ®… |…§…∆v… S…S……« +…ËÆ˙ ¥…∂±…‰π…h… Æ˙{……‰]«ı +±…M… ∞¸{… ∫…‰ |…∫i…÷i… EÚ“ V……i…“ Ω˲* 30. |…∂…∆∫…… +…ËÆ˙ EfiÚi…Y…i…… +…{…E‰Ú x…n‰˘∂…EÚ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™… +…ËÆ˙ ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú +x™… ®…∆j……±…™…… ∫…‰ |……{i… §…Ω÷˛®…⁄±™… ®……M…« x…nÊ˘∂…, ∫…®…l…«x… B¥…∆ ∫…Ω˛EÚ… Æ˙i…… E‰Ú |… i… +…¶……Æ˙ |…EÚ]ı EÚÆ˙i…‰ ΩÈ∆* x…n‰˘∂…EÚ ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ, ¥…… h…V™…EÚ ±…‰J……{…Æ˙“I…… EÚ… |…v……x… x…n‰˘∂…EÚ B¥…∆ {…n‰˘x… ∫…n˘∫™…, ±…‰J……{…Æ˙“I…… ®…∆b˜±…, ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â +…ËÆ˙ +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ…Â u˘…Æ˙… n˘B ∫…Ω˛EÚ… Æ˙i…… +…ËÆ˙ ∫…®…l…«x… E‰Ú |… i… Ω˛…Ãn˘EÚ v…x™…¥……n˘ ¥™…HÚ EÚÆ˙i…‰ ΩÈ˛* x…n‰˘∂…EÚ <∫… +¥…∫…Æ˙ {…Æ˙ E∆Ú{…x…“ E‰Ú §…ÈEÚ‰∫…«, ¥… x…™……®…EÚ |…… v…EÚ…Æ˙“, O……Ω˛EÚ, ¥…G‰Úi……, {…Æ˙…®…∂…«n˘…i……, |……Ët…‰ M…EÚ“ ±…Ë∫…‰x∫…EÚi……«, `‰ˆE‰Ún˘…Æ˙ +…ËÆ˙ +x™… ¥™…¥…∫……™… B∫……‰ ∫…™…‰]¬ı∫… B¥…∆ ¥…GÚ™… ¶……M…“n˘…Æ˙… EÚ…‰ E∆Ú{…x…“ E‰Ú |… i… =x…E‰Ú ±…M……i……Æ˙ ∫…Ω˛™……‰M… +…ËÆ˙ ¥…∑……∫… {…Æ˙ EfiÚi…Y…i…… ¥™…HÚ EÚÆ˙x…‰ EÚ…‰ <∫… +¥…∫…Æ˙ EÚ… ¥… x…™……‰M… EÚÆ˙i…‰ ΩÈ˛* x…n‰˘∂…EÚ BS…B±…B±… {… Æ˙¥……Æ˙ E‰Ú Ω˛Æ‰˙EÚ ∫…n˘∫™… E‰Ú EÚ `ˆx… ®…‰Ω˛x…i…, ∫…®…{…«h… +…ËÆ˙ ∫…∆{…⁄h…« ∏…®… EÚ“ +…‰Æ˙ ∫…Æ˙…Ω˛x…… ¶…“ ¥™…HÚ EÚÆ˙x…… S……Ω˛i…‰ ΩÈ˛ V…x…E‰Ú =i∫……Ω˛, ]ı“®… ¥…E«Ú, x…π`ˆ… +…ËÆ˙ ¥…°Ú…n˘…Æ˙“ x…‰ <∫… E∆Ú{…x…“ EÚ…‰ ¥…˶…¥…∂……±…“ §…x…… n˘“ +…ËÆ˙ ¶… ¥…π™… E‰Ú ±…I™… EÚ…‰ |……{i… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ =x…E‰Ú ±…M……i……Æ˙ ∫…Œ®®…±…x… +…ËÆ˙ +…‰V…∫¥…“ ]ı“®… |…™…ix… EÚ… ¶…“ =i∫…÷EÚi…… ∫…‰ |…i…“I…… EÚÆ˙i…‰ ΩÈ˛* x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ b˜…Ï. B®…. +™™…{{…x… +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ i…Ø˚¥…x…∆i…{…÷Æ˙®… 5 V…÷±……<«, 2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 50 28. CORPORATE GOVERNANCE Your Company is committed to maintain highest standards of good corporate governance and has taken adequate steps to adhere to all stipulations laid down in DPE O.M.No. 18 (8)/2005-GM dated 14-05-2010 issued by Department of Public enterprises. Report on Corporate Governance along with the Certificate of the Statutory Auditors M/s Abraham & Jose, Chartered Accountants confirming compliance of conditions of Corporate Governance form part of this report. 29. MANAGEMENT DISCUSSION AND ANALYSIS REPORT Management Discussion and Analysis Report is presented in a separate section forming part of this report. 30. APPRECIATION AND ACKNOWLEDGEMENTS Your Directors gratefully acknowledge the valuable guidance, support and co-operation received from the Ministry of Health & Family Welfare and other Ministries of Government of India. The Directors express their sincere thanks to the Comptroller and Auditor General of India, the Principal Director of Commercial Audit & Ex-officio Member, Audit Board, Statutory Auditors and Internal Auditors for the co-operation and support extended by them. The Directors take this opportunity to thank the Company’s bankers, regulatory authorities, customers, vendors, consultants, technology licensors, contractors and other business associates and trading partners for their continued support and confidence reposed in the Company. The Directors also wishes to place on record its sincere appreciation for the hard work, dedication and unstinting efforts of every member of HLL family whose enthusiasm, team work, devotion and loyalty has made this Company proud and look forward to their continued involvement and spirited team effort towards achieving the future goals. For and on behalf of the Board of Directors Dr. M. AYYAPPAN CHAIRMAN & MANAGING DIRECTOR Thiruvananthapuram 5th July 2014 Annual Report 2013-2014 51 +x…÷§…∆v…-EÚ x…n‰˘∂…EÚ…Â EÚ“ Æ˙{……‰]«ı EÚ… +x…÷§…∆v… E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 217(1) (<«Û) E‰Ú +x…÷∫……Æ˙ ∫…⁄S…x……, ( x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ Æ˙{……‰]«ı ®… §™……ËÆ˙‰ EÚ… |…EÚ]ı“EÚÆ˙h…) E∆Ú{…x…“ x…™…®… 1988 +…ËÆ˙ 31 ®……S…« 2014 EÚ…‰ ∫…®……{˜˜i… ¥…π…« E‰Ú ±…B x…n‰˘∂…EÚ…Â EÚ“ Æ˙{……‰]«ı E‰Ú ¶……M… EÚ‰ ∞¸{… ®… {…g¯M…‰* °Ú…®…« EÚ ( x…™…®… 2 n‰˘J…Â) ¥…¥…Æ˙h… 2012-13 2013-14 (EÚ) §…V…±…“ +…ËÆ˙ <∆v…x… 1 §…V…±…“ EÚ J…Æ˙“n˘“ M…™…“ (™…⁄ x…]ı) E‰Ú b˜Œ§±…™…÷ BS… 1,81,67,036.00 1,71,98,500.00 Æ˙… ∂… (`) 10,30,81,543.00 9,49,96,496.00 n˘Æ˙ / ™…⁄ x…]ı (`) 5.67 5.52 J… x…V…“ =i{……n˘x… (i) =i˜˜{…… n˘i… ™…⁄ x…]ı (E‰Ú b˜Œ§±…™…÷ BS…) 12,65,337.00 6,05,302.00 BS… B∫… b˜“ i…‰±… EÚ… ={…¶……‰M… ( ±…]ıÆ˙) 3,52,146.00 2,00,044.00 =i˜˜{…… n˘i… ™…⁄ x…]ı/ ±…]ıÆ˙ (E‰Ú b˜Œ§±…™…÷ BS…/ ±…]ıÆ˙) 3.59 3.03 ±……M…i…/™…⁄ x…]ı (`) 14.67 16.36 (ii) ¶……{… ]ıÆ˙§…… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 52 ANNEXURE A ANNEXURE TO DIRECTORS’ REPORT Information as per Section 217 (1) (e) of the Companies Act, 1956 read with Companies (Disclosure of particulars in the Report of Board of Directors) Rules 1988 and forming part of the Directors' Report for the year ended 31st March 2014 FORM A (See Rule 2) Particulars 2012-13 2013-14 (A) Power & Fuel 1. Electricity (a) Purchased (Units)KWH 1,81,67,036.00 1,71,98,500.00 Amount (`) 10,30,81,543.00 9,49,96,496.00 Rate /Unit (`) 5.67 5.52 (b) Own generation (i) Units generated (KWH) 12,65,337.00 6,05,302.00 HSD Oil consumption (Ltr) 3,52,146.00 2,00,044.00 Units generated/ Ltr (KWH/Ltr) 3.59 3.03 Cost /Unit (`) 14.67 16.36 (ii) Through Steam Turbine Generator NA NA 2. Coal NA NA 3. Furnace Oil Quantity (Ltr.) 47,35,250.00 52,15,343.93 Amount (`) 21,72,81,339.00 24,56,04,790.00 Rate /Unit (`) 45.89 47.09 (B) Consumption per unit of production (i) Condoms Unit (M. Pcs) – Production (Moulded) 1,737.66 1,716.85 Electricity (KWH) per M. Pcs (Standard 8418) 7,923.29 4,976.22 Furnace Oil (KL) per M. Pcs (Standard 6.19) 2.75 2.87 Coal NA NA (ii) Copper –T Total Quantity Produced (M. Pcs) 3.68 5.12 Electricity per M. Pcs (KWH) 98,288.00 78,093.00 (iii) Mala-D/N, Saheli, Novex & Preventol Total Quantity Produced (M. Pcs) Mala-D/N (M. Cycles) 46.23 32.25 Saheli, Novex & Preventol 28.52 28.49 Electricity consumed per million cycles of Mala-D/N 20,192.30 27,229.50 Electricity consumed per million cycles of Saheli, Novex & Preventol 1,591.60 282.70 Electricity consumed (both products)-KWH 11,04,913.00 10,12,390.75 (iv) Blood Bags Total Quantity Produced (M. Pcs) 7.93 11.05 Electricity per bag (KWH) 0.24 0.20 Annual Report 2013-2014 53 (v) ∫™…⁄S…‰∫…« =i˜˜{…… n˘i… E÷Ú±… {… Æ˙®……h… (±……J… n˘V…«x…) 1.32 1.42 §…V…±…“ |… i… n˘V…«x… (E‰Ú b˜Œ§±…™…÷ BS…) 4.38 5.57 (vi) §…±EÚ b≈˜M… - ∫…Â]ıGÚ…‰®…Ëx… =i˜˜{…… n˘i… ™…⁄ x…]ı ( EÚ±……‰O……®…) 1,202,41 752.40 J…{…i… EÚ“ M…<« §…V…±…“ (E‰Ú b˜Œ§±…™…÷ BS…) 6,43,331.00 4,61,063.99 J…{…i… EÚ“ M…<« °Úx…«∫… i…‰±… ( ±…]ıÆ˙) 1,39,337.60 1,13,413.74 §…V…±…“ |… i… EÚ±……‰O……®… (E‰Ú b˜Œ§±…™…÷ BS…) 535.04 612.79 °Úx…«∫… i…‰±… |… i… EÚ±……‰O……®… ( EÚ±……‰ ±…]ıÆ˙) 115.88 150.74 (vii) M…¶…« {…Æ˙“I…h… EÚ]ı =i˜˜{…… n˘i… E÷Ú±… {… Æ˙®……h… (n˘∂…±…I… EÚ]ı) 18.06 17.75 §…V…±…“ |… i… n˘∂…±…I… EÚ]ı (E‰Ú b˜Œ§±…™…÷ BS…) 3,072.24 4,418.36 BS… B∫… b˜“ i…‰±… |… i… n˘∂…±…I… EÚ]ı ( ±…]ıÆ˙) 2,405.88 2,465.85 (viii) ®… Ω˛±…… E∆Úb˜…‰®… =i˜˜{…… n˘i… E÷Ú±… {… Æ˙®……h… (+n˘n˘ı) - 10,000.00 §…V…±…“ |… i… +n˘n˘ (E‰Ú b˜Œ§±…™…÷ BS…) - 0.02 (ix) ∫…Ë x…]ıÆ˙“ x…Ë{… EÚx… =i{……n˘x… (n˘∂…±…I… +n˘n˘) 104.95 104.95 J…{…i… EÚ“ M…<« §…V…±…“ (E‰Ú b˜Œ§±…™…÷ BS…) 5,51,408.31 5,24,639.41 J…{…i… EÚ“ M…<« §…V…±…“ |… i… n˘∂…±…I… +n˘n 5,253.92 5,338.03 [EÚ] >V……« ∫…∆Æ˙I…h… EÚ) {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… x…π{…… n˘i… >V……« ∫…∆Æ˙I…h… ={……™… x…“S…‰ =Œ±±… J…i… EÚ™…‰ M…™…‰ ΩÈ˛* l n˘…‰ ®……‰œ±b˜M… ®…∂…“x…… (B®… 5 & B®… 6) ®… P…x…“¶…⁄i… ¥…∫…⁄±…“ |…h……±…“ EÚ…‰ ∫…∆∂……‰ v…i… EÚ™……* E÷Ú±… x…¥…‰∂… `7.5 ±……J… Ω˲ +…ËÆ˙ °Úx…Ê∫… +…Ï™…±… EÚ“ 20.2 E‰Ú B±… EÚ“ ¥……Ãπ…EÚ >V……« §…S…i… Ω˲* <∫…‰ |… i… ¥…π…« ` 10 ±……J… EÚ“ ¥……Ãπ…EÚ §…S…i… |……{i… Ω˛…‰M…“* l §……‰™…±…Æ˙ E‰Ú b‰˜ ]ÈıEÚ ®… +…Ï™…±… EÚ“ ∫]ı“®… Ω˛“À]ıM… E‰Ú ∫……l… ∫…Â]≈ı“}™…⁄V… °Ú±…]≈‰ı∂…x…* <∫…∫…‰ §…x…«Æ˙ ®… §…‰Ω˛i…Æ˙ V¥…±…x… +…ËÆ˙ <∫… ±…B EÚ®… EÚ… ±…J… Ω˛…‰i…… Ω˲* E÷Ú±… x…¥…‰∂… ` 40,000/- Ω˲ +…ËÆ ` 66,150/- EÚ“ ¥……Ãπ…EÚ §…S…i… Ω˛…‰i…“ Ω˲* l ∫…¶…“ ¥…±EÚx……<«À∫…M… ]ı®§±…Æ˙ +…ËÆ˙ +…Æ˙+…Æ˙]ı“ ®…∂…“x… E‰Ú ±…“ÀS…M… ]ÈıEÚ…‰∆ ®… E‰Ú ±…B <±…ŒC]≈ıEÚ±… EÚ… ∫]ı“®… Ω˛“À]ıM…Ú®… +∆i…Æ˙h…* <∫… {… Æ˙¥…i…«x… ∫…‰ +x…÷Æ˙I…h… ®… ∫…÷M…®…i…… ∫…÷v……Æ˙ Ω÷˛+… Ω˲ +…ËÆ˙ •…‰EÚb˜…=x∫… EÚ®… Ω˛…‰ M…™…… Ω˲* E÷Ú±… x…¥…‰∂… >V……« §…S…i… E‰Ú ®……v™…®… ∫…‰ ` 4,23,360/- EÚ“ ¥……Ãπ…EÚ §…S…i… E‰Ú ∫……l… ` 8 ±……J… Ω˲˛* l ` 6 ±……J… EÚ“ E÷Ú±… x…¥…‰∂… E‰Ú ∫……l… ∫…÷v……Æ˙ |… GÚ™…… x…™…∆j…h… +…ËÆ˙ §…‰Ω˛i…Æ˙ ®……Ï x…]ıÀÆ˙M… E‰Ú ±…B ∫…∆™…∆j… - EÚ ®… EÚ…Ï®{……=Àb˜M… ]ÈıEÚ EÚ… +…Ï]ı…‰®…‰∂…x…/ >V……« E‰Ú +{…¥™…™… EÚ®… EÚÆ˙x…‰ E‰Ú u˘…Æ˙… |… i… ¥…π…« `2 ±……J… EÚ“ §…S…i… Ω˛…‰M…“* l ` 0.74 ±……J…/™…⁄ x…]ı E‰Ú x…¥…‰∂… E‰Ú ∫……l… ¥…±EÚx……<À∫…M… ®…∂…“x… ®… >V……« EÚ…™…«I…®… ∫…“v…… b≈˜…<¥… EÚ…‰ |……Æ∆˙¶… EÚÆ˙x……* <∫… {… Æ˙¥…i…«x… ∫…‰ ` 0.73 ±……J…/™…⁄ x…] EÚ“ ¥……Ãπ…EÚ §…S…i… |……{i… Ω÷˛<« ˛* l §…‰Ω˛i…Æ˙ >V……« ®……Ï x…]ıÀÆ˙M… +…ËÆ˙ +…Ï]ı…‰®…‰∂…x… E‰Ú ±…B <∆]‰ı ±…V…Â]ı ∫…§…∫]‰ı∂…x… +…Ï]ı…‰®…‰∂…x… |…h……±…“ EÚ… EÚ…™……«x¥…™…x… * ` 6 ±……J… EÚ“ ¥……Ãπ…EÚ §…S…i… E‰Ú ∫……l… E÷Ú±… x…¥…‰∂… ` 1.7 ±……J… Ω˲* J…) EÚx…M…±…… °ËÚC]ıÆ˙“, §…±…M……®… ®… x…π{…… n˘i… >V……« ∫…∆Æ˙I…h… ={……™… x…“S…‰ n˘™…‰ M…™…‰ ΩÈ˛* l ¥…±EÚx……<À∫…M… +x…÷¶……M… ®… 3.3 BS…{…“ ®……‰]ıÆ˙ u˘…Æ˙… 7.5 BS…{…“ ®……‰]ıÆ˙ |… i…∫l…… {…i… EÚ™……* l b˜∫…S……V…« ]ı⁄§… ±……<]ı E‰Ú ∫l……x… ®… 30 B±…<«b˜“ +…v…… Æ˙i… ]ı⁄§… ±……<]ı EÚ…‰ ∫…∆∫l…… {…i… EÚ™……* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 54 (v) Sutures Total Quantity Produced ( Lacs Dozen) 1.32 1.42 Electricity per dozen (KWH) 4.38 5.57 (vi) Bulk Drug –Centchroman Unit (Kg) produced 1,202.41 752.40 Electricity consumed (KWH) 6,43,331.00 4,61,063.99 Furnace Oil consumed (Lr.) 1,39,337.60 1,13,413.74 Electricity per Kg (KWH) 535.04 612.79 Furnace Oil per Kg (KL) 115.88 150.74 (vii) Pregnancy Test Kits Total Quantity Produced (M. Kit) 18.06 17.75 Electricity per Million Kit (KWH) 3,072.24 4,418.36 HSD Oil per Million Kit (LTR) 2,405.88 2,465.85 (viii) Female Condoms Total Quantity Produced (Pcs) 10,000.00 Electricity per Pc (KWH) 0.02 (ix) Sanitary Napkins Production (M.Pcs) 104.95 97.6 Electricity consumed (KWH) 5,51,408.31 5,24,639.41 Electricity consumed per M.Pcs 5,253.92 5,338.03 [A] CONSERVATION OF ENERGY a) Energy conservation measures executed at the Peroorkada factory, Thiruvananthapuram are mentioned below: l Modified condensate recovery system in two molding machines (M5 & M6). The total investment is `7.5 lacs and has an annual energy savings of 20.2kL of furnace oil. This will derive an annual savings of `10 Lacs per year. l Centrifuge filtration with steam heating of oil in the day tank of boiler. This leads to better combustion in the burner and therefore lesser soot. The total investment is `40,000/- and has an annual savings of `66,150/-. l Conversion of electrical to steam heating in all vulcanizing tumblers and in leaching tanks of RRT machines. This modification has improved the easiness in maintenance and reduced breakdowns. The total investment is `8 Lacs with an yearly savings of `4,23,360/- through energy saving. l Automation of compounding tanks in plant-A for improved process control and better monitoring with a total investment of `6 Lacs. This will have a saving of `2 Lacs per annum by reducing energy wastages. l Introduction of energy efficient direct drives in vulcanizing machines with an investment of `0.74 Lacs/ unit. This modification has derived an annual saving of `0.73 Lacs/ Unit. l Implementation of Intelligent substation automation system (ISAS) for better energy monitoring and automation. The total investment is `1.7 Lacs with an annual savings of `6 Lacs. b) Energy conservation measures executed at the Kanagala factory, Belgaum are mentioned below: l Replaced 7.5 Hp motor by 3.3 Hp motor in vulcanizing section. l Installed 30 No’s of LED based tube lights in place of discharge tube light. Annual Report 2013-2014 55 M…) +…CE÷Ú±…®… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… x…π{…… n˘i… >V……« ∫…∆Æ˙I…h… ={……™… x…“S…‰ n˘™…‰ M…™…‰ ΩÈ˛* • x…<« >V……« EÚ…™…«I…®… b˜§…±… Œ∫EÚx… ]ı…<{… E‰Ú ∫……l… BS…¥…“B∫…“ ∫…∫]ı®… E‰Ú 3 B™…Æ˙ ΩÈ˛b˜À±…M… ™…⁄ x…]ı… (BBS…™…÷) EÚ…‰ |… i…∫l…… {…i… EÚ™…… M…™……* ¥……Ãπ…EÚ §…S…i… - 1,32,900 E‰Úb˜Œ§±…™…÷BS… (+x…÷®…… x…i…)* • =i{……n˘x… I…‰j… ®… 18 ¥……±]ı B±…<«b˜“ ]ı⁄§… ±……<«]ı E‰Ú ∫……l… 175 ∫…∆J™…… ]ı“12 (40 ¥……±]¬ı∫…) }±…⁄Æ˙∫…Â]ı ±…Ë∆{… EÚ…‰ |… i…∫l…… {…i… EÚ™…… M…™……* ¥……Ãπ…EÚ §…S…i… - 33,726 E‰Úb˜Œ§±…™…÷BS… (+x…÷®…… x…i…) * • ¥…t®……x… {…¥…Æ˙ °ËÚC]ıÆ˙ 0.93 ∫…‰ 0.98 i…EÚ §…f¯…x…‰ E‰Ú ±…B ±…… • {…UÙ±…‰ ∫……±… ∫…‰ °Úx…Ê∫… +…Ï™…±… EÚ“ ¥…∂…‰π…ı <»v…x… J…{…i… 5.9% i…EÚ EÚ®… EÚ™…… M…™……* P…) EÚ…CEÚx……b °ËÚC]ıÆ˙“, EÚ…‰ŒSS… ®… x…π{…… n˘i… >V……« ∫…∆Æ˙I…h… ={……™… x…“S…‰ =Œ±±… J…i… ΩÈ˛* • BS…B±…B±… - E‰ÚB°Ú∫…“ ®… n˘…‰ 24 ¥……Ï]ı ∫……‰±……Æ˙ B±…<«b˜“ ±……<]ıÀx…M… ∫…∫]ı®… EÚ…‰ ∫…∆∫l…… {…i… EÚ™…… M…™……* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 56 c) Energy conservation measures taken at Akkulam factory, Thiruvananthapuram are mentioned below: • Replaced 3 Nos. of Air Handling Units (AHUs) of HVAC system with new Energy Efficient Double Skin type. Annual Savings- 1,32,900 KWH (approx.). • Replaced 175 Nos. of T12 (40 Watts) Fluorescent Lamps with 18 Watts LED Tube Light in the production areas. Annual Savings- 33,726 KWH (approx.). • Installed 2 Nos. of 200 KVAR Capacitor Bank with Line Reactors for enhancing the existing Power Factor of 0.93 to 0.98. Annual Savings- `.3.75 Lakhs (approx.). • Reduced Specific Fuel Consumption of Furnace Oil by 5.9% from last year. d) Energy conservation measures taken at Kakkanad factory, Cochin are mentioned below. · Installed 2 nos. of 24W solar LED lighting system at HLL-KFC- Actual expenses (in 2013-14) - `74650/-. Annual Report 2013-2014 57 °Ú…®…« J… ( x…™…®… 2 n‰˘J…Â) [J…] |……Ët…‰ M…EÚ“ +…®…‰±…x…, + ¶…O…Ω˛h… B¥…∆ x…¥……S……Æ 1. ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x… ˙+…{…EÚ“ E∆Ú{…x…“ E‰Ú EÚx…M…±…… °ËÚC]ıÆ˙“, §…‰±…M……®… ®… x…®x… ±… J…i… |……Ët…‰ M… EÚ™…… EÚ…‰ ¥…EÚ ∫…i…/+…®…‰ ±…i…/ + ¶…O… Ω˛i… EÚB M…B* • Œ§±…∫]ıÆ˙ {…ËÀEÚM… ®…∂…“x… E‰Ú ±…B •……]‰ı∫…« Œ∫±…{…ÀÆ˙M… ∫…∆∫l…… {…i… EÚ™…… M…™……* • ∫]≈ı“]ı ±……<]ı E‰Ú ∫¥…S…… ±…i… x…™…∆j…h… ∫…∆∫l…… {…i… EÚ™…… M…™……* • ¥…“b˜“™…÷ ∫…∆™…∆j… ®… S…±…Æ˙ E‰Ú x…™…∆j…EÚ E‰Ú ±…B ∫…I…®… |…S……±…x… +…ËÆ˙ x…™…∆j…h… & ®……Ï x…]ıÀÆ˙M… EÚ“ +…‰Æ˙ {…“B±…∫…“ ∫…∆∫l…… {…i… EÚ™…… M…™……* • ∫…Ë x…]ıÆ˙“ x…Ë{… EÚx… +{… ∂…π]ı ∫…∆O…Ω˛h… |…h……±…“ ¥…EÚ ∫…i… EÚ“ M…™…“, V…∫…E‰Ú u˘…Æ˙… |… i… ¥…π…« 5 n˘∂…±…I… +n˘n˘ + v…EÚ =i{……n˘x… EÚÆ˙E‰Ú ®…∂…“x… EÚ“ ={…±…§v…i…… §…f¯…™…“¯ M…™…“* • ®……‰œ±b˜M… ®…∂…“x… §…“Àb˜M… ™…⁄ x…]ı E‰Ú ±…B b˜<Æ˙C]ı b≈˜…<¥… ±……M…⁄ EÚ™…… M…™……* 2. ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x… EÚ…CEÚx……b˜, EÚ…‰ŒSS… ®… Œ∫l…i… +…{…EÚ“ E∆Ú{…x…“ EÚ“ °ËÚC]ıÆ˙“ x…‰ x…®x… ±… J…i… |……Ët…‰ M…EÚ“ EÚ…‰ ¥…EÚ ∫…i…/ +…®…‰ ±…ıi…/+ ¶…O… Ω˛i…Û EÚ™…‰ Ω˲∆* • B‰Æ˙…{…÷Æ˙®… °ËÚC]ıÆ˙“, EÚ…‰ŒSS… ®… BEÚ“EfiÚi… {……=b˜Æ˙ °Ú x…Àπ…M… E‰Ú ∫……l… S……Æ˙ (4) §…]ıÆ˙}±……<« ]ı…<{… b˜§…±… ]≈ËıEÚ E∆Úb˜…‰®… ®……‰œ±b˜M… ®…∂…“x… ∫…∆∫l…… {…i… EÚ™…… M…™……* <∫… i…EÚx……ϱ…V…“ +…‰EÚ…®……‰]ı…‰ ®……‰œ±b˜M… ®…∂…“x… EÚ… Ω˛“ ¶……M… Ω˲ +…ËÆ +§…˙ §…]ıÆ˙}±……<« ]ı…<{… b˜§…±… ]≈ËıEÚ E∆Úb˜…‰®… ®……‰œ±b˜M… ®…∂…“x… E‰Ú ∫……l… BEÚ“EfiÚi… EÚ™…… M…™…… Ω˲* ™…Ω˛ BEÚ“EÚÆ˙h… V…x…∂… HÚ §…S…i… EÚÆ˙x…‰ +…ËÆ˙ b≈‰˜À∫…M… ∫……®…O…“ E‰Ú ={…¶……‰M… EÚ…‰ EÚ®… EÚÆ˙x…‰ EÚ… ™……‰M…n˘…x… n˘™……* [M…] +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… (+…Æ˙ & b˜“) EÚ…™…«EÚ±……{… {…‰∞¸Æ˙EÚc˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… ({…“ B°Ú ]ı“) • ®…Œ±]ı ]‰ıE¬ÚS…‰b«˜ EÚ…Ïx]ıb«˜ E∆Úb˜…‰®… ¥…EÚ ∫…i… EÚ™…… M…™…… +…ËÆ˙ ∆ =∫…“ EÚ… ¥… x…®……«h… EÚÆ˙x…‰ E‰Ú ±…B ∫…I…®…i…… ∫l…… {…i… EÚ™…… M…™……* °Ú…™…n˘… - §…‰Ω˛i…Æ˙ O……Ω˛EÚ ∫¥…“EfiÚ i… E‰Ú ∫……l… x…B =i{……n˘ ∞¸{……xi…Æ˙* • ¥……Õ®…M… ∫…x…∫…‰∂…x… E‰Ú ∫……l… E∆Úb˜…‰®… E‰Ú ¥… x…®……«h… E‰Ú ±…B ¥……Õ®…M… |…¶……¥… ( ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 58 FORM B (See Rule 2) [B] TECHNOLOGY ABSORBTION, ADOPTION AND INNOVATION 1) During the year under review, your company’s factory at Kanagala, Belgaum developed/absorbed/ adopted the following technologies: • Installed Brushters sliprings to the blister packing machine. • Installed Automatic control of streetlights. • Installed PLC for the controller of chiller in BDU plant for efficient operation and control & monitoring. • Developed Sanitary Napkin Waste Collection System, by which machine availability enhanced to produce 5MPcs extra per annum. • Implemented Direct Drive for Moulding Machine Beading Unit 2) During the year under review, your company’s factory at Kakkanad, Cochin, developed/absorbed/ adopted the following technology: • Installed four (4) butterfly type double track condoms moulding machine with integrated powder finishing at the Irapuram Factory Cochin. This technology has been only part of the Okamoto moulding machine and now has been integrated with butterfly type double track condoms moulding machine. This integration has contributed to manpower saving and reducing the consumption of dressing materials. [C] RESEARCH AND DEVELOPMENT (R&D) ACTIVITIES Peroorkada Factory, Thiruvananthapuram (PFT) • Developed multi textured contoured condoms & established the competency to manufacture the same. Benefit- New Product variant with better customer acceptance. • Developed lubricant with warming effect (in-house development] for the manufacture of condoms with warming sensation. Benefit- New Product variant with warming sensation. • Developed latex formulation containing flavour to mask the rubber smell of the condoms. Benefit- Condoms without rubber smell for better customer acceptance. • Achieved 100% production capacity for Male Condom at HLL Peroorkada factory (1247.96 M. Pcs). Kakkanad Factory, Cochin (KFC) • Developed two types of affordable Latex FC and commercially distributed. Development of products with colours and other ancillary features are currently progressing. Kanagala Factory, Belgaum (KFB) • Developed Drosperinone & Ethinylestradiol tablets U.S.P. were undertaken for new OCP formulation. • Batch process of Levonorgestrel tablets B.P.1.5 mg (B.No. LN03P/13001, LN03P/13002 & LN03P/13003) - R&D pilot batch for WHO dossier submission. • Batch process of Levonorgestrel & Ethinylestradiol tablets B.P.(B.No. LE02P/13001, LE02P/13002 & LE02P/13003) - R&D pilot batch for WHO dossier submission. • Batch process of Levonorgestrel tablets B.P.1.5 mg (B.No. LN-1.5-F4P1-001 LN-1.5-F4P3-001 & LN-1.5-F4P2-001 - R&D trial batch formulation to reduce the solvent, dry mixing formulation & aqueous granulation. Annual Report 2013-2014 59 • x…®x… ±… J…i… =i{……n˘… E‰Ú |… GÚ™…… ∫…i™……{…x… 1) °‰ÚÆ˙∫… ∫…±°‰Ú]ı & °Ú…Ï ±…EÚ B ∫…b˜ EÚ“ M……‰ ±…™……ƒ (335/0.5 ®….O…) 2) °‰ÚÆ˙∫… ∫…±°‰Ú]ı & °Ú…ω ±…EÚ B ∫…b˜ EÚ“ M……‰ ±…™……ƒ (200/0.5 ®….O…) 3) °‰ÚÆ˙∫… ∫…±°‰Ú]ı & °Ú…Ï ±…EÚ B ∫…b˜ EÚ“ M……‰ ±…™……ƒ (100/0.5 ®….O…) 4) °‰ÚÆ˙∫… ∫…±°‰Ú]ı & °Ú…‰ ±…EÚ B ∫…b˜ EÚ“ M……‰ ±…™……ƒ (150/0.4 ®….O…) 5) °‰ÚÆ˙∫… ∫…±°‰Ú]ı & °Ú…Ï ±…EÚ B ∫…b˜ EÚ“ M……‰ ±…™……ƒ (67/0.1 ®….O…) • b˜Œ§±…™…÷BS…+…‰ E‰Ú ¥…∂±…‰π…h… E‰Ú ±…B §…“{…“ - 2013 E‰Ú +x…÷∫……Æ˙ B{…“+…<« E‰Ú ±…B ®……x…EÚ {…Æ˙“I…h… |… GÚ™…… EÚ“ i…Ë™……Æ˙“ +…ËÆ˙ ™…÷ x… {…±… ±…˧… EÚ… BŒC∫… {…™…]¬ı∫…* • 7 °ÚÆ˙¥…Æ˙“ 2014 EÚ…‰ ∫…®……{i… ™…÷ x… {…±… E‰Ú ±…B b˜Œ§±…™…÷BS…+…‰ {…⁄¥…« - +Ω«˛i…… ±…‰J……{…Æ˙“I……* • °‰ÚÆ…‰ {±…∫… E‰Ú x…B ∫…⁄j…“EÚÆ˙h… E‰Ú ±…B °‰ÚÆ˙∫… °⁄Ú®…Ɖ˙]ı & °Ú…‰ ±…EÚ B ∫…b˜ M……‰ ±…™……∆ §…“.{…“ EÚ… ¥…EÚ…∫…* • ±…‰¥…x……‰Æ˙M…∫]≈ı…‰±… M……‰ ±…™……ƒ §…“.{…“ 1.5 ®….O… E‰Ú ±…B ™…÷ x… {…±… §±……ÏEÚ ®… +x…÷E⁄Ú±… ]≈…ı™…±… |… GÚ™……* • b˜Œ§±…™…÷BS…+…‰ E‰Ú ±…B §…ËS… =i{……n˘x… Æ˙EÚ…Ïb«˜¬∫… +…ËÆ˙ +x™… n˘∫i……¥…‰V…… EÚ“ i…Ë™……Æ˙“* • V…x… +…Ëπ…v…“ ∫…⁄j…“EÚÆ˙h… E‰Ú ¶……M… E‰Ú ∞¸{… ®… x…®x… ±… J…i… ∫…⁄j…“EÚÆ˙h… E‰Ú ±…B x…™…‰ ∫…⁄j…“EÚÆ˙h… ¥…EÚ…∫… {…Æ˙“I…h… ±…™…‰ M…™…‰: - B Æ˙m……‰®……< ∫…x… M……‰ ±…™……ƒ +…<«{…“ 250 ®….O… - +…±…§…‰x…b˜W……‰±… M……‰ ±…™……ƒ +…<«{…“ 400 ®….O… - ∫…|……‰}±……‰C∫…… ∫…x… M……‰ ±…™……ƒ +…<«{…“ 500 ®….O… - }±…⁄EÚ…‰h……W……‰±… M……‰ ±…™……ƒ +…<«{…“ 150 ®….O… - + ∫…j……‰®……< ∫…x… M……‰ ±…™……ƒ +…<«{…“ 500 ®….O… - B Æ˙m……‰®……< ∫…x… M……‰ ±…™……ƒ +…<«{…“ 250 ®….O… • ±…‰¥…x……‰Æ˙M…∫]≈ı…‰±… +…<«™…÷B∫… E‰Ú ±…B x…™…… ∞¸{…¶…‰n˘ ¥…EÚ ∫…i… EÚ™……* [P…] ¥…n‰˘∂… ¥… x…®…™… +V…«x… B¥…∆ J…S…« (2012-2013) (2013-2014) M…i… ¥…π…«S……±…⁄ ¥…π…« (```±……J…… ®…Â) (``` ±……J…… ®…Â) 1. +V…«x… 11,564.90 12.874.23 2. J…S…« 12,608.27 10,072.19 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 60 • Process validation of the following products. 1) Ferrous Sulphate & Folic acid tablets (335/0.5 mg) 2) Ferrous Sulphate & Folic acid tablets (200/0.5 mg) 3) Ferrous Sulphate & Folic acid tablets (100/0.5 mg) 4) Ferrous Sulphate & Folic acid tablets (150/0.4 mg) 5) Ferrous Sulphate & Folic acid tablets (67/0.1mg) • Preparation of Standard Testing Procedure for API and excipients of Unipill lab as per BP-2013 for WHO analysis. • WHO pre-qualification audit for Unipill completed on 7th February 2014 • Development of Ferrous Fumarate & Folic Acid Tablets B.P. For new formulation of Ferro Plus • Process optimization trials in Unipill block for Levonorgestrel Tablets B.P.1.5 mg. • Preparation of Batch Production Records & other Documentations for WHO. • New formulation development trials were undertaken for the following formulations a part of JAN OUSHADHI formulation: − Erythromycin tablets IP 250 mg − Albendazole tablets I.P.400 mg − Ciprofloxacin tablets IP 500 mg − Fluconazole tablets IP 150 mg − Azithromycin Tablets IP 500 mg − Erythromycin tablets IP 250 • Developed new variant for Levonogestrol IUS [D] Foreign exchange earnings & outgo (2012-2013) (2013-14) Previous year Current year (` in lacs) (` in lacs) 1. Earnings 11564.90 12874.23 2. Outgo 12608.27 10072.19 Annual Report 2013-2014 61 +x…÷§…∆v… -J… E∆Ú{…x…“ E‰Ú EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… +…ËÆ˙ ∫…i…i… {…Ω˛±…ı EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… (∫…“ B∫… +…Æ˙) +…ËÆ˙ Œ∫l…Æ˙i…… E∆Ú{…x…“ EÚ“ ±……‰EÚ…S……Æ˙ B¥…∆ x…“ i… EÚ… + ¶…z… +∆M… Ω˲ +…ËÆ˙ E∆Ú{…x…“ ±…M……i……Æ˙ <∫…EÚ… {……±…x… EÚÆ˙ Æ˙Ω˛“ Ω˲* ¥…π…« E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ EÚ…‰ ∫…“B∫…+…Æ˙ +…ËÆ˙ B∫…b˜“ EÚ…™…«EÚ±……{…… E‰Ú ±…B ` 196.80 ±……J… EÚ… J…S…« Ω÷˛+… l…… V……‰Ú˛ {…Ë]ı E‰Ú (` 2570.77 ±……J…) 7.65% E‰Ú ∫…®…i…÷±™… Ω˲* ∫…Æ˙EÚ…Æ˙ E‰Ú ∫……l… |… ¥…Œπ]ıi… ∫…®…Z……Ëi…… Y……{…x… E‰Ú +x…÷∫……Æ˙ ¥… ∂…π]ı EÚ…™…«EÚ±……{… |……Æ∆˙¶… ±…B M…B l…‰* EÚ. ∫…“ B∫… +…Æ˙ {…Ω˛±… V…x…Æ˙±… ∫¥……∫l™… ®…‰ b˜EÚ±… ∂… ¥…Æ˙…‰∆ EÚ“ ¥…∂…‰π…i…… BS…B±…B±… x…‰ 2012-14 +¥… v… E‰Ú n˘…ËÆ˙…x… EÚÆ˙E÷Ú±…®… +…ËÆ˙ EÚx…M…±…… ®… 8 ¥…∂…‰π…i…… ∂… ¥…Æ˙… EÚ… +…™……‰V…x… EÚ™…… l…… * ∫……®……x™… ∫¥……∫l™… Æ˙I…… ™…⁄ x…]ı E‰Ú +±……¥…… +…Ï}l…±®……‰±……ÏV…“, n∆˘i…, {…“ b˜™…… ]≈ıEÚ, Ɖ˙Œ∫{…Ɖ˙]ıÆ˙“ |…¶……M… ∂… ¥…Æ˙… ®… ®……ËV…⁄n˘ l…‰* ∂… ¥…Æ˙… ®… ¶……M… ±…™…‰ Æ˙…‰ M…™…… EÚ…‰ ®…÷}i… ®… n˘¥……B∆ +…ËÆ˙ +x™… ∫…‰¥……B∆ n˘™…‰ M…B l…‰* +…Ï}l…±®……‰±……ÏV…“ ™…⁄ x…]ı ®… ¶……M… ±…‰x…‰ ¥……±…‰ Æ˙…‰ M…™…… EÚ…‰ ®…÷}i… ®… S…∂®…… n˘™…… M…™……* Æ˙“V…x…±… <∆Œ∫]ı]ı¨⁄]ı +…Ï°Ú +…Ï}l…±®……‰±……ÏV…“, ∫…Æ˙EÚ…Æ˙ b˜]ı±… Eڅϱ…‰V…, i…Ø˚¥…x…∆i…{…÷Æ˙®…, |……l… ®…EÚ ∫¥……∫l™… EÂÚp˘ +…ËÆ˙ <∆ b˜™…x… +EÚ…n˘®…“ +…Ï°Ú {…“ b˜™…… ]≈ıEÚ¬∫… E‰Ú ∫…Ω˛™……‰M… ∫…‰ ∂… ¥…Æ˙… E‰Ú ∫……l… V…÷b‰˜ Ω÷˛B l…‰ * BS…B±…B±… x…‰ 2012-14 +¥… v… E‰Ú n˘…ËÆ˙…x… <∆ b˜™…x… +EÚ…n˘®…“ +…Ï°Ú {…“ b˜™…… ]≈ıEÚ¬∫… E‰Ú ∫…Ω˛™……‰M… ∫…‰ i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… ∫…Æ˙EÚ…Æ“˙ ∫E⁄Ú±…… E‰Ú 1500 UÙ…j…… EÚ…‰ ∫…®…… ¥…π]ı EÚÆ˙E‰Ú 8 ∂… ¥…Æ˙ +…™……‰ V…i… EÚ™…… * EÈÚ∫…Æ˙ EÚ… ∂…“Q… {…i…… ±…M……x…… +…ËÆ˙ |…§…∆v…x… BS…B±…B±… x…‰ Æ˙“V…x…±… EÈÚ∫…Æ˙ ∫…Â]ıÆ˙, i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰Ú ∫…Ω˛™……‰M… ∫…‰ EÚÆ˙E÷Ú±…®… M……ƒ¥… E‰Ú ®… Ω˛±……+… E‰Ú ±…B ∫i…x… +…ËÆ˙ M…¶……«∂…™… EÈÚ∫…Æ˙ {…Æ˙ ∫GÚ“Àx…M… EÈÚ{… +…™……‰ V…i… EÚ™……* ¥…π…« 2012-14 E‰Ú n˘…ËÆ˙…x…, BS…B±…B±… x…‰ 509 ®… Ω˛±……+… EÚ…‰ ∫…®…… ¥…π]ı EÚÆ˙E‰Ú B‰∫…‰ 5 ∂… ¥…Æ +…™……‰ V…i… EÚ™…… V…∫…®… ∫…‰ 5 (±…M…¶…M… 1%) ∫i…x… /M…¶……«∂…™… EÈÚ∫…Æ˙ E‰Ú ±…I…h…… E‰Ú ∫……l… x…n˘…x… EÚ™…… M…™…… +…ËÆ˙ {…Æ˙“I…h… +…ËÆ ={…S……Æ˙ EÚ“ +x…÷¥…i…‘ EÚ…Æ«˙¥……<« EÚ“ V……i…“ ΩÈ˛* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 62 ANNEXURE- B CORPORATE SOCIAL RESPONSIBILITY & SUSTAINABILITY INITIATIVES OF THE COMPANY Corporate Social Responsibility (CSR) & Sustainability is an integral part of the Company’s ethos and policy and the Company has been pursuing this on a sustained basis. During the year, the Company had incurred an expenditure of ` 196.80 lakh that is equivalent to 7.65% of PAT (`2570.77 lakh) for CSR and SD activities. Specific activities were undertaken in accordance with the MoU entered into with the Government. A. CSR INITIATIVES: General Health Specialty medical camps HLL organized 8 specialty camps in Karakulam and Kanagala during the period 2012 - 2014. Ophthalmology, Dental, Pediatric and Respiratory divisions were present in the camps, in addition to the general health care unit. The patients attended the camps were given free medicines and other services. The patients who attended ophthalmic unit were given the spectacles free of cost. Regional Institute of Ophthalmology, Govt. Dental College, Thiruvananthapuram, Primary Health Centres and Indian Academy of Pediatrics associated with the camps. HLL organised 8 camps covering 1500 students of govt. schools in Thiruvananthapuram city in association with Indian Academy of Pediatrics during the period 2012 - 2014. Early detection and management of cancers HLL in association with the Regional Cancer Centre, Thiruvananthapuram has organised screening camps on breast and cervical cancer for women in Karakulam village. During the years 2012-14, HLL organised 5 such camps covering 509 women, out of which 5 of them (almost 1%) were diagnosed with symptoms of cervical/breast cancer and are taking follow up tests and treatment. The camps have helped the local Panchayat and Primary Health Centre in generating awareness on cancer and early detection of the same in the community. Early detection and management of diabetics Delay in detection of diabetics is identified as one of the major health care issues in Karakulam and Kanagala, during the baseline study. In order to facilitate the timely screening for diabetics, HLL organized a focused campaign in Karakulam and Kanagala villages using a designed Sugar Testing and Review (STAR) Van. Around 7010 people were given the opportunity to screen their diabetics’ status in Karakulam and another 4000 in Kanagala during the period 2012-14. The results show that around 23% of the people are suspected to have diabetics and they have been counseled to do follow up tests and avail treatment. Around 78% of the people who attended the camps were found doing the diabetics’ screening test for the first time. Adolescent health HLL is organizing regular programmes for the adolescent girls in the adopted villages. Training programme on menstrual hygiene, free supply of sanitary napkin etc. are the activities undertaken under the project. The project is being implemented with the support of anganwadies and schools in the villages. HLL has covered around 3000 adolescent girls in Karakulam, Kanagala and Pozhuthana Grama Panchayats. HLL is also supporting the schools and ICDS to conduct training programmes on drug abuse, rational use of mobiles, general health, etc. for the adolescent boys and girls. Education Strengthening education institutions is one of key focus areas of HLL CSR programme under village adoption. HLL is currently supporting 8 schools in Karakulam; 3 schools in Kanagala and 4 schools in Pozhuthana. Annual Report 2013-2014 63 ∫E⁄Ú±……‰∆ ®… ∫…÷ ¥…v…… ∫…÷v……Æ˙ (∂……ËS……±…™……Â, {…“x…‰ EÚ… {……x…“ EÚ“ ∫…÷ ¥…v……B∆, §…SS…… E‰Ú {……E«Ú, ¥…π……« V…±… ∫…∆S…™…x… +…ËÆ˙ {… Æ˙∫…Æ˙ EÚ“ n˘“¥……Æ˙… E‰ x…®……«h…); Ω˛…<« ∫E⁄Ú±… +…ËÆ˙ Ω˛…™…Æ˙ ∫…‰E∆Úb˜Æ˙“ ∫E⁄Ú±… E‰Ú UÙ…j…… E‰Ú ±…B V…“¥…x… EÚ…Ë∂…±… ∂…I…… EÚ…™…«GÚ®…, UÙ…j…… E‰Ú ±…B {…Æ˙…®…∂…« ∫…‰¥……B∆ |…n˘…x… EÚÆ˙x…… +…ËÆ˙ ∂…I…EÚ…Â E‰Ú ±…B |… ∂…I…h… EÚ…™…«GÚ®… +…™……‰ V…i… EÚÆ˙x…… +… n˘ BS…B±…B±… u˘…Æ˙… ±…™…‰ M…™…‰ EÚ…™…«EÚ±……{… ΩÈ˛* BS…B±…B±… +…M……®…“ ¥…π…« ®… ∫E⁄Ú±…… E‰ §…“S… +…M…‰ EÚ‰ Ω˛∫i…I…‰{……‰∆ EÚ…‰ ®…V…§…⁄i… §…x……x…‰ EÚ“ ™……‰V…x…… §…x…… Æ˙Ω˛… Ω˲* {…™……«¥…Æ˙h… +…ËÆ˙ ∫¥…SUÙi…… M……ƒ¥…… EÚ…‰ M……‰n˘ ±…‰x…‰ E‰Ú +v…“x… E‰Ú n˘…‰ ®…÷J™… Ω˛∫i…I…‰{… ΩÈ˛ M……ƒ¥…… ®… {…™……«¥…Æ˙h… ∫…∆Æ˙I…h… +…ËÆ˙ ∫¥…SUÙÙi…… ∫…÷ ¥…v……˙ EÚ… ∫…÷v……Æ˙* ∂……ËËS……±…™… +…ËÆ˙ ®…⁄j……±…™…… E‰Ú x…®……«h… (EÚx…M…±…… ®… 20 ∂……ËS……±…™… +…ËÆ˙ EÚÆ˙E÷Ú±…®… ®… 15 ∂……ËS……±…™… +…ËÆ˙ ®…⁄j……±…™…) +…ËÆ˙ +…®… V…x…i…… +…ËÆ˙ UÙ…j… ∫…®…⁄Ω…‰∆˛ (EÚx…M…±……) E‰Ú §…“S… ∫¥…SUÙi…… {…Æ˙ + ¶…™……x… <∫… |…™……‰V…x… E‰Ú ±…B ∞¸{…… ™…i… M… i… ¥… v…™……ƒ ΩÈ˛* b˜M…⁄ §…÷J……Æ˙ ®……®…±…… EÚ“ ∫…∆J™…… ®… ¥…fi r˘ +…ËÆ˙ `ˆ…‰∫… +{… ∂…π]ıˆ |…§…∆v…x… E‰Ú ®…÷q˘… EÚ…‰ v™……x… ®… Æ˙J…EÚÆ˙˙ BS…B±…B±… x…‰ ¥…‰C]ıÆ˙ V… x…i… Æ˙…‰M…… +…ËÆ˙ +{… ∂…π]ıˆı |…§…∆v…x… {…Æ˙ n˘…‰ + ¶…™……x… ∞¸{…… ™…i… EÚ™…… * ™…Ω˛ ∫l……x…“™… {…∆S……™…i…… +…ËÆ˙ ∫¥……∫l™… ¥…¶……M… E‰Ú ∫…Ω˛™……‰M… ∫…‰ EÚ…™……«Œx¥…i… EÚ™…… V……i…… Ω˲* "¥…π……« V…±… ∫…∆S…™…x…' E‰Ú +…∂…™… EÚ“ ™……‰V…x…… EÚ…‰ §…f¯…¥…… n‰˘x…‰ E‰Ú GÚ®… ®…Â, BS…B±…B±… EÚÆ˙E÷Ú±…®… M……ƒ¥… E‰Ú 5 EÂÚp˘… ®… (∫E⁄Ú±……Â, +∆M…x…¥……b˜“ +…ËÆ˙ ¥…fir˘…∏…®…) ∫…÷ ¥…v……+… EÚ“ ∫l……{…x…… EÚ“* ∫……‰±……Æ˙ ∫]≈ı“]ı±……<]ı E‰Ú ∫…∆∫l……{…x… EÚx…M…±…… E‰Ú ®…÷J™… Ω˛∫i…I…‰{…… ®… BEÚ Ω˲* BS…B±…B±… 2013-14 ®… M……ƒ¥… E‰Ú ®…÷J™… ∫l……x… ®… 9 ∫……‰±……Æ˙ ∫]≈ı“]ı ±…˧… ±…M……™……* ®……<« ∫…]ı“ {… Æ˙™……‰V…x…… - EÚ¥… b˜™……Æ˙ ¥……b«˜, i…Ø˚¥…x…∆i…{…÷Æ˙®… `ˆ…‰∫… +{… ∂…π]ıˆı |…§…∆v…x… BEÚ ∫¥…∫l… {…™……«¥…Æ˙h… §…x……B Æ˙J…x…‰ E‰Ú ±…B +…V…EÚ“ ¥…Ë ∑…EÚ S…÷x……Ë i…™…… ∫…‰ BEÚ §…x… M…™…… Ω˲* <∫… |…∫…∆M… ®… BS…B±…B±… ±……<°ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…‰ x…Ë∂…x…±… ¥…˱™…⁄W… +…Ï°Ú Æ‰˙∫]‰ıƉ˙∂…x… °Ú…‰Æ˙ °Ú…=∆b‰˜∂…x… (B°Ú+…Æ˙Bx…¥…“) E‰Ú ∫…Ω˛™……‰M… ∫…‰ "®……<« ∫…]ı“ {… Æ˙™……‰V…x……' EÚ…‰ |……Æ∆˙¶… EÚ™……* ™…Ω˛ {… Æ˙™……‰V…x…… E‰ÚÆ˙±… ∫…Æ˙EÚ…Æ˙, i…Ø˚¥…x…∆i…{…÷Æ˙®… x…M…Æ˙ x…M…®…, ∂…÷ S…i¥… ®…∂…x…, <∫… I…‰j… E‰Ú x…¥…… ∫…™…… E‰Ú B∫……‰ ∫…B∂…x…… +…ËÆ˙ +x™… ∫…®……x… ¥…S……Æ˙v……Æ˙… ¥……±…‰ ∫…∆M…`ˆx…… E‰Ú ∫…Ω˛™……‰M… ∫…‰ EÚ¥… b˜™……Æ˙ ¥……b«˜ ®… ∫…∆S…… ±…i… EÚ“ V……™…‰M…“* ™…Ω˛ {… Æ˙™……‰V…x…… ∫…Æ˙EÚ…Æ, x…M…®…, M…ËÆ˙ ∫…Æ˙EÚ…Æ˙“ ∫…∆M…`ˆx…… +…ËÆ˙ ¥……b«˜ E‰Ú x…¥…… ∫…™…… E‰Ú u˘…Æ˙… ∫…∆™…÷HÚ ∞¸{… ∫…‰ {…™……«¥…Æ˙h… E‰Ú +x…÷E⁄Ú±… +…ËÆ˙ ±……M…i… |…¶……¥…“ `ˆ…‰∫… +{… ∂…π]ıˆı |…§…∆v…x… |…h……±…“ EÚ… ¥…EÚ…∫… EÚÆ˙x…… ±…I™… EÚÆ˙i…… Ω˲* ˙ ™…Ω˛ {… Æ˙™……‰V…x…… §……™……‰ - b˜O…‰b˜ §…±… +…ËÆ˙ {±……Œ∫]ıEÚ +{… ∂…π]ı |…§…∆v…x… E‰Ú ±…B ∫¥…SUÙi…… i…∆j… EÚ“ ∫…∆∫l……{…x… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú u˘…Æ˙… {… Æ˙™……‰V…x…… I…‰j… E‰Ú +x™…- ®…÷ HÚ ¶…“ ±…I™… EÚÆ˙i…“ Ω˲* E‰ÚÆ˙±… ®… ∫¥…ËŒSUÙEÚ Æ˙HÚn˘…x… EÚ… ∫…∆¥…v…«x…/|……‰i∫……Ω˛x… Æ˙…V™… ¶…Æ˙ ®… ∫¥…ËŒSUÙEÚ Æ˙HÚn˘…x… ∂… ¥…Æ˙ +…ËÆ˙ |……‰z…®…x… M… i… ¥… v…™…… EÚ…‰ +…™……‰ V…i… EÚÆ˙x…… +…ËÆ˙ Æ˙“V…x…±… EÈÚ∫…Æ˙ ∫…Â]ıÆ˙, ∏…“ S…j…… +∫{…i……±… E‰Ú˘ Æ˙…‰ M…™…… EÚ“ ∫…Ω˛…™…i…… EÚÆ˙x…‰ E‰Ú ±…B i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… BEÚ Ω‰˛±{…b‰˜∫EÚ EÚ… |…§…∆v…x… EÚÆ˙x…… +… n˘ <∫… EÚ…™…«GÚ®… E‰Ú +v…“x… ±…™…‰ M…™…‰ EÚ…™…«EÚ±……{… ΩÈ˛* "Ω˛…]«ı§…“]¬∫…' x……®…EÚ BEÚ Ω‰˛±{…b‰˜∫EÚ i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… §±…b˜ EÚ“ +…{……i… +…¥…∂™…EÚi…… {…⁄Æ˙… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ ∫…∆∫l…… {…i… EÚ™…… M…™…… Ω˲* "Ω˛…]«ı§…“]¬∫…ı' i…Ø˚¥…x…∆i…{…÷Æ˙®… ®… ®…÷J™… §±…b˜ §…ÈEÚ…Â EÚ… ∫…®…l…«x… EÚÆ˙x…‰ ¥……±…‰ ∫¥…ËŒSUÙEÚ Æ˙HÚn˘…i……+… EÚ… BEÚ x…‰]ı¥…E«Ú Ω˲* BS…B±…B°Ú{…“{…“]ı“ EÚ…™……«±…™… ∫…‰ ™…Ω˛ Ω‰˛±{… b‰˜∫EÚ |…S……±…x… EÚÆ˙ Æ˙Ω˛… Ω˲* BS…B±…B°Ú{…“{…“]ı“ E‰Ú ∫…®…l…«x… E‰Ú ∫……l… BS…B±…B±… {…Ω˛±… EÚ…‰ ∫…®…l…«x… EÚÆ˙x…‰ E‰Ú ±…B n˘…i……+… EÚ…‰ x……®……∆EÚx… EÚÆ˙x…‰ E‰Ú ±…B Eڅϱ…‰V… UÙ…j…… E‰Ú §…“S… ®… +…ËÆ˙ =SS… EÚ®™…⁄]ı I…‰j…… ®… |…S……Æ˙ E‰Ú ∫…∆¥…v…«x… P…]ıx……+…Âı +…ËÆ˙ + ¶…™……x…… EÚ… +…™……‰V…x… EÚ™…… M…™……* ¥…i…«®……x… ®… ™…Ω˛ Ω‰˛±{… b‰˜∫EÚ i…Ø˚¥…x…∆i…{…÷Æ˙®… V…±…‰ ®… Æ˙Ω˛x…‰¥……±…‰ 7500 §±…b˜ n˘…i……+… E‰Ú BEÚ ®…W…§…⁄i… §…ËEÚ+{… Ω˲* Ω‰˛±{…b‰˜∫EÚ u˘…Æ˙… W…∞¸Æ˙i…®…∆n˘ +…ËÆ˙ +∫…÷ ¥…v……¥……±…‰ Æ˙˙…‰ M…™…… E‰Ú ±…B BEÚ n˘x… ®… +…Ë∫…i…x… 10-15 i…EÚ n˘…i……+… EÚ“ ¥™…¥…∫l…… EÚÆ˙i…… Ω˲* BS…B±…B°Ú{…“{…“]ı“ E‰Ú ∫…®…l…«x… E‰Ú ∫……l… BS…B±…B±… ∫¥…ËŒSUÙEÚ Æ˙HÚn˘…x… EÚ…‰ §…f√¯…¥…… n‰˘x…‰ E‰Ú ±…B ∂…Ë I…EÚ ∫…∆∫l……x…… +…ËÆ˙ ∫……®……x™… ∫…®…÷n˘…™… ®… x…™… ®…i… EÚ…™…«GÚ®……‰∆ EÚ… +…™……‰V…x… EÚÆ˙i…… Ω˲* V……M…∞¸EÚi…… EÚI……+… +…ËÆ˙ |… ∂…I…h… EÚ…™…«GÚ®…… E‰Ú {……±…x… EÚÆ˙i…‰ Ω÷˛B˘, ∫…Æ˙EÚ…Æ˙ §±…b˜ §…ÈEÚ…Â +…ËÆ˙ I…‰j…“™… Æ˙HÚ+…n˘…x… EÂÚp˘… E‰Ú ∫…Ω˛™……‰M… ∫…‰ ∫¥…ËŒSUÙEÚ Æ˙HÚn˘…x… ∂… ¥…Æ˙ Æ˙…V™… E‰Ú ¥… ¥…v… ¶……M…… ®… +…™……‰ V…i… EÚ™…‰ M…™…‰ l…‰* BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ x…‰ 2011-13 EÚ“ +¥… v… E‰Ú n˘…ËÆ˙…x… 5200 ™…⁄ x…]ı §±…b˜ ∫…∆O…Ω˛h… EÚÆ˙x…‰ E‰Ú ±…B 114 ∂… ¥…Æ˙…‰∆ E‰Ú +…™……‰V…x… EÚÆ˙x…‰ ®… Æ˙…V™… EÚ“ ®…n˘n˘ EÚ“* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 64 Facility improvement (construction of toilets, drinking water facilities, children’s parks, rain water harvesting and compound walls) in schools; Life skill education programme for the high school and higher secondary school students, providing Counseling services to students and organizing Training programme for teachers etc. are the activities taken up by HLL. HLL is planning to further strengthen the interventions among schools in coming years. Environment and Sanitation Environment protection and improving sanitation facilities in villages are two key interventions under the adoption of villages. Construction of toilets and urinals (20 toilets in Kanagala and 15 toilets and urinals in Karakulam) and campaign on sanitation among general population and student groups (Kanagala) are the activities designed for the purpose. Taking into consideration of increased number of dengue fever cases and issues of solid waste management, HLL designed 2 campaigns on vector borne diseases and waste management. This is implemented in association with local Panchayats and Health Department. In order to promote the idea of ‘Rain water harvesting’, HLL set up the facilities in 5 centres (schools, anganwadies and old age home) in Karakulam village. Setting up of Solar Streetlights is one of the key interventions in Kanagala. HLL put up 9 solar street lamps in major location of the village in 2013-14. My city project – Kowdiar ward, Thiruvananthapuram Solid waste management has become one of the global challenges of today in maintaining a healthy environment. This is the context in which HLL Lifecare Ltd. formulated ‘My City Project’ in association with Foundation for Restoration of National Values (FRNV). The project will be piloted in Kowdiar ward in association with Govt. of Kerala, Thiruvananthapuram Municipal Corporation, Suchitwa Mission, Residents Associations in the area and other like-minded organizations. The project aims at developing an eco-friendly and cost effective solid waste management system jointly by Government, Corporation, NGOs and the residents of the ward. The project also aims at beautification of the project area by ensuring cleanliness setting up mechanisms for management of bio-degradable and plastic waste. Promotion of voluntary blood donation in Kerala Conduct of voluntary blood donation camps and promotional activities across the State and managing a helpdesk at Thiruvananthapuram to support the patients of Regional Cancer Centre, Sri Chitra Hospital etc. are the activities taken up under the programme. A helpdesk named ‘Heartbeats’ has been set up in order to meet emergency requirement of blood in Thiruvananthapuram. ‘Heartbeats’ is a network of voluntary blood donors that support the major blood banks in Thiruvananthapuram. The help desk is operating from HLFPPT office. HLL with the support of HLFPPT conducts promotional events and campaigns among College students and at high commute areas to enroll donors to support the initiative. Presently, the helpdesk has a strong back up of 7500 blood donors residing in Thiruvananthapuram district. On an average by the helpdesk arrange 10- 15 donors in a day for the needy and disadvantaged patients. HLL with the support of HLFPPT organize regular programmes in educational Institutions and general community for the promotion of voluntary blood donation. Following the awareness classes and training programmes, Voluntary Blood Donation camps were conducted in different part of the State in association with Govt. blood banks and Regional Blood Transfusion Centres. HLL Lifecare Ltd. supported the State in conducting 114 camps collecting 5200 units of blood during the period 2011-13. Annual Report 2013-2014 65 ¥…π…« 2013-14 E‰Ú ±…B ∫…“B∫…+…Æ˙ ¥™…™… E‰Ú ∫…®…‰ EÚi… ¥…¥…Æ˙h… x…“S…‰ i…… ±…EÚ… ®… n˘™…‰ M…™…‰ ΩÈ˛: {… Æ˙™……‰V…x…… EÚ… x……®… J…S…« EÚ“ M…<« Æ˙EÚ®… (` ±……J…… ®…Â) BS…B±…B°Ú{…“{…“]ı“ E‰Ú u˘…Æ˙… EÚÆ˙E÷Ú±…®… M……ƒ¥… E‰Ú ∫E÷Ú±…… ®… ∫……¥…«V… x…EÚ ∫¥……∫l™… EÚ…™…«EÚ±……{… - ®…‰ b˜EÚ±… ∂… ¥…Æ˙…‰∆ +…ËÆ˙ + ¶…™……x… +…ËÆ˙ |……‰z…®…x… EÚ…™…«EÚ±……{…… +…ËÆ˙ +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… * 28.17 EÚx…M…±…… M……ƒ¥… E‰Ú ∫E÷Ú±…… ®… ∫……¥…«V… x…EÚ ∫¥……∫l™… EÚ…™…«EÚ±……{… - ®…‰ b˜EÚ±… ∂… ¥…Æ˙…‰∆ +…ËÆ˙ + ¶…™……x… +…ËÆ˙ |……‰z…®…x… EÚ…™…«EÚ±……{…… +…ËÆ˙ +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… * 15.86 ¥…™…x……b˜ E‰Ú ∂…Ë I…EÚ ∫…∆∫l……x…… EÚ…‰ EÚ∂……‰Æ˙ ∫¥……∫l™… EÚ…™…«GÚ®… +…ËÆ˙ ∫…®…l…«x…* 4.41 ®……x… ∫…EÚ +∫{…i……±… {… Æ˙™……‰V…x…… 6.72 E∆Ú{…x…“ E‰Ú ∫…∆∂……‰ v…i… ∫…“B∫…+…Æ˙ & B∫… b˜“ x…“ i… E‰Ú +x…÷∫……Æ˙ =SS… ∂…I…… E‰Ú ±…B |… i…¶……∂……±…“ +…ËÆ˙ W…∞¸Æ˙i…®…∆n˘ UÙ…j…… E‰Ú ±…B UÙ…j…¥…fi k… {…÷Æ˙∫EÚ…Æ˙ +…ËÆ˙ ∫¥……∫l™… Æ˙I…… ∫…®…l…«x… E‰Ú ±…B |…i…“I…… °Ú…=∆b‰˜∂…x… E‰Ú EÚ…Ï{…«∫… E‰Ú ±…B +∆∂…n˘…x… ˙ 20.00 x…Ë∂…x…±… ¥…˱™…⁄W… +…Ï°Ú Æ‰˙∫]‰ıƉ˙∂…x… °Ú…‰Æ˙ °Ú…=∆b‰˜∂…x… (B°Ú+…Æ˙Bx…¥…“) E‰Ú ∫…Ω˛™……‰M… ∫…‰ ®……<« ∫…]ı“ {… Æ˙™……‰V…x…… ( i…Ø˚¥…x…∆i…{…÷Æ˙®… V…±…‰ E‰Ú EÚ¥… b˜™……Æ˙ ¥……b«˜ ®… GÚ™……Œx¥…i… Ω˲, V…Ω˛…ƒ ®…n˘Æ˙ {±……x]ı ({…“B°Ú]ı“) Œ∫l…i… Ω˲)* 10.19 ∫…®…Z……Ëi…… Y……{…x… E‰Ú ±…I™… E‰Ú +x…÷∫……Æ˙ V…±… ™…… >V……« |…§…∆v…x… & >V……«« n˘I…i…… , >V……« E‰Ú x…¥…“EÚÆ˙h…“™… "∏……‰i…… E‰Ú |……‰z…®…x…, ¥…π……« V…±… ∫…∆S…™…x…, §±…b˜/x…‰j…n˘…x… ∂… ¥…Æ˙, ¥…Æ˙…∫…i… +…ËÆ˙ EÚ±…… E‰Ú ∫…∆¥…v…«x… +…ËÆ˙ ∫…∆Æ˙I…h… +… n˘ E‰Ú I…‰j… ®… {……ƒS… ∫…i…i… ¥…EÚ…∫… {… Æ˙™……‰V…x……* - +x™… B±…{…“B∫… ∫E⁄Ú±… >±…x…{……Æ˙… ®… +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… 0.73 BS…+…<«¥…“ ∫…∆GÚ ®…i… E‰Ú ±…B ¥…k…“™… ∫…®…l…«x… 1.25 EÚ¥… b˜™……Æ˙ +…ËÆ˙ {…⁄V…{{…÷Æ˙… {……EÚ…Á E‰Ú +x…÷Æ˙I…h… 7.44 +…Æ˙∫…“∫…“ E‰Ú ®……v™…®… ∫…‰ {…… ±…™…‰ ]ı¥… E‰Ú™…Æ˙ Æ˙…‰ M…™…… E‰Ú ±…B 50 +…=]ıÆ˙“S… C±…“ x…EÚ 2.50 E÷Ú±… 97.28 J…. ∫…i…i… ¥…EÚ…∫… {…Ω˛±… ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ u˘…Æ˙… EÚ…™……«Œx¥…i… ∫…i…i… ¥…EÚ…∫… {…Ω˛±… x…“S…‰ ∫…∆I…‰ {…i… EÚ™…‰ V……i…‰ ΩÈ˛: GÚ®… ∫…∆. ∫…i…i… ¥…EÚ…∫… EÚ…™…«EÚ±……{… ``` ±……J……‰∆ ®… 1. BS…B±…B±… {…‰∞¸Æ˙EÚb˜… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… (i) S……Æ˙ ®……‰œ±b˜M… ®…∂…“x…… ®… ∫…∆∂……‰ v…i… P…x…“¶…⁄i… Æ˙EÚ¥…Æ˙“ ∫…∫]ı®… (B®… 5,B®…6,B®…B & B®…§…“) 5.62 (ii) §……Ï™…±…Æ˙ b‰˜ ]ÈıEÚ ®… ∫]ı“®… Ω˛“À]ıM… E‰Ú ∫……l… ∫…Â]≈ı“}™…⁄V… °Ú±…¬]≈‰ı∂…x…* 0.19 (iii) ]ı®§…±…Æ˙, ±…“ÀS…M… ]ÈıEÚ ®… ∫]ı“®… Ω˛“À]ıM… E‰Ú ±…B <±…ËŒC]≈ıEÚ±… EÚ… ∞¸{……∆i…Æ˙h…* 4.82 (iv) ∫…∆™…∆j… - EÚ ®… EÚ…Ï{……ËÀb˜M… ]ÈıEÚ E‰Ú +…Ï]ı…‰®…‰∂…x… 5.73 (v) ¥…±EÚx……<À∫…M… ®…∂…“x… ®… ∫…“v…… b≈˜…<¥… EÚ… |……Æ∆˙¶… 12.12 (vi) <∆]‰ı ±…V…Â]ı ={… - ∫]‰ı∂…x… +…Ï]ı…‰®…‰∂…x… ∫…∫]ı®… (+…<«B∫…BB∫…) 9.91 ={… ™……‰M… 38.39 2. BS…B±…B±… EÚ…CEÚx……b√˜ °ËÚC]ıÆ˙“, EÚ…‰ŒSS… (i) 24 ¥……ϱ]ı ∫……‰±……Æ˙ B±…<«b˜“ ±……< ]ı∆M… ∫…∫]ı®… EÚ… ∫…∆∫l……{…x… 0.75 ={… ™……‰M… 0.75 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 66 Consolidated Statement of CSR Expenses for the year 2013-14 is given in the table below. Name of Project Amount Spent (``` in Lacs) Through HLFPPT Public health activities-Medical camps and campaign and promotional activities and infrastructural developments in schools at Karakulam village 28.17 Public health activities-Medical camps and campaign and promotional activities and infrastructural developments in schools at Kanagala village 15.86 Adolescent health programmes and support to educational institutions at Wayanad 4.41 Mental Hospital project 6.72 Contribution to the corpus of Pratheeksha Foundation for award of scholarship to meritorious and needy students for higher education & providing health care support, in line with the revised CSR&SD Policy of the Company 20.00 My City Project (executed in the Kowdiar ward of Trivandrum District where the mother plant (PFT) located, in association with Foundation for Restoration of National Values (FRNV). 10.19 Five Sustainability Development projects in the field of Water or Energy Management & Energy efficiency, Promotion of renewable sources of energy, Rain water harvesting, - Blood/Eye Donation camps, Preservation and promotion of heritage & art etc. as per MoU targets Others Infrastructural developments at LPS school Oolampara 0.73 Financial Support to HIV infected 1.25 Maintenance of Kowdiar & Poojappura Parks 7.44 50 outreach clinics for palliative care patients through RCC 2.50 TOTAL 97.28 B. SUSTAINABILITY DEVELOPMENT INITIATIVES The Sustainability Development initiatives implemented by the Company during year 2013-14 is summarized below. Sl No Sustainable Development Activity Rs. In lacs 1 HLL Peroorkada factory, Thiruvananthapuram (i) Condensate Recovery System modified in four moulding machines (M5, M6, MA & MB). 5.62 (ii) Centrifuge filteration with steam heating of oil at day tank of boiler 0.19 (iii) Conversion of electrical to steam heating in tumblers, leaching tanks 4.82 (iv) Automation of the compounding tanks in Plant - A 5.73 (v) Introduction of Direct Drive in Vulcanizing machine 12.12 (vi) Intelligent sub-station automation system (ISAS) 9.91 Sub-total 38.39 2 HLL Kakkanad factory, Kochi (i) Installation of 2 nos. of 24W solar LED lighting system 0.75 Sub-total 0.75 Annual Report 2013-2014 67 3. BS…B±…B±… EÚx…M…±…… °ËÚC]ıÆ˙“, §…±…M……®… (i) {…Æ∆˙{…Æ˙…M…i… ±…⁄ ®…x…Æ˙“ E‰Ú ∫l……x… {…Æ˙ B±…<«b˜“ +…v…… Æ˙i… ±…⁄ ®…x…Æ˙“ 0.39 (ii) °Úx…Ê∫… +…Ï™…±… E‰Ú ∫l……x… {…Æ˙Ú §……Ï™…±…Æ˙ E‰Ú ±…B +…ϱ]ııÆ˙x…‰]ı <»v…x… EÚ… ¥…EÚ…∫… (V…Ë¥… <»v…x…) 22.44 (iii) EÈÚ]ı“x… ®… §……™……‰ M…Ë∫… EÚ… ∫…∆∫l……{…x… 1.55 ={… ™……‰M… 24.38 4. BS…B±…B±… +…CE÷Ú±…®… °ËÚC]ıÆ˙“, i…Ø˚¥…x…∆i…{…÷Æ˙®… (i) x…B b˜§…±… Œ∫EÚx… ]ı…<{… BBS…™…÷B∫… E‰Ú ∫……l… {…÷Æ…˙x…‰ {…Æ∆˙{…Æ˙…M…i… BBS…™…÷B∫… E‰Ú 3 x…∆ EÚ… |… i…∫l……{…x…* (±…˧…À±…M… I…‰j…, EÚ…Ï{…Æ˙-]ı“ I…‰j… +…ËÆ˙ BS…B°Ú ¥…‰œ±b˜M… I…‰j…) 22.00 (ii) C±…“x… ∞¸®… ®… B±…<«b˜“ ±…È{……‰∆ E‰Ú ∫……l… 175 x…∆ ]ı¨⁄§… ±……<]…‰∆ı E‰Ú |… i…∫l……{…x…* 4.00 (iii) B{…“B°Ú∫…“ {…Ëx…±…… E‰Ú ∫…∆∫l………{…x… EÚÆ˙x…‰ E‰Ú u˘…Æ˙… 0.93 ∫…‰ 0.99 i…EÚ {…¥…Æ˙ °ËÚC]ıÆ˙ EÚ… ∫…÷v……Æ˙* (200 E‰Ú¥…“B+…Æ˙ EÚ{…… ∫…]ıÆ˙ {…Ëx…±… EÚ… 2 x…∆) 10.00 ={… ™……‰M… 36.00 E÷Ú±… 99.52 +…{…EÚ“ E∆Ú{…x…“ u˘…Æ˙… ∫…∆∫l…… {…i… Ω˛xn÷˘∫i……x… ±…Ë]‰ıC∫… {… Æ˙¥……Æ˙ x…™……‰V…x… |……‰z…®…x… x™……∫… (BS…B±…B°Ú{…“{…“]ı“), BEÚ ±……¶… Æ˙ Ω˛i… ¥…fi k…EÚ ∫¥……∫l™… ∫…‰¥…… ∫…∆M…`ˆx…, x…®x… ±… J…i… ∫]≈ı…]‰ı V…EÚ I…‰j…… E‰Ú +v…“x… {… Æ˙™……‰V…x……Bƒ ±…‰x…… V……Æ˙“ Æ˙J…“ Ω˲ * 1. ∫……®…… V…EÚ ¥…{…h…x… +…ËÆ˙ ¥…∂…‰π… ¥…GÚ™… + v…EÚ…Æ˙ 2. BS…+…<«¥…“ E‰Ú ±…B x…¥……Æ˙h…, Æ˙I…… +…ËÆ˙ ∫…®…l…«x… i…l…… Bx…+…Æ˙BS…B®… EÚ…‰ i…EÚx…“EÚ“ ∫…Ω˛…™…i…… 3. Y……x… |…§…∆v…x… 4. EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… {… Æ˙™……‰V…x…… {…Æ˙ ∫……¥…«V… x…EÚ ={…GÚ®…… +…ËÆ˙ |……<¥…]ı EÚ…Ï{……ÊƉ˙]ı EÚ…‰ ±…M……x……* BS…B±…B°Ú{…“{…“]ı“ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙, EÚ<« Æ˙…V™… ∫…Æ˙EÚ…Æ˙… +…ËÆ˙ +∆i…Æ˙…«π]≈ı“™… ¥…EÚ…∫… + ¶…EÚÆ˙h…… EÚ“ ∫……Z…‰n˘…Æ˙“ E‰Ú ∫……l… {…÷x…Ø˚i{……n˘EÚ B¥…∆ ∂…∂…÷ ∫¥……∫l™…, BS… +…<« ¥…“ B¥…∆ Bb¬˜∫… x…¥……Æ˙h…, Æ˙I…… B¥…∆ ∫…®…l…«x… EÚ…™…«GÚ®…… E‰Ú EÚ…™……«x¥…™…x… ®… ∫…®…l…«x… EÚ™…… V…… Æ˙Ω˛… Ω˲* BS…B±…B°Ú{…“{…“]ı“ EÚ…‰ 20 Æ˙…V™…… ®… EÚ…™……«±…™…… E‰Ú ∫……l… {…Ëx… <∆ b˜™…… +…Ï{…Ɖ˙∂…x… ΩÈ˛ +…ËÆ˙ ®…÷J™… I…‰j… {…÷x…Ø˚i{……n˘x… ∫¥……∫l™… Ω˲* ¥…π…« E‰Ú n˘…ËÆ˙…x… EÚ“ ={…±…Œ§v…™……‰∆ E‰Ú ∫…∆ I…{i… ¥…¥…Æ˙h… x…“S…‰ n˘™…‰ V……i…‰ ΩÈ˛* 1. ∫……®…… V…EÚ ¥…{…h…x… +…ËÆ˙ ¥…∂…‰π… ¥…GÚ™… + v…EÚ…Æ˙˙ : i. ¥…π…« 2013-14 ®… Æ˙…π]≈ı“™… Bb¬˜∫… x…™…∆j…h… ∫…∆M…`ˆx… (x……EÚ…‰‰), BS…B±…B°Ú{…“{…“]ı“ EÚ…‰ UÙΩ˛ Æ˙…V™……Â, ™……x…“ +…xw…… |…n‰˘∂…, §…Ω˛…Æ˙, n˘±±…“, ®…v™… |…n‰˘∂…, =k…Æ˙ |…n‰˘∂… +…ËÆ˙ =k…Æ˙…J…∆b˜ ®… ±… I…i… E∆Úb˜…‰®… ∫……®…… V…EÚ ¥…{…h…x… EÚ…™…«GÚ®… E‰Ú EÚ…™……«x¥…™…x… E‰Ú ±…B |…n˘…x… EÚ™…… M…™……* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 68 3 HLL Kanagala factory, Belgaum (i) LED based luminaries in place of conventional luminary 0.39 (ii) Developing alternate fuel for Boiler in place of Furnace Oil (Bio Fuel) 22.44 (iii) Installation of Bio gas at canteen 1.55 Sub-total 24.38 4 HLL Akkulam factory, Thiruvananthapuram (i) Replacement of 3 nos of old Conventional AHUs (Labelling Area, Cu-T Area and HF Welding Area) with new Double Skin type AHUs. 22.00 (ii) Replacement of 175 nos of Tube Lights with LED Lamps in the Clean Rooms. 4.00 (iii) Improvement of Power Factor from 0.93 to 0.99 by installing APFC Panels (2 Nos of 200 KVAR Capacitor Panels) 10.00 Sub-total 36.00 TOTAL 99.52 HINDUSTAN LATEX FAMILY PLANNING PROMOTION TRUST (HLFPPT), a not-for-profit professional Health Service Organisation set up by your company continued to carry out projects under the following strategic areas. 1. Social Marketing and Franchising 2. Prevention, care and support for HIV and Technical Assistance to NRHM 3. Knowledge Management 4. Engaging PSUs and private Corporates on Corporate Social Responsibility Project HLFPPT has been rendering support in implementation of Reproductive and Child Health, HIV and AIDS Prevention, Care and Support Programmes in partnership with Ministry of Health & Family Welfare, Government of India, several sates Governments and International development agencies. HLFPPT has Pan India operations with offices in 20 states and core area is Reproductive Health. The achievements during the year are summarized below: 1. Social Marketing and Franchising: i. In 2013-14, National AIDS Control Organization (NACO) awarded the Targeted Condom Social Marketing Programme to HLFPPT for implementation in six states namely Andhra Pradesh, Bihar, Delhi, Madhya Pradesh, Uttar Pradesh & Uttrakhand. The sales achieved in these states are 234 million pieces of condoms in UP & Uttarkhand, 49 million pieces of condoms in Bihar, 59 million pieces of condoms in MP, 22 million pieces of condoms in Delhi, and 21 million pieces of condoms in AP. ii. HLFPPT is implementing Improved Family Planning and Reproductive Health Services project in Bihar and Orissa with support from DFID to prevent unintended pregnancies and improve contraceptive prevalence especially among young, low parity, poor and socially excluded women. 290 franchise clinics and 16,200 SM outlets are operationalized and 291864 CYPs achieved in 2013-14. iii. To facilitate reduction of Maternal Mortality Rate (MMR) HLFPPT is implementing the project on Access to Maternal Health Products and services in 19 districts of Rajasthan under the Brand name of Merrygold health network. In 2013-14 under MGH 09 Merrygold Hospitals, 06MerrySilver Clinics are operational with 352 community level volunteer or Merry Tarang partners at remote village locations to provide information, counselling and referrals services. iv. HLFPPT implemented oral rehydration salt (ORS) and Zinc social marketing project in 21 districts of 6 states covering 25,000villages with support from UNICEF. More than 26,736 health care providers have been trained on diarrhoea management and around 998270 household were reached through ORS and Zinc demonstrations. Annual Report 2013-2014 69 v. ®…‰Æ˙“M……‰±b˜ ∫¥……∫l™… x…‰]ı¥…E«Ú (B®… V…“ BS… Bx…) ®……Ïb˜±… =SS… M…÷h…¥…k……, EÚ°Ú…™…i…“ ®……i…fi B¥…∆ ∂…∂…÷ ∫¥……∫l™… ∫…‰¥……Bƒ |…n˘…x… EÚÆ˙x…‰ E‰Ú ±…B =k…Æ˙ |…n‰˘∂… E‰Ú 35 V…±…… E‰Ú +…Æ˙-{……Æ˙ ∫…∆∫l…… {…i… BEÚ ¥…∂…‰π… ¥…GÚ™… + v…EÚ…Æ˙ ®……Ïb˜±… Ω˲* ¥…π…« 2013-14 ®…Â, B®… V…“ BS… Bx… E‰Ú +v…“x… 70 ®…‰Æ˙“M……‰±b˜ +∫{…i……±…… +…ËÆ˙ 176 ®…‰Æ˙“ ∫…±¥…Æ˙ ŒC±… x…EÚ, ∫…÷n⁄˘Æ˙ M……ƒ¥… ∫l……x…… ®… V……x…EÚ…Æ˙“, {…Æ˙…®…∂…« +…ËÆ˙ Æ˙°ÚÆ˙±… ∫…‰¥……Bƒ |…n˘…x… EÚÆ˙x…‰ E‰Ú ±…B 9156 ∫…®…÷n˘…™… ∫i…Æ˙ ∫¥…™…∆∫…‰¥…EÚ ™…… ®…‰Æ˙“ i…Æ∆˙M… ∫……Z…‰n˘…Æ˙… E‰Ú ∫……l… =k…Æ˙ |…n‰˘∂… E‰Ú 35 V…±…… ®… {… Æ˙S…… ±…i… ΩÈ˛* ¥…π…« 2013-14 ®…Â, <∫… x…‰]ı¥…E«Ú E‰Ú W… Æ˙B ={…±…§v… EÚÆ˙…<« M…<« E÷Ú±… ∫…‰¥……+… ®… 20265 |…∫…¥…, 76928 BBx…∫…“, 2381 b‰˜ E‰Ú™…Æ˙ |… GÚ™……, 1755 +…<« ™…÷ b˜“ x…¥…‰∂…x…, 174 §…∆v™…EÚÆ˙h… ∂…… ®…±… ΩÈ˛* ¥…π…« 2013-14 E‰Ú ±…B ∫…“ ¥……<« {…“ 43795 Ω˲* vi. ∫……®…… V…EÚ ¥…{…h…x… +…ËÆ˙ £ÂÚS……<ÀV…M… {…Æ˙ ¥…∑… ∫¥……∫l™… ∫…®®…‰±…x… ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, <∆ b˜™…x… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 70 v. The Merrygold Health network (MGHN) model is a franchising model established across 35 districts of Uttar Pradesh to provide high quality affordable maternal and child health services. In 2013-14 under MGHN 70 Merrygold Hospitals 176 Merry Silver Clinics are operational in 35 districts with 9156 Community level volunteer or Merry Tarang partners at remote village locations to provide information, counselling and referrals services. In 2013-14 total services provided to the network include 20265 deliveries, 76928 ANC, 2381 Day care procedure, 1755 IUD insertion, 174 Sterilization. CYP for 2013-14 is 43795. vi. Global Health Conference on Social Marketing and Franchising was convened by HLFPPT at Kochi, Kerala, India from 3-5th December 2013 with the support of Ministry of Health & Family Welfare, Indian Institute of Corporate Affairs (IICA) and HLL Lifecare Ltd. The theme of the Conference was ‘Achieving Universal Coverage for Primary Healthcare through SM&SF route’. 2. HIV Programming and Technical Support in Sexual and Reproductive Health i. Technical Support Group (TSG) for Condom Promotion essentially function with an intent to ensure continuous increase in the demand for social marketed condoms and strengthening logistics, availability, accessibility, reduce wastage of free condoms by working closely with NACO. ii. Global Fund Assisted PACT Program- In its first phase HLFPPT established 36 Community Care Centers (CCCs) in 3 states namely UP, MP, Punjab and Rajasthan reaching out to 50,000 PLHIVs ensuring treatment adherence, reduction in stigma and discrimination, improved care for PLHIV, and increased access to other support services. iii. Source Migration Intervention: HLFPPT is implementing source migration implementation in Uttar Pradesh as Source Implementing Agency (SIA), covering more than 1000 villages in 20 districts through this intervention, as per NACO guidelines. In addition HLFPPT being SIA for link worker scheme in UP is also implementing source migration intervention in 1200 villages of 12 more districts in UP through District implementing agencies. iv. Link Worker Scheme: HLFPPT has been selected as Lead agency by UPSACS to implement Link worker Scheme in12 districts of Uttar Pradesh. The Project is being implemented in rural areas with coverage of 1200 villages from October 2012, reaching out with SRH prevention and promotion services to nearly 5000 rural HRGs, approx 550000 vulnerable populations, 26,000 bridge population including migrants and more than 1000 PLHAs meeting with all the deliverables as per NACO protocol. v. Swagati Project (Intervention at TI level) was operational in coastal districts of Andhra Pradesh among the High Risk Groups, especially female sex workers and Men having sex with Men. The project reaches 30000 FSW, 10000 MSM in nearly 1000 hotspots through 27 implementing partners, engaging approximately 800 peer educators and about 200 outreach workers. Swagati adopts community led approach, encouraging maximum involvement of HRG in program design and implementation. 23 HRG Community Based Organizations (CBOs) empowered resulting in 5 CBOs managing TIs and involved in TI management with partner NGOs. vi. HLFPPT continued to provide Technical Assistance to State AIDS Control Society (SACS) in Andhra Pradesh, Madhya Pradesh & Chhattisgarh through Technical Support Units (TSU). The TSUs contributed significantly in strengthening HIV prevention through development and implementation of evidence based prevention strategies in the respective states. vii. HLFPPT continued promotion of voluntary blood donation in Kerala, with support of KSBTC, KSACS & Networking with NACO supported blood banks, donor banks, donor motivator organization and district forums; organize promotional events and voluntary blood donation camps. HLFPPT partnered with 2200 NGOs, Red Ribbon Clubs, educational institutions, corporate and 55,000 person donated blood in various camps. In addition orientation & capacity building programme organized for 600 Volunteers educators & program Officers in all 14 districts of Kerala. Annual Report 2013-2014 71 II. EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…Æ˙ Æ˙{……‰]«ı 1. EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…Æ˙ E∆Ú{…x…“ EÚ… n˘∂…«x… E∆Ú{…x…“ u˘…Æ˙… + ¶…∫¥…“EfiÚi… EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… x…“ i…™…… EÚ… ®…⁄±… ±…I™… {……Æ˙n˘Ã∂…i……, =k…Æ˙n˘… ™…i¥… +…ËÆ˙ +J…∆b˜i…… EÚ… =SS…i…®… ∫i…Æ˙ |……{i… EÚÆ˙x…… Ω˲* ™…Ω˛ ±…I™… ∫……¥…«V… x…EÚ =t®… ¥…¶……M… u˘…Æ˙… V……Æ˙“ EÚB M…B EÂÚp˘“™… ∫……¥…«V… x…EÚ =t®… E‰Ú ±…B EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…Æ˙ ®……M…« x…nÊ˘∂… E‰Ú +x…÷{……±…x……l…« ®……j… Ω˛“ x…Ω˛”, §…Œ±EÚ EÚ…™…«{…r˘ i…™…… +…ËÆ˙ |…h…… ±…™…… EÚ…‰ ∫… z… ¥…π]ı EÚÆ˙E‰Ú =∫…E‰Ú {…Ɖ˙ ¶…“ V……x…… Ω˲, V……‰ EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… E‰Ú =k…®… |…l…… E‰Ú +x…÷∫……Æ˙ Ω˲* E∆Ú{…x…“ ∫……¥…«V… x…EÚ =t®… ¥…¶……M… u˘…Æ˙… V……Æ˙“ EÚB M…B EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…Æ˙ n˘∂…… x…nÊ˘∂… EÚ… ¥… v…{…⁄¥…«EÚ {……±…x… EÚÆ˙i…“ Æ˙Ω˛“ Ω˲ +…ËÆ˙ ±…M……i……Æ˙ "=iEfiÚπ]ı' ∏…‰h…“ |……{i… EÚÆ˙ Æ˙Ω˛“ Ω˲* EÚ…Ï{……ÊƉ˙]ı EÚ…™…« ®…∆j……±…™… x…‰ 1 +|…˱… 2014 ∫…‰ |…¶…… ¥…i… E∆Ú{…x…“ + v… x…™…®… 2013 E‰Ú §…Ω÷˛®…i… |……¥…v……x……‰∆ EÚ…‰ §…x…… n˘™…… Ω˲* x…™…… + v… x…™…®…, n‰˘∂… ®… EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… ¥™…¥…∫l…… EÚ…‰ ®…W…§…⁄i… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ BEÚ ∫…EÚ…Æ˙…i®…EÚ EÚn˘®… Ω˲* +…{…EÚ“ E∆Ú{…x…“ {…Ω˛±…‰ Ω˛“ x…B EÚ…x…⁄x… E‰Ú +v…“x… |……¥…v……x… EÚB M…B + v…EÚ…∆∂… + ¶…∂……∫…x… +{…‰I……+… EÚ… {…™……«{i… +x…÷{……±…x… EÚÆ˙i…“ Ω˲* E∆Ú{…x…“ E‰Ú EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… x…“ i…™……ƒ B¥…∆ |…l……Bƒ x…®x… ±… J…i… ∫…r˘…∆i…… {…Æ˙ °Ú…‰EÚ∫… EÚÆ˙i…“ Ω∆˲ : EÚ) §……‰b«˜ +…ËÆ˙ |…§…∆v… ∫…‰ ∫…∆§…∆ v…i… EÚ…™…« +…ËÆ˙ =k…Æ˙n˘… ™…i¥…… EÚ…‰ {…Ω˛S……x…x……* J…) |…EÚ]“EÚÆ˙h… ∫i…Æ˙ E‰Ú =SS… b˜O…“ı §…x……™…‰ Æ˙J…EÚÆ˙ =SS…i…®… ∫i…Æ˙ı {……Æ˙n˘Ã∂…i…… |……{i… EÚÆ˙x……* M…) <∫…EÚ“ EÚ…™…« {…r˘ i… ®… =SS… x…Ë i…EÚ ®……x…EÚ ∫…÷ x…Œ∂S…i… EÚÆ˙E‰Ú˙ §…x……™…‰ Æ˙J…x……* P…) V……‰ J…®… |…§…∆v…x… +…ËÆ˙ +…∆i… Æ˙EÚ x…™…∆j…h… EÚ“ ®…W…§…⁄i… {…r˘ i… ∫…÷ x…Œ∂S…i… EÚÆ˙x……* RÛ) ™…Ω ˛∫…÷ x…Œ∂S…i… EÚÆ˙x…… Ω˲ EÚ E∆Ú{…x…“ E‰Ú EÚ®…«S……Æ˙“ EÚ…Ï{……ÊƉ˙]ı ®…⁄±™…… EÚ…‰ ∫¥…“EÚ…Æ˙ EÚÆ˙i…‰ Ω˲∆ +…ËÆ˙ =x…EÚ…‰ +{…x…‰ ¥™…¥…Ω˛…Æ˙ ®… |…™……‰M… EÚÆ˙i…‰ ΩÈ˛* S…) ™…Ω˛ ∫…÷ x…Œ∂S…i… EÚÆ˙x…… EÚ x…h…«™… §…x……x…‰ EÚ“ |… GÚ™…… ∫{…π]ı B¥…∆ {……Æ˙n˘∂…«EÚ Ω˲* UÙ) ™…Ω˛ ∫…÷ x…Œ∂S…i… EÚÆ˙x…… EÚ E∆Ú{…x…“ ¥…Ë ∑…EÚ ∞¸{… ∫…‰ ∫¥…“EfiÚi… EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…r˘ i…™…… EÚ… +x…÷∫…Æ˙h… EÚÆ˙i…“ Ω˲ * +…{…EÚ“ E∆Ú{…x…“ ®… +x…÷∫…Æ˙h… EÚÆ˙x…‰ ¥……±…‰ EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… {…r˘ i…™…… E‰Ú ∫…∆ I…{i… ¥…¥…Æ˙h… x…“S…‰ n˘™…‰ V……i…‰ ΩË∆˛* 2. ¥… ∫…±… §±……‰¥…Æ˙ x…“ i…/ ¥… V…±… ®…‰EÚ… x…∫…®… E∆Ú{…x…“ x…‰ EÚ®…«S…… Æ˙™…… +…ËÆ˙ x…n‰˘∂…EÚ…Â E‰Ú ±…B =x…E‰Ú +x…Ë i…EÚ ¥™…¥…Ω˛…Æ˙ {…Æ˙ ÀS…i…… ™…… ∫…∆ n˘Mv… v……‰J……v…b˜“ E‰Ú ®……®…±…‰, +…S…Æ˙h… B¥…∆ x…Ë i…EÚi…… {…Æ˙ E∆Ú{…x…“ E‰Ú ∫……®……x™… ®……M…«n˘∂…«x…… EÚ‰ =±±…∆P…x… E‰Ú §……Ɖ˙ ®… |…§…∆v… EÚ…‰ Æ˙{……‰]«ı EÚÆ˙x…‰ E‰Ú ±…B BEÚ i…∆j… ∫l…… {…i… EÚÆ˙x…‰ E‰Ú ±…I™… E‰Ú ∫……l… BEÚ ¥… ∫…±… §±……‰¥…Æ˙ x…“ i… EÚ“ ∫l……{…x…… EÚ“ l…“* x…“ i… +i™……S……Æ˙ E‰Ú J…±……°Ú ™…l……l…« ¥… ∫…±… §±……‰¥…Æ˙ EÚ“ ∫…∆Æ˙I…h… EÚÆ˙x…‰ E‰Ú ±…B {…™……«{i… ∫…÷Æ˙I…… |…n˘…x… EÚÆ˙i…“ Ω˲* x…“ i… E∆Ú{…x…“ E‰Ú ¥…‰§…∫……<]ı ®… Æ˙J…“ M…™…“ Ω˲* E∆Ú{…x…“ (®…∆b˜±… §…Ë`ˆEÚ +…ËÆ˙ =∫…EÚ… + v…EÚ…Æ˙) x…™…®…, 2014 E‰Ú x…™…®… 7 E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 177(9) E‰Ú +x…÷∫……Æ˙, |…i™…‰EÚ E∆Ú{…x…“ x…‰ §…ÈEÚ…‰ +…ËÆ˙ ∫……¥…«V… x…EÚ ¥…k…“™… ∫…∆∫l……+… ∫…‰ 50 EÚÆ˙…‰b˜ ∫…‰ V™……n˘… Æ˙EÚ®… =v……Æ˙ ±…™…… Ω˲, i……‰ =x…E‰Ú x…n‰˘∂…EÚ…Â +…ËÆ˙ EÚ®…«S…… Æ˙™…… E‰Ú ±…B +{…x…‰ ¥……∫i… ¥…EÚ ÀS…i……Bƒ ™…… ∂…EÚ…™…i…‰∆ Æ˙{……‰]«ı EÚÆ˙x…‰ EÚ“ +…‰Æ˙ BEÚ ¥… V…±… ®…‰EÚ… x…∫…®… ∫l…… {…i… EÚƉ˙M……* E∆Ú{…x…“ u˘…Æ˙… + ¶…∫¥…“EfiÚi… ¥… ∫…±… §±……‰¥…Æ˙ x…“ i…, E∆Ú{…x…“ (®…∆b˜±… EÚ“ §…Ë`ˆEÚ +…ËÆ˙ =∫…EÚ… + v…EÚ…Æ˙) x…™…®…, 2014 E‰Ú x…™…®… 7 E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®… 2013 u˘…Æ˙… x…v……« Æ˙i… ¥… V…±… ®…‰EÚ… x…∫…®… EÚ“ +{…‰I……Bƒ {…⁄Æ˙“ EÚÆ˙i…“ Ω˲* 3. §……‰b«˜ S……]«ıÆ˙ x™……∫…“ E‰Ú ∞¸{… ®… §……‰b«˜ ™…Ω˛ ∫…÷ x…Œ∂S…i… EÚÆ˙i…… Ω˲ EÚ E∆Ú{…x…“ EÚ…‰ ={…±…Œ§v… E‰Ú ±…B ∫{…π]ı =q‰˘∂™… +…ËÆ˙ x…“ i…™……ƒ ΩÈ˛, V……‰ E∆Ú{…x…“ E‰Ú o˘Œπ]ıEÚ…‰h… +…ËÆ˙ ±…I™… E‰Ú ∫……l… M…`ˆ§…∆ v…i… Ω˲ * §……‰b«˜ ∫]≈ı…]‰ı V…EÚ x…nÊ˘˘∂… |…n˘…x… EÚÆ˙i…… Ω˲, EÚ…Ï{……ÊƉ˙]ı x…π{……n˘x… EÚ“ ∫…®…“I…… EÚÆ˙i…… Ω˲, ∫]≈ı…]‰ı V…EÚ x…h…«™…… EÚ… |…… v…EÚÆ˙h… +…ËÆ˙ +x…÷¥…“I…h…˙ EÚÆ˙i…… Ω˲, ¥… x…™……®…EÚ +x…÷{……±…x… ∫…÷ x…Œ∂S…i… EÚÆ˙i…… Ω˲ +…ËÆ {…h…v…… Æ˙™…… EÚ“ Ω˛i… EÚ“ ∫…÷Æ˙I…… EÚÆ˙i…… Ω˲ * x…n‰˘∂…EÚ ®…∆b˜±… x…‰ x…n‰˘∂…EÚ ®…∆b˜±… u˘…Æ˙… E∆Ú{…x…“ ®… + ¶…∫¥…“EfiÚi…˙ §……‰b«˜ S……]«ıÆ˙ EÚ… {……±…x… EÚ™…… Ω˲, V……‰ E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ®…∆b˜±… E‰Ú EÚi…«¥™…, ∫…∆Æ˙S…x……, =k…Æ˙n˘… ™…i¥… +…ËÆ˙ |…S……±…x… +…ËÆ˙ =∫…E‰Ú |…… v…EÚ…Æ˙ E‰Ú |…i™……™……‰V…x… EÚ…‰ ∫{…π]ı ∞¸{… ∫…‰ x…Ãn˘π]ı EÚÆ˙i…… Ω˲˛ * 4. ¥™…¥…∫……™… +…S…Æ˙h… ∫…∆ Ω˛i…… +…ËÆ˙ +…S……Æ˙ x…“ i… +…{…EÚ“ E∆Ú{…x…“ E‰Ú x…n‰˘∂…EÚ ®…∆b˜±… x…‰ ®…∆b˜±… ∫…n˘∫™…… +…ËÆ˙ E∆Ú{…x…“ E‰Ú ¥… Æ˙π`ˆ |…§…∆v…x… E‰Ú ±…B +…S…Æ˙h… ∫…∆ Ω˛i…… +…ËÆ˙ +…S……Æ˙ x…“ i… x…v……« Æ˙i… EÚ“ Ω˲* ∫…¶…“ ®…∆b˜±…˜ ∫…n˘∫™…… +…ËÆ˙ ¥… Æ˙π`ˆ |…§…∆v…Ú Eڅî…EÚ x…‰ ¥…π…« 2013 - 14 E‰Ú n˘…ËÆ˙…x… +…S…Æ˙h… ∫…∆ Ω˛i…… E‰Ú ∫……l… +x…÷{……±…x… EÚÆ˙x…‰ EÚ“ {…÷Œπ]ı EÚ“ Ω˲* +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ u˘…Æ˙… Ω˛∫i……I… Æ˙i… <∫… |…¶……¥… EÚ“ P……‰π…h…… <∫… Æ˙{……‰]«ı EÚ… ¶……M… ΩË* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 72 II. REPORT ON CORPORATE GOVERNANCE 1. The Company’s philosophy on Corporate Governance The basic objective of Corporate Governance policies adopted by the Company is to attain the highest levels of transparency, accountability and integrity. This objective extends not merely to comply with the Guidelines on Corporate Governance for Central Public Sector Enterprises issued by the Department of Public Enterprises, but also to go beyond them by putting in place procedures and systems, which are in accordance with the best practices of Corporate Governance. The Company has been methodically following the Guidelines on Corporate Governance issued by Department of Public Enterprises and consistently scoring ‘Excellent’ grading. The Ministry of Corporate Affairs has made majority of the provisions of the Companies Act, 2013 effective from 1st April, 2014. The new Act is a positive step towards strengthening corporate governance regime in the country. Your Company is already in substantial compliance of most of the governance requirements provided under the new law. The Company’s Corporate Governance policies and practices focus on the following principles: a) To recognize the respective roles and responsibilities of the Board and management. b) To achieve the highest degree of transparency by maintaining a high degree of disclosure levels. c) To ensure and maintain high ethical standards in its functioning. d) To ensure a sound system of risk management and internal controls. e) To ensure that employees of the Company subscribe to the corporate values and apply them in their conduct. f) To ensure that the decision making process is fair and transparent. g) To ensure that the Company follows globally recognized corporate governance practices. A brief description of the corporate governance practices followed in your Company is given below. 2. Whistle Blower Policy/Vigil Mechanism The Company had established a Whistle Blower Policy with a view to establish a mechanism for the employees and directors to report to the Management about their concerns on unethical behaviour or the cases of suspected fraud, violation of Company’s general guidelines on Conduct and Ethics. The Policy provides for adequate safeguards to protect genuine Whistle Blower against victimisation. The policy has been posted in the Company’s website. According to Section 177 (9) of the Companies Act, 2013 read with Rule 7 of the Companies (Meetings of the Board and its Powers) Rules, 2014, every company that has borrowed money from Banks and Public Financial Institutions in excess of `50 Cr. shall establish a vigil mechanism for their directors and employees to report their genuine concerns or grievances. The Whistle Blower Policy adopted by the Company meets the requirements of the Vigil mechanism stipulated by the Companies Act, 2013 read with Rule 7 of the Companies (Meetings of the Board and its Powers) Rules, 2014. 3. Board Charter As Trustee, the Board ensures that the Company has clear goals and policies for achievement which are in alignment with the Vision and Mission of the company. The Board provides strategic direction, reviews corporate performance, authorizes and monitors strategic decisions, ensures regulatory compliances and safeguards interest of stakeholders. The Board of Directors adhere to the Board Charter adopted by the Board of Directors, which clearly sets out the role, structure, responsibilities and operation of Company’s Board of Directors and its delegation of authority. 4. Code of Business Conduct and Ethics The Board of Directors of your Company has laid down a Code of Conduct and Ethics for the Board Members and Senior Management of the Company. All Board Members and Senior Management personnel have affirmed compliance with the Code of Conduct during the year 2013-14. A declaration to this effect signed by the Chairman & Managing Director forms part of this report. Annual Report 2013-2014 73 BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ EÚ“ {…h…v……Æ˙“ EÚ…‰ ¥…π…™… : +…S…Æ˙h… ∫…∆ Ω˛i…… +…ËÆ˙ +…S…Æ˙h… x…“ i… E‰Ú ∫……l… +x…÷{……±…x… ®…È Bi…n¬˘u˘…Æ˙… P……‰π…h…… EÚÆ˙i…… Ω⁄ƒ˛ EÚ ∫…¶…“ ®…∆b˜±… ∫…n˘∫™… +…ËÆ˙ ¥… Æ˙π`ˆ |…§…∆v… Eڅî…EÚ…Â x…‰ x…n‰˘∂…EÚ ®…∆b˜±… u˘…Æ˙… +{…x……B M…B +…S…Æ˙h… ∫…∆ Ω˛i…… E‰Ú ∫……l… +x…÷{……±…x… EÚ… ∫…®…l…«x… EÚ™…… Ω˲ * b˜…Ï.B®….+™™…{{…x… +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ 5 V…÷±……<«, 2014 i…Ø˚¥…x…∆i…{…÷Æ˙®… 5. =t®… V……‰ J…®… |…§…∆v…x… (<«+…Æ˙B®…) x…“ i… E∆Ú{…x…“ EÚ…‰ BEÚ V……‰ J…®… |…§…∆v…x… x…“ i… +…ËÆ˙ V……‰ J…®… ∂…®…x… ™……‰V…x…… E‰Ú ∫…®…l…«x… EÚÆ˙x…‰ EÚ“ ∞¸{…Ɖ˙J…… Ω˲, V…∫…EÚ…‰ x…™… ®…i… ®…⁄±™……∆EÚx… +…ËÆ˙ i¥… Æ˙i… |… i… GÚ™…… +{…‰ I…i… Ω˲* V……‰ J…®… EÚ“ ∫…∆¶……¥…x…… +…ËÆ˙ |…¶……¥… E‰Ú +…v……Æ˙ {…Æ˙, +{…‰ I…i… x…™…∆∆j…h… +…ËÆ˙ EÚ…™…« ™……‰V…x…… i…Ë™……Æ˙ EÚ“ M…™…“ ΩË∆* E∆Ú{…x…“ ®… V……‰ J…®… |…§…∆v…x… E‰Ú =q‰˘∂™… Ω˲ <∫…EÚ‰ Y……x… = u˘Mx…i……˙ EÚ…‰ §…x……B Æ˙J…x…‰ ®… ∫…®…l…«EÚ E‰Ú ∞¸{… ®… EÚ…™…« EÚÆ˙x……, ¥™…¥…∫……™… EÚ…‰ ∫…i…i… +…ËÆ˙ ¥…∫i……Æ˙ EÚÆ˙x……, |… i…™……‰M…“ Æ˙Ω˛x…… +…ËÆ˙ §…V…]ı EÚ“ M…™…“ ±……M…i… +…ËÆ˙ ∫…®…™… E‰Ú +∆i…M…«i… ™……‰V…x…… E‰Ú x…π{……n˘x… ∫…÷ x…Œ∂S…i… EÚÆ˙x……, =z…i… ¥™……{……Æ˙…¥…i…« +…ËÆ˙ ±……¶…EÚ… Æ˙i…… ®… {… Æ˙h…i… Ω˛…‰x……* ±…‰J…… {…Æ˙“I…… ∫… ®… i… V……‰ J…®… |…§…∆v…x… x…“ i… {…Æ˙ ∫…®…O… n˘∂…… |…n˘…x… EÚÆ˙i…“ Ω˲* 6. 6.1 x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ §…x……¥…]ı ®…∆b˜±… EÚ“ ∫…∆Æ˙S…x……, ¥™……¥…∫…… ™…EÚi……, Y……x… +…ËÆ˙ +x…÷¶…¥… EÚ‰ ∫…¥……Êk…®… ®…∏…h… EÚ… |… i… x… v…i¥… EÚÆ˙i…… Ω˲ +…ËÆ˙ +{…x…“ V…®®…‰n˘… Æ˙™…… EÚ… x…¥…«Ω˛x… EÚÆ˙x…‰ EÚ‰ ±…B §……‰b«˜ EÚ…‰ ∫…I…®… §…x……i…… Ω˲ +…ËÆ˙ ¥™…¥…∫……™… E‰Ú ±…B |…¶……¥…“ x…‰i…fii¥… |…n˘…x… EÚÆ˙i…… Ω˲* +…{…EÚ“ E∆Ú{…x…“ ∫…Æ˙EÚ…Æ˙“ ={…GÚ®… Ω˛…‰x…‰ ∫…‰, ∫…¶…“ x…n‰˘∂…EÚ…Â EÚ“ x…™…÷ HÚ/x……®……∆EÚx… ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™… E‰Ú W… Æ˙B ¶……Æ˙i… E‰Ú Æ˙…π]≈ı{… i… u˘…Æ˙… EÚ™…… V……i…… Ω˲* ®…∆b˜±… ®… EÚ…™…«{……±…EÚ +…ËÆ˙ M…ËÆ˙-EÚ…™…«{……±…EÚ x…n‰˘∂…EÚ…Â EÚ… = S…i… ®…∏…h… Ω˲* E∆Ú{…x…“ E‰Ú ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… ¥… x…v……« Æ˙i… EÚÆ˙i…… Ω˲ EÚ x…n‰˘∂…EÚ…Â EÚ“ ∫…∆J™…… i…“x… (3) ∫…‰ EÚ®… x…Ω˛” +…ËÆ˙ n˘∫… (10) ∫…‰ + v…EÚ x…Ω˛” Ω˛…‰x…“ Ω˲* E∆Ú{…x…“ x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ ¥…i…«®……x… ∂… HÚ x……Ë (8) Ω˲ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú |… i… x… v…i¥… EÚÆ˙x…‰ ¥……±…‰ n˘…‰ (2), i…“x… (3) ∫¥…i…∆j… x…n‰˘∂…EÚ +…ËÆ˙ S……Æ˙ (3) ˙ EÚ…™……«i®…EÚ x…n‰˘∂…EÚ - ™……x…“ +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ , x…n‰˘∂…EÚ ( ¥…k…) +…ËÆ˙ x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…)* BEÚ EÚ…™……«i®…EÚ x…n‰˘∂…EÚ EÚ… {…n˘ (™……x…“ x…n‰˘∂…EÚ ¥…{…h…x…) <∫…“ i……Æ˙“J… i…EÚ Æ˙HÚ Ω˲* BS…B±…B±… E‰Ú ®…∆b˜±… ®… BEÚ ®… Ω˛±…… x…n‰˘∂…EÚ ¶…“ Ω˲* ®…∆b˜±… EÚ“ ∫…∆Æ˙S…x…… ∫……¥…«V… x…EÚ =t®… ¥…¶……M…,¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… V……Æ˙“ EÚB M…B x…M… ®…i… + ¶…∂……∫…x… E‰Ú n˘∂…… x…nÊ˘∂…… E‰Ú +x…÷∫……Æ˙ Ω˲* 1 V…⁄x…, 2014 i…EÚ E‰Ú x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ §…x……¥…]ı x…®x… V…Ë∫…‰ ΩÈ˛: GÚ.∫…∆ x…n‰˘∂…EÚ EÚ… x……®… x…n‰˘∂…EÚ EÚ“ ∏…‰h…“ ∫…∆¶……±…‰ +x™… +x™… E∆Ú{… x…™…… ®… x…n‰˘∂…EÚ ∂…{… EÚ“ ∫…∆J™…… ®…∆b˜±… ∫… ®… i… E‰Ú +v™…I…i…… / ∫…n˘∫™…i…… EÚ“ ∫…∆J™…… 1. b˜…Ï. B®….+™™…{{…x… +v™…I… B¥…∆ |…§…∆v…EÚ x…n‰˘∂…EÚ˛ 5 1 2. ∏…“ M……Ëi…®… M…÷Ω˛… ∫…Æ˙EÚ…Æ˙ x…… ®…i… x…n‰˘∂…EÚ˛ 2 ∂…⁄x™… 3. ∏…“ B∫….E‰Ú Æ˙…¥… ∫…Æ˙EÚ…Æ˙ x…… ®…i… x…n‰˘∂…EÚ˛ 2 ∂…⁄x™… 4. ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ˙ M…ËÆ˙ ∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ x…n‰˘∂…EÚ˛ 5 8 5. ∏…“ +…Æ˙i…“ ¥…V… M…ËÆ˙ ∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ x…n‰˘∂…EÚ˛ ∂…⁄x™… ∂…⁄x™… 6. ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫… M…ËÆ˙ ∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ x…n‰˘∂…EÚ˛ 1 1 7. ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±… x…n‰˘∂…EÚ˛ ( ¥…k…) 4 1 8. b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x… x…n‰˘∂…EÚ˛ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) ∂…⁄x™… ∂…⁄x™… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 74 To the Stakeholders of HLL Lifecare Limited Sub: Compliance with Code of Conduct and Ethics I hereby declare that all the Board Members and Senior Management Personnel have affirmed compliance with the Code of Conduct as adopted by the Board of Directors. Dr. M. Ayyappan Chairman and Managing Director 5 July 2014 Thiruvananthapuram 5. Enterprise Risk Management (ERM) Policy: The Company has a Risk Management policy and a supporting frame work of Risk Mitigation Plan, which require regular assessment and quick response. Based on the probability and impact of the risk, the requisite controls and action plans are designed. The objective of risk management in the Company is to act as enabler in maintaining its knowledge edge, sustaining and expanding the business, being competitive and ensuring execution of projects within the budgeted cost and time resulting in improved turnover and profitability. The Audit Committee provides the overall direction on the risk management policies. 6. 6.1. Composition of Board of Directors: The composition of the Board represents an optimal mix of professionalism, knowledge and experience and enables the Board to discharge its responsibilities and provide effective leadership to the business. Your Company, being a Government Undertaking, the appointment / nomination of all the Directors is done by the President of India, through the Ministry of Health & Family Welfare. The Board has an appropriate mix of executive and non-executive Directors. The Articles of Association of the Company stipulates that the number of Directors shall not be less than three (3) and not more than ten (10). The present strength of Board of Directors of the Company is eight (8) comprising two (2) official Directors representing the Ministry of Health & Family Welfare, Government of India, three (3) Independent Directors and three (3) Functional Directors namely Chairman & Managing Director, Director (F) and Director (T&O). The position of one Functional Director (viz., Director Marketing) is vacant as on date. HLL has also a women director on the Board. The composition of the Board is in line with the Guidelines on Corporate Governance issued by the Department of Public Enterprises, Government of India. The Composition of the Board of Directors as on 1st June, 2014 is as follows: Sl. No Name of the Category of Director No of Other No. of membership / Director Director-ship Chairmanship of held Board Committee in other companies 1 Dr. M. Ayyappan Chairman and Managing Director 5 1 2 Shri Gautam Guha Government Nominee Director 2 Nil 3 Shri S K Rao Government Nominee Director 2 Nil 4 Shri Sanjiv Kapoor Non Official Part time Director 5 8 5 Dr. Aarti Vij Non Official Part time Director Nil Nil 6 Shri K. Mohandas Non Official Part time Director 1 1 7 Shri R.P.Khandelwal Director (Finance) 4 1 8 Dr. K.R.S Krishnan Director (Technical & Operations) Nil Nil Annual Report 2013-2014 75 ®…∆b˜±… +{…x…“ |…i™…™…“ V…®®…‰n˘… Æ˙™…… EÚ… x…¥…«Ω˛x… +{…x…“ ∫]≈Ëı]‰ı V…EÚ {…™…«¥…‰I…h… EÚÆ˙x…‰ ®… ∫¥……™…k…i…… +…ËÆ˙ ∫¥…i…∆j…i…… E‰Ú ∫……l… EÚÆ˙i…… Ω˲ +…ËÆ˙ ∫…÷ x…Œ∂S…i… EÚÆi…… Ω˲ EÚ |…§…∆v… x…Ë i…EÚi……, {……Æ˙n˘Ã∂…i…… +…ËÆ˙ |…EÚ]ı“EÚÆ˙h… E‰Ú =SS…i…®… ®……x…EÚ…Â EÚ… +x…÷∫…Æ˙h… EÚÆ˙i…… Ω˲* M…ËÆ˙ EÚ…™…«{……±…EÚ x…n‰˘∂…EÚ…Â ∫… Ω˛i… ®…∆b˜±… EÚ‰ Ω˛Æ˙ ∫…n˘∫™… EÚ…‰ E∆Ú{…x…“ ∫…‰ ∫…∆§…∆ v…i… EÚ∫…“ ¶…“ V……x…EÚ…Æ˙“ EÚ… {…⁄Æ˙… {…Ω⁄ƒ˛S… Ω˲* 6.2 §…Ë`ˆEÚ +…ËÆ˙ Ω˛… V…Æ˙“ ∫…®…“I……v…“x… ¥…k…“™… ¥…π…« E‰Ú n˘…ËÆ˙…x…, S……Æ˙ ®…∆b˜±… ˜ §…Ë`ˆEÚ‰∆, 26 V…⁄x… 2013; ˙24 V…÷±……<«, 2013; 08 x…¥…∆∆§…Æ˙ 2013 +…ËÆ˙ 10 °ÚÆ˙¥…Æ˙“, 2014 EÚ…‰ +…™……‰ V…i… EÚ“ M…™…” * ®…∆b˜±… §…Ë`ˆEÚ +…ËÆ˙ M…i… ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ EÚ“ Ω˛… W…Æ˙“ ∫…⁄S…x…… x…“S…‰ n˘“ V……i…“ Ω˲* ¥…π…« E‰Ú n˘…ËÆ˙…x… +…™……‰ V…i… 2013-14 E‰Ú n˘…ËÆ˙…x… §…Ë`ˆEÚ EÚ“ Ω˛… V…Æ˙“ x…n‰˘∂…EÚ EÚ… x……®… §…Ë`ˆEÚ…‰∆ EÚ“ ∫…∆J™…… ®…∆b˜±… §…Ë`ˆEÚ M…i… B V…“ B®… b˜…Ï. B®….+™™…{{…x… 4 4 Ω˛…ƒ ∏…“ B∫….E‰Ú. ∏…“¥……∫i…¥…… 3 3 Ω˛…ƒ ∏…“ B∫….E‰Ú Æ˙…¥… 4 4 Ω˛…ƒ ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫… 4 4 Ω˛…ƒ ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ˙ 4 3 Ω˛…ƒ b˜…Ï. +…Æ˙i…“ ¥…V… 4 1 Ω˛…ƒ ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙∂… E÷Ú®……Æ˙ 3 3 Ω˛…ƒ ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±… 4 4 Ω˛…ƒ (|… i… x… v… u˘…Æ˙… b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x…) b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x… 4 4 Ω˛…ƒ [∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±…, ∫…n˘∫™… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E‰Ú ±…B |… i… x… v… E‰Ú ∞¸{… ®…Â] 7. ∫¥…i…∆j… x…n‰˘∂…EÚ…Â EÚ“ §…Ë`ˆEÚ ∫¥…i…∆j… x…n‰˘∂…EÚ…‰∆ EÚ…‰ E∆Ú{…x…“ E‰Ú |…i™…‰EÚ ¥™…¥…∫……™……‰∆ E‰Ú x…π{……n˘x…, +…M…‰ ±…‰ V…… Æ˙Ω˛“ EÚ…™…«x…“ i… +…ËÆ˙ E∆Ú{…x…“ u˘…Æ˙… ±…B V…… Æ˙Ω‰˛/|…∫i…… ¥…i… x…B {…Ω±…÷+… {…Æ˙ x…™… ®…i… ∞¸{… ∫…‰ +ti…x…˛ EÚB V……i…‰ ΩÈ˛* ∫¥…i…∆j… x…n‰˘∂…EÚ, ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫…, ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ˙ +…ËÆ˙ b˜…Ï. +…Æ˙i…“ ¥…V… x…‰ 5 n˘∫…∆§…Æ˙, 2013 EÚ…‰ EÚ∫…“ ¶…“ ¥… Æ˙π`ˆ |…§…∆v…x… Eڅî…EÚ…Â E‰Ú §…x…… §…Ë`ˆEÚ EÚ“* 8. +…<« ∫…“ B∫… +…<« u˘…Æ˙… V……Æ˙“ EÚB M…B ∫…‰G‰Ú]‰ı Æ˙™…±… ∫]Èıb‰˜b«˜ (B∫… B∫…) ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ x…‰ x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ §…Ë`ˆEÚ…‰∆ ∫… ®… i…™…… EÚ“Ú §…Ë`ˆEÚ‰∆ +…ËÆ˙ =∫…∫…‰ ∫…∆§…∆ v…i… ®……®…±…… {…Æ §…Ë`ˆEÚ‰∆ +…™……‰ V…i… EÚÆ˙x…‰ +…ËÆ˙ |…§…∆v…˘ EÚÆ˙x…‰ E‰Ú ±…B x…™…i…ı ∫…r˘…∆i…… {…Æ˙ E∆Ú{…x…“ ∫…‰G‰Ú]Æ˙“∫… +…Ï°Ú <∆ b˜™…… EÚ“Ú ∫…∆∫l…… u˘…Æ˙… V……Æ˙“ EÚB M…B ∫…‰G‰Ú]‰ı Æ˙™…±… ∫]Èıb‰˜b«˜ (B∫…B∫…-1), ı{…™……«{i… ∞¸{… ∫…‰ +x…÷{……±…x… EÚ™…… M…™…… ΩË* 9. ®…∆b˜±… EÚ“ ∫… ®… i…™……ƒ ®…∆b˜±… ∫… ®… i…™……ƒ E∆Ú{…x…“ E‰Ú + ¶…∂……∫…x… ∫…∆Æ˙S…x…… ®… ®…Ω˛i¥…{…⁄h…« ¶…⁄ ®…EÚ… x…¶……i…“ ΩÈ˛ +…ËÆ˙ ¥… ∂…π]ı I…‰j…… {…Æ˙ v™……x… EÂÚ p˘i… EÚÆ˙x…‰ +…ËÆ˙ |…i™……™……‰ V…i… |…… v…EÚ…Æ˙“ E‰Ú ¶…“i…Æ˙ ∫…⁄ S…i… x…h…«™… ±…‰x…‰ E‰Ú ±…B M… `ˆi… EÚ“ M…™…“ Ω˲* V…§… EÚ¶…“ +…¥…∂™…EÚ Ω˛…‰, ∫… ®… i…™……ƒ ¥… ¶…z… ®……®…±…… {…Æ˙ ®…∆b˜±… E‰Ú ±…B ¥… ∂…π]ı ∫…°Ú… Æ˙∂… ¶…“ n‰˘i…“ ΩÈ˛* ∫… ®… i… EÚ… M…`ˆx…, ∫…n˘∫™…… EÚ“ x…™…÷ HÚ +…ËÆ˙ ∫… ®… i… E‰Ú ∫…∆n˘¶…«/¶…⁄ ®…EÚ… EÚ“ ∂…i…Á x…™…i… EÚÆ˙x…‰ ∫…‰ ∫…∆§…∆ v…i… ∫…¶…“ x…h…«™… x…n‰˘∂…EÚ ®…∆b˜±… u˘…Æ˙… ±…™…… V……i…… Ω˲* ∫… ®… i…™…… E‰Ú ∫…¶…“ ]ı{{… h…™……ƒ, ∫…°Ú… Æ˙∂… +…ËÆ˙ x…h…«™…, ∫…⁄S…x……l…« ™…… +x…÷®……‰n˘x……l…« ®…∆b˜±… E‰Ú ∫…®…I… Æ˙J…‰ V……i…‰ ΩÈ˛* E∆Ú{…x…“ x…‰ +§… S……Æ˙ ®…∆b˜±…-∫i…Æ˙ ∫… ®… i…™……ƒ ∫l…… {…i… EÚ“ Ω˲, ™……x…“: 1. ±…‰J……{…Æ˙“I…… ∫… ®… i… 2. x……®……∆EÚx… +…ËÆ˙ {…… Æ˙∏… ®…EÚ ∫… ®… i… 3. EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ V…®®…‰n˘…Æ˙“ +…ËÆ˙ ∫…i…i… ¥…EÚ…∫… ∫… ®… i… 4. EÚ…™…«x…“ i… ∫…⁄j…“EÚÆ˙h… +…ËÆ˙ x…¥…‰∂… ∫… ®… i… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 76 The Board acts with autonomy and independence in exercising its strategic supervision, discharging its fiduciary responsibilities and ensuring that the management observes the highest standards of ethics, transparency and disclosure. Every member of the Board, including the Non-Executive Directors, has full access to any information related to the Company. 6.2. Meeting and Attendance During the financial year under review, four Board meetings were held on 26th June 2013; 24th July 2013; 08th November 2013 and 10th February 2014. Information of attendance at the board meetings and the last annual general meeting is given below. Name of the Director Board No. of Attendance of meeting meetings during 2013-14 Held during the year Board Meetings Last AGM Dr M. Ayyappan 4 4 Yes Shri S.K. Srivastava 3 3 Yes Shri S K Rao 4 4 Yes Shri K. Mohandas 4 4 Yes Shri Sanjiv Kapoor 4 3 Yes Dr Aarti Vij 4 1 Yes Shri K.K. Suresh Kumar 3 3 Yes Shri R.P.Khandelwal 4 4 Yes (By proxy Dr. K.R.S. Krishnan) Dr K.R.S Krishnan 4 4 Yes [As proxy for Shri R.P. Khandelwal, Member and D (F)] 7. Independent Directors' Meeting Independent Directors are regularly updated on performance of each line of business of the Company, strategy going forward and new initiatives being taken/proposed to be taken by the Company. The Independent Directors Mr. K.Mohandas, Mr. Sanjiv Kapoor and Dr. Aarti Vij held a separate meeting on 5 December, 2013 without any Senior Management Personnel. 8. Secretarial Standards (SS) issued by ICSI During the year under review, the Company has substantially complied with the secretarial standard (SS-1), a set of principles for the convening and conduct of Meetings of the Board of Directors, meetings of Committees and matters related thereto, issued by the Institute of Company Secretaries of India. 9. COMMITTEES OF THE BOARD The Board Committees play a crucial role in the governance structure of the Company and have been constituted to focus on specific areas and make informed decisions within the authority delegated. The Committees also make specific recommendations to the Board on various matters whenever required. All decisions pertaining to the constitution of Committees, appointment of members and fixing of terms of reference/role of the Committees are taken by the Board of Directors. All observations, recommendations and decisions of the Committees are placed before the Board for information or for approval. The Company has currently established four Board-level Committees, namely: 1. Audit Committee 2. Nomination and Remuneration Committee 3. CSR&SD Committee 4. Strategy Formulation & Investment Committee Annual Report 2013-2014 77 9.1 ±…‰J……{…Æ˙“I…… ∫… ®… i… 9.1.1 §…x……¥…]ı E∆Ú{…x…“ EÚ“ ±…‰J……{…Æ˙“I…… ∫… ®… i… ®… ∫…¶…“ i…“x… ∫¥…i…∆j… x…n‰˘∂…EÚ ∂…… ®…±… ΩÈ˛* ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ˙˙ u˘…Æ˙… ±…‰J……{…Æ˙“I…… ∫… ®… i… EÚ“ +v™…I…i…… EÚ“ V……i…“ Ω˲ +…ËÆ˙ =∫…E‰Ú ∫…n˘∫™…… E‰Ú ∞¸{… ®… ∏…“ E‰Ú.®……‰Ω˛x…n˘…∫… +…ËÆ˙ b˜…Ï.+…Æ˙i…“ ¥…V… ΩÈ˛* ¥…π…« E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ ∫…‰ <∫i…“°Ú… n˘B ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙∂… E÷Ú®……Æ˙, {…⁄¥…« x…n‰˘∂…EÚ ( ¥…{…h…x…), ∫… ®… i… E‰Ú ∫…n˘∫™… x…Ω˛” Æ˙Ω˛ M…™…… Ω˲* ∫… ®… i… E‰Ú ∫…¶…“ ∫…n˘∫™…… EÚ…‰ ¥…k…“™… ®……®…±…… ®… ∫…÷∫…∆M…i… +x…÷¶…¥… Ω˲ +…ËÆ˙ ∫… ®… i… EÚ… +v™…I…, ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ˙˙ BEÚ ∫…x…n˘“ ±…‰J……EÚ…Æ˙ {…‰∂…‰¥…Æ˙ Ω˲, EÚ…‰ ∫…®…O… ±…‰J……∆EÚx… +…ËÆ˙ ∫…∆§…∆ v…i… ¥…k…“™… |…§…∆v…x… ¥…∂…‰π…Y…i…… Ω˲* ®…<« 2014 ®…Â, ®…∆b˜±… x…‰ E∆Ú{…x…“ + v… x…™…®…, 2013 (+ v… x…™…®…) EÚ“ v……Æ˙… 177(3) E‰Ú |……¥…v……x…… E‰Ú ∫……l… +x…÷{……±…x… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B ={…™…÷«HÚ ∫…n˘∫™…… E‰Ú ∫……l… ±…‰J……{…Æ˙“I…… ∫… ®… i… EÚ… M…`ˆx… EÚ™…… Ω˲* <∫…E‰Ú +±……¥……, ®…∆b˜±… x…‰ + v… x…™…®… EÚ“ v……Æ˙… 177(4) ®… EÚ l…i… ∫…∆n˘¶…« E‰Ú ∂…i…Á V……‰b˜EÚÆ˙ ±…‰J……{…Æ˙“I…… ∫… ®… i… E‰Ú ∫…∆n˘¶…« E‰Ú ∂…i……Á EÚ… ∫…∆∂……‰v…x… EÚ™…… Ω˲* 9.1.2. ¥…S……Æ˙…l…« ¥…π…™… ±…‰J……{…Æ˙“I…… ∫… ®… i… E‰Ú EÚ…™…«I…‰j… ®… ∂…… ®…±… ΩÈ˛&Ú i. E∆Ú{…x…“ E‰Ú ±…‰J……{…Æ˙“I…EÚ…Â EÚ“ x…™…÷ HÚ, {…… Æ˙∏… ®…EÚ +…ËÆ˙ x…™…÷ HÚ E‰Ú ∂…i……Á E‰Ú ±…B ∫…°Ú… Æ˙…∂…; ii. ±…‰J……{…Æ˙“I…EÚ…Â EÚ“ ∫¥…i…∆j…i…… +…ËÆ˙ x…π{……n˘x…, +…ËÆ˙ ±…‰J……{…Æ˙“I…… |… GÚ™…… EÚ“ |…¶……¥…∂…“±…i…… EÚ“ ∫…®…“I…… EÚÆ˙E‰Ú +x…÷¥…“I…h… EÚÆ˙x……; iii. ¥…k…“™… ¥…¥…Æ˙h… EÚ“ {…Æ˙“I…… +…ËÆ˙ =∫… {…Æ˙ ±…‰J……{…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«; iv. ∫…∆§…∆ v…i… {……Ã]ı™…… E‰Ú ∫……l… E∆Ú{…x…“ E‰Ú ±…‰x…n‰˘x…… EÚ… +x…÷®……‰n˘x… ™…… EÚ∫…“ ¶…“ +…M……®…“ ∫…∆∂……‰v…x…; v. +∆i…Æ˙-EÚ…Ï{……ÊƉ˙]ı @Òh… B¥…∆ x…¥…‰∂… EÚ“ V……ƒS…* vi. V…Ω˛…ƒ ¶…“ +…¥…∂™…EÚ Ω˲, ={…GÚ®…… ™…… E∆Ú{…x…“ EÚ“ {… Æ˙∫…∆{… k…™…… EÚ… ®…⁄±™……∆EÚx…;ı vii. +…∆i… Æ˙EÚ ¥…k…“™… x…™…∆j…h… +…ËÆ˙ V……‰ J…®… |…§…∆v…x… |…h……±…“ EÚ… ®…⁄±™……∆EÚx… +…ËÆ˙ viii. ∫……¥…«V… x…EÚ |…∫i……¥…… +…ËÆ˙ ∫…∆§…∆ v…i… ®……®…±…… E‰Ú W… Æ˙B =`ˆ…<« M…<« x… v…™…… E‰Ú +∆ i…®… ={…™……‰M… EÚ… ®……Ï x…]ıÀÆ˙M…; ix. E∆Ú{…x…“ E‰Ú ¥…k…“™… ¥…¥…Æ˙h… ∫…Ω˛“, {…™……«{i… +…ËÆ˙ ¥…∑……∫™… ™……‰M™… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ EÚ…‰ E∆Ú{…x…“ EÚ“ ¥…k…“™… Æ˙{……‰Õ]ıM… |… GÚ™…… E‰Ú x…Æ˙“I…h… EÚÆ˙x…… +…ËÆ˙ <∫…E‰Ú ¥…k…“™… ¥…¥…Æ˙h… E‰Ú |…EÚ]ı“EÚÆ˙h… EÚÆ˙x……; x. ±…‰J……{…Æ˙“I…… ∂…÷÷±EÚ E‰Ú x…™…i…x… E‰Ú ±…B ®…∆b˜±… EÚ…‰ ∫…°Ú… Æ˙∂… EÚÆ˙x……; xi. ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â u˘…Æ˙… |…n˘…x… EÚ“ M…<« EÚ∫…“ ¶…“ +x™… ∫…‰¥……+… E‰Ú ±…B ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ±…B ¶…÷M…i……x… EÚ… +x…÷®……‰n˘x…* xii. ¥……Ãπ…EÚ ¥…k…“™… ¥…¥…Æ˙h… +x…÷®……‰n˘x… E‰Ú ±…B §……‰b«˜ EÚ…‰ |…∫i…÷i… EÚÆ˙x…‰ E‰Ú {…Ω˛±…‰ x…®x… ¥…∂…‰π… ∫…∆n˘¶…« E‰Ú ∫……l… |…§…∆v… E‰Ú ∫……l… ∫…®…“I…… EÚÆ˙x……; EÚ. E∆Ú{…x…“ + v… x…™…®…, 1956 EÚ“ v……Æ˙… 217 E‰Ú J…∆b˜ (2BB) E‰Ú ∂…i……Á ®… ®…∆b˜±… EÚ“ Æ˙{……‰]«ı ®… ∂…… ®…±… EÚB V……x…‰¥……±…‰ x…n‰˘∂…EÚ…Â EÚ“ V…®®…‰n˘…Æ˙“ ¥…¥…Æ˙h… ®… ∂…… ®…±… EÚB V……x…‰¥……±…‰˛ +{…‰ I…i… ®……®…±…‰* J…. ±…‰J……∆EÚx… x…“ i…™…… B¥…∆ |…l……+… ®… ™… n˘ EÚ…‰<« §…n˘±……¥… Ω˲ +…ËÆ˙ <∫…E‰Ú ±…B EÚ…Æ˙h… ; M…. |…§…∆v… u˘…Æ˙… x…h…«™… ±…B V……x…‰ E‰Ú +…v……Æ˙ {…Æ˙ |……EÚ±…x… ∫… Ω˛i… ®…÷J™… ±…‰J…… |… ¥…Œπ]ı™……ƒ; P…. ±…‰J……{…Æ˙“I…… x…πEÚπ……Á ∫…‰ =i{…z… ¥…k…“™… ¥…¥…Æ˙h… ®… §…x……B ®…Ω˛i¥…{…⁄h…« ∫…®……™……‰V…x…; RÛ. ¥…k…“™… ¥…¥…Æ˙h…… ∫…‰ ∫…∆§…∆ v…i… EÚ…x…⁄x…“ +…¥…∂™…EÚi……+… E‰Ú ∫……l… +x…÷{……±…x…; S…. EÚ…‰<« ¶…“ ∫…∆§…∆ v…i… {……]ı‘ ±…‰x…n‰˘x… EÚ… |…EÚ]ı“EÚÆ˙h…; +…ËÆ˙ UÙ. ±…‰J……{…Æ˙“I…… |……∞¸{… Æ˙{……‰]«ı ®… |… i…§…∆v…; xiii. §……‰b«˜ EÚ…‰ +x…÷®……‰n˘x… E‰Ú ±…B |…∫i…÷i… EÚÆ˙x…‰ E‰Ú {…Ω˛±…‰ |…§…∆v… E‰Ú ∫……l… i…®……Ω˛“ ¥…k…“™… ¥…¥…Æ˙h… EÚ“ ∫…®…“I…… EÚÆ˙x……; xiv. |…§…∆v… E‰Ú ∫……l… +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ…Â EÚ‰ x…π{……n˘x… +…ËÆ˙ +…∆i… Æ˙EÚ x…™…∆j…h… |…h…… ±…™…… EÚ“ {…™……«{i…i…… EÚ“ ∫…®…“I…… EÚÆ˙x……; ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 78 9.1 AUDIT COMMITTEE 9.1.1. Composition The Company’s Audit Committee comprises all the three Independent Directors. The Audit Committee is headed by Mr. Sanjiv Kapoor and has Mr. K. Mohandas and Dr.Aarti Vij as its members. During the year, upon resignation from the Company, Shri. K.K. Sureshkumar, former Director (Marketing), ceased to be a member of the Committee. All the members of the Committee have relevant experience in financial matters and the Chairman of the Committee Shri Sanjiv Kapoor is a practicing Chartered Accountant, having extensive accounting and related financial management expertise. In May 2014 the Board re-constituted the Audit Committee with the above Members to ensure compliance with the provisions of Sec. 177(3) of the Companies Act, 2013 [the Act]. Also, the Board revised the terms of reference of the Audit Committee by adding the terms of reference stated in Sec. 177(4) of the Act. 9.1.2. Terms of reference The scope of the Audit Committee includes: i. Recommendation for appointment, remuneration and terms of appointment of auditors of the company; ii. Review and monitor the auditor’s independence and performance, and effectiveness of audit process; iii. Examination of the financial statement and the auditors’ report thereon; iv. Approval or any subsequent modification of transactions of the company with related parties; v. Scrutiny of inter-corporate loans and investments; vi. Valuation of undertakings or assets of the company, wherever it is necessary; vii. Evaluation of internal financial controls and risk management systems; and viii. Monitoring the end use of funds raised through public offers and related matters. ix. Oversight of the company’s financial reporting process and the disclosure of its financial information to ensure that the financial statement is correct, sufficient and credible. x. Recommending to the Board the fixation of audit fees. xi. Approval of payment to statutory auditors for any other services rendered by the statutory auditors. xii. Reviewing, with the management, the annual financial statements before submission to the Board for approval, with particular reference to: a. Matters required to be included in the Directors’ Responsibility Statement to be included in the Board’s report in terms of clause (2AA) of section 217 of the Companies Act, 1956; b. Changes, if any, in accounting policies and practices and reasons for the same; c. Major accounting entries involving estimates based on the exercise of judgment by management; d. Significant adjustments made in the financial statements arising out of audit findings; e. Compliance with legal requirements relating to financial statements; f. Disclosure of any related party transactions; and g. Qualifications in the draft audit report. xiii. Reviewing, with the management, the quarterly financial statements before submission to the Board for approval. xiv. Reviewing, with the management, performance of internal auditors and adequacy of the internal control systems. Annual Report 2013-2014 79 xv. +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…… ¥…¶……M… EÚ“ ∫…∆Æ˙S…x……, ∫]ı…À°ÚM… +…ËÆ˙ ¥…¶……M… E‰Ú |…v……x… EÚÆ˙ Æ˙Ω‰˛ + v…EÚ…Æ˙“ EÚ“ ¥… Æ˙π`ˆi……, Æ˙{……‰Õ]ıM… ∫…∆Æ˙S…x……, ¥…∫i……Æ˙ +…ËÆ˙ +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…… EÚ“ +…¥…fi k… ∫… Ω˛i… EÚ…‰<« +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…… EÚ…™…«EÚ±……{…… EÚ“ {…™……«{i…i…… Ω˲ i……‰ ∫…®…“I…… EÚÆ˙x…… ; xvi. EÚ∫…“ ¶…“ ®…Ω˛i¥…{…⁄h…« x…πEÚπ…« {…Æ˙ +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ∫……l… S…S……« +…ËÆ˙/™…… =∫…{…Æ˙ +x…÷¥…i…‘ EÚ…Æ«˙¥……<« EÚÆ˙x……; xvii. +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ…Â/±…‰J……{…Æ˙“I…EÚ…Â/+ ¶…EÚÆ˙h…… u˘…Æ˙… EÚ…‰<« +…∆i… Æ˙EÚ V……ƒS…-{…b˜i……±… E‰Ú {… Æ˙h……®… EÚ“ ∫…®…“I…… EÚÆ˙x…… V…Ω˛…ƒ ®……®…±…‰ EÚ“ ∫…∆n‰˘ Ω˛i… v……‰J…‰§……W…“, + x…™… ®…i…… ™…… ¶……Ë i…EÚ |…EfiÚ i… E‰Ú +…∆i… Æ˙EÚ x…™…∆j…h… |…h……±…“ EÚ“ +∫…°Ú±…i…… Ω˲ +…ËÆ˙ ®……®…±…‰ §……‰b«˜ EÚ…‰ Æ˙{……‰]«ı EÚÆ˙x……; xviii. ±…‰J……{…Æ˙“I…… ∂…÷∞¸ Ω˛…‰x…‰ E‰Ú {…Ω˛±…‰ ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ∫……l… ±…‰J……{…Æ˙“I…… EÚ“ |…EfiÚ i… +…ËÆ˙ ¥…∫i……Æ˙ E‰Ú §……Ɖ˙ ®… S…S……« EÚÆ˙x…‰ E‰Ú + i… Æ˙HÚ EÚ…‰<« = r˘Mx…i…… E‰Ú I…‰j… E‰Ú {…i…… ±…M……x…‰ E‰Ú ±…B =k…Æ˙ ±…‰J……{…Æ˙“I…… S…S……«; xix. V…®……EÚi……«+…Â,Ú@Òh…{…j…v……Æ˙EÚ…Â, ∂…‰™…Æ˙v……Æ˙EÚ…Â (P……‰ π…i… ±……¶……∆∂…… E‰Ú M…ËÆ˙-¶…÷M…i……x… E‰Ú ®……®…±…‰ ®…Â) +…ËÆ˙ ±…‰x…n˘…Æ˙… EÚ…‰ ¶…÷M…i……x… ®… {…™……«{i… S…⁄EÚ E‰Ú ±…B EÚ…Æ˙h…… ®… V……ƒS…-{…b˜i……±… EÚÆ˙x……; xx. ¥… ∫…±… §±……‰‰¥…Æ ®…‰EÚ… x…∫…®… E‰Ú EÚ…™…« EÚ“ ∫…®…“I…… EÚÆ˙x……; xxi. x…™…∆j…EÚ B¥…∆ ®…Ω˛…±…‰J……{…Æ˙“I…EÚ EÚ“ ±…‰J……{…Æ˙“I…… E‰Ú ±…‰J……{…Æ˙“I…… ]ı{{… h…™…… {…Æ˙ +x…÷¥…i…‘ EÚ…Æ«˙¥……<« EÚ“ ∫…®…“I…… EÚÆ˙x……; xxii. ∫…∆∫…n˘ E‰Ú ∫……¥…«V… x…EÚ ={…GÚ®…… (∫…“ +…‰ {…“ ™…÷) {…Æ˙ EÚ“ M…<« ∫…°Ú… Æ˙∂…… {…Æ˙ ±…“ M…<« +x…÷¥…i…‘ EÚ…Æ«˙¥……<« {…Æ˙ ∫…®…“I…… EÚÆ˙x……˙; xxiii. ∫¥…i…∆j… ±…‰J……{…Æ˙“I…EÚ, +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ +…ËÆ˙ x…n‰˘∂…EÚ ®…∆b˜±… E‰Ú §…“S… ®… BEÚ J…÷±…… +¥…∫…Æ˙ |…n˘…x… EÚÆ˙x…… xiv. E∆Ú{…x…“ ®… ∫…¶…“ ∫…∆§…∆ v…i… {……]ı‘ ±…‰x…n‰˘x… EÚ“ ∫…®…“I…… EÚÆ˙x……* <∫… =q‰˘∂™… E‰Ú ±…B, ±…‰J……{…Æ˙“I…… ∫… ®… i… BEÚ ∫…n˘∫™… EÚ…‰ x…… ®…i… EÚ™…… V……™… V……‰ ∫…∆§…∆ v…i… {……]ı‘ ±…‰x…n‰˘x…… EÚ“ ∫…®…“I…… EÚÆ˙x…‰ E‰Ú ±…B V…®®…‰n˘…Æ˙ Ω˛…‰M……; xxv. ∫¥…i…∆j… ±…‰J……{…Æ˙“I…EÚ E‰Ú ∫……l… EÚ¥…Ɖ˙V… EÚ“ {…⁄h…«i……, x…Æ˙l…«EÚ |…™……∫…… EÚ“ EÚ®…“ +…ËÆ˙ ∫…¶…“ ±…‰J……{…Æ˙“I…… ∫…∆∫……v…x…… E‰Ú |…¶……¥…“ ={…™……‰M… EÚ…‰ +…∑…∫i… EÚÆ˙x…‰ E‰Ú ±…B ±…‰J……{…Æ˙“I…… |…™……∫…… E‰Ú ∫…®…x¥…™…x… EÚ“ ∫…®…“I…… EÚÆ˙x……; xxvi. ∫¥…i…∆j… ±…‰J……{…Æ˙“I…EÚ +…ËÆ˙ |…§…∆v… E‰Ú ∫……l… x…®x… ±… J…i…… EÚ…‰ ¥…S……Æ˙ EÚÆ˙x…… +…ËÆ˙ ∫…®…“I…… EÚÆ˙x……: - E∆Ú{™…⁄]ı“EfiÚi… ∫…⁄S…x…… |…h……±…“ x…™…∆j…h… +…ËÆ˙ ∫…÷Æ˙I…… ∫… Ω˛i… +…∆i… Æ˙EÚ x…™…∆j…h… EÚ“ {…™……«{i…i……, +…ËÆ˙ - |…§…∆v… |… i… GÚ™……+… E‰Ú ∫……l…-∫……l… ∫¥…i…∆j… ±…‰J……{…Æ˙“I…EÚ +…ËÆ˙ +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ E‰Ú ∫…∆§…∆ v…i… x…πEÚπ……Á +…ËÆ˙ ∫…°Ú… Æ˙∂…Â* xxvii. |…§…∆v… +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ +…ËÆ ∫¥…i…∆j… ±…‰J……{…Æ˙“I…EÚ˙ E‰Ú ∫……l… x…®x… ±… J…i… EÚ… ¥…S……Æ˙ EÚÆx…… +…ËÆ˙ ∫…®…“I…… EÚÆ˙x…… - {…UÙ±…“ ±…‰J……{…Æ˙“I…… ∫…°Ú… Æ˙∂…… EÚ“ Œ∫l… i… ∫… Ω˛i… S……±…⁄ ¥…π…« E‰Ú ®…Ω˛i¥…{…⁄h…« x…πEÚπ…« - EÚ…™…«EÚ±……{…… E‰Ú EÚ…™…«-I…‰j… ™…… +{…‰ I…i… V……x…EÚ…Æ˙“ E‰Ú ±…B {…Ω⁄ƒ˛S… {…Æ˙ EÚ…‰<« ¶…“ |… i…§…∆v… ∫… Ω˛i… ±…‰J……{…Æ˙“I…… EÚ…™…« E‰Ú n˘…ËÆ˙…x… ∫……®…x…… EÚÆx…“ {…b˜“ ˙EÚ `ˆx……<™……ƒ xxviii. ±…‰J……{…Æ˙“I…… ∫… ®… i… E‰Ú ∫…∆n˘¶…« E‰Ú ∂…i……Á ®… =Œ±±… J…i… EÚB V…Ë∫…‰ EÚ∫…“ +x™… EÚ…™…« EÚ…™……«Œx¥…i… EÚÆ˙x……* 9.1.3 §…Ë`ˆEÚ‰∆ +…ËÆ˙ Ω˛… V…Æ˙“ 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… ¥…k…“™… ¥…π…« E‰Ú n˘…ËÆ˙…x…, ±…‰J……{…Æ˙“I…… ∫… ®… i… EÚ“ {……ƒS… §…Ë`ˆEÚ +…™……‰ V…i… EÚ“ M…™…”, GÚ®…∂…& 25 V…⁄x…, 2013, 17 V…÷±……<«, 2013, 24 ∫…i…∆§…Æ˙, 2013, 07 n˘∫…∆∆§…Æ˙, 2013 & 10 ®……S…«, 2014* §…Ë`ˆEÚ ®… ∫…n˘∫™…… EÚ“Ú Ω˛… V…Æ˙“ x…®x… V…Ë∫…“ ΩÈ˛: ∫… ®… i… ∫…n˘∫™… E‰Ú x……®… +¥… v… E‰Ú n˘…ËÆ˙…x… ={…Œ∫l…i… §…Ë`ˆEÚ…Â +…™……‰ V…i… §…Ë`ˆEÚ…Â EÚ“ ∫…∆J™…… EÚ“ ∫…∆J™…… ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ˙ 5 5 ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫… 5 5 ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙∂… E÷Ú®……Æ˙ 4 4 b˜…Ï. +…Æ˙i…“ ¥…V… 5 3 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 80 xv. Reviewing the adequacy of internal audit function, if any, including the structure of the internal audit department, staffing and seniority of the official heading the department, reporting structure, coverage and frequency of internal audit. xvi. Discussion with internal auditors and/or auditors any significant findings and follow up there on. xvii. Reviewing the findings of any internal investigations by the internal auditors/auditors/agencies into matters where there is suspected fraud or irregularity or a failure of internal control systems of a material nature and reporting the matter to the Board. xviii. Discussion with statutory auditors before the audit commences, about the nature and scope of audit as well as post-audit discussion to ascertain any area of concern. xix. To look into the reasons for substantial defaults in the payment to the depositors, debenture holders, shareholders (in case of non-payment of declared dividends) and creditors. xx. To review the functioning of the Whistle Blower Mechanism. xxi. To review the follow up action on the audit observations of the C&AG audit xxii. To review the follow up action taken on the recommendations of on Public Undertakings (COPU) of the Parliament. xxiii. Provide an open avenue of communication between the independent auditor, internal auditor and the Board of Directors xxiv. Review all related party transactions in the company. For this purpose, the Audit Committee may designate a member who shall be responsible for reviewing related party transactions. xxv. Review with the independent auditor the co-ordination of audit efforts to assure completeness of coverage, reduction of redundant efforts, and the effective use of all audit resources. xxvi. Consider and review the following with the independent auditor and the management: - The adequacy of internal controls including computerized information system controls and security, and - Related findings and recommendations of the independent auditor and internal auditor, together with the management responses. xxvii.Consider and review the following with the management, internal auditor and the independent auditor: - Significant findings during the year, including the status of previous audit recommendations - Any difficulties encountered during audit work including any restrictions on the scope of activities or access to required information. xxviii. Carrying out any other function as is mentioned in the terms of reference of the Audit Committee. 9.1.3. Meetings and Attendance During the financial year ended 31st March, 2014, five meetings of the Audit Committee were held on 25th June 2013, 17th July 2013, 24th September 2013, 07th December 2013 & 10th March, 2014 respectively. The attendance of the members at the meeting was as follows: Name of the Committee No. of meetings held No. of meetings Member during the period attended Shri Sanjiv Kapoor 5 5 Shri K. Mohandas 5 5 Shri K. K. Suresh Kumar 4 4 Dr. Aarti Vij 5 3 Annual Report 2013-2014 81 9.2 x……®……∆EÚx… B¥…∆ {…… Æ˙∏… ®…EÚ ∫… ®… i… ({…⁄¥…« {…… Æ˙∏… ®…EÚ ∫… ®… i…) ®…<« 2014 ®… i…iEÚ…±…“x… {…… Æ˙∏… ®…EÚ ∫… ®… i… EÚ…‰ E∆Ú{…x…“ (®…∆b˜±… §…Ë`ˆEÚ‰∆ +…ËÆ˙ =∫…EÚ“ ∂… HÚ™……ƒ) x…™…®… 2014 E‰Ú x…™…®… 6 E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®…, 2013 (+ v… x…™…®…) EÚ“ v……Æ˙… 178(1) E‰Ú ∫……l… +x…÷{……±…x… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B x……®……∆EÚx… B¥…∆ {…… Æ˙∏… ®…EÚ ∫… ®… i… E‰Ú ∞¸{… ®… {…÷x…& M… `ˆi… EÚ“ M…<«* E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 178 ®… ∫… ®… i… E‰Ú EÚ…™…«-I…‰j… +…ËÆ˙ ∫…∆n˘¶…« E‰Ú ∂…i……Á E‰Ú ¥… x…Ãn˘π]ı ¥…π…™…… EÚ…‰ ∂…… ®…±… EÚÆ˙E‰Ú §…g¯… n˘™…… M…™…… Ω˲* 9.2.1 §…x……¥…]ı x……®……∆EÚx… B¥…∆ {…… Æ˙∏… ®…EÚ ∫… ®… i… ®… x…®x… ±… J…i… 4 x…n‰˘∂…EÚ ΩÈ˛* EÚ) ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ, ∫¥…i…∆j… x…n‰˘∂…EÚ, (+v™…I…) J…) b˜…Ï. +…Æ˙i…“ ¥…V…, ∫¥…i…∆j… x…n‰˘∂…EÚ M…) ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫…, ∫¥…i…∆j… x…n‰˘∂…EÚ P…) ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±…˙, x…n‰˘∂…EÚ ( ¥…k…) 9.2.2 §…Ë`ˆEÚ +…ËÆ˙ Ω˛… V…Æ˙“ ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, {…… Æ˙∏… ®…EÚ ∫… ®… i… x…‰10 ®……S…« 2014 EÚ…‰ BEÚ §……Æ˙ §…Ë`ˆEÚ EÚ“ +…ËÆ˙ b˜…Ï.+…Æ˙i…“ ¥…V… EÚ…‰ UÙ…‰b˜EÚÆ˙ ∫…¶…“ ∫…n˘∫™… §…Ë`ˆEÚ ®… ¶……M… ±…B M…B* 9.3 EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ V…®®…‰n˘…Æ˙“ +…ËÆ˙ ∫…i…i… ¥…EÚ…∫… ∫… ®… i… 9.3.1 §…x……¥…]ı EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ V…®®…‰n˘…Æ˙“ +…ËÆ˙ ∫…i…i… ¥…EÚ…∫… ∫… ®… i… EÚ“ §…x……¥…]ı x…“S…‰ V…Ë∫…‰ ΩÈ˛* EÚ) b˜…Ï. +…Æ˙i…“ ¥…V…, ∫¥…i…∆j… x…n‰˘∂…EÚ, (+v™…I……) J…) ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫…, ∫¥…i…∆j… x…n‰˘∂…EÚ M…) ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙∂… E÷Ú®……Æ˙, x…n‰˘∂…EÚ ( ¥…{…h…x…) P…) ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±…˙, x…n‰˘∂…EÚ ( ¥…k…) RÛ) b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x…, x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) 9.3.2 ¥…S……Æ˙…l…« ¥…π…™… EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ V…®®…‰n˘…Æ˙“ E‰Ú ¥…S……Æ˙…l…« ¥…π…™… E∆Ú{…x…“ + v… x…™…®…, 2013 E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙ Ω˲* ∫…“B∫…+…Æ˙ +…ËÆ˙ B∫… b˜“ ∫… ®… i… E‰Ú EÚ…™…«I…‰j… / ¥…S……Æ˙…l…« ¥…π…™… ı x…®x… ±… J…i… ΩÈ˛: EÚ) EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ V…®®…‰n˘…Æ˙“ x…“ i… ∫…⁄j…§…r˘ EÚÆx…… +…ËÆ˙ §……‰b«˜ EÚ…‰ ∫…°Ú… Æ˙∂… EÚÆ˙x…… V……‰ E∆Ú{…x…“ u˘…Æ˙… EÚB V……x…‰¥……±…‰ EÚ…™……«EÚ±……{…… EÚ…‰ ∫…⁄ S…i… EÚƉ˙M…“* J…) ={…Æ˙…‰HÚ EÚ…™…«EÚ±……{…… {…Æ˙ J…S…« EÚB V……x…‰ ¥……±…‰ ¥™…™… EÚ“ Æ˙… ∂… EÚ“ ∫…°Ú… Æ˙∂… EÚÆ˙x……* M…) ∫…®…™…-∫…®…™… {…Æ˙ E∆Ú{…x…“ EÚ“ EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ V…®®…‰n˘…Æ˙“ x…“ i… EÚ… +x…÷¥…“I…h… EÚÆ˙x…… * Æ˙{……‰]ı…«v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, ∫…“B∫…+…Æ˙ & B∫… b˜“ ∫… ®… i… x…‰ 6 ∫…i…∆§…Æ˙ 2013 +…ËÆ˙ 5 °ÚÆ˙¥…Æ˙“ 2014 EÚ…‰ n˘…‰ (2) §……Æ˙ §…Ë`ˆEÚ‰∆ EÚ“* §…Ë`ˆEÚ…‰∆ ®… ∫…n˘∫™…… EÚ“ ¶……M…“n˘…Æ˙“ x…®x… V…Ë∫…“‰ ΩÈ˛ : x……®… {…n˘ §…Ë`ˆEÚ…Â EÚ“ ∫…∆J™…… ={…Œ∫l…i… §…Ë`ˆEÚ…Â ¥…π…« E‰Ú n˘…ËÆ˙…x… EÚ“ ∫…∆J™…… b˜…Ï. +…Æ˙i…“ ¥…V… +v™…I…… 2 2 ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫… ∫…n˘∫™… 2 2 ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙∂… E÷Ú®……Æ ∫…n˘∫™… 1 1 ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±… ∫…n˘∫™… 2 1 b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x… ∫…n˘∫™… 2 1 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 82 9.2 Nomination and Remuneration Committee (earlier Remuneration Committee) In May 2014, the erstwhile Remuneration Committee was re-constituted as Nomination and Remuneration Committee to ensure compliance with Sec. 178(1) of the Companies Act, 2013 [the Act] read with Rule 6 of the Companies (Meetings of Board of and its Powers) Rules, 2014. The scope and terms of reference of the Committee was enlarged by including the matters specified in Section 178 of the Companies Act, 2013. 9.2.1. Composition The Nomination and Remuneration Committee consists of the following 4 directors. a) Shri Sanjiv Kapoor, Independent Director, (Chairman) b) Dr. Aarti Vij, Independent Director c) Shri K. Mohandas, Independent Director d) Shri R.P. Khandelwal, Director (Finance) 9.2.2. Meetings and Attendance During the year under review, the Remuneration committee met once on 10th March, 2014 and all Members attended the Meeting except Dr. Aarti Vij. 9.3 Corporate Social Responsibility & Sustainable Development Committee 9.3.1. Composition The composition of CSR & Sustainable Development Committee is as under. a) Dr. Aarti Vij, Independent Director, (Chairperson) b) Shri K. Mohandas, Independent Director c) Shri K.K. Suresh Kumar, Director (Marketing) d) Shri R.P. Khandelwal, Director (Finance) e) Dr. KRS Krishnan, Director (T&O) 9.3.2. Terms of reference The terms of reference of the CSR Committee are as per the provisions of the Companies Act, 2013. The following are the scope/terms of reference of the CSR & SD Committee: a) Formulate and recommend to the Board, a Corporate Social Responsibility Policy which shall indicate the activities to be undertaken by the company b) Recommend the amount of expenditure to be incurred on the above activities c) Monitor the Corporate Social Responsibility Policy of the company from time to time. During the year under report, the CSR&SD Committee met two (2) times on 6th September 2013 and 5th February 2014. The attendance of the members at the meeting was as follows: Name Position No of Meetings No of Meetings during the Year Attended Dr. Aarti Vij Chairperson 2 2 Shri K. Mohandas Member 2 2 Shri K.K. Sureshkumar Member 1 1 Shri. R.P. Khandelwal Member 2 1 Dr K.R.S.Krishnan Member 2 1 Annual Report 2013-2014 83 9.4 x…“ i… +…ËÆ˙ EÚ…™…«x…“ i… ∫…⁄j…“EÚÆ˙h… & x…¥…‰∂… ∫… ®… i… 9.4.1 §…x……¥…]ı ∫…®…“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x…, ®…∆b˜±… EÚ“ n˘…‰ ={… ∫… ®… i…™……ƒ, ™……x…“ (1) x…“ i… B¥…∆˙ EÚ…™…«x…“ i… ∞¸{…“EÚÆ˙h… +…ËÆ x…¥…‰∂… ∫… ®… i…˙ +…ËÆ˙ (2) {… Æ˙™……‰V…x…… EÚ…™……«x¥…™…x… +…ËÆ˙ ®……Ï x…]ıÀÆ˙M… ∫… ®… i…, ∫…n˘∫™…… E‰Ú ∞¸{… ®… x…®x… ±… J…i… x…n‰˘∂…EÚ…Â ∫… Ω˛i… EÚ…™…«x…“ i… ∞¸{…“EÚÆ˙h… +…ËÆ˙ x…¥…‰∂… ∫… ®… i… (B∫… B°Ú +…<« ∫…“) ®… ¥…±…“x… Ω˛…‰ M…™…“* 1) ∏…“ E‰Ú. ®……‰Ω˛x…n˘…∫…, ∫¥…i…∆j… x…n‰˘∂…EÚ - +v™…I… 2) ∏…“ B∫….E‰Ú Æ˙…¥…, ∫…∆™…÷HÚ ∫… S…¥…, ∫…Æ˙EÚ…Æ˙ x…… ®…i… x…n‰˘∂…EÚ 3) ∏…“ ∫…∆V…“¥… EÚ{…⁄Æ, ∫¥…i…∆j… x…n‰˘∂…EÚ 4) ∏…“ E‰Ú.E‰Ú.∫…÷Ɖ˙∂… E÷Ú®……Æ˙, x…n‰˘∂…EÚ ( ¥…{…h…x…) 5) ∏…“ +…Æ˙.{…“. J…hb‰˜±…¥……±…˙, x…n‰˘∂…EÚ ( ¥…k…) 6) b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x…, x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) 9.4.2 ¥…S……Æ˙…l…« ¥…π…™… ∫… ®… i… E‰Ú ¥…S……Æ˙…l…« ¥…π…™… ®… x…®x… ±… J…i… ∂…… ®…±… ΩÈ˛: • E∆Ú{…x…“ E‰Ú ±…B n˘“P……«¥… v… EÚ…™…«x…“ i… B¥…∆ x…“ i… ¥…EÚ ∫…i… EÚÆ˙x……* • BS…B±…B±… E‰Ú +…∆i… Æ˙EÚ +…ËÆ˙ §……¡ ¥™……{……Æ˙ ¥……i……¥…Æ˙h… EÚ… x…v……«Æ˙h… EÚÆ˙x……* • E∆Ú{…x…“ E‰Ú ¥……Ãπ…EÚ ¥™……{……Æ˙ ±…I™……‰∆ EÚ…‰ |……{i… EÚÆ˙x…‰ E‰Ú ±…B BEÚ EÚ…™…«x…“ i… |…§…∆v…x… |… GÚ™…… ¥…EÚ ∫…i… EÚÆ˙x……* • {… Æ˙™……‰V…x……+… E‰Ú EÚ…™……«x¥…™…x… E‰Ú ±…B V……‰ ¥…W…x… 2020 ™……‰V…x…… ®… =Œ±±… J…i… V…Ë∫…‰ BS…B±…B±… E‰Ú ±…I™…… +…ËÆ˙ ™……‰V…x……+… EÚ…‰ ∫…®…l…«x… EÚÆ˙ Æ˙Ω‰˛ ®…⁄±™… x…v……«Æ˙h… +…ËÆ˙ +x…÷®……‰n˘x… EÚÆ˙x……* • EÚ…™…«x…“ i… EÚ…™…«∫…⁄S…“ E‰Ú ∫……l… +…¥… v…EÚ ¥… Æ˙π`ˆ x…‰i…fii¥… §…Ë`ˆEÚ‰∆ x…™……‰ V…i… EÚÆ˙x……* • E∆Ú{…x…“ ®… EÚ…™…«x…“ i… |…§…∆v…˘x… ¥…¶……M… E‰Ú |…¶……¥…“ ∫…∆S……±…x… E‰Ú ±…B ®……M…« x…nÊ˘∂… |…n˘…x… EÚÆ˙x……* • EÚ…™……«x¥…™…x… ∫…®…∫™……+… EÚ…‰ {…Ω˛S……x… EÚÆ˙Ú™…… {… Æ˙™……‰V…x…… |… I…{i… Æ˙{……‰]ı…Á E‰Ú W… Æ˙B =iEfiÚπ]ı x…π{……n˘x… ®… x…n‰˘∂…EÚ ®…∆b˜±… EÚ…‰ {… Æ˙™……‰V…x……+… E‰Ú ®……Ï x…]ıÀÆ˙M… +…ËÆ˙ ®…⁄±™……∆EÚx… EÚÆ˙x…‰ E‰Ú ±…B ®…n˘n˘ EÚÆ˙x……* • ∫…¶…“ {… Æ˙™……‰V…x……+… E‰Ú ¥…k…“™… B¥…∆ x…π{……n˘x… EÚ… ®……Ï x…]ıÆ˙ EÚÆ˙E‰Ú ®…⁄±™……∆EÚx… EÚÆ˙x……* • ®…∆b˜±… EÚ…‰ x…¥…‰∂…/{… Æ˙™……‰V…x…… |…∫i……¥… EÚ…‰ ∫…°Ú… Æ˙∂… EÚÆ˙x……* EÚ…™…«x…“ i… ∫…⁄j…“EÚÆ˙h… +…ËÆ˙ x…¥…‰∂… ∫… ®… i… EÚ…™……«i®…EÚ Ω˛…‰ M…<« ΩÈ˛ +…ËÆ˙ ∫… ®… i… EÚ“ {…Ω˛±…“ §…Ë`ˆEÚ 10 °ÚÆ˙¥…Æ˙“ 2014 EÚ…‰ +…™……‰ V…i… EÚ“ M…<« l…“* 10. x…n‰˘∂…EÚ…Â EÚ… {…… Æ˙∏… ®…EÚ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ +…ËÆ˙ +x™… EÚ…™……«i®…EÚ x…n‰˘∂…EÚ…Â EÚ…‰ x…™…÷HÚ EÚÆ˙i…… Ω˲* ∫……¥…«V… x…EÚ =t®… ¥…¶……M… u˘…Æ˙… =x…E‰Ú x…n‰˘∂…EÚ ∂…{…˘ E‰Ú {…… Æ˙∏… ®…EÚ +…ËÆ˙ ∂…i…« ¥… x…§…∆v…x… E‰Ú x…h…«™… ±…B V……i…‰ Ω∆˲* +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ +…ËÆ˙ EÚ…™……«i®…EÚ x…n‰˘∂…EÚ…Â EÚ…‰ {……ƒS… ¥…π…« EÚ“ +¥… v… E‰Ú ±…B ™…… =x…EÚ“ + v…¥…Ãπ…i…… EÚ“ i……Æ˙“J… i…EÚ ™…… +M…±…‰ +…n‰˘∂…… i…EÚ, V……‰ ¶…“ {…Ω˛±…… Ω˲, x…™…÷HÚ EÚB V……i…‰ ΩÈ˛˛* ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… M…ËÆ˙ ∫…Æ˙EÚ…Æ˙“ +∆∂…EÚ… ±…EÚ ∫¥…i…∆j… x…n‰˘∂…EÚ…Â EÚ…‰ ¶…“ i…“x… ¥…π…« EÚ“ +¥… v… E‰Ú ±…B x…™…÷HÚ EÚB V……i…‰ ΩÈ˛˛ +…ËÆ˙ §……‰b« +…ËÆ˙ §……‰b« u˘…Æ˙… x…™…÷HÚ ={… ∫… ®… i…™…… EÚ“ ˜|…i™…‰EÚ §…Ë`ˆEÚ…ÂÚ ®… ={…Œ∫l…i… Æ˙Ω˛x…‰ E‰Ú ±…B Ø˚ 10,000/- EÚ… §…Ë`ˆEÚ ∂…÷±EÚ |…n˘k… EÚB V……i…‰ ΩÈ˛* 11. ®…÷J™… |…§…∆v…EÚ“™… Eڅî…EÚ…Â EÚ“ x…™…÷ HÚ E∆Ú{…x…“ ( x…™…÷ HÚ B¥…∆ |…§…∆v…EÚ“™… Eڅî…EÚ EÚ… {…… Æ˙∏… ®…EÚ) x…™…®… 2014 V……‰ 1 +|…˱… 2014 EÚ…‰ ±……M…⁄ Ω÷˛+… Ω˲, E‰Ú ∫……l… {… `ˆi… E∆Ú{…x…“ + v… x…™…®… 2013 EÚ“ v……Æ˙… 203 E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙, x…n‰˘∂…EÚ ®…∆b˜±… x…‰ x…®x… ±… J…i… x…n‰˘∂…EÚ…Â/EÚ…™…«{……±…EÚ…Â EÚ…‰ E∆Ú{…x…“ E‰Ú ®…÷J™… |…§…∆v…EÚ“™… Eڅî…EÚ…Â (E‰Ú B®… {…“) E‰Ú ∞¸{… ®… {…… Æ˙∏… ®…EÚ ∫… Ω˛i… =x…E‰Ú ¥…i…«®……x… ∂…i…« ¥… x…§…∆v…x… {…Æ˙ x…™…÷HÚ EÚ™…… Ω˲: 1. b˜…Ï.B®….+™™…{{…x… - +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ 2. ∏…“ +…Æ˙.{…“.J…hb‰˜±…¥……±… - x…n‰˘∂…EÚ ( ¥…k…) 3. b˜…Ï. E‰Ú.+…Æ˙.B∫… EfiÚπh…x… - x…n‰∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) 4. x…n‰˘∂…EÚ ( ¥…{…h…x…) 5. ∏…“ +…Æ˙.M…h…‰∂…x… - ®…÷J™… ¥…k…“™… + v…EÚ…Æ˙“ & ={……v™…I… ( ¥…k…) 6. ∏…“ {…“.∏…“E÷Ú®……Æ˙ - E∆Ú{…x…“ ∫… S…¥… B¥…∆ ={……v™…I… ( ¥…k…) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 84 9.4. Strategy Formulation and Investment Committee 9.4.1. Composition During the year under review, two sub-committees of the Board namely (i) Policy and Strategy Formulation and Investment Committee and (ii) Project Implementation and Monitoring Committee was merged into Strategy Formulation and Investment Committee [SFIC], comprising the following Directors as Members: 1) Shri K. Mohandas, Independent Director – Chairman 2) Shri S K Rao, Joint Secretary, Government Nominee Director 3) Shri Sanjiv Kapoor, Independent Director 4) Shri K. K. Suresh Kumar, Director (Marketing) 5) Shri R.P Khandelwal, Director (Finance) 6) Dr. K.R.S Krishnan, Director (T&O) 9.4.2. Terms of reference The terms of reference of the Committee includes the following: • Develop long-term strategies and policies for the company. • Assessment of HLL’s internal and external business environment. • Develop a strategic management process for achieving company’s annual business targets. • Assess and approve for implementation projects that are supportive of goals and plans of HLL as outlined in the Vision 2020 Plan. • Plan periodic senior leadership meetings with a strategic agenda. • Provide guidance for effective functioning of the strategic management department in the Company. • Assist the Board of directors in monitoring and evaluation of projects by identifying implementation problems or outstanding performance through project exception reports. • Monitor and evaluate financial and physical performance of all projects. • Recommend investment/project proposals to the Board. The Strategy Formulation and Investment Committee have become functional and the first meeting of the Committee was held on 10th February, 2014 10. Remuneration of Directors Ministry of Health & Family Welfare (MoHFW), Government of India appoints Chairman & Managing Director and the other Functional Directors. The remuneration and terms and conditions of their directorship are decided by Department of Public Enterprises. The Chairman & Managing Director and the Functional Directors are appointed for a period of five years or till the date of their superannuation or until further orders, whichever is earlier. Non-official part-time Independent Directors are also appointed by the Ministry of Health & Family Welfare, Government of India for a period of three years and are paid a sitting fee of ` 10,000/- for attending each meeting of the Board and the Board appointed Sub Committees. 11. Appointment of Key Managerial Personnel Pursuant to the provisions of Section 203 of Companies Act 2013 read with Companies (Appointment & Remuneration of Managerial Personnel) Rules 2014, which have come into force from 1st April, 2014 the Board of directors has appointed the following Directors/Executives as the Key Managerial Personnel (KMPs) of the Company on their existing terms & conditions of appointment, including remuneration: 1. Dr. M. Ayyappan – Chairman & Managing Director 2. Shri R.P. Khandelwal – Director (Finance) 3. Dr K.R.S Krishnan – Director (Technical & Operation) 4. Director (Marketing) 5. Shri R. Ganesan – Chief Financial Officer & Vice-President (Finance) 6. Shri P. Sreekumar – Company Secretary & Vice-President (Finance) Annual Report 2013-2014 85 12. 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…B EÚ…™……«i®…EÚ x…n‰˘∂…EÚ…Â EÚ…‰ |…n˘k… {…… Æ˙∏… ®…EÚ EÚ…Ú ¥…¥…Æ˙h…* GÚ.∫…∆ x…n‰˘∂…EÚ {…n˘ E÷Ú±… {…… Æ˙∏… ®…EÚ (Ø˚. ±……J…… ®…Â) 1 b˜…Ï. B®….+™™…{{…x… +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ 42.16 2 ∏…“ E‰Ú.E‰Ú. ∫…÷Ɖ˙π… E÷Ú®……Æ˙ x…n‰˘∂…EÚ ( ¥…{…h…x…) 25.78 (12 n˘∫…∆§…Æ˙ 2013 EÚ…‰ x…n‰˘∂…EÚ E‰Ú ∞¸{… ®… ∫…®……{i… EÚ™…… Ω˲) 3 ∏…“ +…Æ˙.{…“.J…hb‰˜±…¥……±… x…n‰˘∂…EÚ ( ¥…k…) 32.64 4 b˜…Ï.E‰Ú.+…Æ˙.B∫… EfiÚπh…x… x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) 26.48 13. x…n‰˘∂…EÚ ®…∆b˜±… E‰Ú ∫…®…I… |…∫i…÷i… EÚ“ V……x…‰¥……±…“ ∫…⁄S…x…… ®…∆b˜±… EÚ…‰ E∆Ú{…x…“ E‰Ú +∆i…M…«i… EÚ∫…“ ¶…“ ∫…⁄S…x…… E‰Ú ±…B ∫…∆{…⁄h…« {…Ω⁄ƒ˛S… Ω˲* ®…∆b˜±… EÚ…‰ x…™… ®…i… ∞¸{… ∫…‰ |…n˘…x… EÚ“ M…<« ∫…⁄S…x…… ®… ∂…… ®…±… Ω∆˲: EÚ) ¥……Ãπ…EÚ |…S……±…x… ™……‰V…x…… B¥…∆ ˙§…V…]ı +…ËÆ˙ EÚ…‰<« ¶…“ +ti…x… J…) ¥……Ãπ…EÚ J……i……, x…n‰˘∂…EÚ…Â EÚ“ Æ˙{……‰]«ı +… n˘* M…) E∆Ú{…x…“ EÚ“ i…®……Ω˛“ {… Æ˙h……®…* P…) ∫…®…x…÷π…∆M…“ E∆Ú{…x…“ +…ËÆ˙ ∫…∆™…÷HÚ - =t®… E∆Ú{…x…“ E‰Ú EÚ…™…«¥…fik… ∫… Ω˛i… ®…∆b˜±… E‰Ú +x™… ∫… ®… i…™…… +…ËÆ ˙±…‰J…… {…Æ˙“I…… ∫… ®… i… EÚ“ §…Ë`ˆEÚ…‰∆ E‰Ú EÚ…™…«¥…fik…* RÛ) |…®…÷J… x…¥…‰∂…, ∫…®…x…÷π…∆M…“ +…ËÆ ∫…∆™…÷HÚ =t®…, ∫]≈Ëı]‰ı V…EÚ M…`ˆ§…∆v…x…… +… n˘ EÚ…Ú M…`ˆx…* S…) §…b‰˜ ∫…∆ ¥…n˘… |…n˘…x… EÚÆ˙x…… * UÙ) x…n‰˘∂…EÚ ∂…{… E‰Ú §……Ɖ˙ ®… x…n‰˘∂…EÚ…Â EÚ“ÚÚ Ω˛i… EÚ… |…EÚ]ı“EÚÆ˙h… +…ËÆ˙ +x™… E∆Ú{… x…™…… ®… =x…E‰Ú u˘…Æ˙… + v…EfiÚi… ∫… ®… i… {…n˘* V…) E∆Ú{…x…“ EÚ“ ¥…… h…V™…EÚ Œ∫l… i… {…Æ˙ ®…… ∫…EÚ Æ˙{……‰]«ı* Z…) ¥… ¶…z… S……±…⁄ {… Æ˙™……‰V…x……Bƒ/™……‰V…x…… +…ËÆ˙ §…V…]ı ={…™……‰ M…i…… EÚ“ Œ∫l… i… {…Æ˙ Æ˙{……‰]«ı \…) ¥…‰i…x… ∫…®…Z……Ëi…‰ {…Æ˙ Ω˛∫i……I…Æ +… n˘ V…Ë∫…‰ ®……x…¥… ∫…∆∫……v…x…/ +…Ët…‰ M…EÚ ∫…∆{…E«Ú EÚ…™……Á ®… EÚ…‰<« ¶…“ ®…Ω˛i¥…{…⁄h…« ¥…EÚ…∫…* ]ı) ±……¶……∆∂… EÚ… M…ËÆ˙ ¶…÷M…i……x… , ∂…‰‰™…Æ˙ Ω˛∫i……∆i…Æ˙h… ®… ¥…±…∆§… +… n˘ V…Ë∫…‰ EÚ…‰<« ¶…“ ¥… x…™……®…EÚ, ∫……∆ ¥… v…EÚ ™…… ∫…⁄S…“EÚÆ˙h… +{…‰I……+… +…ËÆ˙ +∆∂…v…… Æ˙™…… EÚ“ ∫…‰¥…… EÚ… M…ËÆ˙-+x…÷{……±…x…* `ˆ) +x™… ¥……∫i… ¥…EÚ ®…Ω˛i¥…{…⁄h…« ∫…⁄S…x……* 14. §…Ë`ˆEÚ…‰k…Æ˙ +x…÷¥…i…‘ |…h……±…“ E∆Ú{…x…“ E‰Ú + ¶…∂……∫…x… |… GÚ™…… ®… ®…∆b˜±… +…ËÆ˙ ®…∆b˜±… ∫… ®… i… (+…Â) E‰Ú x…h…«™…… {…Æ˙ ±…“ M…<«/±…∆ §…i… EÚ…Æ«˙¥……<« E‰Ú ±…B |…¶……¥…“ §…Ë`ˆEÚ…‰k…Æ˙ +x…÷¥…i…‘ EÚ…Æ«˙¥……<«, ∫…®…“I…… B¥…∆ Æ˙{……‰Õ]ıM… |… GÚ™…… ∂…… ®…±… Ω∆˲* 15. ∂…‰™…Æ˙v……Æ˙h… ∫¥…∞¸{… BS…B±…B±… EÚ…‰ ¶……Æ˙i… ™…… ¥…n‰˘∂… E‰Ú EÚ…‰<« ¶…“ ∫]ı…ÏEÚ BC∫…S…ÂV… ®… ∫…⁄S…“§…r˘ x…Ω˛” EÚ™…… M…™…… Ω˲* E∆Ú{…x…“ EÚ“ ∫…∆{…⁄h…« |…n˘k… ∂…‰‰™…Æ˙ {…⁄ƒV…“ ¶……Æ˙i… EÚ‰ Æ˙…π]≈ı{… i… +…ËÆ˙ =x…E‰Ú x……Ï ®… i…™…… u˘…Æ˙… + v…EÚ…Æ˙ ®… Æ˙J…“ Ω˲* 16. ∫……®……x™… §…Ë`ˆEÚ : E∆Ú{…x…“ E‰Ú +∆ i…®… i…“x… ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ…Â E‰Ú n˘x……∆EÚ, ∫…®…™… +…ËÆ˙ ∫l……x… x…®x……x…÷∫……Æ˙ Ω˲: BV…“B®… ¥…k…“™… ¥…π…« i……Æ˙“J… ∫…®…™… ∫l……x… C™…… ¥…∂…‰π… ∫…∆EÚ±{… (+…Â) {…… Æ˙i… ™…… x…Ω˛” 45¥…” 2010-2011 6 ∫…i…∆§…Æ˙, 2011 ®…v™……ºx… 12.00 §…V…‰ x…<« n˘±±…“ x…Ω˛” 46¥…” 2011-2012 24 ∫…i…∆§…Æ˙, 2012 +{…Æ˙…ºx… 2.30 §…V…‰ x…<« n˘±±…“ V…“ Ω˛…ƒ, E∆Ú{…x…“ E‰Ú ∂…‰™…Æ…‰∆˙ E‰Ú {…÷x…& GÚ™… ∫…I…®… EÚÆ˙x…‰ E‰Ú ±…B ∫…∆∫l…… E‰Ú +∆i…Ãx…™…®… EÚ…‰ §…n˘±…x……* 47¥…” 2012-2013 6 ∫…i…∆§…Æ˙, 2012 +{…Æ˙…ºx… 4.00 §…V…‰ x…<« n˘±±…“ x…Ω˛” ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 86 12. Details of remuneration paid to Functional directors for the year ended 31st March, 2014 Sl. No Name of Director Position Total Remuneration (` in lakh) 1 Dr. M. Ayyappan Chairman & Managing Director 42.16 2 Sri. K.K. Suresh Kumar Director (Marketing) 25.78 (Ceased as Director on 12th December 2013) 3 Sri. R.P. Khandelwal Director (Finance) 32.64 4 Dr. K R S Krishnan Director (Technical & Operation) 26.48 13. Information to be placed before the Board of Directors The Board has complete access to any information within the Company. The information inter alia, regularly supplied to the Board includes: a) Annual operating plans and budgets and any updates. b) Annual Accounts, Directors’ Report, etc. c) Quarterly results of the company. d) Minutes of meetings of audit committee and other committees of the Board including minutes of Subsidiary Company and Joint-venture Company. e) Major Investments, formation of Subsidiaries and Joint Ventures, Strategic Alliances, etc. f) Award of large Contracts. g) Disclosure of Interest by Directors about directorship and committee positions occupied by them in other Companies. h) Monthly Report on Commercial Status of the Company. i) Report on the status of various ongoing projects/Scheme and Budget Utilization. j) Any significant development in Human Resources/ Industrial Relations front like signing of wage agreement, etc. k) Non-compliance of any regulatory, statutory or listing requirements and shareholders’ service such as non-payment of dividend, delay in share transfer etc. l) Other materially important information. 14. Post meeting follow-up system: The Governance process in the Company include an effective post-meeting follow-up, review and reporting process for action taken/pending on decisions of the Board and the Board Committee(s). 15. Shareholding Pattern HLL is not listed at any Stock Exchange in India or abroad. The entire paid up equity share capital of the Company is held by the President of India and his nominees. 16. General Body meetings: The Date, Time and Venue of the last three Annual General Meetings of the Company are as follows: AGM Financial Date Time Venue Whether Special Year Resolution(s) Passed or Not 45th 2010-2011 6th Sept., 2011 12.00 Noon New Delhi No 46th 2011-2012 24th Sept.,2012 02.30 p.m. New Delhi Yes, to alter Articles of Association enabling buyback of shares of the Company 47th 2012-13 6th Sept.,2013 04.00 p.m. New Delhi No Annual Report 2013-2014 87 E∆Ú{…x…“ E‰Ú 48¥…” ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ E‰ÚÚ i……Æ˙“J…, ∫…®…™… +…ËÆ˙ ∫l……x…* i……Æ˙“J… ∫…®…™… ∫l……x… 28/08/2014 +{…Æ˙…ºx… 3.30 §…V…‰ i…Ø˚¥…x…∆i…{…÷Æ˙®… 17. |…EÚ]ı“EÚÆ˙h…: • ¥…π…« 2013-14 E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ +…ËÆ˙ =∫…E‰Ú ∫…®…x…÷π…∆ M…™……Â, B∫……‰ ∫…™…‰]…‰∆,ı ®…÷J™… |…§…∆v…EÚ“™… Eڅî…EÚ…Â E‰Ú §…“S… E‰Ú ±…‰x…-n‰˘x… EÚ… ¥…¥…Æ˙h…, 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ¥……Ãπ…EÚ ±…‰J…‰ EÚ“ ]ı{{…h…“ E‰Ú ®…n˘ ∫…∆. 24 ®… n˘™…‰ V……i…‰ ΩÈ˛ * ¥……Ãπ…EÚ {…Æ˙“ I…i… ¥…k…“™… E∆Ú{…x…“ +{…x…‰ ±…‰J……+… E‰Ú ¥……Ãπ…EÚ {…Æ˙“ I…i… ±…‰J…… ¥…¥…Æ˙h… EÚ…™……«±…™… E‰Ú ¥…‰§…∫……<]ı ¥…¥…Æ˙h… www.lifecarehll.com ®… |…EÚ… ∂…i… EÚÆ˙i…“ Ω˲* ∫…®……S……Æ˙ ¥…Y…Œ{i… EÚ…™……«±…™… x™…⁄W… |…±…‰J… E∆Ú{…x…“ E‰Ú ®…… ∫…EÚ EÚ…Ï{……ÊƉ˙]ı x™…⁄W… ±…‰]ıÆ˙, j…Ë®…… ∫…EÚ EÚ…Ï{……ÊƉ˙]ı x™…⁄W… {… j…EÚ…+… E‰Ú ®……v™…®… ∫…‰ |…EÚ… ∂…i… EÚ™…‰ V……i…‰ ΩÈ˛ +…ËÆ˙ EÚ…™……«±…™… E‰Ú ¥…‰§…∫……<]ı www.lifecarehll.com {…Æ˙ |…n˘Ã∂…i… EÚ“ V……i…“ Ω˲* ¥…‰§…∫……<]ı E∆Ú{…x…“ E‰Ú EÚ…Ï{……ÊƉ˙] ¥…‰§…∫……<]ı www.lifecarehll.com =i{……n˘… , ¥™……{……Æ˙ I…‰j……Â, +…M……®…“ {… Æ˙™……‰V…x……+… +… n˘ E‰Ú §……Ɖ˙ ®… ¥…∫i…fii… V……x…EÚ…Æ˙“ |…n˘…x… EÚÆ˙i…… Ω˲* ¥……Ãπ…EÚ Æ˙{……‰]«ı E∆Ú{…x…“ E‰Ú ¥……Ãπ…EÚ Æ˙{……‰]«ı ∂…‰™…Æ˙v……Æ˙EÚ…Â, ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J…… {…Æ˙“I…EÚ +…ËÆ˙ ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â +… n˘ V…Ë∫…‰ +x™… ∫…¶…“ +∆∂…v…… Æ˙™…… EÚ…‰ {… Æ˙S…… ±…i… EÚ“ V……i…“ Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 88 Date, Time and Venue of 48th Annual General Meeting of the Company Date Time Venue 28/08/2014 3.30 pm Thiruvananthapuram 17. Disclosures: • Details of transactions between the Company and its subsidiaries, associates, key managerial personnel during the year 2013-14 are given in Point no. 24 of the Notes to the Annual Accounts for the year ended 31 March, 2014. These transactions do not have any potential conflict with the interests of the Company at large. • There were no cases of non-compliance by the company and penalties, strictures imposed on the company by any statutory authority on any statutory payment requirements. • Presidential directives issued by the Central government in respect of Official Language Implementation have been complied with during the year and also in the last three years. • The Company has followed all relevant Accounting Standards notified by the Companies (Accounting Standards) Rules, 2006 while preparing the Financial Statements. • There were no items of expenditure debited in books of accounts, which are not for the purposes of the business. 18. Other Information 18.1. Training of Directors: The Company has adopted Guidelines on Corporate Governance May 2010 issued by Department of Public Enterprise. Based on the DPE guidelines the company has adopted Training policy for board members. During the year under review, the directors of the Company attended training sessions as mentioned below. • Director (Finance) attended 3-days training session of 17th CEOs Conference on the theme “Global Competitiveness: India in Retrospect & Prospects” conducted by Indian Institution of Industrial Engineering, Navi Mumbai. • Mr. K.Mohandas, 3 day training conducted by Institute of Directors at Bengaluru. • Mr. Sanjiv Kapoor, training programme organized by DPE for Independent Directors at New Delhi. 18.2. Means of communication: Annual Audited The Company publishes its annual audited statement of accounts in the official Financial website www.lifecarehll.com Statements News Releases Official news releases are published through Company's Monthly Corporate News letters, Quarterly Corporate News Magazines and displayed on the Company's website www.lifecarehll.com Website The Company's Corporate Website www.lifecarehll.com provides comprehensive information about the products, business segments, upcoming Projects etc. Annual Report The Annual Report of the Company is circulated to the shareholders, Ministry of Health & Family Welfare, Comptroller and Auditor General of India and all others entitled thereto like Statutory Auditors etc. Annual Report 2013-2014 89 18.3 ∫…∆™…∆j… ∫l……x… ¥… x…®……«h… ∫…∆™…∆j… EÚ… x……®… +…ËÆ˙ ∫l……x… {…i…… M…¶…« x…Æ˙…‰v…EÚ {…‰∞¸Æ˙EÚb˜˜ °ËÚC]ıÆ˙“, BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ i…Ø˚¥…x…∆i…{…÷Æ˙®… {…‰∞¸Æ˙EÚb˜˜… °ËÚC]ıÆ˙“, {…‰∞¸Æ˙EÚb˜˜… ({…“ B°Ú ]ı“), E‰ÚÆ˙±… i…Ø˚¥…x…∆i…{…÷Æ˙®… - 695005 +∫{…i……±… =i{……n¢ +…CE÷Ú±…®… °ËÚC]ıÆ˙“ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ i…Ø˚¥…x…∆i…{…÷Æ˙®… +…CE÷Ú±…®… °ËÚC]ıÆ˙“, +…CE÷Ú±…®…, (BB°Ú]ı“), E‰ÚÆ˙±… i…Ø˚¥…x…∆i…{…÷Æ˙®… - 695017 M…¶…« x…Æ˙…‰v…EÚ EÚ…CEÚx……c˜ °ËÚC]ıÆ˙“ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ EÚ…‰ŒSS…, (E‰ÚB°Ú∫…“), E‰ÚÆ˙±… EÚ…‰ S…x… ∫{…‰∂…±… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 90 19.3 Plant Locations Manufacturing Plant Name and Location Address Contraceptives Peroorkada Factory, HLL Lifecare Ltd. Thiruvananthapuram Peroorkada Factory, Peroorkada (PFT), Kerala Thiruvananthapuram-695005 Hospital Products Akkulam Factory, HLL Lifecare Ltd. Thiruvananthapuram, Akkulam Factory, Akkulam (AFT), Kerala Thiruvananthapuram-695017 Contraceptives Kakkanad Factory HLL Lifecare Ltd. Kochi, (KFC), Kerala Cochin Special Economic Zone Division, Plot No. 16A/1 Kakkanadu, Cochin-682037 Contraceptives and Kanagala Factory, Belgaum, HLL Lifecare Ltd. Pharma Products (KFB), Karnataka Kanagala Factory, Belgaum Karnataka-591225 Hospital Products Manesar Factory, Gurgaon, HLL Lifecare Ltd. (MFG), Hariyana Manesar Unit, Plot No. 71 Sector Gurgaon, Hariyana-122050 Pharma Products Sanver Road Factory HLL Lifecare Ltd. Indore, Madhya Pradesh (SFI) Sector-E, Sanver Road, Industrial Area Indore-Madhya Pradesh Contraceptives Irapuram Factory, Cochin, HLL Lifecare Ltd. (IFC), Kerala Re-Survey No. 156/3, Block No. 29 Rubber Park, Valayanchirangara Irapuram, Cochin-683 556 Annual Report 2013-2014 91 B•…Ω…˛®… Bhb˜ V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ˙, IX/467, ®…∂…x… C¥……]Êı∫…« Æ˙…‰c˜ i…fi∂∂…⁄Æ˙ - 680001 n⁄˘Æ˙¶……π… : 0487-2423225, 2426225, °ËÚC∫… : 2424245 <«-®…‰±… : [email protected] ¥…‰§…∫……<]ı : www.abrahamandjose.com n˘.: 09.07.2014 +x…÷{……±…x… |…®……h…-{…j… ∫…‰¥…… ®… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú ∫…n˘∫™… Ω˛®…x…‰ n˘x……∆EÚ 14 ®…<«, 2010 EÚ‰ b˜“ {…“ <« EÚ….Y…….∫…∆.18(8)/2005-V…“ B®… u˘…Æ˙… +x…÷§…∆v… 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… EÚ“ ∂…i……Á E‰Ú +x…÷{……±…x… EÚ“ V……ƒS… EÚ“ Ω˲* EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… EÚ“ ∂…i……Á E‰Ú +x…÷{……±…x… EÚÆ˙x…… |…§…∆v… EÚ… =k…Æ˙n˘… ™…i¥… Ω˲* Ω˛®……Æ˙“ V……ƒS… EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… EÚ“ ∂…i……Á EÚ…‰ ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B E∆Ú{…x…“ u˘…Æ˙… ∫¥…“EfiÚi… EÚ…™…«{…r˘ i…™…… +…ËÆ˙ EÚ…™……«x¥…™…x… i…EÚ ∫…“ ®…i… l…“* ™…Ω˛ E∆Ú{…x…“ E‰Ú˙ ¥…k…“™… ¥…¥…Æ˙h…… EÚ“ ±…‰J……{…Æ˙“I…… ™…… ®…i… EÚ“ + ¶…¥™… HÚ x…Ω˛” Ω˲* Ω˛®……Æ˙“ Æ˙…™…˙ +…ËÆ˙ Ω˛®… n˘B ¥…¥…Æ˙h…… {…Æ˙ +{…x…“ =k…®… ∫…⁄S…x…… E‰Ú +x…÷∫……Æ˙ Ω˛®… |…®…… h…i… EÚÆ˙i…‰ ΩÈ˛ EÚ E∆Ú{…x…“ x…‰ >{…Æ˙ =Œ±±… J…i… b˜“ {…“ <« EÚ….Y…… ®… +x…÷§…∆v…˘ EÚ…Ï{……ÊƉ˙]ı + ¶…∂……∫…x… EÚ“ ∂…i……Á EÚ… ¶…Æ˙{…⁄Æ˙ +x…÷{……±…x… EÚ™…… Ω˲* +…M…‰ Ω˛®… ∫{…π]ı EÚÆ˙i…‰ ΩÈ˛ EÚ B‰∫…… +x…÷{……±…x… x… i……‰ E∆Ú{…x…“ E‰Ú ¶… ¥…π™… EÚ“ ¥™…¥…Ω˛…™…«i…… E‰Ú ±…B BEÚ +…∑……∫…x… Ω˲ x… Ω˛“ EÚ…™…«˘I…®…i…… ™…… |…¶……¥…EÚ… Æ˙i…… V…∫…E‰Ú ∫……l… |…§…∆v…x… x…‰ E∆Ú{…x…“ E‰Ú EÚ…™……Á EÚ…‰ S…±……™…… Ω˲* EfiÚi…‰ B•…Ω˛…®… Bhb˜ V……‰∫…, ∫…x…n˘“ ±…‰J……EÚ…Æ˙ ∏…“. ∫…“.B. V……‰∫… {……‰^ı…‰EÚ…Æ˙x… ∫……Z…‰n˘…Æ˙ ∫…n˘∫™…i…… ∫…∆. 012056B∫… B°Ú.+…Æ˙.x…∆. 000010B∫… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 92 ABRAHAM & JOSE CHARTERED ACCOUNTANTS IX/467, MISSION QUARTERS ROAD, THRISSUR-680001 PHONE : 0487-2423225, 2426225 FAX : 2424245 E-mail : [email protected] Website: www.abrahamandjose.com 09.07.2014 COMPLIANCE CERTIFICATE To The Members of HLL Lifecare Limited We have examined the compliance of conditions of Coporate Governance by HLL Lifecare Limited for the financial year ended on 31st March 2014, as stipulated by DPE OM No. 18 (8)/2005-GM dated 14th May 2010. The compliance of the conditions of Coporate Governance is the responsibility of the management. Our examination was limted to prcocedures and implementation thereof, adopted by the company for ensuring the conditions of Corporate Governance. It is neither an audit nor an expression of opinion on the financial statements of the company. In our opinion and to the best of our information to the explanation given to us, we certify that the Company has complied with the conditions of Corporate Governance as stipulated in the above mentioned DPE O.M. We further state that such compliance is neither an assurance as to the future viability of the Company nor the efficiency or effectiveness with which the management has conducted the affairs of the Company. For M/s Abraham & Jose, Chartered Accountants Shri. CA Jose Pottokaran Partner, M.No. 012056S F.R. No. 000010S Annual Report 2013-2014 93 III. |…§…∆v…x… EÚ“ S…S……« +…ËÆ˙ ¥…∂±…‰π…h… 1. =t…‰M… ¥…∂±…‰π…h… 1.1.M…¶…« x…Æ˙…‰v…EÚ B∫… ]ı“ b˜“ ∫…‰ ∫…÷Æ˙ I…i… Æ˙Ω˛x…‰ EÚ“ +…‰Æ˙ ™…÷¥…… {…“g¯“ u˘…Æ˙… E∆Úb˜…‰®… E‰Ú ={…™……‰M… ®… ¥…fi r˘ E‰Ú ∫……l…-∫……l… §…g¯i…“ ®……Ë∫…®…“ §…GÚ“ E‰Ú EÚ…Æ˙h… ¥…… h…V™…EÚ ¥…{…h…x… E∆Úb˜…‰®… J…∆b˜ x…‰ ™……‰M…n˘…x… EÚ“ |… i…∂…i…i…… ®… ¥…fi r˘ |…n˘Ã∂…i… EÚ“ Ω˲ * ¶……Æ˙i…“™… +…{……i…EÚ…±…“x… M…¶…« x…Æ˙…‰v…EÚ M……‰ ±…™…… EÚ… §……W……Æ˙ ¥…k…“™… ¥…π…« 2015 i…EÚ 33.1% ∫…“ B V…“ +…Æ˙ i…EÚ {…Ω÷ƒ˛S…x…‰ EÚ“ =®®…“n˘ EÚ“ V……i…“ Ω˲ * ¥……∫i…¥… ®… ¥…Ë ∑…EÚ E∆Úb˜…‰®… §……W……Æ˙ 2014-2018 ∫…‰ 8.39% ∫…“ B V…“ +…Æ˙ E‰Ú ∫……l… E÷ÚUÙ ¥…fi r˘ EÚ… ∫……®…x…… EÚÆ˙ Æ˙Ω˛… Ω˲ * °ÚÆ˙ ¶…“ ¥…Ω˛…ƒ +§… ¶…“ ¥…Ë ∑…EÚ E∆Úb˜…‰®… §……W……Æ˙ ®… E÷ÚUÙ EÚ…Æ˙EÚ S…÷x……Ëi…“ n‰˘ Æ˙Ω‰˛ ΩÈ˛ * EÚ<« O……®…“h… I…‰j…… ®… v……î…EÚ ¥…∑……∫…, ∫……®…… V…EÚ EÚ±…∆EÚ +…ËÆ˙ ∂…I…… EÚ… +¶……¥… Æ˙…‰M… x…Æ˙…‰v…EÚ E‰Ú |…∫……Æ˙ ®… M…∆¶…“Æ˙i…… ∫…‰ §……v…… b˜…±…i…‰ ΩÈ˛ * ∫{…‰C]≈ı®… E‰Ú n⁄˘∫…Ɖ˙ UÙ…‰Æ˙ {…Æ˙, +x™… M…¶…« x…Æ˙…‰v…EÚ {…r˘ i… EÚ… ¥…Ãv…i… V……M…∞¸EÚi…… ¶…“ M……‰-]÷ı M…¶…« x…Æ˙…‰v…EÚ E‰Ú ∞¸{… ®… E∆Úb˜…‰®… EÚ“ ±……‰EÚ |…™…i…… ®… |…¶…… ¥…i… EÚÆ˙i…… Ω˲ * i…l…… {…, E∆Úb˜…‰®… ∫…∫i…… Ω˲, ={…™……‰M… EÚÆ˙x…‰ ®… +…∫……x… +…ËÆ˙ ±…M…¶…M… Ω˛Æ˙ V…M…Ω˛ {…Æ˙ ∫…÷±…¶… Ω˲ * <∫…EÚ“ ™…Ω˛ + ¶…M…®™…i…… +…M……®…“ ¥…π……Á ®… §……W……Æ˙ EÚ“ ¥…fi r˘ E‰Ú ±…B ∫…Ω˛…™…EÚ Ω˛…‰M…“ * x…∫…§…∆n˘“ ¶……Æ˙i…“™… M…¶…« x…Æ˙…‰v…EÚ §……W……Æ˙ EÚ…‰ +§…i…EÚ Ω˛…¥…“ EÚÆ˙i…“ Ω˲ * M……‰ ±…™…… +…ËÆ˙ E∆Úb˜…‰®…… EÚ“ ®……ƒM… ®… + v…EÚ…∆∂… ¥…fi r˘ |……<¥…]ı I…‰j… ®… P… ]ıi… Ω˛…‰M……˛ * 1.2 °Ú…®…«∫™…⁄ ]ıEÚ±∫… ¶……Æ˙i…“™… °Ú…®…«∫™…⁄ ]ıEÚ±… =t…‰M… ¥…i…«®……x… ®… +…Ëπ…v… ¥… x…®……«h… +…ËÆ˙ i…EÚx……ϱ…V…“ E‰Ú V… ]ı±… I…‰j… ®… ¥™……{…EÚ I…®…i……+… E‰Ú ∫……l… ¶……Æ˙i… E‰Ú ¥…Y……x… +…v…… Æ˙i… =t…‰M…… E‰Ú §…“S… S……]«ı ®… ∫…§…∫…‰ >{…Æ˙ Ω˲ * ¶……Æ˙i…“™… °Ú…®…«∫™…⁄ ]ıEÚ±… =t…‰M… i…EÚx……ϱ…V…“, M…÷h…¥…k…… +…ËÆ˙ ¥… x…î…i… n˘¥……+… EÚ“ ¥…∫i…fii… ∏…‰h…“ E‰Ú +x…÷∫……Æ˙ ∫…¶…“ i…“∫…Æ˙“ n÷˘ x…™…… E‰Ú n‰˘∂…… E‰Ú §…“S… ®… §…Ω÷˛i… =SS… ÆÈ˙EÚ {…Æ˙ Ω˲ * ¥… x…®……«h… ∫…÷ ¥…v……+… E‰Ú ∫…÷v…Ɖ˙ ¥… x…™……‰M… P…Ɖ˙±…⁄ °Ú…®…«∫™…⁄ ]ıEÚ±… §……W……Æ˙ =SS… Æ˙…V…∫¥… ¥…fi r˘ +…ËÆ˙ ±……¶… ®……ÃV…x… n‰˘J… V……x…‰ EÚ“ ∫…∆¶……¥…x…… Ω˲ * "2014 M±……‰§…±… ±……<¢Ú ∫…… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 94 III. MANAGEMENT DISCUSSION AND ANALYSIS 1. INDUSTRY ANALYSIS 1.1. Contraceptives The commercial marketing condom segment has showcased growth in percentage contribution due to rise in the seasonal sales as well as surge in the usage of condom by the young generation in order to stay safe from STD. The market of the Indian emergency contraceptive pills is expected to reach CAGR of 33.1% by the FY’2015. The Global Condom Market is actually experiencing some growth with a CAGR of 8.39 percent from 2014-2018. Even so, there are still some factors that are challenging the global condom market. In many rural areas religious beliefs, social stigma and lack of education all seriously hamper the proliferation of prophylactics. On the other end of the spectrum, increased awareness of other contraception methods is also impacting the popularity of condoms as a go-to contraceptive. However, Condoms are cheap, easy to use and accessible nearly everywhere. It is this accessibility that will contribute to the growth of the market over the coming years. Sterilisations dominate the Indian contraceptive market to date. Most of the growth in the demand for pills and condoms will occur in the private sector. 1.2. Pharmaceuticals: The Indian Pharmaceutical Industry currently tops the chart amongst India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. The Indian Pharmaceutical Industry ranks very high amongst all third world countries, in terms of technology, quality and the vast range of medicines that are manufactured. On improved utilization of manufacturing facilities, the domestic pharmaceutical market is likely to see high revenue growth and profit margins. Pharmaceutical sales in India are expected to grow by 14.4 per cent to US$ 27 billion in, according to a report by Deloitte called ‘2014 Global Life Sciences Outlook’. India’s pharmaceutical exports stood at US$ 14.84 billion in FY 2013–14. The United States (US) is the country’s biggest market for pharma exports accounting for about 25 per cent, followed by the United Kingdom (UK). India has been able to make its name as a quality supplier of affordable medicines across the globe. Around 12 per cent growth is expected this fiscal (2014– 15). Pharma exports from India will be more than the size of the domestic sales by FY 2015, according to a report by India Ratings & Research. The country provides generic medicines to almost 200 countries. It is responsible for about 40 per cent of the generic and over-the-counter drugs consumed in the US. Indian generics market is expected to grow to US$ 26.1 billion by 2016. Increasing number of Indian pharmaceutical companies have been getting international regulatory approvals for their plants from agencies like USFDA (USA), MHRA (UK), TGA (Australia), MCC (South Africa), Health Canada etc. India has the largest number of USFDA-approved plants for generic manufacture. Considering that the pharmaceutical industry involves sophisticated technology and stringent “Good Manufacturing Practice (GMP) requirements, major share of Indian Pharma exports going to highly developed western countries bears testimony to not only the excellent quality of Indian pharmaceuticals but also its price competitiveness. An increase in insurance coverage, an ageing population, rising income, greater awareness of personal health and hygiene, easy access to high-quality healthcare facilities and favourable government initiatives are some of the important factors expected to drive the pharma industry in India. The Government of India has unveiled ‘Pharma Vision 2020’ aimed at making India a global leader in end-to-end drug manufacturing.100 per cent Foreign Direct Investment (FDI) is allowed under automatic route in the drugs and pharmaceuticals sector including those involving use of recombinant technology. Also, FDI, up to 100%, is permitted for brownfield investments (i.e. investments in existing companies), in the pharmaceuticals sector, under the Government approval route. 1.3. Medical Products Manufacture India today is an attractive low cost destination for Medical Technology manufacturing. Soon India will be able to demonstrate its capabilities as an alternate manufacturing destination to China for many medical products. Access to healthcare is improving in India because hike in expenditure by the central and state governments on the provision of healthcare. Privatization of insurance sector has opened avenues for several private healthcare insurance companies. These are the two major factors driving the growth of Indian medical device market. Indian Medical Equipment industry has a bright future in India with most of the segments experiencing Compounded Annual Growth Rate (CAGR) of over 15-20 per cent. India has an abundant talent pool in the areas of medicine, engineering and information technology. This, combined with infrastructure and labour arbitrage, Annual Report 2013-2014 95 EÚ… ∫……®…x…… EÚÆ˙x…‰ E‰Ú ∫……l… ¶……Æ˙i…“™… ®…‰ b˜EÚ±… ={…EÚÆ˙h… =t…‰M… EÚ…‰ ¶……Æ˙i… ®… =VV¥…±… ¶… ¥…π™… Ω˲ * ¶……Æ˙i… EÚ…‰ S… EÚi∫……, <∆V…“ x…™…ÀÆ˙M… +…ËÆ˙ |……Ët…‰ M…EÚ“ E‰Ú I…‰j…… ®… |…S…÷Æ˙ |… i…¶…… {…⁄±… Ω˲ * ™…Ω˛ +¥…∫…∆Æ˙S…x…… +…ËÆ˙ ∏…®… ¥…¥……S…x… E‰Ú ∫……l…, EÚ<« ¥…Ë ∑…EÚ E∆Ú{… x…™…… E‰Ú ±…B S… EÚi∫…… ={…EÚÆ˙h… ¥… x…®……«h… EÚ“ +…‰Æ˙ ¶……Æ˙i… EÚ…‰ ¥…Æ˙“™… M…∆i…¥™… §…x……™…‰M…… * EÚ®… ±……M…i… ¥… x…®……«h… +M…±…‰ 5-10 ¥…π…« ∫…®…™… ∫…‰ ¶……Æ˙i… ®… EÚ®… ∫¥……∫l™…Æ˙I…… ¥…i…Æ˙h… ±……M…i… ®… W…∞¸Æ˙ §…n˘±… V……BM…… * 1.4 ∫¥……∫l™…Æ˙I…… +¥…∫…∆Æ˙S…x…… ¶……Æ˙i… ¥…π……Á ∫…‰ ∫…∂…HÚ +l…«¥™…¥…∫l…… E‰Ú ∞¸{… ®… =¶…Æ˙ +…™…… Ω˲ * i…l…… {…, =SS… ¥…fi r˘ S…Æ˙h… EÚ“ ®…÷J™… EÚ ®…™…… ®… BEÚ Ω˲, +…Ãl…EÚ ¥…fi r˘ ∫…®……x… ∞¸{… ∫…‰ ¥…i… Æ˙i… x…Ω˛” EÚ“ M…™…“ Ω˲* |…i™…I… +¥…∫…∆Æ˙S…x…… EÚ“ n˘™…x…“™… +¥…∫l…… ®… ®……j…… +…ËÆ˙ M…÷h…¥…k…… n˘…‰x…… E‰Ú ∞¸{… ®… +…Ãl…EÚ ¥…EÚ…∫… EÚ“ Œ∫l…Æ˙i…… E‰Ú ∫…∆§…∆v… ®… +…M…‰ ¶…“ = r˘Mx…i…… =`ˆ…™…“ Ω˲ * E÷ÚUÙ ®…÷J™… ¥…EÚ…∫… I…‰j…… E‰Ú {…⁄h…« ¥…EÚ…∫… I…®…i…… E‰Ú EÚ…™……«x¥…™…x… E‰Ú ®……v™…®… ∫…‰ ®……j… +…Ãl…EÚ ¥…EÚ…∫… ®… |… i… GÚ™…… |……{i… EÚ™…… V…… ∫…EÚi…… Ω˲ * ¥…∂±…‰π…EÚ…Â x…‰ ®…÷J™… ¥…EÚ…∫… S……±…EÚ…Â E‰Ú ∞¸{… ®… |…i™…I… +…ËÆ˙ ∫……®…… V…EÚ +¥…∫…∆Æ˙S…x…… ®… {…™……«{i… x…¥…‰∂…… EÚ…‰ {…Ω˛S……x… EÚ“ Ω˲, V……‰ '∫…®…O… ¥…EÚ…∫…" Ω˛… ∫…±… EÚÆ˙x…‰ E‰Ú ±…B +l…«¥™…¥…∫l…… EÚ…‰ ∫…I…®… EÚƉ˙M…… * ™…t {… ¥…t®……x… n˘∂…EÚ (2011-20) E‰Ú n˘…ËÆ˙…x… ™…‰ n˘…‰ EÚ…Æ˙EÚ ¶……Æ˙i… E‰Ú ¥…EÚ…∫… ™……j…… ®… ®…Ω˛i¥…{…⁄h…« ™……‰M…n˘…x… n‰˘x…‰ EÚ“ =®®…“n˘ EÚ™…… V……i…… Ω˲, +x™… EÚ…Æ˙EÚ…Â (i…EÚx……ϱ… V…EÚ±… ¥…fi r˘, =i{……n˘EÚi…… +…ËÆ˙ ¶……Æ˙i… EÚ“ ™…÷¥…… V…x…∫……∆ŒJ™…EÚ“ ®… ∫…÷v……Æ˙ +… n˘) EÚ“ ¶…⁄ ®…EÚ… EÚ…‰ +x…b˜“Ɖ˙]ı x…Ω˛” EÚ™…… V……BM…… * +…M…‰, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ (V…“ +…‰ +…<«) +…ËÆ˙ x…V…“ I…‰j… EÚ…‰ +∆i… Æ˙®… §…V…]ı E‰Ú +¥…±……‰EÚx……v…“x… ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… |…EÚ… ∂…i… §…V…]ı Ω˛…<±……<]¬ı∫… 2014 E‰Ú +x…÷∫……Æ˙ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ ®…∆j……±…™… E‰Ú {…I… ®… ` 33,725 EÚÆ˙…‰c˜ E‰Ú +x…÷®……x… E‰Ú ∫……l… ¥…k… ¥…π…« ` 555,322 EÚÆ˙…‰c˜ +…ËÆ˙ M…ËÆ˙-™……‰V…x…… ¥™…™… ` 12,07,892 ®… i…™… EÚ™…… M…™…… Ω˲ * ¥…k…“™… ¥…π…« 2014-15 E‰Ú ±…B ∫¥……∫l™…Æ˙I…… I…‰j… ®… ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… +x…÷®…… x…i… x…¥…‰∂… +…ËÆ˙ ¥™…™… {…Æ˙ ¥…S……Æ˙ EÚÆ˙i…‰ Ω÷˛B, ∫…‰¥…… ¥™…¥…∫……™… EÚ“ ∫…∆¶……¥…x……B∆ +l……«i…¬ E∆Ú{…x…“ E‰Ú +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… +…ËÆ˙ |……{…h… {…Æ˙…®…∂…« +…∂……V…x…EÚ |…i…“i… Ω˛…‰i…… Ω˲ * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 96 will make India a preferred destination for Medical Equipment manufacturing for many global companies. Low cost manufacturing should definitely translate into lower healthcare delivery cost in India in the next 5- 10 years time. 1.4. Healthcare Infrastructure India has emerged as a strong economy over the years. However, one of the major drawbacks of high growth phase has been the benefit of economic growth not been equitably distributed. The poor state of the physical infrastructure, both in terms of quantity and quality has further raised concerns regarding the sustainability of economic growth. Rebound in economic growth can only be achieved through realization of full-growth potential of some key growth areas. Analysts have identified substantial investments in physical and social infrastructure as the key growth drivers which will enable the economy to achieve ‘inclusive growth’. Although these two factors is expected to contribute significantly to India’s growth story during the current decade (2011-20), the role of other factors (such as technological progress, improvement in productivity and India’s young demography, etc.) should not be underrated. Further, Government of India (GoI) and the private sector need to undertake necessary integrated efforts to strengthen these growth drivers and achieve high GDP growth. Improvement in social infrastructure (especially health & sanitation and education) will play a key role in achieving inclusive growth over the coming years. Since investment in social infrastructure is necessary condition for attaining higher economic growth, the Government has over the years scaled up investment in social infrastructure. GoI is making major efforts to encourage private investments in infrastructure projects. As a result, the share of the private sector in infrastructure financing gradually increased from a mere 25.5% in FY05 to 39.4% in FY12 and is expected to increase further to 48% in FY20. During the current decade, private investment in the form of Public Private Partnership (PPP) is expected to emerge as the preferred mode of investment in commercially-viable infrastructure projects particularly in healthcare projects. 1.5. Healthcare Services Improvement in health involves improving access and utilization of health, family welfare and nutrition services with special focus on under-served and under- privileged population. It is expected that during the current decade (2011-20) as well, the responsibility of implementing healthcare and sanitation programmes will mainly lie with the state government and local bodies while financial assistance will be provided by the central government and external agencies. Total healthcare financing by the public sector in India is low. However, over the years, India’s share of public expenditure in total health outlay has been increasing steadily. The 12th plan has brought about sweeping changes in the healthcare sector with focus on streamlining expenditure under the National Health Mission (NHM), introduction of district-wise pilots of Universal Health Coverage (UHC), the creation of a public health cadre and providing free medicines through a central procurement agency. These measures, if suitably implemented, can potentially have a lasting impact on India’s medium and long-term growth prospects. According to relevant forecasts, total government expenditure on health is expected to inch up to 2.2% of GDP in financial year 2019-20. As per the budget highlights 2014-15 published by the Government of India, under the interim budget overview, the plan expenditure for the coming fiscal has been fixed at `555,322 crores and non-plan expenditure at `12,07,892 crores with an estimate of `33,725 crores in favour of Ministry of Health and Family. Considering the investment and expenditure projected by the Government of India in the healthcare sector for the financial year 2014-15, the prospects of services business viz. infrastructure development and procurement consultancy of the Company appears promising. Annual Report 2013-2014 97 1,050.31 2013-14 773.40 1,402.68 1,840.35 1,002.33 2010-11 2011-12 2012-13 §…g¯ M…™…… Ω˲* M…™…… §…g¯ 1,279.07 1,439.22 1,581.47 2,084.96 2,375.87 2009-10 % 19,835.30 22,652.84 23,013.02 25,998.71 32,290.70 35,771.72 715.13 896.61 768.01 905.92 2005-06 2006-07 2007-08 2008-09 1850 1845 1917 1880 1927 1922 1939 1900 1875 1831 23.27 26.57 26.57 9.98 10.00 15.00 15.00 15.00 2.00 2.00 573.90115.98 613.78 49.25 661.18 272.50 733.07 447.10 899.59 920.64 756.05 524.37 775.83 361.56 412.80 412.80 155.00 155.35 233.03 233.03 233.03 387.07 387.07 1,361.37 1,206.34 1,004.10 4,061.83 3,777.91 3,684.56 3,323.12 3,474.66 4,296.52 4,713.00 5,413.68 7,268.51 7,839.87 2004-05 2,010.58 1,908.54 1,746.78 1,427.821,553.50 757.83 1,553.506,583.30 1,493.49 1,553.50 8,174.228,136.80 1,843.49 1,553.50 9,442.66 9,727.72 2,054.05 10,688.95 1,553.50 10,996.16 3,007.47 11,249.99 12,242.45 1,553.503,743.71 12,470.75 2,570.77 12,803.50 3,889.58 1,553.50 14,042.50 14,024.25 15,912.59 1,553.50 4,624,37 15,596.00 18,468.10 17,466.09 19,353.50 20,586.01 6,470.55 19,353.50 37,821.60 10,831.22 39,939.51 12,479.05 13.255.75 16,252.62 21,958.17 25,663.52 19,620.49 21,288.5821,054.51 24,348.17 22,545.66 32,850.88 28,906.99 36,641.86 35,004.89 44,006.29 38,188.29 53,310.62 46,548.03 60,900.68 83,294.11 54,119.85 61,893,02 94,168.16 84,000.45 95,368.83 10,249.79 10,944.04 12,313.04 14,807.07 15,002.34 17,375.65 26,474,48 28,795.82 39,135.12 38,447.93 52,661.89 58,029.31 85,811.40 92,345.68 % x…¥…±… +S…±… {… Æ˙∫…∆{… k…™……ƒ +S…±… x…¥…±… ¥…¥…Æ˙h… ¥™……{……Æ˙…¥…k…« +…™… E÷Ú±… ®…⁄±™…ø…∫… §™……V… EÚÆ˙ ±……¶… §……n˘ E‰Ú EÚÆ˙ ±……¶……∆∂… <ŒC¥…]ı“ ±……¶……∆∂… EÚB J…S…« {…⁄ƒV…“ ∂…‰™…Æ˙ <ŒC¥…]ı“ +…Æ˙ I…i… +…ËÆ˙ + v…∂…‰π… ®…⁄±™… x…¥…±… {… Æ˙∫…∆{… k…™……ƒ +S…±… ∫…EÚ±… {… Æ˙∫…∆{… k…™……ƒ E÷Ú±… ∫…∆J™…… EÚ“ EÚ®…«S…… Æ˙™…… (<« §…“ b˜“ +…<« ]ı“) E‰Ú {…⁄¥…« +V…«x… {…⁄¥…« E‰Ú ]ı“) +…<« b˜“ §…“ (<« ®…⁄±™…ø…∫…,§™……V… +…ËÆ˙ EÚÆ˙ {…UÙ±…‰ 10 ¥…π……Á E‰Ú ±…B E∆Ú{…x…“ E‰Ú ∫…∆ I…{i… ¥…k…“™… {… Æ˙h……®… x…“S…‰ n˘B V……i…‰ ΩÈ˛ : ΩÈ˛ V……i…‰ n˘B x…“S…‰ {… Æ˙h……®… ¥…k…“™… ∫…∆ I…{i… E‰Ú E∆Ú{…x…“ ±…B E‰Ú ¥…π……Á 10 {…UÙ±…‰ ®…Â) ±……J…… Ø˚{…B˜ (+…ƒEÚb‰˜ Z…±…EÚ BEÚ E‰Ú x…π{……n˘x… E‰Ú ¥…π……Á n˘∫… 1.9.7 ®… i…÷±…x…… EÚ“ ¥™……{……Æ˙…¥…k…« E‰Ú 2012-13 ¥…π…« ¥™……{……Æ˙…¥…k…« ∫…‰ §…GÚ“) EÚ“ (=i{……n˘… Z…±…EÚ ¥™…¥…∫……™… x…π{……n˘x… ®…⁄±… ®…Â, 2013-14 ¥…π…« ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 98 2013-14 1402.68 1840.35 2009-10 2010-11 2011-12 2012-13 in Lakh) ` 1850 1845 1917 1880 1927 1922 1939 1900 1875 1831 23.27 26.57 26.57 9.98 10.00 15.00 15.00 15.00 2.00 2.00 361.56 412.80 412.80 155.00 155.35 233.03 233.03 233.03 387.07 387.07 2010.58 1908.54 1746.78 1427.821553.50 1553.506583.30 757.83 1553.50 8174.228136.80 1493.39 1843.49 9442.66 1553.50 9727.72 10996.16 10688.95 1553.50 2054.053743.71 11249.99 12242.45 3007.47 1553.50 3889.58 12470.75 12803.50 2570.77 14042.50 1553.50 14024.25 4624.37 15912.59 15596.00 1553.50 18468.10 6470.55 17466.09 19353.50 20586.01 10831.22 37281.60 19353.50 12479.05 39939.51 13255.75 16252.62 21958.17 25663.52 4061.83 3777.91 3684.56 3323.12 3474.66 4296.52 4713.00 5413.68 7268.51 7839.87 2004-05 2005-06 2006-07 2007-08 2008-09 10249.79 10944.04 12313.04 14807.07 19835.30 22652.84 23013.02 25998.71 32290.70 35771.72 19620.49 21288.5821054.51 24348.17 22545.66 32850.88 28906.99 36641.86 35004.89 44006.29 38188.29 53310.62 46548.03 60900.68 54119.85 83294.11 61893.02 94168.16 84000.45 95368.83 Description Dividend Payout Equity Dividend % Equity Share Capital Reserves and Surplus Net Worth Assets Gross Fixed Assets Net Fixed AssetsTotal Number of Employees 15002.34 17375.65 26474.48 28795.82 39135.12 38447.93 52661.89 58029.31 85811.40 92345.68 Tax Profit After Tax 1361.37 1206.34 1004.10 715.13 896.61 768.01 905.92 1002.33 773.40 1050.31 Turnover Income Total Earnings Before Depreciation, Interest (EBDIT) and Tax DepreciationInterest 573.90 613.78 115.98 661.18 49.25 733.07 272.50 899.59 1279.07 447.10 1439.22 920.64 1581.47 756.05 2084.96 2375.87 524.37 775.83 1. PERFORMANCE SNAPSHOT in year 2012-13. In year 2013-14, the turnover from Core business (sale of products) has grown by 9.7% as compared with corresponding The summarized financial results of the company for last 10 years are given below: year’s performance at a glance (Figures Ten Annual Report 2013-2014 99 3. |…i™…I… x…π{……n˘x… BS…B±…B±… ¥…∑… ¶…Æ˙ E‰Ú M…¶…« x…Æ˙…‰v…EÚ =i{……n˘… EÚ“ ∏…‰h…“ E‰Ú +O…h…“ ¥… x…®……«i…… B¥…∆ ¥…{…h…x…EÚi……« Ω˲* ™…Ω˛ ¥… ¥…v… +∫{…i……±… =i{……n˘, °Ú…®……« =i{……n˘ +…ËÆ˙ ∫¥……∫l™… Æ˙I…… ∫…÷{…÷n«˘M…“ ∫…‰¥……Bƒ ¶…“ |…n˘…x… EÚÆ˙i…… Ω˲* BS…B±…B±… ¥™…¥…∫……™… EÚ…™…«EÚ±……{…… EÚ“ ∫…®…“I…… x…“S…‰ n˘“ V……i…“ Ω˲: GÚ.∫…∆. =i{……n˘* ™…⁄ x…]ı ∫…∆∫l…… {…i… ¥… x…î…i… ®……j…… ={…™……‰M… I…®…i…… I…®…i…… ( {…UÙ±…‰ ¥…π…«) (%) 1. E∆Úb˜…‰®… n∂…±…I… +n˘n˘˘ 1,616.00 1638 101.36 (1629.23) 2. §±…b˜ §…ËM… n∂…±…I… +n˘n˘˘ 12.00 11.05 92.08 (7.63) 3. ∫™…⁄S…Æ˙ ±……J… b˜W…x… 2.25 1.42 63.11 (1.33) 4. EÚ…Ï{…Æ˙ ]ı“ n∂…±…I… +n˘n˘˘ 5.50 5.12 93.09 (3.75) 5. Œ∫]ıÆ˙…‰ • V……‰ J…®…: ∫…Æ˙EÚ…Æ˙ BEÚ O……Ω˛EÚ J…∆b˜ E‰Ú ∞¸{… ®… 2020 i…EÚ BS…B±…B±… E‰Ú Æ˙…V…∫¥… EÚ… 65% ™……‰M…n˘…x… EÚÆ˙x…‰ EÚ“ =®®…“n˘ EÚ“ V……i…“ Ω˲* ∫…Æ˙EÚ…Æ˙ EÚ…‰ + v…®…… x…i… ¥…G‰Úi…… Œ∫l… i… EÚ“ Ω˛… x… EÚ…°Ú“ ∞¸{… ∫…‰ BS…B±…B±… EÚ“ n⁄˘Æ˙n˘Ã∂…i…… +…ËÆ˙ EÚ…™…«x…“ i… {…Æ˙ |…¶…… ¥…i… EÚÆÂ˙M…‰* ∂…®…x… ™……‰V…x…… : E∆Ú{…x…“ x…B =i{……n˘… +…ËÆ˙ ∫…‰¥……+… E‰Ú |……Æ∆˙¶… EÚÆ˙E‰Ú +…ËÆ˙ ±…M……i……Æ˙ §…g¯i…“ ®……ÃEÚ]ı ∂…‰™…Æ˙ §…f¯…x…‰ E‰Ú n˘…‰ +…™……®…“ EÚ…™…«x…“ i…™…… u˘…Æ˙… <∫… V……‰ J…®… EÚ…‰ ∂…®…x… EÚÆ˙x…‰ EÚ“ ™……‰V…x…… EÚÆ˙i…“ Ω˲, V……‰ ®…v™…®… V……‰ J…®… EÚ…™…«x…“ i…™……‰∆ ∫…‰ EÚ®… ΩÈ˛* • V……‰ J…®…: x…™……«i… B¥…∆ n‰˘∂…“™… §……W……Æ˙, n˘…‰x…… E‰Ú ±…B +{…‰ I…i… +x…÷{……±…x… E‰Ú ¥…Ãv…i… ∫i…Æ˙, =i{……n˘… +…ËÆ˙ ∫…‰¥……+… EÚ“ ±……M…i… EÚ“ ¥…fi r˘ EÚÆ˙i…“ Ω˲* ∂…®…x… ™……‰V…x…… : E∆Ú{…x…“ EÚ…‰ ±… I…i… Æ˙…V™…I…‰j…… ®… ={…™…÷HÚ ¥… x…™…®…x… E‰Ú ∫……l… +x…÷{……±…x… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B ∫…®…Ã{…i… ]ı“®… EÚ…‰ ∫…÷¥™…¥…Œ∫l…i… EÚÆ˙E‰Ú <∫… V……‰ J…®… EÚ…‰ ∂…®…x… EÚÆ˙x…‰ EÚ… ¶…Æ˙…‰∫…… Ω˲* 5. +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… EÚ…Ï{……ÊƉ˙]ı +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… EÂÚp˘ (∫…“ +…Æ˙ b˜“ ∫…“) ∫¥……∫l™… Æ˙I…… I…‰j… ®… x…B i…EÚx……ϱ…V…“ ¥…EÚ…∫… +…ËÆ˙ ¥…t®……x… i…EÚx……ϱ… V…™…… E‰Ú ®…⁄±™… ∫…∆¥…r«˘x… E‰Ú ±…B ¥…ËY…… x…EÚ Y……x… ∫…fi V…i… EÚÆ˙x…‰ EÚ…‰ ±…I™… EÚÆ˙E‰Ú §…Ω÷˛ +…™……®…“ +x…÷∫…∆v……x… +…ËÆ˙ ¥…EÚ…∫… EÚ…™……«Œx¥…i… EÚÆ˙x…‰ E‰Ú ±…B ∫…®…Ã{…i… Ω˲* ∫…“ +…Æ˙ b˜“ ∫…“ ∫¥……∫l™… Æ˙I…… I…‰j… ®… x…¥…“x… |……Ët…‰ M… EÚ™…… E‰Ú ±…B Y……x… +…v……Æ˙ {…Ën˘… EÚÆ˙E‰Ú, O……Ω˛EÚ =®®…“n˘ {…⁄Æ˙… EÚÆ˙x…‰/=∫…∫…‰ + v…EÚ Ω˛…‰x…‰ EÚ“ ®…⁄±™… ¥…Ãv…i… +…Æ˙ & b˜“ ∫…‰¥……+…Â, M…÷h…¥…k…… ∫…÷v……Æ˙ EÚ…™…«GÚ®…… +…ËÆ˙ ∫¥…∫l… EÚ…™…« {…™……«¥…Æ˙h… E‰Ú W… Æ˙B ®……x…¥… ∫…∆∫……v…x… ¥…EÚ…∫… E‰Ú ®……v™…®… ∫…‰ o˘Œπ]ıEÚ…‰h… |……{i… EÚÆ˙x…‰ E‰Ú ±…B |… i…§…r˘ Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 100 3. PHYSICAL PERFORMANCE HLL is a leading manufacturer and marketer of a range of contraceptive products around the globe. It also provides a variety of hospital products, pharma products and healthcare delivery services. A review of HLL’s manufacturing activities is given below: Sl. Product* Unit Installed Quantity Capacity No. capacity manufactured utilization (Previous year) (%) 1 Condoms M.Pcs 1,616.00 1638 (1629.23) 101.36 2 Blood Bags M.Pcs 12.00 11.05 (7.63) 92.08 3 Suture L.Doz 2.25 1.42 (1.33) 63.11 4 Cu -T M.Pcs 5.50 5.12 (3.75) 93.09 5 Steroidal OCP Million 98.66 32.25 cycles (46.23) 32.69 6 Non-Steroidal OCP Million 30.00 28.49 Tablets (28.52) 94.97 7 Sanitary Napkin M.Pcs 144.00 97.6 (110.95) 67.78 8. Pregnancy Test Card M.Pcs 26.00 17.75 (19.14) 68.27 * HLL’s major products HLL has achieved 100% capacity utilization at its Condom production units. Efforts are being made to achieve better capacity utilization for other products. 4. RISKS AND CONCERNS • Risk: Government as a customer segment is expected to contribute 65% of HLL’s revenues by 2020. Loss of ‘preferred vendor to government’ status may impact HLL’s vision and strategies significantly. Mitigation plan: The Company plans to mitigate this risk by two-pronged strategies of ‘introducing new products and services’ and ‘continuously increasing market share’, which are low to medium risk strategies. • Risk: Increasing levels of compliance required for both export and domestic markets increases cost of products and services. Mitigation plan: The Company is confident of mitigating this risk by establishing dedicated teams to ensure compliance with applicable regulations in target territories. 5. RESEARCH & DEVELOPMENT Corporate R&D Centre (CRDC) is dedicated to carrying out multi-disciplinary research and development aimed at creating scientific knowledge for new technology development and value addition of existing technologies in the healthcare field. CRDC is committed to achieving the vision through generation of knowledge base for novel technologies in healthcare field, value added R&D services that meet/exceed customer expectation and human resource development through quality improvement programmes and safe and healthy work environment. Annual Report 2013-2014 101 5.1 ¥…ËY…… x…EÚ ∫…±……Ω˛EÚ…Æ˙ ∫… ®… i… +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… E‰Ú ∫…÷S……∞¸ ∫…∆S……±…x… EÚ…‰ +…M…‰ §…g¯…x…‰ E‰Ú ±…B BS…B±…B±… E‰Ú +x…÷∫…∆v……x… EÚ…™…«EÚ±……{…… ∫…‰ ∫…∆§…∆ v…i… ¥… ¥…v… I…‰j…… ∫…‰ ∫…‰¥……®…÷HÚ x…®x……∆ EÚi… ¥…ËY…… x…EÚ…Â E‰Ú BEÚ ¥…ËY…… x…EÚ ∫…±……Ω˛EÚ…Æ˙ ∫… ®… i… M… `ˆi… EÚ“ M…™…“* 1) b˜…Ï.B®….B∫….¥… ±…™…k……x… - x……∂…x…±… |……‰°‰Ú∫…Æ˙, (+v™…I…), ®… h…{……±… 2) b˜…Ï.B∫….Bx….{……±… - {…⁄¥…« x…n‰˘∂…EÚ, BS… B∫… ∫…“ ∫…“, n˘±±…“ 3) b˜…Ï.+…Æ˙.E÷Ú®……Æ˙ - |……‰°‰Ú∫…Æ, E‰Ú ®…EÚ±… <∆V…“ x…™…Æ˙“, +…<« +…<« B∫… ∫…“, §…ÈM…±…⁄Æ˙ 4) b˜…Ï.B∫…. ∂…¥…Æ˙…®… - {…⁄¥…« x…n‰˘∂…EÚ, Bx… ∫…“ B±…, {…⁄x…‰ 5) b˜…Ï.∫…i…“∂… M…÷{i…… - ={… x…n‰˘∂…EÚ, Bx… +…<« +…<«, x…<« n˘±±…“ 6) b˜…Ï.∫…÷Ɖ˙π… n˘…∫… - x…n‰˘∂…EÚ, Bx… +…<« +…<« B∫… ]ı“, i…Ø˚¥…x…∆i…{…÷Æ˙®… 7) b˜…Ï.B®….b˜“.x……™…Æ˙ - {…⁄¥…« x…n‰˘∂…EÚ, Œ∫{…EÚ °Ú…®……«, S…‰z…Ë 5.2 +∆i…Æ˙…«π]≈ı“™… x… v…EÚÆ˙h… n˘…‰ +…Æ˙ & b˜“ {… Æ˙™……‰V…x……+… x…‰ M…¶…« x…Æ˙…‰v…EÚ ®… +x…÷∫…∆v……x… E‰Ú ±…B §…±… B¥…∆ ®…À±…n˘… M…‰]¬ı∫… °Ú…=∆b‰˜∂…x… ∫…‰ +∆i…Æ˙…«π]≈ı“™… x… v…EÚÆ˙h… Ω˛… ∫…±… EÚ™…… Ω˲* x…⁄i…x… +…<« ™…÷ b˜“ x…‰ °‰Ú∫… II +x…÷n˘…x… +…ËÆ˙ x…⁄i…x… E∆Úb˜…‰®… {… Æ˙™……‰V…x…… EÚ…‰‰ °‰Ú∫… I +x…÷n˘…x… |……{i… EÚ™…… Ω˲* • ∫……‰±……Æ˙ - BS…B±…B±… ∫…“ +…Æ˙ b˜“ ∫…“ EÚ… O…“x… {…Ω˛±… E‰Ú Ω˛∫∫…‰ E‰Ú ∞¸{… ®… BEÚ 50 E‰Ú b˜Œ§±…™…÷ {…“ ∫……‰±……Æ˙ °Ú…‰]ı…‰¥……‰±…]ı… +…Æ˙ & b˜“ {…Æ˙ ¥™…™… (2013-14) {…⁄ƒV…“ §…V…]ı - ` 12.46 EÚÆ˙…‰c˜ +…¥…i…‘ §…V…]ı- ` 13.62 EÚÆ˙…‰c˜ 5.3. >π®……™…x… EÂÚp˘ ∫…“ +…Æ˙ & b˜“ ∫…“ `158.20 ±……J… EÚ“ +x…÷®…… x…i… ±……M…i… {…Æ˙ ŒC±… x…EÚ±… ]≈ı…™…±∫…, Œ∫l…Æ˙i…… V……ƒS… +…ËÆ˙ V……ƒS… ¥…{…h…x… EÚ…‰ =i{……n˘… E‰Ú |……™……‰ M…EÚ ®……{… =i{……n˘x… E‰Ú ±…B BEÚ >π®……™…x… EÂÚp˘ ∫…∆∫l…… {…i… EÚÆ˙ Æ˙Ω˛… Ω˲* 6. +…∆i… Æ˙EÚ x…™…∆j…h… |…h……±…“ B¥…∆ =x…EÚ“ {…™……«{i…i…… +…{…EÚ“ E∆Ú{…x…“ EÚ“ +…∆i… Æ˙EÚ x…™…∆j…h… |…h……±…“ ¥™…¥…∫……™… EÚ“ M…™…“ |…EfiÚ i… +…ËÆ˙ |…S……±…x… E‰Ú +…EÚ…Æ˙ EÚ…‰ |…n˘…x… EÚÆ˙x…‰ E‰Ú ±…B {… Æ˙EÚŒ±{…i… EÚ“ M…™…“ ΩË* • +…∆i… Æ˙EÚ V……ƒS… +…ËÆ˙ ∂…“Q… Æ˙{……‰Õ]ıM… E‰Ú ∫……l… ±…‰x…-n‰˘x… EÚ… ∫…Ω˛“ Æ˙EÚ…‰Õb˜M…* • |…™……‰V™… ±…‰J…… ®……x…EÚ…Â B¥…∆ x…“ i…™…… EÚ… +x…÷∫…Æ˙h… EÚÆ˙x……* • |…™……‰V™… ∫……∆ ¥… v…EÚ…Â, x…“ i…™…… +…ËÆ˙ |…§…∆v…x… x…“ i…™…… +…ËÆ˙ |… GÚ™……+… E‰Ú ∫……l… +x…÷{……±…x…* • ∫…∆∫……v…x…… E‰Ú |…¶……¥…“ ={…™……‰M… +…ËÆ˙ {… Æ˙∫…∆{… k…™…… EÚ“ Æ˙I…… EÚÆ˙x……* +…∆i… Æ˙EÚ x…™…∆j…h… |…h……±…“ +SUÙ“ i…Æ˙Ω˛ ∫…‰ |…±…‰ J…i… x…“ i…™……ƒ/®……M…« x…nÊ˘∂…, |…… v…EÚÆ˙h… +…ËÆ˙ +x…÷®……‰n˘x… |… GÚ™……Bƒ |…n˘…x… EÚÆ˙i…“ Ω˲* +…{…EÚ“ E∆Ú{…x…“ ∫¥…i…∆j… °Ú®……Á E‰Ú ∫…x…n˘“ ±…‰J……EÚ…Æ˙… B¥…∆ +{…x…‰ Ω˛“ EÚ…Ï{……ÊƉ˙]ı ±…‰J……{…Æ˙“I……/+…∑……∫…x… ∫…‰¥…… |…¶……M… (∫…“ B B∫…) E‰ W… Æ˙B, ∫…¶…“ ∫l……x…… {…Æ˙ +…¥… v…EÚ ±…‰J……{…Æ˙“I…… +…ËÆ˙ ±…‰J……{…Æ˙“I…… ∫… ®… i… u˘…Æ˙… +x…÷®……‰ n˘i… ™……‰V…x…… +…v…… Æ˙i… EÚ…™…«EÚ±……{… EÚ…™……«Œx¥…i… EÚÆ˙i…“ Ω˲ +…ËÆ˙ +…∆i… Æ˙EÚ x…™…∆j…h… |… GÚ™…… E‰Ú ±…B EÚ…‰<« ¶…“ ¥™… i…GÚ®… ±……i…‰ Ω∆˲* E∆Ú{…x…“ EÚ…‰ ¥…π…™… x…π`ˆi…… §…x……B Æ˙J…x…‰ E‰Ú ±…B + v…EÚi…®… ∫…n˘∫™… ∫¥…i…∆j… x…n‰˘∂…EÚ…Â E‰Ú ∫……l… ±…‰J……{…Æ˙“I…… ∫… ®… i… Ω˲* ±…‰J……{…Æ˙“I…… EÚ“ ]ı{{…h…“ EÚ… ∫…∆I…‰{… +…ËÆ˙ EÚ…™……«x¥…™…x… EÚ“ Œ∫l… i… j…Ë®…… ∫…EÚ +…v……Æ˙ {…Æ˙ x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ ±…‰J……{…Æ˙“I…… ∫… ®… i… EÚ…‰ |…∫i…÷i… EÚÆ˙i…… ΩË* ∫…°Ú… Æ˙∂…… E‰Ú EÚ…™……«x¥…™…x… EÚ“ Œ∫l… i… EÚ…‰ x…™… ®…i… +…v……Æ˙ {…Æ˙ ±…‰J……{…Æ˙“I…… ∫… ®… i… u˘…Æ˙… ∫…®…“I…… EÚ“ V……i…“ Ω˲ +…ËÆ˙ ™… n˘ EÚ…‰<« = r˘˘Mx…i…… Ω˲ i……‰ §……‰b« EÚ…‰ Æ˙{……‰]«ı EÚ“ V……i…“ Ω˲* ±…‰J……{…Æ˙“I…… ∫… ®… i… +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…EÚ…Â +…ËÆ˙ ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ∫……l… +…¥… v…EÚ ∞¸{… ∫…‰ §……i…S…“i… EÚÆ˙i…“ Ω˲ +…ËÆ˙ E∆Ú{…x…“ ®… +…∆ i…Æ˙EÚ x…™…∆j…h… |…h……±…“ EÚ“ M…÷h…¥…k…… ˜B¥…∆ {…™……«{i…i…… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B =x…E‰Ú ¥…S……Æ˙ EÚ… {…i…… ±…M……i…… Ω˲* =x…E‰Ú u˘…Æ˙… =`ˆ…B ∫…¶…“ ®…÷q˘… EÚ…‰ = S…i… ∞¸{… ∫…‰ EÚ…Æ«˙¥……<« EÚÆ˙E‰Ú +x…÷¥…i…«x… EÚB M…B Ω∆˲* E∆Ú{…x…“ EÚ…‰ ±……M…⁄ ∫…¶…“ x…™…®…… E‰Ú +x…÷{……±…x… ∫…÷ x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B = S…i… |…h……±…“ ±……M…⁄ Ω˲* E∆Ú{…x…“ ∏…‰π`ˆ ¥…Ë ∑…EÚ |…l……+… E‰Ú ∫……l… +{…x…“ ∫…¶…“ |… GÚ™……+… +…ËÆ˙ x…™…∆j…h… EÚ…‰ GÚ®…§…r˘ Æ˙J…x…‰ E‰Ú ±…B +{…x…… |…™……∫… V……Æ˙“ Æ˙Ω˛i…“ Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 102 5.1. Scientific Advisory Committee A Scientific Advisory Committee consisting of the following emeritus scientists from various fields relevant to HLL’s Research activities was constituted in order to facilitate the smooth functioning of R&D. 1) Dr.M.S.Valiathan- National Professor, (Chairman), Manipal 2) Dr.S.N.Pal – Former Director, HSCC, Delhi 3) Dr.R.Kumar - Professor in Chemical Engg, IISc, Bangalore 4) Dr.S Sivaram- Former Director, NCL, Pune 5) Dr.Satish Gupta- Deputy Director, NII, New Delhi 6) Dr.Suresh Das- Director, NIIST, Trivandrum 7) Dr.M.D.Nair – Former Director, Spic Pharma, Chennai 5.2. International funding Two R&D projects have bagged international funding from Bill Melinda Gates Foundation for research in contraception. Novel IUD has received phase II grant and a novel condom project have received phase I grant. • Solar – As a part of green initiative HLL CRDC, a 50 KWP solar photovoltaic project has been executed. The project shall provide an annual saving of `3.3 lakh. • A small animal experimentation facility has been setup at HLL CRDC for toxicological screening and preclinical pharmacokinetic and histopathological studies. Expenditure on R & D (2013-14) Capital budget – `12.46 Cr Recurring Budget– `13.62 Cr 5.3. Incubation centre The CR & DC is setting up an incubation centre for pilot scale production of products for clinical trials, stability testing and test marketing at an estimated cost of `158.20 Lakh. 6. INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY Given the nature of business and size of operations, your Company’s internal control system has been designed to provide for: • Accurate recording of transactions with internal checks and prompt reporting. • Adherence to applicable Accounting Standards and Policies. • Compliance with applicable statutes, policies and management policies and procedures. • Effective use of resources and safeguarding of assets. The internal control system provides for well documented policies/guidelines, authorisations and approval procedures. Your Company, through independent firms of Chartered Accountants and its own Corporate Audit/ Assurance Service Division (CAS), carries out periodic audits at all locations and functions based on the plan approved by the Audit Committee and brings out any deviation to internal control procedures. The Company has an Audit Committee with majority of Independent Directors as members to maintain the objectivity. The summary of the Internal Audit observations and status of implementation are submitted to the Audit Committee of the Board of Directors on a quarterly basis. The status of implementation of the recommendations is reviewed by the Audit Committee on a regular basis and concerns, if any, are reported to the Board. The Audit Committee periodically interacts with the Internal Auditors and the Statutory Auditors and seeks their views to ensure quality and adequacy of the internal control systems in the Company. All the issues raised by them have been suitably acted upon and followed up. Proper systems are in place to ensure compliance of all laws applicable to the Company. The Company continues its efforts to align all its processes and controls with best global practices. Annual Report 2013-2014 103 7. ∫……¥…«V… x…EÚ =t ®…i…… BS…B±…B±…, BEÚ ∫……¥…«V… ®…EÚ =t ®…i…… E‰Ú ∞¸{… ®…Â, §…Ω÷˛i… +…¥…∂™…EÚ ∫…I…®… EÚ…™…«§…±… EÚ…‰ ¥…EÚ ∫…i… EÚÆ˙x…‰ E‰Ú + i… Æ˙HÚ ∫……¥…«V… x…EÚ ∫…‰¥……+… E‰Ú ±…B x…B ¥…i…Æ˙h… +…ËÆ˙ ∫…∆M…`ˆx……i®…EÚ ®……‰b˜±…… EÚ…‰ ={…™……‰M… EÚÆ˙x…‰ E‰Ú ±…B ∫…Æ˙EÚ…Æ˙ EÚ…‰ ®…n˘n˘ EÚÆ˙i…… Ω˲* <∫… ®…⁄±™… E‰Ú ∫…fiV…x… EÚ“ +…‰Æ˙, BS…B±…B±… x…B ∫…∆§…∆v… +…ËÆ˙ {…Æ∆˙{…Æ˙…M…i… ∫…“®……+… ®… ∫…Ω˛™……‰M… M… f¯i… EÚÆ˙i…… Ω˲* BS…B±…B±… E‰Ú <∫… o˘Œπ]ıEÚ…‰h… x…‰ ∫……¥…«V… x…EÚ ∫…‰¥……+… E‰Ú ¥…i…Æ˙h… EÚ“ n˘I…i…… ®… ∫…÷v……Æ˙ ±……x…‰ +…ËÆ˙˙ ∫…Æ˙EÚ…Æ˙“ x…¥…‰∂…… E‰Ú |…¶……¥… EÚ…‰ §…g¯…x…‰ E‰Ú ±…B ∫…Æ˙EÚ…Æ˙“ ®…∂…“x…Æ˙“ EÚ“ ®…n˘n˘ EÚ“* <∫… |…EÚ…Æ˙, BS…B±…B±… ∫……¥…«V… x…EÚ Ω˛i… ®… x…¥……S……Æ˙, |…™……‰M… +…ËÆ Æ˙S…x……i®…EÚi…… EÚ…‰ ±…I™… EÚÆ˙i…… Ω˲ EÚ ∫……¥…«V… x…EÚ =t®…… EÚ…‰ +x™… EÚ∫…“ ¥™…¥…∫……™… ∫…‰ + v…EÚ =t®…∂…“±…i…… +…ËÆ˙ x…¥……S……Æ˙ Ω˛…‰x…‰ EÚ“ W…∞¸Æ˙i… Ω˲* ˙ 8. ∫…S…‰i…EÚ ¥…¥…Æ˙h… E∆Ú{…x…“ E‰Ú =q‰˘∂™……Â, |…I…‰{…h……Â, =®®…“n˘… B¥…∆ |……EÚ±…x…… E‰Ú ¥…h…«x… EÚÆ˙x…‰ E‰Ú |…§…∆v…x… S…S……« B¥…∆ ¥…∂±…‰π…h… ®… ¥…¥…Æ˙h… S……±…⁄ ¥™…¥…∫……™… {… Æ˙¥…‰∂… E‰Ú +…v……Æ˙ {…Æ˙ Ω˲* EÚ<« P…]ıEÚ E∆Ú{…x…“ E‰Ú ¥……∫i… ¥…EÚ {… Æ˙h……®…, x…π{……n˘x… ™…… ={…±…Œ§v…™…… EÚ… Ω‰˛i…÷ Ω˛…‰M……, V……‰ EÚ…‰<« ¶… ¥…π™… E‰Ú {… Æ˙h……®…, x…π{……n˘x… ™…… ={…±…Œ§v…™…… ∫…‰ + v…EÚ ®……j…… ®… +±…M… Ω˛…‰M……, ¥…Ω˛ B‰∫…‰ +O…¥…i…‘ ¥…¥…Æ˙h……‰∆ u˘…Æ˙… + ¶…¥™…HÚ ™…… ∫…⁄ S…i… EÚ™…… V……BM……* x…n‰˘∂…EÚ ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ b˜…Ï.B®….+™™…{{…x… +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 104 7. PUBLIC ENTREPRENEURSHIP HLL, as a Public Entrepreneur, is helping Governments use new delivery and organizational models for public services besides developing much-needed competent workforce. Towards creating this value, HLL is forging new relationships and collaborating across traditional boundaries to get things done. This approach of HLL has facilitated the Government machinery to improve efficiency in the delivery of public services and boost the impact of Government investments. Thus, HLL aims at innovation, experimentation, and creativity in the public interest buttressing that Public Sector Enterprises need to be entrepreneurial and innovative fully as much as any other business does. 8. CAUTIONARY STATEMENT Statements in Management Discussion and Analysis describing the Company’s objectives, projections, expectations and estimates are based on current business environment. Many factors could cause the actual results, performances or achievements of the Company to be materially different from any future results, performances or achievements that may be expressed or implied by such forward looking statements. For and on behalf of Board of directors Dr. M. Ayyappan Chairman & Managing Director Thiruvananthapuram 05.07.2014 Annual Report 2013-2014 105 B•…Ω…˛®… Bhb˜ V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ˙, IX/467, ®…∂…x… C¥……]Êı∫…« Æ˙…‰c˜ i…fi∂∂…⁄Æ˙ - 680001 n⁄˘Æ˙¶……π… : 0487-2423225, 2426225, °ËÚC∫… : 2424245 <«-®…‰±… : [email protected] ¥…‰§…∫……<]ı : www.abrahamandjose.com BS…B±…B±… ±……<°ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú ∫…n˘∫™…… EÚ…‰ ∫¥…i…∆j… ±…‰J……{…Æ˙“I…… EÚ“Ú Æ˙{……‰]«ı ¥…k…“™… ¥…¥…Æ˙h… {…Æ˙ Æ˙{……‰]«ı 1. Ω˛®…x…‰ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ("E∆Ú{…x…“') E‰Ú ∫…∆±…Mx… ¥…k…“™… ¥…¥…Æ˙h… EÚ“ ±…‰J……{…Æ˙“I…… EÚ“ Ω˲, V…∫…®… 31 ®……S…«, 2014 i…EÚ E‰Ú i…÷±…x… {…j…, +…ËÆ ∫…®……{i… =∫… +¥… v… E‰Ú x…EÚn˘“ |…¥……Ω˛ ¥…¥…Æ˙h… +…ËÆ˙ ±……¶… B¥…∆ Ω˛… x… E‰Ú ¥…¥…Æ˙h… +…ËÆ˙ ∫……l…«EÚ ±…‰J……{…Æ˙“I…… x…“ i…™…… B¥…∆ +x™… ¥™……J™……i®…EÚ ∫…⁄S…x…… EÚ… ∫……Æ˙…∆∂… ∫…®…… ¥…π]ı Ω˲* ˙ ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ±…B |…§…∆v… E‰Ú =k…Æ˙n˘… ™…i¥… 2. E∆Ú{…x…“ E‰Ú |…§…∆v… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 106 ABRAHAM & JOSE CHARTERED ACCOUNTANTS IX/467, MISSION QUARTERS ROAD, THRISSUR-680001 PHONE : 0487-2423225, 2426225 FAX : 2424245 E-mail : [email protected] Website: www.abrahamandjose.com INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF HLL LIFECARE LIMITED REPORT ON THE FINANCIAL STATEMENTS 1. We have audited the accompanying financial statements of HLL LIFECARE LIMITED (" the Company "), which comprise the Balance Sheet as at March 31, 2014, the Statement of Profit and Loss and Cash Flow Statement for the year then ended, and a summary of significant accounting policies and other explanatory information. MANAGEMENT'S RESPONSIBILITY FOR THE FINANCIAL STATEMENTS 2. The Company's Management is responsible for the preparation of these financial statements that give a true and fair view of the financial position, financial performance and cash flows of the Company in accordance with the Accounting Standards notified under the Companies Act, 1956 ("the Act") read with the general circular 15/2013, dated 13th September 2013 of the Ministry of Corporate Affairs in respect of section 133 of the Companies Act 2013 and in accordance with the accounting principles generally accepted in India. This responsibility includes the design, implementation and maintenance of internal control relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error. AUDITOR'S RESPONSIBILITY 3. Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered Accountants of India. Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material missstatement. 4. An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgement, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressisng an opinion on the effectiveness of the company's internal control. An Audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of the accounting estimates made by management, as well as evaulating the overall presentation of the financial statements. 5. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified audit opinion. 6. BASIS FOR QUALIFIED OPINION The company has an investment of `908.42 lacs in M/s. Lifespring Hospitals Private Ltd., a 50:50 joint venture with M/s. Acumen fund, USA. The accumulated loss of the joint venture as per the audited accounts for the year ended 31.03.2014 is `1665.45 lacs and HLL's share of the same is `832.73 lacs. Accordingly, there is a diminution in the carrying value of investment to the extent of `832.73 lacs. No provision for diminution has been made in the accounts of the company for the decline in value of investments, which is not in accordance with AS 13 on Accounting for Investments issued by ICAI. Consequently, the profit as well as reserves and Surplus and the value of investments are overstated by `832.73 lacs. Annual Report 2013-2014 107 Æ˙…™… 7. Ω˛®……Æ˙“ Æ˙…™… ®… i…l…… Ω˛®……Æ˙“ =k…®… V……x…EÚ…Æ˙“ B¥…∆ Ω˛®… n˘B M…B ∫{…π]ı“EÚÆ˙h… E‰Ú +x…÷∫……Æ˙, |… i…§…∆v… ¥…S……Æ˙ E‰Ú {…ËÆ˙… E‰Ú +…v…˘…Æ˙ ®… ¥…Ãh…i… <∫… ®……®…±…‰ E‰Ú |…¶……¥… EÚ…‰ UÙ…‰b˜ EÚÆ˙, {…⁄¥……ÊHÚ ¥…k…“™… ¥…¥…Æ˙h… +{…‰ I…i… i…Æ˙“E‰Ú ®… + v… x…™…®… u˘…Æ˙… +{…‰ I…i… ∫…⁄S…x…… n‰˘i…… Ω˲ +…ËÆ˙ ¶……Æ˙i… ®… ∫……®……x™… ∞¸{… ∫…‰ ∫¥…“EfiÚi… ±…‰J…… i…i¥…… E‰Ú +x…÷∞¸{… ∫…Ω˛“ B¥…∆ ∫{…π]ı o˘Œπ]ı n‰˘i…… Ω˲: (EÚ) 31 ®……S…«, 2014 i…EÚ E‰Ú E∆Ú{…x…“ E‰Ú EÚ…™……Á E‰Ú i…÷±…x… {…j… E‰Ú ®……®…±…‰ ®… ; (J…) =∫…“ i……Æ˙“J… {…Æ˙ ∫…®……{i… ¥…π…« E‰Ú ±…B E∆Ú{…x…“ E‰Ú ±……¶… E‰Ú ±……¶… B¥…∆ Ω˛… x… ¥…¥…Æ˙h… E‰Ú ®……®…±…‰ ®… ; +…ËÆ˙ (M…) =∫… i……Æ˙“J… {…Æ˙ ∫…®……{i… ¥…π…« E‰Ú ±…B E∆Ú{…x…“ E‰Ú x…EÚn˘“ |…¥……Ω˛ E‰Ú x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… E‰Ú ®……®…±…‰ ®… * ®……®…±…‰ EÚ… W……‰Æ˙ 8. n˘x……∆EÚ 05 V…÷±……<«, 2014 E‰Ú Ω˛®……Æ˙“ ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı E‰Ú §……n˘, x…™…∆j…EÚ +…ËÆ˙ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ E‰Ú +¥…±……‰EÚx… E‰Ú +x…÷∫……Æ˙, x…®x… ±… J…i… EÚ…‰ ∫…n˘∫™…… E‰Ú v™……x… +…®…∆ j…i… EÚÆ˙i…‰ ΩÈ˛: Ø˚.809.05 ±……J… ∫… Ω˛i… 31 ®……S…«, 2014 i…EÚ E‰Ú +±{…EÚ… ±…EÚ =v……Æ˙ +…ËÆ˙ {…‰∂… M…™……ƒ, V…∫…®… ∫…‰ Ø˚.307.00 ±……J… ¥…π…« 2013- 14 E‰Ú n˘…ËÆ˙…x… ∫…®……Ω˛ Æ˙i… EÚ™…… M…™…… Ω˲* 31.03.2014 i…EÚ E‰Ú Ø˚. 502.05 ±……J… EÚ“ ∂…‰π… §…EÚ…™…… Æ˙EÚ®… +|… i…¶…⁄i… +…ËÆ˙ ±…∆§…“ ∫…®…™… ∫…‰ ±…∆ §…i… ΩË V…∫…E‰Ú ±…B EÚ…‰<« |……¥…v……x… x…Ω˛” §…x……™…… M…™…… Ω˲, <∫… o˘Œπ]ı ∫…‰, n˘x……∆EÚ 05 V…÷±……<«, 2014 EÚ“ Ω˛®……Æ˙“ ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı˛ EÚ… ∫…∆∂……‰v…x… EÚ™…… M…™……* +x™… ¥… v…EÚ +…ËÆ˙ x…™……®…EÚ +{…‰I……+… {…Æ˙ Æ˙{……‰]«ı 9. + v… x…™…®… EÚ“ v……Æ˙… 227 EÚ“ ={… v……Æ˙… (4B) E‰Ú ∂…i……Á E‰Ú +x…÷∫……Æ˙ ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… V……Æ˙“ EÚ™…‰ E∆Ú{…x…“ (±…‰J……{…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«ı) +…n‰˘∂…, 2003 ("+…n‰˘∂…") u˘…Æ˙… +{…‰ I…i… V…Ë∫…‰, Ω˛®… +…n‰˘∂… E‰Ú +x…÷SU‰Ùn˘ 4 +…ËÆ˙ 5 {…ËÆ˙… ®… ¥… x…Ãn˘π]ı ¥…π…™…… {…Æ˙ ¥…¥…Æ˙h… +x…÷§…∆v… ®… n‰˘i…‰ ΩÈ˛* 10. + v… x…™…®… EÚ“ v……Æ˙… 227 (3) u˘…Æ˙… +{…‰ I…i… V…Ë∫…‰, Ω˛®… Æ˙{……‰]«ı EÚÆ˙i…‰ ΩÈ˛ Ú (EÚ) Ω˛®…‰∆ +{…x…“ ±…‰J……{…Æ˙“I…… E‰Ú =q‰˘∂™… E‰Ú ±…B +…¥…∂™…EÚ Ω˛®……Ɖ˙ =k…®… Y……x… +…ËÆ˙ ¥…∑……∫… E‰Ú +x…÷∞¸{… ∫…¶…“ ∫…⁄S…x…… +…ËÆ˙ ∫{…π]ı“EÚÆ˙h… |……{i… Ω÷˛+… Ω˲* (J…) Ω˛®……Æ˙“ Æ˙…™… ®… +¶…“ i…EÚ EÚ“ Ω˛®……Æ˙“ {…Æ˙“I…… ∫…‰ ±…M…i…‰ ΩÈ˛ EÚ E∆Ú{…x…“ u˘…Æ˙… x…™…®……x…÷∫……Æ˙ +{…‰ I…i… V…Ë∫…‰ = S…i… ±…‰J……§…Ω˛“ §…x……™…“ Æ˙J…“ Ω˲* (M…) <∫… Æ˙{……‰]«ı E‰Ú u˘…Æ˙… ∫…∆§…∆ v…i… i…÷±…x… {…j…, ±……¶… +…ËÆ˙ Ω˛… x… ¥…¥…Æ˙h… +…ËÆ˙ x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… ±…‰J…… §… Ω˛™…… E‰Ú ∫……l… ®…‰±… J……i…… Ω˲* (P…) |… i…§…∆v… ¥…S……Æ˙ {…ËÆ˙… E‰Ú ±…B +…v……Æ˙ ®… ¥…Ãh…i… <∫… ®……®…±…‰ E‰Ú |…¶……¥… EÚ…‰ UÙ…‰b˜EÚÆ˙, Ω˛®……Æ˙“ Æ˙…™… ®… i…÷±…x… {…j… +…ËÆ˙ x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… E∆Ú{…x…“ + v… x…™…®…, 2013 EÚ“ v……Æ˙… 133 E‰Ú ∫…∆§…∆v… ®… EÚ…Ï{……ÊƉ˙]ı +°‰Ú™…∫…« ®…∆j……±…™… (∫…⁄S…x…… B¥…∆ |…∫……Æ˙h… ®…∆j……±…™…) E‰Ú ∫……®……x™… {… Æ˙{…j… 15/2013 n˘x……∆EÚ 13 ∫…i…∆§…Æ˙ , 2013 E‰Ú ∫……l… {… `ˆi… + v… x…™…®… E‰Ú +v…“x… + v…∫…⁄ S…i… ±…‰J…… ®……x…EÚ…Â EÚ… +x…÷{……±…x… EÚÆ˙i…‰ ΩÈ˛* (RÛ) 31 ®……S…«, 2014 EÚ…‰ x…n‰˘∂…EÚ…Â ∫…‰ |……{i… ±… J…i… |… i… x… v…i¥… ˙ +…ËÆ˙ x…n‰˘∂…EÚ ®…∆b˜±… u˘…Æ˙… ±…™…‰ M…™…‰ Æ˙EÚ…b«˜ E‰Ú +…v……Æ˙ {…Æ, 31 ®……S…« 2014 EÚ…‰ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 274 EÚ“ ={… v……Æ˙… (1) E‰Ú J…∆b˜ (UÙ) E‰Ú ∂…i……Á ®… x…n‰˘∂…EÚ…Â ®… ∫…‰ EÚ…‰<« ¶…“ x…n‰∂˘…EÚ E‰Ú ∞¸{… ®… x…™…÷HÚ EÚ™…‰ V……x…‰ ∫…‰ x…n‰˘∂…EÚ EÚ…‰ +™……‰M™… P……‰ π…i… EÚÆ˙ n˘™…… M…™…… ΩË* EfiÚi…‰ B•…Ω…˛®… Bhb˜ V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ˙ B°Ú.+…Æ˙ x…∆. 000010B∫… V……‰∫… {……‰^ı…‰EÚ…Æ˙x… ∫……Z…‰n˘…Æ˙ ∫…n˘∫™…i…… ∫…∆. 012056 ∫l……x… : i…fi∂∂…⁄Æ˙ n˘x……∆EÚ : 04.08.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 108 OPINION 7. In our opinion and to the best of our information and according to the explanations given to us, except for the effects of the matter described in the Basis for Qualified Opinion paragraph, the aforesaid financial statements give the information required by the Act in the manner so required and give a true and fair view in confirmity with the accounting principles generally accepted in India : (a) in the case of the Balance Sheet, of the state of affairs of the Company as at March 31, 2014; (b) in the case of the Statement of Profit and Loss, of the profit of the Company for the year ended on that date; and (c) in the case of the Cash Flow Statement, of the cash flows of the Company for the year ended on that date. EMPHASIS OF MATTER 8. Subsequent to our Audit Report dated 05th July, 2014, as per the observation of C&AG, we invite attention of the members to the following: Short term loans and advances as on 31st March, 2014 included `809.05 lakhs, out of which `307.00 lakhs has been collected during the year 2013-14. Balance outstanding amounting to `502.05 lakhs as on 31.03.2014 is unsecured and long pending for which no provision has been made. In view of the same, our audit report dated 5th July 2014 has been revised. REPORT ON THE OTHER LEGAL AND REGULATORY REQUIREMENTS 9. As required by the Companies (Auditor's Report) Order, 2003 ("the Order") issued by the Central Government of India in terms of sub-section (4A) of section 227 of the Act, we give in the Annexure a statement on the matters specified in paragraphs 4 and 5 of the Order. 10. As required by section 227(3) of the Act, we report that: (a) We have obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit; (b) In our opinion proper books of account as required by law have been kept by the Company so far as appears from our examination of those books; (c) The Balance Sheet, the Statement of Profit and Loss and the Cash Flow Statement dealt with by this Report are in agreement with the books of account; (d) Except for the effects of the matter described in the Basis for Qualified Opinion paragraph, in our opinion, the Balance Sheet, Statement of Profit and Loss and Cash Flow Statement comply with the Accounting Standards Notified under the Act read with the general Circular 15/2013 dated 13th September, 2013 of the Ministry of Corporate Affairs in respect of Section 133 of the Companies Act, 2013. (e) On the basis of written representations received from the directors as on March 31, 2014, and taken on record by the Board of Directors, none of the Directors is disqualified as on March 31, 2014, from being appointed as a director in terms of clause (g) of sub-section (1) of section 274 of the Companies Act, 1956. For Abraham & Jose Chartered Accountants (FRN: 000010S) Jose Pottokaran Place : Thrissur Partner, M.No. 012056 Date : 04-08-2014 Annual Report 2013-2014 109 ¥…k…“™… ¥…π…« 2013-2014 E‰Ú ±…B BS…B±…B±… ±……<«°ÚE‰Ú™…Æ ±… ®…]‰ıb˜˙ E‰Ú ∫…n˘∫™…… EÚ…‰ ±…‰J……{…Æ˙“I…EÚ…Â EÚ“ Æ˙{……‰]«ı EÚ… +x…÷§…∆v… (i) (EÚ) E∆Ú{…x…“ {… Æ˙®……h……i®…EÚ ¥…¥…Æ˙h…, J…Æ˙“n‰˘ ¥…π…«, ∫l……x… +…ËÆ˙ BEÚ±… {…Ω˛S……x… ∫…∆J™…… V…Ë∫…‰ ¥…¥…Æ˙h… E‰Ú ∫……l… +S…±… {… Æ˙∫…∆{… k…™…… EÚ“‰Ú Œ∫l… i… +…ËÆ˙ {…⁄Æ˙… §™……ËÆ˙… n˘J……x…‰ ¥……±…… Æ˙EÚ…b«˜ Æ˙J…i…“ Ω˲˛ * (J…) ¥…π…« E‰Ú n˘…ËÆ˙…x… |…§…∆v… u˘…Æ˙… +S…±… {… Æ˙∫…∆{… k…™…… EÚ… |…i™…I… ∫…i™……{…x… EÚ™…‰ M…™…‰* V…Ë∫…‰ ¶…“ Ω˛…‰, ˛ |…§…∆v…x… x…‰ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú |…i™…I… ∫…i™……{…x… E‰Ú ±…B EÚ…‰<« EÚ…™…« |…h……±…“ x…Ω˛” Æ˙J…“ ΩË +i…& B‰∫…‰ ∫…i™……{…x… E‰Ú +…¥…fi k… +…ËÆ˙ {…™……«{i…i…… {…Æ˙ ]ı“EÚ… - ]ı{{…h…“ x…Ω˛” EÚ“ V…… ∫…EÚi…“ Ω˲ * |…i™…I… ∫…i™……{…x… {…Æ˙ {……<« M…<« ¥…∫…∆M… i…™……ƒ ¶……Ë i…EÚ x…Ω˛” l…” i…l…… B‰∫…“ ¥…∫…∆M… i…™…… E‰Ú ±…B ±…‰J…‰ ®… EÚ…‰<« ∫…®……™……‰V…x… x…Ω˛” §…x……™…“ M…™…“ ΩË * (M…) ¥…π…« E‰Ú n˘…ËÆ˙…x… +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú {…™……«{i… x…{…]ı…x… x…Ω˛” l……, <∫… ±…B S……±…⁄ ®……®…±…‰ +…v…… Æ˙i… ¥…k…“™… ¥…¥…Æ˙h… EÚ“ i…Ë™……Æ˙“ <∫… ±…‰J…‰ {…Æ˙ |…¶…… ¥…i… x…Ω˛” Ω˲ * (ii) (EÚ) ¥…π…« E‰Ú n˘…ËÆ˙…x… i…“∫…Ɖ˙ {……Ã]ı™…… E‰Ú ∫……l… {…b˜“ ¥…∫i…÷∫…⁄ S…™…… E‰Ú +±……¥…… ¥…π…« E‰Ú n˘…ËÆ˙…x… |…§…∆v… u˘…Æ˙… i…Ë™……Æ˙ ®……±……Â, EÚSS…‰ ®……±……Â, {…ËÀEÚM… ®……±……Â, S……±…⁄ EÚ…™…« +…ËÆ˙ <∆V…“ x…™…Æ˙“ ¶…hb˜…Æ˙ EÚ“ |…i™…I… V……ƒS… EÚ“ M…™…“ ΩÈ˛* Ω˛®……Æ˙“ Æ˙…™… ®… ∫…i™……{…x… EÚ“ +…¥…fi k… ™…l……‰ S…i… Ω˲ * (J…) E∆Ú{…x…“ E‰Ú +…EÚ…Æ˙ i…l…… EÚ…Æ˙…‰§……Æ˙ EÚ“ |…EfiÚ i… E‰Ú ∫…∆§…∆v… ®… |…§…xv… u˘…Æ˙… {……±…x… EÚ“ M…™…“ ¥…∫i…÷∫…⁄S…“ E‰Ú |…i™…I… ∫…i™……{…x… EÚ“ EÚ…™…« |…h……±…“ ∫…®…“S…“x… B¥…∆ = S…i… Ω˲ * (M…) E∆Ú{…x…“ ¥…∫i…÷∫…⁄S…“ E‰Ú = S…i… Æ˙EÚ…b«˜ Æ˙J…i…“ Ω˲ i…l…… |…i™…I… ∫…i™……{…x… {…Æ˙ ®…Ω˛i¥…{…⁄h…« ¥…∫i…÷{…Æ˙EÚÚ ¥…∫…∆M… i…™……ƒ x…Ω˛” {……™…“ M…™…” * (iii) (EÚ) E∆Ú{…x…“ x…‰ ∫…⁄ S…i… V…Ë∫…‰, + v… x…™…®… 1956 EÚ“ v……Æ˙… 301 E‰Ú +v…“x… Æ˙J…‰ M…B Æ˙ V…∫]ıÆ˙ ®… |… i…{…… n˘i… E∆Ú{… x…™……Â, °Ú…®……Á ™…… +x™… ¥™… HÚ™…… ∫…‰ |… i…¶…⁄i… ™…… +|… i…¶…⁄i… EÚ…‰<« @Òh… x…Ω˛” ∫¥…“EfiÚi… EÚ™…… M…™…… * i…n˘x…÷∫……Æ˙ {…ËÆ˙… (iii) (J…), (M…) +…ËÆ˙ (P…) ®… §…i……™…… |……¥…v……x… ±……M…⁄ x…Ω˛” Ω˲* (J…) E∆Ú{…x…“ x…‰ ∫…⁄ S…i… V…Ë∫…‰, E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 301 E‰Ú +v…“x… Æ˙J…‰ M…B Æ˙ V…∫]ıÆ˙ ®… |… i…{…… n˘i… E∆Ú{… x…™……Â, °Ú…®……Á ™…… +x™… ¥™… HÚ™…… EÚ…‰/∫…‰ |… i…¶…⁄i… ™…… +|… i…¶…⁄i… EÚ…‰<« @Òh… x…Ω˛” ±…™…… Ω˲ * i…n˘x…÷∫……Æ˙ {…ËÆ˙… (iii) (S…) +…ËÆ˙ (UÙ) ®… §…i……™…… |……¥…v……x… ±……M…⁄ x…Ω˛” Ω˲* (iv) Ω˛®……Æ˙“ Æ˙…™… ®… i…l…… Ω˛®… n˘“ M…<« ∫…⁄S…x…… +…ËÆ˙ ∫{…π]ı“EÚÆ˙h… E‰Ú +x…÷∫……Æ˙ +…EÚ…Æ˙ i…l…… EÚ…Æ˙…‰§……Æ˙ EÚ“ |…EfiÚ i… E‰Ú +x…÷∞¸{… ¥…∫i…÷∫…⁄S…“ i…l…… +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú GÚ™… B¥…∆ ®……±…… +…ËÆ˙ ∫…‰¥……+… EÚ“ §…GÚ“ E‰Ú ±…B ™…l……‰ S…i… {…™……«{i… +…∆i… Æ˙EÚ x…™…∆j…h… EÚ…™…« |…h……±…“ Ω˲ * Ω˛®……Æ˙“ =k…®… V……x…EÚ…Æ˙“ ®…Â Ω˛®……Æ˙“ ±…‰J……{…Æ˙“I…… E‰Ú n˘…ËÆ˙…x… +…∆i… Æ˙EÚ x…™…∆j…h… |…h……±…“ ®… EÚ…‰<« |…®…÷J… EÚ®…“ Ω˛®… Æ˙{……‰]«ı x…Ω˛” EÚ“ Ω˲ ™…… Ω˛®……Ɖ˙ v™……x… ®… +…™…“ Ω˲ * (v) Ω˛®… n˘“ M…<« ∫…⁄S…x…… E‰Ú +x…÷∫……Æ˙, ¥…π…« E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ + v… x…™…®…, 1956 EÚ“ v……Æ˙… 301 E‰Ú +x…÷∫…Æ˙h… ®…Â, Æ˙ V…∫]ıÆ˙ ®… |… ¥…Œπ]ıi… EÚÆ˙x…‰ E‰Ú ±…B EÚ…‰<« `‰ˆE‰Ú ™…… ¥™…¥…∫l……B∆ x…Ω˛” ΩÈ˛* (vi) E∆Ú{…x…“ x…‰ V…x…i…… ∫…‰ EÚ…‰<« V…®…… ∫¥…“EfiÚi… x…Ω˛” EÚ™…… Ω˲ * V…Ë∫…‰ ¶…“ Ω˛…‰, Ω˛®… Æ˙{……‰]«ı EÚÆ˙i…‰ ΩÈ˛ EÚ ¥…Ëv… n˘…™……n˘ E‰Ú §…“S… E‰Ú ¥…¥……n˘ E‰Ú EÚ…Æ˙h… +|…n˘k… `10,000/- ∫……¥… v… V…®…… E‰Ú +v…“x… ∂…‰π… Æ˙Ω˛… Ω˲ * (vii) Ω˛®……Æ˙“ Æ˙…™… ®… E∆Ú{…x…“ EÚ…‰ +{…x…‰ ¥™……{……Æ˙ EÚ‰ +…EÚ…Æ˙ +…ËÆ˙ |…EfiÚ i… E‰Ú +x…÷∫……Æ˙ BEÚ +…∆i… Æ˙EÚ ±…‰J……{…Æ˙“I…… |…h……±…“ Ω˲* (viii) Ω˛®…x…‰ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 209 (1) (P…) E‰Ú +v…“x… ±……M…i… Æ˙EÚ…‰b˜…Á E‰Ú +x…÷Æ˙I…h… E‰Ú ±…B EÂÚp˘ ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… §…x……™…‰ x…™…®… E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ u˘…Æ˙… =i{…… n˘i… §…±EÚ b≈˜M∫… +…ËÆ˙ ∫…⁄j…“EÚÆ˙h…, ®… Ω˛±…… M…¶…« x…Æ˙…‰v…EÚ E∆Úb˜…‰®…, {…÷Ø˚π… M…¶…« x…Æ˙…‰v…EÚ E∆Úb˜…‰®…, EÚ…Ï{…ıÆ˙ -]ı“ (<∆]≈ı… ™…⁄]ı“Æ˙… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 110 ANNEXURE TO AUDITORS’ REPORT TO THE MEMBERS OF HLL LIFECARE LTD. FOR THE FINANCIAL YEAR 2013-14 (i) (a) The company is maintaining records showing particulars and situation of fixed assets, with particulars like quantitative details, year of purchase, location and unique identification number. (b) The fixed assets were physically verified during the year by the Management. However, the management has not laid down procedure for physical verification of fixed assets and hence frequency and adequacy of such verification could not be commented upon. Discrepancies noticed on physical verification were not material and no adjustment has been made in the accounts for such discrepancies. (c) There was no substantial disposal of fixed assets during the year and hence, the preparation of financial statements on going concern basis is not affected on this account. (ii) (a) The stock of finished goods, raw materials, packing materials, work-in-progress and engineering stores have been physically verified by the management during the year, except the inventories lying with third parties. In our opinion, the frequency of verification is reasonable. (b) The procedures for physical verification of inventory followed by management are reasonable and adequate in relation to the size of the company and nature of its business. (c) The company is maintaining proper records of inventory and material discrepancies were not noticed on physical verification. (iii) (a) As informed, the company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under section 301 of the Companies Act, 1956 (the Act). Accordingly the provisions stated in para 4(iii)(b), (c) and (d) are not applicable. (b) As informed, the company has not taken any loans, secured or unsecured to / from companies, firms or other parties covered in the register maintained under section 301 of the Companies Act, 1956. Accordingly the provisions stated in para 4(iii)(f) and (g) are not applicable. (iv) In our opinion and according to the information and explanations given to us, there are reasonably adequate internal control procedures commensurate with the size of the company and nature of its business for the purchase of inventory and fixed assets and for the sale of goods and services. To the best of our knowledge, no major weaknesses in internal control system were either reported or noticed by us during the course of our audit. (v) According to the information given to us, there are no contracts or arrangements during the year that need to be entered into a register in pursuance of Section 301 of the Companies Act, 1956. (vi) The Company has not accepted any deposits from public during the year. However, we report that an amount of ```10,000 is outstanding under fixed deposit not repaid due to dispute between the legal heirs. (vii) In our opinion the company has an internal audit system commensurate with the size and nature of its business. (viii) We have broadly reviewed the books of account maintained by the Company pursuant to the Rules made by the Central Government for the maintenance of cost records under Section 209(1) (d) of the Companies Act, 1956, in respect of Bulk Drugs, Formulations, Female Contraceptive Condoms, Male Contraceptive Condoms, Copper T (Intra uterine devices) and Pregnancy Test Kits produced by the Company and we are of the opinion that prima facie, the prescribed records have been made and maintained. Pursuant to Section 233B of the Companies Act, 1956, the Central Government has prescribed Cost Audit of the Company's Bulk Drugs Divisions, Formulation Divisions, Female and Male Contraceptive Condom Divisions, Copper T (Intra uterine devices) Divisions and Pregnancy Test Kit Divisions. Accordingly, the Company has appointed Cost Auditors for the year ended 31st March 2014. (ix) (a) According to the records, the Company has been generally regular in depositing undisputed statutory dues including Provident Fund, ESI, Income Tax, Wealth Tax, Service Tax, Excise Duty, Cess and other statutory dues with the appropriate authorities. (b) According to the information and explanations given to us, there are no dues of Income Tax, Sales Tax, Wealth Tax, Service Tax, Customs Tax, Excise Duty or Cess not deposited on account of any dispute except Annual Report 2013-2014 111 G∆Ú ∫…∆ EÚ…x…⁄x… EÚ… x……®… ™…Ω˛…ƒ °Ú…‰Æ˙®… ∂…… ®…±… EÚ“ M…™…“ Æ˙EÚ®… +¥… v… ®……®…±…… ±…∆ §…i… Ω˲* ( ``` ±……J…) 1 +…™… EÚÆ˙ + v… x…™…®… , 1961 ∫…“ +…<« ]ı“ (+{…“±…) 10.12 x…v……«Æ˙h… - ¥…π…« 2008-09 2 '' '' 191.54 x…v……«Æ˙h… - ¥…π…« 2009-10 3 '' '' 20.84 x…v……«Æ˙h… - ¥…π…« 2010-11 4 '' '' 40.85 x…v……«Æ˙h… - ¥…π…« 2011-12 5 ∫…“®…… ∂…÷±EÚ + v… x…™…®… , 1962 ∫…“®…… ∂…÷±EÚ +…™…÷HÚ 22.15 2007-08 6 E‰ÚÆ˙±… ®…⁄±™… ∫…∆¥…Ãv…i… EÚÆ˙ b˜“∫…“ (+{…“±…) 263.48 2011-12 + v… x…™…®…, 2003 (x) E∆Ú{…x…“ EÚ…‰ 31 ®……S…« 2014 i…EÚ EÚ…‰<« ˙ ∫…∆ S…i… Ω˛… x… x…Ω˛” Ω˲ +…ËÆ˙ =∫…“ i……Æ˙“J… ®… ∫…®……{i… ˛ ¥…k…“™… ¥…π…« ™…… {…⁄⁄¥…«¥…i…‘ ¥…k…“™… ¥…π…« ®… EÚ…‰<« Æ˙…‰EÚb˜ Ω˛… x… n‰˘™… x…Ω˛” Ω÷˛<« Ω˲* (xi) + ¶…±…‰J…… E‰Ú ∫…i™……{…x… E‰Ú +…v……Æ˙ {…Æ˙ i…l…… Ω˛®… n˘B M…B ∫…⁄S…x…… B¥…∆ ∫{…π]ı“EÚÆ˙h… E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ x…‰ ¥…k…“™… ∫…∆M…`ˆx…… ™…… §…ÈEÚ…Â EÚ…‰ n‰˘™… ¥……{…∫…“ +n˘…™…M…“ ®… ¥™… i…GÚ®… x…Ω˛” EÚ™…… Ω˲ * (xii) Ω˛®… n˘B M…B ∫…⁄S…x…… B¥…∆ ∫{…π]ı“EÚÆ˙h… E‰Ú +x…÷∫……Æ˙, E∆Ú{…x…“ x…‰ V…®……x…i… E‰Ú +…v……Æ˙ {…Æ˙ ∂…‰™…Æ˙…Â, @Òh…{…j… +…ËÆ˙ +x™… |… i…¶…⁄ i…™…… EÚ…‰ M…Æ˙¥…“ Æ˙J…EÚÆ˙ @Òh… ¥… + O…®… ∫¥…“EfiÚi… x…Ω˛” EÚ™…… Ω˲ * (xiii) S…]ı x… v…, x… v… ™…… {……Æ˙∫{… Æ˙EÚ °Ú…™…n˘… x… v…/∫……‰∫……< ]ı™…… E‰Ú ±…B ±……M…⁄ EÚ∫…“ ¶…“ ¥… ∂…π]ı EÚ…x…⁄x…… EÚ… |……¥…v……x…, E∆Ú{…x…“ EÚ…‰ ±……M…⁄ x…Ω˛” Ω˲ * (xiv) E∆Ú{…x…“ ∂…‰™…Æ˙, @Òh…{…j… i…l…… +x™… x…¥…‰∂…… ®… ±…‰x…-n‰˘x… ™…… ]≈‰ıÀb˜M… x…Ω˛” EÚÆ˙i…“ Ω˲ * (xv) E∆Ú{…x…“ x…‰ ¥…k…“™… ∫…∆∫l…… ∫…‰ EÚ®…«S…… Æ˙™…… u˘…Æ˙… ±…B @Òh…… E‰Ú ±…B M……Æ∆˙]ı“ n˘“ Ω˲ V…∫…EÚ… ∂…i…« ¥… x…§…∆v…x… E∆Ú{…x…“ E‰Ú Ω˛i… {…Æ˙ |… i…E⁄Ú±… x…Ω˛” Ω˲* (xvi) Ω˛®……Æ˙“ Æ˙…™… ®…Â, ®…™……n˘“ @Òh… =`ˆı…B M…B =q‰˘˘∂™… E‰Ú ±…B |…™…÷HÚ EÚB M…B Ω∆˲* (xvii) E∆Ú{…x…“ E‰Ú + ¶…±…‰J…… i…l…… S……±…⁄ ¥…π…« E‰Ú E∆Ú{…x…“ E‰Ú i…÷±…x…-{…j… B¥…∆ x…EÚn˘ {…Ën˘…<∂… ¥…¥…Æ˙h… {…Æ˙ ∫…®…O… V……ƒS… E‰Ú +…v……Æ˙ {…Æ˙ +…ËÆ˙ Ω˛®… n˘B M…B ∫…⁄S…x…… B¥…∆ ∫{…π]ı“EÚÆ˙h… E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ x…‰ n˘“P……«¥… v… x…¥…‰∂… E‰Ú ±…B +±{……¥… v… +…v……Æ˙ {…Æ˙ =`ˆ…<« M…<« x… v… i…l…… <∫…∫…‰ =±]‰ı ={…™……‰M… x…Ω˛” EÚ™…… M…™…… Ω˲ * (xviii) ¥…π…« E‰Ú n˘…ËÆ˙…x…, E∆Ú{…x…“ x…‰ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 301 E‰Ú +v…“x… §…x……B Æ˙J…‰ Æ˙ V…∫]ıÆ˙ ®… ∫…Œ®®… ±…i… {……Ã]ı™…… ™…… E∆Ú{… x…™…… EÚ…‰ ∂…‰™…Æ˙ EÚ… EÚ∫…“ ¶…“ + v…®……x™… +…§…∆]ıx… x…Ω˛” EÚ™…… Ω˲ * (xix) ¥…π…« E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ x…‰ EÚ…‰<« ¶…“ @Òh…{…j… V……Æ˙“ x…Ω˛” EÚ™…‰ M…™…‰ ΩÈ˛* (xx) ¥…π…« E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ x…‰ ∫……¥…«V… x…EÚ x…M…«®… u˘…Æ˙… EÚ…‰<« ¶…“ Æ˙EÚ®… =`ˆ…™…“ Ω˲ * (xxi) x…π{…… n˘i… ±…‰J……{…Æ˙“I…… GÚ™…… ¥… v… i…l…… |…§…∆v… ∫…‰ |……{i… + ¶…¥…‰n˘x… E‰Ú +…v……Æ˙ {…Æ˙ Ω˛®… Æ˙{……‰]«ı EÚÆ˙i…‰ ΩÈ˛ EÚ ±…‰J……{…Æ˙“I……v…“x… ¥…π…« E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ {…Æ˙ ™…… u˘…Æ˙… EÚ…‰<« v……‰J…‰§……W…“ v™……x… ®… +…™…… ™…… Æ˙{……‰]«ı x…Ω˛” EÚ“ M…™…“ Ω˲* EfiÚi…‰ B•…Ω…˛®… Bhb˜ V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ˙, B°Ú.+…Æ˙ x…∆. 000010B∫… V……‰∫… {……‰^ı…‰EÚ…Æ˙x… ∫……Z…‰n˘…Æ,˙ ∫…n˘∫™… ∫…∆. 012056 ∫l……x… : i…fi∂∂…⁄Æ˙ n˘x……∆EÚ : 04.08.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 112 Sl. Name of the Statute Forum where the Amout involved Period No. matter is pending (` lacs) 1 The Income Tax Act, 1961 CIT (Appeals) 10.12 Asst. Yr 2008-09 2. Do Do 191.54 Asst. Yr. 2009-10 3. Do Do 20.84 Asst. Yr. 2010-11 4. Do Do 40.85 Asst. Yr 2011-12 5. Customs Act 1962 Commissioner 22.15 2007-08 of Customs 6. Kerala Value Added DC (Appeals) 263.48 2011-12 Tax Act, 2003 (x) The company has no accumulated losses as on 31st March, 2014 and it has not incurred any cash losses in the finacial year ended on that date or in the immediately preceding financial year. (xi) On the basis of verification of records and according to the information and explanations given to us, the Company has not defaulted in repayment of dues to Financial Institutions or Banks. (xii) According to the information and explanations given to us, the Company has not granted any loans and advances on the basis of security by way of pledge of share, debentures and other securities. (xiii) The provisions of any special statute applicable to chit fund, nidhi or mutual benefit fund/societies are not applicable to the Company. (xiv) The Company is not dealing or trading in shares, debentures and other investments. (xv) The company has given guarantee for loans taken by employees from financial institutions, the terms and conditions of which are not prejudicial to the interest of the company. (xvi) In our opinion, the term loans have been applied for the purpose for which they were raised. (xvii) According to the records of the Company and on the basis of an overall examination of the balance sheet and cash flow statement for the current year and the information and explanations given to us, we report that funds raised on short-term basis have not been used during the year for long-term investment and vice- versa. (xviii) During the year, the Company has not made any preferential allotment of shares to parties or companies covered in the Register maintained under Section 301 of the Companies Act, 1956. (xix) The company has not issued any debentures during the year. (xx) The company has not raised any money through public issue during the year. (xxi) Based on the audit procedures performed and the representation obtained from the management we report that no fraud on or by the company has been noticed or reported during the year under audit. For Abraham & Jose Chartered Accountants (FRN: 000010S) Jose Pottokaran Place : Thrissur Partner, M.No. 012056 Date : 04-08-2014 Annual Report 2013-2014 113 EÚ…™……«±…™… ®…Ω˛… x…n‰˘∂…EÚ ¥…… h…ŒV™…EÚ ±…‰J…… {…Æ˙“I…… B¥…∆ {…n‰˘x… ∫…n˘∫™…, ±…‰J……{…Æ˙“I…… §……‰b«˜-IV, x…<« n˘±±…“ ∫…∆. 249-{…“ b˜“ ∫…“ B-B®…B§…“-IV/±…‰J……/BS…B±…B±…B±…B±…/14-15/351 n˘x……∆EÚ 22.08.14 M……‰{…x…“™… ∫…‰¥…… ®… +v™…I… B∆¥… |…§…∆v… x…n‰˘∂…EÚ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜, BS…B±…B±… ¶…¥…x…, {…⁄V…{{…÷Æ˙….{…“.+…‰., i…Ø˚¥…x…∆i…{…÷Æ˙®…-695012. ¥…π…™… : BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…‰J…… {…Æ˙ E∆Ú{…x…“ + v… x…™…®…, 1956 EÚ“ v……Æ˙… 619 (4) E‰Ú i…Ω˛i… ¶……Æ˙i… E‰Ú x…™…∆j…EÚ ¥… ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ EÚ“ ]ı{{… h…™……ƒ* ®…Ω˛…‰n˘™…, ®…È BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…‰J…… {…Æ˙ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 619 (4) E‰Ú i…Ω˛i… ¶……Æ˙i… E‰Ú x…™…∆j…EÚ ¥… ®…Ω˛… ±…‰J…… {…Æ˙“I…EÚ EÚ“ ]ı{{… h…™……ƒ <∫…E‰Ú ∫……l… ∫…∆±…Mx… EÚÆ˙i…… Ω⁄ƒ˛* <∫… {…j… EÚ“ {……¥…i…“ EfiÚ{…™…… n˘“ V…B* ¶…¥…n˘“™……, (+j…‰™…“n˘…∫…ı) ®…Ω˛… x…n‰˘∂…EÚ ¥…… h…ŒV™…EÚ ±…‰J……{…Æ˙“I…… B¥…∆ ∫…∆±…Mx…EÚ : ={…Æ˙…‰HÚ {…n‰˘x… ∫…n˘∫™…, ±…‰J……{…Æ˙“I…… §……‰‰b-IV BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…‰J…… {…Æ˙ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 619 (4) E‰Ú +v…“x… ¶……Æ˙i… E‰Ú x…™…∆j…EÚ B¥…∆ ®…Ω˛… ±…‰J…… {…Æ˙“I…EÚ EÚ“ ]ı{{… h…™……ƒ E∆Ú{…x…“ + v… x…™…®… 1956 E‰Ú +v…“x… x…v……« Æ˙i… ¥…k…“™… Æ˙{……‰Õ]ıM… ∞¸{…Ɖ˙J…… E‰Ú +x…÷∫……Æ˙˙ 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú ¥…k…“™… ¥…¥…Æ˙h… i…Ë™……Æ˙ EÚÆ˙x…… E∆Ú{…x…“ E‰Ú |…§…∆v…x… EÚ… =k…Æ˙n˘… ™…i¥… Ω˲* ¶……Æ˙i…“™… ∫…x…n˘“ ±…‰J……EÚ…Æ˙ EÚ“ ∫…∆∫l…… E‰Ú ¥™……¥…∫…… ™…EÚ x…EÚ…™… u˘…Æ˙… x…v……« Æ˙i… ±…‰J……{…Æ˙“I…h… {…Æ˙ ®……x…EÚ E‰Ú +x…÷∫……Æ˙ ∫¥…i…∆j… ±…‰J……{…Æ˙“I…… E‰Ú +…v……Æ˙ {…Æ˙ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 227 E‰Ú +v…“x…, (+j…‰™…“n˘…∫…ı) ∫l……x… : x…<« n˘±±…“ ®…Ω˛… x…n‰˘∂…EÚ ¥…… h…ŒV™…EÚ ±…‰J……{…Æ˙“I…… B¥…∆ i……Æ˙“J… : 22.08.2014 {…n‰˘x… ∫…n˘∫™…, ±…‰J……{…Æ˙“I…… §……‰‰b-IV +…`ˆ¥……ƒ ¥… x…¥……ƒ i…±…,∫…∆EÚ…™… ¶…¥…x…, 10, §…Ω˛…n÷˘Æ˙ ∂……Ω˛ W…°ÚÆ˙ ®……M…«, x…<« n˘±±…“-110002 n⁄˘Æ˙¶……π…: 23239413, 23239415, 23239419, 23239420, °ËÚC∫…: 23239416 <«-®…˱…: [email protected] ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 114 Office of the Director General of Commercial Audit and Ex-Officio Member, Audit Board-IV, New Delhi No. 249-PDCA-MAB-IV/A/cs/HLLLL/14-15/351 Dated 22.08.14 CONFIDENTIAL To The Chairman & Managing Director HLL Lifecare Limited HLL Bhavan, Poojappura.P.O., Thiruvananthapuram-695012 Sub : Comments of the Comptroller and Auditor General of India under Section 619 (4) of the Companies Act, 1956 on the accounts of HLL Lifecare Limited for the year ended 31st March 2014. Sir, I am to enclose herewith the Comments of the Comptroller and Auditor General of India under Section 619 (4) of the Companies Act, 1956 on the accounts of HLL Lifecare Limited for the year ended 31st March 2014. The receipt of the letter may kindly be acknowledged. Yours faithfully, (Atreyee Das) Director General of Commercial Audit & Encl : as above Ex-Officio Member, Audit Board-IV COMMENTS OF THE COMPTROLLER AND AUDITOR GENERAL OF INDIA UNDER SECTION 619(4) OF THE COMPANIES ACT, 1956 ON THE ACCOUNTS OF HLL LIFECARE LIMITED FOR THE YEAR ENDED 31st MARCH 2014 The preparation of financial statements of HLL Lifecare Limited for the year ended 31st March 2014 in accordance with the financial reporting framework prescribed under the Companies Act 1956, is the responsibility of the management of the Company. The Statutory Auditors appointed by the Comptroller and Auditor General of India under Section 619 (2) of the Companies Act, 1956 are responsible for expressing opinion on these financial statements under Section 227 of the Companies Act, 1956 based on the independent audit in accordance with the Standards on Auditing prescribed by their professional body, the Institute of Chartered Accountants of India. This is stated to have been done by them vide their Audit Report dated 5th July 2014. I, on behalf of the Comptroller and Auditor General of India, have condutcted a supplementary audit under Section 619(3)(b) of the Companies Act, 1956 of the financial statements of HLL Lifecare Limited for the year ended 31st March 2014. This supplementary audit has been carried out independently without access to the working papers of the statutory auditors and is limited primarily to inquiries of the statutory auditors and company personnel and a selective examination of some of the accounting records. Based on my supplementary audit, nothing significant has come to my knowledge which would give rise to any comment upon or supplement the Statutory Auditor's report under Section 619 (4) of the Companies Act 1956. For and on behalf of the Comptroller and Auditor General of India (Atreyee Das) Place: New Delhi Director General of Commercial Audit & Dated : 22.08.2014 Ex-Officio Member, Audit Board-IV 8th & 9th Floor, Annexe Building, 10, Bahadur Shah Zafar Marg, New Delhi-110002 Tel : 23239413, 23239415, 23239419, 23239420, Fax : 23239416. E-mail : [email protected] Annual Report 2013-2014 115 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« EÚ… i…÷±…x…-{…j… ¥…¥…Æ˙h… ]ı{{…h…“ ∫…∆ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ±……J…… ®… ` ±……J…… ®… EÚ <ŒC¥…]ı“ ¥… n‰˘™…i……Bƒ 1. +∆∂…v…… Æ˙™…… EÚ“ x… v… (EÚ) ∂…‰™…Æ˙ {…⁄ƒV…“ 3 19,353.50 19,353.50 (J…) +…Æ˙ I…i… i…l…… + v…∂…‰π… 4 20,586.01 18,468.10 39,939.51 37,821.60 2. M…ËÆ˙-S……±…⁄ n‰˘™…i……Bƒ (EÚ) n˘“P…«EÚ…±…“x… =v……Æ˙ 5 7,722.38 5,265.49 (J…) +…∫l… M…i… EÚÆ˙ n‰˘™…i…… ( x…¥…±…) 23 1,263.47 968.84 8,985.85 6,234.33 3. S……±…⁄ n‰˘™…i……Bƒ (EÚ) ø∫¥…EÚ…±…“x… =v……Æ˙ 6 33,766.91 23,460.38 (J…) ¥™……{……Æ˙ n‰˘™… 7 10,281.87 9,276.92 (M…) +x™… S……±…⁄ n‰˘™…i……Bƒ 8 17,963.19 26,369.72 (P…) +±{…EÚ…±…“x… ¥™…¥…∫l……Bƒ 9 1,395.57 1,765.87 63,407.54 60,872.89 4. EÚ…‰x]≈ı… E‰Ú +x…÷∫……Æ˙ x™……∫… E‰Ú +v…“x… Ω÷˛<« {… Æ˙™……‰V…x……+… E‰Ú ±…B |……{i… {…‰∂… M…™……ƒ 71,015.72 50,466.87 E÷Ú±… 1,83,348.62 1,55,395.69 (J…) {… Æ˙∫…∆{… k…™……ƒ 1. M…ËÆ˙-S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (¬EÚ) +S…±… {… Æ˙∫…∆{… k…™……ƒ (i) ®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 10 EÚ 17,844.57 16,723.51 (ii) +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 10 J…Ú 819.06 740.10 (iii) S……±…⁄ {…⁄ƒV…“ EÚ…™…« 10 M…Ú 6,999.90 4,494.56 25,663.53 21,958.17 (J…) M…ËÆ˙-S……±…⁄ x…¥…‰∂… 11 19,420.17 18,586.42 (M…) +x™… M…ËÆ˙-S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ 11B 567.05 531.00 2 S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (EÚ) ¥…∫i…÷∫…⁄ S…™……ƒ 12 11,704.73 10,492.67 (J…) ¥™……{……Æ˙ |……{™… ¥…∫i…÷B· 13 43,148.25 41,481.83 (M…) Æ˙…‰EÚc˜ ¥… ∫…®…®…⁄±™… Æ˙…‰EÚc˜ 14 1,452.80 1,172.88 (P…) ø∫¥…EÚ…±…“x… @Òh… i…l…… {…‰∂… M…™……ƒ 15 9,991.92 8,550.55 (c˜) +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ 16 384.45 2,155.30 66,682.15 63,853.23 3 EÚ…‰x]≈ı… E‰Ú +x…÷∫……Æ˙ x™……∫… E‰Ú +v…“x… Ω÷˛<« {… Æ˙™……‰V…x……+… E‰Ú Æ˙…‰EÚc˜ ¥… §…ÈEÚ ∂…‰π… 71,015.72 50,466.87 E÷Ú±… 1,83,348.62 1,55,395.69 ¥…k…“™… ¥…¥…Æ˙h… E‰Ú Ω˛∫∫…‰ E‰Ú ∞¸{… ®… ∫…∆±…Mx… ]ı{{… h…™……ƒ n‰˘J…Â* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 116 BALANCE SHEET AS AT 31st MARCH 2014 Particulars Note No AS AT AS AT 31.03.2014 31.03.2013 (` lacs) (` lacs) A. EQUITY AND LIABILITIES 1. Shareholders' funds (a) Share Capital 3 19,353.50 19,353.50 (b) Reserves and Surplus 4 20,586.01 18,468.10 39,939.51 37,821.60 2. Non-current liabilities (a) Long-term borrowings 5 7,722.38 5,265.49 (b) Deferred tax liabilites (net) 23 1,263.47 968.84 8,985.85 6,234.33 3. Current liabilities (a) Short-term borrowings 6 33,766.91 23,460.38 (b) Trade payables 7 10,281.87 9,276.92 (c) Other current liabilities 8 17,963.19 26,369.72 (d) Short-term provisions 9 1,395.57 1,765.87 63,407.54 60,872.89 4. Advances Received for Projects held under Trust as per contra 71,015.72 50,466.87 TOTAL 1,83,348.62 1,55,395.69 B. ASSETS 1. Non-current assets (a) Fixed assets i) Tangible assets 10.A 17,844.57 16,723.51 ii) Intangible assets 10.B 819.06 740.10 iii) Capital work-in-progress 10.C 6,999.90 4,494.56 25,663.53 21,958.17 (b) Non-current investments 11 19,420.17 18,586.42 (c) Other Non-Current assets 11A 567.05 531.00 2. Current assets (a) Inventories 12 11,704.73 10,492.67 (b) Trade receivables 13 43,148.25 41,481.83 (c) Cash and cash equivalents 14 1,452.80 1,172.88 (d) Short-term loans and advances 15 9,991.92 8,550.55 (e) Other current assets 16 384.45 2,155.30 66,682.15 63,853.23 3. Cash and Bank balances of Projects held under Trust as per contra 71,015.72 50,466.87 TOTAL 1,83,348.62 1,55,395.69 See accompanying notes forming part of the financial statements For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 117 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« EÚ… ±……¶…-Ω˛… x… ¥…¥…Æ˙h… ¥…¥…Æ˙h… ]ı{{…h…“ ∫…∆ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ``` ±……J…… ®… ``` ±……J…… ®… EÚ ∫…i…i… |…S……±…x… 1 |…S……±…x…… ∫…‰ Æ˙…V…∫¥… (∫…EÚ±…) 17 94,726.54 83,566.42 x™…⁄x… : =i{……n˘ ∂…÷±EÚ 558.38 272.31 |…S……±…x…… ∫…‰ Æ˙…V…∫¥… ( x…¥…±…) 94,168.16 83,294.11 2 +x™… +…™… 18 1,200.67 706,34 3 E÷Ú±… Æ˙…V…∫¥… (1+2) 95,368.83 84,000.45 4 ¥™…™… (EÚ) ={…¶…÷HÚ ®……±…… EÚ“ ±……M…i… 19 (EÚ) 19,399.17 19,036.76 (J…) ¥™……{……Æ˙ ∫]ı…ÏEÚ E‰Ú GÚ™… 19 (J…) 15,627.36 18,365.52 (M…) i…Ë™……Æ˙ ®……±…, S……±…⁄ EÚ…™…« |…M…˘ i… ®… +…ËÆ˙ ¥™……{……Æ˙ ∫]ı…ÏEÚ EÚ“ ¥…∫i…÷∫…⁄S…“ ®… {… Æ˙¥…i…«x… 19 (M…) (905.31) (2,769.18) (P…) EÚ®…«S……Æ˙“ Ω˛i…±……¶… ¥™…™… 20 13,481.93 12,475.76 (RÛ) ¥…k… ±……M…i… 21 1,840.35 1,402.68 (S…) ®…⁄±™…ø…∫… B¥…∆ {… Æ˙∂……‰v…x… ¥™…™… 10.P… 2,375.88 2,084.96 (UÙ) +x™… ¥™…√™… 22 25,751.23 21,200.86 (V…) `‰ˆEÚ… ¥™…™… 14,177.14 8,422.22 5 E÷Ú±… ¥™…™… 91,747.75 80,219.58 6 ¥…∂…‰π… +…ËÆ˙ +∫……v……Æ˙h… ®…n¢ +…ËÆ˙ EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (3-5) 3,621.08 3,780.87 ¥…∂…‰π… ®…n¢ -- 7 EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (3-5) 3,621.08 3,780.87 8 EÚÆ˙ ¥™…™… (EÚ) S……±…⁄ ¥…π…« E‰Ú ±…B S……±…⁄ EÚÆ˙ ¥™…™… 783.28 791.83 (J…) {…⁄¥…« ¥…π……Á ∫…‰ ∫…∆§…∆ v…i… S……±…⁄ {…Æ˙ ¥™…™… (1.76) (214.51) (M…) B®… B ]ı“ @Òh… {……j…i…… (25.83) (419.00) (P…) +…∫l… M…i… EÚÆ˙ 294.62 615.08 1,050.31 773.40 9 ∫…i…i… |…S……±…x… (6-7) ∫…‰ ¥…π…« E‰Ú ±…B ±……¶…/(Ω˛… x…) 2,570.77 3,000.47 10 Æ˙…‰EÚ n˘B |…S……±…x… (6-7) ∫…‰ ±……¶…/(Ω˛… x…) - - 11 ±……¶…/(Ω˛… x…) 2,570.77 3,007.47 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 118 STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED 31ST MARCH 2014 Particulars Note No Year ended Year ended 31-03-2014 31-03-2013 A. CONTINUING OPERATIONS (` lacs) (` lacs) 1. Revenue from operations (gross) 17 94,726.54 83,566.42 Less: Excise duty 558.38 272.31 Revenue from operations (net) 94,168.16 83,294.11 2. Other income 18 1,200.67 706.34 3. Total revenue (1+2) 95,368.83 84,000.45 4. Expenses (a) Cost of materials consumed 19.A 19,399.17 19,036.76 (b) Purchases of stock-in-trade 19.B 15,627.36 18,365.52 (c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 19.C (905.31) (2,769.18) (d) Employee benefits expense 20 13,481.93 12,475.76 (e) Finance costs 21 1,840.35 1,402.68 (f) Depreciation and amortisation expense 10.D 2,375.88 2,084.96 (g) other expenses 22 25,751.23 21,200.86 (h) Contract Expenses 14,177.14 8,422.22 5. Total expenses 91,747.75 80,219.58 6. Profit/(Loss) before Exceptional and extra ordinary items and tax (3-5) 3,621.08 3,780.87 Exceptional items - - 7. Profit/(Loss) before tax (3-5) 3,621.08 3,780.87 8. Tax expenses : (a) Current tax expenses for current year 783.28 791.83 (b) Current tax expense relating to prior years (1.76) (214.51) (c) MAT Credit Entitlement (25.83) (419.00) (d) Deferred tax 294.62 615.08 1,050.31 773.40 9. Profit/ (Loss) for the period from continuing operations (6-7) 2,570.77 3,007.47 10. Profit/ (Loss) from discontinuing operations (6-7) - - 11. Profit/(Loss) 2,570.77 3,007.47 Annual Report 2013-2014 119 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« EÚ… ±……¶…-Ω˛… x… ¥…¥…Æ˙h… (V……Æ˙“.....) ¥…¥…Æ˙h… ]ı{{…h…“ ∫…∆ 31 ®……S…« 2014 EÚ…‰ 31 ®……S…« 2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ``` ±……J…… ®… ``` ±……J…… ®… 8.i |… i… ∂…‰™…Æ˙ +V…«x… (EÚ) ®…⁄±… 132.83 155.40 (i) ∫…i…i… |…S……±…x… 132.83 155.40 (ii) E÷Ú±… |…S……±…x… (J…) Ω˛±EÚ… (i) ∫…i…i… |…S……±…x… 132.83 155.40 (ii) E÷Ú±… |…S……±…x… 132.83 155.40 8.ii +V…«x… |… i… ∂…‰™…Æ˙ (+∫……v……Æ˙h… ®…n˘… EÚ…‰ UÙ…‰b˜EÚÆ˙) (EÚ) ®…⁄±… (i) ∫…i…i… |…S……±…x… 132.83 155.40 (ii) E÷Ú±… |…S……±…x… 132.83 155.40 (J…) Ω˛±EÚ… (i) ∫…i…i… |…S……±…x… 132.83 155.40 (ii) E÷Ú±… |…S……±…x… 132.83 155.40 ¥…k…“™… ¥…¥…Æ˙h… E‰Ú Ω˛∫∫…‰ E‰Ú ∞¸{… ®… ∫…∆±…Mx… ]ı{{… h…™……ƒ n‰˘J…Â* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 120 STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED 31 MARCH, 2014 Particulars (CONTD.)Note No Year ended Year ended 31-03-2014 31-03-2013 (in ` ) (in `) 8.i Earnings per share (a) Basic (i) Continuing operations 132.83 155.40 (ii) Total operations 132.83 155.40 (b) Diluted (i) Continuing operations 132.83 155.40 (ii) Total operations 132.83 155.40 8.ii Earnings per share (excluding extraordinary items) (a) Basic (i) Continuing operations 132.83 155.40 (ii) Total operations 132.83 155.40 (b) Diluted (i) Continuing operations 132.83 155.40 (ii) Total operations 132.83 155.40 See accompanying notes forming part of the financial statements For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 121 ¥…π…« 31.03.2014 E‰Ú ∫…®……{i… x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ``` ±……J…… ®… ```±……J…… ®… EÚ |…S……±…x… EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ +∫……v……Æ˙h… ®…n˘… +…ËÆ˙ EÚÆ˙ E‰Ú {…⁄¥…« ±……¶… 3,621.08 3,780.87 ∫…®……™……‰V…x… : ®…⁄±™…ø…∫… +…ËÆ˙ {… Æ˙∂……‰v…x… 2,375.88 2,084.96 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ {…Æ˙ Ω˛… x… 2.70 2.08 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ {…Æ˙ ±……¶… (22.54) (0.51) ¥…k… ±……M…i… 1,840.35 1,402.68 §™……V… +…™… (324.92) (396.19) S……±…⁄ {…⁄ƒV…“ {… Æ˙¥…i…«x… E‰Ú {…⁄¥…« |…S……±…x… ±……¶…/(Ω˛… x…) 7,492.55 6,873.89 S……±…⁄ {…⁄ƒV…“ ®… {… Æ˙¥…i…«x… |…S……±…x… {… Æ˙∫…∆{… k…™…… ®… (¥…fi r˘/EÚ®…“) E‰Ú ±…B ∫…®……™……‰V…x…& ¥…∫i…÷∫…⁄S…“ (1,212.06) (3,057.84) ¥™……{……Æ˙ |……{™… ¥…∫i…÷Bƒ (1,666.41) (16,298.28) +±{…EÚ…±…“x… @Òfih… B¥…∆ {…‰∂… M…™……ƒ (1,160.30) (1,709.25) +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (1,770.85) (867.43) |…S……±…x… n‰˘™…i……+… ®… (¥…fi r˘/EÚ®…“) E‰Ú ±…B ∫…®……™……‰V…x… : ¥™……{……Æ˙ |……{™… ¥…∫i…÷Bƒ 1,004.95 1,231.04 +x™… S……±…⁄ n‰˘™…i……™… (8,406.53) 12,773.18 +±{…EÚ…±…“x… |……¥…v……x… (370.30) 408.21 +∫……v……Æ˙h… ®…n˘… ∫…‰ x…EÚn˘ |…¥……Ω˛ (2,547.25) (646.48) |…S……±…x… ∫…‰ §…x……™…“ Æ˙…‰EÚc˜ (2,547.25) (646.48) x…¥…±… +…™… EÚÆ (˙|…n˘k…)/¥……{…∫…“ (1,062.59) (1,049.28) |…S……±…x… EÚ…™…«EÚ±……{…… ∫…‰ (|…™…÷HÚ) x…¥…±… x…EÚn˘ |…¥……Ω˛ - (EÚ) (3,609.84) (1,695.76) J… x…¥…‰∂…“ EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ S……±…⁄ {…⁄ƒV…“ EÚ…™…« ®… |…M… i… (2,505.34) (1,432.15) +S…±… {… Æ˙∫…∆{… k…™…… ®… x…¥…‰∂… (3,572.97) (6,364.63) +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ 16.91 4.70 |……{i… §™……V… 324.92 396.19 ±……<¢Úœ∫|…M… +∫{…i……±… (|……<¥…‰]ı) ±… ®…]‰ıb˜ ®… x…¥…‰∂… (125.00) - BS… §…“ B±… ®… x…¥…‰∂… - (17,801.00) V…“ B {…“ B±… ®… x…¥…‰∂… (708.75) - +x™… M…ËÆ˙ S……±…⁄ {… Æ˙∫…∆{… k…™…… ®… {… Æ˙¥…i…«x… (10.22) (112.00) §…ÈEÚ W…®…… ®… x…¥…‰∂… (i…“x… ∫…‰ + v…EÚ ®…Ω˛“x…… E‰Ú ®…⁄±… {… Æ˙{…C¥…i…… Ω˛…‰x…‰ ¥……±…‰˛) (37.02) 749.36 x…¥…‰∂… EÚ…™…«EÚ±……{…… ∫…‰/(|…™…÷HÚ) x…¥…±… x…EÚn˘ |…¥……Ω˛ (J…) (6,617.48) (24,559.52) M… ¥…k…“™…x… EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ n˘“P…«EÚ…±…“x… @Òh…… ∫…‰ |……Œ{i…™……ƒ 2,456.89 3,417.98 +x™… +±{…EÚ…±…“x… @Òh…… ∫…‰ |……Œ{i…™……ƒ 10,306.53 10,190.49 ¥…k… ±……M…i… - |…n˘k… §™……V… (1,840.35) (1,402.68) ∂…‰™…Æ˙ +…¥…‰n˘x… EÚ“ x…M…«®… |……Œ{i…™……ƒ - 15,000.00 |…n˘k… ±……¶……∆∂… (387.07) (387.07) ±……¶……∆∂… {…Æ˙ EÚÆ˙ (65.79) (64.89) ¥…k…“™…x… EÚ…™…«EÚ±……{…… ∫…‰/(|…™…÷HÚ) x…¥…±… x…EÚn˘ |…¥……Ω˛ (M…) 10,470.21 26,753.83 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 122 CASH FLOW STATEMENT FOR THE YEAR ENDED 31.03.2014 Particulars Year ended Year ended 31.03.2014 31.03.2013 (` lacs) (` lacs) A. Cash flow from operating activities Profit before extraordinary items and tax 3,621.08 3,780.87 Adjustments for : Depreciation and amortisation 2,375.88 2,084.96 Loss on sale of fixed assets 2.70 2.08 Profit on sale of fixed assets (22.54) (0.51) Finance costs 1,840.35 1,402.68 Interest income (324.92) (396.19) Operating profit/(Loss) before working capital changes 7,492.55 6,873.89 Changes in working capital : Adjustment for (increase)/decrease in operating assets : Inventories (1,212.06) (3,057.84) Trade receivables (1,666.41) (16,298.28) Short-term loans and advances (1,160.30) (1,709.25) other current assets 1,770.85 (867.43) Adjustment for increase/(decrease) in operating liabilities : Trade payables 1,004.95 1,231.04 Other current liabilities (8,406.53) 12,773.18 Short-term provisions (370.30) 408.21 (2,547.25) (646.48) Cash flow from extraordinary items Cash generated from operations (2,547.25) (646.48) Net Income tax (paid)/refunds (1,062.59) (1,049.28) Net cash flow from/(used in) operating activities (A) (3,609.84) (1,695.76) B. Cash flow from investing activities Capital Work in Progress (2,505.34) (1,432.15) Investment in Fixed Assets (3,572.97) (6,364.63) Sale of fixed assets 16.91 4.70 Interest received 324.92 396.19 Investment in Lifespring Hospitals (P) Ltd. (125.00) - Investment in HBL - (17,801.00) Investment in GAPL (708.75) - Changes in other non-current assets (10.22) (112.00) Investments in bank deposits (having original maturity of more than three months) (37.02) 749.36 Net cash flow from/(used in) investing activities (B) (6,617.48) (24,559.52) C. Cash flow from financing activities Proceeds from long-term borrowings 2,456.89 3,417.98 Proceeds from other short-term borrowings 10,306.53 10,190.49 Finance cost - Interest paid (1,840.35) (1,402.68) Issue Proceeds of Share Application - 15,000.00 Dividend paid (387.07) (387.07) Tax on dividend (65.79) (64.89) Net Cash flow from/(used in) financing activities (C) 10,470.21 26,753.83 Annual Report 2013-2014 123 ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ ®… x…¥…±… ¥…fi r˘/(EÚ®…“) ``` ±……J…… ®… ```±……J…… ®… ¥…π…« E‰Ú +…Æ∆˙¶… ®… x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ 242.90 498.55 ¥…π…« E‰Ú +∆i… ®… x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ 1,009.63 511.09 i…÷±…x… {…j… E‰Ú ∫……l…˙ x…EÚn˘ i…l…… x…EÚn˘ i…÷±™……∆EÚ EÚ… ∫…®……v……x… 1,252.53 1,009.64 i…÷±…x… {…j… E‰Ú +x…÷∫……Æ˙ x…EÚn˘ i…l…… x…EÚn˘ i…÷±™……∆EÚ ( ]ı{{…h…“ 14 n‰˘J… ) 1,452.80 1,172.88 x™…⁄x…& x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… BB∫… 3 ®… {… Æ˙¶…… π…i… V…Ë∫…‰ x…EÚn˘ i…l…… x…EÚn i…÷±™……∆EÚ §…ÈEÚ ∂…‰π… E‰Ú ∞¸{… ®… x…Ω˛”˛ ®……x…… M…™…… Ω˲˘ 200.27 163.25 ]ı{{…h…“ 14 ®… ∂…… ®…±… EÚB x…¥…±… x…EÚn˘ i…l…… x…EÚn˘ i…÷±™……∆EÚ (x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… BB∫… 3 ®… {… Æ˙¶…… π…i… V…Ë∫…‰) 1,252.53 1,009.63 ¥…π…« E‰Ú +∆i… ®… x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ* ∫…®…… ¥…π]ı * (EÚ) Æ˙…‰EÚc˜ ∂…‰π…˘ 12.78 12.84 (J…) §…ÈEÚ…Â E‰Ú ∫……l… ∂…‰π…˘ (i) S……±…⁄ J……i…‰ ®… 1,226.01 996.77 (ii) <« <« B°Ú ∫…“ J……i…‰ ®… 13.74 0.02 1,252.53 1,009.63 1. ={…™…÷«HÚ x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… ¶……Æ˙i…“™… ∫…x…n˘“ ±…‰J……EÚ…Æ˙ E‰Ú ∫…∆∫l……x… u˘…Æ˙… V……Æ˙“ B B∫…-3 ®… x…Ãn˘π]ı {…Æ˙…‰I… |…h……±…“ E‰Ú +v…“x… i…Ë™……Æ˙ EÚ™…… M…™…… Ω˲* 2. <∫… ∫……±… E‰Ú |…∫i…÷i…“EÚÆ˙h… E‰Ú +x…÷∞¸{… Ω˛…‰x…‰ EÚ“ +…‰Æ˙ {…UÙ±…‰ ¥…π…« E‰Ú +…ƒEÚc…‰∆ EÚ…‰ V…Ω˛…ƒ +…¥…∂™…EÚ Ω˛…‰, {…÷x…¥…«M…‘EfiÚi… EÚ™…… M…™…… Ω˲∆* 3. x…EÚn˘ |…¥……Ω˛ ®… x™……∫… E‰Ú +v…“x… Æ˙Ω˛“ {… Æ˙™……‰V…x…… x… v… E‰Ú ±…‰x… - n‰˘x… +…ËÆ˙ ` 71,015.72 ±……J… ({…⁄¥…« ¥…π…« ` 50,466.87 ±……J…) E‰Ú ∂…‰π… ∂…… ®…±… x…Ω˛” Ω˲* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 124 Year ended Year ended Particulars 31.03.2014 31.03.2013 (` in lacs) (` in lacs) Net increase/(decrease) in cash and cash equivalents 242.90 498.55 Cash and cash equivalents at the beginning of the year 1,009.63 511.09 Cash and cash equivalents at the end of the year 1,252.53 1,009.64 Reconciliation of cash and cash equivalents with the Cash and cash equivalents as per Balance Sheet (Refer Note 14) 1,452.80 1,172.88 Less : Bank balances not considered as cash and cash equivalents as defined in AS 3 Cash Flow Statements 200.27 163.25 Net Cash and cash equivalents (as defined in AS 3 Cash Flow Statements) included in Note 14 1,252.53 1,009.63 Cash and cash equivalents at the end of the year* * Comprises (a) Cash on hand 12.78 12.84 (b) Balances with banks (i) In current accounts 1,226.01 996.77 (ii) In EEFC accounts 13.74 0.02 1,252.53 1,009.63 1 The above Cash Flow Statement has been prepared under the indirect method set out in the AS - 3 issued by the Institute of Chartered Accountants of India. 2 The previous year’s figures have been re-grouped wherever necessary in order to confirm to this year’s presentation. 3 Transactions of project funds held under Trust and balance of `71,015.72 lacs (previous year `50,466.87 lacs) are not included in the Cashflow For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 125 ]ı{{…h…“ 3 ∂…‰™…Æ˙ {…⁄ƒV…“ ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ```±……J…… ®… (EÚ) |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ |…i™…‰EÚ ` 1000/- <ŒC¥…]ı“ ∂…‰™…Æ˙-30,00,000 ∫…∆J™…… 30,000.00 30,000.00 (J…) V……Æ˙“ EÚ“ M…<« ∂…‰™…Æ {…⁄ƒV…“ |…i™…‰EÚ `1000/- <ŒC¥…]ı“ ∂…‰™…Æ-19,35,350 ∫…∆J™…… 19,353.50 19,353.50 (M…) + ¶…n˘k… +…ËÆ˙ {…⁄h…«i…& |…n˘k… ∂…‰™…Æ˙ {…⁄ƒV…“ |…i™…‰EÚ `1000/- <ŒC¥…]ı“ ∂…‰™…Æ˙-19,35,350 ∫…∆J™…… 19,353.50 19,353.50 E÷Ú±… 19,353.50 19,353.50 ∂…‰™…Æ˙ {…⁄ƒV…“ EÚ… ®…‰±… ®…±……{… ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∂…‰™…Æ˙… EÚ“ ∫…∆J™…… ÆEÚ®… ` ±……J…… ®… ∂…‰™…Æ˙… EÚ“ ∫…∆J™…… ÆEÚ®… `±……J…… ®… <ŒCEÚ]ı“ ∂…‰™…Æ˙ {…⁄ƒV…“ |…… v…EfiÚi… +l… ∂…‰π… 30,00,000.00 30,000.00 2,00,000.00 2,000.00 {… Æ˙¥…v…«x… - - 28,00,000.00 28,000.00 +∆ i…®… ∂…‰π… 30,00,000.00 30,000.00 30,00,000.00 30,000.00 V……Æ˙“ EÚB M…B +l… ∂…‰π… 19,35,350.00 19,353,50 2,00,000.00 2,000.00 {… Æ˙¥…v…«x… - - 17,35.350.00 17,353.50 +∆ i…®… ∂…‰π… 19,35,350.00 19,353.50 19,35,350.00 19.353.50 + ¶…n˘k… +…ËÆ˙ |…n˘x… +l… ∂…‰π… 19,35,350.00 19,353.50 1,55,350.00 1,553.50 {… Æ˙¥…v…«x… - - 17,80,000.00 17,800.00 +∆ i…®… ∂…‰π… 19,35,350.00 19,353.50 19,35,350.00 19,353.50 5% ∫…‰ + v…EÚ ∂…‰™…Æ˙ {……∫… Æ˙J…‰ |…i™…‰EÚ ∂…‰™…Æ˙v……Æ˙EÚ E‰Ú ∂…‰™…Æ˙… E‰Ú ¥…¥…Æ˙h… ∂…‰™…Æ˙v……Æ˙EÚ EÚ… x……®… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ v……Æ˙h… EÚ™…‰ v……Æ˙h… EÚ“ v……Æ˙h… EÚB v……Æ˙h… EÚ“ ∂…‰™…Æ˙… EÚ“ ∫…∆J™…… |… i…∂…i…i…… ∂…‰™…Æ˙… EÚ“ ∫…∆J™…… |… i…∂…i…i…… ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ 19,35,350 100% 19,35,350 100% ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 126 Note 3 Share Capital Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs (a) Authorised Share Capital Equity shares of ` 1000/- each - 30,00,000 Nos. 30,000.00 30,000.00 (b) Issued Share Capital Equity shares of ` 1000/- each - 19,35,350 Nos. 19,353.50 19,353.50 (c) Subscribed and fully paid up Share Capital Equity shares of ` 1000/- each - 19,35,350 Nos. 19,353.50 19,353.50 Total 19,353.50 19,353.50 Reconciliation of Share Capital Description AS AT 31.03.2014 AS AT 31.03.2013 No. of Amount No. of Amount shares in lacs shares in lacs Equity Share Capital Authorized Opening Balance 30,00,000.00 30,000.00 2,00,000.00 2,000.00 Additions - - 28,00,000.00 28,000.00 Closing Balance 30,00,000.00 30,000.00 30,00,000.00 30,000.00 Issued Opening Balance 19,35,350.00 19,353.50 2,00,000.00 2,000.00 Additions - - 17,35,350.00 17,353.50 Closing Balance 19,35,350.00 19,353.50 19,35,350.00 19,353.50 Subscribed & Paid up Opening Balance 19,35,350.00 19,353.50 1,55,350.00 1,553.50 Additions - - 17,80,000.00 17,800.00 Closing Balance 19,35,350.00 19,353.50 19,35,350.00 19,353.50 Details of shares held by each shareholder holding more than 5% shares: Name of shareholder AS AT 31.03.2014 AS AT 31.03.2013 Number of % of Number of % of shares held Holding shares held Holding Govt. of India 19,35,350 100% 19,35,350 100% Annual Report 2013-2014 127 ]ı{{…h…“ 4 +…Æ˙ I…i… i…l…… + v…∂…‰π… ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… (EÚ) ∫……®……x™… +…Æ˙ I…i… +l… ∂…‰π… 18,424.24 15,863.46 V……‰b˜ : ±……¶… ¥… Ω˛… x… E‰Ú ¥…¥…Æ˙h… ®… + v…∂…‰π… ∫…‰ +∆i… Æ˙i… 2,081.11 2,511.65 V……‰b˜ : ¥…π…« E‰Ú n˘…ËÆ˙…x… ∫…“ B∫… +…Æ˙ ∫…‰ +∆i… Æ˙i… 43.86 49.13 +∆ i…®… ∂…‰π… 20,549.21 18,424.24 (J…) EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… (∫…“B∫…+…Æ˙) +l… ∂…‰π… 43.86 49.13 V……‰b˜: ¥…π…« E‰Ú n˘…ËÆ˙…x… {… Æ˙¥…v…«x…/+∆i…Æ˙h… 36.80 43.86 x™…⁄x…˜: ¥…π…« E‰Ú n˘…ËÆ˙…x… ∫……®……x™… +…Æ˙ I…i… EÚ…‰˙ +∆i… Æ˙i… 43.86 49.13 +∆ i…®… ∂…‰π… 36.80 43.86 (M…) ±……¶… ¥… Ω˛… x… E‰Ú ¥…¥…Æ˙h… ®… + v…∂…‰π…/P……]ı… +l… ∂…‰π… - - V……‰b˜ : ¥…π…« E‰Ú ±…B ±……¶…/(Ω˛… x…) 2,570.77 3,007.47 V……‰b˜ : {…÷Æ˙…∆ EÚi… ±……¶……∆∂… {…Æ˙ EÚÆ˙ E‰Ú ±…B + v…EÚ |……¥…v……x… - 0.90 x™…⁄x… : |…∫i…… ¥…i… ±……¶……∆∂… <ŒC¥…]ı“ ∂…‰™…Æ˙ v……Æ˙EÚ…Â EÚ…‰ |…∫i…… ¥…i… ±……¶……∆∂… (` 20 |… i… ∂…‰™…Æ˙, {…⁄¥…« ¥…π…« ` 20/- ∂…‰™…Æ) 387.07 387.07 ±……¶……∆∂… {…Æ˙ EÚÆ˙ 65.79 65.79 +∆i… Æ˙i… : ∫…“B∫…+…Æ˙ E‰Ú ±…B +…Æ˙ I…i… 36.80 43.86 ∫……®……x™… +…Æ˙ I…i… 2,081.11 2,511.65 +∆ i…®… ∂…‰π… - - E÷Ú±… 20,586.01 18,468.10 ]ı{{…h…“ 5 n˘“P…«EÚ… ±…EÚ =v……Æ˙ ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… ∫]‰ı] §…ÈEÚ +…Ï°Ú <∆ b˜™…… ∫…‰ (EÚ) +…¥… v…EÚ @Òh… ¥…n‰˘∂…“ ®…÷p˘… @Òh… - |… i…¶…⁄i… 2,830.49 3,975.78 +…¥… v…EÚ @Òh… Ø˚{…™…… - |… i…¶…⁄i… 3,865.56 - (J…) +x™… @Òh… ¥… + O…®… ¥…n‰˘∂…“ ®…÷p˘… G‰Úi…… EÚ“ ∫……J… 1,026.33 1,289.71 E÷Ú±… 7,722.38 5,265.49 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 128 Note 4 Reserves and surplus Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs (a) General reserve Opening balance 18,424.24 15,863.46 Add : Transferred from surplus in Statement of Profit and Loss 2,081.11 2,511.65 Add : Transferred during the year from CSR 43.86 49.13 Closing balance 20,549.21 18,424.24 (b) Corporate Social Responsibility (CSR) Opening balance 43.86 49.13 Add : Additions/transfers during the year 36.80 43.86 Less : Transferred during the year to General Reserve 43.86 49.13 Closing balance 36.80 43.86 (c) Surplus / (Deficit) in Statement of Profit and Loss Opening balance - - Add : Profit / (Loss) for the year 2,570.77 3,007.47 Add : Excess Provision for Tax on dividend Written Back - 0.90 Less : Proposed Dividend Dividend proposed to equity shareholders (`20 per share, Previous year `20 share) 387.07 387.07 Tax on dividend 65.79 65.79 Transferred to : Reserves for CSR 36.80 43.86 General Reserve 2,081.11 2,511.65 Closing balance - - Total 20,586.01 18,468.10 Note 5 Long-term borrowings Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs From State Bank of India (a) Term Loans Foreign currency loan-Secured 2,830.49 3,975.78 Rupee Term Loan-Secured 3,865.56 - (b) Other loans and Advances Foreign currency Buyers Credit 1,026.33 1,289.71 Total 7,722.38 5,265.49 Annual Report 2013-2014 129 ±……J…… ®… ±……J…… +|… i…¶…⁄i… ` 31.03.2013 EÚ…‰ 31.03.2013 ±……J…… ®… ±……J…… |… i…¶…⁄i… ` ±……J…… ®… ±……J…… ` 31.03.2014 EÚ…‰ 31.03.2014 6,696.057,894.156,867.821,026.33 3,975.78 8,289.93 7,000.22 1,289.71 2,499.78 1,593.68 9,195.83 5,569.46 ±……J…… ®… ±……J…… |… i…¶…⁄i… +|… i…¶…⁄i… ` 11.46 ±……J… ` 11.30 ±……J…) 11.30 1582.38 ±……J…) 1582.38 |… i…¶…⁄ i… E‰Ú §™……ËÆ˙… E‰Ú |… i…¶…⁄ i… ` ` 2488.32 ±……J… - ±……J… 2488.32 ` ¶…⁄ ®… ¥… ®…EÚ…x… EÚ…‰ UÙ…‰b˜EÚÆ˙ E∆Ú{…x…“ UÙ…‰b˜EÚÆ˙ EÚ…‰ ®…EÚ…x… ¥… ¶…⁄ ®… |…l…®… {…Æ˙ {… Æ˙∫…∆{… k…™…… +S…±… EÚ“ S……V…«* x……‰Bb˜… EÚ“ ¶…⁄ ®… {…Æ˙ ∫……Œ®™…EÚ §…∆v…EÚ*V…®……x…i…“ {…Æ˙ ¶…⁄ ®… ∫… Ω˛i… 4,440.75* §…∆v…EÚ ∫……Œ®™…EÚ ®… ∞¸{… E‰Ú 5,569.46 ({…⁄¥…« ¥…π…« ({…⁄¥…« (EÚ) ({…⁄¥…« ¥…π…«- ({…⁄¥…« (J…) (M…)®…EÚ…x… E‰Ú i…Ø˚¥…x…∆i…{…÷Æ˙®… {…⁄V…{{…÷Æ˙…, 2. |……‰n¬˘¶…⁄i… §™……V… +…ËÆ˙ n‰˘™…- ¥…¥…Æ˙h… ¥…n‰˘∂…“ ®…÷p˘… @Òh… ®…÷p˘… ¥…n‰˘∂…“ §…ÈEÚ +…Ï°Ú <∆ b˜™…… +x™… @Òh… +…ËÆ˙ + O…®… +…ËÆ˙ @Òh… +x™… ∫……J…-=v……Æ˙EÚ“ G‰Úi……+… =v…˘…Æ˙ +±{…EÚ… ±…EÚ : x™…⁄x… |……{i… u˘…Æ˙… V…®…… {… Æ˙™……‰V…x…… 12 ®…Ω˛“x…… E‰Ú §……n˘ n‰˘™… §……n˘ E‰Ú ®…Ω˛“x…… 12 S……±…⁄ n‰˘™…i……™… ®……x…… V……i…… Ω˲*V……i…… ®……x…… n‰˘™…i……™… S……±…⁄ <∆b˜∫…<∆b˜ §…ÈEÚ<∆b˜∫…<∆b˜ BS… b˜“ B°Ú ∫…“ Ø˚{…™…… @Òh…@Òh… +…¥… v…EÚ ∫…‰ E÷Ú±…-§…ÈEÚ…Â n‰˘™…®… ®…Ω˛“x…‰ 12 +M…±…‰ : x™…⁄x… EÚ∫i… 1. 4,755.08 - - - §…ÈEÚ…Â ∫…‰ +…¥… v…EÚ @Òh… +…¥… v…EÚ ∫…‰ §…ÈEÚ…Â ]ı{{…h…“ : ¥…n‰˘∂…“ ®…÷p˘… G‰Úi……+… EÚ“ ∫……J… =v……Æ˙ {…⁄ƒV…“M…i… ®…n˘… E‰Ú |……{…h… E‰Ú ±…B ΩÈ˛ ={…±…§v…i…… E‰Ú +x…÷∫……Æ˙ i…“x… ¥…π……Á i…EÚ +…M…‰ §…f¯…x…‰ EÚ“ {……j…i…… ΩÈ˛ ¥…Æ˙x…… =∫…EÚ…‰ ®…∆V…⁄Æ˙ EÚB +…¥… v…EÚ @Òh… ®… {… Æ˙¥…Ãi…i… EÚÆÂ˙M…‰* {… Æ˙¥…Ãi…i… ®… @Òh… +…¥… v…EÚ EÚB ®…∆V…⁄Æ˙ =∫…EÚ…‰ ¥…Æ˙x…… ΩÈ˛ {……j…i…… EÚ“ §…f¯…x…‰ +…M…‰ i…EÚ ¥…π……Á i…“x… +x…÷∫……Æ˙ E‰Ú ={…±…§v…i…… ΩÈ˛ E‰Ú ±…B |……{…h… E‰Ú ®…n˘… {…⁄ƒV…“M…i… =v……Æ˙ ∫……J… EÚ“ G‰Úi……+… ®…÷p˘… ¥…n‰˘∂…“ : ]ı{{…h…“ +x™… n˘“P…«EÚ…±…“x… =v……Æ˙ E‰Ú ±…B S…÷EÚ…Ëi…“ E‰Ú ∂…i…« E‰Ú ¥…¥…Æ˙h… +…ËÆ˙ |……{i… +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ∫…∆§…∆v… ®… n˘“ M…<« |… i…¶…⁄ i…* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 130 lacs ` Unsecured AS AT 31.3.2013 AS AT ilability, or else shall be ilability, lacs ` Secured lacs ` Unsecured AS AT 31.3.2014 AS AT -- lacs ` 4,440.754,755.089,195.83 5,569.46 2,499.786,696.057,894.156,867.82 5,569.46 - 1,026.33 1,593.68 3,975.78 8,289.93 7,000.22 1,289.71 Secured 11.30 Lacs) 11.30 1582.38 Lacs) 2488.32 Lacs ` ` ` Details of security* 1.46 Lacs assets of the company excluding Land & Buildings land at Noida collateral over the land with building at Poojappura, Trivandrum. 1 Interest accrued & due ` (b) Equitable Mortgage over the (Previous year (a)First charge over the fixed - (c)Equitable Mortgage as Particulars erm loan from banks : (i) Details of terms of repayment for the other long-term borrowings and security provided in respect of the secured long-term borrowings : (i) Details of terms repayment for the other long-term borrowings and security provided in respect secured T Other loans and advances : Buyers Credit Borrowings Term Less : Short Secured by Project Deposits State Bank of India State Foreign currency loan Payable after 12 months Liabilities 2. months treated as Current (Previous year IndusInd Bank HDFC Rupee Loan loans from Banks Total-Term Less : Payable within next 12 1. Instalment - Note : Foreign Currency Buyers Credit are for Capital item procurement, eligible for roll over upto three years subject to ava Note : Foreign Currency Buyers Credit are for Capital Loan. Term converted into sanctioned Annual Report 2013-2014 131 ±……J…… ®… +|… i…¶…⁄i… ` 2012-13 ±……J…… ®… |… i…¶…⁄i… ` ±……J…… ®… ` 2013-14 - - 644.53 - ±……J…… ®… |… i…¶…⁄i… +|… i…¶…⁄i… 34.31 - 84.51 22.78 208.79 - 181.67 170.98 ` * 7 ±……J… EÚ“ ` 60 ±……J… EÚ“ ∫…®…i…÷±™… EÚ“ ±……J… 60 ∫…®…i…÷±™… EÚ“ ±……J… 15 ` ` b˜…ϱ…Æ˙ EÚ“ ®…… ∫…EÚ EÚ∫i…, +∆ i…®… ®……S…«˙, 2014 S…÷EÚ…Ëi…“ ¥… |… i…¶…⁄ i… E‰Ú ∂…i…« b˜…ϱ…Æ˙ EÚ“ ®…… ∫…EÚ EÚ∫i…, +∆ i…®… ¶…÷M…i……x… +∆ i…®… EÚ∫i…, ®…… ∫…EÚ EÚ“ b˜…ϱ…Æ˙ 2014 ®……S…«, S……V…« {…Æ˙ ®…∂…“x…Æ˙“ J…Æ˙“n˘“ ∫…‰ ¥…k… §…ÈEÚ EÚ…™……«±…™… ∫…∆{…E«Ú ∫……Æ˙h…“- S…÷EÚ…Ëi…“ ¶…÷M…i……x… +∆ i…®… EÚ∫i…, ®…… ∫…EÚ EÚ“ b˜…ϱ…Æ˙ 2014 +H⁄Ú§…Æ˙, +…ËÆ˙ ¶…⁄ ®… + v…EÚ ∫…‰ ∫EÚ.°Ú“ 5000 {…]¬ı]‰ın˘…Æ˙“ {…Æ˙ ¶…¥…x… |…∫i…… ¥…i… {…Æ˙ =∫… §…∆v…EÚ* ∫……Œ®™…EÚ EÚ… + v…EÚ…Æ˙ EÚ…CEÚx……b˜ °ËÚC]ıÆ˙“ ¶…÷M…i……x… x…Ën˘… x…EÚ ∫…‰¥…… |…¶……M… ∫…‰¥…… x…Ën˘… x…EÚ ∫……Æ˙h…“- S…÷EÚ…Ëi…“ §…ÈEÚ ¥…k… ∫…‰ EÚ…CEÚx……b˜ °ËÚC]ıÆ˙“ ®… S……V…« {…Æ˙ ®…∂…“x…Æ˙“ J…Æ˙“n˘“ ¥…¥…Æ˙h… +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ±…B S…÷EÚ…Ëi…“ E‰Ú ∂…i…« E‰Ú ¥…¥…Æ˙h… +…ËÆ˙ |……{i… +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ∫…∆§…∆v… ®… n˘“ M…<« |… i…¶…⁄ i…* ¥…n‰˘∂…“ ®…÷p˘… @Òh… ®…÷p˘… ¥…n‰˘∂…“ (i) §…ÈEÚ…Â ∫…‰ +…¥… v…EÚ @Òh… : <∆ b˜™…… +…Ï°Ú §…ÈEÚ ∫]‰ı]ı {…⁄V…{{…÷Æ˙…, i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰Ú ®…EÚ…x… ∫… Ω˛i… ¶…⁄ ®… {…Æ˙ ∫…∆{……Ã∑…EÚ E‰Ú ∞¸{… ®… ∫……Œ®™…EÚ S…÷EÚ…Ëi…“ ∫……Æ˙h…“- §…∆v…EÚ ∫…®…i…÷±™… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 132 lacs ` Non Current 2012-13 lacs ` Current lacs ` Non Current 2013-14 - - 644.53 - lacs ` 34.31 - 84.51 22.78 Current 208.79 - 181.67 170.98 7 Lacs, final ` security* Terms of repayment and of repayment Terms 60 Lacs, final payment 15 Lacs final payment ` ` October 2014 Equitable mortgage over leasehold rights over 5000 sq.ft of land & proposed bldg. thereon. Kakkanad Factory equivalent of payment July 2014 Charge over the machinery purchased in Kakkanad factory out of banks finance March 2014. Charge over the machinery purchased from Bank finance Liasion Office Repayment schedule-Monthly instalments of dollar equivalent of Diagnostic Service Division Repayment schedule-Monthly instalments of dollar equivalent of Particulars (i) Details of terms repayment for the other long-term borrowings and security provided in respect secured : Equitable Mortgage as collateral over the land with building atTrivandrumPoojappura, Repayment schedule-Monthly instalments of dollar Term loans from banks : Term Bank of India State Foreign currency loan Annual Report 2013-2014 133 ±……J…… ®… +|… i…¶…⁄i… ` 2012-13 ±……J…… ®… |… i…¶…⁄i… ` ±……J…… ®… ` 2013-14 -- - - ±……J…… ®… |… i…¶…⁄i… +|… i…¶…⁄i… ` 226.83 358.99241.60 228.50 - 510.28 250.90 218.21 * 56.25 ±……J… EÚ“ ` +H⁄Ú§…Æ˙, 2015 S…÷EÚ…Ëi…“ ¥… |… i…¶…⁄ i… E‰Ú ∂…i…« 3.37 ±……J… Ω˲* +…CE÷Ú±…®… °ËÚC]ıÆ˙“ S…÷EÚ…Ëi…“ ∫……Æ˙h…“- ` §…ÈEÚ ¥…k… ∫…‰˙ +…CE÷Ú±…®… °ËÚC]ıÆ˙“ ®… S……V…« {…Æ˙ ®…∂…“x…Æ˙“ J…Æ˙“n˘“ °ËÚC]ıÆ˙“ {…‰∞¸Æ˙EÚc˜… EÚ“ ±……J… 1.02 ™…÷B∫…b˜“ ∫……Æ˙h…“- S…÷EÚ…Ëi…“ ¶…÷M…i……x… +∆ i…®… EÚ∫i…, j…Ë®…… ∫…EÚ 2014 n˘∫…∆§…Æ˙˙, ®… °ËÚC]ıÆ˙“ {…‰∞¸Æ˙EÚb˜… ∫…‰˙ ¥…k… §…ÈEÚ S……V…« {…Æ˙ ®…∂…“x…Æ˙“ J…Æ˙“n˘“ ={…™…÷«HÚ @Òh… {…Æ˙ +ÃV…i… §™……V… +…ËÆ˙ n‰˘™… ∫…®…i…÷±™… b˜…ϱ…Æ˙ EÚ“ j…Ë®…… ∫…EÚ EÚ∫i…, +∆ i…®… ¶…÷M…i……x… +v…“x…, ®…÷∆§…<« E‰Ú EÚ…™……«±…™… ®…EÚ…x…, +…‰b˜“∂…… E‰Ú B®… +…Æ˙ +…<« EÂÚp˘, EÚ]¬ı]ıEÚ, §…±……« +…ËÆ˙ §…‰Æ˙Ω˛…®…{…÷Æ˙ E‰Ú ±……<¢ÚE‰Ú™…Æ˙ EÂÚp˘, B +…<« +…<« +…ËÆ˙ EÂÚp˘ b˜…<ıMx……‰Œ∫]ıEÚ E‰Ú Æ˙…™…{…÷Æ˙ B∫…, B®… B‡Æ˙…{…÷Æ˙®… E‰Ú E∆Úb˜…‰®… ¥… x…®……«h… ∫…÷ ¥…v…… S…±… {… Æ˙∫…∆{… k…™…… {…Æ˙ S……V…« * ¥…¥…Æ˙h… +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ±…B S…÷EÚ…Ëi…“ E‰Ú ∂…i…« E‰Ú ¥…¥…Æ˙h… +…ËÆ˙ |……{i… +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ∫…∆§…∆v… ®… n˘“ M…<« |… i…¶…⁄ i…* <∆b˜∫…<∆b˜ §…ÈEÚ<∆b˜∫…<∆b˜ <∆b˜∫…<∆b˜ §…ÈEÚ u˘…Æ˙… x… v…EÚ {… Æ˙™……‰V…x……+… E‰Ú (i) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 134 lacs ` 2012-13 lacs ` lacs ` Non-current Current Non-current 2013-14 ---- lacs ` 226.83 358.99241.60 228.50 510.28 - 250.90 218.21 Current 3.37 lacs ` security* Terms of repayment and of repayment Terms 56.25 Lacs, final payment ` October 2015. Charge over the machinery Akkulam factory purchased in out of banks finance Peroorkada Factory Repayment schedule-Quarterly instalments of USD 1.02 Lacs, final payment December 2014. Charge over the machinery purchased out of banks finance in Peroorkada factory Interest accrued and due on the above loans is Akkulam Factory Repayment schedule-Quarterly instalments of dollar equivalent of Charge on the movable properties created under project funded by IndusInd Bank. ie., Office Building at Mumbai, MRI Centres Odisha, Lifecare centres at Cuttack, Burla Diagnostic Centres & Berhampur, AIIMS, Raipur and New Condom at Manufacturing facility at Irapuram. Particulars (i) Details of terms repayment for the other long-term borrowings and security provided in respect secured : IndusInd Bank Annual Report 2013-2014 135 ±……J…… ®… +|… i…¶…⁄i… ` 2012-13 ±……J…… ®… |… i…¶…⁄i… ` ±……J…… ®… 3,185.92 ` 2013-14 ±……J…… ®… 86.26 679.64 - - |… i…¶…⁄i… +|… i…¶…⁄i… 803.26 ` 898.73 2,471.49 203.57 3,053.53 2,499.77 6,696.04 1,593.68 3,975.78 * S…÷EÚ…Ëi…“ ¥… |… i…¶…⁄ i… E‰Ú ∂…i…« 7.73 ±……J… Ω˲* ` 42.48 ±……J… EÚ… i…®……Ω˛“ ¶…÷M…i……x…* 1.99 EÚÆ˙…‰c˜ EÚ… i…®……Ω˛“ ¶…÷M…i……x…* 8.08 ±……J… Ω˲* EÚ∫i…, +∆ i…®… ¶…÷M…i……x… EÚx…M…±…… ®… ™…⁄ x… {…±… {… Æ˙™……‰V…x…… E‰Ú ±…B ¶…⁄ ®… {…Æ˙ ∫……Œ®™…EÚ §…∆v…EÚ ™…⁄ x… {…±… {… Æ˙™……‰V…x…… EÚ“ ∫…¶…“ {… Æ˙∫…∆{… k…™…… {…Æ˙ |…l…®… +…ËÆ˙ ¥…∂…‰π… S……V…« ={…™…÷«HÚ @Òh… {…Æ˙ +ÃV…i… §™……V… +…ËÆ˙ §…x…… n‰˘™… 26.03.19 EÚ…‰ +∆ i…®… ¶…÷M…i……x…* {…“ B°Ú ]ı“, §……±…Æ˙…®…{…÷Æ˙®… ∫…÷ ¥…v……, ∫…“ +…Æ˙ b˜“ ∫…“, +…CE÷Ú±…®…, ∫…Ë x…]ıÆ˙“ x…ËŒ{EÚx… ¥… x…®……«h… ™…⁄ x…]ı, EÚx…M…±…… ®… =v……Æ˙ E‰Ú §…x…… J…Æ˙“n˘“ S…±… {… Æ˙∫…∆{… k…™…… {…Æ˙ S……V…«* ={…™…÷«HÚ @Òh… {…Æ˙ +ÃV…i… §™……V… +…ËÆ˙ n‰˘™… E÷Ú±… ` ` ` S…÷EÚ…Ëi…“ +x…÷∫…⁄S…“ 26.12.14 ∫…‰ |……Æ∆˙ ¶…EÚ 26.03.19 E‰Ú +∆ i…®… ¶…÷M…i……x…* {…“ B°Ú ]ı“, §……±…Æ˙…®…{…÷Æ˙®… ∫…÷ ¥…v……, ∫…“ +…Æ˙ b˜“ ™…⁄ x…]ı, ¥… x…®……«h… x…ËŒ{EÚx… ∫…“,+…CE÷Ú±…®…,∫…Ë x…]ıÆ˙“ EÚx…M…±…… ®… =v…˘…Æ˙ ∫…‰ J…Æ˙“n˘“ S…±… {… Æ˙∫…∆{… k…™…… {…Æ˙ S……V…«* S…÷EÚ…Ëi…“ +x…÷∫…⁄S…“ 26.06.14 ∫…‰ |……Æ∆˙ ¶…EÚ ™…⁄ x… {…±… {… Æ˙™……‰V…x…… ¥…¥…Æ˙h… BS… b˜“ B°Ú ∫…“ §…ÈEÚ+¥… v…EÚ @Òh… Ø˚{…™…… ∫……®……x™… |…™……‰V…x… @Òh… §……Ω˛Æ˙“ ¥…… h…ŒV™…EÚ =v……Æ˙ {…⁄V…{{…÷Æ˙…, i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰Ú ®…EÚ…x…∫… Ω˛i… ¶…⁄ ®… {…Æ˙ ∫…∆{……Ã∑…EÚ E‰Ú ∞¸{… ®… S…÷EÚ…Ëi…“ ∫……Æ˙h…“-°ÚÆ˙¥…Æ˙“ 2013 ∫…‰ |……Æ∆˙ ¶…i… ∫……Œ®™…EÚ §…∆v…EÚ Ω˛…‰x…‰¥……±…‰ ™…÷B∫…b˜“ 3.75 ±……J… EÚ“ j…Ë®…… ∫…EÚ +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ±…B S…÷EÚ…Ëi…“ E‰Ú ∂…i…« E‰Ú ¥…¥…Æ˙h… +…ËÆ˙ |……{i… +x™… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ∫…∆§…∆v… ®… n˘“ M…<« |… i…¶…⁄ i…* (i) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 136 lacs ` 2012-13 lacs ` lacs ` 679.64 6,696.04 1,593.68 3,975.78 2013-14 lacs 86.26 ` Current Non-current Current Non-current 803.26 3,185.92 898.73 2,471.49 203.57 3,053.53 2,499.77 7.73 lacs 8.08 lacs ` ` 1.99 crs starting 42.48 lacs starting ` ` security* Terms of repayment and of repayment Terms Unipill Project starting from Feb '13 Equitable Mortgage over the land for Unipill project in Kanagala First & exclusive charge on all the assets of Unipill Project Interet accrued and not due on the above loans is from 26.06.14. Final payment on 26.03.19 Charge over movable assets purchased out of the loan at PFT, CRDC, Balaramapuram Facility, Akkulam, Sanitary Napkin manufacturing unit at Kanagala Interest accrued and due on the above loans is from 26.12.14. Final payment on 26.03.19 Chare over movable assets purchased out of the loan at PFT, CRDC, Balaramapuram Facility, Akkulam, Sanitary Napkin manufacturing unit at Kanagala Repayment Schedule Qtrly payments of Repayment Schedule-Qtrly payments of Total Particulars (i) Details of terms repayment for the other long-term borrowings and security provided in respect secured : External Commerical Borrowing Equitable Mortgage as collateralover the land with building atPoojappura, Trivandrum. Repayment schedule-Quarterly instalments of USD 3.75 lacs HDFC Bank LoansRupees Term General Purpose Loan Annual Report 2013-2014 137 ]ı{{…h…“ 6 +±{…EÚ… ±…EÚ =v……Æ˙ ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… (EÚ) ®……∆M… {…Æ˙ |… i…n‰˘™… @Òh… (x…EÚn˘“ @Òh…) ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… ∫…‰- |… i…¶…⁄i… 11,352.87 8,853.99 [|……‰n¬˘¶…⁄i… +…ËÆ˙ n‰˘™… §™……V… EÚ…‰ UÙ…‰b˜EÚÆ˙ - `110.30 ±……J… ({…⁄¥…« ¥…π…« `101.92 ±……J…)] EËÚx…Æ˙… §…ÈEÚ ∫…‰ 4,495.56 0.00 [|……‰n¬˘¶…⁄i… +…ËÆ˙ n‰˘™… §™……V… EÚ…‰ UÙ…‰b˜EÚÆ˙ - `26.13 ±……J… ({…⁄¥…« ¥…π…«-∂…⁄x™…)] BS… b˜“ B°Ú ∫…“ §…ÈEÚ ∫…‰ 223.04 0.00 [|……‰n¬˘¶…⁄i… +…ËÆ˙ n‰˘™… §™……V… EÚ…‰ UÙ…‰b˜EÚÆ˙ - `8.80 ±……J… ({…⁄¥…« ¥…π…«-∂…⁄x™…)] E÷Ú±… 16,071.47 8,853.99 (J…) §…ÈEÚ…Â ∫…‰ +±{…EÚ… ±…EÚ @Òh…-|… i…¶…⁄i… EËÚx…Æ˙… §…ÈEÚ ∫…‰ 2,514.87 2,500.00 <∆b˜∫…<∆b˜ §…ÈEÚ ∫…‰ 5,650.00 5,000.48 B∫… §…“ +…<« ∫…‰ 2,517.52 - E÷Ú±… 10,682.39 7,500.48 (M…) +x™… @Òh… ¥… + O…®… - |… i…¶…⁄i… ¥…n‰˘∂…“ ®…÷p˘… G‰Úi…… EÚ“ ∫……J… - =v……Æ˙ 6,867.82 7,000.22 +x™… @Òh… - |… i…¶…⁄i… |……‰n¬˘¶…⁄i… +…ËÆ˙ n‰˘™… §™……V… ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… 110.30 101.92 EËÚx…Æ˙… §…ÈEÚ 26.13 - BS… b˜“ B°Ú ∫…“ §…ÈEÚ 8.80 - <∆b˜∫…±…xb˜˜ §…ÈEÚ - 3.77 E÷Ú±… 33,766.91 23,460.38 ]ı{{… h…™……ƒ : (i) |……{i… +±{…EÚ… ±…EÚ =v……Æ˙ E‰Ú ±…B |… i…¶…⁄ i… E‰Ú ¥…¥…Æ˙h… ¥…¥…Æ˙h… |… i…¶…⁄ i… EÚ“ |…EfiÚ i… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… §…ÈEÚ…Â ∫…‰ ®……∆M… {…Æ˙ |… i…n‰˘™… @Òh… E∆Ú{…x…“ EÚ“ S……±…⁄ {… Æ˙∫…∆{… k…™…… {…Æ˙ {…… Æ˙ {……∫…÷ 11,463.17 8,955.91 §…ÈEÚ…Â ∫…‰ S……V…«* ¶……Æ˙i…“™… ∫]‰ı] §…ÈEÚ EÚ“ +…‰Æ˙ {…⁄V…{{…÷Æ˙… B∫… §…“ +…<« i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰Ú ®…EÚ…x… ∫… Ω˛i… ¶…⁄ ®… {…Æ˙ V…®……x…i…“ E‰Ú ∞¸{… ®… ∫……Œ®™…EÚ §…∆v…EÚ* EËÚx…Æ˙… §…ÈEÚ 4,521.69 - BS… b˜“ B°Ú ∫…“ §…ÈEÚ 231.84 - §…ÈEÚ…Â ∫…‰ +±{…EÚ… ±…EÚ @Òh… |……{i… EËÚx…Æ˙… §…ÈEÚ ∫…‰ {… Æ˙™……‰V…x…… V…®…… ∫…‰ |… i…¶…⁄i… 2,514.87 2,500.00 <∆b˜∫…<∆b˜ §…ÈEÚ ∫…‰ 5,650.00 5,004.25 B∫… §…“ +…<« ∫…‰ 2,517.52 - 10,682.39 7,504.25 +x™… @Òh… ¥… + O…®… G‰Úi…… EÚ“ ∫……J… - =v……Æ˙ {… Æ˙™……‰V…x…… V…®…… ∫…‰ |… i…¶…⁄i… 7,894.15 8,289.93 x™…⁄x… : n˘“P…«EÚ… ±…EÚ =v……Æ˙ 1,026.33 1,289.71 6,867.82 7,000.22 E÷Ú±… 33,766.91 23,460.38 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 138 Note 6 Short-term borrowings AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Loans repayable on demand (Cash Credit) From State Bank of India - Secured 11,352.87 8,853.99 [Excludes interest accrued & due - `110.30 Lacs (Previous year - `101.92 Lacs)] From Canara Bank 4,495.56 0.00 [Excludes interest accrued & due - ` 26.13 Lacs (Previous year - Nil)] From HDFC Bank 223.04 0.00 [Excludes interest accrued & due - ` 8.80 Lacs (Previous year - Nil)] Total 16,071.47 8,853.99 (b) Short Term Loans from Banks - Secured From Canara Bank 2,514.87 2,500.00 From IndusInd Bank 5,650.00 5,000.48 From SBI 2,517.52 - Total 10,682.39 7,500.48 (c) Other loans and advances - Secured Foreign Currency Buyers Credit 6,867.82 7,000.22 Other loans-secured Interest accred and due State Bank of India 110.30 101.92 Canara Bank 26.13 - HDFC Bank 8.80 - IndusInd Bank - 3.77 Total 33,766.91 23,460.38 Notes : (i) Details of security for the secured short-term borrowings : AS AT AS AT Particulars Nature of security 31.03.2014 31.03.2013 ` lacs ` lacs Loans repayable on demand from banks : SBI 11,463.17 8,955.91 Parri passu charge over current assets of the company. Equitable Mortgage as collateral over the 4,521.69 - Canara Bank land with building at Poojappura, HDFC Bank Trivandrum towards State Bank 231.84 - of India Short Term Loans from Banks - Secured From Canara Bank 2,514.87 2,500.00 From IndusInd Bank Secured by Project Deposits 5,650.00 5,004.25 From SBI 2,517.52 - 10,682.39 7,504.25 Other Loans and Advances : Buyers Credit Secured by Project Deposits 7,894.15 8,289.93 Less : Long Terms Borrowings 1,026.33 1,289.71 6,867.82 7,000.22 Total 33,766.91 23,460.38 Annual Report 2013-2014 139 ]ı{{…h…“ 7 n‰˘™… ¥™……{……Æ˙ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… n‰˘™… ¥™……{……Æ˙ : ∫……®… O…™……Â, ∫…‰¥……+… +…ËÆ˙ ¥™…™…… E‰Ú ±…B - ∫…⁄I®… ±…P…÷ı +…ËÆ˙ ®…v™…®… =t®… 275.23 409.66 - +x™… 10,006.64 8,867.26 E÷Ú±… 10,281.87 9,276.92 ]ı{{…h…“ 8 +x™… S……±…⁄ n‰˘™…i……B∆ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… (EÚ) n˘“P…«EÚ… ±…EÚ @Òh… E‰Ú S……±…⁄ {… Æ˙{…C¥…i……B∆ (x…“S…‰ EÚ“ ]ı{{…h…“ (i) EÚ… ∫…∆n˘¶…« EÚÆÂ˙*) 2,499.78 1,593.68 (J…) +x™… O……Ω˛EÚ/®…÷¥…ŒCEÚ±… ∫…‰ + O…®… 2,627.93 13,250.20 <« B®… b˜“ +…ËÆ˙ ∫…÷Æ˙I…… V…®…… 2,527.02 2,462.12 §™……V… ={……ÃV…i… ±…‰ EÚx… n‰˘™… x…Ω˛” 32.97 51.23 ∫……¥… v… V…®…… 0.10 0.10 +x™… n‰˘™…i……B∆ 10,245.28 8,718.82 +∆∂…n˘…™…“ {…Â∂…x… ™……‰V…x…… 30.11 293.57 E÷Ú±… 17,963.19 26,369.72 ]ı{{…h…“ (i) : n˘“P…«EÚ…±…“x… @Òh… E‰Ú S……±…⁄ {… Æ˙{…C¥…i……Bƒ ( ]ı{{…h…“ 5 ®… ]ı{{…h…“ (i) EÚ… ∫…∆n˘¶…« EÚÆÂ˙ ) |… i…¶…⁄ i… E‰Ú ¥…¥…Æ˙h… E‰Ú ±…B n˘“v…«EÚ… ±…EÚ =v……Æ˙ : ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… ®…™……n˘“ @Òh… BS… b˜“ B°Ú ∫…“ §…ÈEÚ ∫…‰ Ø˚{…™…… ®…™……n˘“ @Òh… 889.51 - ¶……Æ˙i…“™… ∫]‰ı]ı §…ÈEÚ ∫…‰ ¥…n‰˘∂…“ ®…÷p˘… ®…™……n˘“ @Òh… 1,610.27 1,593.68 E÷Ú±… 2,499.78 1,593.68 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 140 Note 7 Trade Payables AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Trade payables : for materials, services and expenses - Micro Small and Medium Enterprises 275.23 409.66 - Others 10,006.64 8,867.26 Total 10,281.87 9,276.92 Note 8 Other current liabilities AS AT AS AT Particulars 31-03-2014 31-03-2013 ` lacs ` lacs (a) Current maturities of long-term debt (Refer Note (i) below) 2,499.78 1,593.68 (b) Others Advance from Customers/Clients 2,627.93 13,250.20 EMD & Security Deposits 2,527.02 2,462.12 Interest Accrued but not due 32.97 51.23 Fixed Deposit 0.10 0.10 Other Liabilities 10,245.28 8,718.82 Contributory Pension Scheme 30.11 293.57 Total 17,963.19 26,369.72 Note (I) : Current maturities of long-term debt (Refer Notes (i) in Note 5 - Long-term borrowings for details of security) : AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Term loans Rupee Term Loan from HDFC Bank 889.51 - Foreign Currency Term Loan from State Bank of India 1,610.27 1,593.68 Total 2,499.78 1,593.68 Annual Report 2013-2014 141 ]ı{{…h…“ 9 +±{…EÚ… ±…EÚ |……¥…v……x… ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… (EÚ) EÚ®…«S……Æ˙“ Ω˛i…±……¶… E‰Ú ±…B |……¥…v……x… : (i) §…˛…Ïx…∫… +…ËÆ˙ |……‰i∫……Ω˛x… E‰Ú ±…B |……¥…v……x… 140.05 135.16 (ii) x…π{……n˘x… ∫…∆§…∆v…“ ¥…‰i…x… E‰ ±…B |……¥…v……x… 112.07 198.99 (iii) +x…÷±…Œ§v…™…… +…ËÆ˙ ¶…k…… E‰Ú ±…B |……¥…v……x… - 226.23 (iv) ={…n˘…x… E‰Ú ±…B |……¥…v……x… 515.35 583.16 (v) O…⁄{… <« B±… |…“ ®…™…®… E‰Ú ±…B |……¥…v……x… 175.25 169.47 942.72 1,313.01 (J…) +x™… |……¥…v……x… : (i) |…∫i…… ¥…i… <ŒC¥…]ı“ ±……¶……∆∂… E‰Ú ±…B |……¥…P……x… 387.07 387.07 (ii) |…∫i…… ¥…i… ±……¶……∆∂… {…Æ EÚÆ E‰Ú ±…B |……¥…v……x… 65.78 65.79 452.85 452.86 E÷Ú±… 1,395.57 1,765.87 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 142 Note 9 Short-term provisions AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Provision for employee benefits : (i) Provision for bonus and incentive 140.05 135.16 (ii) Provision for Performance related pay 112.07 198.99 (iii) Provision for Perks & Allowance - 226.23 (iv) Provision for gratuity 515.35 583.16 (v) Provision for group EL Premium 175.25 169.47 942.72 1,313.01 (b) Provision - Others : (i) Provision for proposed equity dividend 387.07 387.07 (ii) Provision for tax on proposed dividends 65.78 65.79 452.85 452.86 Total 1,395.57 1,765.87 Annual Report 2013-2014 143 3 3 ±……J…… ®… ±……J…… ` x…¥…±… §±……ÏEÚ 31 ®……S…« 2014®……S…« 31 2012 ®……S…« 31 201 ®……S…« 31 - 1,999.61 2,442.44 - 555.44 5.28 - 400.00 5.48 - 2,764.74 1,793.91 - 5.48 1.16 - 3,062.41 1,581.17 --- - 140.12 88.55 - 208.81 140.12 - 1,257.94 555.44 - 1,793.91 2,442.44 - 24.62 24.62 - 2,368.40 1,999.61 - 4,494.56 3,062.41 - 6,999.89 4,494.56 226.80 722.29 23.36 31 ®……S…« 2014 ®……S…« 31 (0.51) ------1.12 - 1.12 33.55 - ∫…∆ S…i… ®…⁄±™…ø…∫… +…ËÆ˙ Ω˛… x… +…ËÆ˙ ®…⁄±™…ø…∫… ∫…∆ S…i… ®…⁄±™…ø…∫…/{…Æ˙ x…{…]ı…x… E‰Ú @Òh…®…÷ HÚ ¥™…™…@Òh…®…÷ HÚ M…™…… Ω˛]ı…™…… 1.12 8.35 - 9.47 41.92 33.56 1 +|…˱… 2013+|…˱… 1 ¥…π…« E‰Ú n˘…ËÆ˙…x… {… Æ˙∫…∆{… i…™…… 484.80 27.37 4.90 - 32.37 452.53 457.43 130.97 20,814.94 9,938.46 1,445.67 40.16 11,343.97 9,470.97 8,661.54 130.55159.67 25,049.6331,205.18 11,191.4212,581.72 1,502.201,966.35 111.91 66.40 12,581.71 14,481.67 12,467.92 16,723.51 11,651.22 12,467.91 946.59 4,494,56 - - 6.56 105.08 53.97 14.80 5.51 63.26 41.82 57.67 - - 484.80 32.27 4.90 - 37.37 447.63 452.53 - - 24.62 - ∫…EÚ±… §±……ÏEÚ 232.04 3.53 1,307.35209.33 603.76 0.04 140.37 1,260.12 2.69 344.29 741.44 138.73 565.91 475.08 0.04 482.98 777,14 706.54 - 34.68 - 34.68 - 1.165.28 4.32 555.44 5.28 - 555-44 5.38 - - 5.48 394.52 - 400.00 - 88.55 51.57 - 140.12 - 34.68 16.71 - 51.39 24.62 949.08170.38 136.44 778.80 - 0.10 1,085.52 949.08 226.80 147.02 118.62 79.27 - 345.42 740.10 722.28 524.98 1,278.49 9.56 1,793.91 - 555.44 843.05 140.54 1,257.95 - 701.82111.64 380.46 3.44 1,078.84 502.48 103.53 2.25140.12 603.76 68.69 475.08 199.34 - 208.81 - 484.80 105.08637.10932.18 26.33 313.78241.41 22.33949.08 18.7033.59 101.76 109.08 1,140.00 932.18 532.70 63.26 469.35 - 137.51 15.62 81.83 1,050.84 23.32 17.58 18.48 226.80 646.89 61.30 532.70 117.50 493.12 399.48 47.78 399.48 - 167.75 41.82 344.29 706.55 722.28 949.08 136.44 - 1,085.52 226.80 118.62 - 345.42 740.10 722.28 793.91 1,009.23 38.40 2,764.74 - 2,442.44 488.92 931™…75 1,999.61 - 1,581.17 3,229.66 1,748.41 3,062.41 - 3,062.41 2,378.74 946.59 4,494.56 - 4,494.56 3,815.57 1,310.23 6,999.90 - 1, 4,489.65 3,275.06 0 7,764.71 1,590.09 315.62 - 1,905.71 5,859.00 2,89.56 7,764.71 646.15 - 8,410.86 1,905.71 372.45 - 2,278.16 6,132.70 5,859.00 1,050.83 3,062.41 2,378.74 1,085.51 226.44 0.04 1,311.51 345.41 147.08 0.04 492.45 819.06 740.10 22,842.6425,049.63 2,337.54 6,315.22 25,049.6331,205.17 6,315.223,392.06 159.67137.02 31,205.1834,460.21 12,581.7214,481.66 1,966.352,228.79 66.4094.81 14,481.6716,615.65 16,723.5117,844.57 12,467.91 16,723.51 1 +|…˱… 2013+|…˱… 1 {… Æ˙¥…v…«x… x…{…]ı…x…2014 ®……S…« 31 ¥™…™… ¥™…™… ®…∂…“x…Æ˙“ 18,600.00 2,345.91 ®…∂…“x…Æ˙“ 20,814.94 2,246.13 77.57 22,983.50 11,343.96 1,557.95 51.22 12,850.69 10,132.81 9,470.98 {… Æ˙™……‰V…x……+… {…Æ˙ {… Æ˙™……‰V…x……+… ®…∂…«S……V…« °Úx…‘S…Æ˙ ¥… V…÷b˜x……Æ˙ ¥… °Úx…‘S…Æ˙ ®……‰]ıÆ˙ M…… b˜™……ƒ <®……Æ˙i… S……±…⁄ ∫… ¥…±… EÚ…™…«{…Æ˙…®…∂…« S……V…« +…EÚŒ∫®…EÚ {…“ +…<« b˜Œ§±…™…÷ 1,999.61®…∂…“x…Æ˙“ 1,500.08 1,131.29 2,368.40 - S……±…⁄ EÚÆ˙x…‰ E‰Ú ±…B EÚÆ˙x…‰ S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ {…b˜“ + x…h…«™……v…“x… EÚ…™……«±…™… ={…EÚÆ˙h… {…]¬ı]‰ı {…Æ˙ ¶…⁄ ®… V…÷b˜x……Æ˙¥… °Úx…‘S…Æ˙ EÚ…™……«±…™… ={…EÚÆ˙h… E÷Ú±… 1,078.84 {…UÙ±…‰ ¥…π…« E÷Ú±… ¥…π…« {…UÙ±…‰ <®……Æ˙i… ®……‰]ıÆ˙ M…… b˜™……ƒ {… Æ˙∫…∆{… k…™……ƒ x…<« {… Æ˙™……‰V…x……+… {…Æ˙ x…<« +…EÚŒ∫®…EÚ E÷Ú±… {…UÙ±…‰ ¥…π…« ®…∂…“x…Æ˙“ b˜Œ§±…™…÷ +…<« {…“ +…<« b˜Œ§±…™…÷ ®…∂…“x…Æ˙“ ¶…⁄ ®… {…⁄h…« ∫¥…… ®…i¥… +S…±… {… Æ˙∫…∆{… k…™……ƒ (P…) (M…) ¥… ∫…∆™…∆j… (RÛ) ¥…π…« {…UÙ±…‰ (J…) E÷Ú±… (J…) (J…)EÚ…™…« ∫… ¥…±… S……±…⁄ (M…) (M…) {…Æ˙… (P…) x…™…‰ (RÛ) (EÚ) (S…) (P…) (S…) ÚE∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ˙ ∫……Ï}]ı¥…‰™…Æ˙ {…‰]Âı]ı +…ËÆ˙ ]≈‰ıb˜®……E«Ú (J…) (M…) ¥… ∫…∆™…∆j… (RÛ) {…‰]Âı]ı +…ËÆ˙ ]≈‰ıb˜®……E«Ú E÷Ú±… {…UÙ±…‰ ¥…π…« (EÚ)E‰Ú ±…B EÚ®…“∂…Àx…M… (P…) (RÛ) (EÚ) M…EÚ…™…« {…⁄ƒV…“ S……±…⁄ J…+…Œ∫i…™……ƒ +®…⁄i…« M… S……±…⁄ {…⁄ƒV…“ EÚ…™…« EÚ ®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ 31 ®……S…« 2014 EÚ…‰‰ ∫…®……{i… ¥…π…« E‰Ú ±…B ¥…¥…Æ˙h… EÚ“ ]ı{{… h…™……ƒ {… Æ˙∫…∆{… k…™……ƒ +S…±… 10 ]ı{{…h…“ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 144 lacs 5.48 ` Net Block 7.78 41.82 447,63 452.53 2014 2013 31 March 31 March, - 400.00 - 208.81 140.12 - 6,999.89 4,494.56 -- 2,764.74 2,368.40 1,793.91 1,999.61 - 1,257.94 555.44 - 24.62 24.62 492.45 819.06 740.10 482.98 777.14 706.54 741.44 565.91 475.08 2014 2,278.16 6,132.70 5,859.00 31 March - - 345.42 740.10 722.28 - 37.17 - - - - - 9.47 41.92 33.56 - - 0.04 0.04 2.69 Eliminated ------4.90 the year amortisation on disposal expense for of assets ------Accumulated Depreciation and impairment 2013 345.41 147.08 1 April, 1 Depreciation/ March, 109.08 63.26 15.62 17.58 61.30 4 208.81 1,260.12 344.29 138.73 1,307.35 603.76 140.37 8,410.86 1,905.71 372.45 - 400.00 - 484.80 32.27 - - 1,085.52 226.80 118.62 - 24.62 - 51.39 1.12 8.35 0.04 1,311.51 0.04 3.53 - - Gross Block 6.33 22.33 8.69 394.52 2,246.13 77.57 22,983.50 11,343.96 1,557.95 51.22 12,850.69 10,132.81 9,470.98 5.48 34.68 16.71 24.62 484.80 949.08 136.44 105.08932.18 2 241.41 33.59 1,140.00 532.70 137.51 23.32 646.89 493.12 399.48 555.44 843.05 140.54 1,257.95 140.12 6 2013 2014 1 April,1 Additions Disposals 31 1,085.51 226.04 7,764.71 646.15 1,078.84 232.04 3,062.41 2,378.74 946.59 4,494.56 4,494.56 3,815.57 1,310.23 6,999.90 1,793.91 1,009.23 38.40 2,764.74 1,999.61 1,500.08 1,131.29 2,368.40 1,050.83 209.33 31,205.1725,049.63 3,392.06 6,315.22 137.02 159.67 34,460.21 31,205.18 14,481.66 2,228.79 12,581.72 1,966.35 94.81 66.40 16,615.65 14,481.67 17,844.57 16,723.51 16,723.51 12,467.91 Fixed Assets Freehold Leasehold Assets Pending Commissioning Total Previous year (a) Trademarks & Patents Computer software (b) Buildings (c) Plant and Machinery(d) Furniture & Fixture 20,814.94 (e) Motor Vehicles (f) Office Equipment Total Previous year (a) Land Previous year Total (e) Machinery WIP (d) Incidental Expenses on New Projects (b) Civil work in progress (c) Consultancy Charges C Capital Work in Progress B Intangible Assets A Assets Tangible HLL Lifecare Limited Notes to financial statements for the year ended 31st March 2014 Assets Note 10 Fixed Annual Report 2013-2014 145 400 ±……J… ∂…… ®…±… Ω˲* ` 2.00 ±……J… {…Æ˙)* ¶…⁄ ®… E‰Ú +∆i…Æ˙h… +¶…“ i…EÚ x…Ω˛” EÚ™…… M…™…… Ω˲, M…™…… EÚ™…… x…Ω˛” i…EÚ +¶…“ +∆i…Æ˙h… E‰Ú ¶…⁄ ®… {…Æ˙)* ±……J… 2.00 ` “ Ɖ˙J…… |…h……±…“ ∫¥…“EÚ…Æ˙ EÚ“ M…™…“ Ω˲* ∫…‰ {…⁄Ɖ˙ EÚB E∆Úb˜…‰®… ¥… x…®……«h… ∫…÷ ¥…v…… E‰Ú +V…«x… ±…B |…n˘k… 2/- Æ˙Ω˛… Ω˲* Æ˙Ω˛… 2/- 1/- {…Æ 36 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {…]¬ı]‰ı {…Æ˙ n˘“ V……x…“ Ω˲* V…Ë∫…‰ ¶…“ Ω˛…‰, ™…Ω˛ ±…‰x…n‰˘x… +¶…“ i…EÚ |…¶……¥… ®… x…Ω˛” +…™…… M…™…… Ω˲* M…™…… +…™…… x…Ω˛” ®… |…¶……¥… i…EÚ +¶…“ ±…‰x…n‰˘x… ™…Ω˛ Ω˛…‰, ¶…“ V…Ë∫…‰ Ω˲* V……x…“ n˘“ {…Æ˙ {…]¬ı]‰ı ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á 36 {…Æ 1/- ` 130.46 ±……J… Æ˙Ω˛“ Ω˲* Æ˙Ω˛“ ±……J… 130.46 ` ` ±……J…… ®… ±……J…… ±……J…… ®… 238.68 152.60 16.50 ±……J… {…Æ˙ +…ËÆ˙ Ω˛±±……‰EÚ E‰Ú 44 BEÚb˜ |… i… BEÚb˜ |… i… BEÚb˜ 44 E‰Ú Ω˛±±……‰EÚ +…ËÆ˙ {…Æ˙ ±……J… 16.50 ` ` 2,127.79 ` 3.94 1.68 ®…⁄±… ±……M…i… ±……J…… ®… ±……J…… 869.21 2,569.57 ±……J…… ®… 457.96 408.46 499.59 2,213.76 2013-14` 2012-13 ` 2013-14 2012-13 1,006.531,085.17 2,679.84 2,302.31 13.08 1,613.33 5000 ±……M…i… ∫…‰ EÚ®… ±……M…i… {… Æ˙∫…∆{… k…™……Â, V……‰ {…⁄Æ˙“ i…Æ˙Ω˛ ∫…‰ ®…⁄±™…ø… ∫…i… EÚ™…… M…™…… Ω˲. E‰Ú + i… Æ˙HÚ ∂…‰π… +x™… ∫……Æ˙“ {… Æ˙∫…∆{… k…™…… {…Æ˙ ®…⁄±™…ø…∫… ®…⁄±™… {…r˘ i… +{…x……™…“ M…™…“ Ω˲* ` 10.12 EÚÆ˙…‰b˜ EÚ“ n˘Æ˙ {…Æ˙ = q˘π]ı EÚ™…… (56 BEÚb˜ |… i… BEÚb˜ E‰Ú ±…B E‰Ú BEÚb˜ |… i… BEÚb˜ (56 EÚ™…… = q˘π]ı {…Æ˙ n˘Æ˙ EÚ“ EÚÆ˙…‰b˜ 10.12 ` 3.76 ±……J… EÚx……«]ıEÚ +…Ët…‰ M…EÚ˙ I…‰j… ¥…EÚ…∫… §……‰b«˜ EÚ…‰ |…n˘k… {…⁄h…« ∫¥…… ®…i¥… {…Æ˙ ¶…⁄ ®… E‰Ú +x…∆ i…®… ®…⁄±™… Æ˙Ω˛… Ω˲* Æ˙Ω˛… ®…⁄±™… +x…∆ i…®… E‰Ú ¶…⁄ ®… {…Æ˙ ∫¥…… ®…i¥… {…⁄h…« |…n˘k… EÚ…‰ §……‰b«˜ ¥…EÚ…∫… I…‰j… +…Ët…‰ M…EÚ˙ EÚx……«]ıEÚ ±……J… 3.76 99 EÂÚp˘“™… ±…‰|…∫…“ ∂…I…h… B¥…∆ +x…÷∫…∆v……x… ∫…∆∫l……x… (∫…“ B±… ]ı“ +…Æ˙ +…<«), i… ®…±…x……b÷˜ ∫…‰ S…ÂM…±…{…‰]¬ı]÷ı, i… ®…±…x……b÷˜ ®… 99 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B +…§…∆ ]ıi… 430.10 BEÚc˜ ¶…⁄ ®… E‰Ú ®…⁄±™… Æ˙Ω˛… Ω˲* Æ˙Ω˛… ®…⁄±™… E‰Ú ¶…⁄ ®… BEÚc˜ Ω˲* Æ˙Ω˛… ®…⁄±™… 430.10 +…§…∆]ıx… EÚ… ¶…⁄J…∆b˜ ®…“]‰ı∫…« ∫C¥…™…Æ˙ 1005.22 ±…B {…Æ˙ {…]¬ı]‰ı E‰Ú ±…B ¥…π……Á 60 ®… +…§…∆ ]ıi… ®…÷∆§…<« ±……J… 92.41 ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á 99 ®… i… ®…±…x……b÷˜ S…ÂM…±…{…‰]¬ı]÷ı, ∫…‰ i… ®…±…x……b÷˜ +…<«), +…Æ˙ ]ı“ B±… (∫…“ ∫…∆∫l……x… +x…÷∫…∆v……x… B¥…∆ ∂…I…h… ±…‰|…∫…“ EÂÚp˘“™… 99 261.94 ±……J… x™…⁄ +…‰J…±…… +…Ët…‰ M…EÚ ¥…EÚ…∫… |…… v…EÚ…Æ˙“ (x……‰Bb˜…), =k…Æ˙ |…n‰˘∂… ®… 90 ¥…π……Á E‰Ú ±…B +…§…∆ ]ıi… 5000 ∫C¥…™…Æ˙ ®…“]ıÆ˙ {…]¬ı]‰ı {…Æ˙ ±…B ¶…⁄J…∆b˜ EÚ… ®…⁄±™… Æ˙Ω˛… Ω˲* Æ˙Ω˛… ®…⁄±™… EÚ… ¶…⁄J…∆b˜ ±…B {…Æ˙ {…]¬ı]‰ı ®…“]ıÆ˙ ∫C¥…™…Æ˙ 5000 +…§…∆ ]ıi… ±…B E‰Ú ¥…π……Á 90 ®… |…n‰˘∂… =k…Æ˙ (x……‰Bb˜…), |…… v…EÚ…Æ˙“ ¥…EÚ…∫… +…Ët…‰ M…EÚ +…‰J…±…… x™…⁄ ±……J… 261.94 E÷Ú±… 4,574.24 9,679.52 +…CE÷Ú±…®… ∫…∆™…∆j… +…CE÷Ú±…®… ∫…∆™…∆j… i…Ø˚¥…x…∆i…{…÷Æ˙®… ∫…∆™…∆j… §…‰±…M……®… ®…∂…“x… +…<« +…Æ˙ B®… <®……Æ˙i…∫…∆™…∆j… B¥…∆ {…÷V…Ê 9.86 1,412.34 °Úx…‘S…Æ˙ B¥…∆ V…÷b˜x……Æ˙B¥…∆ °Úx…‘S…Æ˙ 14.75 EÚ…™……«±™… ={…EÚÆ˙h… +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ …i™…‰EÚ ` EÚ…x…⁄x…“ EÚ…™…«¥……Ω˛“ ±…∆ §…i… Ω˲* Ω˛®… §…“S… ®…Â, E∆Ú{…x…“ x…‰ +{…x…‰ + v…EÚ…Æ˙ E‰Ú 430.10 BEÚc˜ ¶…⁄ ®… E‰Ú ¥…S……Æ˙ E‰Ú ±…B BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ EÚ…‰ 20.02.2014 E‰Ú |…¶……¥… ∫…‰ ={… {…]¬ı]‰ı {…Æ˙ n˘™…… Ω˲* n˘™…… {…Æ˙ {…]¬ı]‰ı ={… ∫…‰ |…¶……¥… E‰Ú 20.02.2014 EÚ…‰ ±… ®…]‰ıb˜ §……™……‰]‰ıEÚ BS…B±…B±… ±…B E‰Ú ¥…S……Æ˙ E‰Ú ¶…⁄ ®… BEÚc˜ 430.10 E‰Ú + v…EÚ…Æ˙ +{…x…‰ x…‰ E∆Ú{…x…“ ®…Â, §…“S… Ω˛®… Ω˲* ±…∆ §…i… EÚ…™…«¥……Ω˛“ EÚ…x…⁄x…“ Ω˲*˙ M…™…“ EÚ“ {… Æ˙∂……‰ v…i… {…Æ˙ +…v……Æ˙ ∫…®…x…÷{…… i…EÚ ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á i…“x… ∫……Ï}]ı¥…‰™…Æ˙ E∆Ú®{…⁄]ıÆ +x™… Ω˲* M…™…… EÚ™…… ` ` ` EÚ…‰ 4.17 EÚÆ˙…‰c˜ E‰Ú n˘“v…« n˘“P…«EÚ… ±…EÚ ¥…n‰˘∂…“ ®…÷p˘… @Òh… {…Æ˙ EÚ…±{… x…EÚ ¥…n‰˘∂…“ ¥… x…™…®… P…]ı…¥…-§…g¯…¥… EÚ…‰ ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú n˘ 29.12.11 E‰Ú + v…∫…⁄S…x…… ∫…∆ V…“ B∫… +…Æ˙ 913 (<«) +…ËÆ˙ {… Æ˙{…j… +…ËÆ˙ (<«) 913 +…Æ˙ B∫… V…“ ∫…∆ + v…∫…⁄S…x…… E‰Ú 29.12.11 n˘ E‰Ú ∫…Æ˙EÚ…Æ˙ ¶……Æ˙i… EÚ…‰ P…]ı…¥…-§…g¯…¥… ¥… x…™…®… ¥…n‰˘∂…“ EÚ…±{… x…EÚ {…Æ˙ @Òh… ®…÷p˘… ¥…n‰˘∂…“ n˘“P…«EÚ… ±…EÚ n˘“v…« E‰Ú EÚÆ˙…‰c˜ 4.17 EÚ) E‰ÚÆ˙±… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… x…:∂…÷˝±EÚ +∆i… Æ˙i… 11.44 BEÚc˜ i…l…… 7.14 BEÚb˜ ¶…⁄ ®… E‰Ú ]ı…‰EÚx… ®…⁄±™… ]ı…‰EÚx… E‰Ú ¶…⁄ ®… BEÚb˜ 7.14 i…l…… BEÚc˜ 11.44 +∆i… Æ˙i… EÚ) x…:∂…÷˝±EÚ u˘…Æ˙… ∫…Æ˙EÚ…Æ˙ E‰ÚÆ˙±… J…) ±……M…i… <®……Æ˙i… +…ËÆ˙ ¶…⁄ ®… BEÚc˜˜ 3 Æ˙Ω˛“Ú {…Æ˙ {…]¬ı]‰ı ®… §……±…Æ˙…®…{…÷Æ˙®… E‰Ú E‰ÚÆ˙±… EÚ)E‰Ú ±…B ¥…π……Á 99 (P…)| S…) + v…EÚ…Æ˙ E‰Ú 430.10 BEÚb˜… ®… 3.38 BEÚb˜ ¶…⁄ ®… i… ®…±…x……b÷˜ Æ˙…V™… ¥…t÷i… §……‰b«˜ EÚ…‰ |… i… ¥…π…« |… i… EÚ…‰ §……‰b«˜ ¥…t÷i… Æ˙…V™… i… ®…±…x……b÷˜ ¶…⁄ ®… BEÚb˜ 3.38 S…)®… BEÚb˜… 430.10 E‰Ú + v…EÚ…Æ˙ (EÚ) <« +…Æ˙ {…“ ∫……Ï}]ı¥…‰™…Æ˙ (B∫… B {…“) ®… x…¥…‰∂… 8 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B ∫…“v…“ Ɖ˙J…… +…v……Æ˙ {…Æ˙ ®…⁄±™…ø… ∫…i… EÚ™…… M…™…… Ω˲* +x™… E∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ i…“x… ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B ∫…®…x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ Ω˲* M…™…“ EÚ“ {… Æ˙∂……‰ v…i… ±…B E‰Ú +¥… v… EÚ“ ¥…π…« {……ƒS… ]≈‰ıb˜®……E«Ú/{…‰]Âı]ı (J…) (M…) BS…B±…B±… E‰Ú ∫…∆™…∆j… +…ËÆ˙ ®…∂…“x…Æ˙“ E÷ÚUÙ ®…n˘… ∫…∆§…∆v… ®… x…“S…‰ ∫…⁄ S…i… EÚB V…Ë∫…“ ®…⁄±™…ø…∫… EÚ“ ∫…“v… J…) M…) ±… ®…]‰ıb˜ §……™……‰]‰ıEÚ BS…B±…B±… ¶…⁄ ®… BEÚb˜ 100 ®… ¶…⁄ ®… BEÚb˜ 430.10 E‰Ú P…) I…‰j… + v…EÚ…Æ˙ +{…x…‰ +x…÷∫……Æ˙, E‰Ú ∫…°Ú… Æ˙∂… EÚ“ ∫…Æ˙EÚ…Æ˙ ¶……Æ˙i… ®…∆j……±…™…, ¥…k… §…“), RÛ)+…<« ({…“ §……‰b«˜ x…¥…‰∂… ∫……¥…«V… x…EÚ Ω˲* ∂…… ®…±… +¥… v… {…]¬ı]ı… EÚ“ ¥…π……Á 99 Ω÷˛<« ∂…÷∞¸ ∫…‰ 01.03.2005 +…ËÆ˙ + v…EÚ…Æ˙ {…]¬ı]‰ın˘…Æ˙“ E‰Ú ¶…⁄ ®… EÚ“ +…EÚ…Æ˙ ∫…Â]ı˜ 306 ®… ±……M…i… +V…«x… <∫… ` ]ı{{…h…“ : ]ı{{…h…“ - ΩÈ˛ ∂…… ®…±… 1.®… ®…⁄±™… E‰Ú ¶…⁄ ®… ∫¥…… ®…i¥… {…⁄h…« 2. {…]¬ı]‰ı {…Æ˙ ¶…⁄ ®… E‰Ú ®…⁄±™… x…®x… ±… J…i… ∂…… ®…±… Ω˲* ∂…… ®…±… 2. x…®x… ±… J…i… ®…⁄±™… E‰Ú ¶…⁄ ®… {…Æ˙ {…]¬ı]‰ı 3.ΩÈ˛* V…Ë∫…“ x…®x… Æ˙“ i… ®…⁄±™…ø…∫… M…<« +{…x……<« 4. S……±…⁄ {…⁄ƒV…“ EÚ…™…« ®… B‡Æ˙…{…÷Æ˙®…, {…‰Ø˚®§……¥…⁄Æ˙, E‰ÚÆ˙±… Æ˙…V™… E‰Ú ∫¥…… ®…i¥… ¥……±…‰ Æ˙§…b˜ {……E«Ú ¶…… M…EÚ ∞¸{… 5. Ω˲* M…™…… EÚ™…… ∂…… ®…±… ®… {… Æ˙∫…∆{… k…™…… +S…±… Ω÷˛B EÚÆ˙i…‰ +x…÷∫…Æ˙h… E‰Ú x…“ i… ±…‰J…… {…Æ˙ +…v……Æ˙ E‰Ú 2012 +M…∫i…, 9 n˘x……∆EÚ 25/2012 ∫…∆ 6. +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ±…B + i… Æ˙HÚ +x…÷®……‰n˘x… +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ∫…÷ ¥…v…… ®… EÚB M…B x…®x… {…⁄ƒV…“ ¥™… ™… EÚ“ ®…⁄±… ±……M…i… ∂…… ®…±… Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 146 h for 90 years. s in possession, for HLL Biotech s in possession, for HLL amortised over a period of 3 years on 5000 each ` 1 per year to Tamil Nadu State Electricity Board. However this ' Nadu State Tamil 1 per year to ` 4.17 crs has been capitalised in line with the Accounting Policy based on the in line with the 4.17 crs has been capitalised ` 2.00 Lacs per acre). ` 1.68 238.68 152.60 408.46 in lacs in lacs 2,213.76 ` 1,412.34 ` 869.21 2,569.57 in lacs 3.94 9.86 2013-14 2012-13 ` in lacs 1,613.33 2,127.79 4,574.24 9,679.52 1,006.53 2,679.84 1,085.17 2,302.31 14.75 13.08 2013-14 2012-13 ` 16.50 Lacs per acre and 44 acres of hillock@ 499.59 457.96 ` Original Cost 94 for a period of 94 years, w.e.f. 20.02.2014. 94 for a period of years, w.e.f. ` 400 lacs, paid for the acquisition of partly completed condom manufacturing facility at State owned Rubber Park at Irapuram, completed condom manufacturing facility at State for the acquisition of partly 400 lacs, paid ` 10.12 crores (56 acres@ ` being the value of 5000 sq. Mtr. of leasehold land allotted in New Okhla Industrial Development Authority (Noida), Uttar Prades Uttar Authority (Noida), of leasehold land allotted in New Okhla Industrial Development being the value of 5000 sq. Mtr. being the price of freehold land paid to Area Karnataka Development Industrial Board. 2/- being the token value of 11.44 acres and 7.14 of land transferred by the Govt. Kerala free cost. 2/- being the token value of 11.44 130.46 lacs being the cost of 3 acres leasehold land and building at Balaramapuram, Kerala for 99 years. 92.41 lacs being the allotment value of 1005.22 sq. meters plot in Mumbai on lease for 60 years. 261.94 lacs Belgaum Plant MRI Machine Total Trivandrum Plant Akkulam Plant Plant & Machinery Furniture & Fittings Building Office Equipment Intangible assets and Research Institute (CLTRI) Training 99/- being the value of 430.10 acres leasehold land alloted in Chengalpettu, Chennai for 99 years from Central Leprosy 3.76 lacs ` ` ` ` in Tamil Nadu. Tamil in Limited, valued@ Transfer of land is yet to be effected, pending legal procedures. In the meantime, company has sub-leased 100 acres earmarked out 430.10 at a consideration of Biotech Ltd. to HLL pro-rata basis. transaction has so far not been effected. ` ` which have been fully depreciated d) a) b) a) b) c) e) 100 acres of land is earmarked out the 430.10 acre Affairs, In line with the decision of Cabinet Committee on Economic f)Acres of land, out 430.10 acres in possession, to be given on lease for a period 36 years @ 3.38 a) Investment in ERP software (SAP) is depreciated on a straight line basis for period of 8 yrs. Other computer softwares are d) Written down value method of depreciation has been adopted on all the remaining assets, other than assets costing less b) Trade Mark/Patents are amortised over a period of 5 years. c) items of Plant & Machinery as indicated below. line method has been adopted in respect of certain Straight Notification no. GSR 913 (E) dtd. 29-12-11 of Government of India and Cirular No. 25/2012 dated 9th August, 2012. of Government India and Cirular No. 25/2012 dated 9th 29-12-11 Notification no. GSR 913 (E) dtd. Perumbavoor, Kerala. This acquisition cost includes leasehold rights in land admeasuring 306 cents, and the lease period is for 99 years, commencing from 01.03.2005. Note: 1. Cost of Free hold Land includes - 2. Cost of Lease hold land includes the following 3. Methods of depreciation adopted are as follows. 4. in Progress includes Work Capital 6. expenditure incurred in the approved R&D facility. include Original cost of the following Capital Additions to fixed assets 5. Foreign Currency Loan currently amounting to Term Notional Foreign Exchange fluctuation loss on Long Annual Report 2013-2014 147 ±……J…… ®… ` ` ` ` ` ` ` ` 31.03.2013 EÚ…‰ 31.03.2013 147.08 118.62 ±……J…… ®… 2,228.79 1,966.35 2,375,87 2,084.97 31.03.2014 EÚ…‰ 31.03.2014 ` ` ` ` ` ` ` ` ¥…¥…Æ˙h… ∫…i…i… ∫…∆S……±…x… ∫…‰ ∫…∆§…∆ v…i… ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ ∫…i…i… ∫…∆S……±…x… ∫…‰ ∫…∆§…∆ v…i… ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ ]ı{{…h…“ 10 B E‰Ú +x…÷∫……Æ˙ ¥…π…« ®…⁄i…« {… Æ˙∫…∆{… k…™…… ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ ]ı{{…h…“ 10 §…“ E‰Ú +x…÷∫……Æ˙ +®…⁄i…« {… Æ˙∫…∆{… k…™…… {…Æ˙ ¥…π…« E‰Ú ±…B ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ P…. ]ı{{…h…“ 10 +S…±… {… Æ˙∫…∆{… k…™……ƒ (V……Æ˙“...) {… Æ˙∫…∆{… k…™……ƒ +S…±… 10 ]ı{{…h…“ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 148 lacs ` AS AT lacs 147.08 118.62 ` AS AT 2,228.792,375.87 1,966.35 2,084.97 31.03.2014 31.03.2013 Particulars Depreciation and amortisation for the year on tangible assets as per Note 10 A as per Note 10 assets Depreciation and amortisation for the year on tangible Depreciation and amortisation for the year on intangible assets as per Note 10 B Depreciation and amortisation relating to continuing operations D. Depreciation and amortisation relating to continuing operations : Note 10 Fixed assets (Contd.) Note Annual Report 2013-2014 149 ÷Ú±… ±……J…… ®… ±……J…… ` ±……J…… ®… ±……J…… +x…÷n¬˘v…fii… E ` 31.03.2013 EÚ…‰ 31.03.2013 ±……J…… ®… ±……J…… =n¬˘v…fii… ` ---- ±……J…… ®… ±……J…… ` - 2.00 2.00 - 2.00 2.00 ±……J…… ®… ±……J…… 783.42 783.42125.00 125.00 - 783.42 - 783.42 - - +x…÷n¬˘v…fii… E÷Ú±… ` 18,509.75 18,509.75 - 17.801.00 17,801.00 19,420.17 19,420.17 - 18,586.42 18,586.42 31.03.2014 EÚ…‰ 31.03.2014 - - - - ±……J…… ®… ±……J…… =n¬˘v…fii… ` E÷Ú±… - 19,420.17 19,420.17 - 18,586.42 18,586.42 J…) - 19,420.17 19,420.17 - 18,586.42 18,586.42 + E÷Ú±… - ¥™……{……Æ˙ (B)¥™……{……Æ˙ - E÷Ú±… - ¥…¥…Æ˙h… E÷Ú±… (EÚ E÷Ú±… E÷Ú±…-+x™… x…¥…‰∂… (J…) x…¥…‰∂… E÷Ú±…-+x™… - ∫…®…x…÷π…∆M…“Ú E∆Ú{… x…™…… E‰Ú E∆Ú{… x…™…… ∫…®…x…÷π…∆M…“Ú E‰Ú E∆Ú{… x…™…… =t®… ∫…∆™…÷HÚ E‰Ú ∫…k…… +x™… E‰Ú E∆Ú{… x…™…… =t®… ∫…∆™…÷HÚ (i) (ii) (ii) (i) <ŒC¥…]ı“ ={…EÚÆ˙h…… ®… x…¥…‰∂… ({…⁄h…«∞¸{… ∫…‰ |…n˘k…)) ∫…‰ ({…⁄h…«∞¸{… x…¥…‰∂… ®… ={…EÚÆ˙h…… <ŒC¥…]ı“ x™…⁄x… : x…¥…‰∂… E‰Ú ®…⁄±™… ®… P…]ıi…“ E‰Ú ±…B |……¥…v……x…- ±…B E‰Ú P…]ıi…“ ®… ®…⁄±™… E‰Ú x…¥…‰∂… : x™…⁄x… ®…⁄±™… ∫…∆EÚ ±…i… E‰Ú x…¥…‰∂…… =n¬˘v…fii… EÚB x…Ω˛” ±…‰ EÚx… ∫…⁄S…“§…r˘ Æ˙… ∂… ∫…∆EÚ ±…i… EÚ“ x…¥…‰∂…… +x…÷n¬˘v…fii… ------(J…)|…n˘k…) ∫…‰ ({…⁄h…«∞¸{… x…¥…‰∂… ®… b˜§…ÂS…Æ˙… x…¥…‰∂… (±……M…i… {…Æ˙) (±……M…i… x…¥…‰∂… EÚ. ¥™……{……Æ˙ J…. +x™… x…¥…‰∂… +x™… J…. (EÚ) ]ı{{…h…“ 11 M…ËÆ˙ S……±…⁄ x…¥…‰∂… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 150 lacs ` lacs ` AS AT 31.03.2013 AS AT lacs ` lacs ` 2.00 2.00 - 2.00 2.00 lacs ` 783.42 783.42125.00 125.00 - 783.42 - 783.42 - - 19,420.1719,420.17 19,420.17 19,420.17 - - 18,586.42 18,586.42 18,586.42 18,586.42 AS AT 31.03.2014 AS AT ------lacs ` Quoted Unquoted Total Quoted Unquoted Total Total - Trade (A) - Trade Total Total - Other Investments (B) - Other Investments Total - Particulars Total - 19,420.17 19,420.17 - 18,586.42 18,586.42 (i) of subsidiary companies(ii) of joint venture companies - - 18,509.75 18,509.75 - 17,801.00 17,801.00 (ii) of other entities - (i) of joint venture companies - B. Other investments : (a)Investment in equity instruments (fully paid) (b)Investment in debentures (fully paid) (A+B) Total Less : Provison for diminution in value of investmentsAggregate value of listed but not quoted investments - - aggregate amount of unquoted investments - - - - - Investments (At cost) : A. Trade Note 11 Non-current investments Note 11 Annual Report 2013-2014 151 Æ˙EÚ®… 31 ®……S…«. 2013 EÚ…‰ 2013 ®……S…«. 31 125.00 - - 19,420.17 18,586.42 31 ®……S…«, 2014 EÚ…‰ 2014 ®……S…«, 31 0.16 20,000 2.00 20,000 2.00 50.00 78,34,188 783.42 78,34,188 783.42 100.00 17,80,10,000 17,801.00 17,80,10,000 17,801.00 +x™… ∫…∆™…÷HÚ =t®…/ ±…B E‰Ú ∫…“®……∫…∆J™…… EÚ“ ®… ±……J…… ∫…∆J™…… EÚ“ ®… ±……J…… x…™…∆ j…i… ∫…k……/ x…™…∆ j…i… ®…⁄±™… +∆ EÚi… V…“ B {…“ B±…±……<¢Úœ∫|…M… +∫{…i……±… |……<¥…‰]ı ±… ®…]‰ıb˜(±……M…i… {…Æ˙) E‰ÚÆ˙±… Bx… ¥…Æ˙…‰ +¥…∫…∆Æ˙S…x…… ±… ®…]‰ıb˜ ∫…∆™…÷HÚ =t®…®… b˜§…ÂS…Æ˙… |…n˘k… +x…÷rfi˘i…-{…⁄h…« x…¥…‰∂… ®… b˜§…ÂS…Æ˙… +x™…±……<¢Úœ∫|…M… +∫{…i……±… |……<¥…‰]ı ±… ®…]‰ıb˜ (±……M…i… 10/- {…Æ˙) ∫…®…x…÷π…∆M…“ 10/- 100/- 74.00 ∫…∆™…÷HÚ =t®… 14,07,480 100/- 708.75 - - 1,25,000 - BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ ∫…®…x…÷π…∆M…“ 10/- . (J…) (EÚ) <ŒC¥…]ı“ ={…EÚÆ˙h…… ®… x…¥…‰∂… (1) (2) (3) (4) (5) (6) (7) ∫…∆ GÚ®….x……®…EÚ… x…EÚ…™… x…M… ®…i… ∫…®…x…÷π…∆M…“/∫…Ω˛™……‰M…“ ™…⁄ x…]ı |… i… EÚ“ v……Æ˙h… ∂…‰™…Æ˙/™…⁄ x…]ı… Æ˙EÚ®… ∂…‰™…Æ˙/™…⁄ x…]ı… ]ı{{…h…“ : +x™… x…¥…‰∂…… E‰Ú ¥…¥…Æ˙h… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 152 2.00 lacs ` Amount in (7) 20,000 Units No. of Shares/ 2.00 lacs ` Amount in 19,420.17 18.586.42 (6) nits 20,000 1,25,000 125.00 - - As at 31st March 2014 As at 31st March 2013 0.16 (5) lding (%) U (4) 10/- 10/- 50.00 78,34,188 783.42 78,34,188 783.42 per unit Ho Face Value Extent of No. of Shares/ (3) Subsidiary/ SubsidiarySubsidiary 10/- 100/-Others 100.00 74.00 17,80,10,000 17,801.00 14.07,480 17,80,10,000 17,801.00 708.75 - - Entity/Others JV/Controlled/ (2) GAPL (at cost) Pvt. Ltd Hospital Life Spring Kerala Enviro Infrastructures Ltd. Joint Venture Unquoted-Fully paid equity shares HLL Biotech Ltd. Unquoted-Fully paid Debentures (at cost) Pvt. Ltd Hospitals Life Spring Joint Venture 100/- - Sl. Name of the Body Corporate (1) No. Associate/ (b) Investment in Debentures (a) Investments in Equity Instruments Note : Details of Other Investments Annual Report 2013-2014 153 ]ı{{…h…“ 11 B +x™… M…ËÆ˙ S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… §…]¬ı]‰ı J……i…‰ x…Ω˛” b˜…±…“ M…™…“ ∫…“®…… i…EÚ |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ EÚ…‰ §…g¯…x…‰ E‰Ú ±…B +…Æ˙ +…‰ ∫…“ EÚ… ∂…÷±EÚ 84.00 112.00 <« ∫…“ §…“ @Òh… + O…®… ∂…÷±EÚ 38.22 - B®… B ]ı“ G‰Ú b˜]ı {……j…i…… 444.83 419.00 E÷Ú±… 567.05 531.00 ]ı{{…h…“ 12 ¥…∫i…÷∫…⁄S…“ ( x…®x…i…®… ±……M…i… {…Æ˙ +…ËÆ˙ x…¥…±… ¥…∫…⁄±…“ ∫……v™… ®…⁄±™…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… EÚ. EÚSS…‰ ®……±… (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 2,096.60 2,021.12 +x™…… E‰Ú ∫……l… EÚSS…‰ ®……±… (±……M…i… {…Æ ®…⁄±™……∆ EÚi…) - - 2,096.60 2,021.12 J…. {…È EÚM… ∫……®…O…“ (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 1,010.12 978.02 1,010.12 978.02 M…. S……±…⁄ EÚ…™…« (¥……∫i… ¥…EÚ |… EÚ™…… ±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 1,545.38 1,794.56 1,545.38 1,794.56 P…. i…Ë™……Æ˙ ®……±… ( x…®x…i…®… ±……M…i… {…Æ˙ ™…… Bx… +…Æ˙ ¥…“ {…Æ˙ ®…⁄±™……∆ EÚi…) ¥… x…î…i… =i{……n˘ 3,636.46 2,083.68 ∫……®…… V…EÚ ¥…{…h…x… =i{……n˘ 94.64 222.61 ¥™……{……Æ˙ =i{……n˘ 2,027.23 2.295.79 ®……M…«∫l… ®……±… 13.33 15.39 5,771.96 4,617.47 RÛ. ∫……®……x™… ¶…∆b˜…Æ˙ B¥…∆ ={…¶……‰V™… (±……M…i… {…Æ˙ ®…⁄±™…) 102.67 100.69 102.67 100.69 S…. +x™… ∫……®… O…™……ƒ, ®…∂…“x…Æ˙“, + i… Æ˙HÚ {…÷V…Á, <®……Æ˙i…“ ∫……®……x… +… n˘ (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 1,043.01 868.13 1,043.01 868.13 UÙ. |…§…∆v… u˘…Æ˙… {…÷x…®…⁄«±™……∆ EÚi… +…ËÆ˙ |…®…… h…i… +…ËV……Æ˙ 13.82 3.56 13.82 3.56 V…. +x™… Æ˙q˘“/+ v…∂…‰π… ∫…∆{… k…™……ƒ (EÚ®… J……i…… ±……M…i… ™…… x…¥…±… ¥…∫…⁄±…“ ∫……v™… ®…⁄±™… {…Æ˙) 25.39 13.31 ={…Ω˛…Æ˙ ®…n¢ (±……M…i… {…Æ˙) 126.19 128.79 ±…‰J…x… ∫……®…O…“ (±……M…i… {…Æ˙) 65.54 64.97 217.12 207.07 11,800.68 10,590.62 x™…⁄x… : +|…™…÷HÚ ∫]ı…ÏEÚ E‰Ú ±…B +∆ i…®… |……¥…v……x… 95.95 97.95 E÷Ú±… 11,704.73 10,492.67 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 154 Note 11.A. Other Non-Current Assets AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Fee for RoC for enhancing Authorised Share Capital to the extend not written off 84.00 112.00 ECB Loan Upfront charges 38.22 - MAT Credit Entitlement 444.83 419.00 Total 567.05 531.00 Note 12 Inventories (At lower of cost and net realisable value) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs a. Raw Materials (Valued at cost) 2,096.60 2,021.12 Raw Materials with others (Valued at cost) - - 2,096,60 2,021.12 b. Packing Materials (Valued at cost) 1,010.12 978.02 1,010.12 978.02 c. Work-in-progress (Valued at Actual Process Cost) 1,545.38 1,794.56 1,545.38 1,794.56 d. Finished goods (Valued at Lower of cost or NRV) Manufactured Products 3,636.46 2,083.68 Social Marketing Products 94.94 222.61 Trading Products 2,027.23 2,295.79 Goods-in-transit 13.33 15.39 5,771.96 4,617.47 e. General Stores and Consumables (Valued at cost) 102.67 100.69 102.67 100.69 f. Other materials, machinery, spare parts, building materials etc. (Valued at cost) 1,043.01 868.13 1,043.01 868.13 g. Tools revalued & certified by management 13.82 3.56 13.82 3.56 h. Others Scrapped/Surplus Assets (at lesser of cost or net realisable value) 25.39 13.31 Gift items (at cost) 126.19 128.79 Stationery (at cost) 65.54 64.97 217.12 207.07 11,800.68 10,590.62 Less:Closing Provision for Obsolete Stock 95.95 97.95 Total 11,704.73 10,492.67 Annual Report 2013-2014 155 ]ı{{…h…“ 13 |……{™… ¥…∫i…÷+… EÚ… ¥™……{……Æ˙ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… ¶…÷M…i……x… E‰Ú ±…B x…™…i… i……Æ˙“J… ∫…‰ UÙΩ˛ ®…Ω˛“x…‰ EÚ“ EÚ®… +¥… v… E‰Ú ±…B §…EÚ…™…… |……{™… ¥™……{……Æ˙ ¥…∫i…÷B∆ |… i…¶…⁄i…, ∂…˝…‰v™… ∫…®…Z…‰ M…B 80.40 114.89 +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 30,304.31 27,573.95 30,384.71 27,688.84 ¶…÷M…i……x… E‰Ú ±…B x…™…i… i……Æ˙“J… ∫…‰ UÙΩ˛ ®…Ω˛“x…‰ EÚ“ + v…EÚ +¥… v… E‰Ú ±…B §…EÚ…™…… |……{™… ¥™……{……Æ˙ ¥…∫i…÷B∆ |… i…¶…⁄i…, ∂…˝…‰v™… ∫…®…Z…‰ M…B 0.37 - +|… i…¶…⁄i…, ∂…˝…‰v™… ∫…®…Z…‰ M…B 12,763.17 13,792.99 ∫…∆ n˘Mv… ∫…®…Z…‰ M…B 987.92 1,094.99 13,751.46 14,887.98 x™…⁄x… : ∫…∆ n˘Mv… |……{™… ¥™……{…˙…Æ E‰Ú ±…B |……¥…v……x… 987.92 1,094.99 12,763.54 13,792.99 E÷Ú±… 43,148.25 41,481.83 ]ı{{…h…“ 14 Æ˙…‰EÚc˜ +…ËÆ˙ Æ˙…‰EÚc˜ ∫…®……x……l…‘ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) Ω˛…l… ®… EËÚ∂…/∫]ı…®{… 12.78 12.84 (J…) §…ÈEÚ ∂…‰π… (i) S……±…⁄ J……i…‰ ®… 1,226.01 996.77 (ii) <« <« B°Ú ∫…“ J……i…‰ ®… 13.74 0.02 1,252.53 1,009.63 (iii) 3 ®…Ω˛“x…‰ ∫…‰ + v…EÚ +¥… P… E‰Ú {… Æ{…C¥…i…… Æ˙Ω˛x…‰ ¥……±…‰ V…®……Bƒ 200.00 23.56 (iv) =v……Æ +…ËÆ˙ M……Æ∆˙]ı“ E‰Ú ±…B ®……ÃV…x… ®…h…“ E‰Ú ∞¸{… ®… Æ˙J…‰ V…®……B∆ 0.27 139.69 200.27 163.25 E÷Ú±… 1,452.80 1,172.88 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 156 Note 13 Trade receivables AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Trade receivables outstanding for a period less than six months from the date they were due for payment Secured, considered good 80.40 114.89 Unsecured, considered good 30,304.31 27,573.95 30,384.71 27,688.84 Trade receivables outstanding for a period exceeding six months from the date they were due for payment Secured, considered good 0.37 - Unsecured, considered good 12,763.17 13,792.99 considered doubtful 987.92 1,094.99 13,751.46 14,887.98 Less : Provision for doubtful trade receivables 987.92 1,094.99 12,763.54 13,792.99 Total 43,148.25 41,481.83 Note 14 Cash and cash equivalents AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Cash/stamps on hand 12.78 12.84 (b) Balances with banks (i) In current accounts 1,226.01 996.77 (ii) In EEFC accounts 13.74 0.02 1,252.53 1,009.63 (iii) Deposits having maturity period of above 3 months 200.00 23.56 (iv) Deposits held as margin money for borrowings and guarantees 0.27 139.69 200.27 163.25 Total 1,452.80 1,172.88 Annual Report 2013-2014 157 ]ı{{…h…“ 15 +±{…EÚ… ±…EÚ @Òh… B¥…∆ {…‰∂… M…™……ƒ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) |… i…¶…⁄ i… V…®…… B¥…∆ <« B®… b˜“ 328.87 274.92 |… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B - - ={… ™……‰M… 328.87 274.92 (J…) EÚ®…«S…… Æ˙™…… EÚ…‰ @Òh… B¥…∆ {…‰∂… M…™……ƒ |… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 17.62 17.49 +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 358.94 314.01 ∫…∆ n˘Mv… ∫…®…Z…‰ M…B 1.17 2.57 377.73 334.07 x™…⁄x… : ∫…∆ n˘Mv… @Òh… +…ËÆ˙ {…‰∂… M…™…… E‰Ú ±…B |……¥…v……x… 1.17 2.57 ={… ™……‰M… 376.56 331.50 (M…) {…⁄¥…«|…n˘k… ¥™…™… - +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 177.62 210.70 177.62 210.70 (P…) ∫…Æ˙EÚ…Æ˙“ |…… v…EÚ… Æ˙™…… E‰Ú ∫……l… ∂…‰π… +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B (i) +…™…EÚÆ˙ {…‰∂…M…“ 929.58 648.51 (ii) §…GÚ“ EÚÆ˙ {…‰∂…M…“ 4.39 2.29 933.97 650.80 (RÛ) +x™… |… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 837.17 937.41 +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 7,337.73 6,145.22 ∫…∆ n˘Mv… ∫…®…Z…‰ M…B 440.79 454.89 ı 8,615.69 7,537.52 x™…⁄x… : ∫…∆ n˘Mv… @Òh… +…ËÆ˙ {…‰∂… M…™…… E‰Ú ±…B |……¥…v……x… 440.79 454.89 ={… ™……‰M… 8,174.90 7,082.63 E÷Ú±… 9,991.92 8,550.55 ]ı{{…h…“ : n‰˘™… Æ˙EÚ®… ®… +±{…EÚ… ±…EÚ @Òh… B¥…∆ {…‰∂…M…“ ∂…… ®…±… Ω˲ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… x…n‰˘∂…EÚ 0.52. 0.18 E∆Ú{…x…“ E‰Ú +x™… + v…˘EÚ…Æ˙“ 88.45 44.59 88.97 44.77 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 158 Note 15 Short-term loans and advances AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Security deposits & EMD 328.87 274.92 Secured, considered good - - Sub Total 328.87 274.92 (b) Loans and advances to employees Secured, considered good 17.62 17.49 Unsecured, considered good 358.94 314.01 Considered Doubtful 1.17 2.57 377.73 334.07 Less : Provision for doubtful loans and advances 1.17 2.57 Sub Total 376.56 331.50 (c) Prepaid expenses - Unsecured, considered good 177.62 210.70 177.62 210.70 (d) Balances with government authorities Unsecured, considered good (i) Advance Income Tax 929.58 648.51 (ii) Sales Tax Advances 4.39 2.29 933.97 650.80 (e) Others Secured, considered good 837.17 937.41 Unsecured, considered good 7,337.73 6,145.22 Considered Doubtful 440.79 454.89 8,615.69 7,537.52 Less : Provision for doubtful loans and advances 440.79 454.89 Sub Total 8,174.90 7,082.63 Total 9,991.92 8,550.55 Note : Short-term loans and advances include amounts due from : AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Directors 0.52 0.18 Other officers of the Company 88.45 44.59 88.97 44.77 Annual Report 2013-2014 159 ]ı{{…h…“ : 16 +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) |……‰n¬˘¶…¥…x… (i) B°Ú b˜“ +…Æ˙ ∫…‰ |……‰n¬˘¶…⁄i… §™……V… 0.22 3.93 (ii) V…®……Æ˙… ∂…™…… {…Æ˙ |……‰n¬˘¶…⁄i… §™……V… - 1.52 (iii) ®……ÃV…x… Æ˙… ∂… {…Æ˙ |……‰n¬˘¶…⁄i… §™……V… - 12.86 0.22 18.31 (J…) +x™… (i) {… Æ˙™……‰V…x……+… ∫…‰ |……{™… ¥…∫i…÷Bƒ 126.41 1,591.69 (ii) x…™……«i… |……‰i∫……Ω˛x…/¥……{…∫…“ ∂…÷±EÚ 257.82 428.83 (iii) {…Â∂…x… ™……‰V…x…… E‰Ú ±…B EÚ®…«S…… Æ˙™…… ∫…‰ |……{™… ¥…∫i…÷™… - 116.47 384.23 2,136.99 E÷Ú±… 384.45 2,155.30 √ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 160 Note 16 Other current assets AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Accruals (i) Interest accrued on FDR 0.22 3.93 (ii) Interest accrued on Deposits - 1.52 (iii) Interest accrued on Margin Money - 12.86 0.22 18.31 (b) Others (i) Receivables from Projects 126.41 1,591.69 (ii) Export Incentives/Duty Draw back 257.82 428.83 (iii) Receivable from employees for Pension scheme - 116.47 384.23 2,136.99 Total 384.45 2,155.30 Annual Report 2013-2014 161 ]ı{{…h…“ : 17 {… Æ˙S……±…x… ∫…‰ Æ˙…V…∫¥… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) =i{……n˘… EÚ“ §…GÚ“ 68,404.21 64,769.29 (J…) ∫…‰¥……+… EÚ“ §…GÚ“ 5,410.69 4,054.83 (M…) `‰ˆE‰Ú ∫…‰ +…™… 17,948.86 11,980.62 (P…) +x™… |…S……±…x… Æ˙…V…∫¥… 2,962.78 2,761.68 94,726.54 83,566.42 x™…⁄x… : (RÛ) =i{……n˘ ∂…÷±EÚ 558.38 272.31 E÷Ú±… 94,168.16 83,294.11 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ]ı{{…h…“ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (i) M…¶…« x…Æ˙…‰v…EÚ =i{……n˘… EÚ“ §…GÚ“ 38,437.13 37,572.07 ∫¥……∫l™…Æ˙I…… =i{……n˘… EÚ“ §…GÚ“ 16,090.37 11,823.40 ∫……®…… V…EÚ ¥…{…h…x… =i{……n˘… EÚ“ §…GÚ“ 1,880.95 1,767.26 ¥™……{……Æ˙ =i{……n˘ +…ËÆ˙ +x™…… EÚ“ §…GÚ“ 11,616.20 13,003.46 ∫…Ω‰˛±…“ {…Æ˙ =i{……n˘ <˛®…n˘…n˘ 262.58 254.52 ±……M…i… ¥…fi r˘ n˘…¥…… E∆Úb˜…‰®… - 525.48 {…“ ]ı“ E‰Ú - (182.15) ®……Ë J…EÚ M…¶…« x…Æ˙…‰v…EÚ (5.43) 5.25 EÚ…Ï{…Æ˙-]ı“ 95.04 - ]ı¨⁄§…±… ÀÆ˙M… 27.36 - ={… ™……‰M… 68,404.21 64,769.29 ∫…‰¥……+… EÚ“ §…GÚ“ 5,410.70 4,054.83 `‰ˆE‰Ú ∫…‰ +…™… 17,948.86 11,980.62 +x™… |…S……±…x… Æ˙…V…∫¥… 2,962.78 2,761.68 E÷Ú±… 94,726.54 83,566.42 +x™… |…S……±…x… Æ˙…V…∫¥… ∂…… ®…±… Ω˲ +{…⁄Ãi… EÚ“ M…™…“ ®…÷~i… x…®…⁄x…‰ EÚ“ ±……M…i… 1,648.42 1,423.25 ∫……®…… V…EÚ ¥…{…h…x… {…Æ˙ |……‰i∫……Ω˛x… 58.27 65.42 ∫…Ω‰˛±…“ +…ËÆ˙ x……‰¥…‰C∫… EÚ“ §…GÚ“ {…Æ˙ |……‰i∫……Ω˛x… <˛®…n˘…n˘ 419.02 434.41 ∂…÷±EÚ U⁄Ù]ı/∂…÷±EÚ ¥……{…∫…“/+x™… x…™……«i… |……‰i∫……Ω˛x… 341.73 388.57 Æ˙q˘“ ®……±…, Æ˙q˘“ E∆Úb˜…‰®… +…ËÆ˙ +x™… ¥… ¥…v… ®…n˘… EÚ“ §…GÚ“ 428.65 408.60 x… ¥…n˘… °Ú…®…« EÚ“ §…GÚ“ 66.69 41.43 E÷Ú±… 2,962.78 2,761.68 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 162 Note 17 Revenue from operations Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Sale of products 68,404.21 64,769.29 (b) Sale of services 5,410.69 4,054.83 (c) Income from Contract 17,948.86 11,980.62 (d) Other operating revenues 2,962.78 2,761.68 94,726.54 83,566.42 Less : (e) Excise duty 558.38 272.31 Total 94,168.16 83,294.11 Year Ended Year Ended Note Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Sale of Contraceptive Products 38,437.13 37,572.07 Sale of Healthcare Products 16,090.37 11.823.40 Sale of Social Marketing Products 1,880.95 1,767.26 Sale of Trading Products and Others 11,616.20 13.003.46 Product subsidy on saheli 262.58 254.52 Cost Escalation Claims Condoms - 525.48 PTK (182.15) Oral Contraceptives (5.43) 5.25 Copper-T 95.04 - Tubal Ring 27.36 - Sub Total 68,404.21 64,769.29 Sale of services 5.410.70 4,054.83 Income from Contract 17,948.86 11,980.62 Other operating revenues 2,962.78 2,761.68 Grand Total 94,726.54 83,566.42 Other operating revenues comprise : Cost of free sample supplied 1,648.42 1,423.25 Incentive on Social Marketing 58.27 65.42 Promotional Subsidy on Saheli and Novex sales 419.02 434.41 Duty Rebate/Duty drawback/Other export incentives 341.73 388.57 Sale of scrap, waste condoms and other misc. items 428.65 408.60 Sale of tender form 66.69 41.43 Total 2,962.78 2,761.68 Annual Report 2013-2014 163 ]ı{{…h…“ : 18 +x™… +…™… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) §™……V… +…™… (x…“S…‰ ]ı{{…h…“ (i) n‰˘J…Â) 324.92 396.19 (J…) +x™… M…ËÆ˙-|…S……±…x… +…™… (x…“S…‰ ]ı{{…h…“ (ii) n‰˘J…Â) 875.75 310.15 E÷Ú±… 1,200.67 706.34 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ]ı{{…h…“ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (i) §™……V… +…™… ®… ∂…… ®…±… Ω˲ : §…ËEÚ…Â ∫…‰ §™……V… : EÚ) +±{……¥… v… V…®…… {…Æ˙ 295.18 371.22 J…) +x™…… {…Æ˙ 29.74 24.97 E÷Ú±…-§™……V… +…™… 324.92 396.19 (ii) +x™… M…ËÆ˙-|…S……±…x… +…™… ®… ∂…… ®…±… Ω˲: EÚ®…«S……Æ“ +…¥……∫…… ∫…‰ EÚÆ˙…B EÚ… +…™… 2.66 2.55 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ EÚÆ˙ ±……¶… 22.54 0.51 §…“®…… n˘…¥…… 5.25 0.65 {…÷Æ˙…∆ EÚi… EÚB + v…EÚ |……¥…v……x…/@Òh… 424.96 17.40 {…]¬ı]ı… EÚÆ˙…™…… 48.57 46.89 +x™… ¥… ¥…v… +…™… 371.77 242.15 E÷Ú±…-+x™… M…ËÆ˙-|…S……±…x… +…™… 875.75 310.15 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 164 Note 18 Other income Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Interest income (Refer Note (i) below) 324.92 396.19 (b) Other non-operating income (Refer Note (ii) below) 875.75 310.15 Total 1,200.67 706.34 Year Ended Year Ended Note Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (i) Interest income comprises : Interest from banks on : a) On short term deposit 295.18 371.22 b) On Others 29.74 24,97 Total - Interest income 324.92 396.19 (ii) Other non-operating income comprises : Rental income from Staff quarters 2.66 2.55 Profit on sale of fixed assets 22.54 0.51 Insurance claims 5.25 0.65 Excess provision / credits written back 424.96 17.40 Lease rent 48.57 46.89 Other Misc. Income 371.77 242.15 Total - Other non-operating income 875.75 310.15 Annual Report 2013-2014 165 ]ı{{…h…“ : 19.EÚ J……{…… Ω÷˛+… ®……±… EÚ“ ±……M…i… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… +…Æ∆˙ ¶…EÚ ∫]ı…ÏEÚ 2,999.14 2,784.12 V……‰b˜ : J…Æ˙“n˘ 19,506.75 19,251.78 22,505.89 22,035.90 x™…⁄x… : +∆ i…®… ∫]ı…ÏEÚ 3,106.72 2,999.14 J……{…… Ω÷˛+… ®……±… EÚ“ ±……M…i… 19,399.17 19,036.76 ={…¶…÷HÚ ∫……®…O…“ ®… ∂…… ®…±… Ω˲: EÚSS…‰ ®……±… 11,236.30 11,351.74 Æ˙∫……™…x… 2,610.13 2,448.78 {…ËÀEÚM… ∫……®… O…™……ƒ 5,077.21 4,749.66 M…÷h…¥…k…… B¥…∆ ={…-`‰ˆEÚ… ¥™…™… EÚ“ ±……M…i… 475.53 486.98 E÷Ú±… 19,399.17 19,036.76 ]ı{{…h…“ : 19.J…Ú ¥…G‰Ú™… ®……±…… EÚ“ J…Æ˙“n˘ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… ¥™……{……Æ˙ =i{……n˘ 14,183.58 16,748.41 ∫……®…… V…EÚ ¥…{…h…x… •……∆b‰˜b˜ =i{……n˘ 1,443.78 1,617.11 E÷Ú±… 15,627.36 18,365.52 ]ı{{…h…“ : 19.M… i…Ë™……Æ˙ ®……±…… EÚ“ ¥…∫i…÷∫…⁄S…“ +…ËÆ˙ S……±…⁄ EÚ…™…« ®… {… Æ˙¥…i…«x… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… ¥…π…« E‰Ú +∆i… ®… ¥…∫i…÷∫…⁄S…“ i…Ë™……Æ˙ ®……±… 5,771.96 4,617.47 S……±…⁄ EÚ…™…« 1,545.38 1,794.56 7,317.34 6,412.03 ¥…π…« E‰Ú |……Æ∆˙¶… ®… ¥…∫i…÷∫…⁄S…“ i…Ë™……Æ˙ ®……±… 4,617.47 2,416.21 S……±…⁄ EÚ…™…« 1,794.56 1,226.64 6,412.03 3,642.85 x…¥…±… (¥…fi r˘)/EÚ®…“ (905.31) (2,769.18) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 166 Note 19.A Cost of materials consumed Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Opening stock 2,999.14 2,784.12 Add : Purchases 19,506.75 19,251,78 22,505.89 22,035,90 Less : Closing stock 3,106.72 2,999.14 Cost of material consumed 19,399.17 19,036.76 Materials consumed comprises : Raw Materials 11,236.30 11,351.34 Chemicals 2,610.13 2,448.78 Packing Materials 5,077.21 4,749.66 Cost of quality and sub contract expense 475.53 486.98 Total 19,399.17 19,036.76 Note 19.B Purchases of Stock-in-trade Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Trading Products 14,183.58 16,748.41 Social Marketing Branded Products 1,443.78 1,617.11 Total 15,627.36 18,365.52 Note 19.C Changes in inventories of finished goods, and work-in-progress Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Inventories at the end of the year : Finished goods 5,771.96 4,617.47 Work-in-progress 1,545.38 1,794.56 7,317.34 6,412.03 Inventories at the beginning of the year : Finished goods 4,617.47 2,416.21 Work-in-progress 1,794.56 1,226.64 6,412.03 3,642.85 Net (Increase) / decrease (905.31) (2,769.18) Annual Report 2013-2014 167 ]ı{{…h…“ : 20Ú EÚ®…«S……Æ˙“ Ω˛i…±……¶… ¥™…™… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) ¥…‰i…x… +…ËÆ˙ |……‰i∫……Ω˛x… 10,223.42 9,418.39 (J…) +∆∂…n˘…x… ¶… ¥…π™… x… v… 964.80 897.97 x…™…“ {…Â∂…x… ™……‰V…x…… 150.78 267.37 ={…n˘…x… x… v… +∆∂…n˘…x… 515.91 587.46 +ÃV…i… U÷Ù]¬ı]ı“ x… v… 175.18 169.41 EÚ®…«S……Æ˙“ Æ˙…V™… §…“®…… ®… +∆∂…n˘…x… 53.58 24.67 (M…) EÚ®…«S……Æ˙“ EÚ±™……h… ¥™…™… 1,398,26 1,110.49 E÷Ú±… 13,481,93 12,475.76 ]ı{{…h…“ : 21Ú ¥…k… ±……M…i… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) §™……V… ¥™…™… : (i) x…EÚn˘“ =v……Æ˙ 1,539.71 957.75 (ii) +…¥… v…EÚ @Òh… 98.17 215.74 (J…) +x™… =v……Æ˙ ±……M…i… 202.47 229.19 E÷Ú±… 1,840.35 1,402.68 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 168 Note 20 Employee benefits expense Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Salaries and incentives 10,223.42 9,418.39 (b) Contribution to - Provident fund 964.80 897.97 New pension scheme 150.78 267.37 Gratuity fund contributions 515.91 587.46 Earned Leave Fund 175.18 169.41 Contribution to ESI 53.58 24.67 (c) Staff welfare expenses 1,398.26 1,110.49 Total 13,481.93 12,475.76 Note 21 Finance costs Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Interest expense on : (i) Cash Credit 1,539.71 957.75 (ii) Term Loan 98.17 215.74 (b) Other borrowing costs 202.47 229.19 Total 1,840.35 1,402.68 Annual Report 2013-2014 169 ]ı{{…h…“ : 22Ú +x™… ¥™…™… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… ¥…Y……{…x… B¥…∆ |…S……Æ˙ +…ËÆ˙ §…GÚ“ |……‰z…®…x… ¥™…™… 4,815.61 4,883.05 §…V…±…“ +…ËÆ˙ <∆v…x… S……V…« 3,907.26 3,528.40 ¶……c˜… +…ËÆ˙ +x™… ¥…GÚ™… ¥™…™… 3,299.95 2,650.52 ™……j…… i…l…… {… Æ˙¥…Ω˛x… 1,790.08 1,609.55 +x™… =i{……n˘x… ¥™…™… 1,753.76 1,269.18 `‰ˆE‰Ú EÚ®…«S…… Æ˙™…… EÚ…‰ ¥…‰i…x… 1,684.76 1,306.94 {…Æ˙…®…∂…« i…l…… ∫…‰¥…… ∂…÷±EÚ 1,179.32 917.54 ®…÷}i… x…®…⁄x…… ¥…i…Æ˙h… 1,733.97 1,442.09 ¥… ¥…v… ¥™…™… 868.04 693.14 +∂……‰v™… +…ËÆ˙ ∫…∆ n˘Mv… EÚV…«/+ O…®…… E‰Ú ±…B |……¥…v……x… 254.09 116.16 ®…Æ˙®®…i… i…l…… +x…÷Æ˙I…h… ®…∂…“x…Æ˙“ 401.68 322.94 b˜…EÚ, i……Æ˙ i…l…… n⁄˘Æ¶……π… 342.45 281.64 +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ¥™…™… 2.56 20.91 x…M… ®…i… +…Æ˙ & b˜“ EÂÚp˘ ¥™…™… 480.25 401.75 EÚÆ˙…™…… 415.91 374.44 ®…÷p˘h… i…l…… ±…‰J…x… ∫……®… O…™……ƒ 236.27 176.94 +x™… {… Æ˙∫…∆{… k…™…… E‰Ú ®…Æ˙®®…i… i…l…… +x…÷Æ˙I…h… 115.23 77.09 V…±… S……V…« 139.92 138.54 §…“®…… S……V…« 172.91 118.02 §…ÈEÚ S……V…« 178.71 165.72 ¥… x…®…™… =i……Æ˙-S…g¯…¥… 1,086.91 1.12 EÚ®…«S…… Æ˙™…… EÚ“ ¶…i…‘ ¥™…™… 97.71 54.03 n˘Æ˙ B¥…∆ EÚÆ˙ 118.72 123.01 §…]¬ı]‰ı J……i…‰ b˜…±…‰ M…B §…‰EÚ…Æ˙ ¶…∆b˜…Æ˙ E‰Ú ±…B |……¥…v……x… 41.88 75.66 ¥…¥…… n˘i… n‰˘™…i……+… E‰Ú ±…B |……¥…v……x… 2.55 - §…]¬ı]‰ı J……i…‰ b˜…±…‰ M…B §…‰EÚ…Æ˙ {… Æ˙∫…∆{… k…™……ƒ/¶…∆b˜…Æ˙ E‰Ú §…Ω˛“ ®…⁄±™… 43.98 74.63 |… ∂…I…h… EÚ…™…«GÚ®… ¥™…™… 93.48 108.28 <®……Æ˙i…… EÚ“ ®…Æ˙®®…i… i…l…… +x…÷Æ˙I…h… 144.04 124.11 §…]¬ı]‰ı J……i…‰ b˜…±…‰ M…B +∂……‰v™… EÚV…« B¥…∆ + O…®… 236.23 56.82 ±…‰J……{…Æ˙“I…EÚ…Â EÚ…‰ ¶…÷M…i……x… (x…“S…‰ ]ı{{…h…“ (i) n‰˘J…Â) 28.82 24.04 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“/Æ˙q˘“ {… Æ˙∫…∆{… k…™…… {…Æ˙ Ω˛… x… 2.70 2.08 x…M… ®…i… ∫……®…… V…EÚ n˘… ™…i¥… J…S…« 97.28 66.89 n˘…x… 0.11 0.32 {…⁄¥…« +¥… v… ®…n¢ ( x…¥…±…)/(x…“S…‰ ]ı{{…h…“ (ii) n‰˘J…Â) (15.91) (4.69) E÷Ú±… 25,751.23 21,200.86 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 170 Note 22 Other expenses Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Advertisement & Publicity and Sales Promotion Expenses 4,815.61 4,883.05 Power & fuel charges 3,907.26 3,528.40 Freight & Other Selling Expenses 3,299.95 2,650.52 Travelling & Conveyance 1,790.08 1,609.55 Other Production expenses 1,753.76 1,269.18 Wages to Contract Labourers 1,684.76 1,306.94 Consultancy & Service Charges 1,179.32 917.54 Free sample distribution 1,733.97 1,442.09 Miscellaneous Expenses 868.04 693.14 Provision for bad & doubtful debts/Advances 254.09 116.16 Repairs & Maintenance Machinery 401.68 322.94 Postage & Telegram, Telephone 342.45 281.64 Research & Development Expenses 2.56 20.91 Corporate R & D Centre Expenses 480.25 401.75 Rent 415.91 374.44 Printing & Stationery 236.27 176.94 Repairs & maintenance of other assets 115.23 77.09 Water charges 139.92 138.54 Insurance charges 172.91 118.02 Bank charges 178.71 165.72 Exchange Fluctuation 1,086.91 1.12 Staff recruitment expenses 97.71 54.03 Rates & Taxes 118.72 123.01 Provision for obsolete stores written off 41.88 75.66 Provision for Disputed Liabilities 2.55 - Book value of obsolete assets/stores written off 43.98 74.63 Training program expenses 93.48 108.28 Repairs & Maintenance of buildings 144.04 124.11 Bad debt & advances written off 236.23 56.82 Payments to auditors (Refer Note (i) below) 28.82 24.04 Loss on sale of Fixed Assets/scrapped assets 2.70 2.08 Corporate Social Responsibility expenses 97.28 66.89 Donation 0.11 0.32 Prior period items (net) (Refer Note (ii) below) (15.91) (4.69) Total 25,751.23 21,200.86 Annual Report 2013-2014 171 ]ı{{…h…“ : 22 +x™… +…™… (V……Æ˙“....) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (i) ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ¶…÷M…i……x… ®… ∂…… ®…±… Ω˲ ±…‰J……{…Æ˙“I…… ∂…÷±EÚ 11.50 11.50 ±…‰J……{…Æ˙“I…… ∂…÷±EÚ EÚÆ˙ 1.50 1.12 ±…‰J……{…Æ˙“I…… ¥™…™… 11.82 8.69 ±…‰J……{…Æ˙“I…… ∂…÷±EÚ ±……M…i… 4.00 2.73 E÷Ú±… 28.82 24.04 (ii) {…⁄¥…« +¥… v… ®…n˘… E‰Ú ¥…¥…Æ˙h… ( x…¥…±…) {…⁄¥…« +¥… v… +…™… +x™… +…™… 72.90 21.73 ={…¶…÷HÚ ®……±… - - n˘Æ˙ B¥…∆ EÚÆ˙ - - E÷Ú±… 72.90 21.73 {…⁄¥…« +¥… v… ¥™…™… EÚ®…«S……Æ˙“™…… E‰Ú ¥…‰i…x… +…ËÆ˙ ®…W…n⁄˘Æ˙“ - - |…∂……∫… x…EÚ ¥™…™… 56.99 17.04 ®…⁄±™…ø…∫… - - +x™… ¥™…™… -- E÷Ú±… 56.99 17.04 {…⁄¥…« +¥… v… ®…n¢ ( x…¥…±…) (15.91) (4.69) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 172 Note 22 Other expenses (Contd.) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (i) Payments to the auditors comprises Audit fees 11.50 11.50 Tax Audit fees 1.50 1.12 Audit expenses 11.82 8.69 Costl Audit fees 4.00 2.73 Total 28.82 24.04 (ii) Details of Prior period items (net) Prior period income Other Income 72.90 21.73 Material consumed - - Rates & Taxes - - Total 72.90 21.73 Prior period expenses Employees Salaries & Wages - - Administrative Expenses 56.99 17.04 Depreciation -- Other Expenses - - Total 56.99 17.04 Prior period items (net) (15.91) (4.69) Annual Report 2013-2014 173 ±……J…… ®… ±……J…… ` E÷Ú±… b˜“ ∫…÷ ¥…v……B∆ b˜“ & b˜“ & ∫…÷ ¥…v……B∆+…Æ˙ +x™… 9.869.86 582.71 582.71 - - - - 9.86 9.86 582.71 582.71 +x…÷®……‰ n˘i… +…Æ˙ +x…÷®……‰ n˘i… 489.73 801.42 - - 489.73 801.42 192.46 147.37251.32 232.85 - 2.56 - 20.91 192.46 253.88 147.37 253.77 969.98 1,203.17 2.56 20.91 972.54 1,224.08 480.25 401.75 2.56 20.91 482.81 422.66 969.98 1,203.17 2.56 20.91 972.54 1,224.08 2013-14 2012-13 2013-14 2012-13 2013-14 2012-13 ∂…… ®…±… E‰Ú x……‰]ı ®… ]ı{{…h…“ 22 ¥…k…“™… ¥…¥…Æ˙h…… ¥…k…“™… b˜“) ∫…÷ ¥…v……+… {…Æ˙ Ω÷˛B ¥™…™…… E‰Ú ¥…¥…Æ˙h… & ) iv ) (EÚ) ∫…‰ ii ) - ( - ) iii ) (RÛ) E‰Ú E÷Ú±… ii ) (P…) E‰Ú E÷Ú±…) ii ( <®……Æ˙i… {…⁄ƒV…“ ={…EÚÆ˙x…√{…⁄ƒV…“ 10 ]ı{{…h…“ x…¥…±… Æ˙EÚ®… ( Æ˙EÚ®… x…¥…±… ∫……®…O…“/={…¶……‰M™…/{…÷V…Á∫…“v…‰ +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ∫…‰ ¥™…™… +x™… ∫…∆§…∆ v…i… 4.45 5.79 - - 4.45 5.79 ¥…‰i…x…/®…W…n⁄˘Æ˙“ ) (M…) +…ËÆ˙ ( i ( (EÚ)¶…⁄ ®…(J…) ------(M…) ∫…÷ ¥…v……+… u˘…Æ˙… |……{i… Æ˙EÚ®…|……{i… u˘…Æ˙… ∫…÷ ¥…v……+… ------(J…) (M…) ={…™……‰ M…i……™…Â(P…) (RÛ) E÷Ú±… Æ˙…V…∫¥… ¥™…™… ( 32.02 15.74 - - 32.02 15.74 (EÚ) E÷Ú±… +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ¥™…™… Æ˙…V…∫¥… ¥™…™… ( x…¥…±…) ¥™…™… Æ˙…V…∫¥… {…⁄ƒV…“ ¥™…™… ) x™…÷x… : +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ) (EÚ) +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ¥™…™… EÚ… ¥™…™… ¥…EÚ…∫… B¥…∆ +x…÷∫…∆v……x… (EÚ) ) ( ( ¥…¥…Æ˙h… (i) (ii) (iii) (iii) - ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 174 Lacs ` 9.86 582.71 -- Facilities Other R&D Facilities Total 9.869.86 582.71 582.71 - - 9.86 582.71 4.45 5.79 - - 4.45 5.79 Approved R &D 32.02 15.74 - - 32.02 15.74 969.98 1,203.17969.98 1,203.17 2.56 20.91 2.56 972.54 20.91 1,224.08 972.54 1,224.08 251.32 232.85480.25 401.75 2.56 20.91 2.56 253.88 20.91 482.81 253.77 422.66 489.73 801.42192.46 147.37 - - - 489.73 - 192.46 801.42 147.37 2013-14 2012-13 2013-14 2012-13 2013-14 2012-13 notes to financial Note 10 Included in R&D Expenditure Other Expenses directly related to R&D (ii)(a) to (ii) (d) Note 22 (Total of (i) (c) and (ii) (e) (Total (e) of revenue expenditure (Total Total (a) Land(b) Building ------(c) Capital equipments (c) Utilities (b) Material/Consumables/Spares (d) (a) Salaries/Wages iv)Amount received by R&D facilities Less : v)Amount of R&D expenditure (iii)-(iv) Net ------iii) Total iii) Total i) Capital Expenditure ii) Revenue Expenditure (Net) (iii) Details of expenditure incurred on in house research and development (R&D) Facilities Particulars statements Annual Report 2013-2014 175 ]ı{{…h…“ : 23Ú ±…‰J…… ®……x…EÚ-22 E‰Ú +v…“x… |…EÚ]ı“EÚÆ˙h…-+…™… {…Æ˙ EÚÆ˙ E‰Ú ±…B ±…‰J…… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ]ı{{…h…“ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… 23 +…∫l… M…i… EÚÆ˙ (n‰˘™…i……)/{… Æ˙∫…∆{… k…™……ƒ ®…⁄±™…ø…∫… (1,827.92) (1,652.66) +…∫l… M…i… EÚÆ˙ n‰˘™…i…… Ω˛…‰x…‰ ¥……±…‰ ®…n… E‰Ú EÚÆ˙ |…¶……¥… (1,827.92) (1,652.66) +…∫l… M…i… EÚÆ˙ n‰˘™…i…… Ω˛…‰x…‰ ¥……±…‰ ®…n… E‰Ú EÚÆ˙ |…¶……¥… 335.79 355.27 ∫…∆ n˘Mv… @Òh… E‰Ú ±…B |……¥…v……x… 29.42 28.08 ∫…®…™……‰{… Æ˙ §…EÚ…™…… E‰Ú ±…B |……¥…v……x… 15.54 120.26 §……Ïx…∫… E‰Ú ±…B |……¥…v……x… 183.70 180.20 +x™… 564.45 683.81 +…∫l… M…i… EÚÆ˙ Ω˛…‰x…‰ ¥……±…“ {… Æ˙∫…∆{… k…™…… E‰Ú ®…n˘… E‰Ú EÚÆ˙ |…¶……¥… x…¥…±… +…∫l… M…i… EÚÆ˙ (n‰˘™…i……)/{… Æ˙∫…∆{… k… (1,263.47) (968.85) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 176 Note 23. Disclosures under Accounting Standards - 22 Accounting for Taxes on Income As at As at Notes Particulars 31.03.2014 31.03.2013 ` lacs ` lacs 23 Deferred tax (liability)/asset Depreciation (1,827.92) (1,652.66) Tax effect of items constituting deferred tax liability (1,827.92) (1,652.66) Tax effect of items constituting deferred tax assets Provision for doubtful debts 335.79 355.27 Provision for Overtime arrear 29.42 28.08 Provision for Bonus 15.54 120.26 Others 183.70 180.20 Tax effect of items constituting deferred tax assets 564.45 683.81 Net deferred tax (liability) / asset (1,263.47) (968.85) Annual Report 2013-2014 177 ]ı{{…h…“ : 24Ú ¥…k…“™… ¥…¥…Æ˙h… E‰Ú + i… Æ˙HÚ ∫…⁄S…x…… EÚ. +…™……i… EÚ… ®…⁄±™… (∫…“ +…<« B°Ú) ` ±……J…… ®… ¥…¥…Æ˙h… 2013-14 2012-13 EÚSS…‰ ®……±… 1,782.66 2,449.40 ∫…∆P…]ıEÚ i…l…… {…÷V…Á 106.61 105.17 {…⁄ƒV…“M…i… ®……±… 604.72 294.04 ¥™……{……Æ˙ =i{……n˘… EÚ… GÚ™… 6,469.10 8,497.16 E÷Ú±… 8,963.09 11,345.76 J…. ¥…n‰˘∂…“ ®…÷p˘… ®… ¥™…™… ` ±……J…… ®… ¥…¥…Æ˙h… 2013-14 2012-13 ™……j…… 80.36 103.03 ∫…‰¥…… S……V…« 301.54 239.86 §…GÚ“ |……‰z…®…x… ¥™…™… 304.10 331.05 ¶……b˜… +…ËÆ˙ ŒC±…™…ÀÆ˙M… ¥™…™… 228.25 130.19 §™……V… +…ËÆ˙ +x™… S……V…« 194.85 458.38 E÷Ú±… 1,109.10 1,262.51 M…. ¥…n‰˘∂…“ ¥… x…®…™… ®… +V…«x… ` ±……J…… ®… ¥…¥…Æ˙h… 2013-14 2012-13 x…™……«i… §…GÚ“/x…®…⁄x…… (B°Ú +…‰ §…“ ®…⁄±™…) 12,049.53 10,801.46 ¶……c˜… & §…“®…… 809.70 763.44 +x™… 15.01 0.00 E÷Ú±… 12,874.23 11,564.90 P…. x…n‰˘∂…EÚ…Â EÚ…‰ {…… Æ˙∏… ®…EÚ ` ±……J…… ®… ¥…¥…Æ˙h… 2013-14 2012-13 ¥…‰i…x… 76.29 58.50 ¶… ¥…π™… x… v… +∆∂…n˘…x… 7.32 5.71 +∆∂…n˘…x… {…Â∂…x… +∆∂…n˘…x… 1.41 1.02 +x…÷±…Œ§v…™……ƒ 42.04 36.30 E÷Ú±… 127.05 101.83 ={…n˘…x… +…ËÆ˙ +ÃV…i… U÷Ù]¬ı]ı“ EÚ“ n‰˘™…i……B∆ ¶……Æ˙i… E‰Ú V…“¥…x… §…“®…… x…M…®… EÚ“ O…⁄{… ={…n˘…x… ™……‰V…x…… u˘…Æ˙… x… v…EÚ EÚ“ V……i…“ Ω˲* <∫… ±…B |…“ ®…™…®… ¥™… HÚM…i… i……ËÆ˙ {…Æ˙ + ¶… x…Œ∂S…i… x…Ω˛” Ω˲ +i…: ∂…… ®…±… x…Ω˛” Ω˲* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 178 Note 24. Additional Information to the Financial Statement A. Value of Imports : CIF ` lacs Particulars 2013-14 2012-13 Raw Materials 1,782.66 2,449.40 Components and Spares 106.61 105.17 Capital Goods 604.72 294.04 Finished Products 6,469.10 8,497.16 Total 8,963.09 11,345.76 B.Expenditure in Foreign Currency ` lacs Particulars 2013-14 2012-13 Travelling 80.36 103.03 Service Charges 301.54 239.86 Sales Promotion Expenses 304.10 331.05 Freight and Clearing expenses 228.25 130.19 Interest and other charges 194.85 458.38 Total 1,109.10 1,262.51 C.Earning in Foreign Exchange ` lacs Particulars 2013-14 2012-13 Export Sales / Samples (FOB Value) 12,049.53 10,801.46 Freight & Insurance 809.70 763.44 Others 15.01 0.00 Total 12,874.23 11,564.90 D.Remuneration to Directors ` lacs Particulars 2013-14 2012-13 Salary 76.29 58.50 P.F. Contribution 7.32 5.71 Contributory Pension Contribution 1.41 1.02 Perquisites 42.04 36.60 Total 127.05 101.83 The Gratuity & Earned leave Liability are funded through Group Scheme of LIC of India. As such the premium is not ascertainable on individual basis and hence not included. For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 179 % E÷Ú±… 11,766.88 100.00 ®…⁄±™… ±……J…… ®… ` 7.18 % ®…⁄±™… ±……J…… ®… ` 54.58 3.75 45.42 8.25 100.00 83.20 208.4476.95 16.81 498.54 1,240.31 100.00 23.05 2,163.20 100.00 100.00 - - 1,043.44 100.00 % n‰˘∂…“ +…™…… i…i… 1.34 6.05 20.75 93.95 22.09 100.00 19.50 55.62 15.56 44.38 35.06 100.00 411.41309.80 100.00 90.89 -134.56 31.05971.00612.87 31.09 9.11 100.00 - 298.21 66.56 340.84 411.41 307.91 - 100.00 68.91 100.00 33.44 432.77 - 100.00 920.78 971.00 100.00 100.00 ®…⁄±™… 10,921.88 92.82 845.00 ±……J…… ®… 17,168.10 2,231.08 19,399.17 ` ¥…¥…Æ˙h… E÷Ú±… 14. +x™… 23.18 92.49 1.88 7.51 25.06 100.00 4.5.]ı“ EÚ…Ï{…Æ˙ ®… Ω˛±…… ∫¥……∫l™… Æ˙I…… =i{……n˘10.EÚ…b«˜ ]‰ı∫]ı |…‰Mx…‰x∫…“ 11. ∫…Ë x…]ıÆ˙“ x…Ë{… EÚx… 12. 1,043.44 ®…‰∂…13. B ®…±…“ 18.08 4.50 100.00 - - 18.08 100.00 1. E∆Úb˜…‰®… 2.3.{…“∫…“ +…‰ Œ∫]ıÆ˙…‰ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 180 % TOTAL 8.25 100.00 25.06 100.00 18.08 100.00 971.00 100.00 432.77 100.00 920.78 100.00 lacs 19.399.17 ` - - 7.51 % VALUE 45.42 33.44 68.91 IMPORTED - - lacs ` VALUE 2,231.08 54.58 3.75 92.49 1.88 66.56 307.91 31.09 298.21 100.00 % 100.000 INDIGENOUS 4.50 23.18 18.08 971.00 612.87 309.80 90.89 31.05 9.11 340.84 100.00 lacs ` 1,031.881,043.44 83.201,664.66 208.44 100.00 76.95 16.81 498.54 - 1,240.31 23.05 100.00 - 2,163.20 1,043.44 100.00 100.00 VALUE 17,168.10 10.921.88 92.82 845.00 7.18 11,766.88 100.00 PARTICULARS TOTAL 13. Emily 14. Others 10. Card Pregnancy Test 11. Sanitary Napkin 12. Mesh 1.2. Condom 3. OCPs Steroidal 4. OCPs Non-Steroidal 5. Copper T 6. Woman health care products 7. Blood Bag 8. Hydrocephalus Shunt9. Tubal Ring Suture 411.41 100.00 1.34 - 19.50 6.05 134.56 20.75 - 55.62 93.95 15.56 411.41 100.00 44.38 22.09 100.00 35.06 100.00 SL. NO NOTE NO 25. VALUE OF INDIGENOUS AND IMPORTED MATERIALS CONSUMED FOR THE YEAR 2013-14 CONSUMED FOR THE AND IMPORTED MATERIALS NOTE NO 25. VALUE OF INDIGENOUS Annual Report 2013-2014 181 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…B ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ¶……M… EÚ“ ]ı{{…h…“ GÚ®… ∫…∆. ¥…¥…Æ˙h… x…M… ®…i… ∫…⁄S…x…… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E∆Ú{…x…“ + v… x…™…®… 1956 E‰Ú |……¥…v……x…… E‰Ú +v…“x… ∫…∆∫l…… {…i… ¶……Æ˙i… ®… + v…¥…… ∫…i… ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… {…⁄h…« ∞¸{… ∫…‰ ∫¥…… ®…i¥… Æ˙J…‰, ®… x…Æ˙ix…… =t®… Ω˲ * BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ EÚ…‰ 21 °ÚÆ˙¥…Æ˙“, 2012 ∫…‰ ∫……¥…«V… x…EÚ ±… ®…]‰ıb˜ E∆Ú{…x…“ E‰Ú ∞¸{… ®… {… Æ˙¥…Ãi…i… EÚ™…… M…™…… Ω˲ * E∆Ú{…x…“ M…¶…« x…Æ˙…‰v…EÚ =i{……n˘… E‰Ú ¥… x…®……«h… B¥…∆ ¥…{…h…x…, +∫{…i……±… =i{……n˘‰∆, ®… Ω˛±…… ∫¥……∫l™… °Ú…®……« =i{……n¢, ∫……®…… V…EÚ ¥…{…h…x… =i{……n¢ +…ËÆ˙ ∫¥……∫l™… Æ˙I…… +¥…∫…∆Æ˙S…x…… +…ËÆ˙ |……{…h… +…ËÆ˙ x…Ën˘… x…EÚ ∫…‰¥……+… E‰Ú ±…B {…Æ˙…®…∂…« B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ |…n˘…x… EÚÆ˙x…‰ ®… ±…M…“ Æ˙Ω˛i…“ Ω˲ * E∆Ú{…x…“ n‰˘∂…“™… +…ËÆ˙ +∆i…Æ˙…«π]≈ı“™… n˘…‰x…… §……W……Æ˙… EÚ…‰ |…§…∆v… EÚÆ˙i…“ Ω˲ * 1. ∫……l…«EÚ ±…‰J…… x…“ i…™……ƒ ¶……Æ˙i… ®… ∫……®……x™… ∞¸{… ∫…‰ ∫¥…“EfiÚi… ±…‰J…… x…“ i…™…… (<∆ b˜™…x… V…“ B B {…“) E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ E‰Ú ¥…k…“™… ¥…¥…Æ˙h… §…x……™…‰ M…™…‰ ΩÈ˛* E∆Ú{…x…“ x…‰ ¶……Æ˙i… E‰Ú ∫…x…n˘“ ±…‰J……EÚ…Æ˙ ∫…∆∫l……{…x… E‰Ú =n¬˘P……‰π…h……/ ®……M…«n˘∂…‘ ∫…r˘…∆i…… E‰Ú +±……¥…… E∆Ú{…x…“ x…™…®… 2006 (™…l…… ∫…∆∂……‰ v…i…) E‰Ú (±…‰J…… ®……x…EÚ) +…ËÆ˙ E∆Ú{…x…“ + v… x…™…®… 1956 E‰Ú ∫…÷∫…∆M…i… |……¥…v……x…… E‰Ú +v…“x… + v…∫…⁄ S…i… ±…‰J…… ®……x…EÚ E‰Ú ∫……l… ∫…¶…“ ¶……Ë i…EÚ ∫…∆§…∆v… ®… +x…÷{……±…x… EÚÆ˙E‰Ú ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 182 Notes forming part of the financial statement for the year ended 31st March, 2014 Sl.No. Particulars Corporate information HLL Life care Limited is a Mini Ratna Enterprise, fully owned by Government of India domiciled in India and incorporated under the provisions of the Companies Act, 1956. HLL Lifecare Ltd was converted into a Public Limited Company with effect from 21st February 2012. The company is engaged in the manufacturing and marketing of contraceptive products, Hospital products, Women Health Pharma products, providing Consultancy & Contract services for healthcare infrastructure, Procurement and Diagnostic services. The company caters to both domestic and international markets. 1. Significant accounting policies The financial statements of the company have been prepared in accordance with generally accepted accounting principles in India (Indian GAAP). The company has prepared these financial statements to comply in all material respect with the accounting standards notified under the Companies (Accounting Standards) Rules, 2006 (as amended) and the relevant provisions of the Companies Act, 1956, besides the pronouncements/guidelines of the Institute of Chartered Accountants of India. The financial statements have been prepared on an accrual basis and under the historical cost convention. The accounting policies adopted in the preparation of financial statements are consistent with those of previous years. 1.1 Basis of accounting and preparation of financial statements With effect from 1st April 2011, the revised Schedule VI notified under the Companies Act 1956, has become applicable to the company, for preparation and presentation of its financial statements. The adoption of revised Schedule VI does not impact recognition and measurement principles followed for preparation of financial statements. However, it has significant impact on presentation and disclosure made in the financial statements. 1.2 Use of estimates The preparation of the financial statements is in conformity with Indian GAAP, requires the Management to make estimates and assumptions considered in the reported amounts of assets and liabilities (including contingent liabilities) and the reported income and expenses during the year. The Management believes that the estimates used in preparation of the financial statements are prudent and reasonable. Future results could differ due to these estimates and the difference between the actual results and the estimates are recognized in the periods in which the results are known / materialized. 1.3 Inventories The weighted average formula is used for the valuation of raw materials, stores and spares. Work-in- progress, materials in transit/under inspection are carried at actual process cost. Unused Loose Tools are revalued every year taking into account the useful life of the tools and carried at the revalued cost. Finished goods manufactured/goods purchased for trading are valued at lower of cost/net realizable value, including excise duty, wherever applicable. Manufactured /traded finished goods in stock whose shelf life expires upto 30th June, 2014 are taken at NIL value. 1.4 Cash and cash equivalents (for purpose of Cash Flow Statement) Cash comprises cash on hand and demand deposits with banks. Cash equivalents are short- term balances (with an original maturity of three months or less from the date of acquisition), highly liquid investments that are readily convertible into known amounts of cash and which are subject to insignificant risk of change in value. 1.5 Cash flow statement Cash flows are reported using the indirect method, whereby profit /(loss) before extraordinary items and tax is adjusted for the effects of transactions of non-cash nature and any deferrals or accruals of past or future cash receipts or payments. The cash flows from operating, investing and financing activities of the Company are segregated based on audited financial statements. Annual Report 2013-2014 183 1.6 +S…±… {… Æ˙∫…∆{… k…™……ƒ ®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ +S…±… {… Æ˙∫…∆{… k…™……ƒ {…∆Æ˙{…Æ˙…M…i… ±……M…i… {…Æ˙ ∫…∆ S…i… ®…⁄±™…ø…∫… EÚ®… EÚÆ˙E‰Ú n˘“ M…<« ΩÈ˛ * ±……M…i… ®… ∫…‰x…¥……]ı G‰Ú b˜]ı E‰Ú x…¥…±… V…Ω˛…ƒ EÚΩ˛” ±……M…⁄ Ω˲, ∫…¶…“ |……∫…∆ M…EÚ ¥™…™… ∂…… ®…±… Ω˲ * x…<« {… Æ˙™……‰V…x……Bƒ/x…B ¥™…¥…∫……™…… EÚ…‰ {…Ω˛S……x…x…‰ E‰Ú ±…B J…S…« Ω÷˛B Æ˙…V…∫¥… ¥™…™… S……±…⁄ {…⁄ƒV…“ EÚ…™…« E‰Ú ∞¸{… ®… ®……x…… V……i…… Ω˲ * ™…Ω˛ ¥™…¥…∫……™… |……Æ∆˙¶… EÚÆ˙x…‰ E‰Ú |…l…®… ¥…π…« ®… {… Æ˙™……‰V…x…… ±……M…i… ®… +…®…‰ ±…i… EÚ™…… V……BM……* ™… n˘ x…<« {… Æ˙™……‰V…x……/x…B ¥™…¥…∫……™… 3 ¥…k…“™… ¥…π……Á EÚ“ +¥… v…™…… ®… EÚ…™……«Œx¥…i… x…Ω˛” EÚB M…B ΩË∆˛ i……‰ ∫…¶…“ ¥™…™… i…“∫…Ɖ˙ ¥…π…« ®… Æ˙…V…∫¥… ®… |…¶…… Æ˙i… EÚÆÂ˙M…‰ * {…^ı…¶…⁄ ®… E‰Ú ®…⁄±™… {…^‰ı +¥… v… {…Æ˙ {… Æ˙∂……‰ v…i… EÚ™…… M…™…… Ω˲ * +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ ±……M…i… ®… =v……Æ˙ {…Æ˙ §™……V… (¶…… Æ˙i… +…Ë∫…i… n˘Æ˙ {…Æ˙ {… Æ˙EÚ ±…i…) +…ËÆ˙ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú + v…O…Ω˛h… E‰Ú ±…B ¥…∂…‰π… ∞¸{… ∫…‰ +…Æ˙…‰{™… |…∂……∫… x…EÚ ¥™…™… ∂…… ®…±… ΩÈ˛ * +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 1.4.2003 ∫…‰ J…S…« Ω÷˛B E∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ˙ EÚ“ ±……M…i… +…ËÆ˙ ±……<∫…Â∫… ∂…÷±EÚ EÚ…‰ +®…⁄i…« {… Æ˙∫…∆{… k…™…… E‰Ú ∞¸{… ®… ¥…M…‘EfiÚi… EÚB V……i…‰ ΩÈ˛* <« +…Æ˙ {…“ ∫……Ï}]ı¥…‰™…Æ˙ ∫……‰±…⁄∂…x… E‰Ú +±……¥…… E∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ˙… EÚ“ ±……M…i… ∫…®……x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ 3 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B ∫…®……x… ∞¸{… ∫…‰ {… Æ˙∂……‰v…x… EÚ™…… V……i…… Ω˲ V…§… EÚ <« +…Æ˙ {…“ ∫……Ï}]ı¥…‰™…Æ ∫……‰±…⁄∂…x… ∫…®……x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ 8 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ˙∂……‰v…x… EÚ™…… V……i…… Ω˲ * |…n˘k… ±……<∫…Â∫… ∂…÷±EÚ EÚ…‰ ∫…®…Z……Ëi…‰ EÚ“ +¥… v… ®… ∫…®……x… ∞¸{… ∫…‰ {… Æ˙∂……‰v…x… EÚ™…… V……i…… Ω˲ * ]≈‰ıb˜ ®……E«Ú ¥™…™… ]≈‰ıb˜ ®……E«Ú {…∆V…“EÚÆ˙h… {…Æ˙ J…S…« Ω÷˛B ¥™…™…, S……±…⁄ {…⁄ƒV…“ EÚ…™…« E‰Ú ∞¸{… ®… ®……x…… V……BM…… +…ËÆ˙ ˛±……<∫…Â∫… |……{i… Ω˛…‰i…‰ Ω˛“ "+®…⁄i…« {… Æ˙∫…∆{… k…™……‰∆' E‰Ú +v…“x… {…⁄ƒV…“EfiÚi… EÚ™…… V……BM……* =∫… EÚ…‰ +®…⁄i…« {… Æ˙∫…∆{… k… EÚ“ ®……x™…i…… EÚ“ i……Æ˙“J… ∫…‰ 5 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ˙∂……‰v…x… EÚ™…… V……BM……˛* ±……<∫…Â∫… {…Æ˙ J…S…« Ω÷˛B =k…Æ˙¥…i…‘ ¥™…™…, V……‰ {…Ω˛±…‰ Ω˛“ {…⁄ƒV…“EfiÚi… Ω˲, EÚ…‰ B‰∫…‰ ¥™…™… J…S…« Ω˛…‰ V……x…‰ EÚ“ +¥… v… ®… Æ˙…V…∫¥… ¥™…™… E‰Ú ∞¸{… ®… ®……x™…i…… n˘“ V……BM…“* ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ +t…¥… v… ∫…∆∂……‰ v…i… E∆Ú{…x…“ + v… x…™…®…, 1956 EÚ“ +x…÷∫…⁄S…“ XIV ®… x…v……« Æ˙i… n˘Æ˙… E‰Ú +x…÷∫……Æ˙ ®…⁄±™…ø…∫… ¥™…¥…Œ∫l…i… EÚ™…… M…™…… Ω˲ * +S…±… {… Æ˙∫…∆{… k…™…… ∫…‰ {… Æ˙¥…v…«x…/EÚ]ı…Ëi…“ {…Æ˙ ®…⁄±™…ø…∫… nˢ x…EÚ ∫…®……x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ n˘B V……i…‰ Ω∆˲ * +¥… v… ∫…®……{i…/Æ˙q˘“ i…l…… x…{…]ı…x… E‰Ú ±…B {…b˜“ +S…±… {… Æ˙∫…∆{… k…™…… EÚ…‰ x…®x…i…®… §…Ω˛“ ®…⁄±™…Ú/ x…¥…±… ¥…∫…⁄±…“ ™……‰M™… ®…⁄±™… {…Æ˙ x…™…i… Ω˲ +…ËÆ "Æ˙q˘“/+ v…∂…‰π… {… Æ˙∫…∆{… k…" ∂…“π…« E‰Ú +v…“x… ∫…∆{… k… ∫…⁄S…“ ®… ¥…M…‘EÚfii… EÚB V……˙i…‰ ΩÈ˛ * ®…⁄±™…ø…∫…/@Òh…®…÷ HÚ EÚ“ ¥… v… EÚ) 01.04.1993 ∫…‰ +S…±… {… Æ˙∫…∆{… k…™…… ®… |… i… ` 5000/- ™…… =∫…∫…‰ EÚ®… ±……M…i… E‰Ú {… Æ˙¥…v…«x……‰∆ EÚ…‰ {… Æ˙¥…v…«x… EÚ“ i……Æ˙“J… EÚ…‰ v™……x… ®… Æ˙J…‰ §…x…… {…⁄h…«i…™…… ®…⁄±™…ø…∫… EÚ™…‰ V……i…‰ ΩÈ˛* J…) ={…EÚÆ˙h… E‰Ú ∫……l… +ÃV…i… ®…∂…“x…Æ˙“ {…÷V……Á EÚ… ®…⁄±™…ø…∫… ®…⁄±… ®…∂…“x…Æ˙“ E‰Ú ±…B ={…™…÷HÚ n˘Æ˙ ¥… |…h……±…“ EÚ‰ |…™……‰M… EÚÆ˙E‰Ú EÚB V……i…‰ ΩÈ˛* M…) ¶… ¥…π™… E‰Ú |…™……‰M… E‰Ú ±…B +±…M… ∞¸{… ∫…‰ |……{…h… EÚB ®…∂…“x…Æ˙“ {…÷V……Á E‰Ú ®……®…±…‰ ®…Â, ∫…∆§…∆ v…i… ®…∂…“x…Æ˙“ EÚ“ ∫…®……{i… +¥… v… E‰Ú ±…B ∫…∆ S…i… ®…⁄±™…ø…∫… E‰Ú ∫…®…i…÷±™… n˘Æ˙ +V…«x… ¥…π…« ®… =∫… ¥…π…« E‰Ú ®…⁄±™…ø…∫… E‰Ú ∫……l… S……V…« EÚB V……i…‰ ΩÈ˛ * P…) {…^‰ı {…Æ˙ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ®…⁄±™…ø…∫…/{… Æ˙∂……‰v…x… E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 205(5) (B) E‰Ú +v…“x… {… Æ˙¶…… π…i… V…Ë∫…‰ {…]¬ı]ı…Âı EÚ“ |……l… ®…EÚ +¥… v… {…Æ˙ ∫…“v…“ Ɖ˙J…… |…h……±…“ {…Æ˙ x…v……« Æ˙i… +¥… v… {…Æ, V……‰ EÚ®… Ω˲ E‰Ú +…v……Æ˙ {…Æ˙ |……¥…v……x… n˘™…… V……i…… Ω˲ * {…^‰ı {…Æ˙ ∫…÷v……Æ˙ ∫…‰ ∫…∆§…∆ v…i… ®…⁄±™…ø…∫… {…^‰ı EÚ“ |……l… ®…EÚ +¥… v… {…Æ˙ ∫…“v…“ Ɖ˙J…… |…h……±…“ {…Æ˙ |…n˘…x… EÚ™…… V……i…… Ω˲ *˙ RÛ) +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ±…B {… Æ˙¥…v…«x…˜/ ¥…±……‰{…x… E‰Ú ±…B ®…⁄±™…ø…∫… S……V…« EÚÆ˙x…‰ EÚ“ ¥… v… nˢ x…EÚ +…x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ Ω˲*˘ ˙ 1.7 Æ˙…V…∫¥… ®……x™…i…… §…GÚ“ ®… §…GÚ“ EÚÆ˙ +…ËÆ˙ §…]¬ı]‰ı EÚ…‰ UÙ…‰c˜EÚÆ˙ ∫…“®…… ∂…÷±EÚ ∫… Ω˛i… ®……±…… E‰Ú §…GÚ“ E‰Ú ®…⁄±™… ( x…¥…±… ¥……{…∫…“) ∫…®…… ¥…π]ı Ω˲ * §…“®…… n˘…¥…… |……Œ{i… E‰Ú +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛ * x…¥…‰∂……‰∆ {…Æ˙ §™……V…, x…¥…‰ ∂…i… Æ˙EÚ®… +…ËÆ˙ §™……V… E‰Ú x…™…i… n˘Æ˙ {…Æ v™……x… Æ˙J…EÚÆ˙˙ ∫…®…™… +x…÷{……i… E‰Ú +…v……Æ˙ {…Æ˙ §…÷EÚ EÚ™…… V……i…… Ω˲ * x…Ën˘… x…EÚ ∫…‰¥……+… ∫…‰ Æ˙…V…∫¥… |……‰n¬˘¶…¥…x… +…v……Æ˙ {…Æ˙ |…n˘…x… EÚ™…… V……i…… Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 184 1.6 Fixed Assets Tangible Assets Fixed Assets are stated at historical cost less accumulated deprectiation. Cost includes all incidental expenditure net of CENVAT credit wherever applicable. Revenue expenses incurred for identification of new projects / new line of businesses are treated as capital work in progress. This will be absorbed into the project cost in the first year of commencing the business. If the new project / new line of business do not materialize within a period of three financial years, the entire expenses shall be charged to Revenue in the 3rd year. The cost of fixed assets includes interest on borrowings (calculated at the weighted average rates) and administrative expenses specifically attributable to the acquisition of fixed assets. Intangible Asset a) Cost of computer software and License fee incurred from 1.4.2003 are classified as intangible assets. The cost of computer software other than ERP Software Solution is amortized equally over a period of 3 years, whereas ERP software solution is amortized over a period of 8 years on pro-rata basis. License fee paid is amortized equally over the agreement period. Trade Mark Expenses Expenses incurred on trade mark registrations will be treated as Capital work in progress and will be capitalized under 'intangible assets' when licenses are received. Same shall be amortized over a period of 5 years from the date of recognition of intangible asset. Subsequent expenditure incurred on licences which is already capitalized will be recognized as revenue expenses in the period in which such expenses are incurred. Depreciation and amortization Depreciation has been provided as per the rates prescribed under Schedule XIV of the Companies Act, 1956 as amended up to date. The depreciation on additions to / deductions from fixed assets are provided on prorata daily basis. Fixed Assets retired / scrapped and pending disposal are stated at lower of book value / net realizable value and grouped under inventories under the head "Scrapped / Surplus Asset" Method of depreciation / Amortization a) Additions to Fixed Assets from 01.04.1993 costing ` 5000/- each or less are fully depreciated irrespective of date of addition. b) Machinery spares acquired with the equipment are depreciated using the same rates and method applicable for the original machinery. c) In the case of Machinery spares procured separately for future use, rate equivalent to accumulated depreciation for the expired life of the relative machinery are charged in the year of acquisition along with the depreciation for the year. d) Depreciation / amortization of fixed assets on lease is provided on the straight line method over the primary period of leases or over the specified period, as defined under Section 205(5) (a) of the Companies Act, 1956, whichever is shorter. Depreciation in respect of Leasehold Improvements is provided on the straight-line method over the primary period of the lease. e) The method of charging depreciation for addition to / deletion for fixed assets is on a daily pro rata basis. 1.7 Revenue recognition Sales comprise of value of sale of goods (net of returns) excluding sales tax and discounts but including excise duty. Insurance claims are accounted on receipt basis. Interest on investments is booked on a time proportion basis taking into account the amounts invested and the fixed rate of interest. Revenue from Diagnostics services is recognized on accrual basis. Revenues from maintenance Annual Report 2013-2014 185 `‰ˆE‰Ú +x…÷Æ˙I…h… ∫…‰ Æ˙…V…∫¥… `‰ˆE‰Ú EÚ“Ú+¥… v… {…Æ˙ ™…l……x…÷{……i… ∞¸{… ∫…‰ {…Ω˛S……x… EÚ“ V……i…“ Ω˲ * +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… |…¶……M… +…ËÆ˙ |……{…h… {…Æ˙…®…∂…« |…¶……M… ∫…‰ ∫…∆§…∆ v…i… EÚ…™…«EÚ±……{…… ∫…‰ Æ˙…V…∫¥… x…®x… V…Ë∫…‰ |…n˘…x… EÚB V……i…‰ ΩÈ˛; EÚ) ]ıx…«EÚ“ `‰ˆE‰Ú E‰Ú ®……®…±…‰ ®…‰∆, ∫…¥…ÊI…h… |…h……±…“ E‰Ú +v…“x… `‰ˆE‰Ú ®…⁄±™… E‰Ú ±…B §…œ±±…M… |…M… i… E‰Ú +…v……Æ˙ {…Æ˙ Ω˲* J…) +x™… `‰ˆE‰Ú E‰Ú ®……®…±…‰ ®…Â, ∫…∆§…∆ v…i… + ¶…EÚÆ˙h…… E‰Ú ∫……l… `‰ˆE‰Ú E‰Ú ∂…i……Á E‰Ú +x…÷∫……Æ˙ n˘… ™…i¥… {…⁄Æ˙… EÚÆ˙x…‰ E‰ +…v……Æ˙ {…Æ˙ Ω˲* 1.8 +x™… |…S……±…x… Æ˙…V…∫¥… Æ˙q˘“ ±…Ë]‰ıC∫…, +∫¥…“EfiÚi… ∫……®… O…™……ƒ i…l…… EÚhb˜…‰®… EÚ“ ¥…∫…⁄±…“ EÚ“ +…‰Æ˙ Æ˙…V…∫¥… Æ˙…‰EÚc˜ +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛* x…™……«i… §…GÚ“ ∫…‰ ∫…∆§…∆ v…i… ∂…÷±E ¥……{…∫…“Ú/ x…™……«i… |……‰i∫……Ω˛x…, x…™……«i… E‰Ú ¥…π…« ®… {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛ * +|…S… ±…i… {… Æ˙∫…∆{… k…™……Â/§…]¬ı]‰ı J……i…‰ b˜…±…“ M…™…“ ∫……®… O…™…… EÚ“ ¥…∫…⁄±…“, Æ˙…‰EÚc˜ +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚ“ V……i…“ ΩË * §…“V…EÚ ®… x…v……« Æ˙i… V…Ë∫…‰ ¥… ¥…v… n‰˘x…n˘…Æ˙… ∫…‰ ¥…±…∆ §…i… ¥…∫…⁄±…“ E‰Ú ±…B ™… n˘ EÚ…‰<« §™……V… +…™… Ω˲ i……‰ =∫…EÚ“ {…Ω˛S……x… x…Ω˛” EÚ“ Ω˲* 1.9 ¥…n‰˘∂…“ ®…÷p˘… ±…‰x…-n‰˘x… ¥……™…n˘… ∫…∆ ¥…n˘… u˘…Æ˙… ∫…®……¥…‰ ∂…i… ¥…n˘‰∂…“ ¥… x…®…™… E‰Ú + i… Æ˙HÚ ±…‰x…-n‰˘x……‰∆ EÚ…‰ ±…‰x…-n‰˘x……‰∆ EÚ“ i……Æ˙“J… {…Æ˙ |…S… ±…i… ¥… x…®…™… n˘Æ˙ ®… {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛ * ¥……™…n˘… `‰ˆEÚ… u˘…Æ˙… ∫…®……¥…‰ ∂…i… EÚ…‰ UÙ…‰c˜EÚÆ˙ +x™… ¥…n‰˘∂…“ ®…÷p˘… +V…«x…/n‰˘™… ¥…π……»xi… EÚ…‰‰ ¥… x…®…™… n˘Æ˙ {…Æ˙ §…n˘±… n˘B V……i…‰ ΩÈ˛ * <∫… §…n˘±…“ ∫…‰ Ω˛…‰x…‰ ¥……±…‰ ±……¶… ™…… x…π]ı ±……¶…-Ω˛… x… ±…‰J…‰ ®… ∫…®……™……‰ V…i… EÚB V……i…‰ ΩÈ˛ * ¥…n‰˘∂…“ ®…÷p˘… @Òh…, ¥…π……»i… ¥… x…®…™… n˘Æ˙ {…Æ˙ ®…⁄±™……∆ EÚi… EÚB V……i…‰ ΩÈ˛ * ™… n˘ i…÷±…x… {…j… EÚ“ i……Æ˙“J… {…Æ §…EÚ…™…… ¥……™…n˘… `‰ˆEÚ… EÚ…‰<« ΩË i……‰,˛ ˙i……Æ˙“J… {…Æ˙ |…S… ±…i… ¥… x…®…™… n˘Æ˙ {…Æ˙ §…Ω˛…±… EÚB V……i…‰ ΩÈ˛* ¥… x…®…™… +∆i…Æ˙ ¥™…¥…Ω˛…Æ˙ n˘“v…«EÚ…±…“x… ¥…n‰˘∂…“ ®…÷p˘… ®……Ë p˘EÚ ®…n˘… E‰Ú +∆i…Æ˙h… ™…… ¥™…¥…∫l……{…x… {…Æ˙ ¥… x…®…™… +∆i…Æ˙ (+l……«i…, V…∫…EÚ… ¥™…¥…∫l……{…x… EÚ“ +¥… v… =∫…E‰Ú |……Æ∆˙¶… EÚ“ i……Æ˙“J… ∫…‰ §……Æ˙Ω˛ ®…Ω˛“x…‰ ∫…‰ + v…EÚ Ω˲ *), V……‰ {…UÙ±…‰ ¥…k…“™… ¥…¥…Æ˙ h…™…… ®… {…Ω˛±…‰ Ω˛“ Æ˙EÚ…‰b«˜ EÚB M…B ™…… Æ˙{……‰]«ı EÚB ∫…‰ +±…M… ΩÈ, V…Ω˛…ƒ i…EÚ EÚ ™…Ω˛ n˘x……∆EÚ 31.3.2009 +…ËÆ˙ 29.02.2012 E‰Ú ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ EÚ“ + v…∫…⁄S…x…… E‰Ú +x…÷∫……Æ˙ {… Æ˙∫…∆{… k…™…… EÚ“ ±……M…i… E‰Ú ±…B ∫…®……™……‰ V…i… EÚB M…B ®…⁄±™…ø…∫… EÚÆ˙x…‰ ™……‰M™… {… Æ˙∫…∆{… k…™…… ∫…‰ ∫…∆§…∆ v…i… Ω˲ +…ËÆ˙ {… Æ˙∫…∆{… k…™…… E‰Ú ∂…‰π… EÚ…±… {… Æ∂˙……‰ v…i… EÚ™…… V……BM…… * o˘f¯ |… i…§…r˘i…… ±…‰x…n‰˘x… E‰Ú EÚ…Æ˙h…˙ ¥…π…« E‰Ú +∆i… ®… §…EÚ…™…… ¥……™…n˘… ¥… x…®…™… ∫…∆ ¥…n˘…™… §……W……Æ˙ EÚ“ +…‰Æ˙ +∆ EÚi…Ú EÚ™…‰ V……i…‰ ΩÈ˛ +…ËÆ˙ ™… n˘ EÚ…‰<« Ω˛… x… Ω˲ i……‰ ±……¶…-Ω˛… x… ±…‰J…‰ ®… ∫¥…“EfiÚi… EÚ™…… V……i…… Ω˲ +…ËÆ˙ ¥™…÷i{…z…… E‰Ú ±…B ±…‰J…… {…r˘ i… {…Æ˙ ®……S…« 2008 ®… V……Æ˙“ EÚ™…‰ M…™…‰ ¶……Æ˙i…“™… ∫…x…n˘“ ±…‰J……{…Æ˙“I…… ∫…∆∫l……x… EÚ“ P……‰π…h…… E‰Ú +x…÷∫……Æ˙ ±……¶… EÚ“ ={…‰I…… EÚ“ V……i…“ Ω˲ * 1.10 ∫…Æ˙EÚ…Æ˙“ +x…÷n˘…x… EÚ) x…¥…‰∂… <®…n˘…n˘ E‰Ú ∞¸{… ®… Æ˙Ω‰˛ +x…÷n˘…x…… EÚ…‰ +±…M… +…Æ˙ I…i… ®… V…®…… EÚB V……i…‰ ΩÈ˛* J…) §… GÚ™…… ∫…‰ ∫…∆§…∆ v…i… Æ˙…V…∫¥… +x…÷n˘…x…/<®…n˘…n˘ (=i{……n˘ <®…n˘…n˘ ∫…‰ ¶…z…) +x™… +…™… E‰Ú +v…“x… +±…M… ∞¸{… ∫…‰ |…EÚ]ı EÚB V……i…‰ ΩÈ˛ V…§… EÚ =i{……n˘ <®…n˘…n˘, §…GÚ“ +…ËÆ˙ ∫…‰¥……+… E‰Ú +v…“x… |…EÚ]ı EÚB V……i…‰ ΩÈ˛* 1.11 x…¥…‰∂… ™… n˘ EÚ…‰<« +∫l……™…“ E‰Ú +±……¥…… EÚ®…“ E‰Ú |……¥…v……x… Ω˲ i……‰ =∫…‰ EÚ®… EÚÆ˙x…‰ EÚ… |……¥…v……x… n‰˘EÚÆ˙ x…¥…‰∂… ±……M…i… {…Æ˙ |…EÚ]ı EÚB V……i…‰ ΩÈ˛* 1.12 EÚ®…«S……Æ˙“ °Ú…™…n‰˘ EÚ) ={…n˘…x… +…ËÆ˙ U÷Ù]¬ı]ı“ +¶™…{…«h… ={…n˘…x… n‰˘™…i…… +…ËÆ˙ U÷Ù]¬ı]ı“ +¶™…{…«h… n‰˘™…i……Bƒ V…“¥…x… §…“®…… x…M…®… E‰Ú ∫……l… +x…÷Æ˙ I…i… {…fil…EÚ O…⁄{… ™……‰V…x……+… E‰Ú +v…“x… x…v……« Æ˙i… EÚ“ V……i…“ ΩÈ˛* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 186 contracts are recognized pro rata over the period of the contract. Revenue from Infrastructure - development division and Procurement Consultancy division related activities are recognized as follows; a) In case of turnkey contracts, on the basis of progress billing to the contract value under survey method. b) In the case of other contracts, on the basis of completion of obligation as per the terms of contract with the agencies concerned. 1.8 Other Operating Revenues The revenue against realization of waste latex, rejected materials and condoms are accounted on cash basis. Duty drawback / export incentive in respect of export sales are accounted in the year of export. The realization in respect of obsolete assets/materials written off is accounted on cash basis. Interest income if any for delayed realization from sundry debtors as stipulated in invoices is not recognized, unless realized. 1.9 Foreign currency transactions and translations Transactions in foreign exchange other than those covered by forward contracts are accounted for at the exchange rates prevailing on the date of transactions. Foreign currency receivables/payables other than those covered by forward contracts are translated at the year end exchange rates. Gain or losses arising out of such transaction are adjusted to the Profit and Loss Account. Foreign Currency loans are valued at year end exchange rates. Outstanding forward contracts, if any, as the Balance Sheet date are reinstated at the exchange rate prevailing on the date. Treatment of exchange differences Exchange differences on translation or settlement of long term foreign currency monetary items (i.e., whose term of settlement exceeds twelve months from the date of its origination) at rates different from those at which they were initially recorded or reported in the previous financial statements, in so far as it relates to acquisition of depreciable assets are adjusted to the cost of the assets as per GOI notification dated 31.03.2009 and 29.12.2011 and this will be amortized over the remaining life of the Asset. Forward exchange contracts outstanding as at the year end on account of firm commitment transactions are marked to market and the losses, if any are recognized in the profit and loss account and gains are ignored in accordance with the announcement of the Institute of Chartered Accountants of India on Accounting for Derivatives issued in March 2008. 1.10 Government grants a) Grants in the form of investment subsidy are credited to separate reserve. b) Revenue grants / subsidy (other than product subsidy) relating to sales are disclosed separately under other operating revenues, whereas product subsidy are disclosed under sales and services. 1.11 Investments Investments are stated at cost less provision for diminution other than temporary, if any. 1.12 Employee benefits a) Gratuity and Leave Encashment The Gratuity Liability and Leave Encashment liabilities are determined under separate group schemes maintained with LIC of India. The liabilities towards these schemes are estimated yearly, based on the actuarial valuation, in addition to the valuation provided by LIC of India. The incremental liabilities on year to year basis are funded as per demand raised by LIC of India and is charged to the revenue. Annual Report 2013-2014 187 J…) ∫¥…ËŒSUÙEÚ ∫…‰¥…… x…¥…fi k… ™……‰V…x…… ¥…“ +…Æ˙ B∫… E‰Ú +v…“x… +n˘…™…M…“ E‰Ú EÚ…Æ˙h… {…⁄Æ˙“ n‰˘™…i……Bƒ =∫…“ ¥…π…« E‰Ú ±……¶…-Ω˛… x… ±…‰J…‰ EÚ“ +…‰Æ˙ |…¶…… Æ˙i… EÚB M…B ΩÈ˛ * M…) Æ˙…‰W…M……Æ˙…‰k…Æ˙ S… EÚi∫…… ±……¶… 01.07.2005 ∫…‰ E∆Ú{…x…“ E‰Ú {…∆V…“ ®… Æ˙Ω‰˛ EÚ®…«S…… Æ˙™…… (=∫…EÚ…/=∫…EÚ“ {… i… ™…… {…ix…“ ∫… Ω˛i…) EÚ…‰, ®…Ë∫…∫…« x…Ë∂…±…x… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 188 b) Voluntary Retirement Benefits The entire liability on account of payment under VRS is charged off to the Profit and Loss Account in the same year. c) Post Employment Medical Benefits The Employees (including his/her spouse) on the rolls of the Company from 01.07.2005 are covered under Group Medical Insurance Scheme of M/s. National Insurance Company Ltd. d) Bonus/Performance Related Payment Provision for bonus for the employees is made on the basis of Productivity Linked Incentive Scheme as per the Long Term Agreement entered into with the recognized trade unions. Executives at the Board level and below the Board level are covered for Performance Related Pay (PRP) as per the guidelines issued by the Department of Public Enterprise. e) Pension Scheme Company has introduced a contributory pension scheme from 1-4-2011 for the permanent employees who are on the rolls of the company as on 9-10-2012. Company will contribute 3% of basic plus DA with matching contribution from employees. The pension scheme is managed by LIC of India. 1.13 Borrowing costs The borrowing cost incurred/attributable to the acquisition for the purpose of obtaining a qualifying asset is capitalized. Interest on loan taken specifically for the acquiring assets and the interest thereon are proportionately allocated to respective assets based on asset value. 1.14 Segment reporting The Company has identified its reportable segements for Segment Reporting, in accordance with Accounting Standard 17, as contraceptive Products, Health Care Products, Trading Products, Services and Contracts which are the primary groups. In addition, the following specific accounting policies have been followed for segment reporting: a) Segment revenue includes sales and other income directly identifiable with/allocable to the segment, including inter segment revenue. b) Expenses that are directly identifiable with/allocable to the segment are considered for determining the Segment Result. Expenses which relate to the Company as a whole and not allocable to segments are included under "Unallocable Expenditure" c) Income which relates to the Company as a whole and not allocable to segments is included in "Unallocable Income". d) Segment assets and liabilities include those directly identifiable with the respective segments. Unallocable Corporate assets and liabilities represents the assets and liabilities that relate to the Company as a whole and not allocable to any segment. 1.15 Leases Fixed Assets acquired and given on lease are shown as part of fixed assets. Lease rental income is accounted on accrual basis. 1.16 Taxes on income Provision for current Tax is made on the basis of estimated taxable income for the current accounting period in accordance with the provisions of the Income Tax Act, 1961. Deferred Tax resulting from timing difference between book and taxable profit for the year is accounted for using the Tax rates and laws that are applicable as on the Balance Sheet Date. The deffered Tax asset is recognized and carried forward only to the extent there is a reasonable certainty of its realization in future. Minimum Alternative Tax (MAT) paid in accordance with the provisions of Income Tax Act 1961, which gives rise to future economic benefits in the form of adjustment of future income tax liability, is considered as asset in the balance sheet. Annual Report 2013-2014 189 1.17 +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… {…Æ˙ {…⁄ƒV…“ ¥™…™… EÚ…‰ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ∫…®……x… =∫…“ i…Æ˙“E‰Ú ∫…‰ ®……x…… V……i…… Ω˲* +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… {…Æ˙ Æ˙…V…∫¥… ¥™…™… ¥…π…« ®… <∫…E‰Ú J…S…« Ω÷˛B {…Æ˙ |…¶…… Æ˙i… EÚB M…B * 1.18 ∫…∆{… k…™…… EÚ“ +∫…®…l…«i…… +∫…®…l…«i…… EÚ… ∫…∆E‰Úi… ®…±…i…‰ ∫…®…™… {… Æ˙∫…∆{… k…™…… EÚ“ +∫…®…l…«i…… E‰Ú §……Ɖ˙ ®… {…Ω˛S……x… EÚ“ V……i…“ Ω˲ * B‰∫…‰ ∫…∆E‰Úi… {…Æ˙ ∫…∆{… k…™…… EÚ“ ¥…∫…⁄±…“ ™……‰M™… Æ˙EÚ®… +x…÷®…… x…i… EÚ“ V……i…“ Ω˲ i…l…… ™… n˘ B‰∫…… |……EÚ±…x… =∫…E‰Ú Æ˙J……¥… Æ˙EÚ®… ∫…‰ EÚ®… Ω˲, i……‰ Æ˙J……¥… Æ˙EÚ®… EÚ…‰ ¥…∫…⁄±…“ ™……‰M™… Æ˙EÚ®… ®… P…]ı V……i…… Ω˛Ë˛ * 1.19 |……¥…v……x… +…ËÆ˙ +…EÚŒ∫®…EÚ ¥™…™… M…i… P…]ıx……+… E‰Ú {… Æ˙h……®… ∫¥…∞¸{… E∆Ú{…x…“ EÚ…‰ +§… §……v™…i…… Ω˛…‰x…‰ ∫…‰ BEÚ |……¥…v……x… ∫¥…“EfiÚi… EÚ™…… V……i…… Ω˲ +…ËÆ˙ ™…Ω˛ ∫…∆¶…… ¥…i… EÚ“ Ω˲ * n˘… ™…i¥… EÚ…‰ x…{…]ı…x…‰ E‰Ú ±…B ∫…∆∫……v…x…… EÚ… §… Ω˛M…«®…x… +{…‰ I…i… Ω˛…‰M…… V…∫… ∫…∆§…∆v… ®… BEÚ ¥…∑…∫…x…“™… |……EÚ±…x… §…x…… V…… ∫…EÚi…… Ω˲ * |……¥…v……x… (∫…‰¥…… x…¥…fi k…-±……¶… EÚ…‰ UÙ…‰b˜EÚÆ˙) =x…E‰Ú ¥…i…«®……x… ®…⁄±™… EÚ…‰ §…^ı… x…Ω˛” EÚ…]ı… Ω˲˲ +…ËÆ˙ i…÷±…x…-{…j… E‰Ú i……Æ˙“J… EÚ…‰ §……v™…i…… x…{…]ı…x… EÚÆ˙x…‰ EÚ…‰ +{…‰ I…i… =k…®… +…EÚ±…x… E‰Ú +…v……Æ˙ {…Æ˙ x…v……« Æ˙i… EÚ™…‰ V……i…‰ ΩÈ˛ * ™…‰ |…i™…‰EÚ i…÷±…x…-{…j… i……Æ˙“J…Ú {…Æ˙ ∫…®…“I…… EÚ“ V……i…“ ΩÈ˛ +…ËÆ˙ S……±…⁄ =k…®… +…EÚ±…x… {…Æ˙ |… i…À§… §…i… EÚÆ˙x…‰ EÚ…‰ ∫…®……™……‰ V…i… EÚ™…… Ω˲ * |……∫…∆ M…EÚÚ n‰˘™…i……B∆ +±…M… ∞¸{… ∫…‰ |…EÚ]ı EÚ“ V……i…“ ΩÈ˛ * ]ı{{…h…“ ®… |…EÚ]ı |……∫…∆ M…EÚ {… Æ˙∫…∆{… k…™…… EÚ…‰ ¥…k…“™… ¥…¥…Æ˙h… ®… x… i……‰ ∫¥…“EfiÚi… ™…… |…EÚ]ı EÚ™…… M…™…… Ω˲ * 1.20 {…⁄¥…« |…n˘k… J…S…« |… i… `2000/- i…l…… =∫…∫…‰ EÚ®… E‰Ú ®…n˘… ∫…‰ ∫…∆§…∆ v…i… {…⁄¥…« |…n˘k… J…S…« Æ˙…V…∫¥… EÚ“ +…‰Æ˙ |…¶…… Æ˙i… EÚB M…B ΩÈ˛* 1.21 {…⁄¥…«EÚ… ±…EÚ ¥™…™…/+…™… |…i™…‰EÚ ®……®…±…‰ ®… `5000/- ∫…‰ + v…EÚ +…x…‰¥……±…‰ {…⁄¥…«EÚ… ±…EÚ +…™… +…ËÆ˙ ¥™…™… {…⁄¥…«EÚ…±…Ú E‰Ú +v…“x… {… Æ˙EÚ ±…i… EÚ™…… V……i…… Ω˲* 1.22 ∫……®…x™… ¶…hb˜…Æ˙/+ i… Æ˙HÚ {…÷V…Ê/EÚSS…‰ ®……±…/i…Ë™……Æ˙ =i{……n˘ v…“Ɖ˙ S…±…x…‰¥……±…“ ®…n˘… EÚ“ ∫……®… O…™…… i…Ë™……Æ˙ =i{……n˘… E‰Ú ∫…∆§…∆v… ®… ™… n˘ EÚ…‰<« x…÷EÚ∫……x… EÚ… |……¥…v……x… B‰∫…‰ =i{……n˘… E‰Ú ={…™……‰ M…i……/ ¥…G‰Ú™…i…… E‰Ú ∫…∆§…∆v… ®… i…EÚx…“EÚ“ Æ˙…™… |……{i… EÚÆ˙x…‰ E‰Ú §……n˘ {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛Ë˛* 1.23 x…®……«h… +¥… v… E‰Ú n˘…ËÆ˙…x… J…S…« EÚ… |… i…{……n˘x…˙ x…®……«h… EÚ…±… +¥… v… E‰Ú n˘…ËÆ˙…x… J…S…« {…⁄ƒV…“ EÚ…™…« |…M… i… E‰Ú +v…“x… ∂…… ®…±… EÚ™…… M…™…… Ω˲ +…ËÆ˙ =∫…EÚ…‰˛ x…®……«h… E‰Ú ∫…®……{…x… {…Æ˙ ∫…∆§…∆ v…i… +S…±… {… Æ˙∫…∆{… k…™…… {…Æ˙ +…§…∆ ]ıi… EÚ™…… V……i…… Ω˲ * 1.24 {… Æ˙∫…∆{… k…™……‰∆ +…ËÆ˙ n‰˘™…i……+… E‰Ú S……±…⁄ ™…… M…ËÆ˙ S……±…⁄ E‰Ú ∞¸{… ®… ¥…M…‘EÚÆ˙h… E∆Ú{…x…“ E‰Ú ∫……®……x™… |…S……±…x… ∫……< EÚ±… +…ËÆ˙ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ +x…÷∫…⁄S…“ VI ®… x…Ãn˘π]ı EÚ™…‰ +x™… ®……x…n∆˘b˜… E‰Ú +…v……Æ˙ {…Æ˙ ∫…¶…“ {… Æ˙∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… EÚ…‰ S……±…⁄ ™…… M…ËÆ˙ S……±…⁄ E‰Ú ∞¸{… ®… ¥…M…‘EfiÚi… EÚ™…‰ M…™…‰ ΩÈ˛ * =i{……n˘… EÚ“ |…EfiÚ i… +…ËÆ˙ {… Æ˙∫…∆{… k…™…… E‰Ú +V…«x… +…ËÆ˙ x…EÚn˘ +…ËÆ˙ ∫…®…i…÷±™… x…EÚn˘ ®… =x…EÚ“ ¥…∫…⁄±…“ E‰Ú §…“S… EÚ… ∫…®…™… E‰Ú +…v……Æ˙ {…Æ˙ {… Æ˙∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… E‰Ú S……±…⁄ ™…… M…ËÆ˙ S……±…⁄ ¥…M…‘EÚÆ˙h… E‰Ú =q‰˘∂™… E‰Ú ±…B E∆Ú{…x…“ u˘…Æ˙… 12 ®…Ω˛“x…… x…v……« Æ˙i… EÚ™…… M…™…… Ω˲ * 2 ¥™……J™……i®…EÚ/ ∫{…π]ı“EÚÆ˙h……i®…EÚ ]ı{{…h…“ 2.1 ˙¥…π…« 2012-13 E‰Ú n˘…ËÆ˙…x… E∆Ú{…x…“ EÚ“ |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ `20 EÚÆ˙…‰b˜ ∫…‰ `300 EÚÆ˙…‰b˜ i…EÚ §…g¯… n˘“ M…™…“ Ω˲* ∂…‰™…Æ˙ {…⁄ƒV…“ EÚ“ ¥…fi r˘ EÚ“ +…‰Æ˙ J…S…« Ω÷˛B ¥™…™… ¥…π…« 2012-13 ∫…‰ {……ƒS… ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ˙∂……‰ v…i… EÚ™…… V……i…… Ω˲* E∆Ú{…x…“ +{…x…‰ `1000/- E‰Ú <ŒC¥…]ı“ ∂…‰™…Æ˙… EÚ‰ +∆ EÚi… ®…⁄±™…… EÚ…‰ |…i™…‰EÚ `10/- E‰Ú 100 <ŒC¥…]ı“ ∂…‰™…Æ…‰∆ ®…‰ ={… ¥…¶…… V…i… EÚÆ˙x…‰ EÚ“ <Æ˙…n˘… Æ˙J…i…“ Ω˲*˙ E∆Ú{…x…“ EÚ…‰‰ 8 x…¥…∆§…Æ˙ 2013 EÚ…‰ +…™……‰ V…i… 242¥…” §……‰b«˜ §…Ë`ˆEÚ ®… x…n‰˘∂…EÚ ®…∆b˜±… +…ËÆ˙ n˘x……∆EÚ 12 ®……S…« 2014 E‰Ú EÚ….Y……. ∫…∆.B°Ú x…∆.B 45013/77/2010- BS…B±…B±… E‰Ú +x…÷∫……Æ˙ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™… EÚ… +x…÷®……‰n˘x… |……{i… Ω÷˛+… Ω˲* |…∫i……¥… +§… +…M……®…“ ¥……Ãπ…EÚ ∫……®……x™… §…Ë`ˆEÚ ®… ∂…‰™…Æ˙v……Æ˙EÚ…Â E‰Ú +x…÷®……‰n˘x… E‰Ú ±…B Æ˙J…… V……BM……* 2.2 n‰˘x…n˘…Æ˙, ±…‰x…n˘…Æ˙ i…l…… @Òh… ¥… {…‰∂… M…™…… ®… ∂…‰π… {…÷Œπ]ı/®…‰±…- ®…±……{… E‰Ú +v…“x… Ω˲ * x…™……«i… §…GÚ“ ∫…‰ |……{™… ¥…n‰˘∂…“ ®…÷p˘…, ®…‰±… ®…±……{… E‰Ú +v…“x… Ω˲ +…ËÆ˙ <∫…E‰Ú °Ú±…∫¥…∞¸{…, ¥…n‰˘∂…“ ®…÷p˘… ®…⁄±™……∆EÚx… EÚ… ±……¶… ™…… Ω˛… x… ¶…z… Ω˛…‰ ∫…EÚi…‰ ΩÈ˛ * 2.3 ∫…⁄I®…, ±…P…÷ B¥…∆ ®…v™…®… =t®… ¥…EÚ…∫… [B®… B∫… B®… <« b˜“] ¥™…¥…∫……™… + v…˘ x…™…®…, 2006 u˘…Æ˙… +…¥…∂™…EÚ |…EÚ]ı“EÚÆ˙h… x…“S…‰ V…Ë∫…‰ ΩÈ˛ : ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 190 1.17 Research and development expenses Capital expenditure on Research and Development is treated in the same manner as Fixed Assets. The Revenue expenditure on Research and development is charged off in the year in which it is incurred. 1.18 Impairment of assets Impairment of assets is recognized when there is an indication of impairment. On such indication the recoverable amount of the assets is estimated and if such estimation is less that its carrying amount, the carrying amount is reduced to recoverable amount. 1.19 Provisions and contingencies A provision is recognized when the Company has a present obligation as a result of past events and it is probable that an outflow of resources will be required to settle the obligation in respect of which a reliable estimate can be made. Provisions (excluding retirement benefits) are not discounted to their present value and are determined based on the best estimate required to settle the obligation at the Balance Sheet date. These are reviewed at each Balance Sheet date and adjusted to reflect the current best estimates. Contingent liabilities are disclosed seperately. Contingent assets are neither recognized nor disclosed in financial statement. 1.20 Prepaid Expenses Prepaid expenses of items of `2000/- each and below are charged off to the revenue. 1.21 Prior Period Expenses/Income Income and expenditure relating to prior period exceeding `5000/- in each case only is accounted under prior period. 1.22 General Stores/Spares/Raw Materials/Finished Products The provision for loss if any in respect of slow moving items of materials/finished products are accounted after obtaining the technical opinion regarding the usability/marketability. 1.23 Treatment of expenditure during construction Period Expenditure during construction period is included under capital work -in-progress and the same is allocated to the respective fixed assets on the completion of construction. 1.24 Classification of Assets and Liabilitis as Current and Non-Current All assets and liabilities are classified as current or non-currrent as per the company's normal operating cycle and other criteria set out in schedule VI to the Companies Act, 1956. Based on the nature of products and time between acquisition of assets for processing and their realization in cash and cash equivalents, 12 months has been considered by the Company for the purpose of current or non current classification of Assets and Liabilities. 2. EXPLANATORY / CLARIFICATORY NOTES 2.1 Authorized Share capital of the Company was increased from `20 Cr to `300 Cr during the year 2012-13 and expenditure incurred towards increase of share capital is amortized over period of five years starting from 2012-13 onwards. The Company intends to sub-divide the face value of its Equity Shares of `1,000/- each to 100 Equity Shares of `10/- each. The Company has received approval of the Board of Directors in the 242nd Board meeting held on 8th Novermber 2013 and that of the Ministry of Health & Family Welfare, Govt. of India, vide O.M.No.F.No.A-45013/77/2010-HLL dated 12th March 2014. The proposal shall now be placed for Shareholder's approval in the ensuing Annual General Meeting. 2.2 Balance in Debtors, Creditors and loans and advances are subject to confirmation / reconciliation. Receivable in Foreign Currency out of Export sales is subject to reconciliation and consequently Foreign Currency Valuation gain or loss may vary. 2.3 Disclosures required by the Micro, Small and Medium Enterprises Development (MSMED) Act, 2006 are as under: Annual Report 2013-2014 191 (` ±……J…… ®…Â) GÚ.∫…∆. 31.03.2014 31.03.2013 (EÚ) ¥…π……»i… ®… +¥…Ëi… x…EÚ ∂…‰π… ®…⁄±…v…x… Æ˙… ∂… 275.23 409.66 (J…) ¥…π…« E‰Ú n˘…ËÆ˙…x… x…™…i… i……Æ˙“J… ∫…‰ {…Ɖ˙ |…n˘k… ∂…⁄x™… ∂…⁄x™… ®…⁄±… Æ˙… ∂… EÚ… ¥…±…∆ §…i… ¶…÷M…i……x… (M…) B®… B∫… B®… <« b˜“ + v…˘ x…™…®… EÚ“ v……Æ˙… 16 E‰Ú ∂…⁄x™… ∂…⁄x™… +v…“x… |…n˘k… ¥……∫i… ¥…EÚ §™……V… (P…) ∫…Ω˛®…i… ∂…i……Á E‰Ú +x…÷∫……Æ˙ ∫…¶…“ ¥…±…∆ §…i… ¶…÷M…i……x… E‰Ú ∂…⁄x™… ∂…⁄x™… ±…B ¥…π…« E‰Ú n˘…ËÆ˙…x… n‰˘™… B¥…∆ |…n˘k… ∫……®……x™… §™……V… (RÛ) ¥…π…« E‰Ú n˘…ËÆ˙…x… E÷Ú±… +ÃV…i… §™……V… +…ËÆ˙ +|…n˘k… ∂…‰π… ∂…⁄x™… ∂…⁄x™… <∫…˛ ∫…⁄S…x…… EÚ…‰ BEÚ ∫…“®…… i…EÚ x…v……« Æ˙i… EÚ™…… M…™…… Ω˲ EÚ B‰∫…“ {……Ã]ıı™…… EÚ…‰ E∆Ú{…x…“ E‰Ú ∫……l… ={…±…§v… ∫…⁄S…x…… E‰Ú +…v……Æ˙ {…Æ˙ {…Ω˛S……x… EÚ“ M…™…“ Ω˲* 2.4 ®…fii™…÷ Ω÷˛B V…®…… v……Æ˙EÚ E‰Ú ¥…Ëv… ¥…… Æ˙∫… ∫…‰ n˘…¥…… ®… ¥…¥……n˘ E‰Ú EÚ…Æ˙h… `10,000/- EÚ… n‰˘™… +…¥… v…EÚ V…®…… |…n˘k… x…Ω˛” EÚ™…… M…™…… Ω˲ * §™……V… {… Æ˙{…C¥…i…… i… l… E‰Ú §……n˘ ={……ÃV…i… x…Ω˛” EÚÆ˙i…… Ω˲ +…ËÆ˙ +i…& |……¥…v……x… x…Ω˛” n˘™…… M…™……* 2.5 E∆Ú{…x…“ x…‰ EÚ…‰ S…x… BC∫…{……‰]«ı |……‰∫…À∫…M… W……‰x… ®… Œ∫l…i… +{…x…‰ ™…⁄ x…]ı ®… °Ú“®…‰<±… E∆Úb˜…‰®… B°Ú ∫…“ 2 x……<]≈‰ı±… ¥…W…«x… E‰Ú ¥… x…®……«h… E‰Ú ±…B @Òh… E‰Ú +…v……Æ˙ {…Æ˙ `89.27 ±……J… ®…⁄±™… E‰Ú ={…EÚÆ˙h… ®…Ë∫…‰∫…« °Ú®……<±… Ω‰˛±l… E∆Ú{…x…“ (™…÷ E‰Ú) ∫…‰ |……{i… EÚ™…… l…… * {…⁄Ãi… EÚ“ M…<« ∫…∆{… k… B¥…∆ ={…EÚÆ˙h… E‰Ú ∂…“π…«EÚ ®…Ë∫…‰∫…« °Ú®……<±… Ω‰˛±l… E∆Ú{…x…“, ™…÷ E‰Ú E‰Ú ∫……l… x… Ω˛i… Ω˛…‰x…‰ ∫…‰ EÚ…‰<« ±…‰J…… |… ¥…Œπ]ı™……ƒ x…Ω˛” EÚ“ M…<« ΩÈ˛* +…M…‰, ={…™…÷«HÚ {… Æ˙∫…∆{… k…™…… {…Æ˙ EÚÆ˙…B S……V…« EÚ…‰ ¥……∫i… ¥…EÚ ={…™……‰M… E‰Ú +…v……Æ˙ {…Æ˙ {…Ω˛S……x… EÚ“ V……i…“ Ω˲* 2.6 ¥…π…« E‰Ú n˘…ËÆ˙…x… {…⁄ƒV…“EfiÚi… =v……Æ˙ ±……M…i… `158.28 ±……J… Ω˲* ( {…UÙ±…‰ ¥…π…« `171.22 ±……J… Ω˲ ) 2.7 BS…B±…B±… +…ËÆ˙ ®…‰∫…‰∫…« +E÷Ú®…x… °∆Úb˜, ™…÷ B∫… B E‰Ú §…“S… ®… 50:50 ∫……®™…… ∂…‰™…Æ˙v…… Æ˙™…… E‰Ú ∫……l… ∫…∆™…÷HÚ =t®… ∫…k…… E‰Ú ∞¸{… ®… °ÚÆ˙¥…Æ˙“ 2008 ®… ®…‰∫…‰∫…« ±……<°Úœ∫|…M… +∫{…i……±… |……<¥…‰]ı ±… ®…]‰ıb˜ EÚ…‰ M… `ˆi… EÚ™…… M…™…… Ω˲* ®…‰∫…‰∫…« +E÷Ú®…x… °∆Úb ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 192 ( in lacks) Sl. No. 31-03-2014 31-03-2013 (a) The principal amount remaining unpaid at the end of the year 275.23 409.66 (b) The delayed payments of principal amount paid beyond the Nil Nil appointed date during the year (c) Interest actually paid under Section 16 of the MSMED Act Nil Nil (d) Normal Interest due and payable during the year, for all Nil Nil the delayed payments, as per the agreed terms. (e) Total interest accrued during the year and remaining unpaid Nil Nil This informtion has been determined to the extent such parties have been identified on the basis of information available with the Company. 2.4 Matured fixed deposit of `10000/- has not been paid due to dispute in claim from the legal heirs of the deceased deposit holder. Interest does not accrue beyond maturity date and hence not provided for. 2.5 The Company had received from M/s. Female Health Company (UK) equipment's valuing `89.27 Lakhs on loan basis for the manufacture of female condom FC2 Nitrile version at its unit located in Cochin Export Processing Zone. No accounting entries have been passed as the property & title of the equipment supplied vests with M/s. Female Health Company, U.K. Further, rental charges on the said assets are recognized on actual utilization basis. 2.6 Borrowing costs capitalized during the year is `158.28 lacs. (Previous Year is ` 171.22 lacs) 2.7 M/s. Life Spring Hospitals Private Limited was formed in February 2008 as a joint Venture entity with 50:50 equity shareholdings between HLL Lifecare Ltd. (HLL) and M/s Acumen Fund Inc., USA (Acumen). HLL had contributed `783.42 lacs towards the equity Share Capital of the Joint Venture Company, as per the terms of Shareholders agreement entered into with Acumen. This JV was formed with the objective of providing High Quality, Affordable Maternal Health Care for Low-Income Women across India. It operates small-sized (20 bed) maternity hospitals in the proximity of urban slums. The hospitals also provide paediatric care (including immunisations), diagnostic and pharmacy services, and health care education to the communities in which its hospitals are located. Presently, the JV is running a cluster of 12 hospitals in Hyderabad. Among these, 1 hospital has completed 6 years, 2 have completed 5 years, 3 have completed 4 years remaining 6 have completed/nearing 3 years of operations only, as on 31.03.2014. Normally for any hospital business models, the gestation period is fairly long. As the services at Life Spring Hospitals are offered at very affordable rates, aimed at meeting socially committed objective, the gestation period may take 5-7 years to achieve breakeven levels in operations. Among the 4-6 year old hospitals, 4 hospitals are generating profits since 2012-13. The JVs performance at the Enteprise level is also has been steadily improving. The loss of the JV Company has been steadily coming down since last 4 years, from `303.75 lacs (2011-12) to `185.23 lacs (2012-13) to ` 54.20 lacs (2013-14). The J.V Company has reported cash profits of ` 0.12 lacs for the year 2013-14. The cumulative loss as on 31.03.2014 is `1665.45 lacs and HLL's share of cumulative loss is `832.73 lacs. Annual Report 2013-2014 193 +|…˱… 2013 E‰Ú n˘…ËÆ˙…x…, BS…B±…B±… +…ËÆ˙ +E÷Ú®…x… x…‰ |… i… ¥…π…« 12.5% ®… ∏…i… §™……V… ±…‰EÚÆ˙ {… Æ˙¥…i…«x…“™… b˜§…ÂS…Æ˙ EÚ…‰ + x…¥……™…«i…& +|… i…¶…⁄i… E‰Ú ∞¸{… ®… +…ËÆ˙ ∫……i… (7) ¥…π……Á ∫…‰ x…¥…“x…i…®… <ŒC¥…]ı“ ∂…‰™…Æ˙ ®… §…n˘±…x…‰ E‰Ú ±…B |…i™…‰EÚ `125.00 ±……J… EÚ“ + v…EÚ ¥…k…“™… ∫…Ω˛…™…i…… |…n˘…x… EÚ“ l…“*˜ ∫…∆™…÷HÚ =t®… E∆Ú{…x…“ EÚ… x…¥…±… ®…⁄±™… 2.13 {…UÙ±…‰ ¥…π…« E‰Ú ±…B +…ƒEÚb‰˜, V…Ω˛…ƒ i…EÚ +…¥…∂™…EÚ Ω˛…‰, {…÷x…& ¥™…¥…∫l…… {…i… B¥…∆ {…÷x…& ¥…M…‘EfiÚi… EÚ™…‰ M…™…‰ ΩË∆˛* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 194 During April 2013, HLL and Acumen had provided further financial assistance of `125.00 lacs each to LifeSpring, in the form of Unsecured Compulsorily Convertible Debentures carrying interest of 12.5% compounded per annum and convertible to equity shares latest by seven (7) years. The net worth of the JV Company will improve further on conversion of these debentures. In view of the improved performance and also for funding the expansion plans to add one more cluster of 10-12 hospitals, the JV Company is intended to induct one more investor and the discussions towards finalizing the Term sheets are progressing. Lifespring business model has been well appreciated both in national and international forums and earned prestigious awards. Lifespring has earned a good brand value and the shares of the JV fetches good valuation among interested groups. The indicative pre-money evaluation works out to `21.60, being the average value for each share of nominal value of `10/-. Considering all the above, the diminution if any, in the carrying value of the investment in the JV company is purely of temporary nature only and hence management is of the view that no provisioning towards diminution in value of investment is required as on 31.03.2014. 2.8 During the year there was no payment towards voluntary retirement scheme. 2.9 As per the DPE guidelines. the Company is to spend minimum 3% of the previous year's net profit for CSR activities and unspent amount if any, need to be carried over as CSR Reserve. The CSR Reserve available as on beginning of the year was `43.86 lacs. The Company had spent `97.28 lacs during the year 2013-14 towards approved CSR activities. Taking into account the above position, net unspent amount of `36.80 lacs is appropriated out of the current year profits towards CSR Reserve. 2.10 Loans and advances include ` 587.45 lacs (previous year ` 809.05 lacs) relating to trading business aged two years and above, are considered good, though unsecured. 2.11 Insurance premium includes instalment of medical insurance premium paid for post-retirement medical benefits. 2.12 31-3-2014 31-3-2013 Numerator Net Profit (In Lacs) Basic 2570.77 3007.47 Diluted 2570.77 3,007.47 Denominator - Average number of equity shares outstanding during the year Basic 19,35,350 19,35,350 Diluted 19,35,350 19,35,350 Earnings per share ( `) Basic 132.83 155.40 Diluted 132.83 155.40 Annual Report 2013-2014 195 2.14 ∫…∆§…∆ v…i… {……]ı‘ ±…‰x…n‰˘x… E‰Ú ∫…∆§…∆v… ®… |…EÚ]ı“EÚÆ˙h… +…ËÆ˙ J…∆b˜ Æ˙{……‰Õ]ıM… GÚ®…∂…& +x…÷§…∆v… I & II ®… |…∫i…÷i… EÚB V……i…‰ Ω∆˲* 2.15 ¶……Æ˙i… E‰Ú ∫…x…n˘“ ±…‰J……EÚ…Æ˙ E‰Ú ∫…∆∫l……x… E‰Ú ¥…∂…‰π…Y… ∫…±……Ω˛EÚ…Æ˙ ∫… ®… i… EÚ“ Æ˙…™… E‰Ú +x…÷∫……Æ˙ i…÷±…x…-{…j… ®… E∆Ú{…x…“ u˘…Æ˙… ±…B M…B Æ˙…‰EÚc˜ ¥… §…ÈEÚ ∂…‰π…… EÚ…‰ x™……∫… +…ËÆ˙ ∫…∆§…∆ v…i… n‰˘™…i……+… E‰Ú +v…“x… EÚ…Ïx]≈ı… ®…n˘ E‰Ú ∞¸{… ®… |…EÚ]ıx… EÚ™…‰ M…™…‰ ΩÈ˛ * |……{…h… {… Æ˙™……‰V…x……Bƒ, +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… {… Æ˙™……‰V…x……™…Â, {… Æ˙∫…∆{… k…™……ƒ +…ËÆ˙ n‰˘™…i……B∆ {… Æ˙˙ ∂…π]ı - III ®… |…EÚ]ı EÚ“ V……i…“ ΩË∆˛∆* 2.16 EÚ®…«S……Æ˙“ °Ú…™…n‰˘ EÚ) ={…n˘…x… x… v… |…EÚ]ıx…/{…⁄¥……«x…÷®……x… 31-3-2014 31-3-2013 §…^ı… n˘Æ˙ 8% 8% ¥…‰i…x… ¥…fi r˘ 5% 5% x… v… ®…⁄±™… (Ø˚{…B ±……J…… ®…Â) 3497.23 3088.83 ®…⁄±™…x… ¥… v… |… I…{i… ™…⁄ x…]ı =v……Æ˙ ¥… v… |… I…{i… ™…⁄ x…]ı =v……Æ˙ ¥… v… +…Ω˛Æ˙h… n˘Æ ˙+…™…÷ E‰Ú +…v……Æ˙ {…Æ˙ 1% +…™…÷ E‰Ú +…v……Æ˙ {…Æ˙ 1% ∫…‰Ú 3 % i…EÚ ∫…‰Ú3 % i…EÚ ®…⁄±™…x… (Ø˚{…B ±……J…… ®…Â) 3997.05 3508.21 §…Ω˛“ ®… §…x……™…… |……¥…v……x… (Ø˚{…B ±……J…… ®…Â) 515.35 581.63 ¥……∫i… ¥…EÚ +ÃV…i… §™……V… (Ø˚{…B ±……J…… ®…Â∆) 279.84 254.86 ={…n˘…x… E‰Ú ±…B >{…Æ˙“ ∫…“®…… 10 10 O…⁄{… ={…n˘…x… x…“ i… E‰Ú +v…“x… |… i… EÚ®…«S……Æ˙“ EÚ…‰ §…“®……EfiÚi… Æ˙… ∂… (Ø˚{…B ±……J…… ®…Â) 10 10 J…) U÷Ù]¬ı]ı“ +¶™…{…«h… x… v… |…EÚ]ıx…/{…⁄¥……«x…÷®……x… 31-3-2014 31-3-2013 §…^ı… n˘Æ˙ 8% 8% ¥…‰i…x… ¥…fi r˘ 5% 5% x… v… ®…⁄±™… (Ø˚{…B ±……J…… ®…Â) 1066.70 940.62 ®…⁄±™…x… ¥… v… |… I…{i… ™…⁄ x…]ı |… I…{i… ™…⁄ x…] =v……Æ˙ ¥… v… =v……Æ˙ ¥… v… +…Ω˛Æ˙h… n˘Æ˙ +…™…÷ E‰Ú +…v……Æ˙ {…Æ˙ +…™…÷ E‰Ú +…v……Æ˙ {…Æ 1% ∫…‰Ú 3 % i…EÚ ˙ 1% ∫…‰Ú 3% i…EÚ ®…⁄±™…x… (Ø˚{…B ±……J…… ®…Â) 1241.41 1059.57 §…Ω˛“‰ ®… §…x……™…… |……¥…v……x… (Ø˚{…B ±……J…… ®…Â) 175.25 169.42 ¥……∫i… ¥…EÚ +ÃV…i… §™……V… (Ø˚{…B ±……J…… ®…Â∆) 85.76 77.24 +ÃV…i… U÷Ù^ı“ E‰Ú ±…B >{…Æ˙“ ∫…“®…… 300 n˘x… 300 n˘x… E∆Ú{…x…“ 15.05.2014 EÚ…‰ +…™……‰ V…i… +{…x…“ 244¥…” §……‰b«˜ §…Ë`ˆEÚ ®… ∫…‰¥…… x…¥…fi k… E‰Ú ∫…®…™… {…Æ˙ 300 n˘x…… EÚ“ + v…EÚi…®… ∫…“®…… E‰Ú +v…“x… +ÃV…i… U÷Ù^ı“ E‰Ú +±……¥…… +v…« ¥…‰i…x… U÷Ù^ı“ ¶…÷x……x…‰ EÚ“ ∫…÷ ¥…v…… EÚ…‰ +x…÷®……‰ n˘i… EÚ“ M…<« Ω˲* =∫…“ EÚ“ +…‰Æ˙ 31.03.2014 i…EÚ EÚ“ n‰˘™…i……Bƒ x…v……« Æ˙i… EÚ“ V……x…“ Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 196 2.13 Figures for the previous year have been rearranged and regrouped wherever necessary. 2.14 Disclosure in respect of Related Party transactions and Segment Reporting are presented in Annexure I & II respectively. 2.15 The cash and bank balances held by the Company under trust and the relative liabilities are disclosed as contra items in the Balance Sheet in accordance with the opinion of the Expert Advisory Committee of the Institute of Chartered Accountants of India. The Assets & Liabilities of Procurement Projects, & Infrastructure Development Projects are disclosed in Annexure III. 2.16 Employee Benefits a) Gratuity The Fund disclosures/assumptions 31-3-2014 31-3-2013 Discount rate 8% 8% Salary Escalation 5% 5% Fund value (` lacs) 3497.23 3,088.83 Valuation Method Projected Unit Projected Unit' Credit method Credit method Withdrawal rate 1% to 3% 1% to 3% Depending on age Depending on age Valuation (`lacs) 3997.05 3,508.21 Provision made in the books (`lacs)* 515.35 581.63 Interest earned actual (` lacs) 279.84 254.86 Upper limit for Gratuity 10 10 Sum insured per employee under Group Gratuity Policy (`lacs) 10 10 b) Leave Encashment The Fund disclosures/assumptions 31-3-2014 31-3-2013 Discount rate 8% 8% Salary Escalation 5% 5% Fund value (`lacs) 1066.70 940.62 Valuation method Projected Unit Projected Unit Credit method Credit method Withdrawal rate 1% to 3% 1% to 3% Depending on age Depending on age Valuation (` lacs) 1241.41 1,059.57 Provision made in books (`lacs) 175.25 169.42 Interest earned actual (`lacs) 85.76 77.24 Upper limited for earned leave 300 days 300 days The Company in its 244th Board Meeting held on 15.05.2014 approved the facility of encashment of Half Pay Leave in addition to Earned Leave at the time of superannuation subject to an overall ceiling of 300 days. The liability as on 31.03.2014 towards the same is yet to be determined. Annual Report 2013-2014 197 2.17 ¥…n‰˘∂…“ ®…÷p˘… n‰˘x…n˘…Æ˙ Æ˙EÚ®… E‰Ú ±…B 31.03.2014 i…EÚ EÚ“ ±…∆ §…i… ¥……™…n˘… ∫…∆ ¥…n˘… Æ˙EÚ®… ∂…⁄x™… Ω˲* 2.18 E∆Ú{…x…“ x…‰ ®……S…« 2013 E‰Ú n˘…ËÆ˙…x… `400 ±……J… E‰Ú |… i…°Ú±… E‰Ú ±…B B‰Æ˙…{…÷Æ˙®…, {…‰Ø˚®§……¥…⁄Æ˙, E‰ÚÆ˙±… ®… Œ∫l…i… Æ˙…V™… ∫¥…… ®…k… Æ˙§…c˜ {……E«Ú ®… x…®……«h……v…“x… BEÚ E∆Úb˜…‰®… ¥… x…®……«h… ™…⁄ x…] EÚ…‰ı EËÚx…Æ˙… §…ÈEÚ, EÚ…‰ S…x… u˘…Æ˙… x…“±……®… u˘…Æ˙… Ω˛… ∫…±… EÚ™…… l……* + v…O…Ω˛h… ±……M…i… ®… 123.80 BEÚc˜ (306 ∫…Â]ı) EÚ“ {…^ı…v…fii… ¶…⁄ ®… (01.03.2005 ∫…‰ 99 ¥…π……Á E‰Ú ±…B) +…ËÆ˙ 3479 ∫EÚ.®…“. °ËÚC]ıÆ˙“ +…ËÆ˙ |…∂……∫… x…EÚ ®…EÚ…x… ∫… Ω˛i… +v… §…x…“ ∫…÷ ¥…v…… +…ËÆ˙ {…⁄Æ˙… Ω˛…‰x…‰‰ {…Æ˙, 120 n˘∂…±…I… +n˘n˘ {…÷Ø˚π… E∆Úb˜…‰®… E‰Ú =i{……n˘x… EÚÆ˙x…‰ E‰Ú ±…B +{…‰ I…i… ∫…∆™…∆j… E‰Ú ®…÷J™… ¶……M…, ®…∂…“x…Æ˙“ B¥…∆ ={…EÚÆ˙h… ∂…… ®…±… ΩÈ˛* ∫…∆{… k… {…∆V…“EfiÚi… EÚÆ˙x…‰ E‰Ú §……n˘ BS…B±…B±… E‰Ú x……®… ®… Ω˲* E∆Ú{…x…“ +§… +v… §…x…“˙ ∫…÷ ¥…v…… {…⁄Æ˙… EÚÆ˙x…‰ E‰Ú ±…B + i… Æ˙HÚ {…⁄ƒV…“ ¥™…™… J…S…« EÚÆ˙ Æ˙Ω˛“ ΩË +…ËÆ˙ |… i… ¥…π…« 300 n˘∂…±…I… +n˘n˘ E‰Ú ±…B E∆Úb˜…‰®… =i{……n˘x… I…®…i…… ¶…“ §…f¯…i…“ Ω˲*˛ {…⁄Æ˙… x…¥…‰∂… +§… {…⁄ƒV…“ EÚ…™…« |…M… i… E‰Ú +v…“x… n˘J……B V……i…‰ ΩÈ˛* + v…O…Ω˛h… E‰Ú ∫…®…™… {…Æ˙ ¥…t®……x… <∫… ∫…∆{… k… E‰Ú `36.88 ±……J… EÚ… @Òh…¶……Æ |……∫…∆ M…EÚ n‰˘™…i……+… ®… ∂…… ®…±… Ω˲* 2.19 E∆Ú{…x…“ EÚ…‰ V…x…¥…Æ˙“ 2008 ∫…‰ 430.10 BEÚc˜ ¶…⁄ ®… EÚ… + v…EÚ…Æ˙ Ω˲, V……‰ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ E‰Ú x…nÊ˘∂…… E‰Ú +v…“x… EÂÚp˘“™… E÷Úπ`ˆ ∂…I…h… ∂……‰v… ∫…∆∫l……x… (∫…“ B±… ]ı“ +…Æ˙ +…<«), i… ®…±…x……b÷˜ ∫…‰ 99 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {…^‰ı {…Æ˙ +…§…∆ ]ıi… EÚ™…… l……˛* 10.02.2012 EÚ…‰ +…™……‰ V…i… ∫……¥…«V… x…EÚ x…¥…‰∂… §……‰b«˜ ({…“ +…<« §…“), ¥…k… ®…∆j……±…™…, ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ EÚ“ §…Ë`ˆEÚ ®… =∫…x…‰ 10.12 EÚÆ˙…‰b˜ (|… i… BEÚc˜ E‰Ú ±…B `16.50 ±……J… EÚ“ n˘Æ˙ {…Æ˙ 56 BEÚc˜ +…ËÆ˙ |… i… BEÚc˜ `2 ±……J… EÚ“ n˘Æ˙ {…Æ˙ UÙ…‰]ı“ {…Ω˛…b˜“ E‰Ú 44 BEÚc˜) E‰Ú ®…⁄±™… E‰Ú ±…B BEÚ“EfiÚi…˜ ¥…ËC∫…“x… EÚ…Ï{±…‰C∫… (+…<« ¥…“ ∫…“) E‰Ú ∫…∆∫l……{…x… EÚ“ +…‰Æ˙ S…ÂM…±…{…‰^Ÿı ®… E∆Ú{…x…“ E‰Ú + v…EÚ…Æ˙ E‰Ú 430.10 BEÚc ®… ∫…‰ 100 BEÚc˜ +x…÷n˘…x… n‰˘x…‰ E‰Ú ±…B ∫…°Ú… Æ∂˙… EÚ“ l…“˛* {…“ +…<« §…“ EÚ“ ∫…°Ú… Æ∂˙…… EÚ…‰ +…Ãl…EÚ EÚ…™…« E‰Ú EËÚ §…x…]ı ∫… ®… i… (∫…“ ∫…“ <« B) u˘…Æ˙… +x…÷®……‰ n˘i… EÚB M…B ΩÈ˛* E∆Ú{…x…“ x…‰ ®……S…« 2012 ®… {…“ +…<« §…“ EÚ“ ∫…°Ú… Æ∂˙…… E‰Ú +x…÷∫……Æ˙ +…<« ¥…“ ∫…“ E‰Ú ∫…∆∫l……{…x… EÚÆ˙x…‰ E‰Ú ±…B ∫…∆{…⁄h…« ∫¥…… ®…k… ∫…®…x…÷π…∆M…“ E∆Ú{…x…“, ®…‰∫…‰∫…« BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ (BS… §…“ B±…) EÚ…‰ §…x……™…… Ω˲* BS… §…“ B±… E‰Ú x……®… ®… 100 BEÚb˜ ¶…⁄ ®… E‰Ú +∆i…Æ˙h… EÚ“ EÚ…x…⁄x…“ +…Ë{…S…… Æ˙EÚi……Bƒ {…⁄Æ˙… Ω˛…‰ V……x…‰ E‰Ú EÚ…Æ˙h…, E∆Ú{…x…“ x…‰ °ÚÆ˙¥…Æ˙“ 2014 ®… <∫… =q‰˘∂™… E‰Ú ±…B {…Ω˛S……x… EÚ“ M…<« 100 BEÚb˜ ¶…⁄ ®… 94 ¥…π……Á E‰Ú ±…B `1/- EÚ“ n˘Æ˙ {…Æ˙ BS… §…“ B±… E‰Ú x……®… ®… ={… {…^‰ı {…Æ˙ n˘“ Ω˲* E∆Ú{…x…“ E‰Ú + v…EÚ…Æ˙ E‰Ú 430.10 BEÚc ®… ∫…‰ 3.38 BEÚc˜ ¶…⁄ ®… `1.00 E‰Ú ¥……Ãπ…EÚ {…^ı… ¶……c˜‰ E‰Ú ±…B 36 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B i… ®…±…x……b÷˜ Æ˙…V™… <±…ŒC]≈ı ∫…]ı“ §……‰b« EÚ…‰ {…^‰ı {…Æ˙ n‰˘x…… Ω˲*˜ ™…t {… <∫… ±…‰x…-n‰˘x… EÚ…‰ +§… i…EÚ |…¶…… ¥…i… x…Ω˛” EÚ™…… M…™…… Ω˲* 2.20 ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ x…‰ ∫¥……∫l™… B¥…∆ {… Æ˙¥……Æ˙ EÚ±™……h… ®…∆j……±…™… EÚ…‰ ¥… ¥…v… M…¶…« x…Æ˙…‰v…EÚ =i{……n˘… EÚ“ +…{…⁄Ãi… E‰Ú ±…B ¥…π…« 2005 ®… BS…B±…B±… EÚ…‰ "EËÚŒ{]ı¥… ™…⁄ x…]ı' E‰Ú ∞¸{… ®… P……‰ π…i… EÚ™…… Ω˲* E∆Ú{…x…“ ®…∆j……±…™… EÚ…‰ M…¶…« x…Æ˙…‰v…EÚ =i{……n˘ (E∆Úb˜…‰®…, ®……Ë J…EÚ M…¶…« x…Æ˙…‰v…EÚ M……‰ ±…™……ƒ, <« ∫…“ M……‰ ±…™……ƒ, EÚ…Ï{…Æ˙-]ı“ +…ËÆ˙ ]ı¨⁄§…±… ÀÆ˙M∫…), |…ÂMx…x…∫…“ ]‰ı∫]ı EÚ]ı +…ËÆ˙ ∫…Ë x…]ıÆ˙“ x…Ë{… EÚx… EÚ“ +…{…⁄Ãi… EÚÆ˙ Æ˙Ω˛“ Ω˲* "EËÚŒ{]ı¥… ™…⁄ x…]ı" {…Æ˙ EËÚ §…x…]ı +…n‰˘∂… E‰Ú +x…÷∫……Æ˙, ®…∆j……±…™… J…÷±…… x… ¥…n˘… |… GÚ™…… E‰Ú W… Æ˙B ¥……Ãπ…EÚ +…v……Æ˙ {…Æ +…{…⁄Ãi… ®…⁄±™… EÚ… +∆ i…®… ∞¸{… n˘™…… V……BM…… +…ËÆ˙ §……‰±…“ +…n‰˘∂… |… GÚ™…… E‰Ú W… Æ˙B x…v……« Æ˙i… B±… 1 ®…⁄±™… ®…∆j……±…™… EÚ…‰ BS…B±…B±… EÚ“ +…{…⁄Ãi… E‰Ú ±…B ±……M…⁄ Ω˛…‰M……* x… ¥…n˘… |… GÚ™…… E‰Ú W… Æ˙B B±… 1 ®…⁄±™… x…v……«Æ˙h… E‰Ú +¶……¥… ®…Â, BS…B±…B±… ∫…‰ +…{…⁄Ãi… EÚÆ˙x…‰ E‰Ú ±…B +∆ EÚi… ®…⁄±™… x…v……«Æ˙h… EÚÆ˙x…‰ EÚ“ +…‰Æ˙ ¥…k… ®…∆j……±…™… E‰Ú ]Ëı Æ˙°Ú EÚ®…“∂…x…/±……M…i… B¥…∆ ±…‰J…… ∂……J…… EÚ…‰ ∫…∆n˘¶…« §…x……™…… V……BM……* E∆Úb˜…‰®… +…{…⁄Ãi… E‰Ú ∫…∆§…∆v… ®…Â, ¥…π…« 2011-12 ®… ®…⁄±™… BEÚ x… ¥…n˘… |… GÚ™…… E‰Ú W… Æ˙B x…v……« Æ˙i… EÚB M…B ΩÈ˛ +…ËÆ˙ =∫…“ EÚ…‰ ¥…π…« 2012- 13 +…ËÆ˙ 2013-14 E‰Ú n˘…ËÆ˙…x… +…{…⁄Ãi…™……‰∆ E‰Ú ±…B +x…∆ i…®… ®…⁄±™… E‰Ú ∞¸{… ®… §…g¯…¥…… n˘™…… M…™…… Ω˲* ¥…π…« 2012-13 +…ËÆ˙ 2013-14 E‰Ú ±…B x…V…“ ¥… x…®……«i……+… ∫…‰ EÚ…‰<« ¶…“ |……{…h… x… EÚB V……x…‰ E‰Ú EÚ…Æ˙h…, ®…∆j……±…™…, ]Ëı Æ˙°Ú EÚ®…“∂…x… E‰ÚÚ ∫…∆n˘¶…« EÚÆ˙E‰Ú x…v……« Æ˙i… ®…⁄±™… |……{i… EÚÆ˙x…‰ E‰Ú ±…B ¥…S……Æ˙ EÚ™…… V…… Æ˙Ω˛… Ω˲* +i…& ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 198 2.17 Pending forward contracts as on 31.03.2014 for Foreign Curreny Debtors amounts to Nil. 2.18 The Company, during the year in March 2013, had acquired in auction by Canara Bank, Kochi, a Condom manufacturing unit under construction, situated in the state owned Rubber Park at Irapuram, Perumbavoor, Kerala, for a consideration of `400 lacs. The cost of acquisition includes leasehold plot of land (for 99 years from 01.03.2005) measuring 123.80 acres (306 cents) and semi-finished facility comprising of 3479 sq. mtrs of factory & administrative building and major part of the plant, machineries and equipments required for production of 120 Mn Pcs of male condoms, when completed. The property is since registered in the name of HLL. The Company is currently incurring additional capital expenditure to complete the semi-finished facility and also augmenting the condom production capacity to 300 Min. Pcs p.a. The entire investments are currently shown under Capital Work-in-Progress. An encumbrance of `36.88 lacs on this property existing at the time of acquisition is included in the contigent liabilities. 2.19 The Company is in possession of 430.10 acres of land since January 2008, allotted on lease for a period of 99 years from the Central Leprosy Teaching Research Institute (CLTRI), Tamil Nadu, under directives from Ministry of Health & Family Welfare, Govt. of India. The Public Investment Board (PIB), Ministry of Finance, Govt. of India in its meeting held on 10.02.2012 had recommended to earmark 100 acres of land out of the 430.10 acres in possession with the Company at Chengalpattu, for setting up of the Integrated Vaccine Complex (IVC) for a value of `10.12 crores (56 acres@ `16.50 lacs per acre and 44 acres of hillock @ `2 lacs per acre) The recommendations of the PIB are approved by the Cabinet Committee of Economic Affairs (CCEA). The Company in March 2012 has formed a fully owned subsidiary company, M/s. HLL Biotech Limited (HBL), for setting up the IVC, in line with the PIB recommendations. As the legal formalities of transfer of 100 acres of land in the name of HBL is yet to be completed, the Company has, in February 2014, sub-leased the 100 acres identified for the purpose, in favour of HBL @ `1/- for 94 years. 3.38 Acres of land, out of 430.10 acres in possession, to be given on lease to Tamil Nadu State Electricity Board for a period of 36 years for an annual lease rent of `1/- only. However this transaction has so far not been effected. 2.20 Govt. of India has declared HLL as "captive unit" in 2005 for the supply of various Contraceptive products to the Ministry of Health & Family Welfare. The Company has been supplying Contraceptive products (Condoms, Oral Contraceptive Pills, EC Pills, Copper-T and Tubal Rings), Pregnancy Test Kits and Sanitary Napkins to the Ministry. As per the Cabinet order on "captive unit", the Ministry shall be finalizing the supply price on yearly basis through an open tender process and the L1 price determined through the bidding process shall be made applicable to HLL for its supplies to Ministry. In the absence of L1 price determination through tender process, reference shall be made to Tariff Commission / Cost & Accounts Branch of the Ministry of Finance for determining the fair price for the supplies from HLL. As regards Condoms supplies, the prices were determined in 2011-12 through a tender process and the same has been extended as provisional price for the supplies during the years 2012-13 & 2013-14. As no procurement could be done from private manufacturers for the years 2012-13 and 2013-14, Ministry is contemplating to get the price determined by referring to the Tariff Commission. Hence, the supplies during these two years are made at the provisional price and no cost escalation benefits are considered in the accounts. As regards Oral Contraceptive Pills, the supplies during 2013-14 are billed at the price determined by the Ministry through tender process in 2012-13 and hence the price for the year 2013-14 is yet to be firmed up. In the case of Copper-T and Tubal Rings, the supplies during 2013-14 are billed at the old price determined by the Ministry for the year 2012-13. The supply prices for Cu-T and Tubal Rings are determined through tender process during the year 2013-14. Based on this tender price, cost escalation benefit of `122.40 lacs is considered in the 2013-14 accounts. Annual Report 2013-2014 199 |…‰Mx…x∫…“ ]‰ı∫]ı EÚ]ı E‰Ú ∫…∆§…∆v… ®… BS…B±…B±… ®…∆j……±…™… EÚ… BEÚ±… +…{…⁄Ãi…EÚ…Æ˙ Ω˲* ¥…π…« 2009-10 +…ËÆ˙ 2010-11 E‰Ú ±…B ®…∆j……±…™… ∫…‰ §…x……B ∫…∆n˘¶…« E‰Ú +…v……Æ˙ {…Æ˙, ]Ëı Æ˙°Ú EÚ®…“∂…x… x…‰ ¥…π…« 2013 E‰Ú n˘…ËÆ˙…x… ®…∆j……±…™… EÚ…‰ |…∫i…÷i… EÚ“ M…<« =x…EÚ“ Æ˙{……‰]«ı ®… = S…i… ®…⁄±™… E‰Ú ∞¸{… ®… |… i… EÚ]ı E‰Ú ±…B `10/- E‰Ú ∫……l… ={…™…÷«HÚ EÚÆx…‰ ˙EÚ“ ∫…°Ú… Æ˙∂… EÚ“ l…“* ¥…π…« 2012-13 +…ËÆ˙ 2013-14 E‰Ú n˘…ËÆ˙…x… {…“ ]ı“ E‰Ú +…{…⁄Ãi…™…… E‰Ú ±…B {…÷x…& ®…∆j……±…™… x…‰ ±……M…⁄ EÚÆ˙ E‰Ú ∫……l… GÚ®…∂…& `9/- +…ËÆ˙ `10/- EÚ“ n˘Æ˙ {…Æ˙ +x…∆ i…®… ®…⁄±™… ∫…°Ú… Æ∂˙… EÚ“ l…“* ®…∆j……±…™… x…‰ ¥…π…« 2011-12, 2012-13 +…ËÆ˙ 2013-14 E‰Ú ±…B +∆ EÚi… ®…⁄±™… x…™…i… EÚÆ˙x…‰ E‰Ú ±…B ]Ëı Æ˙°Ú EÚ®…“∂…x…/±……M…i… ±…‰J…… ∂……J…… EÚ…‰ ∫…∆n˘¶…« +¶…“ i…EÚ x…Ω˛” §…x……™…… Ω˲* +i…& E∆Ú{…x…“ x…‰ ±…‰J…‰ ®… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 200 In the case of Pregnancy Test Kit, HLL is the sole supplier to the Ministry. Based on the reference made from the Ministry for the years 2009-10 & 2010-11, Tariff Commission had recommended `10/- per Kit plus applicable tax, as the reasonable price, in their report submitted to Ministry during 2013. Again the Ministry had fixed provisional price @ `9/- and `10/- respectively, plus applicable tax for the PTK supplies during the years 2012-13 and 2013-14. The Ministry has so far not made a reference to Tariff Commission / Cost Accounts Branch to fix the fair price for the years 2011-12, 2012-13 and 2013-14. Hence, Company has not considered any additional cost escalation benefits for the years in the accounts. The Ministry has also made reference to Tariff Commission to determine the prices to be paid for Sanitary Napkin supplies during the years 2011-12 & 2012-13 and the recommendations are awaited. 2.21 The Company has taken on lease a Condom manufacturing facility situated in 5.21 acres of land together with factory building / shed having plinth area of 40000 sq. ft and machinery, in Sy. No. 1005, AA, Gajwel Village, Medak District in Telangana during February 2012. The lease is for a period of 5 years commencing from 1st March 2012 terminable by giving 3 months notice from either side, with lease rent of Rs.18 lakh per month. The company has issued Notice of termination of Lease Deed on 29.03.2014 to terminate the lease w.e.f 30.06.2014 hence disclosure of future lease payments as per AS 19 is not given. 2.22 The Company, on 19th March, 2014 has acquired 74% of Equity Share Capital of M/s Goa Antiblotics & Pharmaceuticals Limited (GAPL) for a considertion of Rs. 700 lacs based on a due diligence conducted on the company. GAPL was a wholly owned subsidiary company of M/s. EDC Limited, a Govt. of Goa undertaking and is engaged in the manufacturing & selling of various pharmaceuticals products. The consideration paid together with statutory levies is shown as part of non current investments. 2.23 Details of Contract Revenue and costs (Amount in lacs) 31-03-2014 31-03-2013 Contract revenue recognised during the year 17,948.86 11,980.62 Aggregate of amount of costs incurred upto reporting date 33,783.73 19,897.79 Recognized profits up to reporting date 12,553.80 8,574.71 Advances received for contracts in progress 13,188.88 12,973.00 Retention money for contracts in progress - - Gross amount due from customers for contract 13,671.63 7,490.62 work (asset) Annual Report 2013-2014 201 31.03.2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…B ¥…k…“™… ¥…¥…Æ˙h… EÚ“ ]ı{{…h…“ |……∫…∆ M…EÚ n‰˘™…i……B∆ +…ËÆ˙ |… i…§…r˘i……Bƒ (|……¥…v……x… x…Ω˛” n˘B Ω˛n˘ i…EÚ) 2013-14 2012-13 ` ` ±……J…… ®… ` ±……J…… ®… (i) |……∫…∆ M…EÚ n‰˘™…i……B∆ (i) +…™… EÚÆ˙ EÚ) E∆Ú{…x…“ E‰Ú ¥…Ø˚r˘ {…b‰˜ +…™… EÚÆ˙ ®……ƒM… , @Òh… E‰Ú ∞¸{… ®… ∫¥…“EfiÚi… x…Ω˛” EÚB M…B ΩÈ˛ i…l…… E∆Ú{…x…“ +{…“±… ®… Æ˙Ω‰˛ E‰Ú ∫…∆§…∆v… ®… |……¥…v……x… x…Ω˛” EÚB M…B ΩÈ˛ i…l…… x…h…«™……v…“x… {…b‰˜ x…v……«Æ˙h… B¥…∆ §™……V…… ∫…‰ ∫…∆§…∆ v…i… B‡∫…‰ ®……®…±…‰ ¶…“ UÙ…‰b˜ n˘B M…B ΩÈ˛* 312.16 222.50 J…) @Òh… E‰Ú ∞¸{… ®… ∫¥…“EfiÚi… x…Ω˛” EÚ™…‰ M…™…‰ E∆Ú{…x…“ E‰Ú J…±……°Ú {…b‰˜ §…GÚ“ EÚÆ˙ n˘…¥…… * 263.48 263.48 (ii) @Òh… E‰Ú ∞¸{… ®… ∫¥…“EfiÚi… x…Ω˛” EÚ™…‰ M…™…‰ E∆Ú{…x…“ E‰Ú J…±……°Ú {…b‰˜ n˘…¥…… 4,978.93 4,307.42 (iii) M……Æ∆˙]ı“ (EÚ) + v…EÚ… Æ˙™…… E‰Ú ±…B EÚ®…«S……Æ˙“ +…¥……∫…˛ @Òh… E‰Ú ±…B E∆Ú{…x…“ EÚ“ M……Æ∆˙]ı“ 2.38 4.03 (J…) +x™…… E‰Ú ±…B EÚ®…«S……Æ˙“ +…¥……∫… @Òh… E‰Ú ±…B E∆Ú{…x…“ EÚ“ M……Æ∆˙]ı“ 8.06 15.92 (iv) ∫…Æ˙EÚ…Æ˙“ ¥…¶……M……‰∆ E‰Ú ±…B §…ÈEÚ M……Æ∆˙]ı“ ( x…¥…±… ®……ÃV…x… Æ˙… ∂…) 161.33 1,764.24 (v) +x™…… E‰Ú ±…B §…ÈEÚ M……Æ∆˙]ı“ 4,718.11 12,981.07 (vi) V……Æ˙“ EÚ“ M…<«˙ EÚ…Ï{……ÊƉ˙]ı M……Æ∆˙]ı“ 2,579.94 2,580.00 (vii) ∫……J…-{…j… ( x…¥…±… ®……ÃV…x… Æ˙… ∂…) 428.75 769.25 (viii) ∫…“®…… ∂…÷±EÚ E‰Ú ±…B |……¥…v……x… 49.12 45.13 (ix) EÚ…‰ S…x… ∫{…‰∂…±… (ii) °Ú…™…±… EÚB +{…“±…… E‰Ú ±…B ±…∆ §…i… U⁄Ù]ı n˘…¥…… 5.61 2.00 E÷Ú±… 1,953,50 3,299.39 E÷Ú±… ™……‰M… 15,958.57 26,755,24 |……∫…∆ M…EÚ n‰˘™…i…… EÚ…‰ |… i… ¥…π…« ®…⁄±… {±…∫… 12% EÚ“ §™……V… n˘Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚ™…… M…™…… Ω˲* n˘…¥…‰n˘…Æ˙… u˘…Æ˙… §…x……B M…B n˘…¥…‰ 8.24% ∫…‰ ±…‰EÚÆ˙ Ω˲* V…Ë∫…‰ ¶…“ Ω˛…‰, +…™…EÚÆ˙ +…ËÆ˙ |……EfiÚ i…EÚ x™……™… ∫…r˘…xi… V…Ë∫…‰ ∫……∆ ¥… v…EÚ §™……V… ±…‰¥…“ EÚ…‰ v™……x… ®… Æ˙J…EÚÆ˙ |… i… {…π…« 12% n˘Æ˙ ∫…‰ + v…EÚ +…x…‰ ¥……±…‰ ®……®…±…… ®… |… i… ¥…π…« 12% EÚ“ n˘Æ˙ {…Æ˙ ∫…¶…“ n˘…¥…… E‰Ú ±…B §™……V… n˘Æ˙ ±…“ M…™…“ Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 202 NOTES TO FINANCIAL STATEMENTS FOR THE YEAR ENDED 31.03.2014 Contigent liabilities and commitments (to the extent not provided for) 2013-14 2012-13 ` lacs ` lacs (I) Contingent Liabilities (i) Income Tax (a) Income Tax demands against the Company not acknowledged as debt and not provided for in respect of which the Company is in appeal and exclusive of the similar matters in respect of pending assessments and interest 312.16 222.50 (b) Sales Tax Claims against the Co. not acknowledged as debt 263.48 263.48 (ii) Claims against the Company not acknowledged as debts 4,978.93 4,307.42 (iii) Gurantee (a) Company's guarantee for Employees Housing Loan for Officers 2.38 4.03 (b) Company's guarantee for Employees Housing Loan for others 8.06 15.92 (iv) Bank Guarantees to Govt. Departments. (Net of Margin Money) 161.33 1,764.24 (v) Bank Guarantees to others 4,718.11 12,981.07 (vi) Corporate Guarantee issued 2,579.94 2,580.00 (vii) Letter of Credits (net of Margin Money) 428.75 769.25 (viii) Provision of Customs Duty 49.12 45.13 (ix) Bond cum legal undertaking in favour of Cochin Special Economic Zone 465.92 465.92 (x) Encumbrance/Amount payable, existing on the property acquired in auction 36.88 36.88 TOTAL 14,005.06 23,455.85 (II) Commitments (i) Estimated amount of contracts remaining to be executed on Capital Account and not provided for (Net of advances) 1,947.89 3,297.39 (ii) Pending rebate claim for which appeals filed 5.61 2.00 TOTAL 1,953.50 3,299.39 GRAND TOTAL 15,958.57 26,755.24 Contingent liability has been calculated as Principal plus interest @ 12% p.a. The claims made by the claimants have ranged from 8-24%. However, keeping in view of the statutory interest levies like Income Tax and principle of Natural Justice, the rate of interest for all claims have been taken @ 12% p.a. in cases where the interest is above 12% p.a. Annual Report 2013-2014 203 +x…÷∫…⁄S…“ I - ]ı{{…h…“ x…∆.2.14 ®… =Œ±±… J…i… ±…‰J…… ®……x…EÚ 18 E‰Ú +x…÷∫……Æ˙ ∫…∆§…∆ v…i… {……]ı‘ E‰Ú §……Ɖ˙ ®… |…EÚ]ı“EÚÆ˙h… Æ˙∂i…‰ EÚ… ¥…¥…Æ˙h… ∫…∆§…∆ v…i… {……Ã]ı™…… E‰Ú x……®… ∫…®…x…÷π…∆M…“ BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ ∫…∆™…÷HÚ =t®… V…“B{…“B±… ±……<¢Úœ∫|…M… +∫{…i……±… |……<¥…‰]ı ±… ®…]‰ıb˜ ∫…Ω˛™……‰M…“ ÀΩ˛n÷˘∫i……x… ±…Ë]‰ıC∫… {… Æ˙¥……Æ˙ x…™……‰V…x… |……‰z…®…x… x™……∫… ®…÷J™… |…§…∆v…x… Eڅî…EÚ (E‰Ú B®… {…“) b˜…Ï. B®…. +™™…{{…x… - +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ b˜…Ï. E‰Ú.+…Æ˙.B∫…. EfiÚπh…x…˙ - x…n‰˘∂…EÚ (i…EÚx…“EÚ“ B¥…∆ |…S……±…x…) +…Æ˙˙.{…“. J…hb‰˜±…¥……±… - x…n‰˘∂…EÚ ( ¥…k…) ®…÷J™… |…§…∆v…x… Eڅî…EÚ EÚ…‰ |…n˘k… {…… Æ˙∏… ®…EÚ ∫…‰ ∫…∆§…∆ v…i… ∫…⁄S…x…… ]ı{{…h…“ 24 ®… ={…±…§v… ΩË* ÀΩ˛n÷˘∫i……x… ±…Ë]‰ıC∫… ±……<°ÚŒ∫|…∆M… +∫{…i……±… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ V…“B{…“B±… {… Æ˙¥……Æ x…™……‰V…x… |……<¥…‰]ı ±… ®…]‰ıb˜ ±… ®…]‰ıb˜ E‰Ú ({…⁄h…« |……‰z…®…x… x™……∫… (¶……Æ˙i…“™… E∆Ú{…x…“ ∫¥…… ®…i¥… ∫…®…x…÷π…∆M…“ ∫…k…… EÚ… x……®… (j……¥…h…EÚ…‰Æ˙-EÚ…‰ŒSS… + v… x…™…®…, 1956 E‰Ú BS…B±…B±… §……™……‰]‰ıEÚ ∫…… Ω˛Œi™…EÚ, ¥…ËY…… x…EÚ, +v…“x… {…∆V…“EfiÚi… E∆Ú{…x…“) ±… ®…]‰ıb˜) v…®……«l…« ∫……‰∫……<]ı“ ¥… x…™…®…x… + v… x…™…®… E‰Ú +v…“x… x™……∫…) C™…… x…™…∆j…h… ±……M…⁄ Ω˲ ∂…⁄x™… 50% 100% 74% 2013-14 2012-13 2013-14 2012-13 2013-14 2012-13 2013-14 2012-13 ` ±……J…… ®… ` ±……J…… ®… ` ±……J…… ®… ` ±……J…… ®… ` ±……J…… ®… ` ±……J…… ®… ` ±……J…… ®… ` ±……J…… ®… i) +…™… §…GÚ“ 1,167.97 321.22 {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ {…Æ˙ ±……¶…/Ω˛… x… ------EÚÆ˙…™…… +…™… 40.00 23.18 ------{…Æ˙…®…∂…« - - - - 42.52 4.45 - - b˜§…ÂS…ıÆ˙ §™……V… - - 15.63 - - - - - ii) J…S…« §…GÚ“ EÚ®…“∂…x… ------|…§…∆v… ∂…÷±EÚ ------§…GÚ“ |……‰z…®…x… ------¥…‰i…x… B¥…∆ ¶…k…… ------+x™… ¥™…™… - - - - 78.26 93.84 - - iii) {… Æ˙∫…∆{… k…™……ƒ ¥… ¥…v… n‰˘x…n˘…Æ˙ 463.38 124.97 32.22 - 78.78 - - - + O…®… - 26.09 - 14.79 - - - - ∂…‰™…Æ˙… ®… x…¥…‰∂… - - 783.42 783.42 17,801.00 17,801.00 708.75 b˜§…ÂS…Æ˙ §™……V… - - 125.00 - - - - - iv) n‰˘™…i……Bƒ J…S……Á E‰Ú ±…B |……¥…v……x… ------+x™… n‰˘™…i……Bƒ - - - - 1,126.65 - - - ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 05.07.2014 2013-2014 204 ANNEXURE I - Referred to in Note No. 2.14 Disclosure in respect of related party pursuant to Accounting Standard 18 Description of relationship Names of related parties Subsidiaries HLL Biotech Ltd. GAPL Joint Venture Life Spring Hospitals Private Ltd. Associates Hindustan Latex Family Planning Promotion Trust Key Management Personnel (KMP) Dr. M. Ayyappan - Chairman & Managing Director Dr. K.R.S. Krishnan - Director (Technical & Operations) R.P. Khandelwal - Director (Finance) Information regarding remuneration paid to Key Managerial Personnel are available in Note 24. (`(`(` lacs) Hindustan Latex Life Spring Hospitals Family Planning Private Ltd. HLL Biotech Ltd. Promotion Trust (A Company (Wholly owned Name of Entity registered under the GAPL (A Trust under the subsidiary of Indian Companies Act, Travancore - Kochi 1956) HLL Lifecare Literary Scientific, Limited) CharitableSocieties Regulation Act) Whether Control exist Nil 50% 100% 74% 2013-14 2012-13 2013-14 2012-13 2013-14 2012-13 2013-14 2012-13 ``` lacs ``` lacs ``` lacs ``` lacs ``` lacs ``` lacs ``` lacs ``` lacs i) Income Sales 1,167,97 321.22 Profit/Loss on sales of Assets ------Rental Income 40.00 23.18 ------Consultancy - - - - 42.52 4.45 - - Debenture Interest - - 15.63 ii) Expenses Sales Commission ------Management Fee ------Sales Promotion ------Salaries & Allowances ------other expenses - - - - 78.26 93.84 - - iii) Assets Sundry Debtors 463.38 124.97 32.22 - 78.78 - - - Advances - 26.09 - 14.79 - - - - Investment in Shares - - 783.42 783.42 17,801.00 17,801.00 708.75 - Investment in Debentures - - 125.00 - - - - - iv) Liabilities Provision for Expenses ------Other Liabilities - - - - - 1,126.65 - - For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 205 +x…÷∫…⁄S…“ II - ]ı{{…h…“ x…∆.2.14 ®… =Œ±±… J…i… ±…‰J…… ®……x…EÚ 17 E‰Ú +v…“x… |…EÚ]ı“EÚÆ˙h… J…∆b˜ Æ˙{……‰Õ]ıM… 1. |……<®…Æ˙“ J…∆b˜ ∫…⁄S…x…… Ú ¥…¥…Æ˙h… Æ˙…V…∫¥… J…∆b ` ±……J…… ®… M…¶…« x…Æ˙…‰v…EÚ ∫¥……∫l™… Æ˙I…… ¥™……{……Æ˙ |……{…h… B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ E÷Ú±… =i{……n˘ {…Æ˙…®…∂…« ∫…‰¥……B∆ x…¥…±… §…GÚ“ +…ËÆ˙ ∫…‰¥……Bƒ 40,496.88 15,671.93 16,297.36 3,681.04 17,948.86 94,096.07 +x™… + ¥… x…v……x…“™… Æ˙…V…∫¥… 1,272.76 E÷Ú±… 95,368.83 x…™…÷HÚ {…⁄ƒV…“ M…¶…« x…Æ˙…‰v…EÚ ∫¥……∫l™… Æ˙I…… ¥™……{……Æ˙ |……{…h… B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ E÷Ú±… =i{……n˘ {…Æ˙…®…∂…« ∫…‰¥……B∆ §™……V… +…ËÆ˙ EÚÆ˙ E‰Ú {…Ω˛±…‰ ±……¶… 4,926.12 (736.12) 439.34 1,361.36 3,979.09 9,969.78 x™…⁄x… : §™……V… 1,840.35 x™…⁄x… : +x™… + ¥… x…v……x…“™… ¥™…™… 4,492.44 {…⁄¥…« +¥… v… ®…n¢ (15.91) V……‰b˜ : +x™… + ¥… x…v……x…“™… ¥™…™… 0.00 EÚÆ˙ E‰Ú {…⁄¥…« ±……¶… 3,621.08 M…¶…« x…Æ˙…‰v…EÚ ∫¥……∫l™… Æ˙I…… ¥™……{……Æ˙ |……{…h… B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ E÷Ú±… x…™…÷HÚ {…⁄ƒV…“ =i{……n {…Æ˙…®…∂…« ∫…‰¥……B∆ +…§…∆ ]ıi… +S…±… {… Æ˙∫…∆{… k…™……ƒ (EÚ) 12,707.12 6,398.41 44.66 923.87 0.94 20,074.99 +…§…∆ ]ıi… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (J…) 28,270.55 13,237.20 4,025.68 9,755.91 11,386.74 66,676.08 EÚ + J… 40,977.67 19,635.61 4,070.34 10,679.77 11,387.68 86,751.07 +…§…∆ ]ıi… S……±…⁄ n‰˘™…i……Bƒ 10,253.00 7,374.34 1,799.61 3,341.20 6,675.23 29,443.38 x…™…÷HÚ {…⁄ƒV…“ +…§…∆]ıx… 30,724.67 12,261.27 2,270.73 7,338.58 4,712.45 57.307.69 x…™…÷HÚ {…⁄ƒV…“ E‰Ú + ¥… x…v……x…“™… +∆∂… (28,369.55) E÷Ú±… x…™…÷HÚ {…⁄ƒV…“ 28,938.14 2. ∫…‰EÚxb˜Æ˙“ J…∆b˜ ∫…⁄S…x…… - ¶……ËM……‰ ±…EÚ Æ˙…V…∫¥… ¶……Æi… 81,972.49 ¶……Æi… E‰Ú §……Ω˛Æ˙ 13,396.34 95,368.83 x…™…÷HÚ {…⁄ƒV…“ 23,473.24 ¶……Æ˙i… 5,464.90 ¶……Æ˙i… E‰Ú §……Ω˛Æ˙ 28,938.14 ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 206 ANNEXURE II - Referred to in Note No. 2.14 Disclosures under Accounting Standards-17 SEGMENT REPORTING 1. Primary Segment Information Particulars ``` lakhs Segment Revenue Contraceptives Health Care Trading Procurement Contract Total Products and Services Consultancy Services Net Sales & Services 40,496.88 15,671.93 16,297.36 3,681.04 17,948.86 94,096.07 Other Unallocable Revenue 1,272,76 Total 95,368.83 Capital Employed Contraceptives Health Care Trading Procurement Contract Total Products and Services Consultancy Services Profit before Interest & Tax 4,926.12 (736.12) 439.34 1,361.36 3,979.09 9,969.78 Less: Interest 1,840.35 Less : Other Unallocable Expenditure 4,492.44 Prior period items (15.91) Add : Other Unallocable Income 0.00 Profit before tax 3,621.08 Capital Employed Contraceptives Health Care Trading Procurement Contract Total Products and Services Consultancy Services Allocated Fixed Assets (a) 12,707.12 6,398.41 44.66 923.87 0.94 20,074.99 Allocated Current Assets (b) 28,270.55 13,237.20 4,025.68 9,755.91 11,386.74 66,676.08 a+b 40,977,67 19,635.61 4,070.34 10,679.77 11,387.68 86,751.07 Allocated Current Liabilities 10,253.00 7,374.34 1,799.61 3,341.20 6,675.23 29,443.38 Capital Employed Allocation 30,724.67 12,261.27 2,270.73 7,338.58 4,712.45 57,307.69 Unallocable portion of Capital Employed (28,369.55) Total Capital Employed 28,938.14 2.Secondary Segment Information - Geographical Revenue India 81,972.49 Outside India 13,396.34 95,368.83 Captial Employed India 23,473.24 Outside India 5,464.90 28,938.14 For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 207 E÷Ú±… n‰˘™…i……Bƒ S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ S……±…⁄ 2013-14 2012-13 2013-14 2012-13 E÷Ú±… 1,210.34 1,145.61 1,210.34 1,145.61 1,210.34 1,145.61 2013-14 2012-13 7,796.98 1,654.41 14,294.52 1,654.41 14,294.52 1,654.41 14,294.52 - ]ı{{…h…“ x…∆.2.15 ®… =Œ±±… J…i… ®… x…∆.2.15 ]ı{{…h…“ - III {… Æ˙∫…∆{… k…™……ƒ 2.78 2.78 2.780.16 2.78 - 2.78 0.16 2.78 - 2.78 0.16 2.78 - 0.16 - 0.89 0.89 0.89 0.89 0.89 0.89 0.89 0.89 4.662.24 245.82 - 2.24 4.66 245.82 2.24 - 245.82 4.66 2.24 245.82 - 4.66 - 23.40 32.75 +x™… S……±…⁄ n‰˘™…i……Bƒ S……±…⁄ +x™… 165.32 +x…÷∫…⁄S…“ 2013-14 2012-13 31 ®……S…«, 2014 EÚ…‰ EÚ…™……«x¥…™……v…“x… {…c˜“ {… Æ˙™……‰V…x…… EÚ“ {… Æ˙∫…∆{… k…™……ƒ +…ËÆ˙ n‰˘™…i……Bƒ +…ËÆ˙ {… Æ˙∫…∆{… k…™……ƒ EÚ“ {… Æ˙™……‰V…x…… {…c˜“ EÚ…™……«x¥…™……v…“x… EÚ…‰ 2014 ®……S…«, 31 3.51 3.51 - - 3.51 3.51 3.51 3.51 3.51 3.51 21.2887.63 242.85 339.98 37.4062.38 29.92 25.26 62.38 39.39 58.68 - 117.55 268.10 379.37 - 58.68 117.55 268.10 62.38 379.37 58.68 62.38 117.55 268.10 379.37 62.38 62.38 62.38 62.38 11.39 11.16 1.20 1.45 12.59 12.61 12.59 12.61 12.59 12.61 341.62265.37 28.30125,39 592.51 99.57 125.39 96.22 99.57 48.85 - 441.19 361.59 127.87 - 641.36 441.19 125.39 361.59 127.87 125.39 641.36 441.19 361.59 125.39 127.87 641.36 125.39 125.39 125.39 649.35116.71 ------649.35 116.71 - - 649.35 116.71 - - 649.35 116.71 - - 217.42144.65 80.94 170.12 0.64 22.02 28.32 4.54 218.06 166.67 109.26 174.66 218.06 166.67 109.26 174.66 218.06 166.67 109.26 174.66 1,186.94 1,112.86 1,489.09 6,497.54 38,744.87 13,865.01 2,128.56 8,054.85 40,873.43 22,369.86 40,873.43 22,369.86 40,873.43 22,369.86 BS…B±…B±… E‰Ú ∫……l… x™……∫… E‰Ú x™……∫… ∫……l… E‰Ú BS…B±…B±… 2013-14 2012-13 +v…“x… {…b‰˜ x…n˘EÚ +…ËÆ˙ §…ÈEÚ ∂…‰π… §…ÈEÚ +…ËÆ˙ x…n˘EÚ {…b‰˜ +v…“x… 43,456.21 23,121.38 2,613.78 16,830.00 46,069.99 39,951.39 46,069.99 39,951.39 46,069.99 39,951.39 EÚ…‰±b˜ S…‰ ™…x… EÚ…‰±b˜ & {… Æ˙™……‰V…x……Bƒ B°Ú b˜Œ§±…™…÷) B°Ú ∫……E«Ú ∫…“∂…‰±∫…®…∆j……±…™…, EÚ…™…« ¥…n‰˘∂… Bx…¥…“§…“b˜“∫…“{…“ x……EÚ…‰ B®…∫…“b˜“ ∫…“V…“BS…B®… {…“∫…“b˜“ {… Æ˙™……‰V…x…… ∫…“¥…“B®… -{…“∫…“b˜“{… Æ˙™……‰V…x…… B®…V…‰B∫… Ω˛®……S…±… |…n‰˘∂… ∫…Æ˙EÚ…Æ˙ {… Æ˙™……‰V…x…… - - - - - ±…b˜…EÚ Ω˛±… ¥…EÚ…∫… {… Æ˙π…n¬˘ ¥…EÚ…∫… Ω˛±… ±…b˜…EÚ n˘±±…“ B∫…∫…“]ı“ ∫…“∫…“+…Æ˙B∫… E÷Ú±… +…<« b˜“ =k…Æ˙ +…<«{…“∫…“ (M…… W…™……§……n˘) - - {…“B®…B∫…B∫…¥……<« (V…“B®…B∫…b˜“) ]ı“EÚ…EÚÆ˙h… (B®…+…‰BS… ]ı“EÚ…EÚÆ˙h… (V…“B®…B∫…b˜“) Bx… +…<« §…“ Bx… +…<« BS… E‰Ú <∆ b˜™…x… ®…‰ b˜ ∫…x∫… °Ú…®…«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜E∆Ú{…x…“ - - {…“ ∫…“ b˜“ ∫…“ {…“ +…™…÷π… & ∫…“B§…“ (+…<«+…<«{…“B∫…) ∫…“B§…“ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 208 245.82 Total 2.24 2013-14 2012-13 LIABILITIES 245.82 268.10 58.68 268.10 2.24 8.68 62.38 62.38 62.38 62.38 12.59 12.61 12.59 12.61 Current Liabilities 2013-14 2012-13 245.82 268.10 5 Total 2.24 218.06166.67 109.26 174.66 218.06 166.67 109.26 174.66 218.06 166.67 109.26 174.66 1,210.34 1,145.61 1,210.34 1,145.61 1,210.34 1,145.61 2013-14 2012-13 245.82 ASSETS 2.78 2.780.16 2.784.66 2.782.24 - - 2.78 0.161.20 4.66 2.78 - 1.45 2.78 - 0.16 12.59 2.78 4.66 12.61 - - 0.16 4.66 - - 0.89 0.89 0.89 0.89 0.89 0.89 0.89 0.89 7.40 25.26 58.68 2.02 4.54 3.40 32.75 2013-14 2012-13 Other Current Assets Other ANNEXURE III - Referred to in Note No. 2.15 0.94 0.64 28.32 242.85 3 3.51 3.51 - - 3.51 3.51 3.51 3.51 3.51 3.51 16.71 - - - 116.71 - 116.71 - 116.71 - 341.62 28.30 99.57 99.57 441.19 127.87 441.19 127.87 441.19 127.87 125.39 125.39649.35 - - - 125.39 - 125.39 125.39 - 125.39 649.35 125.39 125.39 - 649.35 - 649.35 - 217.42 8 1,489.09 6,497.54 165.32 7,796.98 1,654.41 14,294.52 1,654.41 14,294.52 1,654.41 14,294.52 1,186.94 1,112.86 2 Assets and Liabilities of projects under implementation as on 31st March 2014 Cash & Bank balances Cash 2013-14 2012-13 held under trust with HLL Projects NVBDCPNACO MCDCGHSHIMACHAL PRADESH PROJECTGOVT. LADAKH HILL DEVELOPMENT 87.63COUNCIL 339.98 265.37 62.38 29.92 592.51 - 62.38 39.39 96.22 117.55 - - 48.85 - 379.37 361.59 - 117.55 - 641.36 379.37 361.59 62.38 117.55 641.36 62.38 379.37 361.59 641.36 Ministry of External Affairs, Ministry of External Sychelles PROJECTS PCD C.V.M. PCDMJS PROJECT -NCT DELHI CCRSTOTAL -ID North - IPC (Gaziabad) - 43,456.21 1 11.39 23,121.38 2,613.78 11.16 16,830.00 46,069.99 39,951.39 46,069.99 39,951.39 46,069.99 39,951.39 NIBNIHK Indian Medicines Pharmaceuticals Co LtdCAB (IIPS) SAARC - 144.65 170.12 - 2 21.28 PMSSY(GMSD)Immunisation(MOH&FW) & Cold Chain 38,744.87 13,865.01 2,128.56 8,054.85 40,873.43 22,369.86 40,873.43 22,369.86 40873.43 22,369.86 PCD AYUSH Annual Report 2013-2014 209 1,193.64 E÷Ú±… 853.82 n‰˘™…i……Bƒ 1,193.64 S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ S……±…⁄ 853.82 2013-14 2012-13 2013-14 2012-13 1,193.64 9,763.20 10,406.07 9,763.20 10,406.07 9,763.20 E÷Ú±… 1,208.36 3,590.10 1,208.36 3,590.10 1,206.36 3,590.10 1,220.59 1,321.90 1,220.59 1,321.90 1,220.59 1,321.90 2013-14 2012-13 30.37 499.92 419.30 499.92 419.30 499.92 419.30 - ]ı{{…h…“ x…∆.2.15 ®… =Œ±±… J…i… ®… x…∆.2.15 ]ı{{…h…“ - III {… Æ˙∫…∆{… k…™……ƒ 0.29 - 0.29 - 0.29 - 0.29 - 3.01 - 3.01 - 3.01 - 3.01 - +x™… S……±…⁄ n‰˘™…i……Bƒ S……±…⁄ +x™… 142.99 655.68 750.81 527.47 10,406.07 400.05 - 162.19 133.48 2,458.18 1,887.01 2,458.18 1,887.01 2,458.18 1,887.01 +x…÷∫…⁄S…“ 2013-14 2012-13 36.04 91.18 32.15 91.18 68.19 91.18 68.19 91.18 68.19 991.65 89.23 66.98 1,378.77 1,058.63 1,378.77 1,058.63 1,378.77 1,058.63 663.34 - 35.15 - 698.49 - 698.49 - 698.49 1,321.90 31 ®……S…«, 2014 EÚ…‰ EÚ…™……«x¥…™……v…“x… {…c˜“ {… Æ˙™……‰V…x…… EÚ“ {… Æ˙∫…∆{… k…™……ƒ +…ËÆ˙ n‰˘™…i……Bƒ +…ËÆ˙ {… Æ˙∫…∆{… k…™……ƒ EÚ“ {… Æ˙™……‰V…x…… {…c˜“ EÚ…™……«x¥…™……v…“x… EÚ…‰ 2014 ®……S…«, 31 89.8511.23 110.6644.4544.96 77.70 54.12 - 37.54 0.09 - 10.06 167.55 233.11 19.67 0.16 148.20 54.49 21.29 44.54 167.55 278.07 19.67 148.20 54.49 54.49 167.55 21.29 44.54 148.20 278.07 19.67 54.28 54.49 21.29 44.54 278.07 19.67 54.28 54.49 41.23 155.45 0.45 9.44 41.68 164.89 41.68 164.89 41.68 164.89 367.45 900.60 486.37 293.03 853.82 820.54 130.75 58.32 43.74 31.40 174.49 89.72 174.49 89.72 174.49 89.72 135.87 141.38 135.41 0.46 271.28 141.84 271.28 141.84 271.28 141.84 1,065.37 2,934.42 9,655.26 9,235.73 BS…B±…B±… E‰Ú ∫……l… x™……∫… E‰Ú x™……∫… ∫……l… E‰Ú BS…B±…B±… 2013-14 2012-13 +v…“x… {…b‰˜ x…n˘EÚ +…ËÆ˙ §…ÈEÚ ∂…‰π… §…ÈEÚ +…ËÆ˙ x…n˘EÚ {…b‰˜ +v…“x… 14,453.13 16,078.68 2,016.42 1,776.57 16,469.55 17,885.24 16,469.55 17,855.24 16,469.55 17,855.24 {… Æ˙™……‰V…x……Bƒ Bx…<«+…<«B°ÚB®…, +…™…÷π… E‰Ú +v…“x… {……∫…“M…g¯+… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 210 Total 2013-14 2012-13 LIABILITIES Current Liabilities 2013-14 2012-13 164.89 41.68 164.89 41.68 164.89 Total 174.49167.55 89.72 148.20 174.49 167.55 89.72 148.20 174.49 167.55 148.20 89.72 271.28 141.84 271.28 141.84 271.28 141.84 1,378.77 1,058.63 1,378.77 1,058.63 1,378.77 1,058.63 2012-13 2012-13 0.46 ASSETS 0.29 -3.01 0.29 - -0.45 3.01 0.29 9.44 - 41.68 - 3.01 0.29 - - 3.01 - 7.70 37.54 9.23 66.98 233.11 54.49 278.07 54.49 278.07 54.49 278.07 54.49 142.99 655.68 1,208.36 3,590.10 1,208.36 3,590.10 1,208.36 3,590.10 2013-14 2012-13 Other Current Assets Other ANNEXURE III - Referred to in Note No. 2.15 58.32 43.74 31.40 10.66 7 663.34155.45 - 35.15 - 698.49 - 698.49 - 698.49 1.23 - 10.06 19.67 21.29 19.67 21.29 19.67 21.29 19.67 367.45 900.60820.54 486.37 1,321.90 293.03 400.05 853.82 1,193.64 - 1,220.59 853.82 1,321.90 1,193.64 1,220.59 853.82 1,321.90 1,193.64 1,220.59 1,321.90 845.07135.87 1,673.84308.55 141.38 433.73 135.41 388.93 353.17 191.37 1,278.80 2,027.01 30.37 1,278.80 499.92 2,027.01 1,278,80 419.30 2,027.01 499.92 419.30 499.92 419.30 3,306.252,295.99 2,351.22 1,753.53 1,923.78 162.19 189.84 133.48 5,230.03 2,541.06 2,458.18 1,887.01 5,230.03 2,541.06 2,458.18 5,230.03 1,887.01 2,541.06 2,458.18 1,887.01 1,243.58 683.21 142.47 231.95 1,386.05 915.17 1,386.05 915.17 1,386.05 915.17 1,289.54 991.65 8 Assets and Liabilities of projects under implementation as on 31st March 2014 Cash & Bank balances Cash 2013-14 2012-13 held under trust with HLL Projects IID-PULAYANARKOTTAAyakar Seva KendraDrugs Control BoardNIIST 89.85 1 1 44.45 54.12 0.09 44.96 0.16 - 44.54 54.28 44.54 54.28 44.54 54.28 Aligarh Medical College (PMSSY) 1,065.37PGIMS ROHTAK NIPS/RIPS 2,934.42 BARIHAR RGL ACHARYA CANCER CENTRE CUTTACK CGHSTOTALID South JIPMER Trivandrum MC 9,655.26Salem MC 9,235.73Bangalore MC 750.81 14,453.13 527.47 16,078.68 - 10,406.07 2,016.42 9,763.20 1,776.57 41.23 10,406.07 16,469.55 - - 17,855.24 9,763.20 10,406.07 16,469.55 9,763.20 17,855.24 16,469.55 17,855.24 NEIFM, Pasighat under AYUSH NEIFM, Pasighat under IMPCL_MOHAN_PMC - - NRHM Malabar Cancer Cente Social Welfare Dept.IMHANS DPE - 36.04 130.75 91.18 32.15 91.18 68.19 91.18 68.19 91.18 68.19 PMSSY (Residential Projects (Rishikesh & Patna) Annual Report 2013-2014 211 E÷Ú±… n‰˘™…i……Bƒ S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ S……±…⁄ 2013-14 2012-13 2013-14 2012-13 E÷Ú±… 3,047.38 1,720.13 3,047.38 1,720.13 3,047.38 1,720.13 2013-14 2012-13 0.15 - ]ı{{…h…“ x…∆.2.15 ®… =Œ±±… J…i… ®… x…∆.2.15 ]ı{{…h…“ - III {… Æ˙∫…∆{… k…™……ƒ +x™… S……±…⁄ n‰˘™…i……Bƒ S……±…⁄ +x™… 57.00 - 2,691.50 1,504.99 2,691.50 1,504.99 2,691.50 1,504.99 +x…÷∫…⁄S…“ 2013-14 2012-13 31 ®……S…«, 2014 EÚ…‰ EÚ…™……«x¥…™……v…“x… {…c˜“ {… Æ˙™……‰V…x…… EÚ“ {… Æ˙∫…∆{… k…™……ƒ +…ËÆ˙ n‰˘™…i……Bƒ +…ËÆ˙ {… Æ˙∫…∆{… k…™……ƒ EÚ“ {… Æ˙™……‰V…x…… {…c˜“ EÚ…™……«x¥…™……v…“x… EÚ…‰ 2014 ®……S…«, 31 9.03 - - - 9.03 - 9.03 - 9.03 98.72 -32.22 50.3913.17 - - - 149.11 4.25 - - - - 149.11 36.47 13.17 - - 149.11 - 36.47 13.17 - - - 36.47 13.17 - - 48.40 160.90 0.15 0.15 48.55 161.05 48.55 161.05 48.55 161.05 126.72190.64149.13160.52 - -278.70 - 0.44 - 0.66 29.80 105.77 - - - - - 127.16307.33 - 191.30 178.93 266.29 54.09 - - - - - 127.16 278.70 191.30 - 178.93 266.29 - - - - - 127.16 - 191.30 278.70 307.33 178.93 266.29 - 54.09 - - - - 307.33 278.70 54.09 - 307.33 54.09 1,803.10 2,160.00 1,294.20 - 3,097.30 2,160.00 3,097.30 2,160.002,990.23 3,097.30 2,160.00 1,719.98 57.15 BS…B±…B±… E‰Ú ∫……l… x™……∫… E‰Ú x™……∫… ∫……l… E‰Ú BS…B±…B±… 71,015.72 50,466.87 9,475.67 19,534.04 80,491.39 70,000.91 80,491.39 70,000.91 80,491.39 70,000.91 10,116.15 9,546.83 4,788.32 927.32 14,904.47 10,474.15 14,904.47 10,474.15 14,904.47 10,474.15 2013-14 2012-13 +v…“x… {…b‰˜ x…n˘EÚ +…ËÆ˙ §…ÈEÚ ∂…‰π… §…ÈEÚ +…ËÆ˙ x…n˘EÚ {…b‰˜ +v…“x… {… Æ˙™……‰V…x……Bƒ E÷Ú±… ™……‰M… E÷Ú±… E‰ÚB∫…B∫…]ı“B®… BS…§…“B±… BB®…∫…“ ]ı“B®…∫…“ Eڅϱ…‰V… ®…‰ b˜EÚ±… EÚ…‰]¬ı]ı™…®… Eڅϱ…‰V… ®…‰ b˜EÚ±… EÚ…‰ π…EÚ…‰b˜ {……±……‰b˜ §……™……‰±…V…“ ®……<«GÚ…‰ +…Æ˙+…<«BBS…B∫… i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰ÚB∫…¥……<«b˜Œ§±…™…÷§…“, ¥…E«Ú EÚ±……, |…n˘∂…«x… E÷Ú±… <∆ b˜™…… +…Ï°Ú <∆Œ∫]ı]ı¨⁄]ı {……∫S…Æ˙ {… Æ˙™……‰V…x…… E÷Ú±… +x™… +…Ï°Ú <∆Œ∫]ı]ı¨⁄]ı +x…÷∫…∆v……x… EÂÚp˘“™… <∆ b˜™…… EÚ∫……˱…“ §…“ ∫…“ V…“ ¥…ËC∫…“x… |…™……‰M…∂……±…… 2,634.50 1,504.99 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 212 ------Total 2013-14 2012-13 - 13.17 - 278.70 -- 149.11 -- 127.16 - 191.30 178.93 266.29 - 36.47 - 9.03 LIABILITIES 9.03 Current Liabilities 2013-14 2012-13 - 13.17 - 278.70 -- 149.11 - 127.16 191.30 -- 178.93 266.29 - 36.47 - 161.05 48.55 161.05 48.55 161.05 Total 149.11 127.16 191.30 3,047.38 1,720.13 3,047.38 1,720.13 3,047.38 1,720.13 2013-14 2012-13 - 307.33 54.09 307.33 54.09 307.33 54.09 - 2,691.50 1,504.99 2,691.50 1,504.99 2,691.50 1,504.99 - 13.17 - 278.70 - - - -- 178.93 266.29 - 3,097.30 2,160.00 3,097.30 2,160.00 3,097.30 2,160.00 - 36.47 - 9.03 0.15 927.32 14,904.47 10,474.15 14,904.47 10,474.15 14,904.47 10,474.15 - - - - ASSETS 0.15 0.15 48.55 0.44 0.66 Other Current Assets Other Current 2013-14 2012-13 - - -- 50.39 - -- 29.80 105.77 - - 4.25 ANNEXURE III - Referred to in Note No. 2.15 160.90 3.17 8.72 9.03 48.40 1 9 32.22 307.33 54.09 278.70 126.72 190.64 149.13 160.52 2,990.23 1,719.98 57.15 2,634.50 1,504.99 57.00 1,803.10 2,160.00 1,294.20 Assets and Liabilities of projects under implementation as on 31st March 2014 Cash & Bank balances 71,015.72 50,466.87 9,475.67 19,534.04 80,491.39 70,000.91 80,491.39 70,000.91 80,491.39 70,000.91 10,116.15 9,546.83 4,788.32 2013-14 2012-13 held under trust with HLL Projects RIAHS KSYWB Trivandrum Performing, Arts, Vark HBL AMC TMC Kottayam Med. College Kozhikode Med. College Micro Biology Palode KSSTM TOTAL GRAND TOTAL TOTAL Others Central Research Institute of India, Kassauli Laboratory BCG Vaccine Pateur Institute of India Project Annual Report 2013-2014 213 B•…Ω…˛®… Bhb˜ V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ˙, IX/467, ®…∂…x… C¥……]Êı∫…« Æ˙…‰c˜ i…fi∂∂…⁄Æ˙ - 680001 n⁄˘Æ˙¶……π… : 0487-2423225, 2426225, °ËÚC∫… : 2424245 <«-®…‰±… : [email protected] ¥…‰§…∫……<]ı : www.abrahamandjose.com ∫¥…i…∆j… ±…‰J……{…Æ˙“I…EÚ…Â EÚ“Ú Æ˙{……‰]«ı BS…B±…B±… ±……<°ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E‰Ú ∫…n˘∫™…… EÚ…‰ ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… {…Æ˙ Æ˙{……‰]«ı Ω˛®…x…‰ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ("E∆Ú{…x…“")˜ <∫…EÚ“ ∫…®…x…÷π…∆M…“ (x……®…i…: BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ +…ËÆ˙ M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜) +…ËÆ˙ ∫…∆™…÷HÚ =t®… (x……®…i…: ±……<¢Úœ∫|…M… |……<¥…‰]ı ±… ®…]‰ıb˜), ∫……®…⁄ Ω˛EÚ ∞¸{… ∫…‰ O…⁄{… E‰Ú ∞¸{… ®… ∫…∆n˘Ã¶…i…, E‰Ú ∫…∆±…Mx… ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… EÚ“ ±…‰J……{…Æ˙“I…… EÚ“ Ω˲, V…∫…®… 31 ®……S…«, 2014 i…EÚ E‰Ú ∫…®…‰ EÚi… i…÷±…x… {…j…, +…ËÆ ∫…®……{i… =∫… ¥…π…« E‰Ú ∫…®…‰ EÚi… x…EÚn˘“ |…¥……Ω˛ ¥…¥…Æ˙h… +…ËÆ˙ ±……¶… B¥…∆ Ω˛… x… E‰Ú ¥…¥…Æ˙h… +…ËÆ˙ ∫……l…«EÚ ±…‰J……{…Æ˙“I…… x…“ i…™…… B¥…∆ +x™… ¥™……J™……i®…EÚ ∫…⁄S…x…… EÚ… ∫……Æ˙…∆∂… ∫…®…… ¥…π]ı Ω˲* ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ±…B |…§…∆v…x… =k…Æ˙n˘… ™…i¥… |…§…∆v…x… +±…M… ¥…k…“™… ¥…¥…Æ˙h… +…ËÆ˙ ∫…∆P…]ıEÚ…Â E‰Ú ∫…∆§…∆v… +x™… ¥…k…“™… ∫…⁄S…x……+… E‰Ú +…v……Æ˙ {…Æ˙ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 214 ABRAHAM & JOSE CHARTERED ACCOUNTANTS IX/467, MISSION QUARTERS ROAD, THRISSUR-680001 PHONE : 0487-2423225, 2426225 FAX : 2424245 E-mail : [email protected] Website: www.abrahamandjose.com INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF HLL LIFECARE LIMITED REPORT ON THE CONSOLIDATED FINANCIAL STATEMENTS We have audited the accompanying Consolidated Financial Statements of HLL LIFECARE LIMITED (the "Company "), its Subsidiaries (viz., HLL Biotech Ltd., and Goa Antiblotics and Pharmaceuticals Ltd) and Joint Venture (Viz., Lifespring Hospitals Pvt. Ltd.,), collectively referred to as the "Group", which comprise the Consolidated Balance Sheet as at March 31, 2014, and the Consolidatd Statement of Profit and Loss and the Consolidated Cash Flow Statement for the year then ended and a summary of significant accounting policies and other explanatory information. MANAGEMENT'S RESPONSIBILITY FOR THE CONSOLIDATION OF THE FINANCIAL STATEMENTS. Management is responsible for the preparation of these Consolidated Financial Statements on the basis of separate financial statements and other financial information regarding components that give a true and fair view of the consolidated financial position, consolidated financial performance and consolidated cash flows of the Group in accordance with accounting principles generally accepted in India; this included the design, implementation and maintenance of internal control relevant to preparation and presentation of the Consolidated Financial Statements that give a true and fair view and are free from material misstatement, whether due to fraud or error. AUDITOR'S RESPONSIBILITY (a) Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered Accountants of India. Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material missstatement. (b) An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditor's judgement, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Company's preparation and presentation of the consolidated financial statements that give a true and fair view in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. An Audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of the accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified audit opinion. Annual Report 2013-2014 215 {… Æ˙ ®…i… ¥…S……Æ˙… EÚ… +…v……Æ˙ ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h…… EÚ“ ]ı{{…h…“ı x…∆ ∫…“. 8 ®… ¥™……J™…… n˘B V…Ë∫…‰ M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ BEÚ ∫…®…x…÷π…∆M…“ E∆Ú{…x…“ x…‰ ¥…π…« E‰Ú n˘…ËÆ˙…x… BB∫…-15 , EÚ®…«S……Æ˙“ Ω˛i…±……¶… E‰Ú ±…B ±…‰J……∆EÚx… u˘…Æ˙… +{…‰ I…i… V…Ë∫…‰ EÚ…‰<« ¶…“ §…“®……∆ EÚEÚ ®…⁄±™……∆EÚx… EÚ… {……±…x… x…Ω˛” EÚ™…… Ω˲* E∆Ú{…x…“ u˘…Æ˙… i…Ë™……Æ˙ EÚB |… i…EÚÆ˙ U÷Ù^ı“ +x…÷{…Œ∫l… i… ¥…¥…Æ˙h… E‰Ú +x…÷∫……Æ˙ +…ËÆ˙ V…“¥…x… §…“®…… x…M…®… ∫…‰ |…®……h… {…j… E‰Ú +…v…˘…Æ˙ {…Æ˙ ={…n˘…x… x… v… ®… EÚ®…“, ™…Ω˛…ƒ GÚ®…∂…: `160.37 ±……J… +…ËÆ˙ `122.90 ±……J… E‰Ú EÚ®… |……¥…v……x… Ω˲* i…n˘x…÷∫……Æ˙, ¥…π…« E‰Ú ±…B x…¥…±… ±……¶… `283.27±……J… ∫…‰ + v…EÚ Ω˲ +…ËÆ˙ ∫…‰¥…… x…¥…fi k… Ω˛i…±……¶… E‰Ú ±…B |……¥…v……x… `283.27 ±……J… ∫…‰ EÚ®… Ω˲* Ω˛®… ¥…∑……∫… EÚÆ˙i…‰ ΩÈ EÚ Ω˛®… |……{i… ±…‰J……{…Æ˙“I…… |…®……h… Ω˛®……Æ˙“ ±…‰J……{…Æ˙“I…… Æ˙…™… E‰Ú +∫¥…“EÚÆ˙h… BEÚ +…v……Æ˙ n‰˘x…‰ EÚ…‰ {…™……«{i… B¥…∆ = S…i… Ω˲*˛ +∫¥…“EÚÆ˙h… ¥…S……Æ˙… EÚ… +…v……Æ˙ M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb,˜ BEÚ ∫…®…x…÷π…∆M…“ E‰Ú ®……®…±…‰ ®…Â, {…™……«{i… = S…i… ±…‰J…… {…Æ˙“I…… ∫……I™… E‰Ú +¶……¥… ®…Â, x…®x… ±… J…i… ®……®…±…… E‰Ú ∫…∆§…∆v… ®… EÚ…‰<« ¶…“ ∫…®……™……‰V…x… +…¥…∂™…EÚ EÚ™…… M…™…… Ω˲ i……‰ ™…Ω˛ x…v……« Æ˙i… EÚÆ˙x…‰ ®… +∫…®…l…« l……: EÚ. §…EÚ…™…… E‰Ú O……Ω˛EÚ ¥……Æ˙ ¥…∂±…‰π…h… E‰Ú ∫……l… BEÚ +…™…÷ ¥……Æ ¥…∂±…‰π…h… Æ˙{……‰]«ı E‰Ú +¶……¥… ®… §…EÚ…™…… |……Œ{i…™…… EÚ“ +…‰Æ˙ §…x……B Æ˙J…‰ |……¥…v……x…… EÚ“ {…™……«{i…i……* J…. ]ı{{…h…“ ∫…∆ ∫…“. 13 ®… |… i…{…… n˘i… V…Ë∫…‰ E÷ÚUÙ ™…⁄ x…]ı… E‰Ú ∫…∆§…∆v… ®… E∆Ú{…x…“ u˘…Æ˙… {……±…x… EÚ™…‰ +{…™……«{i… +…∆i… Æ˙EÚ x…™…∆j…h… B¥…∆ ±…‰J…… |… GÚ™…… +…ËÆ˙ ı∫…®…x…÷π…∆M…“ E‰Ú ∫……∆ ¥… v…EÚ ±…‰J……{…Æ˙“I…EÚ…‰∆ u˘…Æ˙… x…Æ˙“I…h… x…Ω˛” EÚB EÚ i…{…™… ™…⁄ x…]ı… ∫…‰ |……{i… = S…i… Æ˙EÚ…b«˜ +…ËÆ˙ n˘∫i……¥…‰V…… EÚ“ +™……‰M™…i……* M…. ]ı{{…h…“ ∫…∆. ∫…“. 14 ®… |… i…{…… n˘i… V…Ë∫…‰ +x…÷®…… x…i… n‰˘™…i…… E‰Ú ±…B Ú E∆Ú{…x…“ u˘…Æ˙… ¥… x…î…i… =i{……n˘… E‰Ú ¥… ¶…z… ∏…‰ h…™…… E‰Ú ∫…∆§…∆v… ®… M……Æ∆˙]ı“/¥……Æ∆˙]ı“ n˘…¥…… EÚ“ +…‰Æ˙ ¥™…™… n‰˘x…‰ E‰Ú ±…B +{…‰ I…i… |……¥…v……x…˛, +…<«∫…“B+…<« u˘…Æ˙… V……Æ˙“ EÚB |……∫…∆ M…EÚ n‰˘™…i……B∆ +…ËÆ˙ |……∫…∆ M…EÚ {… Æ˙∫…∆{… k…™……‰∆ {…Æ˙ BB∫… - 29 E‰Ú +x…÷∫……Æ˙ +{…‰ I…i… V…Ë∫…‰ x…Ω˛” EÚ™…… M…™…… Ω˲* ˙Æ˙…™… Ω˛®… Æ˙{……‰]«ı EÚÆ˙i…‰ Ω∆˲ EÚ ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… ¶……Æ˙i… E‰Ú ∫…x…n˘“ ±…‰J……EÚ…Æ˙ E‰Ú ∫…∆∫l……x… u˘…Æ˙… V……Æ˙“ EÚB M…B ∫…∆™…÷HÚ =t®… ®… ¥…k…“™… Æ˙{……‰Õ]ıM… EÚ“ ±…‰J…… ®……x…EÚ (BB∫…) - 21 ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… +…ËÆ˙ ±…‰J…… ®……x…EÚ (BB∫… 27) Ω˛i… E‰Ú ¥…k…“™… Æ˙{……‰Õ]ıM… EÚ“ +{…‰I……+… +…ËÆ˙ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜, +{…x…‰ ∫…®…x…÷π…∆M…“ +…ËÆ˙ ∫…∆™…÷HÚ =t®… E‰Ú +±…M… ±…‰J…… {…Æ˙“ I…i… ¥…k…“™… ¥…¥…Æ˙h… E‰Ú +…v……Æ˙ {…Æ˙ i…Ë™……Æ˙ EÚB M…™…‰ ΩÈ˛* Ω˛®……Æ˙“ Æ˙…™… ®… i…l…… Ω˛®……Æ˙“ =k…®… V……x…EÚ…Æ˙“ B¥…∆ Ω˛®… n˘B M…B ∫{…π]ı“EÚÆ˙h… E‰Ú +x…÷∫……Æ˙ +…ËÆ˙ ∫…®…x…÷π…∆ M…™…… +…ËÆ˙ ∫…∆™…÷HÚ =t®… E‰Ú ¥…k…“™… ¥…¥…Æ˙h… {…Æ˙ +x™… ±…‰J…… {…Æ˙“I…EÚ…Â E‰Ú Æ˙{……‰]…‰∆« {…Æ˙ ¥…S……Æ˙ EÚÆ˙x……, x…“S…‰ n˘™…‰ M…™…‰ {…ËÆ˙… ""+x™… ®……®…±……Â"" ®… =Œ±±… J…i… V…Ë∫…‰ , {… Æ˙ ®…i… ¥…S……Æ˙ {…ËÆ˙… E‰Ú ±…B +…v……Æ˙ ®… ¥…Ãh…i… <∫… ®……®…±…‰ E‰Ú |…¶……¥… +…ËÆ˙ Æ˙…™… {…ËÆ˙… E‰Ú +∫¥…“EÚÆ˙h… EÚ…‰ UÙ…‰b˜EÚÆ˙, ¥…k…“™… ¥…¥…Æ˙h… +{…‰ I…i… i…Æ˙“E‰Ú ®… + v… x…™…®… u˘…Æ˙… +{…‰ I…i… ∫…⁄S…x…… n‰˘i…… Ω˲ +…ËÆ˙ ¶……Æ˙i… ®… ∫……®……x™… ∞¸{… ∫…‰ ∫¥…“EfiÚi… ±…‰J…… i…i¥…… E‰Ú +x…÷∞¸{… ∫…Ω˛“ B¥…∆ ∫{…π]ı o˘Œπ]ı n‰˘i…… Ω˲* i) 31 ®……S…« 2014 EÚ…‰ O…⁄{… EÚ…™……Á EÚ“ Œ∫l… i… E‰ÚÚ ∫…®…‰ EÚi… i…÷±…x… {…j… E‰Ú ®……®…±…‰ ®…Â, ii) =∫…“ i……Æ˙“J… {…Æ˙ ∫…®……{i… ¥…π…« E‰Ú ±…B ±……¶… B¥…∆ Ω˛… x… ±…‰J……, ±……¶… E‰Ú ∫…®…‰ EÚi… ¥…¥…Æ˙h… E‰Ú ®……®…±…‰ ®… ; +…ËÆ˙ iii) =∫… i……Æ˙“J… {…Æ˙ ∫…®……{i… ¥…π…« E‰Ú ±…B x…EÚn˘“ |…¥……Ω˛ E‰Ú ∫…®…‰ EÚi… x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… E‰Ú ®……®…±…‰ ®… * ®……®…±…‰ EÚ… W……‰Æ˙ n˘x……∆EÚ 05 V…÷±……<«, 2014 E‰Ú Ω˛®……Æ˙“ ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı E‰Ú §……n˘, x…™…∆j…EÚ +…ËÆ˙ ®…Ω˛… ±…‰J……{…Æ˙“I…EÚ E‰Ú +¥…±……‰EÚx… E‰Ú +x…÷∫……Æ˙, x…®x… ±… J…i… EÚ…‰ ∫…n˘∫™…… E‰Ú v™……x… +…®…∆ j…i… EÚÆ˙i…‰ ΩÈ˛: Ø˚.809.05 ±……J… ∫… Ω˛i… 31 ®……S…«, 2013 i…EÚ E‰Ú +±{…EÚ… ±…EÚ =v……Æ˙ +…ËÆ˙ {…‰∂… M…™……ƒ, V…∫…®… ∫…‰ Ø˚.307.00 ±……J… ¥…π…« 2013- 14 E‰Ú n˘…ËÆ˙…x… ∫…®……Ω˛ Æ˙i… EÚ™…… M…™…… Ω˲* 31.03.2014 i…EÚ E‰Ú Ø˚. 502.05 ±……J… EÚ“ ∂…‰π… §…EÚ…™…… Æ˙EÚ®… +|… i…¶…⁄i… +…ËÆ˙ ±…∆§…“ ∫…®…™… ∫…‰ ±…∆ §…i… ΩË V…∫…E‰Ú ±…B EÚ…‰<« |……¥…v……x… x…Ω˛” §…x……™…… M…™…… Ω˲, <∫… o˘Œπ]ı ∫…‰, n˘x……∆EÚ 05 V…÷±……<«, 2014 E‰Ú Ω˛®……Æ˙“ ±…‰J……{…Æ˙“I…… Æ˙{……‰]«ı˛ EÚ… ∫…∆∂……‰v…x… EÚ™…… M…™……* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 216 BASIS FOR QUALIFIED OPINION As explained in Note No. C-8 to the Consolidated Financial Statements, Goa Antibiotics and Pharmaceuticals Ltd., a subsidiary company, has not carried out any actuarial valuation as required by AS-15. Accounting for Employee Benefits, during the year. As per compensated leave absences statement prepared by the company and deficit in gratuity fund based on certificate from Life Insurance Corporation, there is a short provision of `160.37 lacs and `122.90 Lacs respectively. Accordingly, net profit for the year is higher by `283.27 Lacs and Provision for retirement benefits is lower by ` 283.27 Lacs. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our disclaimer of audit opinion. BASIS FOR DISCLAIMER OPINION In the case of Goa Antibiotics and Pharmaceuticals Ltd., a subsidiary, due to the absence of sufficient appropriate audit evidence, it was unable to determine whether any adjustments might have been necessary on the accounts in respect of the following cases: a. Adequacy of provision maintained against outstanding receivables in the absence of an age wise analysis report with customer wise analysis of outstanding; b. Inadequate internal controls and accounting procedures followed by the company in respect of certain unit as stated in Note No. C.13 and inability to obtain proper records and documents from certain units not visited by the statutory auditors of the subsidiary; c. As stated in Note No. C.14 provision for estimated liability that may be required to honour expenditure towards guarantee/warranty claims in respect of various classes of products manufactured by the company has not been made as required as per AS-29 on Provisions, Contingent Liabilities and Contingent Assets issued by ICAI. OPINION We report that the Consolidated Financial Statements have been prepared by the Company's management in accordance with the requirements of the AS 21- "Consolidated Financial Statements" and AS 27 - Financial reporting of interest in Joint Venture, issued by the Institute of Chartered Accountants of India and on the basis of the separate audited financial statements of HLL Lifecare Ltd., its subsidiaries and joint venture. In our opinion and to the best of our information and according to the explanations given to us and based on consideration of the reports of the other auditors on the financial statements of the subsidiaries and Joint Venture, as mentioned in the 'other matters' paragraph below, except for the effects of the matter described in the Basis for Qualified Opinion paragraph and Disclaimer of Opinion paragraph, the consolidated financial statements give the information required by the Act in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in india: (i) In the case of the Consolidated Balance Sheet, of the state of affairs of the Group as at March 31st, 2014; (ii) In the case of Consolidated Statement of Profit and Loss, of the profit for the year ended on that date; and (iii) In the case of consolidated Cash Flow Statement, of the cash flows for the year ended on that date. EMPHASIS OF MATTER Subsequent to our Audit Report dated 05th July, 2014, as per the observation of C&AG, who invite attention of the members to the following: Short term loans and advances as on 31st March, 2013 included `809.05 lakhs, out of which `307.00 lakhs has been collected during the year 2013-14. Balance outstanding amounting to `502.05 lakhs as on 31.03.2014 is unsecured and long pending for which no provision has been made, in view of the same, our audit report dated 5th July 2014 has been revised. Annual Report 2013-2014 217 +x™… ®……®…±…… Ω˛®… x…‰ n˘…‰ ∫…®…x…÷π…∆M…“ E‰Ú ¥…k…“™… ¥…¥…Æ˙h… ±…‰J……{…Æ˙“ I…i… x…Ω˛” EÚ™…… l……, V…∫…EÚ… ¥…k…“™… ¥…¥…Æ˙h… 31 ®……S…«, 2014 EÚ…‰ `17,944.80 ±……J… EÚ“ E÷Ú±… {… Æ˙∫…∆{… k… ( x…¥…±…)˛, `4059.31 ±……J… EÚ“ E÷Ú±… Æ˙…V…∫¥… +…ËÆ˙ =∫…“ i……Æ˙“J… ®… ∫…®……{i… ¥…π…« E‰Ú ±…B `877.27 ±……J… Æ˙… ∂… E‰Ú x…¥…±… x…EÚn˘ |…¥……Ω n∂……«i…… Ω˲* Ω˛®… x…‰ ∫…∆™…÷HÚ =t®… E‰Ú ¥…k…“™… ¥…¥…Æ˙h… ±…‰J……{…Æ˙“ I…i… x…Ω˛” EÚ™…… l……, V…∫…EÚ… ¥…k…“™… ¥…¥…Æ˙h… 31 ®……S…«, 2014 EÚ…‰ `(-) 98.61 ±……J… EÚ“ E÷Ú±… {… Æ˙∫…∆{… k… ( x…¥…±…)˛, `1184.84 ±……J… EÚ“ ∫…EÚ±… Æ˙…V…∫¥… +…ËÆ˙ =∫…“ i……Æ˙“J… ®… ∫…®……{i… ¥…π…« E‰Ú ±…B `30.13 ±……J… Æ˙… ∂… E‰Ú x…¥…±… x…EÚn˘ |…¥……Ω n∂……«i…… Ω˲, ™…Ω˛ ¶…“ ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… ®… ∂…… ®…±… EÚ™…… M…™…… * ™…‰ ¥…k…“™… ¥…¥…Æ˙h… n⁄˘∫…Ɖ˙ ±…‰J……{…Æ˙“I…EÚ u˘…Æ˙… ±…‰J……{…Æ˙“I…… EÚ“ M…™…“ Ω˲, V…∫…EÚ“ Æ˙{……‰]«ı |…§…∆v…x… u˘…Æ˙… Ω˛®…EÚ…‰‰ |…∫i…÷i… EÚ“ M…™…“ Ω˲, +…ËÆ˙ Ω˛®……Æ˙“‰˙ Æ˙…™… E‰Ú¥…±… n⁄˘∫…Ɖ˙ ±…‰J……{…Æ˙“I…EÚ EÚ“ Æ˙{……‰]ı…Á {…Æ˙ Ω˲* EfiÚi…‰ B•…Ω˛…˛®… Bhb˜ V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ˙ B°Ú.+…Æ˙ x…∆. 000010B∫… V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙˙x… ∫……Z…‰n˘…Æ˙ ∫…n˘∫™… ∫…∆. 012056 ∫l……x… : i…Ø˚¥…x…∆i…{…÷Æ˙®… n˘x……∆EÚ : 04.08.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 218 OTHER MATTERS We did not audit the financial statement of two subsidiaries whose financial statements reflects total assets (net) of `17,944.80 Lacs as on 31st March 2014, total revenue of `4059.31 lacs and net cash outflows aggregating to `877.27 Lacs for the period then ended on that date. We also did not audit the financial statement of the Joint Venture whose financial statements reflects total assets (net) of `(-)98.61 lacs as at 31st March 2014, gross revenue of `1184.84 lacs and net cash inflow amounting to `30.13 lacs for the then year then ended on that date are also included in the Consolidated Financial Statements. These financial statements have been audited by other auditors, whose report has been furnished to us by the management and our opinion are solely on the reports of the other auditors. For Abraham & Jose Chartered Accountants (FRN: 000010S) Jose Pottokaran Place : Thrissur Partner, M.No. 012056 Date : 04-08-12014 Annual Report 2013-2014 219 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ∫…®…‰ EÚi… i…÷±…x…-{…j… ¥…¥…Æ˙h… ]ı{{…h…“ ∫…∆ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ``` ±……J…… ®… EÚ <ŒC¥…]ı“ +…ËÆ˙ n‰˘™…i……B∆ ∫…®……{i… 1 +∆∂…v…… Æ˙™…… EÚ“ x… v… (EÚ) ∂…‰™…Æ˙ {…⁄ƒV…“ 3 19,353.50 19,353.50 (J…) +…Æ˙ I…i… i…l…… + v…∂…‰π… 4 19,875.08 17,751.86 39,228.58 37.105.36 2 +±{…∫…∆J™…EÚ §™……V… 40.30 - 3 M…ËÆ˙-S……±…⁄ n‰˘™…i……B∆ (EÚ) ±…∆§…“ +¥… v… E‰Ú @Òh… 5 8,787,37 5,528.79 (J…) +…∫l… M…i… EÚÆ˙ n‰˘™…i…… ( x…¥…±…) 23 1,301.00 1,007.85 10,088.37 6,536.64 4 S……±…⁄ n‰˘™…i……Bƒ (EÚ) +±{…EÚ… ±…EÚ @Òh… 6 33,779.24 23,513.56 (J…) ¥™……{……Æ˙ n‰˘™… 7 11,488.50 9,319.78 (M…) +x™… S……±…⁄ n‰˘™…i……B∆ 8 18,253.53 25,289.69 (P…) +±{…EÚ… ±…EÚ |……¥…v……x… 9 1,442.14 1,765.87 64,963.41 59,888.90 5 EÚ…Ïx]≈ı… E‰Ú +x…÷∫……Æ˙ x™……∫… E‰Ú +v…“x… {…b˜“ {… Æ˙™……‰V…x……+… E‰Ú ±…B {…‰∂… M…™……ƒ 71,015.72 50,466.87 E÷Ú±… 1,85,336.38 1,53,997.77 J… {… Æ˙∫…∆{… k…™……ƒ - - 1. M…ËÆ˙-S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ - - (¬EÚ) +S…±… {… Æ˙∫…∆{… k…™……ƒ - - (i) ®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 10.EÚ 18,694.07 16,959.24 (ii) +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 10.J… 898.91 822.05 (iii) S……±…⁄ {…⁄ƒV…“ EÚ…™…« 10.M… 9,060.07 4,954.97 (iv) ¥…EÚ…∫……v…“x… +®…⁄i…« ∫…∆{… k…™……ƒ 310.48 131.71 (v) ∫…n¬˘¶……¥…x…… {…Æ˙ ∫…®…‰EÚx… 601.93 29,565.46 22,867.97 (J…) M…ËÆ˙-S……±…⁄ x…¥…‰∂… 11 2.25 2.00 (M…) n˘“P…«EÚ… ±…EÚ @Òh… +…ËÆ˙ {…‰∂… M…™……ƒ 11.EÚ 2,190.14 2,282.56 (RÛ) +x™… M…ËÆ˙-S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ 11.J… 567.57 531.52 +…∫l… M…i… EÚÆ˙ {… Æ˙∫…∆{… k…™……ƒ 2 S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (EÚ) ¥…∫i…÷∫…⁄S…“ 12 11,853.46 10,517.91 (J…) |……{™… ¥™……{……Æ˙ 13 44,526.61 41,478.95 (M…) x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™… 14 14,849.73 15,069.01 (P…) +±{…EÚ… ±…EÚ @Òh… +…ËÆ˙ {…‰∂… M…™……ƒ 15 10,260.02 8,625.68 (RÛ) +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ 16 505.42 2,155.30 81,995.24 77,846.85 3 EÚ…Ïx]≈ı… E‰Ú +x…÷∫……Æ˙ x™……∫… E‰Ú +v…“x… {…b˜“ {… Æ˙™……‰V…x……+… E‰Ú ±…B {…‰∂… M…™……ƒ 71,015.72 50,466.87 E÷Ú±… 1,85,336.38 1,53,997.77 ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ¶……M… §…x…x…‰¥……±…‰ ∫…∆±…Mx… ]ı{{…h…“ n‰˘J…Â* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ |…§…∆v… x…n‰˘∂…EÚ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 220 CONSOLIDATED BALANCE SHEET AS AT 31st MARCH 2014 Particulars Note No AS AT AS AT 31.03.2014 31.03.2013 (` lacs) (` lacs) A. EQUITY AND LIABILITIES 1. Shareholders' funds (a) Share Capital 3 19,353.50 19,353.50 (b) Reserves and Surplus 4 19,875.08 17,751.86 39,228.58 37,105.36 2. Minority Interest 40.30 - 3. Non-current liabilities (a) Long-term borrowings 5 8,787.37 5,528.79 (b) Deferred tax liabilites (net) 23 1,301.00 1,007.85 10,088.37 6,536.64 4. Current liabilities (a) Short-term borrowings 6 33,779.24 23,513.56 (b) Trade payables 7 11,488.50 9,319.78 (c) Other current liabilities 8 18,253.53 25,289.69 (d) Short-term provisions 9 1,442.14 1,765.87 64,963.41 59,888.90 5. Advances Received for Projects held under Trust as per contra 71,015.72 50,466.87 TOTAL 1,85,336.38 1,53,997.77 B. ASSETS 1. Non-current assets (a) Fixed assets i) Tangible assets 10.A 18,694.07 16,959.24 ii) Intangible assets 10.B 898.91 822.05 iii) Capital work-in-progress 10.C 9,060.07 4,954.97 iv) Intangible asset under development 310.48 131.71 v) Goodwill on consolidation 601.93 - 29,565.46 22,867.97 (b) Non-current investments 11 2.25 2.00 (c) Long Term Loans and Advances 11A 2,190.14 2,282.56 (c) Other Non-Current assets deferred tax asset 11.B 567.57 531.52 2. Current assets (a) Inventories 12 11,853.46 10,517.91 (b) Trade receivables 13 44,526.61 41,478.95 (c) Cash and cash equivalents 14 14,849.73 15,069.01 (d) Short-term loans and advances 15 10,260.02 8,625.68 (e) Other current assets 16 505.42 2,155.30 81,995.24 77,846.85 3. Cash and Bank balances of Projects held under Trust as per contra 71,015.72 50,466.87 TOTAL 1,85,336.38 1,53,997.77 See accompanying notes forming part of the financial statements For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 219221 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« EÚ… ∫…®…‰ EÚi… ±……¶… +…ËÆ˙ Ω˛… x… ±…‰J…… ¥…¥…Æ˙h… ]ı{{…h…“ ∫…∆. 31.03.2014 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«EÚ…‰ ∫…®……{i… ¥…π…« (`(`(` ±……J…… ®…Â) (`(`(` ±……J…… ®…Â) 1. |…S……±…x… ∫…‰ Æ˙…V…∫¥… (∫…EÚ±…) 17 95,421.01 83,963.16 x™…⁄x… : =i{……n˘ ∂…÷±EÚ 563.04 272.31 |…S……±…x… ∫…‰ Æ˙…V…∫¥… ( x…¥…±…) 94,857.97 83,690.85 2. +x™… +…™… 18 1,189.49 706.55 3. E÷Ú±… Æ˙…V…∫¥… (1+ 2) 96,047.46 84,397.40 4. ¥™…™… : EÚ) |…™…÷HÚ ∫……®…O…“ EÚ“ ±……M…i… 19.EÚ 19.482.63 19,064.57 J…) ®……±… ¶…∆b˜…Æ˙ EÚ… GÚ™… 19.J… 15,653.75 18,365.52 M…) i…Ë™……Æ˙ ®……±…, EÚ…™…« |…M… i… +…ËÆ˙ ®……±… ¶…∆b˜…Æ˙ E‰Ú ¥…∫i…÷ {… Æ˙¥…i…«x… 19.M… (898.31) (2,769.18) P…) EÚ®…«S……Æ˙“ °Ú…™…n˘… J…S…« 20 13,829.61 12,700.87 RÛ) ¥…k… ±……M…i… 21 1,799.57 1,347.82 S…) ®…⁄±™…ø…∫… +…ËÆ˙ {… Æ˙∂……‰v…x… ¥™…™… 2,412.44 2,119.34 UÙ) +x™… J…S…« 22 25,963.20 21,367.59 V…) `‰ˆEÚ… J…S…« 14,177.14 8,422.22 5. E÷Ú±… J…S…« 92,420.03 80,618.75 6. ¥… ∂…π]ı +…ËÆ˙ +∫……v……Æ˙h… ®…n˘ +…ËÆ˙ EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (6-7) 3,627.43 3,778.64 7. ¥…∂…‰π… ®…n¢ (1.15) - 8. ¥…∂…‰π… ®…n¢ +…ËÆ˙ EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (6-7) 3,628.58 3,778.64 9. +∫……v……Æ˙h… ®…n˘ 0.87 - 10. EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (8-9) 3,627.71 3,778.64 11. EÚÆ˙ ¥™…™… EÚ) S……±…⁄ ¥…π…« E‰Ú ±…B S……±…⁄ EÚÆ˙ ¥™…™… 783.29 791.83 J…) {…⁄¥…« ¥…π……Á ∫…‰ ∫…∆§…∆ v…i… S……±…⁄ EÚÆ˙ ¥™…™… (1.76) (214.51) M…) B®… B ]ı“ G‰Ú b˜]ı {……j…i…… (25.83) (419.00) P…) +…∫l… M…i… EÚÆ˙ 293.14 616.08 1,048.84 774.40 12. ∫…i…i… |…S……±…x… EÚ“ +¥… v… ∫…‰ ¥…π…« E‰Ú ±…B ±……¶…/(Ω˛… x…) 2,578.87 3,004.24 13. ∫…®……{i… Ω˛…‰ Æ˙Ω‰˛ |…S……±…x… ∫…‰ ±……¶…/(Ω˛… x…) (6-7) - - 14. x…¥…±… +…™… EÚÆ˙ +±{…∫…∆J™…EÚ §™……V… 2.77 - 15. ±……¶…/(Ω˛… x…) 2,576.10 3,004.24 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 222 CONSOLIDATED STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED 31ST MARCH 2014 Particulars Note No Year Ended Year Ended 31.3.2014 31.3. 2013 (` lacs) (` lacs) 1. Revenue from operations (gross) 17 95,421.01 83,963.16 Less: Excise duty 563.04 272.31 Revenue from operations (net) 94,857.97 83,690.85 2. Other income 18 1,189.49 706.55 3. Total revenue (1+2) 96,047.46 84,397.40 4. Expenses (a) Cost of materials consumed 19.A 19,482.63 19,064.57 (b) Purchases of stock-in-trade 19.B 15,653.75 18,365.52 (c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 19.C (898.31) (2,769.18) (d) Employee benefits expense 20 13,829.61 12,700.87 (e) Finance costs 21 1,799.57 1,347.82 (f) Depreciation and amortisation expense 2,412.44 2,119.34 (g) other expenses 22 25,963.20 21,367.59 (h) Contract Expenses 14,177.14 8,422.22 5. Total expenses 92.420.33 80.618.75 6. Profit/(Loss) before Exceptional and extra ordinary items and tax (3-5) 3,627.43 3,778.64 7. Exceptional items (1.15) - 8. Profit/(Loss) before extra ordinary items and tax (6-7) 3,628.58 3,778.64 9. Extra-ordinary item 0.87 - 10. Profit/(Loss) before tax (8-9) 3,627.71 3,778.64 11. Tax expense : (a) Current tax expense for current year 783.29 791.83 (b) Current tax expense relating to prior years (1.76) (214.51) (c) MAT Credit Entitlement (25.83) (419.00) (d) Deferred tax 293.14 616.08 1,048.84 774.40 12. Profit/ (Loss) for the period from continuing operations 2,578.87 3,004.24 13. Profit/ (Loss) from discontinuing operations (6-7) - - 14. Minority Interest on Net Income 2.77 - 15. Profit/(Loss) 2,576.10 3,004.24 Annual Report 2013-2014 223 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« EÚ… ∫…®…‰ EÚi… ±……¶…-Ω˛… x… ¥…¥…Æ˙h… (V……Æ˙“) 31.03.2014 31.03.2013 ¥…¥…Æ˙h… ]ı{{…h…“ ∫…∆. EÚ…‰ ∫…®……{i… ¥…π…«EÚ…‰ ∫…®……{i… ¥…π…« (`(`(` ±……J…… ®…Â) (`(`(` ±……J…… ®…Â) 8.i. |… i… ∂…‰™…Æ˙ +…™… (EÚ) ®…⁄±… (i) ∫…i…i… |…S……±…x… 155.23 (ii)E÷Ú±… |…S……±…x… 133.11 155.23 (J…)Ω˛±EÚ… (i) ∫…i…i… |…S……±…x… 155.23 (ii)E÷Ú±… |…S……±…x… 133.11 155.23 8.ii. |… i… ∂…‰™…Æ˙ +V…«x… (+∫……v……Æ˙h… ®…n˘… EÚ…‰ UÙ…‰b˜EÚÆ˙) (EÚ) ®…⁄±… (i) ∫…i…i… |…S……±…x… 155.23 (ii)E÷Ú±… |…S……±…x… 133.11 155.23 (J…) Ω˛±EÚ… (i) ∫…i…i… |…S……±…x… 155.23 (ii)E÷Ú±… |…S……±…x… 133.11 155.23 ¥… k…™… ¥…¥…Æ˙h… E‰Ú ¶……M… §…x…x…‰¥……±…‰ ∫…∆±…Mx… ]ı{{…h…“ n‰˘J…Â* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 224 CONSOLIDATED STATEMENT OF PROFIT AND LOSS FOR THE YEAR ENDED 31 MARCH, 2014 (CONTD.) Year Ended Year Ended Particulars Note No 31.3. 2014 31.3.2013 (in ` ) (in `) 8.i Earnings per share (a) Basic (i) Continuing operations 155.23 (ii) Total operations 133.11 155.23 (b) Diluted (i) Continuing operations 155.23 (ii) Total operations 133.11 155.23 8.ii Earnings per share (excluding extraordinary items) (a) Basic (i) Continuing operations 155.23 (ii) Total operations 133.11 155.23 (b) Diluted (i) Continuing operations 155.23 (ii) Total operations 133.11 155.23 See accompanying notes forming part of the financial statements For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 225 31.03.2014 EÚ…‰ ∫…®……{i… ∫…®…‰ EÚi… x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ (`(`(` ±……J…… ®…Â) (`(`(` ±……J…… ®…Â) (EÚ) |…S……±…x… EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ +∫……v……Æ˙h… ®…n¢˘ +…ËÆ˙ EÚÆ˙ +…ËÆ˙ +±{…∫…∆J™…EÚ §™……V… E‰Ú {…⁄¥…« ±……¶… 3,623.79 3,778.64 ∫…®……™……‰V…x… : ®…⁄±™…ø…∫… +…ËÆ˙ {… Æ˙∂……‰v…x… 2,412.44 2,119.34 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ {…Æ˙ Ω˛… x… 2.70 2.08 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ {…Æ˙ ±……¶… (22.54) (0.51) ¥…k… ±……M…i… 1,799.57 1,347.82 |……Æ∆˙ ¶…EÚ ¥™…™… - 1.16 §™……V… +…™… (312.88) (369.19) S……±…⁄ {…⁄ƒV…“ {… Æ˙¥…i…«x… E‰Ú {…⁄¥…« |…S……±…x… ±……¶…/(Ω˛… x…) 7,503.08 6,852.34 S……±…⁄ {…⁄ƒV…“ ®… {… Æ˙¥…i…«x… : |…S……±…x… {… Æ˙∫…∆{… k…™…… ®… (¥…fi r˘)/EÚ®…“ E‰Ú ±…B ∫…®……™……‰V…x… - - ¥…∫i…÷∫…⁄S…“ (1,335.55) (3,083.09) |……{™… ¥…∫i…÷+… EÚ… ¥™……{……Æ˙ (3,047.66) (16,297.30) +±{……¥… v…Ú @Òh… B¥…∆ {…‰∂… M…™……ƒ (1,200.47) (1,767.17) n˘˘“P……«¥… v…Ú @Òh… B¥…∆ {…‰∂… M…™……ƒ 92.42 (2,227.83) +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ 1.649.88 (867.43) |…S……±…x… n‰˘™…i……+… ®… ¥…fi r˘/(EÚ®…“) E‰Ú ±…B ∫…®……™……‰V…x… n‰˘™… ¥™……{……Æ˙ 2,168.72 1,251.86 +x™… S……±…⁄ n‰˘™…i……Bƒ (7,036.16) 11,688.02 +±{……¥… v… |……¥…v……x… (323.72) 408.21 (1,529.46) (4,042.39) +∫……v……Æ˙h… ®…n˘… ∫…‰ x…EÚn˘ |…¥……Ω˛ 1.15 - |…S……±…x… ∫…‰ =i{…z… Æ˙…‰EÚc˜ (1,528.31) (4,042.39) x…¥…±… +…™… EÚÆ˙(|…n˘k…)/¥……{…∫…“ (1,215.42) (1,049.27) |…S……±…x… EÚ…™…«EÚ±……{…… ∫…‰ (|…™…÷HÚ) x…¥…±… x…EÚn˘ |…¥……Ω (EÚ) (2,743.73) (5,091.66) J…. x…¥…‰∂…“ EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ S……±…⁄ {…⁄ƒV…“ EÚ…™…« ®… |…M… i… (4,105.10) (2,024.27) +S…±… {… Æ˙∫…∆{… k…™…… ®… x…¥…‰∂… (5,035.87) (6,410.31) +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ 50.88 4.70 |……{i… §™……V… 312.88 396.19 x…¥…‰∂… (0.25) - +x™… M…ËÆ˙ S……±…⁄ {… Æ˙∫…∆{… k…™…… ®… {… Æ˙¥…i…«x… (10.22) (112.52) §…ÈEÚ W…®…… ®… x…¥…‰∂… (i…“x… ®…Ω˛“x……‰∆ ∫…‰ + v…EÚ ®…⁄±… {… Æ˙{…C¥…i…… ¥……±…‰) (3,297.69) (12,708.65) x…¥…‰∂… EÚ…™…«EÚ±……{…… ∫…‰ (|…™…÷HÚ) x…¥…±… x…EÚn˘ |…¥……Ω˛ (J…) (5.489.99) (20,854.86) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 226 CONSOLIDATED CASH FLOW STATEMENT FOR THE YEAR ENDED 31.03.2014 AS AT AS AT Particulars 31.03.2014 31.03.2013 (` lacs) (` lacs) A. Cash flow from operating activities Profit before extraordinary items and tax and excluding minority interest 3,623.79 3,778.64 Adjustments for : Depreciation and amortisation 2,412.44 2,119.34 Loss on sale of fixed assets 2.70 2.08 Profit on sale of fixed assets (22.54) (0.51) Finance costs 1,799.57 1,347.82 Priliminary expenses - 1.16 Interest Income (312.88) (396.19) Operating profit/(Loss) before working capital changes 7,503.08 6,852.34 Changes in working capital : Adjustment for (increase/(decrease) in operating assets : Inventories (1,335.55) (3,083.09) Trade receivables (3,047.66) (16,297.30) Short-term loans and advances (1,200.47) (1,767.17) Long-term loans and advances 92.42 (2,227.83) Other current assets 1,649.88 (867.43) Adjustment for increase/(decrease) in operating liabilities : Trade payables 2,168.72 1,251.86 Other current liabilities (7,036.16) 11,688.02 Short-term provisions (323.72) 408.21 (1,529.46) (4,042.39) Cash flow from extra ordinary items 1.15 - Cash generated from operations (1,528.31) (4,042.39) Net Income tax (paid)/refunds (1,215.42) (1,049.27) Net cash flow from/(used in) operating activities (A) (2,743.73) (5,091.66) B. Cash flow from investing activities Capital Work in Progress (4,105.10) (2,024.27) Investment in fixed assets (5,035.87) (6,410.31) Sale of fixed assets 50.88 4.70 Interest received 312.88 396.19 Investment (0.25) - Changes in other non-current assets (10.22) (112.52) Investments in bank deposits (having original maturity of more than three months) 3,297.69 (12,708.65) Net cash flow from/(used in) investing activities (B) (5,489.99) (20,854.86) Annual Report 2013-2014 227 ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… M…. ¥…k…“™…x… EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ n˘“P…«EÚ…±…“x… @Òh…… ∫…‰ |……Œ{i…™……ƒ 3,258.58 3,478.81 +±{…∫…∆J™…EÚ §™……V… EÚ…‰ ¶…÷M…i……x… 40.30 - +x™… +±{…EÚ…±…“x… @Òh…… ∫…‰ |……Œ{i…™……ƒ 10,265.68 10,191.06 ¥…k… ±……M…i…-|…n˘i… §™……V… (1,799.57) (1.347.82) |…™…÷HÚ ∂…‰™…Æ˙… EÚ“ |……Œ{i…™……ƒ - 15,000 |…n˘k… ±……¶……∆∂… (387.07) (387.07) ±……¶……∆∂… {…Æ˙ EÚÆ˙ (65.79) (64.89) ¥…k…“™…x… EÚ…™…«EÚ±……{…… ∫…‰ (|…™…÷HÚ) x…¥…±… x…EÚn˘ |…¥……Ω˛ (M…) 11,312.13 26,870.09 x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ ®… x…¥…±… ¥…fi r˘/(EÚ®…“) (EÚ)+(J…)+(M…) 3,078.41 923.57 ¥…π…« E‰Ú +…Æ∆˙¶… ®… x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ 1,447.75 524.18 ¥…π…« E‰Ú +∆i… ®… x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ 4,526.16 1,447.75 i…÷±…x… {…j… E‰Ú ∫……l… x…EÚn B¥…∆ x…EÚn˘ i…÷±™……∆E EÚ… ®…±……x… i…÷±…x… {…j… E‰Ú +x…÷∫……Æ˙ x…EÚn i…l…… x…EÚn˘ i…÷±™……∆E ( ]ı{{…h…“ 14 n‰˘J…Â) 14,849.73 15,069.01 x™…⁄x… : x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… BB∫… 3 ®… {… Æ˙¶…… π…i… V…Ë∫…‰ x…EÚn˘ i…l…… x…EÚn˘ 10,323.57 13,621.26 i…÷±™……∆EÚ E‰Ú ∞¸{… ®… x…Ω˛” ®……x…‰ M…™…‰ §…ÈEÚ ∂…‰π…* ]ı{{…h…“ 14 ®… ∂…… ®…±… EÚB M…B x…¥…±… x…EÚn˘ i…l…… x…EÚn˘ i…÷±™……∆EÚ (x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… B B∫… 3 ®… {… Æ˙¶…… π…i… V…Ë∫…‰) 4,526.16 1,447.75 ¥…π…« E‰Ú +∆i… ®… x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™……∆EÚ* ∫…®…… ¥…π]ı* (EÚ) Æ˙…‰EÚc˜ ∂…‰π… 25.88 16.13 (J…) §…ÈEÚ…Â E‰Ú ∫……l… ∂…‰π… - - ˛(i) S……±…⁄ J……i…‰ ®… 4,188.49 1,431.60 (ii) <« <« B°Ú ∫…“ J……i…‰ ®… 13.74 0.02 (iii) +…‰ b˜“ J……i…‰ ®… 298.05 - 4,526.16 1,447.75 ]ıı{{…h…“ : 1) ={…™…÷«HÚ x…EÚn˘“ |…¥……Ω˛ ¥…¥…Æ˙h… ¶……Æ˙i… E‰Ú ∫…x…n˘“ ±…‰J……EÚ…Æ˙… E‰Ú ∫…∆∫l……x… u˘…Æ˙… B B∫… 3 ®… |……Æ∆˙ ¶…i… {…Æ˙…‰I… |…h……±…“ E‰Ú +v…“x… i…Ë™……Æ˙ EÚ™…… M…™…… Ω˲* 2) <∫… ¥…π…« EÚ…‰ +x…÷E⁄Ú±… EÚÆ˙ n‰˘x…‰ EÚ“ +…‰Æ˙ V…Ω˛…ƒ EÚΩ˛” +…¥…∂™…EÚ Ω˲, {…UÙ±…‰ ¥…π…« E‰Ú +…ƒEÚb‰˜ EÚ…‰ {…÷x…¥…«M…‘EfiÚi… EÚB M…B Ω˲∆* 3) x™……∫… +…ËÆ˙ ∂…‰π… E‰Ú +v…“x… ` 71,015.72 ±……J… (M…i… ¥…π…« ` 50,466.87 ±……J…) EÚ“ {… Æ˙™……‰V…x…… x… v… E‰Ú ±…‰x…-n‰˘x… x…EÚn˘“ |…¥……Ω˛ ®… ∂…… ®…±… x…Ω˛” EÚB M…B ΩÈ˛˛* ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… & V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 228 AS AT AS AT Particulars 31.03.2014 31.03.2013 (` lacs) (` lacs) C. Cash flow from financing activities Proceeds from long-term borrowings 3,258.58 3,478.81 Payment to Minority Interest 40.30 - Proceeds from other short-term borrowings 10,265.68 10,191.06 Finance cost - Interest paid (1,799.57) (1,347.82) Issue Proceeds of Share Application - 15,000.00 Dividend paid (387.07) (387.07) Tax on dividend (65.79) (64.89) Net Cash flow from/(used in) financing activities (C) 11,312.13 26,870.09 Net increase/(decrease) in cash and cash equivalents (A+B+C) 3,078.41 923.57 Cash and cash equivalents at the beginning of the year 1,447.75 524.18 Cash and cash equivalents at the end of the year 4,526.16 1,447.75 Reconciliation of cash and cash equivalents with the Balancesheet : Cash and cash equivalents as per Balance Sheet (Refer Not 14) 14,849.73 15,069.01 Less : Bank balances not considered as cash and cash equivalents as defined in AS 3 Cash Flow Statements 10,323.57 13,621.26 Net cash and cash equivalents (as defined in AS 3 Cash Flow Statements) included in Note 14 4,526.16 1,447.75 Cash and cash equivalents at the end of the year* * Comprises (a) Cash on hand 25.88 16.13 (b) Balances with bank (i) In current accounts 4,188.49 1,431.60 (ii) In EEFC accounts 13.74 0.02 (iii) In OD accounts 298.05 - 4,526.16 1,447.75 Notes : 1 The above Cash Flow Statement has been prepared under the indirect method set out in the AS - 3 issued by the Institute of Chartered Accountants of India. 2 The previous year’s figures have been re-grouped wherever necessary in order to conform to this year’s presentation. 3 Transactions of project funds held under Trust and balance of `71,015.72 lacs (previous year `50,466.87 lacs) are not included in the Cashflow. For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 229 ]ı{{…h…“ 3 ∂…‰™…Æ˙ {…⁄ƒV…“ (∫…®…‰ EÚi…) ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ```±……J…… ®… (EÚ) |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ |…i™…‰EÚ `1000/- <ŒC¥…]ı“ ∂…‰™…Æ ˙- 30,00,000 ∫…∆J™…… 30,000.00 30,000.00 (J…) V……Æ˙“ EÚ“ M…<« ∂…‰™…Æ˙˙ {…⁄ƒV…“ |…i™…‰EÚ `1000/- <ŒC¥…]ı“ ∂…‰‰™…Æ ˙- 19,35,350 ∫…∆J™…… 19,353.50 19,353.50 (M…) + ¶…n˘k… +…ËÆ˙ {…⁄h…«i…& |…n˘k… ∂…‰™…Æ˙˙ {…⁄ƒV…“ |…i™…‰EÚ `1000/- <ŒC¥…]ı“ ∂…‰™…Æ ˙- 19,35,350 ∫…∆J™…… 19,353.50 19,353.50 E÷Ú±… 19,353.50 19,353.50 ∂…‰™…Æ˙ {…⁄ƒV…“ EÚ… ®…‰±… ®…±……{… ¥…¥…Æ˙h…˜ 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∂…‰™…Æ˙… EÚ“ ∫…∆J™…… ``` ±……J…… ®… ∂…‰™…Æ˙… EÚ“ ∫…∆J™…… ```±……J…… ®… <ŒC¥…]ı“ ∂…‰™…Æ˙ {…⁄ƒV…“ |…… v…EfiÚi… +l… ∂…‰π… 30,00,000.00 30,00,000.00 2,00,000.00 2,000.00 {… Æ˙¥…v…«x… - - 28,00,000.00 28,000.00 +∆ i…®… ∂…‰π… 30,00,000.00 30,00,000.00 30,00,000.00 30,000.00 V……Æ˙“ EÚB M…B +l… ∂…‰π… 19,35,350.00 19,353,50 2,00,000.00 2,000.00 {… Æ˙¥…v…«x… - - 17,35.350.00 17,353.50 +∆ i…®… ∂…‰π… 19,35,350.00 19,353.50 19,35,350.00 19.353.50 + ¶…n˘k… +…ËÆ˙ |…n˘k… +l… ∂…‰π… 19,35,350.00 19,353.50 1,55,350.00 1,553.50 {… Æ˙¥…v…«x… - - 17,80,000.00 17,800.00 +∆ i…®… ∂…‰π… 19,35,350.00 19,353.50 19,35,350.00 19,353.50 5% ∫…‰ + v…EÚ ∂…‰™…Æ˙ {……∫… Æ˙J…‰ |…i™…‰EÚ ∂…‰™…Æ˙v……Æ˙EÚ E‰Ú ∂…‰™…Æ˙… E‰Ú ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.3.2013 EÚ…‰ ∂…‰™…Æ˙v……Æ˙EÚ EÚ… x……®… |……{i… ∂…‰™…Æ˙… v……Æ˙h… EÚ“ |……{i… ∂…‰™…Æ˙… v……Æ˙h… EÚ“ EÚ“ ∫…∆J™…… |… i…∂…i…i…… EÚ“ ∫…∆J™…… |… i…∂…i…i…… ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ 19,35,350 100% 19,35,350 100% ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 230 Note 3 Share Capital (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Authorised Share Capital Equity shares of (`1000/- each - 30,00,000 Nos.) 30,000.00 30,000.00 (b) Issued Share Capital Equity shares of (`1000/- each - 19,35,350 Nos.) 19,353.50 19,353.50 (c) Subscribed and fully paid up Share Capital Equity shares of (`1000/- each - 19,35,350 Nos.) 19,353.50 19,353.50 Total 19,353.50 19,353.50 Reconciliation of Share Capital Description AS AT 31.03.2014 AS AT 31.03.2013 No. of Shares ``` lacs No. of Shares ``` lacs Equity Share Capital Authorised Opening Balance 30,00,000.00 30,000.00 2,00,000.00 2,000.00 Additions - - 28,00,000.00 28,000.00 Closing Balance 30,00,000.00 30,000.00 30,00,000.00 30,000.00 Issued Opening Balance 19,35,350.00 19,353.50 2,00,000.00 2,000.00 Additions - - 17,35,350.00 17,353.50 Closing Balance 19,35,350.00 19,353.50 19,35,350.00 19,353.50 Subscribed & Paid up Opening Balance 19,35,350.00 19,353.50 1,55,350.00 1,553.50 Additions - - 17,80,000.00 17,800.00 Closing Balance 19,35,350.00 19,353.50 19,35,350.00 19,353.50 Details of shares held by each shareholder holding more than 5% shares : AS AT 31.03.2014 AS AT 31.03.2013 Name of shareholder Number of % of Number of % of shares held Holding shares held Holding Govt of India 19,35,350 100% 19,35,350 100% Annual Report 2013-2014 231 ]ı{{…h…“ 4 +…Æ˙ I…i… i…l…… + v…∂…‰π… (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) ∫……®……x™… +…Æ˙ I…i… +l… ∂…‰π… 17,707.98 15,150.45 V……‰b˜ : ±……¶… ¥… Ω˛… x… E‰Ú ¥…¥…Æ˙h… ®… + v…∂…‰π… ∫…‰ +∆i… Æ˙i… 2,086.44 2,508.41 V……‰b˜ : ¥…π…« E‰Ú n˘…ËÆ˙…x… ∫…“ B∫… +…Æ˙ E‰Ú ±…B +…Æ˙ I…i… x… v… ∫…‰ +∆i… Æ˙i… 43.86 49.13 +∆ i…®… ∂…‰π… 19,838.28 17,707.99 (J…) EÚ…Ï{……ÊƉ˙]ı ∫……®…… V…EÚ =k…Æ˙n˘… ™…i¥… (∫…“B∫…+…Æ˙) +l… ∂…‰π… 43.86 49.13- V……‰b˜: ¥…π…« E‰Ú n˘…ËÆ˙…x… {… Æ˙¥…v…«x…/+∆i…Æ˙h… 36.80 43.87 x™…⁄x…˜: ¥…π…« E‰Ú n˘…ËÆ˙…x… ∫……®……x™… +…Æ˙ I…i… EÚ“ +…‰Æ˙ +∆i… Æ˙i… 43.86 49.13 +∆ i…®… ∂…‰π… 36.80 43.87 (M…) ±……¶… ¥… Ω˛… x… E‰Ú ¥…¥…Æ˙h… ®… + v…∂…‰π…/P……]ı… +l… ∂…‰π… - - V……‰b˜ : ¥…π…« E‰Ú ±…B ±……¶…/(Ω˛… x…) 2,576.10 3,004.24 V……‰b˜ : {…÷Æ˙…∆ EÚi… ±……¶……∆∂… {…Æ˙ EÚÆ˙ E‰Ú ±…B + i… Æ˙HÚ |……¥…v……x… - 0.90 x™…⁄x… : |…∫i…… ¥…i… ±……¶……∆∂… <ŒC¥…]ı“ ∫……®™…… ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ…‰ |…∫i…… ¥…i… ±……¶……∆∂… (`20 |… i… ∂…‰™…Æ, M…i… ¥…π…« 20.00 |… i… ∂…‰™…Æ˙) 387.07 387.07 ±……¶……∆∂… {…Æ˙ EÚÆ˙ 65.79 65.79 +∆i… Æ˙i… : ∫…“B∫…+…Æ˙ E‰Ú ±…B +…Æ˙ I…i… x… v… 36.80 43.87 ∫……®……x™… +…Æ˙ I…i… x… v… 2,086.44 2,508.41 +∆ i…®… ∂…‰π… - - E÷Ú±… 19,875,08 17,751.86 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 232 Note 4 Reserves and surplus (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) General reserve Opening balance 17,707.98 15,150.45 Add : Transferred from surplus in Statement of Profit and Loss 2,086.44 2,508.41 Add : Transferred during the year from CSR 43.86 49.13 Closing balance 19,838.28 17,707.99 (b) Corporate Social Responsibility (CSR) Opening balance 43.86 49.13 Add : Additions/transfers during the year 36.80 43.87 Less : Transferred during the year to General Reserve 43.86 49.13 Closing balance 36.80 43.87 (c) Surplus / (Deficit) in Statement of Profit and Loss Opening balance - - Add : Profit / (Loss) for the year 2,576.10 3,004.24 Add : Excess Provision for Tax on dividend Written Back - 0.90 Less : Proposed Dividend Dividend proposed to equity shareholders (` 20 per share, Previous year ` 20.00 per share) 387.07 387.07 Tax on dividend 65.79 65.79 Transferred to : Reserves for CSR 36.80 43.87 General Reserve 2,086.44 2,508.41 Closing balance - - Total 19,875.08 17,751.86 Annual Report 2013-2014 233 ]ı{{…h…“ 5 n˘“P…«EÚ… ±…EÚ =v……Æ˙ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) §……∆b˜/ b˜§…‰S…∫…« (+|… i…¶…⁄i…) (i) b˜§…∆‰S…∫…« - 62.65 (EÚ) +…¥… v…EÚ @Òh… (|… i…¶…⁄i…) ¥…n‰˘∂…“ ®…÷p˘… @Òh… 2,830.49 3,975.78 ¶……Æ˙i…“™… Ø˚{…B @Òh… 4,635.39 200.65 (J…) +…¥… v…EÚ @Òh… (+|… i…¶…⁄i…) 277.41 - (M…) +x™… @Òh… ¥… + O…®… (i) ¥…n‰˘∂…“ ®…÷p˘… G‰Úi…… EÚ“ ∫……J…-=v……Æ˙ 1,026.33 1,289.71 (ii) ∫…÷Æ˙I…… V…®…… 15.71 - (iii) ∫…÷Æ˙I…… V…®…… {…Æ˙ §™……V… 2.04 - E÷Ú±… 8,787.37 5,528.79 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 234 Note 5 Long-term borrowings (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Bonds/Debentures (Unsecured) (i) Debentures - 62.65 (b) Term Loans (Secured) Foreign currency loan-Secured 2,830.49 3,975.78 Indian rupee loan 4,635.39 200.65 (c) Term Loans (Unsecured) 277.41 - (d) Other Loans and Advances (i) Foreign currency Buyers Credit 1,026.33 1,289.71 (ii) Security Deposits 15.71 - (iii) Interest on Security Deposits 2.04 - Total 8,787.37 5,528.79 Annual Report 2013-2014 235 (i) |……{i… n˘“P…«EÚ… ±…EÚ =v……Æ˙ E‰Ú ∫…∆§…∆v… ®… n˘“ M…<« |… i…¶…⁄ i… E‰Ú ¥…¥…Æ˙h… ¥…¥…Æ˙h… |… i…¶…⁄ i… E‰Ú ∂…i…«* 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ §…ÈEÚ…Â ∫…‰ +…¥… v…EÚ @Òh… ¥…n‰˘∂…“ ®…÷p˘… @Òh… (EÚ) ¶…⁄ ®… ¥… ®…EÚ…x… (BS…B±…B±…) EÚ…‰ UÙ…‰b˜EÚÆ˙ E∆Ú{…x…“ EÚ… +S…±… {… Æ˙∫…∆{… k…™…… {…Æ˙ |…l…®… S……V…«* ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… ∫…‰ (J…) x……‰Bb˜… (BS…B±…B±…) EÚ“ ¶…⁄ ®… {…Æ˙ ∫……Œ®™…EÚ 4,440.75 5,569.46 §…∆v…EÚ (M…) {…⁄V…{{…÷Æ˙…, i…Ø˚¥…x…∆i…{…÷Æ˙®… (BS…B±…B±…) E‰Ú ®…EÚ…x… ∫… Ω˛i… ¶…⁄ ®… {…Æ˙ ∫…∆{……Ã∑…EÚ E‰Ú ∞¸{… ®… ∫……Œ®™…EÚ §…∆v…EÚ* <∆b˜∫…<∆b˜ §…ÈEÚ - - Ø˚{…™…… +…¥… v…EÚ @Òh… BS… b˜“ B°Ú ∫…“ §…ÈEÚ ∫…‰ (P…) {…⁄V…{{…÷Æ˙…, i…Ø˚¥…x…∆i…{…÷Æ˙®… (BS…B±…B±…) E‰Ú 4,755.08 - ®…EÚ…x… ∫… Ω˛i… ¶…⁄ ®… {…Æ˙ ∫…∆{……Ã∑…EÚ E‰Ú ∞¸{… ®… ∫……Œ®™…EÚ §…∆v…EÚ* ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… ∫…‰ (c˜) {…]¬ı]‰ı EÚ“ ¶…⁄ ®… + v…EÚ…Æ˙, ®…EÚ…x… +…ËÆ˙ ¶…⁄ ®… {…Æ˙ +x™… f¯…ƒS…… E‰Ú ∫……Œ®™…EÚ §…∆v…EÚ E‰Ú |… i…¶…⁄i…* ∫…∆™…∆j… +…ËÆ˙ ®…∂…“x…Æ˙“, |…™……‰M…∂……±…… ={…EÚÆ˙h…, §…V…±…“ EÚ“ ∫l……{…x……, °Úx…‘S…Æ˙ +…ËÆ˙ V…÷c˜x……Æ˙, ¥……Ω˛x… +…ËÆ˙ +x™… S…±… ∫…∆{… k… (V…“ B {…“ B±…) EÚ“ M…Æ˙¥…“* 564.07 - ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… ∫…‰ (S…) ±……<¢Úœ∫|…M… +∫{…i……±… (|……<¥…‰]ı) ±… ®…]‰ıb˜- {…]¬ı]‰ı EÚ“ ¶…⁄ ®… + v…EÚ…Æ˙ +…ËÆ˙ +∫{…i……±… ={…EÚÆ˙h… EÚ“ M…Æ˙¥…“ E‰Ú |… i… |… i…¶…⁄i… 406.41 200.65 §…ÈEÚ…‰ ∫…‰ E÷Ú±… +…¥… v…EÚ @Òh… 10,166.31 5,770.11 x™…⁄x… : +M…±…‰ 12 ®…Ω˛“x…… ®… n‰˘™… S……±…⁄ n‰˘™…i……™… 2,499.78 1,593.68 12 ®…Ω˛“x…… E‰Ú §……n˘ n‰˘™… 7,666.53 4,176.43 +x™… @Òh… +…ËÆ˙ ∫……J…-=v……Æ˙ G‰Úi……+… EÚ“ ∫……J…-=v……Æ˙ {… Æ™……‰V…x…… V…®…… ∫…‰ |… i…¶…⁄i… 7,894.15 8,289.93 x™…⁄x… : +±{…EÚ… ±…EÚ =v……Æ˙ 6,867.82 7,000.22 1,026.33 1,289.71 ]ı{{…h…“: ¥…n‰˘∂…“ ®…÷p˘… G‰Úi……+… EÚ“ ∫……J… =v……Æ˙ {…⁄ƒV…“M…i… ®…n˘… E‰Ú |……{…h… E‰Ú ±…B ΩÈ˛ ={…±…§v…i…… E‰Ú +x…÷∫……Æ˙ i…“x… ¥…π……Á i…EÚ +…¥…i…‘ E‰Ú ±…B {……j…i…… ΩÈ˛ ™…… =∫…EÚ…‰ ®…∆V…⁄Æ˙ EÚB M…B +…¥… v…EÚ @Òh… ®… {… Æ˙¥…Ãi…i… EÚ™…… V……BM……* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 236 (i) Details of security provided in respect of the secured long-term borrowings : AS AT AS AT Particulars Details of security* 31.03.2014 31.03.2013 Term loans from banks : Term loans from Banks Foreign Currency Loan (a)First charge over the fixed assets of the company excluding Land & Buildings (HLL) From State Bank of India (b) Equitable Mortgage over the land at Noida (HLL) 4,440.75 5,569.46 (c)Equitable Mortgage as collateral over the land with building at Poojappura, Trivandrum. (HLL) From IndusInd Bank Rupee Term Loan - - From HDFC Bank (d)Equitable Mortgage as collateral 4,755.08 - over the land with building at Poojappura, Trivandrum. (HLL) From State Bank of India (e)Secured by an equitable mortgage 564.07 - of leasehold rights of the land, building and other structures on the land. Hypothecation of plant & machinery, laboratory equipments electrical installations, furniture & fixtures, vehicles and other movable assets (GAPL) From State Bank of India (f) Secured against Hypothecation of 406.41 200.65 Leasehold Rights & Hospital equipments-Life Spring Hospitals (P) Ltd Total - Term loans from banks 10,166.31 5,770.11 Less : Payable within next 12 2,499.78 1,593.68 months treated as Current Liabilities Payable after 12 months 7,666.53 4,176.43 Other loans and advances : Buyers Credit Secured by Project Deposits 7,894.15 8,289.93 Less : Short Term Borrowings 6,867.82 7,000.22 1,026.33 1,289.71 Note : Foreign Currency Buyers Credit are for Capital item procurement, eligible for roll over upto three years subject to availability, or else shall be converted into sanctioned Term Loan. Annual Report 2013-2014 237 ]ı{{…h…“ 6 +±{…EÚ… ±…EÚ =v……Æ˙˙ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) ®……∆M… {…Æ˙ |… i…n‰˘™… @Òh… (x…EÚn˘“ @Òh…) ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… ∫…‰ - |… i…¶…⁄i… 11.365.19 8,907.17 EËÚx…Æ˙… §…ÈEÚ ∫…‰ 4,495.56 - BS… b˜“ B°Ú ∫…“ §…ÈEÚ ∫…‰ 223.04 - E÷Ú±… 16,083.79 8,907.17 (J…) §…ÈEÚ…Â ∫…‰ +±{…EÚ…±…“x… @Òh… - |… i…¶…⁄i… EËÚx…Æ˙… §…ÈEÚ ∫…‰ 2,514.87 2,500.00 <∆b˜∫…<∆b˜ §…ÈEÚ 5,650.00 5,000.48 B∫… §…“ +…<« ∫…‰ (®……∆M… @Òh…) 2,517.53 - 10,682.40 7,500.48 (M…) +x™… @Òh… ¥… + O…®… - |… i…¶…⁄i… ¥…n‰˘∂…“ ®…÷p˘ G‰Úi…… EÚ“ ∫……J… - =v……Æ˙ 6,867.82 7,000.22 +x™… @Òh… |… i…¶…⁄i… |……‰n¬˘¶…⁄i… +…ËÆ˙ n‰˘™… §™……V… - - ∫]‰ı]ı §…ÈEÚ +…Ï°Ú <∆ b˜™…… 110.30 101.92 EËÚx…Æ˙… §…ÈEÚ ∫…‰ 26.13 - BS… b˜“ B°Ú ∫…“ §…ÈEÚ ∫…‰ 8.80 - <∆b˜∫…<∆b˜ §…ÈEÚ - 3.77 E÷Ú±… 33.779.24 23.513.56 ]ı{{… h…™……ƒ : (i) |……{i… +±{…EÚ… ±…EÚ =v……Æ˙ E‰Ú ±…B |… i…¶…⁄ i… E‰Ú ¥…¥…Æ˙h… ¥…¥…Æ˙h… |… i…¶…⁄ i… EÚ“ |…EfiÚ i… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… §…ÈEÚ…Â ∫…‰ ®……∆M… {…Æ˙ |… i…n‰˘™… @Òh… B∫… §…“ +…<« BS…B±…B±… EÚ“ S……±…⁄ {… Æ˙∫…∆{… k…™…… {…Æ˙ {…… Æ˙ {……∫…÷ 11,463.17 9,009.09 EËÚx…Æ˙… §…ÈEÚ S……V…«* ¶……Æ˙i…“™… ∫]‡ı]ı §…ÈEÚ E‰Ú |… i… {…⁄V…{{…÷Æ˙… 4,521.69 - BS… b˜“ B°Ú ∫…“ §…ÈEÚ i…Ø˚¥…x…∆i…{…÷Æ˙®… E‰Ú ®…EÚ…x… ∫… Ω˛i… ¶…⁄ ®… {…Æ˙ V…®……x…i…“ 231.84 - E‰Ú ∞¸{… ®… ∫……Œ®™…EÚ §…∆v…EÚ* B∫… §…“ +…<« ∫…‰ {…]¬ı]‰ı v……Æ˙“ + v…EÚ…Æ˙ +…ËÆ˙ +∫{…i……±… ={…EÚÆ˙h…- 12.32 - ±……<¢Ú œ∫|…M… +∫{…i……±… ({…“) ±… ®…]‰ıb˜ E‰Ú §…∆v…EÚ §…ÈEÚ…Â ∫…‰ +±{…EÚ… ±…EÚ @Òh… - |… i…¶…⁄i… EËÚx…Æ˙… §…ÈEÚ ∫…‰ {… Æ˙™……‰V…x…… V…®…… u˘…Æ˙… |… i…¶…⁄i… (BS…B±…B±…) 2,514.87 2,500.00 <∆b˜∫…<∆b˜ §…ÈEÚ ∫…‰ 5,650.00 5,004.25 B∫… §…“ +…<« ∫…‰ 2,517.52 - 10,682.39 7,504.25 +x™… @Òh… ¥… + O…®… {… Æ˙™……‰V…x…… V…®…… u˘…Æ˙… |… i…¶…⁄i… (BS…B±…B±…) J…Æ˙“n˘…Æ˙… E‰Ú G‰Ú b˜]ı 7,894.15 8,289.93 x™…⁄x… : n˘“P…«EÚ…±…“x… =v……Æ˙ 1,026.33 1,289.71 6,867.82 7,000.22 E÷Ú±… 33,779.23 23,513.56 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 238 Note 6 Short-term borrowings (Consolidated) Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs (a) Loans repayable on demand (Cash Credit) From State Bank of India - Secured 11,365.19 8,907.17 From Canara Bank 4,495.56 - From HDFC Bank 223.04 - Total 16,083.79 8,907.17 (b) Short Term Loans from Banks - Secured From Canara Bank 2,514.87 2,500.00 From IndusInd Bank 5,650.00 5,000.48 From SBI (Demand Loan) 2,517.53 - 10,682.40 7,500.48 (c) Other loans and advances - Secured Foreign Currency Buyers Credit 6,867.82 7,000.22 Other loans secured Interest accrued and due State Bank of India 110.30 101.92 Canara Bank 26.13 - HDFC Bank 8.80 - IndusInd Bank - 3.77 Total 33,779.24 23,513.56 Notes : (i) Details of security for the secured short-term borrowings : Particulars Nature of security AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs Loans repayable on demand from banks : SBI Parri passu charge over current 11,463.17 9,009.09 Canara Bank assets of HLL. Equitable Mortgage 4,521.69 - HDFC Bank as collateral over the land with 231.84 - building at Poojappura, Trivandrum towards State Bank of India From SBI Hypothecation of Lease Hold Rights & Hospital Equipments - Life Spring Hospitals (P) Ltd 12.32 - Short Term Loans from Banks- Secured From Canara Bank Secured by Project Deposits (HLL) 2,514.87 2,500.00 From IndusInd Bank 5.650.00 5,004.25 From SBI 2,517.53 - 10,682.39 7,504.25 Other loans and advances : Secured by Project Deposits (HLL) Buyers Credit 7,894.15 8,289.93 Less : Long Term Borrowings 1,026.33 1,289.71 6,867.82 7,000.22 Total 33,779.23 23,513.56 Annual Report 2013-2014 239 ]ı{{…h…“ 7 n‰˘™… ¥™……{……Æ˙ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… n‰˘™… ¥™……{……Æ˙ : ∫……®… O…™……Â, ∫…‰¥……+… +…ËÆ˙ ¥™…™…… E‰Ú ±…B - ∫…⁄I®… ±…P…÷ı +…ËÆ˙ ®…v™…®… =t®… 294.95 409.66 - +x™… 11,193.55 8,910.12 E÷Ú±… 11,488.50 9,319.78 ]ı{{…h…“ 8 +x™… S……±…⁄ n‰˘™…i……B∆ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.3.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… (EÚ) n˘“P……«¥… v… @Òh… EÚ“ S……±…⁄ {… Æ˙{…C¥…i……Bƒ (x…“S…‰ EÚ“ ]ı{{…h…“ (i) EÚ… ∫…∆n˘¶…« EÚÆÂ˙*) 2,668.53 1,593.68 (J…) +x™… O……Ω˛EÚ/®…÷¥… EÚ±…… ∫…‰ + O…®… 2,640.16 13,253.09 <« B®… b˜“ +…ËÆ˙ ∫…÷Æ˙I…… V…®…… 2,527.22 2,464.75 §™……V… ={……ÃV…i… ±…‰ EÚx… n‰˘™… x…Ω˛” 63.87 51.23 ∫……¥… v… V…®…… 0.10 0.10 +x™… n‰˘™…i……Bƒ 10,317.55 7,663.27 +∆∂…n˘…™…“ {…Â∂…x… ™……‰V…x…… 35.03 293.57 +…™… E‰Ú + O…®… ∫…‰ |……{i… 0.11 - |…™……‰M…∂……±…… +…ËÆ˙ °Ú…®…«∫…“ ∫…‰ V…®…… 0.96 - E÷Ú±… 18,253.53 25,289.69 ]ı{{…h…“ (i) : ±…∆§…“ +¥… v… E‰Ú EÚV…« EÚ“ ¥…i…«®……x… {… Æ˙{…C¥…i……Bƒ ( ]ı{{…h…“ 5 ®… ]ı{{…h…“ (i) EÚ… ∫…∆n˘¶…« EÚÆÂ˙ - n˘“P…«EÚ… ±…EÚ @Òh… E‰Ú ±…B |… i…¶…⁄ i… E‰Ú ¥…¥…Æ˙h…): ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… ®…™……n˘“ @Òh… BS… b˜“ B°Ú ∫…“ ∫…‰ |… i…¶…⁄ i… 889.51 - ¥…n‰˘∂…“ ®…÷p˘… ®…™……n˘“ @Òh… 1,779.02 1,593.68 E÷Ú±… 2,668.53 1,593.68 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 240 Note 7 Trade Payables (Consolidated) Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs Trade payables : for materials, services and expenses - Micro Small and Medium Enterprises 294.95 409.66 - Others 11,193.55 8,910.12 Total 1,488.50 9,319.78 Note 8 Other current liabilities (Consolidated) Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs (a) Current maturities of long-term debt (Refer Note (1) below) 2,668.53 1,593.68 (b) Others Advance from Customers/Clients 2,640.16 13.253.09 EMD & Security Deposits 2,527.22 2,464.75 Interest Accrued but not due 63.87 51.23 Fixed Deposit 0.10 0.10 Other Liabilities 10,317.55 7,633.27 Contributory Pension Scheme 35.03 293.57 Income Received in Advance 0.11 - Deposits from Laboratories & Pharmacies 0.96 - Total 18,253.53 25,289.69 Note (I) : Current maturities of long-term debt (Refer Notes (i) in Note 5 - Long-term borrowings for details of security) : Particulars AS AT AS AT 31.03.2014 3.1.03.2013 ` lacs ` lacs Term loans From HDFC- Secured 889.51 - Foreign Currency Term Loan 1,779.02 1,593.68 Total 2,668.53 1,593.68 Annual Report 2013-2014 241 ]ı{{…h…“ 9 +±{…EÚ… ±…EÚ |……¥…v……x… (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ``` ±……J…… ®… ` ±……J…… ®… (EÚ) EÚ®…«S……Æ˙“ Ω˛i…±……¶… E‰Ú ±…B |……¥…v……x… : (i) §…˛…Ïx…∫… +…ËÆ˙ |……‰i∫……Ω˛x… E‰Ú ±…B |……¥…v……x… 140.37 135.16 (ii) x…π{……n˘x… ∫…∆§…∆v…“ ¥…‰i…x… E‰ ±…B |……¥…v……x… 149.38 198.99 (iii) +x…÷±…Œ§v…™…… +…ËÆ˙ ¶…k…… E‰Ú ±…B |……¥…v……x… 1.28 226.23 (iv) ={…n˘…x… E‰Ú ±…B |……¥…v……x… 516.41 583.16 (v) O…⁄{… <« B±… |…“ ®…™…®… E‰Ú ±…B |……¥…v……x… 181.85 169.47 989.29 1,313.01 (J…) +x™… |……¥…v……x… : (i) |…∫i…… ¥…i… <ŒC¥…]ı“ ±……¶……∆∂… E‰Ú ±…B |……¥…P……x… 387.07 387.07 (ii) |…∫i…… ¥…i… ±……¶……∆∂… {…Æ EÚÆ E‰Ú ±…B |……¥…v……x… 65.78 65.79 452.85 452.86 E÷Ú±… 1,442.14 1,765.87 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 242 Note 9 Short-term provisions (Consolidated) Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs (a) Provision for employee benefits : (i) Provision for bonus and incentive 140.37 135.16 (ii) Provision for Performance related pay 149.38 198.99 (iii)Provision for Perks & Allowance 1.28 226.23 (iv) Provision for gratuity 516.41 583.16 (v) Provision for group EL Premium 181.85 169.47 989.29 1,313.01 (b) Provision - Others : (i) Provision for proposed equity dividend 387.07 387.07 (II) Provision for tax on proposed dividends 65.78 65.79 452.85 452.86 Total 1,442.14 1,765.87 Annual Report 2013-2014 243 3 ±……J…… ®… ±……J…… ` x…¥…±… §±……ÏEÚ x…¥…±… 2014 2013 31 ®……S…«31 ®……S…« ®……S…«31 31 9,060.074,954.97 4,954.96 3,062.42 31 ®……S…« 2014®……S…« 31 2012 ®……S…« 31 - 1,999.61 2,442.44 - 555.44 5.28 - 24.62 24.62 - 5.48 1.16 - 3,062.41 1,581.17 - 140.12 88.55 - 1,793.91 2,442.44 - 4,494.56 3,062.41 2014 31 ®……S…« 31 226.80 722.29 23.36 31 ®……S…« 2014 ®……S…« 31 31 ®……S…« 2014 ®……S…« 31 ∫l……x……∆i…Æ˙h… +∆i…Æ˙ ™…⁄ x…]ı +∆i…Æ˙ (0.51) {… Æ˙∫…∆{… i…™…… {… Æ˙∫…∆{… i…™…… E‰Ú x…{…]ı…x… {…Æ˙ x…{…]ı…x… E‰Ú E‰Ú x…{…]ı…x… {…Æ˙ x…{…]ı…x… E‰Ú E‰Ú x…{…]ı…x… E‰Ú {… Æ˙∫…∆{… i…™…… - 344.29 706.55 722.28 ------32.37 452.53 457.43 -- -- ∫…∆ S…i… ø…∫… +…ËÆ˙ Ω˛… x… +…ËÆ˙ ø…∫… ∫…∆ S…i… ∫…∆ S…i… ®…⁄±™…ø…∫… +…ËÆ˙ Ω˛… x… +…ËÆ˙ ®…⁄±™…ø…∫… ∫…∆ S…i… ®…⁄±™…ø…∫…/ ®…⁄±™…ø…∫…/ @Òh…®…÷ HÚ ¥™…™…@Òh…®…÷ HÚ M…™…… Ω˛]ı…™…… @Òh…®…÷ HÚ ¥™…™…@Òh…®…÷ HÚ M…™…… Ω˛]ı…™…… ®…⁄±™…ø…∫…/ @Òh…®…÷ HÚ ¥™…™…@Òh…®…÷ HÚ Ω˛]ı…x…… EÚ…‰ ------2013 1 +|…˱…1 n˘…ËÆ˙…x… E‰Ú ¥…π…« 1 +|…˱… 2013+|…˱… 1 n˘…ËÆ˙…x… E‰Ú ¥…π…« 1 +|…˱… 2013+|…˱… 1 n˘…ËÆ˙…x… E‰Ú ¥…π…« 2014 ∫l……x……∆i…Æ˙h… +∆i…Æ˙ ™…⁄ x…]ı+∆i…Æ˙ ®……S…« 31 484.80 27.37 4.90 x…{…]ı…x…2014 ®……S…« 31 ∫…EÚ±… §±……ÏEÚ ∫…EÚ±… - - 24.62 - - 1,050.84 226.80 117.50 ∫…EÚ±… §±……ÏEÚ ∫…EÚ±… 34.68 - 34.68 - 1.12 - 1.12 33.55 - {… Æ˙¥…v…«x… x…{…]ı…x… - 6.56 105.08 53.97 14.80 5.51 63.26 41.82 57.67 - 1.165.28 4.32 555.44 5.28 - 555-44 5.38 - - 5.48 394.52 - - 400.00 - - - - - 400.00 5.48 7.87 0.47 0.03 - 8.32 1.42 0.19 0.03 - 1.58 6.74 - 24.62 88.55 51.57 - 140.12 - 36.30 16.71 0.04 - 52.97 1.84 8.43 0.04 - 10.23 42.75 34.46 24.62 - - - 24.62 - - - - - 24.62 24.62 701.82 380.46 3.44 1,078.84 502.48 103.53 2.25 603.76 475.08 199.34 637.10 313.78 18.70 932.18 469.35 81.83 18.48 532.70 399.48 167.75 949.08170.38 136.44 778.80 - 0.10 1,085.52 949.08 226.80 147.02 118.62 79.27 - 345.42 740.10 722.28 524.98 1,278.49 9.56 1,793.91 - 555.44 843.05 140.54 - 1,257.95 - - - - - 1,257.95 555.44 511.14 68.66 - - 579.80 - - - - - 579.80 598.91 140.67 - - - 140.67 70.33 14.07 - - 84.40 56.27 70.33 105.08 26.33 22.33 - 109.08 63.26 15.62 17.58 - 61.30 47.78 41.82 484.80 0.00 - - 484.80 32.37 4.90 - - 37.17 447.63 452.53 4,489.65 3,275.06 0 7,764.71 1,590.09 315.62 - 1,905.71 5,859.00 2,89.56 2,442.44 488.92 931™…75 1,999.61 - 1,581.17 3,229.66 1,748.41 3,062.41 - 3,062.41 2,378.74 946.59 4,494.56 - 1,021.69 421.19 38.411,063.84 - 219.60 1,404.46 0.04 570.84 171.95 - 28.12 1,283.40 0.99 345.28 714.68 142.16 689.78 0.04 440.51 - 487.39 796.01 718.16 8,059.16 649.361,114.55 268.24 - 4.33 - - 8,708.52 1,378.46 2,031.90 383.29 614.78 147.19 - 3.46 - - 2,414.19 758.51 6,294.33 5,859.00 619.95 488.19 1,793.91 1,009.231,999.60 3,190.88 40.02 1,131.29 1.62 - 2,763.12 4,059.19 ------2,763.12 4,059.19 1,795.53 1,999.60 4,865.57 5,506.343,062.41 1,311.85 2,839.15 946.59 1.62 9,060.07 - 4,954.97 1,275.191,089.75 236.31 148.85 0.08 - - 1,511.42 - 437.27 1,238.60 175.33 282.07 133.49 0.08 - - 612.52 - 898.91 416.56 752.62 822.04 806.68 5,322.47 6,351.74 159.67 - 31,514.54 12,632.58 1,989.13 66.40 - 14,555.31 16,959.23 12,689.89 18,600.00 2,345.91 130.97 20,814.94 9,938.46 1,445.67 40.16 11,343.97 9,470.97 8,661.54 22,842.64 2,337.54 130.55 25,049.63 11,191.42 1,502.20 111.91 12,581.71 12,467.92 11,651.22 2013 25,049.63 6,315.22 159.67 31,205.18 12,581.72 1,966.35 66.40 14,481.67 16,723.51 12,467.91 21,613.02 2,266.89 91.02 - 23,788.89 11,687.51 1,602.46 64.30 - 13,225.67 10,563.22 9,652.56 1 +|…˱… 1 32,430.80 3,632.48 156.12 - 35,907.16 15,001.97 2,324.60 113.48 0.99 17,213.10 18,694.07 16,959.23 1 +|…˱… 2013+|…˱… 1 {… Æ˙¥…v…«x… b˜“ 34.38 - - - 34.38 19.82 10.68 - - 30.50 3.89 - & ¥™…™… 111.64 949.08 101.76 484.80 ¥™…™… {… Æ˙™……‰V…x……+… {…Æ˙ {… Æ˙™……‰V…x……+… ®…∂…«S……V…« {… Æ˙™……‰V…x……+… {…Æ˙ {… Æ˙™……‰V…x……+… ®…∂…« S……V…« ®…∂…« S……±…⁄ ®…∂…“x…Æ˙“ EÚ…™…« ®…∂…“x…Æ˙“ S……±…⁄ E÷Ú±… ¥…π…« {…UÙ±…‰ +…EÚŒ∫®…EÚ +…EÚŒ∫®…EÚ E÷Ú±… ¥…π…«2 {…UÙ±…‰ EÚ…™……«±…™… ={…EÚÆ˙h… EÚ…™……«±…™… ∫…∆™…∆j… ¥… ®…∂…“x…Æ˙“ ¥… ∫…∆™…∆j… M…… b˜™……ƒ ®……‰]ıÆ˙ ¶…⁄ ®… ∫¥…… ®…i¥… {…⁄h…« ¶…⁄ ®… {…Æ˙ {…]¬ı]‰ı <®……Æ˙i… EÚ®…“∂…Àx…M… E‰Ú ±…B EÚ®…“∂…Àx…M… {… Æ˙∫…∆{… k…™……ƒ ±…∆ §…i… +S…±… {… Æ˙∫…∆{… k…™……ƒ +S…±… ¶…⁄ ®… {…⁄h…«∫¥…… ®…i¥… <®……Æ˙i… ®…∂…“x…Æ˙“ ¥… ∫…∆™…∆j… ®……‰]ıÆ˙ M…… b˜™……ƒ ®……‰]ıÆ˙ EÚ…™……«±…™… ={…EÚÆ˙h… EÚ…™……«±…™… E÷Ú±… ¥…π…« {…UÙ±…‰ {…]¬ı]‰ı {…Æ˙ ¶…⁄ ®… {…Æ˙ {…]¬ı]‰ı +…EÚŒ∫®…EÚ +…EÚŒ∫®…EÚ {…“ +…<« b˜Œ§±…™…÷ ®…∂…“x…Æ˙“ S……±…⁄ EÚÆ˙x…‰ E‰Ú ±…B EÚÆ˙x…‰ S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ {…b˜“ + x…h…«™……v…“x… E÷Ú±… ¥…π…« {…UÙ±…‰ (RÛ) (P…) x…<« +…]«ı +…ËÆ˙ §±……ÏEÚ/+…Æ˙ +…ËÆ˙ +…]«ı (UÙ){… Æ˙∫…∆{… k… +x™… ∫……Ï}]ı¥…‰™…Æ˙ ÚE∆Ú{™…⁄]ıÆ˙ {…‰]Âı]ı +…ËÆ˙ ]≈‰ıb˜®……E«Ú ""±……<¢Úœ∫|…M…'' •……∆b˜ (P…)V…÷b˜x……Æ˙ ¥… °Úx…‘S…Æ˙ (S…) (M…) (RÛ) (EÚ) (J…) (J…)EÚ…™…« ∫… ¥…±… S……±…⁄ (M…) {…Æ˙… (EÚ) E÷Ú±… ¥…π…« {…UÙ±…‰ (EÚ) (J…) (M…) (P…)V…÷b˜x……Æ˙ ¥… °Úx…‘S…Æ˙ (RÛ) (S…) ÚE∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ˙ ÚE∆Ú{™…⁄]ıÆ˙ {…‰]Âı]ı +…ËÆ˙ ]≈‰ıb˜®……E«Ú E÷Ú±… {…UÙ±…‰ ¥…π…« {…UÙ±…‰ (J…)EÚ…™…« ∫… ¥…±… S……±…⁄ (M…) {…Æ˙… (P…) x…™…‰ (RÛ) (EÚ) J…{… Æ˙∫…∆{… k…™……ƒ +®…⁄i…« EÚ{… Æ˙∫…∆{… k…™……ƒ ®…⁄i…« M…EÚ…™…« {…⁄ƒV…“ S……±…⁄ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ±……<¢ÚE‰Ú™…Æ˙ BS…B±…B±… 31 ®……S…« 2014 EÚ…‰ ∫…®……{i… ∫…®…‰ EÚi… ¥… k…™… ¥…¥…Æ˙h… EÚ“ ]ı{{…h…“ {… Æ˙∫…∆{… k…™……ƒ +S…±… 10 ]ı{{…h…“ EÚ{… Æ˙∫…∆{… k…™……ƒ ®…⁄i…« J…+…Œ∫i…™……ƒ +®…⁄i…« M…EÚ…™…« {…⁄ƒV…“ S……±…⁄ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 244 lacs 5.48 2013 ` Net Block 3.89 - 2014 31 March 31 March 10.23 42.75 34.46 2014 612.52 898.91 752.62 17,213.10 18,694.07 16,959.23 0.99 0.08 - 66.40 - 14,555.31 16,959.23 12,689.89 64.30 - 13,225.67 10,563.22 9,652.56 the year of assets expense for disposal amortisation on transfer Depreciation Eliminated Inter UnitMarch, 31 Accumulated Depreciation and impairment 1.84 8.43 0.04 - 2013 1 April, 1 1,687.51 1,602.46 52.97 484.80 32.27 4.90 - - 37.17 447.63 452.53 March, 2014 1,511.42 437.27 175.33 9,060.07 - - - - - 9.060.07 4,954.96 1,283.40 345.28 142.16 0.04 - 487.39 796.01 718.16 1,378.46 614.78 147.19 3.46 - 758.51 619.95 488.19 2,763.12 - - - - - 2,763.12 1,795.53 1.62 1.62 transfer 0.08 - 0.040.04 - - 4.33 - Gross Block 0.00 - - 394.52 - - 400.00 - - - - - 400.00 Additions Disposals Inter Unit 31 7.87 0.47 0.03 - 8.32 1.42 0.19 0.03 - 1.58 6.74 - 5.48 1.14 68.66 - - 579.80 - - - - - 579.80 598.91 34.38 - - - 34.38 19.82 10.68 - - 30.50 14.55 268.24 36.30 16.71 24.62 - - - 24.62 - - - - - 24.62 24.62 2013 105.08 26.33 22.33 - 109.08 63.26 15.62 17.58 - 61.30 47.78 41.82 555.44 843.05 140.54 - 1,257.95 - - - - - 1,257.95 555.44 1 April, 1 1,063.84 219.60 1,021.69 421.19 38.41 - 1,404.46 570.84 171.95 28.12 0.99 714.68 689.78 440.51 1,999.60 3,190.88 1,131.29 - 4,059.19 - - - - - 4,059.19 1,999.60 1,793.91 1,009.23 40.02 21,613.02 2,266.89 91.02 - 23,788.89 1 Fixed Assets Previous Year 25,322.47 6,351.74 159.67 - 31,514.54 12,632.58 1,989.13 Other asset Total 32,430.80 3,632.48 156.12 - 35,907.16 15,001.97 2,324.60 113.48 New Projects Freehold Leasehold 484.80 Assets Pending Commissioning Trademarks & Patents Brand "Lifespring"Art & Block/R&D 140.67 - - - 140.67 70.33 14.07 - - 84.40 56.27 70.33 Computer software Total 1,275.19 236.31 (f) Office Equipment (e) Motor Vehicles (g) Previous Year 1,089.75 148.85 - - 1,238.60 283.07 133.49 - - 416.56 822.04 806.68 (b) Buildings(c) Plant and Machinery (d) Furniture & Fixture 1,1 8,059.16 649.36 - - 8,708.52 2,031.90 382.29 - - 2,414.19 6,294.33 5,859.00 Previous Year 3,062.41 2,839.15 946.59 - 4,954.97 - - - - - 4,954.97 3,062.42 Total 4,865.57 5,506.34 1,311.85 (b) Civil work in progress (c) Consultancy Charges(d) Incidental Expenses on (e) Machinery WIP 51 (a) Land (a) B Intangible Assets C Capital Work in Progress A Assets Tangible HLL Lifecare Limited Notes to Consolidated financial statements for the year ended 31st March 2014 Assets Note 10 Fixed Annual Report 2013-2014 245 400 ±……J… ∂…… ®…±… Ω˲* ∂…… ®…±… ±……J… 400 ` 2.00 ±……J… {…Æ˙)* ¶…⁄ ®… E‰Ú +∆i…Æ˙h… +¶…“ i…EÚ x…Ω˛” EÚ™…… M…™…… Ω˲, M…™…… EÚ™…… x…Ω˛” i…EÚ +¶…“ +∆i…Æ˙h… E‰Ú ¶…⁄ ®… {…Æ˙)* ±……J… 2.00 ` V…“ B {…“ B±… u˘…Æ˙… {…“UÙ… EÚ™…… M…™…… Ω˲* M…™…… EÚ™…… {…“UÙ… u˘…Æ˙… B±… {…“ B V…“ % “ Ɖ˙J…… |…h……±…“ ∫¥…“EÚ…Æ˙ EÚ“ M…™…“ Ω˲* M…™…“ EÚ“ ∫¥…“EÚ…Æ˙ |…h……±…“ Ɖ˙J…… “ 130.46 ±……J… Æ˙Ω˛“ Ω˲* Æ˙Ω˛“ ±……J… 130.46 2/- Æ˙Ω˛… Ω˲* Æ˙Ω˛… 2/- ` 4.71 ` @ 1/- {…Æ 36 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {…]¬ı]‰ı {…Æ˙ n˘“ V……x…“ Ω˲* V…Ë∫…‰ ¶…“ Ω˛…‰, ™…Ω˛ ±…‰x…n‰˘x… +¶…“ i…EÚ |…¶……¥… ®… x…Ω˛” +…™…… M…™…… Ω˲* M…™…… +…™…… x…Ω˛” ®… |…¶……¥… i…EÚ +¶…“ ±…‰x…n‰˘x… ™…Ω˛ Ω˛…‰, ¶…“ V…Ë∫…‰ Ω˲* V……x…“ n˘“ {…Æ˙ {…]¬ı]‰ı ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á 36 {…Æ 1/- ` ±……J…… ®… ±……J…… ` ±……J…… ®… ±……J…… 16.50 ±……J… {…Æ˙ +…ËÆ˙ Ω˛±±……‰EÚ E‰Ú 44 BEÚb˜ |… i… BEÚb˜ |… i… BEÚb˜ 44 E‰Ú Ω˛±±……‰EÚ +…ËÆ˙ {…Æ˙ ±……J… 16.50 2012-13 ` 2,127.79 ` ±……J…… ®… ±……J…… 916.24924.74 - 568.93 ` 2013-14 1,840.98 568.93 ®…⁄±… ±……M…i… ®…⁄±… ±……J…… ®… ±……J…… 869.21 2,569.57 2013-14` 2012-13 1,006.531,085.17 2,679.84 2,302.31 ®…⁄±… ±……M…i… 1,613.33 3,166.00 E‰Ú {…]¬ı]‰ı {…Æ˙ EÚÆ˙…™…‰ E‰Ú ±…B 19.04.1982 ∫…‰ 99 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B M……‰¥…… ∫…Æ˙EÚ…Æ˙ E‰Ú {…]¬ı]‰ı {…Æ˙ ¶…⁄ ®… ®… Œ∫l…i… 84,413 ∫C¥…™…Æ˙ ®…“]ıÆ˙ EÚ… V…“ B {…“ B±… °ËÚC]ıÆ˙“ {… Æ˙∫…Æ˙, +S…±… {… Æ˙∫…∆{… k… +S…±… {… Æ˙∫…Æ˙, °ËÚC]ıÆ˙“ B±… {…“ B V…“ EÚ… ®…“]ıÆ˙ ∫C¥…™…Æ˙ 84,413 Œ∫l…i… ®… ¶…⁄ ®… {…Æ˙ {…]¬ı]‰ı E‰Ú ∫…Æ˙EÚ…Æ˙ M……‰¥…… ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á 99 ∫…‰ 19.04.1982 ±…B E‰Ú EÚÆ˙…™…‰ {…Æ˙ {…]¬ı]‰ı E‰Ú 3,166.00 ` 10.12 EÚÆ˙…‰b˜ EÚ“ n˘Æ˙ {…Æ˙ = q˘π]ı EÚ™…… (56 BEÚb˜ |… i… BEÚb˜ E‰Ú ±…B E‰Ú BEÚb˜ |… i… BEÚb˜ (56 EÚ™…… = q˘π]ı {…Æ˙ n˘Æ˙ EÚ“ EÚÆ˙…‰b˜ 10.12 5000 ±……M…i… ∫…‰ EÚ®… ±……M…i… {… Æ˙∫…∆{… k…™……Â, V……‰ {…⁄Æ˙“ i…Æ˙Ω˛ ∫…‰ ®…⁄±™…ø… ∫…i… EÚ™…… M…™…… Ω˲, E‰Ú + i… Æ˙HÚ ∂…‰π… +x™… ∫……Æ˙“ {… Æ˙∫…∆{… k…™…… {…Æ˙ ®…⁄±™…ø…∫… ®…⁄±™… {…r˘ i… +{…x……™…“ M…™…“ Ω˲ M…™…“ +{…x……™…“ {…r˘ i… ®…⁄±™… ®…⁄±™…ø…∫… {…Æ˙ {… Æ˙∫…∆{… k…™…… ∫……Æ˙“ +x™… ∂…‰π… + i… Æ˙HÚ E‰Ú Ω˲, M…™…… EÚ™…… ®…⁄±™…ø… ∫…i… ∫…‰ i…Æ˙Ω˛ {…⁄Æ˙“ V……‰ {… Æ˙∫…∆{… k…™……Â, ±……M…i… EÚ®… ∫…‰ ±……M…i… 5000 ` ` 3.76 ±……J… EÚx……«]ıEÚ +…Ët…‰ M…EÚ˙ I…‰j… ¥…EÚ…∫… §……‰b«˜ EÚ…‰ |…n˘k… {…⁄h…« ∫¥…… ®…i¥… ¶…⁄ ®… EÚ… ®…⁄±™… Æ˙Ω˛… Ω˲* Æ˙Ω˛… ®…⁄±™… EÚ… ¶…⁄ ®… ∫¥…… ®…i¥… {…⁄h…« |…n˘k… EÚ…‰ §……‰b«˜ ¥…EÚ…∫… I…‰j… +…Ët…‰ M…EÚ˙ EÚx……«]ıEÚ ±……J… 3.76 Ω˲* Æ˙Ω˛… ®…⁄±™… +…§…∆]ıx… Ω˲* EÚ… Æ˙Ω˛… {±……‰]ı˜ ®…⁄±™… ®…“]‰ı∫…« EÚ… ∫C¥…™…Æ˙ ¶…⁄J…∆b˜ 1005.22 ±…B ±…B {…Æ˙ {…Æ˙ {…]¬ı]‰ı {…]¬ı]‰ı ®…“]ıÆ˙ E‰Ú ±…B Ω˲* ∫C¥…™…Æ˙ ¥…π……Á 5000 Æ˙Ω˛… 60 +…§…∆ ]ıi… ®…⁄±™… ®… ±…B E‰Ú ®…÷∆§…<« E‰Ú ¶…⁄ ®… ±……J… ¥…π……Á BEÚc˜ 92.41 90 430.10 ®… ±…B |…n‰˘∂… E‰Ú =k…Æ˙ +¥… v… (x……‰Bb˜…), EÚ“ |…… v…EÚ…Æ˙“ ¥…π……Á ¥…EÚ…∫… 99 +…Ët…‰ M…EÚ ®… +…‰J…±…… i… ®…±…x……b÷˜ x™…⁄ S…ÂM…±…{…‰]¬ı]÷ı, ±……J… ∫…‰ 261.94 i… ®…±…x……b÷˜ +…<«), +…Æ˙ ]ı“ B±… (∫…“ ∫…∆∫l……x… +x…÷∫…∆v……x… B¥…∆ ∂…I…h… ±…‰|…∫…“ EÂÚp˘“™… 99 E÷Ú±… 4,574.24 9,679.52 +…CE÷Ú±…®… ∫…∆™…∆j… +…CE÷Ú±…®… ∫…∆™…∆j… i…Ø˚¥…x…∆i…{…÷Æ˙®… ∫…∆™…∆j… §…‰±…M……®… ®…∂…“x… +…<« +…Æ˙ B®… +x…÷∫…⁄S…“ ®… ∂…… ®…±… x…Ω˛” EÚ™…… M…™…… Ω˲* M…™…… EÚ™…… x…Ω˛” ∂…… ®…±… ®… +x…÷∫…⁄S…“ Ω˲*˙ M…™…“ EÚ“ {… Æ˙∂……‰ v…i… {…Æ˙ EÚ…x…⁄x…“ EÚ…™…«¥……Ω˛“ ±…∆ §…i… Ω˲* Ω˛®… §…“S… ®…Â, E∆Ú{…x…“ x…‰ +{…x…‰ + v…EÚ…Æ˙ E‰Ú 430.10 BEÚc˜ ¶…⁄ ®… E‰Ú ¥…S……Æ˙ E‰Ú ±…B BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ EÚ…‰ 20.02.2014 E‰Ú |…¶……¥… ∫…‰ ={… {…]¬ı]‰ı {…Æ˙ n˘™…… Ω˲* n˘™…… {…Æ˙ {…]¬ı]‰ı ={… ∫…‰ |…¶……¥… E‰Ú 20.02.2014 EÚ…‰ ±… ®…]‰ıb˜ §……™……‰]‰ıEÚ BS…B±…B±… ±…B E‰Ú ¥…S……Æ˙ E‰Ú ¶…⁄ ®… BEÚc˜ 430.10 E‰Ú + v…EÚ…Æ˙ +{…x…‰ x…‰ E∆Ú{…x…“ ®…Â, §…“S… Ω˛®… Ω˲* ±…∆ §…i… EÚ…™…«¥……Ω˛“ EÚ…x…⁄x…“ ` ` ` ` EÚ…‰ 4.17 EÚÆ˙…‰c˜ E‰Ú n˘“P…«EÚ… ±…EÚ ¥…n‰˘∂…“ ®…÷p˘… @Òh… {…Æ˙ EÚ…±{… x…EÚ ¥…n‰˘∂…“ ¥… x…™…®… P…]ı…¥…-§…g¯…±… EÚ…‰ ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ E‰Ú n˘ 29.12.11 E‰Ú + v…∫…⁄S…x…… ∫…∆ V…“ B∫… +…Æ˙ 913 (<«) +…ËÆ˙ {… Æ˙{…j… +…ËÆ˙ (<«) 913 +…Æ˙ B∫… V…“ ∫…∆ + v…∫…⁄S…x…… E‰Ú 29.12.11 n˘ E‰Ú ∫…Æ˙EÚ…Æ˙ ¶……Æ˙i… EÚ…‰ P…]ı…¥…-§…g¯…±… ¥… x…™…®… ¥…n‰˘∂…“ EÚ…±{… x…EÚ {…Æ˙ @Òh… ®…÷p˘… ¥…n‰˘∂…“ n˘“P…«EÚ… ±…EÚ E‰Ú EÚÆ˙…‰c˜ 4.17 EÚ) E‰ÚÆ˙±… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… x…:∂…÷˝±EÚ +∆i… Æ˙i… 11.44 BEÚc˜ i…l…… 7.14 BEÚb˜ ¶…⁄ ®… E‰Ú ]ı…‰EÚx… ®…⁄±™… ]ı…‰EÚx… E‰Ú ¶…⁄ ®… BEÚb˜ 7.14 i…l…… BEÚc˜ 11.44 +∆i… Æ˙i… EÚ) x…:∂…÷˝±EÚ u˘…Æ˙… ∫…Æ˙EÚ…Æ˙ E‰ÚÆ˙±… (EÚ) <« +…Æ˙ {…“ ∫……Ï}]ı¥…‰™…Æ˙ (B∫… B {…“) ®… x…¥…‰∂… 8 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B ∫…“v…“ Ɖ˙J…… +…v……Æ˙ {…Æ˙ ®…⁄±™…ø… ∫…i… EÚ™…… M…™…… Ω˲* +x™… E∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ i…“x… ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B ∫…®…x…÷{…… i…EÚ +…v……Æ˙ UÙ)∫…®…x…÷{…… i…EÚ ±…B E‰Ú ¥…π…« +¥… v… |… i… EÚ“ ¥…π……Á i…“x… ∫……Ï}]ı¥…‰™…Æ E∆Ú{™…⁄]ıÆ˙ +x™… Ω˲* M…™…… EÚ™…… ®…⁄±™…ø… ∫…i… {…Æ˙ +…v……Æ˙ Ɖ˙J…… ∫…“v…“ ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á 8 x…¥…‰∂… ®… {…“) B (B∫… ∫……Ï}]ı¥…‰™…Æ˙ {…“ +…Æ˙ <« (EÚ) |…h……¥…“ B®… B±… B∫… +…ËÆ˙ Ω˲ M…™…“ EÚ“ {… Æ˙∂……‰ v…i… ±…B E‰Ú +¥… v… EÚ“ ¥…π……Á {……ƒS… ]≈‰ıb˜®……E«Ú/{…‰]Âı]ı (J…) S…) + v…EÚ…Æ˙ E‰Ú 430.10 BEÚb˜… ®… 3.38 BEÚb˜ ¶…⁄ ®… i… ®…±…x……b÷˜ ¥…t÷i… §……‰b«˜ EÚ…‰ |… i… ¥…π…« |… i… EÚ…‰ §……‰b«˜ ¥…t÷i… i… ®…±…x……b÷˜ ¶…⁄ ®… BEÚb˜ 3.38 S…)®… BEÚb˜… 430.10 E‰Ú + v…EÚ…Æ˙ J…) ±……M…i… EÚ“ <®……Æ˙i… +…ËÆ˙ ¶…⁄ ®… BEÚc˜˜ 3 Æ˙Ω˛“Ú {…Æ˙ {…]¬ı]‰ı ®… §……±…Æ˙…®…{…÷Æ˙®… E‰Ú E‰ÚÆ˙±… EÚ)E‰Ú ±…B ¥…π……Á 99 J…) M…) ±… ®…]‰ıb˜ §……™……‰]‰ıEÚ BS…B±…B±… ¶…⁄ ®… BEÚb˜ 100 ®… ¶…⁄ ®… BEÚb˜ 430.10 E‰Ú P…) I…‰j… + v…EÚ…Æ˙ +{…x…‰ +x…÷∫……Æ˙, E‰Ú ∫…°Ú… Æ˙∂… EÚ“ ∫…Æ˙EÚ…Æ˙ ¶……Æ˙i… ®…∆j……±…™…, ¥…k… §…“), RÛ)+…<« ({…“ §……‰b«˜ x…¥…‰∂… ∫……¥…«V… x…EÚ (P…) V…“ B {…“ B±… ±……<¢Úœ∫|…M… +∫{…i……±… |……<¥…‰]ı ±… ®…]‰ıb˜ ®… ®…⁄±™…ø…∫… ∫…“v…“ Ɖ˙J…… |…h……±…“ ∫¥…“EÚ…Æ˙ EÚ“ M…™…“ Ω˲* M…™…“ EÚ“ ∫¥…“EÚ…Æ˙ |…h……±…“ Ɖ˙J…… ∫…“v…“ ®…⁄±™…ø…∫… ®… ±… ®…]‰ıb˜ |……<¥…‰]ı +∫{…i……±… ±……<¢Úœ∫|…M… B±… {…“ B V…“ (P…) (M…) BS…B±…B±… E‰Ú ∫…∆™…∆j… +…ËÆ˙ ®…∂…“x…Æ˙“ E‰Ú E÷ÚUÙ ®…n˘… E‰Ú ∫…∆§…∆v… ®… x…“S…‰ ∫…⁄ S…i… EÚB V…Ë∫…“ ®…⁄±™…ø…∫… EÚ“ ∫…“v… EÚ“ ®…⁄±™…ø…∫… V…Ë∫…“ EÚB ∫…⁄ S…i… x…“S…‰ ®… ∫…∆§…∆v… E‰Ú ®…n˘… E÷ÚUÙ E‰Ú ®…∂…“x…Æ˙“ +…ËÆ˙ ∫…∆™…∆j… E‰Ú BS…B±…B±… (M…) <∫… +V…«x… ±……M…i… ®… 306 ∫…Â]ı +…EÚ…Æ˙ EÚ“ ¶…⁄ ®… E‰Ú {…]¬ı]‰ın˘…Æ˙“ + v…EÚ…Æ˙ +…ËÆ˙ 01.03.2005 ∫…‰ ∂…÷∞¸ Ω÷˛<« 99 ¥…π……Á EÚ“ {…]¬ı]ı… +¥… v… ∂…… ®…±… Ω˲* ∂…… ®…±… +¥… v… {…]¬ı]ı… EÚ“ ¥…π……Á 99 Ω÷˛<« ∂…÷∞¸ ∫…‰ 01.03.2005 +…ËÆ˙ + v…EÚ…Æ˙ {…]¬ı]‰ın˘…Æ˙“ E‰Ú ¶…⁄ ®… EÚ“ +…EÚ…Æ˙ ∫…Â]ı 306 ®… ±……M…i… +V…«x… <∫… ` ]ı{{…h…“ : ]ı{{…h…“ - ΩÈ˛ ∂…… ®…±… 1.®… ®…⁄±™… E‰Ú ¶…⁄ ®… ∫¥…… ®…i¥… {…⁄h…« 3.ΩÈ˛* V…Ë∫…“ x…®x… Æ˙“ i… ®…⁄±™…ø…∫… M…<« +{…x……<« 2. {…]¬ı]‰ı {…Æ˙ ¶…⁄ ®… E‰Ú ®…⁄±™… x…®x… ±… J…i… ∂…… ®…±… Ω˲* ∂…… ®…±… 2. x…®x… ±… J…i… ®…⁄±™… E‰Ú ¶…⁄ ®… {…Æ˙ {…]¬ı]‰ı 4. S……±…⁄ EÚ…™…« {…⁄ƒV…“ ®… B‡Æ˙…{…÷Æ˙®…, {…‰Ø˚®§……¥…⁄Æ˙, E‰ÚÆ˙±… Æ˙…V™… E‰Ú ∫¥…… ®…i¥… ¥……±…‰ Æ˙§…b˜ {……E«Ú E‰Ú ¶…… M…EÚ ∞¸{… ∫…‰ {…⁄Ɖ˙ EÚB E∆Úb˜…‰®… ¥… x…®……«h… ∫…÷ ¥…v…… E‰Ú +V…«x… E‰Ú ±…B |…n˘k… ¥…n‰˘∂…“ |…n˘k… ±…B E‰Ú +V…«x… E‰Ú |…i™…‰EÚ ∫…÷ ¥…v…… (P…) ¥… x…®……«h… E∆Úb˜…‰®… EÚB {…⁄Ɖ˙ ∫…‰ ∞¸{… ¶…… M…EÚ E‰Ú {……E«Ú Æ˙§…b˜ ¥……±…‰ ∫¥…… ®…i¥… E‰Ú Æ˙…V™… E‰ÚÆ˙±… 4.{…‰Ø˚®§……¥…⁄Æ˙, B‡Æ˙…{…÷Æ˙®…, ®… {…⁄ƒV…“ EÚ…™…« S……±…⁄ 5. ∫…∆ 25/2012 n˘x……∆EÚ 9 +M…∫i…, 2012 E‰Ú +…v……Æ˙ {…Æ˙ ±…‰J…… x…“ i… E‰Ú +x…÷∫…Æ˙h… EÚÆ˙i…‰ Ω÷˛B +S…±… {… Æ˙∫…∆{… k…™…… ®… ∂…… ®…±… EÚ™…… M…™…… Ω˲* M…™…… EÚ™…… ∂…… ®…±… ®… {… Æ˙∫…∆{… k…™…… +S…±… Ω÷˛B EÚÆ˙i…‰ +x…÷∫…Æ˙h… E‰Ú x…“ i… ±…‰J…… {…Æ˙ +…v……Æ˙ E‰Ú 2012 +M…∫i…, 9 n˘x……∆EÚ 25/2012 ∫…∆ M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ °Ú…®…«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ °Ú…®…«∫™…⁄ ]ıEÚ±∫… +…ËÆ˙ B∆]ı“§……™……‰ ]ıC∫… M……‰¥…… ±… ®…]‰ıb˜ (|……<¥…‰]ı) +∫{…i……±… ±……<¢Úœ∫|…M… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 246 ch Institute (CLTRI) 5000 each which ` the lease period is elow. 1/year to Tamil Nadu Electricity Board. However Tamil 1/year to ` 2.00 Lacs per acre). Transfer of land is yet to be effected, 4.17 crs has been capitalised in line with the Accounting Policy in line with the 4.17 crs has been capitalised ` ` in lacs in lacs ` ` 16.50 Lacs per acre and 44 acres of hillock@ ` in lacs 869.21 2,569.57 in lacs Original Cost 2013-14 2012-13 ` ` Original Cost 2013-14916.24 2012-13 924.741,840.98 - 568.93 568.93 1,006.53 2,679.84 1,613.33 2,127.79 400 lacs paid for the acquisition of partly completed condom manufacturing facility at State owned completed condom manufacturing facility at State 400 lacs paid for the acquisition of partly ` 10.12 crores (56 acres@ ` 94 for a period of 94 years w.e.f. 20.02.2014. 94 for a period of years w.e.f. ` 3,166.00 per annum is not inclued in Fixed asset schedule. being the value of 5000 sq.mtr of leasehold land allotted in the New Okhla Industrial Development Authority (NOIDA),Uttar Authority (NOIDA),Uttar Pra desh for 90 being the value of 5000 sq.mtr leasehold land allotted in New Okhla Industrial Development ` being the price of freehold land paid to Karnataka Industrial Area Development Board. Development Area Industrial Karnataka to paid being the price of freehold land 2/- being the token value of 11.44 acres and 7.14 of land transferred by the Govt. Kerala free cost. 2/- being the token value of 11.44 130.46 lacs being the cost of 3 acres leasehold land and building at Balaramapuram, Kerala for 99 years. years. 60 for lease on Mumbai in 92.41 lacs being the allotment value of 1005.22 sq.mtrs. plot 261.94 lacs 3.76 lacs 99/- being the value of 430.10 acres land alloted in Chengalpettu, Chennai for 99 years, from Central Leprosy Teaching & Resear Teaching 99/- being the value of 430.10 acres land alloted in Chengalpettu, Chennai for 99 years, from Central Leprosy ` ` ` ` years. Limited valued@ years on pro-rata basis. pending in legal procedures. In the meantime, company has sub-leased 100 acres of land earmarked out 430.10 to HLL Biotech Ltd. at a consideration of lease rent of ` ` based on the notification no. GSR 913 (E) dtd. 29-12-11 of Government of India and Circular No. 25/2012 dated 9th August, 2012. of Government India and Circular No. 25/2012 dated 9th 29-12-11 based on the notification no. GSR 913 (E) dtd. have been fully depreciated a) d) b) b) c) a) Tamilnadu. e) Biotech possession, for HLL 100 acres of land is earmarked out the 430.10 in Affairs, In line with the decision of Cabinet Committee on Economic a) Investment in ERP Software (SAP) is depreciated on a straight line basis for period of 8 yrs. Other computer softwares are amortised over a period of three b) Trade Mark/Patents are amortised over a period of 5 years and SLM method @4.71% is followed by GAPL. c) as indicated b items of Plant & Machinery HLL line method of depreciation has been adopted in respect certain Straight f)Acres of land, out 430.10 acres in possession, to be given on lease for a period 36 years @ 3.38 Rubber Park at Irapuram, Perumbavoor, Kerala. This acquisition cost includes leasehold right in land admeasuring 306 cents, and This acquisition cost includes leasehold right in land admeasuring 306 cents, Kerala. Rubber Park at Irapuram, Perumbavoor, for 99 years, commencing from 01.03.2005. Akkulam Plant PlantTrivandrum Belgaum Plant Antibiotics and Pharmaceuticals Ltd Goa 1,085.17 2,302.31 MRI Machine Totald) Pvt. Ltd Hospital and Life Spring line method of Depreciation has been adopted in GAPL Straight (P) Ltd. Hospitals Life Spring d) Written down value method of depreciation has been adopted on all the remaining assets, other than assets costing less 4,574.24 9,679.52 this 'transaction has so far not been effected. g) GAPL factory premises situated in the Leasehold land from Govt. of Goa, admeasuring 84,413 Sq.mts for a period 99 years commencing from 19.04.1982 for Note: 1. Cost of Free hold Land includes - 2. Cost of Lease hold land includes the following 3. Methods of depreciation adopted are as follows. 5. Foreign Currency Loan amounting to Term Notional Foreign Exchange fluctuation loss on Long 4. in Progress includes Work Capital Annual Report 2013-2014 247 E÷Ú±… ±……J…… ®… ±……J…… ` ) 0.16 % 31.03.2014 x…™…∆j…h… EÚ“ ∫…“®…… EÚ“ x…™…∆j…h… x…÷rfi˘i… ±……J…… ®… ±……J…… ` 31.03.2013 EÚ…‰ 31.03.2013 +…∆ ∂…EÚÚ/ {…⁄h…« ∞¸{… ∫…‰ |…n˘i…∫…‰ ∞¸{… {…⁄h…« ( ±……J…… ®… ±……J…… =rfi˘i… + É` ---- E÷Ú±… ±……J…… ®… ±……J…… +x…÷rfi˘˘˘i…|…n˘k… ∫…‰ Ø˚{… {…⁄h…« ` - 2.25 2.25 - 2.00 2.00 2.25 2.25 - 2.00 2.00 x…÷rfi˘i… ±……J…… ®… ±……J…… ` 31.03.2014 EÚ…‰ 31.03.2014 - - =rfi˘i… + ±……J…… ®… ±……J…… ` 20,000 20,000 31.03.2014 31.03.2013 E÷Ú±… - 2.25 2.25 - 2.00 2.00 J…) - 2.25 2.25 - 2.00 2.00 + E÷Ú±… - ¥™……{……Æ˙ (B) ¥™……{……Æ˙ - E÷Ú±… =t˘®…/ x…™…∆ j…i… ∫…k……/+x™… =t˘®…/ x…™…∆ j…i… ¥…¥…Æ˙h… x…¥…‰∂…… E‰Ú ∫…∆EÚ ±…i… ®…⁄±™… ∫…∆EÚ ±…i… E‰Ú x…¥…‰∂…… E÷Ú±… (EÚ E÷Ú±… E÷Ú±…-+x™… x…¥…‰∂… (J…) x…¥…‰∂… E÷Ú±…-+x™… - =rfi˘i… ∫…®…x…÷π…∆M…“ E∆Ú{… x…™……ƒ ∫…®…x…÷π…∆M…“ E∆Ú{… x…™……ƒ =t®… ∫…∆™…÷HÚ E‰Ú ∫…k…… +x™… E∆Ú{… x…™……ƒ =t®… ∫…∆™…÷HÚ <ŒC¥…]ı“ ={…EÚÆ˙h…… ®… x…¥…‰∂… ®… ={…EÚÆ˙h…… <ŒC¥…]ı“ Bx… ¥…Æ˙…‰ E‰ÚÆ˙±… ±… ®…]‰ıb˜ ]ı{{…h…“ 11. M…ËÆ˙ ¥…i…«®……x… x…¥…‰∂… (∫…®…‰ EÚi…) x…¥…‰∂… ¥…i…«®……x… M…ËÆ˙ 11. ]ı{{…h…“ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 248 lacs ` (7) 31.03.2014 Holding (%) lacs ` AS AT 31.03.2013 AS AT (6) lacs ` (5) lacs ` Unquoted Fully paid UnquotedUnquoted fully paid fully paid 0.16 ------2.252.25 2.25 2.25 - - 2.00 2.00 2.00 2.00 lacs ` 31.03.2013 (4) AS AT 31.03.2014 AS AT 20,000 20,000 31.03.2014 - 2.25 2.25 - 2.00 2.00 lacs ` Quoted Unquoted Total Quoted Unquoted Total (3) Others Others 250 - Associate/ Subsidiary/Shares/Unitsof No. Quoted/ Parly Paid/of Extent Entity/Others JV/Controlled/ Total - Trade (A) - Trade Total Total - Other Investments (B) - Other Investments Total - Particulars (2) Name of the Body Corporate other entities Total - 2.25 2.25 - 2.00 2.00 Investments in Equity Instruments (i) of joint venture companies ------Other investments : Other investments (i) of subsidiary companies (ii) of joint venture companies(iii) of - (a) Kerala Enviro Infrastructures Ltd. (b) Co-operative Bank Ltd. Goa State (1) Sl. (b)Investment in debentures (fully paid) (A+B) Total Less : Provison for diminution in value of investments ------Investments (At cost) : A. Trade B. (a)Investment in equity instruments (fully paid) ------No. Aggregate value of listed but not quoted investments Aggregate amount of unquoted investments Note 11. Non-current investments (Consolidated) Non-current investments Note 11. Note : Details of Other Investments Annual Report 2013-2014 249 ]ı{{…h…“ 11 EÚ. n˘“P…«EÚ…±…“x… @Òh… B¥…∆ + O…®… (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… n˘“P…«EÚ…±…“x… @Òh… B¥…∆ + O…®… +|… i…¶…⁄i…, ™……‰M™… ∫…®…Z…‰ M…B {…⁄ƒV…“ + O…®… 2,133.84 2,230.93 {…]¬ı]‰ı {…Æ˙ ®…EÚ…x… V…®…… 48.53 50.00 ∫…÷Æ˙I…… V…®…… 7.77 1.63 ∫…∆ n˘Mv… E÷Ú±… 2,190.14 2,282.56 ]ı{{…h…“ 11 J…. +x™… M…ËÆ˙ S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… §…]¬ı]‰ı J……i…‰ x…Ω˛” b˜…±…“ M…™…“ ∫…“®…… i…EÚ |…… v…EfiÚi… ∂…‰™…Æ˙ {…⁄ƒV…“ §…g¯…x…‰ E‰Ú ±…B +…Æ˙ +…‰ ∫…“ EÚ… S……V…« 84.00 112.00 <« ∫…“ §…“ @Òh… + O…®… ∂…÷±EÚ 38.22 - |……Æ∆˙ ¶…EÚ J…S…« 0.52 0.52 ®……]ıı G‰Ú b˜]ı {……j…i…… 444.83 419.00 E÷Ú±… 567.57 531.52 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 250 Note 11.A. Long Term Loans & Advances (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs LONG TERM LOANS & ADVANCES Unsecured, considered good Capital advances 2,133.84 2,230.93 Lease Building deposits 48.53 50.00 Security Deposits 7.77 1.63 Doubtful -- Total 2,190.14 2,282.56 Note 11.B. Other Current Assets (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Fee for ROC for enhancing Authorised Share Capital to the extent not written off 84.00 112.00 ECB Loan Upfront charges 38.22 - Preliminary Expenses 0.52 0.52 MAT Credit Entitlement 444.83 419.00 Total 567.57 531.52 Annual Report 2013-2014 251 ]ı{{…h…“ 12 ¥…∫i…÷∫…⁄S…“ (∫…®…‰ EÚi…) ( x…®x…i…®… ±……M…i… {…Æ˙ +…ËÆ˙ x…¥…±… ¥…∫…⁄±…“ ∫……v™… ®…⁄±™…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… EÚ. EÚSS…‰ ®……±… (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 2,151.31 2,021.12 +x™…… E‰Ú ∫……l… EÚSS…‰ ®……±… (±……M…i… {…Æ ®…⁄±™……∆ EÚi…) - - 2,151.31 2,021.12 J…. {…È EÚM… ∫……®…O…“ (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 1,028.06 978.02 1,028.06 978.02 M…. S……±…⁄ EÚ…™…« (¥……∫i… ¥…EÚ |… EÚ™…… ±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 1,552.05 1,794.56 1,552.05 1,794.56 P…. i…Ë™……Æ˙ ®……±… ( x…®x…i…®… ±……M…i… {…Æ˙ ™…… Bx… +…Æ˙ ¥…“ {…Æ˙ ®…⁄±™……∆ EÚi…) ¥… x…î…i… =i{……n˘ 3,654.90 2,083.68 ∫……®…… V…EÚ ¥…{…h…x… =i{……n˘ 94.94 222.61 ¥™…¥…∫……™… =i{……n˘ 2,064.80 2,295.79 ®……M…«∫l… ®……±… 13.33 15.39 5,827.97 4,617.47 RÛ. ∫……®……x™… ¶…∆b˜…Æ˙ B¥…∆ ={…¶……‰V™… (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 104.89 125.93 104.89 125.93 S…. +x™… ∫……®… O…™……ƒ, ®…∂…“x…Æ˙“, + i… Æ˙HÚ {…÷V…Á, <®……Æ˙i…“ ∫……®……x… +… n˘ (±……M…i… {…Æ˙ ®…⁄±™……∆ EÚi…) 1,053.76 868.13 1,053.76 868.13 UÙ. |…§…∆v… u˘…Æ˙… {…÷x…®…⁄«±™……∆ EÚi… +…ËÆ˙ |…®…… h…i… +…ËV……Æ˙ 13.82 3.56 13.82 3.56 V…. +x™… Æ˙q˘“/+ v…∂…‰π… ∫…∆{… k…™……ƒ ( x…®x…i…®… ±……M…i… ™…… x…¥…±… ¥…∫…⁄±…“ ∫……v™… ®…⁄±™… {…Æ˙) 25.39 13.31 ={…Ω˛…Æ˙ ®…n¢ (±……M…i… {…Æ˙) 126.19 128.79 ±…‰J…x… ∫……®…O…“ (±……M…i… {…Æ˙) 65.97 64.97 217.55 207.07 11,949.41 10,615.86 x™…⁄x… : +|…™…÷HÚ ∫]ı…ÏEÚ E‰Ú ±…B +∆ i…®… |……¥…v……x… 95.95 97.95 E÷Ú±… 11,853.46 10,517.91 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 252 Note 12 Inventories (Consolidated) (At lower of cost and net realisable value) AS AT AS AT Particulars 31.03.2014 3.103.2013 ` lacs ` lacs a. Raw Materials (Valued at cost) 2,151.31 2,021.12 Raw Materials with others (Valued at cost) - - 2,151.31 2,021.12 b. Packing Materials (Valued at cost) 1,028.06 978.02 1,028.06 978.02 c. Work-in-progress (Valued at Actual Process Cost) 1,552.05 1,794.56 1,552.05 1,794.56 d. Finished goods (Valued at Lower of cost or NRV) Manufactured Products 3,654.90 2,083.68 Social Marketing Products 94.94 222.61 Trading Products 2,064.80 2,295.79 Goods-in-transit 13.33 15.39 5,827.97 4,617.47 e. General Stores and Consumables (Valued at cost) 104.89 125.93 104.89 125.93 f. Other materials, machinery, spare parts, building materials etc. (Valued at cost) 1,053.76 868.13 1,053.76 868.13 g. Tools revalued & certified by management 13.82 3.56 13.82 3.56 h. Others Scrapped/Surplus Assets (lesser of cost or net realisable value) 25.39 13.31 Gift items (at cost) 126.19 128.79 Stationary (at cost) 65.97 64.97 217.55 207.07 11,949.41 10,615.86 Less:Closing Provision for Obsolete Stock 95.95 97.95 Total 11,853.46 10,517.91 Annual Report 2013-2014 253 ]ı{{…h…“ 13 |……{™… ¥…∫i…÷+… EÚ… ¥™……{……Æ˙ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… ¶…÷M…i……x… E‰Ú ±…B x…™…i… i……Æ˙“J… ∫…‰ UÙΩ˛ ®…Ω˛“x…‰ EÚ“ EÚ®… +¥… v… E‰Ú ±…B §…EÚ…™…… ¥™……{……Æ˙ |……{™… ¥…∫i…÷B∆ |… i…¶…⁄i…, ∂…˝…‰v™… ∫…®…Z…‰ M…B 80.40 114.89 +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 30,671.65 27,571.07 30,752.05 27,685.96 ¶…÷M…i……x… E‰Ú ±…B x…™…i… i……Æ˙“J… ∫…‰ UÙΩ˛ ®…Ω˛“x…‰ EÚ“ + v…EÚ +¥… P… E‰Ú ±…B §…EÚ…™…… |……{™… ¥™……{……Æ˙ ¥…∫i…÷B∆ |… i…¶…⁄i…, ∂…˝…‰v™… ∫…®…Z…‰ M…B 0.37 - +|… i…¶…⁄i…, ∂…˝…‰v™… ∫…®…Z…‰ M…B 13,774.19 13,792.99 ∫…∆ n˘Mv… ∫…®…Z…‰ M…B 1,316.36 1,094.99 15,090.92 14,887.98 x™…⁄x… : ∫…∆ n˘Mv… |……{™… ¥™……{…˙…Æ E‰Ú ±…B |……¥…v……x… 1,316.36 1,094.99 13,774.56 13,792.99 E÷Ú±… 44,526.61 41,478.95 ]ı{{…h…“ 14 Æ˙…‰EÚc˜ +…ËÆ˙ Æ˙…‰EÚc˜ ∫…®……x……l…‘ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) Ω˛…l… ®… EËÚ∂…/∫]ı…®{… 25.88 16.13 (J…) §…ÈEÚ ∂…‰π… (i) S……±…⁄ J……i…‰ ®… 4,188.49 1,431.60 (ii) <« <« B°Ú ∫…“ J……i…‰ ®… 13.74 0.02 (iii)+…‰¥…Æ˙b≈˜…}]ı J……i…‰ ®… (V…®…… J……i……) 298.05 - 4,526.16 1,447.75 (iv) 3 ®…Ω˛“x…‰ ∫…‰ + v…EÚ +¥… P… E‰Ú {… Æ{…C¥…i…… Æ˙Ω˛x…‰ ¥……±…‰ V…®……Bƒ 10,310.50 13.481.57 (v) =v……Æ +…ËÆ˙ M……Æ∆˙]ı“ E‰Ú ±…B ®……ÃV…x… ®…h…“ E‰Ú ∞¸{… ®… Æ˙J…‰ V…®…… 13.07 139.69 10,323.57 13,621.26 E÷Ú±… 14,849.73 15,069.01 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 254 Note 13 Trade receivables (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Trade receivables outstanding for a period less than six months from the date they were due for payment Secured, considered good 80.40 114.89 Unsecured, considered good 30,671.65 27,571.07 30,752.05 27,685.96 Trade receivables outstanding for a period exceeding six months from the date they were due for payment Secured, considered good 0.37 - Unsecured, considered good 13,774.19 13,792.99 Considered Doubtful 1,316.36 1,094.99 15,090.92 14,887.98 Less : Provision for doubtful trade receivables 1,316.36 1,094.99 13,774.56 13.792.99 Total 44,526.61 41,478.95 Note 14 Cash and cash equivalents (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Cash/stamps on hand 25.88 16.13 (b) Balances with banks - - (i) In current accounts 4,188.49 1,431.60 (ii) In EEFC accounts 13.74 0.02 (iii)In Overdraft A/c (Debit balance) 298.05 - 4,526.16 1,447.75 (iv) Deposits having maturity period of above 3 months 10,310.50 13,481.57 (v) Deposits held as margin money for borrowings and guarantees 13.07 139.69 10,323.57 13,621.26 Total 14,849.73 15,069.01 Annual Report 2013-2014 255 ]ı{{…h…“ 15 +±{…EÚ… ±…EÚ @Òh… B¥…∆ {…‰∂… M…™……ƒ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) |… i…¶…⁄ i… V…®…… B¥…∆ <« B®… b˜“ 337.07 281.51 |… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B - - ={… ™……‰M… 337.07 281.51 (J…) EÚ®…«S…… Æ˙™…… EÚ…‰ @Òh… B¥…∆ {…‰∂… M…™……ƒ |… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 17.62 17.49 +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 395.27 321.59 ∫…∆ n˘Mv… ∫…®…Z…‰ M…B 1.17 2.57 414.06 341.65 x™…⁄x… : ∫…∆ n˘Mv… @Òh… +…ËÆ˙ {…‰∂… M…™…… E‰Ú ±…B |……¥…v……x… 1.17 2.57 ={… ™……‰M… 412.89 339.08 (M…) {…⁄¥…«|…n˘k… ¥™…™… - +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 182.33 210.70 182.33 210.70 (P…) ∫…Æ˙EÚ…Æ˙“ |…… v…EÚ… Æ˙™…… E‰Ú ∫……l… ∂…‰π… +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B (i) +…™…EÚÆ˙ {…‰∂…M…“ 1,126.55 692.67 (ii) §…GÚ“ EÚÆ˙ {…‰∂…M…“ 4.39 2.29 (iii) +x™… 10.89 3.30 ={… ™……‰M… 1,141.83 698.26 (RÛ) +x™… |… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 837.17 937.41 +|… i…¶…⁄i…, ∂……‰v™… ∫…®…Z…‰ M…B 7,348.73 6,158.72 ∫…∆ n˘Mv… ∫…®…Z…‰ M…B 440.79 454.89 ı 8,626.69 7,551.02 x™…⁄x… : ∫…∆ n˘Mv… @Òh… +…ËÆ˙ {…‰∂… M…™…… E‰Ú ±…B |……¥…v……x… 440.79 454.89 ={… ™……‰M… 8,185.90 7,096.13 E÷Ú±… 10,260.02 8,625.68 ]ı{{…h…“ : +±{…EÚ… ±…EÚ @Òh… B¥…∆ {…‰∂… M…™…… ®… n‰˘™… Æ˙EÚ®… ∂…… ®…±… Ω˲ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… x…n‰˘∂…EÚ 0.52 0.24 E∆Ú{…x…“ E‰Ú +x™… + v…˘EÚ…Æ˙“ 88.45 56.05 88.97 56.29 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 256 Note 15 Short-term loans and advances (Consolidated) AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Security deposits & EMD 337.07 281.51 Secured, considered good - - Sub Total 337.07 281.51 (b) Loans and advances to employees Secured, considered good 17.62 17.49 Unsecured, considered good 395.27 321.59 Considered Doubtful 1.17 2.57 414.06 341.65 Less : Provision for doubtful loans and advances 1.17 2.57 Sub Total 412.89 339.08 (c) Prepaid expenses - Unsecured, considered good 182.33 210.70 182.33 210.70 (d) Balances with government authorities Unsecured, considered good (i) Advance Income Tax 1,126.55 692.67 (ii) Sales Tax Advances 4.39 2.29 (iii) Others 10.89 3.30 1,141.83 698.26 (e) Others Secured, considered good 837.17 937.41 Unsecured, considered good 7,348.73 6,158.72 Considered Doubtful 440.79 454.89 8,626.69 7,551.02 Less : Provision for doubtful loans and advances 440.79 454.89 Sub Total 8,185.90 7,096.13 Total 10,260.02 8,625.68 Note : Short-term loans and advances include amounts due from : AS AT AS AT Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Directors 0.52 0.24 Other officers of the Company 88.45 56.05 88.97 56.29 Annual Report 2013-2014 257 ]ı{{…h…“ : 16 +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) |……‰n¬˘¶…¥…x… (i) B°Ú b˜“ +…Æ˙ ∫…‰ |……‰n¬˘¶…⁄i… §™……V… 64.29 3.93 (ii) V…®……Æ˙… ∂…™…… {…Æ˙ |……‰n¬˘¶…⁄i… §™……V… 0.83 1.52 (iii) ®……ÃV…x… ®… h… {…Æ˙ |……‰n¬˘¶…⁄i… §™……V… - 12.86 65.12 18.31 (J…) +x™… (i) {… Æ˙™……‰V…x……+… ∫…‰ |……{™… ¥…∫i…÷Bƒ 126.41 1,591.69 (ii) x…™……«i… |……‰i∫……Ω˛x…/¥……{…∫…“ ∂…÷±EÚ 257.82 428.83 (iii) {…Â∂…x… ™……‰V…x…… E‰Ú ±…B EÚ®…«S…… Æ˙™…… ∫…‰ |……{™… - 116.47 (iv) ={…n˘…x… |……{™… {…Æ˙ §™……V… 46.95 - (v) ∫…∆ ¥…n˘…i®…EÚ |… i…{…⁄Ãi… EÚ… J…S…« 9.07 - (vi) +x™… M…ËÆ˙-|…S……±…x… +…™… 0.05 - 440.30 2,136.99 E÷Ú±… 505.42 2,155.30 √ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 258 Note 16 Other current assets (Consolidated) Particulars AS AT AS AT 31.03.2014 31.03.2013 ` lacs ` lacs (a) Accruals (i) Interest accrued on FDR 64.29 3.93 (ii) Interest accrued on Deposits 0.83 1.52 (iii)Interest accrued on Margin Money - 12.86 65.12 18.31 (b) Others (i) Receivables from Projects 126.41 1,591.69 (ii) Export Incentives/Duty Draw back 257.82 428.83 (iii)Receivable from employees for Pension scheme - 116.47 (iv) Interest on Subsidy Receivable 46.95 - (v) Contractualy reimbursable expenses 9.07 - (vi) Other non-operating income 0.05 - 440.30 2,136.99 Total 505.42 2,155.30 Annual Report 2013-2014 259 ]ı{{…h…“ : 17 {… Æ˙S……±…x… ∫…‰ Æ˙…V…∫¥… (∫…®…‰ EÚi…) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) =i{……n˘… EÚ“ §…GÚ“ 68,538.45 64,769.29 (J…) ∫…‰¥……+… EÚ“ §…GÚ“ 5,955.12 4,441.10 (M…) `‰ˆE‰Ú ∫…‰ +…™… 17,948.86 11,980.62 (P…) +x™… |…S……±…x… Æ˙…V…∫¥… 2,978.57 2,772.15 95,421.00 83,963.16 x™…⁄x… : (RÛ) =i{……n˘ ∂…÷±EÚ 563.04 272.31 E÷Ú±… 94,857.96 83,690.85 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ]ı{{…h…“ ¥…¥…Æ˙h… ` ±……J…… ®… ` ±……J…… ®… (i) =i{……n˘… EÚ“ §…GÚ“ ®… ∂…… ®…±… ΩÈ˛ M…¶…« x…Æ˙…‰v…EÚ =i{……n˘… EÚ“ §…GÚ“ 38,437.14 37,572.07 ∫¥……∫l™…Æ˙I…… =i{……n˘… EÚ“ §…GÚ“ 16,189.97 11,823.40 ∫……®…… V…EÚ ¥…{…h…x… =i{……n˘… EÚ“ §…GÚ“ 1,880.95 1,767.26 ¥™……{……Æ˙ =i{……n˘ +…ËÆ˙ +x™…… EÚ“ §…GÚ“ 11,650.84 13,003.46 ∫…Ω‰˛±…“ {…Æ˙ =i{……n˘ <˛®…n˘…n˘ 262.58 254.52 ±……M…i… ¥…fi r˘ n˘…¥…… E∆Úb˜…‰®… - 525.48 {…“ ]ı“ E‰Ú ]‰ı∫]ı EÚ]ı - (182.15) ®……Ë J…EÚ M…¶…« x…Æ˙…‰v…EÚ (5.43) 5.25 EÚ…Ï{…Æ˙-]ı“ 95.04 - ]ı¨⁄§…±… ÀÆ˙M… 27.36 - ={… E÷Ú±… 68,538.45 64.769.29 ∫…‰¥……+… EÚ“ §…GÚ“ 5,955.12 4,441.10 `‰ˆE‰Ú ∫…‰ +…™… 17,948.86 11,980.62 +x™… |…S……±…x… Æ˙…V…∫¥… 2,978.57 2,772.15 E÷Ú±… 95,421.00 83,963.16 +x™… |…S……±…x… Æ˙…V…∫¥… ®… ∂…… ®…±… Ω˲ x…: ∂…÷±EÚ x…®…⁄x…‰ EÚ“ ±……M…i… EÚ“ +{…⁄Ãi… 1,648.42 1,423.25 ∫……®…… V…EÚ ¥…{…h…x… {…Æ˙ |……‰i∫……Ω˛x… 58.27 65.42 ∫…Ω‰˛±…“ +…ËÆ˙ x……‰¥…‰C∫… EÚ“ §…GÚ“ {…Æ˙ |…S……±…x… <˛®…n˘…n˘ 419.02 434.41 ∂…÷±EÚ ®… U⁄Ù]ı/∂…÷±EÚ ¥……{…∫…“/+x™… x…™……«i… |……‰i∫……Ω˛x… 341.73 388.57 Æ˙q˘“, +{… ∂…π]ı E∆Úb˜…‰®… +…ËÆ˙ +x™… ¥… ¥…v… ®…n˘… EÚ“ §…GÚ“ 428.82 408.60 x… ¥…n˘… |…{…j… EÚ“ §…GÚ“ 66.69 41.43 +x™… 15.62 10.47 E÷Ú±… 2,978.57 2,772.15 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 260 Note 17 Revenue from operations (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Sale of products 68,538.45 64.769.29 (b) Sale of services 5.955.12 4,441.10 (c) Income from Contract 17,948.86 11,980.62 (d) Other operating revenues 2,978.57 2,772.15 95,421.00 83.963.16 Less : (e) Excise duty 563.04 272.31 Total 94,857.96 83,690.85 Year Ended Year Ended Note Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (i) Sale of product comprises - Sale of Contraceptive Products 38,437.14 37,572.07 Sale of Healthcare Products 16,189.97 11,823.40 Sale of Social Marketing Products 1,880.95 1,767.26 Sale of Trading Products and Others 11,650.84 13,003.46 Product subsidy on saheli 262.58 254.52 Cost Escalation Claims Condoms - 525.48 PTK Test Kit - (182.15) Oral Contraceptives (5.43) 5.25 Copper-T 95.04 - Tubel Ring 27.36 - Sub Total 68,538.45 64,769.29 Sale of services 5,955.12 4,441.10 Income from Contract 17,948.86 11,980.62 Other operating revenues 2,978.57 2,772.15 Total 95,421.00 83,963.16 Other operating revenues comprise : Cost of free sample supplied 1,648.42 1,423.25 Incentive on Social Marketing 58.27 65.42 Promotional Subsidty on Saheli and Novex sales 419.02 434.41 Duty Rebate/Duty drawback/Other export incentives 341.73 388.57 Sale of scrap, waste condoms and other misc. items 428.82 408.60 Sale of tender form 66.69 41.43 Others 15.62 10.47 Total 2,978.57 2,772.15 Annual Report 2013-2014 261 ]ı{{…h…“ : 18 +x™… +…™… (∫…®…‰ EÚi…) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) §™……V… +…™… (x…“S…‰ ]ı{{…h…“ (i) n‰˘J…Â) 312.88 396.19 (J…) +x™… M…ËÆ˙-|…S……±…x… +…™… (x…“S…‰ ]ı{{…h…“ (ii) n‰˘J…Â) 876.61 310.36 E÷Ú±… 1,189.49 706.55 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ]ı{{…h…“ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (i) §™……V… +…™… ®… ∂…… ®…±… Ω˲ : §…ËEÚ…Â ∫…‰ §™……V… : EÚ) +±{……¥… v… V…®…… {…Æ˙ 298.76 371.22 J…) +x™…… {…Æ˙ 14.12 24.97 E÷Ú±…-§™……V… +…™… 312.88 396.19 (ii) +x™… M…ËÆ˙-|…S……±…x… +…™… ®… ∂…… ®…±… Ω˲: EÚ®…«S……Æ“ +…¥……∫…… ∫…‰ EÚÆ˙…B EÚ“ +…™… 2.66 2.55 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“ EÚÆ˙ ±……¶… 22.54 0.51 §…“®…… n˘…¥…… 5.25 0.65 {…÷Æ˙…∆ EÚi… EÚB + v…EÚ |……¥…v……x…/@Òh… 425.41 17.40 {…]¬ı]ı… EÚÆ˙…™…… 48.57 46.89 +x™… ¥… ¥…v… +…™… 372.18 242.36 E÷Ú±…-+x™… M…ËÆ˙-|…S……±…x… +…™… 876.61 310.36 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 262 Note 18 Other income (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Interest income (Refer Note (i) below) 312.88 396.19 (b) Other non-operating income (Refer Note (ii) below) 876.61 310.36 Total 1,189.49 706.55 Year Ended Year Ended Note Particulars 31.03.2014 31.03.2013 ` ` lacs ` lacs (i) Interest income comprises : Interest from banks on : a) On short term deposit 298.76 371.22 b) On Others 14.12 24.97 Total - Interest income 312.88 396.19 (ii) Other non-operating income comprises : Rental income from Staff quarters 2.66 2.55 Profit on sale of fixed assets 22.54 0.51 Insurance claims 5.25 0.65 Excess provision / credits written back 425.41 17.40 Lease rent 48.57 46.89 Other Misc. Income 372.18 242.36 Total - Other non-operating income 876.61 310.36 Annual Report 2013-2014 263 ]ı{{…h…“ : 19.EÚ J…{…… Ω÷˛+… ®……±… EÚ“ ±……M…i… (∫…®…‰ EÚi…) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… +…Æ∆˙ ¶…EÚ ∫]ı…ÏEÚ 3,000.10 2,784.12 V……‰b˜ : J…Æ˙“n˘ 19,590.76 19,279.59 22,590.86 22,063.71 x™…⁄x… : +∆ i…®… ∫]ı…ÏEÚ 3,108.23 2,999.14 J…{…… Ω÷˛+… ®……±… EÚ“ ±……M…i… 19,482.63 19,064.57 ={…¶…÷HÚ ∫……®…O…“ ®… ∂…… ®…±… Ω˲: EÚSS…‰ ®……±… 11,291.81 11,351.34 E‰Ú ®…EÚ±∫… 2,610.13 2,448.78 {…ËÀEÚM… ∫……®… O…™……ƒ 5,084.06 4,749.66 M…÷h…¥…k…… B¥…∆ ={…-`‰ˆEÚ… ¥™…™… EÚ“ ±……M…i… 475.53 486.98 ={…¶……‰V™… 21.10 27.81 E÷Ú±… 19,482.63 19,064.57 ]ı{{…h…“ : 19.J…Ú ¥…GÚ™… ®……±…… EÚ“ J…Æ˙“n˘ (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… ¥™……{……Æ˙ =i{……n˘ 14,209.96 16,748.41 ∫……®…… V…EÚ ¥…{…h…x… •……∆b‰˜b˜ =i{……n˘ 1,443.78 1,617.11 E÷Ú±… 15,653.75 18,365.52 ]ı{{…h…“ : 19.M… i…Ë™……Æ˙ ®……±…… EÚ“ ¥…∫i…÷∫…⁄S…“ +…ËÆ˙ S……±…⁄ EÚ…™…« ®… {… Æ˙¥…i…«x… (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… ¥…π…« E‰Ú +∆i… ®… ¥…∫i…÷∫…⁄S…“ i…Ë™……Æ˙ ®……±… 5,772.62 4,617.47 S……±…⁄ EÚ…™…« 1,545.62 1,794.56 ∫]ı…ÏEÚ ®… ¥™……{……Æ˙ 1.34 - 7,319.58 6,412.03 ¥…π…« E‰Ú |……Æ∆˙¶… ®… ¥…∫i…÷∫…⁄S…“ i…Ë™……Æ˙ ®……±… 4,619.24 2,416.21 S……±…⁄ EÚ…™…« 1,801.00 1,226.64 ∫]ı…ÏEÚ ®… ¥™……{……Æ˙ 1.04 - 6,421.28 3,642.85 x…¥…±… (¥…fi r˘)/EÚ®…“ (898.30) (2,769.18) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 264 Note 19.A Cost of materials consumed (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Opening stock 3,000.10 2,784.12 Add : Purchases 19,590.76 19.279.59 22,590.86 22,063.71 Less : Closing stock 3,108.23 2,999.14 Cost of material consumed 19,482.63 19,064.57 Materials consumed comprises : Raw Materials 11,291.81 11,351.34 Chemicals 2,610.13 2,448.78 Packing Materials 5,084.06 4,749.66 Cost of quality and Sub Contract Expense 475.53 486.98 Consumables 21.10 27.81 Total 19,482.63 19,064.57 Note 19.B Purchase of stock-in-trade (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Trading Products 14,209.96 16,748.41 Social Marketing Branded Products 1,443.78 1,617.11 Total 15,653.75 18,365.52 Note 19.C Changes in inventories of finished goods, and work-in-progress (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Inventories at the end of the year : Finished goods 5,772.62 4,617.47 Work-in-progress 1,545.62 1,794.56 Stock in trade 1.34 - 7,319.58 6,412.03 Inventories at the beginning of the year : Finished goods 4,619.24 2,416.21 Work-in-progress 1,801.00 1,226.64 Stock in trade 1.04 - 6421.28 3,642.85 Net (Increase) / decrease (898.30) (2,769.18) Annual Report 2013-2014 265 ]ı{{…h…“ : 20Ú EÚ®…«S……Æ˙“ Ω˛i…±……¶… ¥™…™… (∫…®…‰ EÚi…) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) ¥…‰i…x… +…ËÆ˙ |……‰i∫……Ω˛x… 10,558.79 9,634.79 (J…) +∆∂…n˘…x… ¶… ¥…π™… x… v… 974.54 904.38 x…™…“ {…Â∂…x… ™……‰V…x…… 150.78 267.37 ={…n˘…x… x… v… ™……‰M…n˘…x… 516.16 588.20 +ÃV…i… U÷Ù]¬ı]ı“ x… v… 175.18 169.41 EÚ®…«S……Æ˙“ Æ˙…V™… §…“®…… ®… +∆∂…n˘…x… 53.58 24.67 (M…) EÚ®…«S……Æ˙“ EÚ±™……h… ¥™…™… 1,400.58 1,112.05 E÷Ú±… 13,829.61 12,700.87 ]ı{{…h…“ : 21Ú ¥…k… ±……M…i… (∫…®…‰ EÚi…) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (EÚ) §™……V… ¥™…™… : (i) x…EÚn˘“ =v……Æ˙ 1,577.19 996.73 (ii) +…¥… v…EÚ @Òh… 98.17 215.74 (J…) +x™… =v……Æ˙ ±……M…i… 124.21 135.35 E÷Ú±… 1,799.57 1,347.82 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 266 Note 20 Employee benefits expense (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Salaries and incentives 10,558.79 9,634.79 (b) Contribution to - Provident fund 974.54 904.38 New pension scheme 150.78 267.37 Gratuity fund contributions 516.16 588.20 Earned Leave Fund 175.18 169.41 Contribution to ESI 53.58 24.67 (c) Staff welfare expenses 1,400.58 1,112.05 Total 13,829.61 12,700.87 Note 21 Finance costs (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (a) Interest expense on : (i) Cash Credit 1,577.19 996.73 (ii) Term Loan 98.17 215.74 (b) Other borrowing costs 124.21 135.35 Total 1,799.57 1,347.82 Annual Report 2013-2014 267 ]ı{{…h…“ : 22Ú +x™… ¥™…™… (∫…®…‰ EÚi…) ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… ¥…Y……{…x… B¥…∆ |…S……Æ˙ +…ËÆ˙ §…GÚ“ |……‰z…®…x… ¥™…™… 4,824.01 4,892.06 §…V…±…“ +…ËÆ˙ <∆v…x… S……V…« 3,931.11 3,545,25 ¶……c˜… +…ËÆ˙ +x™… ¥…GÚ™… ¥™…™… 3,304.40 2,650.52 ™……j…… i…l…… {… Æ˙¥…Ω˛x… 1,798.78 1,617.94 +x™… =i{……n˘x… ¥™…™… 1,777.34 1,282.68 `‰ˆE‰Ú EÚ®…«S…… Æ˙™…… EÚ…‰ ¥…‰i…x… 1,684.76 1,306.94 {…Æ˙…®…∂…« i…l…… ∫…‰¥…… ∂…÷±EÚ 1,206.63 942.75 ®…÷}i… x…®…⁄x…… ¥…i…Æ˙h… 1,733.97 1,442.09 ¥… ¥…v… ¥™…™… 882.08 702.93 +∂……‰v™… +…ËÆ˙ ∫…∆ n˘Mv… EÚV…«/+ O…®…… E‰Ú ±…B |……¥…v……x… 254.09 116.16 ®…Æ˙®®…i… i…l…… +x…÷Æ˙I…h… ®…∂…“x…Æ˙“ 415.62 335.61 b˜…EÚ, i……Æ˙ i…l…… n⁄˘Æ¶……π… 347.68 286.27 +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ¥™…™… 6.14 20.92 x…M… ®…i… +…Æ˙ & b˜“ EÂÚp˘ ¥™…™… 480.25 401.75 EÚÆ˙…™…… 477.63 432.28 ®…÷p˘h… i…l…… ±…‰J…x… ∫……®… O…™……ƒ 240.02 180.41 +x™… {… Æ˙∫…∆{… k…™…… E‰Ú ®…Æ˙®®…i… i…l…… +x…÷Æ˙I…h… 115.23 77.09 V…±… S……V…« 139.92 138.54 §…“®…… S……V…« 174.85 119.95 §…ÈEÚ S……V…« 178.71 165.72 ¥… x…®…™… =i……Æ˙-S…g¯…¥… 1,086.91 1.12 EÚ®…«S…… Æ˙™…… EÚ“ ¶…i…‘ ¥™…™… 97.71 54.03 n˘Æ˙ B¥…∆ EÚÆ˙ 126.24 124.06 §…]¬ı]‰ı J……i…‰ b˜…±…‰ M…B §…‰EÚ…Æ˙ ¶…∆b˜…Æ˙ E‰Ú ±…B |……¥…v……x… 41.88 75.66 ¥…¥…… n˘i… n‰˘x…n˘… Æ˙™…… E‰Ú ±…B |……¥…v……x… 2.55 - §…]¬ı]‰ı J……i…‰ b˜…±…‰ M…B §…‰EÚ…Æ˙ {… Æ˙∫…∆{… k…™……ƒ/¶…∆b˜…Æ˙ E‰Ú §…Ω˛“ ®…⁄±™… 43.98 74.63 |… ∂…I…h… EÚ…™…«GÚ®… ¥™…™… 93.48 108.28 <®……Æ˙i…… EÚ“ ®…Æ˙®®…i… i…l…… +x…÷Æ˙I…h… 144.37 124.11 §…]¬ı]‰ı J……i…‰ b˜…±…‰ M…B +∂……‰v™… EÚV…« B¥…∆ + O…®… 236.33 56.82 ±…‰J……{…Æ˙“I…EÚ…Â EÚ…‰ ¶…÷M…i……x… (x…“S…‰ ]ı{{…h…“ (i) n‰˘J…Â) 31.47 26.43 +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ §…GÚ“/Æ˙q˘“ {… Æ˙∫…∆{… k…™…… {…Æ˙ Ω˛… x… 2.70 2.08 ={…EÚÆ˙h… EÚÆ˙…™…… S……V…« 0.58 - x…M… ®…i… ∫……®…… V…EÚ n˘… ™…i¥… J…S…« 97.28 66.89 n˘…x… 0.11 0.32 {…⁄¥…« +¥… v… ®…n¢ ( x…¥…±…)/(x…“S…‰ ]ı{{…h…“ (ii) n‰˘J…Â) (15.81) (4.69) E÷Ú±… 25,963.20 21,367.59 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 268 Note 22 Other expenses (Consolidated) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs Advertisement & Publicity and Sales Promotion Expenses 4,824.01 4,892.06 Power & fuel charges 3,931.11 3,545.25 Freight & Other Selling Expenses 3,304.40 2,650.52 Travelling & Conveyance 1,798.78 1,617.94 Other Production expenses 1,777.34 1,282.68 Wages to Contract Labourers 1,684.76 1,306.94 Consultancy & Service Charges 1,206.93 942.75 Free sample distribution 1,733.97 1,442.09 Miscellaneous Expenses 882.08 702.93 Provision for bad & doubtful debts/Advances 254.09 116.16 Repairs & Maintenance Machinery 415.62 335.61 Postage & Telegram, Telephone 347.68 286.27 Research & Development Expenses 6.14 20.92 Corporate R & D Centre Expenses 480.25 401.75 Rent 477.63 432.28 Printing & Stationery 240.02 180.41 Repairs & maintenance of other assets 115.23 77.09 Water charges 139.92 138.54 Insurance charges 174.85 119.95 Bank charges 178.71 165.72 Exchange Fluctuation 1,086.91 1.12 Staff recruitment expenses 97.71 54.03 Rates & Taxes 126.24 124.06 Provision for obsolete stores written off 41.88 75.66 Provision for disputed liabilities 2.55 - Book value of obsolete assets/stores written off 43.98 74.63 Training program expenses 93.48 108.28 Repairs & Maintenance of buildings 144.37 124.11 Bad debt & advances written off 236.23 56.82 Payments to auditors (Refer Note (i) below) 31.47 26.43 Loss on sale of Fixed Assets/scrapped assets 2.70 2.08 Equipment hire charges 0.58 - Corporate Social Responsibility expenses 97.28 66.89 Donation 0.11 0.32 Prior period items (net) (Refer Note (ii) below) (15.81) (4.69) Total 25,963.20 21,367.59 Annual Report 2013-2014 269 ]ı{{…h…“ : 22Ú +x™… ¥™…™… (∫…®…‰ EÚi…) (V……Æ˙“.....) 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ¥…¥…Æ˙h… ∫…®……{i… ¥…π…«∫…®……{i… ¥…π…« ` ` ±……J…… ®… ` ±……J…… ®… (i) ±…‰J……{…Æ˙“I…EÚ…Â E‰Ú ¶…÷M…i……x… ®… ∂…… ®…±… Ω˲ ±…‰J……{…Æ˙“I…… ∂…÷±EÚ 13.15 11.50 ±…‰J……{…Æ˙“I…… ∂…÷±EÚ EÚÆ˙ 1.63. 1.12 ±…‰J……{…Æ˙“I…… ¥™…™… 12.69 8.69 ±…‰J……{…Æ˙“I…… ∂…÷±EÚ ±……M…i… 4.00 2.73 E÷Ú±… 31.47 24.04 (ii) {…⁄¥…« +¥… v… ®…n˘… E‰Ú ¥…¥…Æ˙h… ( x…¥…±…) {…⁄¥…« +¥… v… +…™… +x™… +…™… 72.91 21.73 E÷Ú±… 72.91 21.73 {…⁄¥…« +¥… v… +…™… |…∂……∫… x…EÚ ¥™…™… 56.99 17.04 +x™… ¥™…™… 0.11 - E÷Ú±… 57.10 17.04 {…⁄¥…« +¥… v… ®…n¢ ( x…¥…±…) (15.81) (4.69) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 270 Note 22 Other expenses (Consolidated) (Contd.) Year Ended Year Ended Particulars 31.03.2014 31.03.2013 ` lacs ` lacs (i) Payments to the auditors comprises Audit fees 13.15 11.50 Tax Audit fees 1.63 1.12 Audit expenses 12.69 8.69 Cost Audit fees 4.00 2.73 Total 31.47 24.04 (ii) Details of Prior period items (net) Prior period income Other Income 72.91 21.73 Total 72.91 21.73 Prior period expenses Administrative Expenses 56.99 17.04 Other Expenses 0.11 - Total 57.10 17.04 Prior period items (net) (15.81) (4.69) Annual Report 2013-2014 271 ]ı{{…h…“ : 23Ú ±…‰J…… ®……x…EÚ-22 E‰Ú +v…“x… |…EÚ]ı“EÚÆ˙h…-+…™… {…Æ˙ EÚÆ˙ E‰Ú ±…B ±…‰J…… (∫…®…‰ EÚi…) ]ı{{…h…“ ¥…¥…Æ˙h… 31.03.2014 EÚ…‰ 31.03.2013 EÚ…‰ ` ` ±……J…… ®… ` ±……J…… ®… 23 +…∫l… M…i… EÚÆ˙ (n‰˘™…i……)/{… Æ˙∫…∆{… k…™……ƒ ®…⁄±™…ø…∫… (1.866.93) 1,072.78 +…∫l… M…i… EÚÆ˙ n‰˘™…i…… Ω˛…‰x…‰ ¥……±…“ ®…n… E‰Ú EÚÆ˙ |…¶……¥… (1.866.93) 1,072.78 +…∫l… M…i… EÚÆ˙ n‰˘™…i…… Ω˛…‰x…‰ ¥……±…“ ®…n˘… E‰Ú EÚÆ˙ |…¶……¥… ∫…∆ n˘Mv… @Òh… E‰Ú ±…B |……¥…v……x… 335.79 344.10 ∫…®…™……‰{… Æ˙ §…EÚ…™…… E‰Ú ±…B |……¥…v……x… 29.42 28.11 §……Ïx…∫… E‰Ú ±…B |……¥…v……x… 15.54 89.95 +x™… 185.18 158.85 +…∫l… M…i… EÚÆ˙ Ω˛…‰x…‰ ¥……±…“ {… Æ˙∫…∆{… k…™…… E‰Ú ®…n˘… E‰Ú EÚÆ˙ |…¶……¥… 565.93 621.01 x…¥…±… +…∫l… M…i… EÚÆ˙ (n‰˘™…i……)/{… Æ˙∫…∆{… k… (1,301.00) (391.77) ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 272 Note 23. Disclosures under Accounting Standards - 22 Accounting for Taxes on Income (Consolidated) As at As at Notes Particulars 31.03.2014 31.03.2013 ` lacs ` lacs 23 Deferred tax (liability)/asset Depreciation (1,866.93) (1,012.78) Tax effect of items constituting deferred tax liability (1,866.93) (1,012.78) Tax effect of items constituting deferred tax assets Provision for doubtful debts 335.79 344.10 Provision for Overtime arrear 29.42 28.11 Provision for Bonus 15.54 89.95 Others 185.18 158.85 Tax effect of items constituting deferred tax assets 565.93 621.01 Net deferred tax (liability) / asset (1301.00) (391.77) Annual Report 2013-2014 273 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…B ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ¶……M… EÚ“ ]ı{{…h…“ GÚ®… ∫…∆. ¥…¥…Æ˙h… EÚ ∫…®…‰EÚx… ∫…r˘…∆i… BS…B±…B±… ±……<°ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ ( E∆Ú{…x…“), =∫…E‰Ú ∫…®…x…÷π…∆M…“ +…ËÆ˙ ∫…∆™…÷HÚ =t®… ∫…‰ ∫…∆§…∆ v…i… ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h…* ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… x…®x… ±… J…i… +…v……Æ˙ {…Æ˙ i…Ë™……Æ˙ EÚB M…B Ω∆˲: EÚ.1 "∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h…" {…Æ˙ ±…‰J…… {…r˘ i… x…“ i… ®……x…EÚ - 21 E‰Ú +x…÷∫……Æ˙ ®…⁄±… E∆Ú{…x…“ +…ËÆ˙ =∫…EÚ“ ∫…®…x…÷π…∆M…“ E∆Ú{…x…“ E‰Ú ¥…k…“™… ¥…¥…Æ˙h… EÚ…‰ EÚ.4.1 BS…B±…B±… §……™……‰]‰ıEÚ ±… ®…]‰ıb˜ ¶……Æ˙i… ∫…®…x…÷π…∆M…“ 100% EÚ.4.2 M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb(V…“ B {…“ B±…) ¶……Æ˙i… ∫…®…x…÷π…∆M…“ 74% EÚ.4.3 ±……<°Úœ∫|…M… +∫{…i……±… |……<¥…‰]ı ±… ®…]‰ıb˜ ¶……Æ˙i… ∫…∆™…÷HÚ =t®… 50% EÚ.5 <ŒC¥…]ı“ E‰Ú ®…⁄±… Ω˛∫∫…‰ {…Æ˙ BEÚ ∫…®…x…÷π…∆M…“ ®… ®…⁄±… E∆Ú{…x…“ E‰Ú x…¥…‰∂… E‰Ú + i… Æ˙HÚ ±……M…i… EÚ…‰ V…∫… i……Æ˙“J…Ú {…Æ˙ x…¥…‰∂… EÚ™…… V……i…… Ω˲, EÚ…‰ ∫…n¬˘¶……¥…x…… (∫…®…‰EÚx… {…Æ˙) E‰Ú ∞¸{… ®… ®……x™…i…… |……{i… Ω˲ +…ËÆ˙ +®…⁄i…« {… Æ˙∫…∆{… k…™…… E‰Ú ∞¸{… ®… +±…M… ∞¸{… ∫…‰ ®……x™…i…… |……{i… Ω˲* =∫…“EÚ…‰ =k…Æ˙¥…i…‘ ¥…k…“™… ¥…π…« ∫…‰ 10 ¥…π……Á EÚ“ +¥… v… ®… {… Æ∂˙……‰ v…i… EÚ™…… V……BM……* EÚ.6 ∫…®…‰ EÚi… ∫…®…x…÷π…∆M…“ EÚ“ x…¥…±… {… Æ˙∫…∆{… k…™…… E‰Ú +±{…∫…∆J™…EÚ §™……V… ®… i……Æ˙“J… {…Æ˙ +±{…∫…∆J™…EÚ ∂…‰™…Æ˙v……Æ˙EÚ…Â EÚ…‰Ú |…n˘…x… EÚÆ˙x…‰ ™……‰M™… <ŒC¥…]ı“ Æ˙EÚ®… ∂…… ®…±… Ω˲, V…∫… {…Æ˙ ∫…®…x…÷π…∆M…“ E∆Ú{…x…“ ®… x…¥…‰∂… EÚ™…… V……i…… Ω˲ +…ËÆ˙ x…¥…‰∂… EÚ“ i……Æ˙“J… E‰Ú i…n˘x…xi…Æ˙ <ŒC¥…]ı“ ®… +…M…‰ EÚ… ∫…∆S……Æ˙ Ω˛…‰M……* EÚ.7 ∫…®…x…÷π…∆M…“ (V…“ B {…“ B±…) E‰Ú |…S……±…x… EÚ… {… Æ˙h……®…, {…ËÆÂ˙]ı-∫…®…x…÷π…∆M…“ ∫…∆§…∆v… +Œ∫i…i¥… ®… +…x…‰ EÚ“ i……Æ˙“J…, ™……x…“ 19.03.2014 ∫…‰ ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… ®… ∂…… ®…±… EÚB V……i…‰ ΩÈ˛ *˙ |…S……±…x… EÚ… {… Æ˙h……®…, {…⁄¥…« + v…O…Ω˛h… +…ËÆ˙ =k…Æ˙ + v…O…Ω˛h… {…∂S……i… x…¥…±… |…S……±…x… {… Æ˙h……®… E‰Ú ∞¸{… ®… +…x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ +…§…∆ ]ıi… EÚB V……i…‰ ΩÈ˛* J… ∫……l…«EÚ ±…‰J…… x…“ i…™……ƒ J….1 ®…⁄±… E∆Ú{…x…“ E‰Ú ∫……l…«EÚ ±…‰J…… x…“ i…™……ƒ +x…÷§…∆v… - I E‰Ú ∞¸{… ®… ∫…∆±…Mx… EÚB V……i…‰ ΩÈ˛* J….2 ¥…∫i…÷∫…⁄S…“ EÚSS…‰ ®……±…, ¶…hb˜…Æ˙ B¥…∆ + i… Æ˙HÚ {…÷V……Á E‰Ú ®…⁄±™……∆EÚx… E‰Ú ±…B +…Ë∫…i…x… ¶……Æ˙ °Ú…®…÷«±…… EÚ… <∫i…‰®……±… EÚ™…… V……i…… Ω˲* ™…t {… M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb(V…“ B {…“ B±…) u˘…Æ˙… ¥…∫i…÷∫…⁄S…“ E‰Ú ®…⁄±™……∆EÚx… EÚ“ °Ú°Ú…‰ |…h……±…“ EÚ… +x…÷∫…Æ˙h… EÚ™…… M…™…… Ω˲*˙ ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 274 Notes forming part of the Consolidated financial statement for the year ended 31st March, 2014 Sl.No. Particulars A Principles of Consolidation The consolidated financial statements relates to HLL Lifecare Limited ('the Company'), its subsidiary and Joint Venture. The consolidated financial statements have been prepared on the following basis : A.1 The financial statements of the Parent Company and its Subsidiary Companies are combined on a line-by-line basis by adding together the book values of like items of assets, liabilities, income and expenses, after eliminating the intra-group balances, intra-group transactions in accordance with Accounting Standard-21 on "Consolidated Financial Statements". A.2 The financial statements of Joint Venture are combined by applying proportionate consolidation method of line-by-line basis on items of assets, liabilities, income and expenses after in accordance with Accounting Standard-27 on "Financial Reporting of Interest in Joint Ventures". A.3 As far as possible, the consolidated financial statements have been prepared using uniform accounting policies for like transactions and events in similar circumstances and are presented to the extent possible, in the same manner as the Parent Company's separate financial statements. A.4 Name of the Country of Relationship Ownership Company Incorporation Interest A.4.1 HLL Biotech Limited India Subsidiary 100% (HBL) A.4.2 Goa Antibiotics and India Subsidiary 74% Pharmaceuticals Limited (GAPL) A.4.3 Life Spring Hospitals India Joint Venture 50% Pvt. Ltd. A.5 The excess of cost to the parent of its investments in a subsidiary over the parents portion of equity at the date on which investment is made, is recognised as goodwill (on consolidation) and recognised separately as intangible assets. The same shall be amortized over a period of 10 years from the succeeding financial year. A.6 Minority Interest in the net assets of consolidated subsidiary consists of the amount of equity attributable to the minority shareholders at the date on which investment in subsidiary company is made and further movements in the equity, subsequent to the date of investment. A.7 The results of operations of a subsidiary (GAPL) are included in the consolidated financial statements from the date on which parent-subsididary relationship came in existence ie.,19.03.2014. Results of operations are allocated on a pro rata basis as pre-acquisition and post-acquisition net operating result. B Significant Accounting Policies B.1 Significant accounting policies of parent company are enclosed as Annexure-1. B.2 Inventories The weighted average formula is used for the valuation of raw materials, stores and spares. However FIFO Method of valuation of inventories has been followed by Goa Antibiotics and Pharmaceuticals Ltd. (GAPL). Annual Report 2013-2014 275 J….3 +S…±… {… Æ˙∫…∆{… k…™……ƒ J….3.1 ∫…∆™…÷HÚ =t®… EÚ… •……∆b˜ x……®… "±……<°Úœ∫|…M…" 10 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ∂˙˙……‰ v…i… EÚ™…… V……i…… Ω˲* J….3.2 ]≈‰ıb˜ ®……E«Ú ¥™…™… J….3.3 ®…⁄±… E∆Ú{…x…“ (BS…B±…B±…) ®…Â, ]≈‰ıb˜ ®……E«Ú {…∆V…“EÚÆ˙h… {…Æ˙ J…S…« Ω÷˛B ¥™…™…, S……±…⁄ {…⁄ƒV…“ EÚ…™…« E‰Ú ∞¸{… ®… ®……x… ±…™…… V……BM…… +…ËÆ˙ ˛±……<∫…Â∫… |……{i… EÚB V……x…‰ {…Æ˙ "+®…⁄i…« {… Æ˙∫…∆{… k…™……‰∆' E‰Ú +v…“x… {…⁄ƒV…“EfiÚi… EÚ™…… V……BM……* =∫… EÚ…‰ +®…⁄i…« {… Æ˙∫…∆{… k… EÚ“ ®……x™…i…… EÚ“ i……Æ˙“J… ∫…‰ 5 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ∂˙……‰v…x… EÚ™…… V……x…… Ω˲* ±……<∫…Â∫… {…Æ˙ J…S…« Ω÷˛B =k…Æ˙¥…i…‘ ¥™…™…, V……‰ {…Ω˛±…‰ Ω˛“ {…⁄ƒV…“EfiÚi… Ω˲, EÚ…‰ B‰∫…‰ ¥™…™… J…S…« Ω˛…‰ V……x…‰ EÚ“ +¥… v… ®… Æ˙…V…∫¥… ¥™…™… E‰Ú ∞¸{… ®… ®……x™…i…… |……{i… Ω˛…‰ V……BM……* V…“ B {…“ B±… E‰Ú ®……®…±…‰ ®…Â, ]≈‰ıb˜ ®……E«Ú ∫…“v…“ Ɖ˙J…… +…v……Æ˙ {…Æ˙ {… Æ∂˙……‰ v…i… EÚ™…… V……i…… Ω˲* J….4 ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ EÚ“ |…h……±…“ EÚ) =i{……n˘x… EÚ“ {… Æ˙∫…∆{… k…™……‰∆ EÚ…‰ ∫…“v…‰ +…Æ˙…‰{™… +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… ¥™…™… EÚ…‰ "+®…⁄i…« {… Æ˙∫…∆{… k…™……‰∆' E‰Ú ∞¸{… ®… ±……M…i… {…Æ˙ {…⁄ƒV…“EfiÚi… EÚB V……i…‰ ΩÈ˛ +…ËÆ˙ BS… §…“ B±… ®… 10 ¥…π……Á EÚ“ +¥… v… +…ËÆ˙ V…“ B {…“ B±… ®… 5 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ∂˙……‰ v…i… EÚB V……B∆M…‰˛ * J…) |……Æ∆˙ ¶…EÚ ¥™…™…, ¥…… h…ŒV™…EÚ |…S……±…x… E‰Ú |……Æ∆˙¶… ¥…π…« ∫…‰ 5 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B §…^‰ı J……i…‰ ®… b˜…±…… V……BM……* J….5 Æ˙…V…∫¥… ®……x™…i…… J….6 BS… §…“ B±… +§… i…EÚ ¥…… h…ŒV™…EÚ |…S……±…x… ∂˙…÷∞¸ EÚÆ˙x…‰ E‰Ú ±…B Ω˲ +…ËÆ˙ {… Æ˙™……‰V…x…… x…®……«h… E‰Ú +v…“x… Ω˲* x…®……«h… +¥… v… E‰Ú n˘…ËÆ˙…x… J…S…« Ω÷˛B Æ˙…V…∫¥… ¥™…™… ∫…‰ +|…™…÷HÚ + v…∂˙…‰π… x… v… {…Æ˙ ={……ÃV…i… §™……V… EÚ…]ı ±…™…… V……i…… Ω˲ +…ËÆ˙ x…®……«h… {…⁄Æ˙… Ω˛…‰i…‰ Ω˛“ B‰∫…‰ Æ˙…V…∫¥… ¥™…™… EÚ… x…¥…±… Æ˙EÚ®… {…⁄ƒV…“EfiÚi… EÚ“ V……BM…“* J….7 J…∆b˜ Æ˙{……‰Õ]ıM… E∆Ú{…x…“ x…‰ ±…‰J……∆EÚx… ®……x…EÚ 17 E‰Ú +x…÷∫……Æ˙, M…¶…« x…Æ˙…‰v…EÚ =i{……n¢, ∫¥……∫l™… Æ˙I…… =i{……n¢, ]≈‰ıÀb˜M… =i{……n¢, ∫…‰¥…… B¥…∆ `‰ˆE‰Ú V……‰ |……<®…Æ˙“ O…⁄{… ΩÈ˛, E‰Ú ∞¸{… ®… J…∆b˜ Æ˙{……‰Õ]ıM… E‰Ú ±…B =∫…E‰Ú Æ˙{……‰]«ı EÚÆ˙x…‰ ™……‰M™… J…∆b…‰∆ EÚ…‰ {…Ω˛S……x… EÚ“ Ω˲* <∫…E‰Ú +±……¥……, x…®x… ±… J…i… ¥… x…Ãn˘π]ı ±…‰J……∆EÚx… x…“ i…™……ƒ J…∆b˜ Æ˙{……‰Õ]ıM… E‰Ú ±…B {……±…x… EÚ“ M…<« ΩÈ˛* (EÚ) ˜ J…∆b˜ Æ˙…V…∫¥… ®… +∆i…Æ˙ J…∆b˜ Æ˙…V…∫¥… ∫… Ω˛i… J…∆b˜ E‰Ú ±…B ∫…“v…‰ + ¶…Y…‰™…/+…§…∆ ]ıi… §…GÚ“ +…ËÆ˙ +x™… +…™… ∂˙…… ®…±… ΩÈ˛* (J…) J…∆b˜ E‰Ú ±…B ∫…“v…‰ + ¶…Y…‰™…/+…§…∆ ]ıi… ¥™…™… EÚ…‰ J…∆b˜ {… Æ˙h……®… EÚ‰ x…v……«Æ˙h… E‰Ú ±…B ¥…S……Æ˙ EÚB V……i…‰ ΩÈ˛* {…⁄Ɖ˙ E∆Ú{…x…“ E‰Ú ∞¸{… ®… +…ËÆ˙ J…∆b˜ EÚ…‰ x… +…§…∆ ]ıi… ∫…‰ ∫…∆§…∆ v…i… ¥™…™… EÚ…‰ "+ ¥… x…v……x…“™… ¥™…™… " E‰Ú +v…“x… ∂˙…… ®…±… EÚB V……i…‰ ΩÈ˛* (M…) {…⁄Ɖ˙ E∆Ú{…x…“ E‰Ú ∞¸{… ®… +…ËÆ˙ J…∆b˜ EÚ…‰ x… +…§…∆ ]ıi… ∫…‰ ∫…∆§…∆ v…i… +…™… EÚ…‰ "+ ¥… x…v……x…“™… +…™… " E‰Ú +v…“x… ∂˙…… ®…±… EÚ™…… V……i…… Ω˲* (P…) J…∆b˜ {… Æ˙∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… ®… ∫…∆§…∆ v…i… J…∆b˜ E‰Ú ∫……l… ∫…“v…‰ + ¶…Y…‰™… ∂˙…… ®…±… ΩÈ˛* + ¥… x…v……x…“™… EÚ…Ï{……ÊƉ˙]ı {… Æ˙∫…∆{… k…™……ƒ +…ËÆ˙ n‰˘™…i……Bƒ, {…⁄Ɖ˙ E∆Ú{…x…“ E‰Ú ∞¸{… ®… +…ËÆ˙ EÚ∫…“ ¶…“ J…∆b˜ EÚ…‰ x… +…§…∆ ]ıi… ∫…‰ ∫…∆§…∆ v…i… {… Æ˙∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… EÚ… |… i… x… v…i¥… EÚÆ˙i…‰ ΩÈ˛* ∫…®…x…÷π…∆ M…™…… +…ËÆ˙ ∫…∆™…÷HÚ =t®… E‰Ú ¥™…¥…∫……™… J…∆b˜… E‰Ú ∫…∆§…∆v… ®…Â, =∫…‰ ∫…®…‰ EÚi… J…∆b˜ Æ˙{……‰Õ]ıM… ®… ∫¥……∫l™… Æ˙I…… E‰Ú +v…“x… ¥…S……Æ˙ EÚ™…… M…™…… Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 276 B.3 Fixed Assets B.3.1 The brand name "Lifespring" of Joint Venture is amortized over a period of 10 years. B.3.2 Trade Mark Expenses B.3.3 In parent company (HLL), Expenses incurred on trade mark registrations will be treated as Capital Work in progress and will be capitalised under 'intangible assets' when licenses are received. Same shall be amortised over a period of 5 years from the date of recognition of intangible asset. Subsequent expenditure incurred on licences which is already capitalised will be recognised as revenue expenses in the period in which such expenses are incurred. In case of GAPL, trade mark is amortised on straight line basis. B.4 Method of depreciation / Amortisation a) Research and Development expenses directly attributable to generating asset are capitalized at cost as 'Intangible Asset' and will be amortized over a period of 10 years in HBL and amortized over a period of 5 years in GAPL. b) Preliminary expenses will be written off over a period of 5 years from the year of commencement of commercial operation. B.5 Revenue recognition B.6 HBL is yet to commence the commercial operation and the project is under construction stage. Interest earned during the construction period on un-utilised surplus funds is deducted from the revenue expenditure incurred during the construction period and the net amount of such revenue expenditure will be capitalised when the construction is completed. B.7 Segment reporting The Company has identified its reportable segments for Segment Reporting. In accordance with Accounting Standard 17, as Contraceptive Products, Healthcare Products, Trading Products, Services and Contracts which are the primary groups. In addition, the following specific accounting policies have been followed for Segment Reporting. (a) Segment revenue includes sales and other income directly identifiable with / allocable to the segment, including inter segment revenue. (b) Expenses that are directly identifiable with / allocable to segments are considered for determining the segment results. Expenses which relate to the company as a whole and not allocable to segments are included under "Unallocable expenditure" (c) Income which relates the company as a whole and not allocable to segments is included in "unallocable Income". (d) Segment assets and liabilities include those directly identifiable with the respective segments. Unallocable Corporate assets and liabilities represent the assets and liabilities that relate to the company as a whole and not allocable to any segment. In respect of business segments of subsidiaries and Joint venture, the same has been considered under Health Care in the Consolidated Segment Reporting. Annual Report 2013-2014 277 M… ¥™……J™……i®…EÚ ]ı{{… h…™……ƒ ®…⁄±… E∆Ú{…x…“ E‰Ú ∫]Èıb˜ +±……‰x… ¥…k…“™… ¥…¥…Æ˙h…… E‰Ú Ω˛∫∫…‰ E‰Ú ∞¸{… ®… ¥™……J™……i®…EÚ ]ı{{…h…“ E‰Ú ∫…∆™……‰V…x… E‰Ú ∫……l… {…g¯“ V……x…“ Ω˲ * M….1 |… i… ∂˙…‰™…Æ˙ ®…⁄±… B¥…∆ Ω˛±EÚ… +…™… 31-03-2014 31-03-2013 M…h…EÚ x…¥…±… ±……¶… (`(`(` ±……J…… ®…Â) ®…⁄±… 2,576.10 3,004.24 Ω˛±EÚ… 2,576.10 3,004.24 b˜x……‰ ®…x…‰]ıÆ˙-¥…π…« E‰Ú n˘…ËÆ˙…x… §…EÚ…B ∫……®™…… ∂˙…‰™…Æ˙… EÚ“ +…Ë∫…i…x… ∫…∆J™…… ®…⁄±… 19,35,350.00 19,35,350.00 Ω˛±EÚ… 19,35,350.00 19,35,350.00 +V…«x… |… i… ∂˙…‰™…Æ˙ (`) ®…⁄±… 133.11 155.23 Ω˛±EÚ… 133.11 155.23 M….2 EÚÆ˙…v……x… +…¥…‰n˘x… ∫…∆ 136/§…“ ∫…“/2014, n˘x……∆EÚ 26/02/2014 E‰Ú +x…÷∫……Æ˙ V…“ B {…“ B±… x…‰ 31-12-2013 EÚ…‰ ∫…EÚ…Æ˙…i®…EÚ §…x…x…‰ E‰Ú ∞¸{… ∫…‰ +{…x…‰ x…¥…±… ®…⁄±™… {…Æ˙ §…“ +…<« B°Ú +…Æ˙/ B∫… +…<« ∫…“ B E‰Ú EÚ…™…«I…‰j… ∫…‰ E∆Ú{…x…“ E‰Ú x…¥…«Ω˛x… EÚ“ ®……∆M… EÚÆ˙E‰Ú˛ +…Ët…‰ M…EÚ B¥…∆ ¥…k…“™… {…÷x…M…«`ˆx… E‰Ú ±…B §……‰b«˜ EÚ…‰ BEÚ +…¥…‰n˘x… n˘™…… Ω˲* Ω˛…±……∆ EÚ <∫… i……Æ˙“J… {…Æ˙ §……‰b«˜ x…‰ §…“ +…<« B°Ú +…Æ˙/ B∫… +…<« ∫…“ B E‰Ú EÚ…™…«I…‰j… ∫…‰ E∆Ú{…x…“ EÚ… x…¥…«Ω˛x… x…Ω˛” EÚ™…… Ω˲* +i…& ®……]ı EÚ… |……¥…v……x… +…ËÆ˙ +…∫l… M…i… EÚÆ˙ ¥…k…“™… ¥…¥…Æ˙h… ®… |…n˘…x… x…Ω˛” EÚ™…… M…™…… Ω˲* E∆Ú{…x…“ x…‰ ∫…∆∂˙……‰ v…i… ®…∫……Ën˘… {…÷x…¥……«∫… ™……‰V…x…… E‰Ú +v…“x… x…®x… ±… J…i… Æ˙…Ω˛i…/ Æ˙™……™…i… EÚ“ ®……ƒM… ¶…“ EÚ“ Ω˲* EÚ) v……Æ˙… 43 (§…“) E‰Ú |……¥…v……x…… ∫…‰ E∆Ú{…x…“ EÚ…‰ ®…÷HÚ EÚÆ˙x…… - <∫… v……Æ˙… ®… ¥… x…Ãn˘π]ı EÚÆ˙, ∂˙…÷±EÚ +…ËÆ˙ +x™… Æ˙EÚ®… E‰Ú M…ËÆ˙- ¶…÷M…i……x… E‰Ú EÚ…Æ˙h… ∫…‰ ¥……{…∫…“ EÚB M…B +…™… EÚ…‰ {… Æ˙¥…v…«x… E‰Ú EÚ…Æ˙h… x… §…x… V……x…… * J…) + v… x…™…®… EÚ“ v……Æ˙… 139(3) E‰Ú +x…÷∫……Æ˙ °Ú…<±… EÚB M…B ¥…¥…Æ˙ h…™…… E‰Ú +x…÷∫…Æ˙h… ®… x…v……« Æ˙i… x… ÚEÚ“ M…<« v……Æ˙… 72(1)/72(3)/74§…“ (3) E‰Ú +x…÷∫……Æ˙ x…÷C∫……x… EÚ…‰ +…M…‰ ±…‰ V……x…‰ +…ËÆ˙ {…fil…EÚ EÚÆ˙x…‰ E‰Ú ∫…∆§…∆v… ®… +…<« ]ı“ + v… x…™…®… EÚ“ v……Æ˙… 80 E‰Ú |……¥…v……x… ∫…‰ E∆Ú{…x…“ EÚ…‰ ®…÷HÚ EÚÆ˙x…… * M…) {…⁄¥…« {…÷x…¥……«∫… ®… ∫…Ω˛…™…i…… EÚÆ˙x…‰ E‰Ú ±…B x…v……«˘ Æ˙i… +¥… v…, +…`ˆ ¥…π……Á E‰Ú {…Ɖ˙ ±……¶… {…Æ ˙x…÷C∫……x… EÚ…‰ +…M…‰ ±…‰ V……x…‰ +…ËÆ˙ {…fil…EÚ EÚÆ˙x…‰ E‰Ú ±…B +x…÷®… i… |…n˘…x… EÚÆ˙x……* P…) ¥…π…« 1997-98 ∫…‰ v……Æ˙… 41(1) E‰Ú +v…“x… ®……ƒM… EÚ“ M…<« Æ˙…Ω˛i…/ Æ˙™……™…i… E‰Ú ∫…∆§…∆v… ®… {…Ω˛±…‰ Ω˛“ °Ú…<±… EÚB E∆Ú{…x…“ E‰Ú +…™… EÚÆ˙ ¥…¥…Æ˙h…“ E‰Ú ∫…∆∂˙……‰v…x…, E∆Ú{…x…“ u˘…Æ˙… {…Ω˛±…‰ Ω˛“ §…x……B +|… i…¶…⁄i… ±…‰x…n˘…Æ˙…Â/§™……V… ¥……{…∫… ±…J…x…‰ E‰Ú ±…B E∆Ú{…x…“ EÚ…‰ +x…÷®… i… n‰˘x……* M….3 n‰˘x…n˘…Æ, ±…‰x…n˘…Æ˙ +…ËÆ˙ @Òh… ¥… {…‰∂˙… M…™…… ®… ∂˙…‰π…, ˙{…÷Œπ]ı/∫…®……v……x… E‰Ú +v…“x… Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 278 C. Explanatory Notes These notes are to be read in conjunction with the explanatory notes forming part of the stand alone financial statements of the parent company. C.1 Basic and Diluted Earnings per share 31-03-2014 31-03-2013 Numerator Net Profit (``` in lacs) Basic 2,576.10 3,004.24 Diluted 2,576.10 3,004.24 Denominator-Average number of equity shares outstanding during the year Basic 19,35,350.00 19,35,350.00 Diluted 19,35,350.00 19,35,350.00 Earnings per share (`) Basic 133.11 155.23 Diluted 133.11 155.23 C.2 Taxation GAPL, vide Application No.136/BC/2014 dated 26/02/2014 has made an application to Board for Industrial & Financial Reconstruction seeking discharge of the company from the purview of BIFR/SICA upon its Net - worth getting positive as on 31-12-2013. However as on date the Board has not discharged the company from the purview of BIFR/SICA. Hence, provision for MAT and Deferred Tax is not provided in the financial statement. Company has also sought following reliefs/concession under Modified Draft Rehabilitation Scheme a) To Exempt Company from the provisions of section 43(B) - additions not to be caused to the returned income due to non-payment of taxes, duties and other amout specified in this section. b) To exempt the company from the provision of section 80 of the IT Act in regard to carry forward and set off of losses in accordance with Section 72(1)/72(3)/74A(3) not determined in pursuance of the returns filed in accordance with Section 139(3) of the Act. c) To grant permission for "carry forward and set-off of losses" against the profits beyond the prescribed period of eight years to assist in early rehabilitation. d) To allow the company for amendment of company's Income Tax returns already filed in respect of reliefs and concessions sought u/s 41(1), unsecured creditors/ interest write back already made by the company, from the year 1997-98. C.3 Balance in Debtors, Creditors and loans and advances are subject to confirmation / reconciliation Annual Report 2013-2014 279 M….4 ∫…⁄I®…, ±…P…÷ ¥… ®…v™…®… =t…‰M… ¥…EÚ…∫… + v… x…™…®…, 2006 u˘…Æ˙… +…¥…∂˙™…EÚ |…EÚ]ı“EÚÆ˙h… x…“S…‰ V…Ë∫…‰ ΩÈ˛: (`±……J…… ®…Â) GÚ.∫…∆. ¥…¥…Æ˙h… 31-03-2014 31-03-2013 (EÚ) ¥…π……»i… ®… ∂˙…‰π… +|…n˘k… ®…⁄±… Æ˙… ∂˙… 294.95 409.66 (J…) ¥…π…« E‰Ú n˘…ËÆ˙…x… x…™…i… i……Æ˙“J… ∫…‰ {…Ɖ˙ |…n˘k… ®…⁄±… Æ˙… ∂… EÚ… ¥…±…∆ §…i… ¶…÷M…i……x… ∂˙…⁄x™… ∂˙…⁄x™… (M…) B®… B∫… B®… b˜“ + v… x…™…®… EÚ“ v……Æ˙… 16 ¥……∫i…¥… ®… |…n˘k… §™……V… ∂…⁄x™… ∂…⁄x™… (P…) ∫…Ω˛®…i… ∂…i……Á E‰Ú +x…÷∫……Æ˙ ∫…¶…“ ¥…±…∆ §…i… ¶…÷M…i……x… E‰Ú ±…B ¥…π…« E‰Ú n˘…ËÆ˙…x… n‰˘™… B¥…∆ S…÷EÚ…x…‰ ™……‰M™… ∫……®……x™… §™……V… ∂…⁄x™… ∂…⁄x™… (RÛ) ¥…π…« E‰Ú n˘…ËÆ˙…x… +ÃV…i… E÷Ú±… §™……V… +…ËÆ˙ ∂…‰π… +|…n˘k… ∂…⁄x™… ∂…⁄x™… ™…Ω˛ V……x…EÚ…Æ˙“ E∆Ú{…x…“ EÚ…‰ ={…±…§v… V……x…EÚ…Æ˙“ E‰Ú +…v……Æ˙ {…Æ˙ {…Ω˛S……x… EÚB M…B B‰∫…‰ {……Ã]ı™…… E‰Ú Ω˛n˘ i…EÚ x…v……« Æ˙i… EÚ“ M…<« Ω˲* M….5 ∫…®…‰ EÚi… J…∆b˜ Æ˙{……‰]«ı +x…÷§…∆v… 2 ®… |…∫i…÷i… EÚ™…… V……i…… Ω˲* M….6 ∫…®…x…÷π…∆M…“/∫…∆™…÷HÚ =t®…… E‰Ú ∫…∆§…∆v… ®… ¥…k…“™… V……x…EÚ…Æ˙“ +x…÷§…∆v… 3 ®… n˘“ V……i…“ Ω˲* M….7 V…“ B {…“ B±… E‰Ú ∫…∆§…∆v… ®…Â, J…∆b˜ Æ˙{……‰Õ]ıM… E‰Ú +v…“x… +{…‰ I…i… V…Ë∫…‰ + i… Æ˙HÚ ¶……ËM……‰ ±…EÚ J…∆b˜ EÚ“ {…Ω˛S……x… x…Ω˛” EÚ“ M…™…“ Ω˲* +i…& <∫…‰ n‰∂˘…“™… ¥™…¥…∫……™… E‰Ú ∞¸{… ®… ¥…M…‘EfiÚi… EÚ™…… V……i…… Ω˲* M….8 |… i…EÚÆ˙ U÷Ù^ı“ +x…÷{…Œ∫l… i… +…ËÆ˙ ={…n˘…x… EÚ…‰ x…EÚn˘ +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚ™…… ΩË* E∆Ú{…x…“ x…‰ ¥…π…« E‰Ú n˘…ËÆ˙…x… EÚ…‰<« ¶…“ §…“®……∆ EÚEÚ ®…⁄±™……∆EÚx… {…⁄Æ˙… x…Ω˛” EÚ™…… ΩË* E∆Ú{…x…“ u˘…Æ˙… i…Ë™……Æ˙ EÚB |… i…EÚÆ˙ U÷Ù^ı“ +x…÷{…Œ∫l… i… ¥…¥…Æ˙h… +…ËÆ˙ V…“¥…x… §…“®…… x…M…®… ∫…‰ |…®……h…{…j… E‰Ú +…v……Æ˙ {…Æ˙ ={…n˘…x… E‰Ú +x…÷∫……Æ˙ GÚ®…∂…& `160.37 ±……J…Ú +…ËÆ˙ `122.90 ±……J… EÚ… BEÚ UÙ…‰]ı… |……¥…v……x… Ω˲*˛ M….9 ∫…®…x…÷π…∆M…“ E∆Ú{…x…“, V…“ B {…“ B±… EÚ…‰ ®…Ë∫…∫…« M……‰¥…… °÷Úb˜ B¥…∆ °Ú…®……« (|……) ±… ®…]‰ıb˜ E‰Ú ∫……l… ¥…{…h…x… ¥™…¥…∫l……Bƒ l…”˲* {……]ı‘ ®…v™…∫l…i…… B¥……b«˜ E‰Ú ∂…i……Á E‰Ú +x…÷∫……Æ˙ `8.50 EÚÆ˙…‰b EÚ“ E∆Ú{…x…“ EÚV…«n˘…Æ˙ Ω˲ V…∫…®… ∫…‰ ®…⁄±… n˘…¥…‰ EÚ“ +…‰Æ˙ `4.13 EÚÆ˙…‰b +…ËÆ˙ §™……V… EÚ“ +…‰Æ˙ `4.37 EÚÆ˙…‰b ΩË* +∂……‰v™… EÚV…« E‰Ú ±…B |……¥…v……x… §™……V… EÚ“ +…‰Æ˙ E‰Ú¥…±… `2.65 EÚÆ˙…‰b E‰Ú ±…B |…n˘…x… EÚ™…… M…™…… Ω˲* n˘…‰ +x™… {……Ã]ı™……Â, ®…Ë∫…∫…«« B®…∫…“ Bx]ıÆ˙|……<∫…∫… +…ËÆ˙ ®…Ë∫…∫…« ®…v…÷Æ˙ °Ú…®……« E‰Ú ®……®…±…‰ ®… ¶…“ E∆Ú{…x…“ x…‰ GÚ®…∂…& `55.27 ±……J… +…ËÆ˙ `15.05 ±……J… E‰Ú n‰˘™… Æ˙EÚ®… EÚ“ ¥…∫…⁄±…“ EÚÆ˙x…‰ E‰Ú ±…B =x…E‰Ú J…±……°Ú +{…“±… EÚ“ M…<« Ω˲* <∫…E‰Ú ±…B +∂……‰v™… EÚV…« EÚ“ +…‰Æ˙ EÚ…‰<« ¶…“ |……¥…v……x… x…Ω˛” §…x……™…… M…™…… Ω˲* M….10 V…“ B {…“ B±… x…‰ +{…x…‰ °ËÚC]ı Æ˙™…… +…ËÆ˙ ®…‰ b˜∫…Â]ıÆ˙… E‰Ú ±…B |…S……±…x… {…^ı… ¥™…¥…∫l……+… ®… |…¥…‰∂… EÚ™…… Ω˲* ±…‰J……∆EÚx… ®……x…EÚ (B B∫…) 19- E‰Ú +x…÷∫……Æ˙ {…^ı… ±…‰J……∆EÚx… E‰Ú ∫…∆§…∆v… ®… |…EÚ]ı“EÚÆ˙h… |…n˘…x… x…Ω˛” EÚ™…… M…™…… Ω˲* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 280 C.4 Disclosures required by the Micro, Small and Medium Enterprises Development (MSMED) Act, 2006 are as under: (` in lacs) Sl. No. Particulars 31.03.2014 31.03.2013 (a) The principal amount remaining unpaid 294.95 409.66 at the end of the year (b) The delayed payments of principal amount Nil Nil paid beyond the appointed date during the year (c) Interest actually paid under under Section 16 Nil Nil of the MSMED Act (d) Normal interest due and payable during the Nil Nil year, for all the delayed payments, as per the agreed terms. (e) Total interest accrued during the year and Nil Nil remaining unpaid. This information has been determined to the extent such parties have been identified on the basis of information available with the Company. C.5 Consolidated Segment Report is presented in Annexure 2. C.6 Financial information regarding the subsidiary/joint ventures is given in Annexure 3. C.7 In the case of GAPL, secondary geographical segment as required under Segment Reporting, has not been identified. Hence this is grouped as Domestic business. C.8 GAPL compensated leave absences and gratuity accounted on cash basis. Company has not carried out any actuarial valuation during the year. As per compensated leave absences statement prepared by the company and Gratuity based on certificate from Life Insurance Corporation, there is a short provision of `160.37 Lacs and `122.90 Lacs respectively. C.9 The subsidiary company GAPL had marketing arrangements with M/s. Goa Food & Pharma (P) Limited. The party owes the company an amount of ` 8.50 Cr as per the terms of Arbitration Award out of which ` 4.13 Cr is towards substantive claims and ` 4.37 Cr towards interest. Provision for bad debts was provided for ` 2.65 Cr only towards interest. In case of two other parties M/s. Emcee Enterprises and M/s. Madhur Pharma, also the Company has preferred an appeal against them for recovering dues amounting to ` 55.27 lacs and ` 15.05 lacs respectively. No provision for bad debts has been created for the same. C.10 GAPL has entered into operating lease arrangements for its factories and medicentres. Disclosures regarding lease accounting as per Accounting Standard (AS) 19 - is not provided. Annual Report 2013-2014 281 M….11 `34.38 ±……J… EÚ‰ +…∫l… M…i… Æ˙…V…∫¥… ¥™…™… EÚ…‰ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ¶……M… E‰Ú ∞¸{… ®… +®…⁄i…« {… Æ˙∫…∆{… k…™…… E‰Ú +v…“x… +…]«ı §±……ÏEÚ/¥…“ +…Æ˙ B∫…/∫……Ï}]ı¥…‰™…Æ˙ E‰Ú ∞¸{… ®… ¥…M…‘EfiÚi… EÚB M…B ΩÈ˛* M….12 V…“ B {…“ B±… ®… +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ =∫…E‰Ú +x…÷®…… x…i… ={…™……‰M…“ ±……<°Ú E‰Ú +…v……Æ˙ {…Æ˙ {… Æ˙∂……‰ v…i… x…Ω˛” EÚ“ V……i…“ ΩË* M….13 V…“ B {…“ B±… x…‰ +…™…÷¥…Ê n˘EÚ +…ËÆ˙ Ω˛…‰ ®…™……‰{…Ë l…EÚ =i{……n˘… E‰Ú ¥… x…®……«h… E‰Ú ±…B Æ˙…V…∫l……x… E‰Ú +V…®…‰Æ˙ +…ËÆ˙ V…™…{…÷Æ˙ ®… n˘…‰ °ËÚC]ı Æ˙™……ƒ ={… {…^‰ı {…Æ˙ ±…™…… Ω˲* n˘B M…B §…™……x… E‰Ú +…v……Æ˙ {…Æ˙ ∫…¶…“ J…Æ˙“n˘ +…ËÆ˙ ¥™…™… E‰Ú ±…B E∆Ú{…x…“ Ω˛∫……§… Æ˙J…i…“ ΩË*˘ M….14 E∆Ú{…x…“ u˘…Æ˙… ¥… x…î…i… =i{……n˘… E‰Ú ¥… ¥…v… ¥…M…« E‰Ú ∫…∆§…∆v… ®… E∆Ú{…x…“ E‰Ú M……Æ∆˙]ı“ B¥…∆ ¥……Æ∆˙]ı“ ∂…i…Á +…ËÆ˙ x…“ i…™……ƒ +…ËÆ˙ B‰∫…‰ n˘…¥…‰ EÚ“ +…‰Æ˙ ¥™…™… EÚ… ∫…®®……x… EÚÆ˙x…‰ E‰Ú ±…B +{…‰ I…i… +x…÷®…… x…i… n‰˘™…i……Bƒ V…“ B {…“ B±… ®… x…Ω˛” §…x……B M…B ΩÈ˛* M….15 ¥…k…“™… ¥…¥…Æ˙h… E‰Ú ¶……M… E‰Ú ∫…®…‰ EÚi… |……∫…∆ M…EÚ n‰˘™…i……Bƒ +x…÷§…∆v… 3 ®… |…∫i…÷i… EÚ™…… V……i…… Ω˲* M….16 ¥…… h…ŒV™…EÚ EÚÆ˙ EÚ…™……«±…™…, Ω˲n˘Æ˙…§……n˘ x…‰ ¥…π…« 1999-2000 ∫…‰ 2003-2004 i…EÚ E‰Ú ¥…π……Á ∫…‰ ∫…∆§…∆ v…i… §…GÚ“ EÚÆ˙, §™……V… +…ËÆ˙ V…÷®……«x…‰ EÚ“ +…‰Æ˙ `452.66 ±……J… V…“ B {…“ B±… EÚ…‰ n˘x……∆EÚ 22.03.2006 E‰Ú ®……∆M… EÚ“ ∫…⁄S…x…… V……Æ˙“ EÚ“ l…“˛* E∆Ú{…x…“ x…‰ ={…™…÷«HÚ EÚ“ +…‰Æ˙ `62.76 ±……J… {…Ω˛±…‰ Ω˛“ |…n˘k… EÚ™…… Ω˲ +…ËÆ˙ ∂…‰π… `389.30 ±……J… n‰˘™… Ω˲* E∆Ú{…x…“ x…‰ V…÷®……«x…‰ EÚ“ U⁄Ù]ı +…ËÆ˙ §™……V… n˘Æ˙ ®… EÚ]ı…Ëi…“ E‰Ú ±…B BEÚ +x…÷Æ˙…‰v… E‰Ú ∫……l… `82.71 ±……J… E‰Ú BEÚ®…÷∂i… x…{…]ı…x… E‰Ú ±…B ¥…… h…ŒV™…EÚ EÚÆ˙ +…™…÷HÚ, Ω˲n˘Æ˙…§……n EÚ…‰ ∫…∆{…E«Ú EÚ™…… Ω˲* ™…Ω˛ §…“ +…<« B°Ú +…Æ˙ E‰Ú ∫……l… ¶…“ ∫…∆§……‰ v…i… EÚ™…… M…™…… Ω˲* `389.90 ±……J… E “ n‰˘™… Æ˙EÚ®… ∫…®…‰ EÚi… |……∫…∆ M…EÚ n‰˘™…i……+… ®… ∂…… ®…±… Ω˲* M….17 {…UÙ±…‰ ¥…π…« E‰Ú +…ƒEÚb‰˜ EÚ…‰, V…Ω˛…ƒ i…EÚ +…¥…∂˙™…EÚ Ω˛…‰, S……±…⁄ ¥…π…« EÚ“ +…¥…∂˙™…EÚi……+… EÚ“ +{…‰I…… +…ËÆ˙ x…EÚ]ıi…®… ±……J… ®… {…⁄h……»EÚ EÚÆ˙x…‰ E‰Ú ±…B {…÷x…& ¥™…¥…Œ∫l…i… +…ËÆ˙ {…÷x…& ¥…M…‘EfiÚi… EÚB M…B ΩÈ˛ * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 282 C.11 Deferred revenue expenses amounting to ` 34.38 lacs which have been grouped as art block / VRS / software under intangible asset as part of fixed asset. C.12 Intangible Assets in GAPL are amortised not on the basis of its estimated useful life. C.13 GAPL has taken on sub-lease, two factories at Ajmer and Jaipur in Rajasthan for manufacture of Ayurvedic and Homeopathic products. The company accounts for all purchases and all expenses based on statements provided. C.14 Guarantee and warranty terms and policies of company in respect of various class of products manufactured by the company and terms for providing of estimated liability that may be required to honour expenditure towards such claims has not been made in GAPL. C.15 The consolidated Contingent liabilities forming part of the financial statements, is presented in Annexure 3. C.16 Commercial Tax Office, Hyderabad had issued a notice of demand dated 22.03.2006 to GAPL for ` 452.66 lacs, towards sales tax, interest and penalties pertaining to years 1999- 2000 to 2003-2004. The Company has already paid ` 62.76 lacs towards the above and the balance of ` 389.30 lacs is payable. The Company has approached the Commissioner of Commercial Taxes, Hyderabad for One Time Settlement of ` 82.71 lacs with a request for waiver of penalty and reduction in interest rate. This has also been addressed with BIFR. The amount payable of ` 389.90 lacs is included in Consolidated Contingent Liabilities. C.17 Figures of the previous year have been rearranged and regrouped wherever necessary to suit current year's requirements and rounded off to the nearest Lacs. Annual Report 2013-2014 283 +x…÷§…∆v… I +x…÷§…∆v… 1 - ®…⁄±… E∆Ú{…x…“ E‰Ú ®…Ω˛i¥…{…⁄h…« ∫……l…«EÚ ±…‰J…… x…“ i…™……ƒ GÚ®… ¥…¥…Æ˙h… ∫…∆. x…M… ®…i… ∫…⁄S…x…… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ E∆Ú{…x…“ + v… x…™…®… 1956 E‰Ú |……¥…v……x…… E‰Ú +v…“x… ∫…∆∫l…… {…i… ¶……Æ˙i… ®… + v…¥…… ∫…i… ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ u˘…Æ˙… {…⁄h…« ∞¸{… ∫…‰ ∫¥…… ®…i¥… Æ˙J…‰, ®… x…Æ˙ix…… =t®… Ω˲ * BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜ EÚ…‰ 21 °ÚÆ˙¥…Æ˙“, 2012 ∫…‰ ∫……¥…«V… x…EÚ ±… ®…]‰ıb˜ E∆Ú{…x…“ E‰Ú ∞¸{… ®… {… Æ˙¥…Ãi…i… EÚ™…… M…™…… Ω˲ * E∆Ú{…x…“ M…¶…« x…Æ˙…‰v…EÚ =i{……n˘… E‰Ú ¥… x…®……«h… B¥…∆ ¥…{…h…x…, +∫{…i……±… =i{……n˘‰∆, ®… Ω˛±…… ∫¥……∫l™… °Ú…®……« =i{……n¢, ∫……®…… V…EÚ ¥…{…h…x… =i{……n¢ +…ËÆ˙ ∫¥……∫l™… Æ˙I…… +¥…∫…∆Æ˙S…x…… +…ËÆ˙ |……{…h… +…ËÆ˙ x…Ën˘… x…EÚ ∫…‰¥……+… E‰Ú ±…B {…Æ˙…®…∂…« B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ |…n˘…x… EÚÆ˙x…‰ ®… ±…M…“ Æ˙Ω˛i…“ Ω˲ * E∆Ú{…x…“ n‰˘∂…“™… +…ËÆ˙ +∆i…Æ˙…«π]≈ı“™… n˘…‰x…… §……W…Æ˙… EÚ…‰ |…§…∆v… EÚÆ˙i…“ Ω˲ * 1. ∫……l…«EÚ ±…‰J…… x…“ i…™……ƒ ¶……Æ˙i… ®… ∫……®……x™… ∞¸{… ∫…‰ ∫¥…“EfiÚi… ±…‰J…… x…“ i…™…… (<∆ b˜™…x… V…“ B B {…“) E‰Ú +x…÷∫……Æ˙ E∆Ú{…x…“ E‰Ú ¥…k…“™… ¥…¥…Æ˙h… §…x……™…‰ M…™…‰ ΩÈ˛* E∆Ú{…x…“ x…‰ ¶……Æ˙i… E‰Ú ∫…x…n˘“ ±…‰J……EÚ…Æ˙ ∫…∆∫l……{…x… E‰Ú =n¬˘P……‰π…h……/ ®……M…«n˘∂…‘ ∫…r˘…∆i…… E‰Ú +±……¥…… E∆Ú{…x…“ x…™…®… 2006 (™…l…… ∫…∆∂……‰ v…i…) E‰Ú (±…‰J…… ®……x…EÚ) +…ËÆ˙ E∆Ú{…x…“ + v… x…™…®… 1956 E‰Ú ∫…÷∫…∆M…i… |……¥…v……x…… E‰Ú +v…“x… + v…∫…⁄ S…i… ±…‰J…… ®……x…EÚ E‰Ú ∫……l… ∫…¶…“ ¶……Ë i…EÚ ∫…∆§…∆v… ®… +x…÷{……±…x… EÚÆ˙E‰Ú ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 284 Annexure I Annexure I - Significant Accounting Policies of Parent Company Sl Particulars No. Corporate Information HLL Life care Limited is a Mini Ratna Enterprise, fully owned by Government of India domiciled in India and incorporated under the provisions of the Companies Act, 1956. HLL Lifecare Ltd was converted into a Public Limited Company with effect from 21st February 2012. The Company is engaged in the manufacturing and marketing of contraceptive products, Hospital products, Women Health Pharma products, providing consultancy & Contract services for healthcare infrastructure, Procurement and Diagnostic services. The company caters to both domestic and international markets. 1. Significant accounting policies The financial statements of the company have been prepared in accordance with generally accepted accounting principles in India (Indian GAAP). The company has prepared these financial statements to comply in all material respect with the accounting standards notified under the Companies (Accounting Standards) Rules, 2006, (as amended) and the relevant provisions of the Companies Act, 1956, besides the pronouncements/guidelines of the Institute of Chartered Accountants of India. The financial statements have been prepared on an accrual basis and under the historical cost convention. The accounting policies adopted in the preparation of financial statements are consistent with those of previous years. 1.1 Basis of accounting and preparation of financial statements With effect from 1 st April 2011, the revised Schedule VI notified under the Companies Act 1956, has become applicable to the company, for preparation and presentation of its financial statements. The adoption of revised Schedule VI does not impact recognition and measurement principles followed for preparation of financial statements. However, it has significant impact on presentation and disclosure made in the financial statements. 1.2 Use of estimates The preparation of the financial statments is in conformity with Indian GAAP, requires the Management to make estimates and assumptions considered in the reported amounts of assets and liabilities (including contingent liabilities) and the reported income and expenses during the year. The Management believes that the estimates used in preparation of the financial statements are prudent and resonable. Future results could differ due to these estimates and the difference between the actual results and the estimates are recognized in the periods in which the results are known/materialized. 1.3 Inventories The weighted average formula is used for the valuation of raw materials, stores and spares. Work -in-progress, materials in transit/under inspection are carried at actual process cost. Unused Loose Tools are revalued every year taking into account the useful life of the tools and carried at the revalued cost. Finished goods manufactured/good purchased for trading are valued at lower of cost/net realizable value, including excise duty, wherever applicable. Manufactured/traded finished goods in stock whose shelf life expires upto 30th June, 2014 are taken at NIL value. Annual Report 2013-2014 285 1.4 x…EÚn˘ +…ËÆ˙ x…EÚn˘ i…÷±™……∆EÚ (x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… E‰Ú =q‰˘∂™… E‰Ú ±…B) Ω˛…l… ®… x…EÚn˘ +…ËÆ˙ §…ÈEÚ E‰Ú ∫……l… ®……ƒM… V…®…… ∫…®……¥…‰ ∂…i… Ω˲ * x…EÚn˘ i…÷±™……∆EÚ +±{……¥… v… ∂…‰π… E‰Ú Ω˲(i…“x… ®…Ω˛“x…‰ E‰Ú ®…⁄±… {… Æ˙{…C¥…i…… E‰Ú ∫……l… ™…… +V…«x… E “ i……Æ˙“J… ∫…‰ EÚ®…) =SS… x…EÚn˘“ x…¥…‰∂…, V……‰ x…EÚn˘ EÚ“ Y……i… Æ˙EÚ®… ®… +…∫……x…“ ∫…‰ {… Æ˙¥…i…«x…“™… Ω˲ +…ËÆ˙ ®…⁄±™… ®… {… Æ˙¥…i…«x… +∫……l…«EÚ V……‰ J…®… E‰Ú +…v……Æ˙ {…Æ˙ Ω˲* 1.5 x…EÚn˘ |…¥……Ω˛ ¥…¥…Æ˙h… x…EÚn˘ |…¥……Ω˛ +|…i™…I… |…h……±…“ E‰Ú ={…™……‰M… EÆ˙E‰Ú Æ˙{……‰]«ı EÚ™…… M…™…… ΩË V…∫…E‰Ú u˘…Æ˙… M…ËÆ˙ x…EÚn˘“ |…EfiÚ i… E‰Ú +…ËÆ˙ EÚ∫…“ +…∫l…M…x… ™…… M…i… ™…… ¶… ¥…π™… EËÚ∂… +…¥… i…™…… E‰Ú |……‰n¬˘¶…¥…x… ™…… ¶…÷M…i……x… E‰Ú ±…‰x…n‰˘x… E‰Ú |…¶……¥… E‰Ú ±…B +∫……v……Æ˙h… ®…n˘… E‰Ú ±……¶…/ (Ω˛… x…) +…ËÆ˙ EÚÆ˙ ∫…®……™……‰ V…i… EÚÆ˙i…… Ω˲* E∆Ú{…x…“ E‰Ú |…S……±…x…, x…¥…‰∂… +…ËÆ˙ ¥…k…“™… |…§…∆v… EÚ…™…«EÚ±……{…… ∫…‰ x…EÚn˘ |…¥……Ω˛ ±…‰J…… {…Æ˙“ I…i… ¥…k…“™… ¥…¥…Æ˙h…… E‰Ú +x…÷∫……Æ˙ +±…M… EÚB V……i…‰ ΩÈ˛* ˛ 1.6 +S…±… {… Æ˙∫…∆{… k…™……ƒ ®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ +S…±… {… Æ˙∫…∆{… k…™……ƒ {…Æ∆˙˙{…Æ˙…M…i… ±……M…i… {…Æ˙ ∫…∆ S…i… ®…⁄±™…ø…∫… EÚ®… EÚÆ˙E‰Ú n˘“ M…<« ΩÈ˛ * ±……M…i… ®… ∫…‰x…¥……]ı G‰Ú b˜]ı E‰Ú x…¥…±… V…Ω˛…ƒ EÚΩ˛” ±……M…⁄ Ω˲, ∫…¶…“ |……∫…∆ M…EÚ ¥™…™… ∂…… ®…±… Ω˲ * x…<« {… Æ˙™……‰V…x……Bƒ/x…B ¥™…¥…∫……™…… EÚ…‰ {…Ω˛S……x…x…‰ E‰Ú ±…B J…S…« Ω÷˛B Æ˙…V…∫¥… ¥™…™… S……±…⁄ {…⁄ƒV…“ EÚ…™…« E‰Ú ∞¸{… ®… ®……x…… V……i…… Ω˲ * ™…Ω˛ ¥™…¥…∫……™… |……Æ∆˙¶… EÚÆ˙x…‰ E‰Ú |…l…®… ¥…π…« ®… {… Æ˙™……‰V…x…… ±……M…i… ®… +…®…‰ ±…i… EÚ™…… V……BM……* ™… n˘ x…<« {… Æ˙™……‰V…x……/x…B ¥™…¥…∫……™… 3 ¥…k…“™… ¥…π……Á EÚ“ +¥… v…™…… ®… EÚ…™……«Œx¥…i… x…Ω˛” EÚB M…B ΩË∆˛ i……‰ ∫…¶…“ ¥™…™… i…“∫…Ɖ˙ ¥…π…« ®… Æ˙…V…∫¥… ®… |…¶…… Æ˙i… EÚÆÂ˙M…‰ * {…^ı…¶…⁄ ®… E‰Ú ®…⁄±™… {…^‰ı +¥… v… {…Æ˙ {… Æ∂˙……‰ v…i… EÚ™…… M…™…… Ω˲ * +S…±… {… Æ˙∫…∆{… k…™…… EÚ“ ±……M…i… ®… =v……Æ˙ {…Æ˙ §™……V… (¶…… Æ˙i… +…Ë∫…i… n˘Æ˙ {…Æ˙ {… Æ˙EÚ ±…i…) +…ËÆ˙ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú + v…O…Ω˛h… E‰Ú ±…B ¥…∂…‰π… ∞¸{… ∫…‰ +…Æ˙…‰{™… |…∂……∫… x…EÚ ¥™…™… ∂…… ®…±… ΩÈ˛ * +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 1.4.2003 ∫…‰ J…S…« Ω÷˛B E∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ˙ EÚ“ ±……M…i… +…ËÆ˙ ±……<∫…Â∫… ∂…÷±EÚ EÚ…‰ +®…⁄i…« {… Æ˙∫…∆{… k…™…… E‰Ú ∞¸{… ®… ¥…M…‘EfiÚi… EÚB V……i…‰ ΩÈ˛* <« +…Æ˙ {…“ ∫……Ï}]ı¥…‰™…Æ˙ ∫……‰±…⁄∂…x… E‰Ú +±……¥…… E∆Ú{™…⁄]ıÆ˙ ∫……Ï}]ı¥…‰™…Æ˙… EÚ“ ±……M…i… ∫…®……x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ 3 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B ∫…®……x… ∞¸{… ∫…‰ {… Æ˙∂……‰v…x… EÚ™…… V……i…… Ω˲ V…§… EÚ <« +…Æ˙ {…“ ∫……Ï}]ı¥…‰™…Æ˙˙ ∫……‰±…⁄∂…x… ∫…®……x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ 8 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ˙∂……‰v…x… EÚ™…… V……i…… Ω˲ * |…n˘k… ±……<∫…Â∫… ∂…÷±EÚ EÚ…‰ ∫…®…Z……Ëi…‰ EÚ“ +¥… v… ®… ∫…®……x… ∞¸{… ∫…‰ {… Æ˙∂……‰v…x… EÚ™…… V……i…… Ω˲ * ]≈‰ıb˜ ®……E«Ú ¥™…™… ]≈‰ıb˜ ®……E«Ú {…∆V…“EÚÆ˙h… {…Æ˙ J…S…« Ω÷˛B ¥™…™…, S……±…⁄ {…⁄ƒV…“ EÚ…™…« E‰Ú ∞¸{… ®… ®……x…… V……BM…… +…ËÆ˙ ˛±……<∫…Â∫… |……{i… Ω˛…‰i…‰ Ω˛“ "+®…⁄i…« {… Æ˙∫…∆{… k…™……‰∆' E‰Ú +v…“x… {…⁄ƒV…“EfiÚi… EÚ™…… V……BM……* =∫… EÚ…‰ +®…⁄i…« {… Æ˙∫…∆{… k… EÚ“ ®……x™…i…… EÚ“ i……Æ˙“J… ∫…‰ 5 ¥…π……Á EÚ“ +¥… v… E‰Ú ±…B {… Æ˙∂……‰v…x… EÚ™…… V……BM……˛* ±……<∫…Â∫… {…Æ˙ J…S…« Ω÷˛B =k…Æ˙¥…i…‘ ¥™…™…, V……‰ {…Ω˛±…‰ Ω˛“ {…⁄ƒV…“EfiÚi… Ω˲, EÚ…‰ B‰∫…‰ ¥™…™… J…S…« Ω˛…‰ V……x…‰ EÚ“ +¥… v… ®… Æ˙…V…∫¥… ¥™…™… E‰Ú ∞¸{… ®… ®……x™…i…… n˘“ V……BM…“* ®…⁄±™…ø…∫… +…ËÆ˙ @Òh…®…÷ HÚ +t…¥… v… ∫…∆∂……‰ v…i… E∆Ú{…x…“ + v… x…™…®…, 1956 EÚ“ +x…÷∫…⁄S…“ XIV ®… x…v……« Æ˙i… n˘Æ˙… E‰Ú +x…÷∫……Æ˙ ®…⁄±™…ø…∫… ¥™…¥…Œ∫l…i… EÚ™…… M…™…… Ω˲ * +S…±… {… Æ˙∫…∆{… k…™…… ∫…‰ {… Æ˙¥…v…«x…/EÚ]ı…Ëi…“ {…Æ˙ ®…⁄±™……ø…∫… nˢ x…EÚ ∫…®……x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ n˘B V……i…‰ Ω∆˲ * +¥… v… ∫…®……{i…/Æ˙q˘“ i…l…… x…{…]ı…x… E‰Ú ±…B {…b˜“ +S…±… {… Æ˙∫…∆{… k…™…… EÚ…‰ x…®x…i…®… §…Ω˛“ ®…⁄±™…Ú/ x…¥…±… ¥…∫…⁄±…“ ™……‰M™… ®…⁄±™… {…Æ˙ x…™…i… Ω˲ +…ËÆ "Æ˙q˘“/+ v…∂…‰π… {… Æ˙∫…∆{… k…" ∂…“π…« E‰Ú +v…“x… ∫…∆{… k… ∫…⁄S…“ ®… ¥…M…‘EÚfii… EÚB V……˙i…‰ ΩÈ˛ * ®…⁄±™…ø…∫…/@Òh…®…÷ HÚ EÚ“ ¥… v… EÚ) 01.04.1993 ∫…‰ +S…±… {… Æ˙∫…∆{… k…™…… ®… |… i… `5000/- ™…… =∫…∫…‰ EÚ®… ±……M…i… E‰Ú {… Æ˙¥…v…«x……‰∆ EÚ…‰ {… Æ˙¥…v…«x… EÚ“ i……Æ˙“J… EÚ…‰ v™……x… ®… Æ˙J…‰ §…x…… {…⁄h…«i…™…… ®…⁄±™…ø…∫… EÚ™…‰ V……i…‰ ΩÈ˛* J…) ={…EÚÆ˙h… E‰Ú ∫……l… +ÃV…i… ®…∂…“x…Æ˙“ {…÷V……Á EÚ… ®…⁄±™…ø…∫… ®…⁄±… ®…∂…“x…Æ˙“ E‰Ú ±…B ={…™…÷HÚ n˘Æ˙ ¥… |…h……±…“ EÚ‰ |…™……‰M… EÚÆ˙E‰Ú EÚB V……i…‰ ΩÈ˛* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 286 1.4 Cash and cash equivalents (for purpose of Cash Flow Statement) Cash comprises cash on hand and demand deposits with banks. Cash equivalents are short-term balances (with an original maturity of three months or less from the date of acquisition), highly liquid investments that are readily convertible into known amounts of cash and which are subject to insignificant risk of changes in value. 1.5 Cash Flow statement Cash flows are reported using the indirect method, whereby profit/(loss) before extraordinary items and tax is adjusted for the effects of transactions of non-cash nature and any deferrals or accruals of past or future cash receipts or payments. The cash flows from operating, investing and financing activities of the Company are segregated based on audited financial statements. 1.6 Fixed Assets Tangible Assets Fixed Assets are stated at historical cost less accumulated depreciation. Cost includes all incidental expenditure net of CENVAT credit wherever applicable. Revenue expenses incurred for identification of new projects/new line of businesses are treated as capital work in progress. This will be absorbed into the project cost in the first year of commencing the business. If the new project / new line of business do not materialize within a period of three financial years, the entire expenses shall be charged to Revenue in the 3rd year. The cost of fixed assets includes interest on borrowings (calculated at the weighted average rates) and administrative expenses specifically attributable to the acquisition of fixed assets. Intangible Asset a) Cost of computer software and License fee incurred from 1.4.2003 are classified as intangible assets. The cost of computer software other than ERP Software Solution is amortized equally over a period of 3 years, whereas ERP software solution is amortized over a period of 8 years on pro-rata basis. License fee paid is amortized equally over the agreement period. Trade Mark Expenses Expenses incurred on trade mark registrations will be treated as Capital work in progress and will be capitalized under 'intangible assets' when licenses are received. Same shall be amortized over a period of 5 years from the date of recognition of intangible asset. Subsequent expenditure incurred on licences which is already capitalized will be recognized as revenue expenses in the period in which such expenses are incurred. Depreciation and amortization Depreciation has been provided as per the rates prescribed under Schedule XIV of the Companies Act, 1956 as amended up to date. The depreciation on additions to/deductions from fixed assets are provided on prorata daily basis. Fixed Assets retired/scrapped and pending disposal are stated at lower of book value/net realizable value and grouped under inventories under the head "Scraped/Surplus Asset" Method of depreciation/Amortization a) Additions to Fixed Assets from 01.04.1993 costing `5000/- each or less are fully depreciated irrespective of date of addition. b) Machinery spares acquired with the equipment are depreciated using the same rates and method applicable for the original machinery Annual Report 2013-2014 287 M…) ¶… ¥…π™… E‰Ú |…™……‰M… E‰Ú ±…B +±…M… ∞¸{… ∫…‰ |……{…h… EÚB ®…∂…“x…Æ˙“ {…÷V……Á E‰Ú ®……®…±…‰ ®…Â, ∫…∆§…∆ v…i… ®…∂…“x…Æ˙“ EÚ“ ∫…®……{i… +¥… v… E‰Ú ±…B ∫…∆ S…i… ®…⁄±™…ø…∫… E‰Ú ∫…®…i…÷±™… n˘Æ˙ +V…«x… ¥…π…« ®… =∫… ¥…π…« E‰Ú ®…⁄±™…ø…∫… E‰Ú ∫……l… S……V…« EÚB V……i…‰ ΩÈ˛ * P…) {…^‰ı {…Æ˙ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ®…⁄±™…ø…∫…/{… Æ∂˙……‰v…x… E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ v……Æ˙… 205(5) (B) E‰Ú +v…“x… {… Æ˙¶…… π…i… V…Ë∫…‰ {…^‰ı EÚ“ |……l… ®…EÚ +¥… v…™…… {…Æ˙ ∫…“v…“ Ɖ˙J…… |…h……±…“ {…Æ˙ x…v……« Æ˙i… +¥… v… {…Æ, V……‰ EÚ®… Ω˲ E‰Ú +…v……Æ˙ {…Æ˙ |……¥…v……x… n˘™…… V……i…… Ω˲ * {…^‰ı {…Æ˙ ∫…÷v……Æ˙ ∫…‰ ∫…∆§…∆ v…i… ®…⁄±™…ø…∫… {…^‰ı EÚ“ |……l… ®…EÚ +¥… v… {…Æ˙ ∫…“v…“ Ɖ˙J…… |…h……±…“ {…Æ˙ |…n˘…x… EÚ™…… V……i…… Ω˲ *˙ RÛ) +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ±…B {… Æ˙¥…v…«x…˜/ ¥…±……‰{…x… E‰Ú ±…B ®…⁄±™…ø…∫… S……V…« EÚÆ˙x…‰ EÚ“ ¥… v… nˢ x…EÚ +…x…÷{…… i…EÚ +…v……Æ˙ {…Æ˙ Ω˲*˘ ˙ 1.7 Æ˙…V…∫¥… ®……x™…i…… §…GÚ“ ®… §…GÚ“ EÚÆ˙ +…ËÆ˙ §…]¬ı]‰ı EÚ…‰ UÙ…‰c˜EÚÆ˙ ∫…“®…… ∂…÷±EÚ ∫… Ω˛i… ®……±…… E‰Ú §…GÚ“ E‰Ú ®…⁄±™… ( x…¥…±… ¥……{…∫…“) ∫…®…… ¥…π]ı Ω˲ * §…“®…… n˘…¥…… |……Œ{i… E‰Ú +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛ * x…¥…‰∂……‰∆ {…Æ˙ §™……V…, x…¥…‰ ∂…i… Æ˙EÚ®… +…ËÆ˙ §™……V… E‰Ú x…™…i… n˘Æ˙ {…Æ v™……x… Æ˙J…EÚÆ˙˙ ∫…®…™… +x…÷{……i… E‰Ú +…v……Æ˙ {…Æ˙ §…÷EÚ EÚ™…… V……i…… Ω˲ * x…Ën˘… x…EÚ ∫…‰¥……+… ∫…‰ Æ˙…V…∫¥… |……‰n¬˘¶…¥…x… +…v……Æ˙ {…Æ˙ |…n˘…x… EÚ™…… V……i…… Ω˲* `‰ˆE‰Ú +x…÷Æ˙I…h… ∫…‰ Æ˙…V…∫¥… `‰ˆE‰Ú EÚ“Ú+¥… v… {…Æ˙ ™…l……x…÷{……i… ∞¸{… ∫…‰ {…Ω˛S……x… EÚ“ V……i…“ Ω˲ * +¥…∫…∆Æ˙S…x…… ¥…EÚ…∫… |…¶……M… +…ËÆ˙ |……{…h… {…Æ˙…®…∂…« |…¶……M… ∫…‰ ∫…∆§…∆ v…i… EÚ…™…«EÚ±……{…… ∫…‰ Æ˙…V…∫¥… x…®x… V…Ë∫…‰ |…n˘…x… EÚB V……i…‰ ΩÈ˛; EÚ) ]ıx…« EÚ“ `‰ˆE‰Ú E‰Ú ®……®…±…‰ ®…‰∆, ∫…¥…ÊI…h… |…h……±…“ E‰Ú +v…“x… `‰ˆE‰Ú ®…⁄±™… E‰Ú ±…B §…œ±±…M… |…M… i… E‰Ú +…v……Æ˙ {…Æ˙ Ω˲* J…) +x™… `‰ˆE‰Ú E‰Ú ®……®…±…‰ ®…Â, ∫…∆§…∆ v…i… + ¶…EÚÆ˙h…… E‰Ú ∫……l… `‰ˆE‰Ú E‰Ú ∂…i……Á E‰Ú +x…÷∫……Æ˙ n˘… ™…i¥… {…⁄Æ˙… EÚÆ˙x…‰ E‰ +…v……Æ˙ {…Æ˙ Ω˲* 1.8 +x™… |…S……±…x… Æ˙…V…∫¥… Æ˙q˘“ ±…Ë]‰ıC∫…, +∫¥…“EfiÚi… ∫……®… O…™……ƒ i…l…… EÚhb˜®…… EÚ“ ¥…∫…⁄±…“ EÚ“ +…‰Æ˙ Æ˙…V…∫¥… Æ˙…‰EÚc˜ +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛* x…™……«i… §…GÚ“ ∫…‰ ∫…∆§…∆ v…i… ∂…÷±E ¥……{…∫…“Ú/ x…™……«i… |……‰i∫……Ω˛x…, x…™……«i… E‰Ú ¥…π…« ®… {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛ * +|…S… ±…i… {… Æ˙∫…∆ k…™……Â/§…]¬ı]‰ı J……i…‰ b˜…±…“ M…™…“ ∫……®… O…™…… EÚ“ ¥…∫…⁄±…“, Æ˙…‰EÚc˜ +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚ“ V……i…“ ΩË * §…“V…EÚ ®… x…v……« Æ˙i… V…Ë∫…‰ ¥… ¥…v… n‰˘x…n˘…Æ˙… ∫…‰ ¥…±…∆ §…i… ¥…∫…⁄±…“ E‰Ú ±…B ™… n˘ EÚ…‰<« §™……V… +…™… Ω˲ i……‰ =∫…EÚ“ {…Ω˛S……x… x…Ω˛” EÚ“ Ω˲ * 1.9 ¥…n‰˘∂…“ ®…÷p˘… ±…‰x…-n‰˘x… ¥……™…n˘… ∫…∆ ¥…n˘… u˘…Æ˙… ∫…®……¥…‰ ∂…i… ¥…n˘‰∂…“ ¥… x…®…™… E‰Ú + i… Æ˙HÚ ±…‰x…-n‰˘x……‰∆ EÚ…‰ ±…‰x…-n‰˘x……‰∆ EÚ“ i……Æ˙“J… {…Æ˙ |…S… ±…i… ¥… x…®…™… n˘Æ˙ ®… {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛ * ¥……™…n˘… `‰ˆEÚ… u˘…Æ˙… ∫…®……¥…‰ ∂…i… EÚ…‰ UÙ…‰c˜EÚÆ˙ +x™… ¥…n‰˘∂…“ ®…÷p˘… +V…«x…/n‰˘™… ¥…π……»xi… EÚ…‰‰ ¥… x…®…™… n˘Æ˙ {…Æ˙ §…n˘±… n˘B V……i…‰ ΩÈ˛ * <∫… §…n˘±…“ ∫…‰ Ω˛…‰x…‰ ¥……±…‰ ±……¶… ™…… x…π]ı ±……¶…-Ω˛… x… ±…‰J…‰ ®… ∫…®……™……‰ V…i… EÚB V……i…‰ ΩÈ˛ * ¥…n‰˘∂…“ ®…÷p˘… @Òh…, ¥…π……»i… ¥… x…®…™… n˘Æ˙ {…Æ˙ ®…⁄±™……∆ EÚi… EÚB V……i…‰ ΩÈ˛ * ™… n˘ i…÷±…x… {…j… EÚ“ i……Æ˙“J… {…Æ §…EÚ…™…… ¥……™…n˘… `‰ˆEÚ… EÚ…‰<« ΩË i……‰,˛ ˙i……Æ˙“J… {…Æ˙ |…S… ±…i… ¥… x…®…™… n˘Æ˙ {…Æ˙ §…Ω˛…±… EÚB V……i…‰ ΩÈ˛* ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 288 c) In the case of Machinery spares procured separately for future use, rate equivalent to accumulated depreciation for the expired life of the relative machinery are charged in the year of acquisition along with the depreciation for the year. d) Depreciation/amortization of fixed assets on lease is provided on the straight line method over the primary period of leases or over the specified period, as defined under Section 205 (5) (a) of the Companies Act, 1956, whichever is shorter. Depreciation in respect of Leasehold Improvements is provided on the straight-line method over the primary period of the lease. e) The method of charging depreciation for addition to/deletion for fixed assets is on a daily prorata basis. 1.7 Revenue recognition Sales comprise of value of sale of goods (net of returns) excluding sales tax and discounts but including excise duty. Insurance claims are accounted on receipt basis. Interest on investments is booked on a time proportion basis taking into account the amounts invested and the fixed rate of interest. Revenue from Diagnostics services is recognized on accural basis. Revenues from maintenance contracts are recognized pro rata over the period of the contract. Revenue from Infrastructure-development division and Procurement Consultancy Division related activities are recognized as follows; a) In case of turn key contracts, on the basis of progress billing to the contract value under survey method. b) In the case of other contracts, on the basis of completion of obligation as per the terms of contract with the agencies concerned. 1.8 Other Operating Revenues The revenue against realization of waste latex, rejected materials and condoms are accounted on cash basis. Duty drawback/export incentive in respect of export sales are accounted in the year of export. The realization in respect of obsolete assets/materials written off is accounted on cash basis. Interest income if any for delayed realization from sundry debtors as stipulated in invoices is not recognized, unless realized. 1.9 Foreign currency transactions and translations Transactions in foreign exchange other than those covered by forward contracts are accounted for at the exchange rates prevailing on the date of transactions. Foreign currency receivables/ payables other than those covered by forward contracts are translated at the year-end exchange rates. Gain or losses on arising out of such transactions are adjusted to the Profit and Loss Account. Foreign Currency Loans are valued at year end exchange rates. Outstanding forward contracts, if any, as at the Balance Sheet date are reinstated at the exchange rate prevailing on the date. Annual Report 2013-2014 289 ¥… x…®…™… +∆i…Æ˙ ¥™…¥…Ω˛…Æ˙ n˘“P…«EÚ…±…“x… ¥…n‰˘∂…“ ®…÷p˘… ®……Ë p˘EÚ ®…n˘… E‰Ú +∆i…Æ˙h… ™…… ¥™…¥…∫l……{…x… {…Æ˙ ¥… x…®…™… +∆i…Æ˙ (+l……«i…, V…∫…EÚ… ¥™…¥…∫l……{…x… EÚ“ +¥… v… =∫…E‰Ú |……Æ∆˙¶… EÚ“ i……Æ˙“J… ∫…‰ §……Æ˙Ω˛ ®…Ω˛“x…‰ ∫…‰ + v…EÚ ΩË), V……‰ {…UÙ±…‰ ¥…k…“™… ¥…¥…Æ˙ h…™…… ®… {…Ω˛±…‰ Ω˛“ Æ˙EÚ…‰b«˜ EÚB M…B ™…… Æ˙{……‰]«ı EÚB ∫…‰ +±…M… ΩÈ, V…Ω˛…ƒ i…EÚ EÚ ™…Ω˛ n˘x……∆EÚ 31.3.2009 +…ËÆ˙ 29.02.2012 E‰Ú ¶……Æ˙i… ∫…Æ˙EÚ…Æ˙ EÚ“ + v…∫…⁄S…x…… E‰Ú +x…÷∫……Æ˙ {… Æ˙∫…∆{… k…™…… EÚ“ ±……M…i… E‰Ú ±…B ∫…®……™……‰ V…i… EÚB M…B ®…⁄±™…ø…∫… EÚÆ˙x…‰ ™……‰M™… {… Æ˙∫…∆{… k…™…… ∫…‰ ∫…∆§…∆ v…i… Ω˲ +…ËÆ˙ {… Æ˙∫…∆{… k…™…… E‰Ú ∂…‰π… EÚ…±… {… Æ∂˙……‰ v…i… EÚ™…… V……BM……* o˘f¯ |… i…§…r˘i…… ±…‰x…n‰˘x… E‰Ú EÚ…Æ˙h…˙ ¥…π…« E‰Ú +∆i… ®… §…EÚ…™…… ¥……™…n˘… ¥… x…®…™… ∫…∆ ¥…n˘…™… §……W……Æ˙ EÚ“ +…‰Æ˙ +∆ EÚi…Ú EÚ™…‰ V……i…‰ ΩÈ˛ +…ËÆ˙ ™… n˘ EÚ…‰<« Ω˛… x… Ω˲ i……‰ ±……¶…-Ω˛… x… ±…‰J…‰ ®… ∫¥…“EfiÚi… EÚ™…… V……i…… Ω˲ +…ËÆ˙ ¥™…÷i{…z…… E‰Ú ±…B ±…‰J…… {…r˘ i… {…Æ˙ ®……S…« 2008 ®… V……Æ˙“ EÚ™…‰ M…™…‰ ¶……Æ˙i…“™… ∫…x…n˘“ ±…‰J……{…Æ˙“I…… ∫…∆∫l……x… EÚ“ P……‰π…h…… E‰Ú +x…÷∫……Æ˙ ±……¶… EÚ“ ={…‰I…… EÚ“ V……i…“ Ω˲ * 1.10 ∫…Æ˙EÚ…Æ˙“ +x…÷n˘…x… EÚ) x…¥…‰∂… <®…n˘…n˘ E‰Ú ∞¸{… ®… Æ˙Ω‰˛ +x…÷n˘…x…… EÚ…‰ +±…M… +…Æ˙ I…i… ®… V…®…… EÚB V……i…‰ ΩÈ˛* J…) §… GÚ™…… ∫…‰ ∫…∆§…∆ v…i… Æ˙…V…∫¥… +x…÷n˘…x…/<®…n˘…n˘ (=i{……n˘ <®…n˘…n˘ ∫…‰ ¶…z…) +x™… +…™… E‰Ú +v…“x… +±…M… ∞¸{… ∫…‰ |…EÚ]ı EÚB V……i…‰ ΩÈ˛ V…§… EÚ =i{……n˘ <®…n˘…n˘, §…GÚ“ +…ËÆ˙ ∫…‰¥……+… E‰Ú +v…“x… |…EÚ]ı EÚB V……i…‰ ΩÈ˛* 1.11 x…¥…‰∂… ™… n˘ EÚ…‰<« +∫l……™…“ E‰Ú +±……¥…… EÚ®…“ E‰Ú |……¥…v……x… Ω˲ i……‰ =∫…‰ EÚ®… EÚÆ˙x…‰ EÚ… |……¥…v……x… n‰˘EÚÆ˙ x…¥…‰∂… ±……M…i… {…Æ˙ |…EÚ]ı EÚB V……i…‰ ΩÈ˛* 1.12 EÚ®…«S……Æ˙“ °Ú…™…n‰˘ EÚ) ={…n˘…x… +…ËÆ˙ U÷Ù]¬ı]ı“ +¶™…{…«h… ={…n˘…x… n‰˘™…i…… +…ËÆ˙ U÷Ù]¬ı]ı“ +¶™…{…«h… n‰˘™…i……Bƒ V…“¥…x… §…“®…… x…M…®… E‰Ú ∫……l… +x…÷Æ˙ I…i… {…fil…EÚ O…⁄{… ™……‰V…x……+… E‰Ú +v…“x… x…v……« Æ˙i… EÚ“ V……i…“ ΩÈ˛* <∫… ™……‰V…x……+… EÚ“ +…‰Æ˙ n‰˘™…i……Bƒ V…“¥…x… §…“®…… x…M…®… u˘…Æ˙… |…n˘…x… EÚB ®…⁄±™……∆EÚx… E‰Ú +±……¥…… §…“®……∆ EÚEÚ ®…⁄±™……∆EÚx… E‰Ú +…v……Æ˙ {…Æ˙ ¥……Ãπ…EÚ ∞¸{… ∫…‰ |……EÚ ±…i… EÚ“ V……i…“ ΩÈ˛* ¥…fi r˘∂…“±… n‰˘™…i……Bƒ ¥…π……«x…÷¥…π…« +…v……Æ˙ {…Æ˙ V…“¥…x… §…“®…… x…M…®… u˘…Æ˙… =`ˆ…<« M…<« ®……ƒM… E‰Ú +x…÷∫……Æ˙ x… v…EÚ EÚ“ V……i…“ Ω˲ +…ËÆ˙ Æ˙…V…∫¥… ®… S……V…« EÚ“ V……i…“ ΩÈ˛* J…) ∫¥…ËŒSUÙEÚ ∫…‰¥…… x…¥…fi k… ™……‰V…x…… ¥…“ +…Æ˙ B∫… E‰Ú +v…“x… +n˘…™…M…“ E‰Ú EÚ…Æ˙h… {…⁄Æ˙“ n‰˘™…i……Bƒ =∫…“ ¥…π…« E‰Ú ±……¶…-Ω˛… x… ±…‰J…‰ EÚ“ +…‰Æ˙ |…¶…… Æ˙i… EÚB M…B ΩÈ˛ * M…) Æ˙…‰W…M……Æ˙…‰k…Æ˙ S… EÚi∫…… ±……¶… 01.07.2005 ∫…‰ E∆Ú{…x…“ E‰Ú {…∆V…“ ®… Æ˙Ω‰˛ EÚ®…«S…… Æ˙™…… (=∫…EÚ…/=∫…EÚ“ {… i… ™…… {…ix…“ ∫… Ω˛i…) EÚ…‰, ®…Ë∫…∫…« x…Ë∂…±…x… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 290 Treatment of exchange differences Exchange differences on translation or settlement of long term foreign currency monetary items (i.e., whose term of settlement exceeds twelve months from the date of its origination) at rates different from those at which they were initially recorded or reported in the previous financial statements, in so far as it relates to acquisition of depreciable assets are adjusted to the cost of the assets as per GOI notification dated 31.03.2009 and 29.12.2011 and this will be amortized over the remaining life of the Asset. Forward exchange contracts outstanding as at the year end on account of firm commitment transactions are marked to market and the losses, if any are recognized in the profit and loss account and gains are ignored in accordance with the announcement of the Institute of Chartered Accountants of India on Accounting for Derivatives issued in March 2008. 1.10 Government grants a) Grants in the form of investment subsidy are credited to separate reserve. b) Revenue grants/subsidy (other than product subsidy) relating to sales are disclosed separately under other operating revenues, whereas product subsidy are disclosed under sales and services. 1.11 Investments Investments are stated at cost less provision for diminution other than temporary, if any. 1.12 Employee benefits a) Gratuity and Leave Encashment The Gratuity Liability and Leave Encashment liabilities are determined under separate group schemes maintained with LIC of India. The liabilities towards these schemes are estimated yearly, based on the actuarial valuation, in addition to the valuation provided by LIC of India. The incremental liabilities on year to year basis are funded as per demand raised by LIC of India and is charged to the revenue. b) Voluntary Retirement Benefits The entire liability on account of payments under VRS is charged off to the Profit and Loss Account in the same year c) Post Employment Medical Benefits The Employees (including his/her spouse) on the rolls of the Company from 01.07.2005 are covered under Group Medical Insurance Scheme of M/s. National Insurance Company Ltd. d) Bonus/Performance Related Payment Provision for bonus for the employees is made on the basis of Productivity Linked Incentive Scheme as per the Long Term Agreement entered into with the recognized trade unions. Executives at the Board level and below the Board level are covered for Performance Related Pay (PRP) as per the guidelines issued by the Department of Public Enterprise. e) Pension Scheme Company has introduced a contributory pension scheme from 1-4-2011 for the permanent employees who are on the rolls of the company as on 9-10-2012. Company will contribute 3% of the basic plus DA with a matching contribution from employees. The pension scheme is managed by LIC of India. Annual Report 2013-2014 291 1.13 =v……Æ˙ ±……M…i… +Ω«˛EÚ {… Æ˙∫…∆{… k… Ω˛… ∫…±… EÚÆ˙x…‰ E‰Ú =q‰˘∂™… ∫…‰ J…S…« Ω÷˛B /+…Æ˙…‰{™… =v……Æ˙ ±……M…i… {…⁄ƒV…“EfiÚi… EÚ“ V……i…“ Ω˲∆* {… Æ˙∫…∆{… k…™……‰∆ E‰Ú +V…«x… E‰Ú ±…B ¥…∂…‰π… ∞¸{… ∫…‰ ±…B @Òh… {…Æ˙ §™……V… +…ËÆ =∫… {…Æ˙ §™……V… EÚ…‰˙ {… Æ˙∫…∆{… k… ®…⁄±™… E‰Ú +…v……Æ˙ {…Æ˙ ∫…∆§…∆ v…i… {… Æ˙∫…∆{… k…™…… {…Æ˙ +…x…÷{…… i…EÚ ∞¸{… ∫…‰ +…§…∆ ]ıi… EÚB V……i…‰ ΩÈ˛* 1.14 J…hb˜ Æ˙{……‰Õ]ıM… E∆Ú{…x…“ x…‰ Æ˙{……‰]«ı EÚÆ˙x…‰ ™……‰M™… J…∆b˜ V……‰ |……l… ®…EÚ n˘±… E‰Ú ΩÈ˛, ±…‰‰J…… ®……x…EÚ 17 E‰Ú +x…÷∫……Æ˙ <∫…E‰Ú J…hb˜ Æ˙{……‰Õ]ıM… E‰Ú ±…B M…¶…« x…Æ˙…‰v…EÚ =i{……n˘, ∫¥……∫l™… Æ˙I…… =i{……n˘, ¥™……{……Æ˙ =i{……n˘‰∆, ∫…‰¥……B∆ B¥…∆ `‰ˆEÚ… E‰Ú ∞¸{… ®… {…Ω˛S……x… EÚ“ ΩÈ ˛* <∫…E‰Ú +±……¥……, x…®x… ±… J…i… ¥… x…Ãn˘π]ı ±…‰J…… x…“ i…™……ƒ, J…∆b˜ Æ˙{……‰Õ]ıM… E‰Ú ±…B {……±…x… EÚ“ V……i…“ ΩÈ˛ : (EÚ) J…∆b˜ Æ˙…V…∫¥… ®… +xi…Æ˙ J…∆b˜ Æ˙…V…∫¥… ∫… Ω˛i… J…∆b˜ E‰Ú ±…B ∫…“v…‰ + ¶…Y…‰™…/ ¥… x…™……‰V™… §…GÚ“ B¥…∆ +x™… +…™… ∂…… ®…±… Ω˲ * (J…) J…∆b˜ {… Æ˙h……®… x…Œ∂S…i… EÚÆ˙x…‰ E‰Ú ±…B ∫…“v…‰ + ¶…Y…‰™…/ ¥… x…™……‰V™… J…S…« J…hb…‰∆˜ {…Æ˙ ¥…S……Æ˙ EÚB V……i…‰ ΩÈ˛* {…⁄h…« ∞¸{… ∫…‰ E∆Ú{…x…“ ∫…‰ ∫…∆§…∆ v…i… J…S…« +…ËÆ˙ J…∆b˜… EÚ…‰ + ¥… x…™……‰V™… J…S……Á EÚ…‰ '+ ¥… x…v……x…“™… ¥™…™…' E‰Ú +v…“x… ∂…… ®…±… EÚB V……i…‰ ΩÈ˛ * (M…) E∆Ú{…x…“ E‰Ú {…⁄h…« ∞¸{… ∫…‰ ∫…∆§…∆ v…i… J…hb…‰∆˜ E‰Ú ±…B + ¥… x…™……‰V™… +…™… EÚ…‰ +…ËÆ˙ '+ ¥… x…v……x…“™… +…™…' E‰Ú +v…“x… ∂…… ®…±… EÚB V……i…‰ ΩÈ˛ * (P…) J…hb˜ {… Æ˙∫…∆{… k…™……‰∆ +…ËÆ˙ n‰˘™…i……+… ®… ∫…∆§…∆ v…i… J…hb˜… E‰Ú ∫……l… ∫…“v…‰ + ¶…Y…‰™… ∂…… ®…±… ΩÈ˛* + ¥… x…v……x…“™… E∆Ú{…x…“ {… Æ˙∫…∆{… k…™……‰∆ B¥…∆ n‰˘™…i……Bƒ E∆Ú{…x…“ EÚ…‰ {…⁄h…« ∞¸{… ∫…‰ ∫…∆§…Œxv…i… ∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… E‰Ú |… i… x… v…i¥… EÚÆ˙i…‰ ΩÈ˛ +…ËÆ˙ EÚ∫…“ ¶…“ J…∆b˜ E‰Ú ±…B ¥… x…™……‰V™… x…Ω˛” Ω˲* 1.15 {…^ı… +ÃV…i… +…ËÆ˙ {…^‰ı {…Æ˙ n˘“ M…<« +S…±… {… Æ˙∫…∆{… k…™…… EÚ…‰ +S…±… {… Æ˙∫…∆{… k…™……‰∆ EÚ‰ Ω˛∫∫…‰ E‰Ú ∞¸{… ®… n˘J……™…‰ V……i…‰ ΩË∆˛* {…^ı… EÚÆ˙…™…… +…™… |……‰n¬˘¶…¥…x… +…v……Æ˙ {…Æ˙ {… Æ˙EÚ ±…i… EÚ™…… V……i…… Ω˲* 1.16 +…™… {…Æ˙ EÚÆ˙ +…™…EÚÆ˙ + v… x…™…®… 1961 E‰Ú |……¥…v……x…… E‰Ú +x…÷∫……Æ˙ S……±…⁄ ±…‰J…… ¥… v… E‰Ú J……i…‰ EÚ“ +¥… v… E‰Ú ±…B +x…÷®…… x…i… EÚÆ ˙™……‰M™… +…™… E‰Ú +…v……Æ˙ {…Æ˙ S……±…⁄ EÚÆ˙ EÚ… |……¥…v……x… EÚ™…… V……i…… Ω˲ * ¥…π…« E‰Ú J……i…… +…ËÆ˙ EÚÆ˙ ™……‰M™… ±……¶…˙ E‰Ú §…“S… E‰Ú ∫…®…™… +∆i…Æ˙ ∫…‰Ú {… Æ˙h……®…“ +…∫l… M…i… EÚÆ˙, EÚÆ˙ n˘Æ˙ +…ËÆ˙ x…™…®…… E‰Ú |…™……‰M… E‰Ú ±…B {… Æ˙EÚ ±…i… EÚ™…… V……i…… Ω˲ V……‰ i…÷±…x…-{…j… EÚ“ i……Æ˙“J…Ú ∫…‰ ±……M…⁄ Ω˲ * ¶… ¥…π™… ®… <∫…EÚ“ ¥…∫…⁄±…“ ®… BEÚ = S…i… x…Œ∂S…i…i…… Ω˲ i……‰ +…∫l… M…i… EÚÆ˙ {… Æ˙∫…∆{… k… EÚ…‰ =∫… Ω˛n˘ i…EÚ ∫¥…“EfiÚi… B¥…∆ +…M…‰ EÚ“ +…‰Æ˙ ±…‰ V……i…“ Ω˲ * +…™…EÚÆ˙ + v… x…™…®… 1961 E‰Ú +x…÷∫……Æ˙ x™…⁄x…i…®… ¥…ËEÚŒ±{…EÚ EÚÆ˙ (B®… B ]ı“) |…n˘k… EÚ™…… Ω˲, V……‰ ¶… ¥…π™… +…™… EÚÆ˙ n‰˘™…i…… E‰Ú ∫…®……™……‰V…x… E‰Ú ∞¸{… ®… ¶… ¥…π™… +…Ãl…EÚ °Ú…™…n˘… §…g¯…i…“ Ω˲, EÚ…‰ i…÷±…x… {…j… ®… {… Æ˙∫…∆{… k… E‰Ú ∞¸{… ®… ¥…S……Æ˙ EÚ™…… V……i…… Ω˲* 1.17 +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… {…Æ˙ {…⁄ƒV…“ ¥™…™… EÚ…‰ +S…±… {… Æ˙∫…∆{… k…™…… E‰Ú ∫…®……x… =∫…“ i…Æ˙“E‰Ú ∫…‰ ®……x…… V……i…… Ω˲* +x…÷∫…∆v……x… B¥…∆ ¥…EÚ…∫… {…Æ˙ Æ˙…V…∫¥… ¥™…™… ¥…π…« ®… <∫…E‰Ú J…S…« Ω÷˛B {…Æ˙ |…¶…… Æ˙i… EÚB M…B * 1.18 ∫…∆{… k…™…… EÚ“ +∫…®…l…«i…… +∫…®…l…«i…… EÚ… ∫…∆E‰Úi… ®…±…i…‰ ∫…®…™… {… Æ˙∫…∆{… k…™…… EÚ“ +∫…®…l…«i…… E‰Ú §……Ɖ˙ ®… {…Ω˛S……x… EÚ“ V……i…“ Ω˲ * B‰∫…‰ ∫…∆E‰Úi… {…Æ˙ ∫…∆{… k…™…… EÚ“ ¥…∫…⁄±…“ ™……‰M™… Æ˙EÚ®… +x…÷®…… x…i… EÚ“ V……i…“ Ω˲ i…l…… ™… n˘ B‰∫…… |……EÚ±…x… =∫…E‰Ú Æ˙J……¥… Æ˙EÚ®… ∫…‰ EÚ®… Ω˲, i……‰ Æ˙J……¥… Æ˙EÚ®… EÚ…‰ ¥…∫…⁄±…“ ™……‰M™… Æ˙EÚ®… ®… P…]ı V……i…… Ω˛Ë˛ * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 292 1.13 Borrowing costs The borrowing cost incurred / attributable to the acquisition for the purpose of obtaining a qualifying asset is capitalized. Interest on loan taken specifically for the acquiring assets and the interest thereon are proportionately allocated to respective assets based on asset value. 1.14 Segment reporting The Company has identified its reportable segments for Segment Reporting, in accordance with Accounting Standard 17, as Contraceptive Products, Healthcare Products, Trading Products, Services and Contracts which are the primary groups. In addition, the following specific accounting policies have been followed for Segment Reporting : a) Segment revenue includes sales and other income directly identifiable with/allocable to the segment, including inter segment revenue. b) Expenses that are directly identifiable with/allocable to segments are considered for determining the segment results. Expenses which relate to the Company as a whole and not allocable to segments are included under "Unallocable Expenditure". c) Income which relate to the Company as a whole and not allocable to segments is included in "Unallocable Income". d) Segment assets and liabilities include those directly identifiable with the respective segments. Unallocable corporate assets and liabilities represents the assets and liabilities that relate to the Company as a whole and not allocable to any segment. 1.15 Leases Fixed Assets acquired and given on lease are shown as part of fixed assets. Lease rental income is accounted on accrual basis. 1.16 Taxes on income Provision for current Tax is made on the basis of estimated taxable income for the current accounting period in accordance with the provisions of the Income Tax Act, 1961. Deferred Tax resulting from timing difference between book and taxable profit for the year is accounted for using the Tax rates and laws that are applicable as on the Balance Sheet Date. The deferred Tax asset is recognized and carried forward only to the extent there is a reasonable certainty of its realization in future. Minimum Alternative Tax (MAT) paid in accordance with the provisions of Income Tax Act 1961, which gives rise to future economic benefits in the form of adjustment of future income tax liability, is considered as asset in the balance sheet. 1.17 Research and development expenses Capital expenditure on Reserch and Development is treated in the same manner as Fixed Assets. The revenue expenditure on Research and Developmment is charged off in the year in which it is incurred. 1.18 Impairment of assets Impairment of assets is recognized when there is an indication of Impairment. On such indication the recoverable amount of the assets is estimated and if such estimation is less than its carrying amount, the carrying amount is reduced to recoverable amount. Annual Report 2013-2014 293 1.19 |……¥…v……x… +…ËÆ˙ +…EÚŒ∫®…EÚ ¥™…™… M…i… P…]ıx……+… E‰Ú {… Æ˙h……®… ∫¥…∞¸{… E∆Ú{…x…“ EÚ…‰ +§… §……v™…i…… Ω˛…‰x…‰ ∫…‰ BEÚ |……¥…v……x… ∫¥…“EfiÚi… EÚ™…… V……i…… Ω˲ +…ËÆ˙ ™…Ω˛ ∫…∆¶…… ¥…i… EÚ“ Ω˲ * n˘… ™…i¥… EÚ…‰ x…{…]ı…x…‰ E‰Ú ±…B ∫…∆∫……v…x…… EÚ… §… Ω˛M…«®…x… +{…‰ I…i… Ω˛…‰M…… V…∫… ∫…∆§…∆v… ®… BEÚ ¥…∑…∫…x…“™… |……EÚ±…x… §…x…… V…… ∫…EÚi…… Ω˲ * |……¥…v……x… (∫…‰¥…… x…¥…fi k…-±……¶… EÚ…‰ UÙ…‰b˜EÚÆ˙) =x…E‰Ú ¥…i…«®……x… ®…⁄±™… EÚ…‰ §…^ı… x…Ω˛” EÚ…]ı… Ω˲˲ +…ËÆ˙ i…÷±…x…-{…j… E‰Ú i……Æ˙“J… EÚ…‰ §……v™…i…… x…{…]ı…x… EÚÆ˙x…‰ EÚ…‰ +{…‰ I…i… =k…®… +…EÚ±…x… E‰Ú +…v……Æ˙ {…Æ˙ x…v……« Æ˙i… EÚ™…‰ V……i…‰ ΩÈ˛ * ™…‰ |…i™…‰EÚ i…÷±…x…-{…j… i……Æ˙“J…Ú {…Æ˙ ∫…®…“I…… EÚ“ V……i…“ ΩÈ˛ +…ËÆ˙ S……±…⁄ =k…®… +…EÚ±…x… {…Æ˙ |… i…À§… §…i… EÚÆ˙x…‰ EÚ…‰ ∫…®……™……‰ V…i… EÚ™…… Ω˲ * |……∫…∆ M…EÚÚ n‰˘™…i……B∆ +±…M… ∞¸{… ∫…‰ |…EÚ]ı EÚ“ V……i…“ ΩÈ˛ * ]ı{{…h…“ ®… |…EÚ]ı |……∫…∆ M…EÚ {… Æ˙∫…∆{… k…™…… EÚ…‰ ¥…k…“™… ¥…¥…Æ˙h… ®… x… i……‰ ∫¥…“EfiÚi… ™…… |…EÚ]ı EÚ™…… M…™…… Ω˲ * 1.20 {…⁄¥…« |…n˘k… J…S…« |… i… `2000/- i…l…… =∫…∫…‰ EÚ®… E‰Ú ®…n˘… ∫…‰ ∫…∆§…∆ v…i… {…⁄¥…« |…n˘k… J…S…« Æ˙…V…∫¥… EÚ“ +…‰Æ˙ |…¶…… Æ˙i… EÚB M…B ΩÈ˛ * 1.21 {…⁄¥…«EÚ… ±…EÚ ¥™…™…/+…™… |…i™…‰EÚ ®……®…±…‰ ®… `5000/-∫…‰ + v…EÚ +…x…‰¥……±…‰ {…⁄¥…«EÚ… ±…EÚ +…™… +…ËÆ˙ ¥™…™… {…⁄¥…«EÚ…±…Ú E‰Ú +v…“x… {… Æ˙EÚ ±…i… EÚ™…… V……i…… Ω˲ * 1.22 ∫……®……x™… ¶…hb˜…Æ˙/+ i… Æ˙HÚ {…÷V…Ê/EÚSS…‰ ®……±…/i…Ë™……Æ˙ =i{……n˘ v…“Ɖ˙ S…±…x…‰¥……±…“ ®…n˘… EÚ“ ∫……®… O…™…… i…Ë™……Æ˙ =i{……n˘… E‰Ú ∫…∆§…∆v… ®… ™… n˘ EÚ…‰<« x…÷EÚ∫……x… EÚ… |……¥…v……x… B‰∫…‰ =i{……n˘… E‰Ú ={…™……‰ M…i……/ ¥…G‰Ú™…i…… E‰Ú ∫…∆§…∆v… ®… i…EÚx…“EÚ“ Æ˙…™… |……{i… EÚÆ˙x…‰ E‰Ú §……n˘ {… Æ˙EÚ ±…i… EÚB V……i…‰ ΩÈ˛Ë˛* 1.23 x…®……«h… +¥… v… E‰Ú n˘…ËÆ˙…x… J…S…« EÚ… |… i…{……n˘x…˙ x…®……«h… EÚ…±… +¥… v… E‰Ú n˘…ËÆ˙…x… J…S…« {…⁄ƒV…“ EÚ…™…« |…M… i… E‰Ú +v…“x… ∂…… ®…±… EÚ™…… M…™…… Ω˲ +…ËÆ˙ =∫…EÚ…‰˛ x…®……«h… E‰Ú ∫…®……{…x… {…Æ˙ ∫…∆§…∆ v…i… +S…±… {… Æ˙∫…∆{… k…™…… {…Æ˙ +…§…∆ ]ıi… EÚ™…… V……i…… Ω˲ * 1.24 {… Æ˙∫…∆{… k…™……‰∆ +…ËÆ˙ n‰˘™…i……+… E‰Ú S……±…⁄ ™…… M…ËÆ˙ S……±…⁄ E‰Ú ∞¸{… ®… ¥…M…‘EÚÆ˙h… E∆Ú{…x…“ E‰Ú ∫……®……x™… |…S……±…x… ∫……< EÚ±… +…ËÆ˙ E∆Ú{…x…“ + v… x…™…®… 1956 EÚ“ +x…÷∫…⁄S…“ VI ®… x…Ãn˘π]ı EÚ™…‰ +x™… ®……x…n∆˘b˜… E‰Ú +…v……Æ˙ {…Æ˙ ∫…¶…“ {… Æ˙∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… EÚ…‰ S……±…⁄ ™…… M…ËÆ˙ S……±…⁄ E‰Ú ∞¸{… ®… ¥…M…‘EfiÚi… EÚ™…‰ M…™…‰ ΩÈ˛ * =i{……n˘… EÚ“ |…EfiÚ i… +…ËÆ˙ {… Æ˙∫…∆{… k…™…… E‰Ú +V…«x… +…ËÆ˙ x…EÚn˘ +…ËÆ˙ ∫…®…i…÷±™… x…EÚn˘ ®… =x…EÚ“ ¥…∫…⁄±…“ E‰Ú §…“S… E‰Ú ∫…®…™… E‰Ú +…v……Æ˙ {…Æ˙ {… Æ˙∫…∆{… k…™…… +…ËÆ˙ n‰˘™…i……+… E‰Ú S……±…⁄ ™…… M…ËÆ˙ S……±…⁄ ¥…M…‘EÚÆ˙h… E‰Ú =q‰˘∂™… E‰Ú ±…B E∆Ú{…x…“ u˘…Æ˙… 12 ®…Ω˛“x…… x…v……« Æ˙i… EÚ™…… M…™…… Ω˲ * ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 294 1.19 Provisions and contingencies A provision is recognized when the Company has a present obligation as a result of past events and it is probable that an outflow of resources will be required to settle the obligation in respect of which a reliable estimate can be made. Provisions (excluding retirement benefits) are not discounted to their present value and are determined based on the best estimate required to settle the obligation at the Balance Sheet date. These are reviewed at each Balance Sheet date and adjusted to reflect the current best estimates. Contingent liabilities are disclosed separately. Contingent assets are neither recognized nor disclosed in financial statement. 1.20 Prepaid Expenses Prepaid expenses of items of ` 2000/- each and below are charged off to the revenue. 1.21 Prior Period Expenses/Income Income and expenditure relating to prior period exceeding ` 5000/- in each case only is accounted under prior period. 1.22 General Stores/Spares/Raw Materials/Finished Products The provision for loss if any in respect of slow moving items of materials/finished products are accounted after obtaining the technical opinion regarding the usability/marketability. 1.23 Treatment of expenditure during construction Period Expenditure during construction period is included under capital work-in-progress and the same is allocated to the respective fixed assets on the completion of construction. 1.24 Classification of Assets and Liabilities as Current and Non-Current All assets and liabilities are classified as current or non-current as per the company's normal operating cycle and other criteria set out in schedule VI to the Companies Act, 1956. Based on the nature of products and time between acquisition of assets for processing and their realization in cash and cash equivalents, 12 months has been considered by the Company for the purpose of current or non-current classification of assets and Liabilities. Annual Report 2013-2014 295 31 ®……S…«, 2014 EÚ…‰ ∫…®……{i… ¥…π…« E‰Ú ±…B ∫…®…‰ EÚi… ¥…k…“™… ¥…¥…Æ˙h… EÚ“ ]ı{{…h…“ ∫…®…‰ EÚi… |……∫…∆ M…EÚ n‰˘™…i……B∆ +…ËÆ˙ |… i…§…r˘i……B∆ (|……¥…v……x… x…Ω˛” n˘B Ω˛n˘ i…EÚ) 2013-14 2012-13 ` ` ±……J…… ®… ` ±……J…… ®… (i) |……∫…∆ M…EÚ n‰˘™…i……B∆ (i) +…™… EÚÆ˙ EÚ) E∆Ú{…x…“ E‰Ú ¥…Ø˚r˘ {…b‰˜ +…™… EÚÆ˙ n˘…¥…‰, @Òh… E‰Ú ∞¸{… ®… ∫¥…“EfiÚi… x…Ω˛” EÚB M…B ΩÈ˛ i…l…… E∆Ú{…x…“ +{…“±… ®… Æ˙Ω‰˛ n˘…¥…‰ E‰Ú ∫…∆§…∆v… ®… |……¥…v……x… x…Ω˛” EÚB M…B ΩÈ˛ i…l…… x…h…«™……v…“x… {…b‰˜ x…v……«Æ˙h… B¥…∆ §™……V…… ∫…‰ ∫…∆§…∆ v…i… B‰∫…‰ ®……®…±…‰ ¶…“ UÙ…‰b˜ n˘B M…B ΩÈ˛* 312.16 222.50 J…) @Òh… E‰Ú ∞¸{… ®… ∫¥…“EfiÚi… x…Ω˛” EÚB M…B E∆Ú{…x…“ E‰Ú ¥…Ø˚r˘ {…b‰˜ §…GÚ“ EÚÆ˙ n˘…¥…‰* 687.64 263.48 (ii) @Òh… E‰Ú ∞¸{… ®… ∫¥…“EfiÚi… x…Ω˛” EÚ™…‰ E∆Ú{…x…“ E‰Ú J…±……°Ú {…b‰˜ n˘…¥…‰* 4,981.76 4,308.84 (iii) M……Æ∆˙]ı“ (EÚ) + v…EÚ… Æ˙™…… E‰Ú ±…B EÚ®…«S……Æ˙“ +…¥……∫…˛ @Òh… E‰Ú ±…B E∆Ú{…x…“ EÚ“ M……Æ∆˙]ı“ 2.38 4.03 (J…) +x™…… E‰Ú ±…B EÚ®…«S……Æ˙“ +…¥……∫… @Òh… E‰Ú ±…B E∆Ú{…x…“ EÚ“ M……Æ∆˙]ı“ 8.06 15.92 (iv) ∫…Æ˙EÚ…Æ˙“ ¥…¶……M……‰∆ E‰Ú ±…B §…ÈEÚ M……Æ∆˙]ı“ ( x…¥…±… ®……ÃV…x… Æ˙… ∂…) 161.33 1,764.24 (v) +x™…… E‰Ú ±…B §…ÈEÚ M……Æ∆˙]ı“ 4,718.11 12,981.07 (vi) V……Æ˙“ EÚ“ M…<«˙ x…M… ®…i… M……Æ∆˙]ı“ 2,579.94 2,580.00 (vii) ∫……J…-{…j… ( x…¥…±… ®……ÃV…x… Æ˙… ∂…) 428.75 769.25 (viii) ∫…“®…… ∂…÷±EÚ E‰Ú ±…B |……¥…v……x… 49.12 45.13 (ix) EÚ…‰ S…x… ∫{…‰∂…±… (x) x…“±……®…“ ®… +ÃV…i… ∫…∆{… k… {…Æ˙ ¥…t®……x…/n‰˘™… Æ˙… ∂…* 36.88 36.88 (xi) ®……x…x…“™… =SS… x™……™……±…™… ®…÷∆§…<« E‰Ú ∫……l… B®… B∫… B®… <« b˜“ {…Æ˙ n‰˘™… §™……V… - - E÷Ú±… 14,432.05 23,457.27 (ii) |… i…§…r˘i……B∆ (i) {…⁄ƒV…“ ±…‰J…‰ {…Æ˙ EÚ…™……«Œx¥…i… EÚB V……x…‰ E‰Ú ±…B ∂…‰π… `‰ˆE‰Ú E‰Ú +x…÷®…… x…i… Æ˙EÚ®… +…ËÆ˙ |……¥…v……x… x…Ω˛” EÚB M…B* (+ O…®……‰∆ EÚ… x…¥…±…) 14,365.89 15,947.38 (ii) °Ú…™…±… EÚB +{…“±…… E‰Ú ±…B ±…∆ §…i… U⁄Ù]ı n˘…¥…… 5.61 2.00 E÷Ú±… 14,371.50 15,949.38 E÷Ú±… ™……‰M… 28,803.57 39,406.66 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 296 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31.03.2014 Consolidated Contingent Liabilities and commitments (to the extent 2013-14 2012-13 not provided for) ` lacs ` lacs (I)Contigent Liabilities (i) Income Tax (a) Income Tax demands against the Company not acknowledged as debt and not provided for in respect of which the Company is in appeal and exclusive of the similar matters in respect of pending assessments and interest 312.16 222.50 (b) Sales Tax Claims against the Co. not acknowledged as debt 687.64 263.48 (ii) Claims against the company not acknowledged as debt 4981.76 4308.84 (iii) Guarantee (a)Company's guarantee for Employees Housing Loan for Officers 2.38 4.03 (b)Company's guarantee for Employees Housing Loan for Others 8.06 15.92 (iv) Bank Guarantees to Govt. Departments. (Net of Margin Money) 161.33 1,764.24 (v) Bank Guarantees to others 4,718.11 12,981.07 (vi) Corporate Guarantees issued 2,579.94 2,580.00 (vii) Letter of Credits (Net of Margin Money) 428.75 769.25 (viii) Provision for Customs Duty 49.12 45.13 (ix) Bond cum legal undertaking in favour of Cochin Special Economic Zone 465.92 465.92 (x) Encumbrance/amount payable, existing on the property acquired in auction 36.88 36.88 (xi) Interest payable on MSMED overdues and claims with the Hon. High Court, Mumbai - - TOTAL 14,432.05 23,457.27 (II) Commitments (i) Estimated amount of contracts remaining to be executed on Capital Account and not provided for (Net of advances) 14,365.89 15,947.38 (ii) Pending rebate claim for which appeals filed 5.61 2.00 TOTAL 14,371.50 15,949.38 GRAND TOTAL 28,803.57 39406.66 Annual Report 2013-2014 297 +x…÷∫…⁄S…“ 3 : ∫…®…‰ EÚi… ]ı{{…h…“ x…∆. ∫…“ 6 ®… +Œ±±… J…i… 31 ®……S…«, 2014 EÚ…‰ ∫…∆™…÷HÚ =t®… & ∫…®…x…÷π…∆ M…™…… E‰Ú ±…‰J……{…Æ˙“ I…i… i…÷±…x…-{…j… ∫……Æ˙ ¥…¥…Æ˙h… ±……<¢Úœ∫|…M… +∫{…i……±… BS…B±…B±… §……™……‰]‰ıııEÚ M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ ({…“) ±… ®…]‰ıb˜ ±… ®…]‰ıb˜ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ EÚ) <ŒC¥…]ı“ ¥… n‰˘™…i……™… 1. +∆∂…v…… Æ˙™…… EÚ“ x… v… (EÚ) ∂…‰™…Æ˙ {…⁄ƒV…“ 1,566.84 17,801.00 1,902.00 (J…) +…Æ˙ I…i… i…l…… + v…∂…‰π… (1,665.45) (11.18) (1,746.98) (98.61) 17,789.82 155.02 2. M…ËÆ˙-S……±…⁄ n‰˘™…i……Bƒ (EÚ) n˘“P…«EÚ…±…“x… =v……Æ˙ 661.52 - 859.23 (J…) +…∫l… M…i… EÚÆ˙ n‰˘™…i…… ( x…¥…±…) 75.05 - - 736.57 - 859.23 3. S……±…⁄ n‰˘™…i……Bƒ (EÚ) ø∫¥…EÚ…±…“x… =v……Æ˙ 24.64 - 0.01 (J…) ¥™……{……Æ˙ n‰˘™… 74.80 24.30 1,177.14 (M…) +x™… S……±…⁄ n‰˘™…i……Bƒ 38.11 35.27 236.95 (P…) +±{…EÚ…±…“x… ¥™…¥…∫l……Bƒ - 6.59 39.97 137.55 66.16 1,454.07 E÷Ú±… 775.51 17,855.98 2,468.32 J… {… Æ˙∫…∆{… k…™……ƒ 1. M…ËÆ˙-S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (EÚ) +S…±… {… Æ˙∫…∆{… k…™……ƒ - - - (i) ®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 413.74 195.76 446.88 (ii) +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ 112.53 17.98 5.60 (iii) S……±…⁄ {…⁄ƒV…“ EÚ…™…« - 1,935.07 - (iv) ¥…EÚ…∫……v…“x… +®…⁄i…« {… Æ˙∫…∆{… k…™……ƒ - 310.48 - 526.27 2,459.29 452.48 (J…) M…ËÆ˙-S……±…⁄ x…¥…‰∂… - - 0.25 (M…) n˘“P…«EÚ…±…“x… @Òh… +…ËÆ˙ {…‰∂… M…™……ƒ 101.87 2,056.00 5.36 (P…) +x™… M…ËÆ˙-S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ - 0.52 - 2. S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (EÚ) ¥…∫i…÷∫…⁄ S…™……ƒ 0.85 32.59 115.72 (J…) |……{™… ¥™……{……Æ˙ 5.30 - 1,486.72 (M…) x…EÚn˘ B¥…∆ x…EÚn˘ i…÷±™… 95.85 13,023.33 325.68 (P…) ø∫¥…EÚ…±…“x… @Òh… i…l…… {…‰∂… M…™……ƒ 45.37 220.70 25.26 (RÛ) +x™… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ - 63.55 56.85 147.37 13,340.17 2,010.23 E÷Ú±… 775.51 17,855.98 2,468.32 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 298 Annexure 3 : Referred to in Consolidated Notes No. C.6 Audited Balance Sheet abstract of Joint Venture & Subsidiaries as at 31st March 2014 Particulars Life Spring HLL Biotech Goa Antibiotics and Hospitals (P) Ltd Ltd Pharmaceuticals Ltd A. EQUITY AND LIABILITIES 1. Shareholders' funds (a) Share Capital 1,566.84 17,801.00 1,902.00 (b) Reserves and Surplus (1,665.45) (11.18) (1,746.98) (98.61) 17,789.82 155.02 2. Non-current liabilities (a) Long-term borrowings 661.52 - 859.23 (b) Deferred tax liabilities (net) 75.05 - - 736.57 - 859.23 3. Current liabilities (a) Short-term borrowings 24.64 - 0.01 (b) Trade payables 74.80 24.30 1,177.14 (c) Other current liabilities 38.11 35.27 236.95 (d) Short-term provisions - 6.59 39.97 137.55 66.16 1,454.07 TOTAL 775.51 17,855.98 2,468.32 B. ASSETS 1. Non-current assets (a) Fixed assets i) Tangible assets 413.74 195.76 446.88 ii) Intangible assets 112.53 17.98 5.60 iii) Capital work-in-progress - 1,935.07 - iv) Intangible asset under development - 310.48 - 526.27 2,459.29 452.48 (b) Non-current investments - - 0.25 (c) Long Term Loans and Advances 101.87 2,056.00 5.36 (c) Other Non-Current assets - 0.52 - 2. Current assets (a) Inventories 0.85 32.59 115.72 (b) Trade receivables 5.30 - 1,486.72 (c) Cash and cash equivalents 95.85 13,023.33 325.68 (d) Short-term loans and advances 45.37 220.70 25.26 (e) Other current assets - 63.55 56.85 147.37 13,340.17 2,010.23 TOTAL 775.51 17,855.98 2,468.32 Annual Report 2013-2014 299 +x…÷∫…⁄S…“ 3 : ∫…®…‰ EÚi… ]ı{{…h…“ x…∆. ∫…“ 6 ®… +Œ±±… J…i… 31 ®……S…«, 2014 EÚ…‰ ∫…∆™…÷HÚ =t®… & ∫…®…x…÷π…∆ M…™…… E‰Ú ±…B ±……¶… +…ËÆ˙ Ω˛… x… E‰Ú ±…‰J……{…Æ˙“ I…i… ¥…¥…Æ˙h…˙ ¥…¥…Æ˙h… ±……<¢Úœ∫|…M… +∫{…i……±… BS…B±…B±… §……™……‰]‰ıEÚ M……‰¥…… B∆]ı“§……™……‰ ]ıC∫… +…ËÆ˙ ({…“) ±… ®…]‰ıb˜ ±… ®…]‰ıb˜ °Ú…®……«∫™…⁄ ]ıEÚ±∫… ±… ®…]‰ıb˜ 1. |…S……±…x… ∫…‰ Æ˙…V…∫¥… (∫…EÚ±…) 1,184.84 - 4,059.31 x™…⁄x…: =i{……n˘ ∂…÷±EÚ - - 130.95 |…S……±…x… ∫…‰ Æ˙…V…∫¥… ( x…¥…±…) 1,184.84 - 3,928.36 2. +x™… +…™… 7.92 - 13.86 3. E÷Ú±… Æ˙…V…∫¥… (1+2) 1,192.76 - 3,942.22 4. ¥™…™… (EÚ) ={…¶…÷HÚ ®……±…… EÚ“ ±…M…i… 72.52 - 1,325.21 (J…) ¥™……{……Æ˙ ∫]ı…ÏEÚ E‰Ú GÚ™… - - 740.93 (M…) i…Ë™……Æ˙ ®……±…, S……±…⁄ EÚ…™…« |…M… i… ®… +…ËÆ˙ ¥™……{……Æ˙ ∫]ı…ÏEÚ EÚ“ ¥…∫i…÷∫…⁄S…“ ®… {… Æ˙¥…i…«x… - - 196.68 (P…) EÚ®…«S……Æ˙“ Ω˛i…±……¶… ¥™…™… 647.49 - 672.06 (RÛ) ¥…k… ±……M…i… 102.89 - 46.71 (S…) ®…⁄±™…ø…∫… B¥…∆ {… Æ˙∂……‰v…x… ¥™…™… 69.14 - 55.89 (UÙ) +x™… ¥™…™… 354.77 11.18 656.79 (V…) `‰ˆEÚ… ¥™…™… - - - 5. E÷Ú±… ¥™…™… 1,246.81 11.18 3,694.27 6. ¥…∂…‰π… +…ËÆ˙ +∫……v……Æ˙h… ®…n¢ +…ËÆ˙ EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (3-5) (54.05) (11.18) 247.95 7. ¥…∂…‰π… ®…n¢ 2.11 - (61.83) 8. +∫……v……Æ˙h… ®…n¢ +…ËÆ˙ EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (6-7) (56.16) (11.18) 309.78 9. ¥…∂…‰π… ®…n¢ 1.00 - 10.32 10. EÚÆ˙ E‰Ú {…⁄¥…« ±……¶…/(Ω˛… x…) (8-9) (57.16) (11.18) 299.46 11. EÚÆ˙ ¥™…™… (EÚ) S……±…⁄ ¥…π…« E‰Ú ±…B S……±…⁄ EÚÆ˙ ¥™…™… - - - (J…) {…⁄¥…« ¥…π……Á ∫…‰ ∫…∆§…∆ v…˘i… S……±…⁄ EÚÆ˙ ¥™…™… - - - (M…) B®… B ]ı“ @Òh… {……j…i…… - - - (P…) +∫l… M…i… EÚÆ˙ (2.96) - - 2.96 - - 12. ∫…i…i… |…S……±…x… EÚ“ ¥…π…« ∫…‰ ±……¶…/(Ω˛… x…) (54.20) (11.18) 299.46 13. Æ˙…‰EÚ n˘B |…S……±…x… (6-7) ∫…‰ ±……¶…/(Ω˛… x…) - - - 14. ±……¶…/(Ω˛… x…) (54.20) (11.18) 299.46 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 300 Annexure 3 : Referred to in Consolidated Notes No. C.6 Audited Statement of Profit and Loss for Joint Venture & Subsidiaries for the year ended 31st March 2014 Particulars Life Spring HLL Biotech Goa Antibiotics and Hospitals (P) Ltd Ltd Pharmaceuticals Ltd 1. Revenue from operations (gross) 1,184.84 - 4,059.31 Less: Excise duty - - 130.95 Revenue from operations (net) 1,184.84 - 3928.36 2. Other income 7.92 - 13.86 3. Total revenue (1+2) 1,192.76 - 3,942.22 4. Expenses (a) Cost of materials consumed 72.52 - 1,325.21 (b) Purchases of stock-in-trade - - 740.93 (c) Changes in inventories of finished goods, work-in-progress and stock-in-trade - - 196.68 (d) Employee benefits expense 647.49 - 672.06 (e) Finance costs 102.89 - 46.71 (f) Depreciation and amortisation expense 69.14 - 55.89 (g) other expenses 354.77 11.18 656.79 (h) Contract Expenses - - - 5. Total expenses 1,246.81 11.18 3,694.27 6. Profit/(Loss) before Exceptional and extra ordinary items and tax (3-5) (54.05) (11.18) 247.95 7. Exceptional items 2.11 - (61.83) 8. Profit/ (Loss) before extra ordinary items and tax (6-7) (56.16) (11.18) 309.78 9. Extra ordinary item 1.00 - 10.32 10. Profit/ (Loss) before tax (8-9) (57.16) (11.18) 299.46 11. Tax expenses : (a) Current tax expenses for current year - - - (b) Current tax expense relating to prior years - - - (c) MAT Credit Entitlement - - - (d) Deferred tax (2.96) - - (2.96) - - 12. Profit/ (Loss) for the year from continuing operations (54.20) (11.18) 299.46 13. Profit/ (Loss) from discontinuing operations (6-7) - - - 14. Profit/(Loss) (54.20) (11.18) 299.46 Annual Report 2013-2014 301 +x…÷∫…⁄S…“ II - ]ı{{…h…“ x……‰]ı x…∆. ∫…“ 5 ®… =Œ±±… J…i… ±…‰J…… ®……x…EÚ 17 E‰Ú +v…“x… |…EÚ]ı“EÚÆ˙h… ∫…®…‰ EÚi… J…∆b˜ Æ˙{……‰Õ]ıM… 1. |……<®…Æ˙“ J…∆b˜ ∫…⁄S…x…… Ú ¥…¥…Æ˙h… Æ˙…V…∫¥… J…∆b ` ±……J…… ®… M…¶…« x…Æ˙…‰v…EÚ ∫¥……∫l™… Æ˙I…… ¥™……{……Æ˙ |……{…h… B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ E÷Ú±… =i{……n¢ {…Æ˙…®…∂…« ∫…‰¥……B∆ x…¥…±… §…GÚ“ +…ËÆ˙ ∫…‰¥……Bƒ 40,496.88 16,361.74 16,297.36 3,681.04 17,948.86 94,785.88 +x™… + ¥… x…v……x…“™… Æ˙…V…∫¥… 1,261.58 E÷Ú±… 96,047.46 x…™…÷HÚ {…⁄ƒV…“ M…¶…« x…Æ˙…‰v…EÚ ∫¥……∫l™… Æ˙I…… ¥™……{……Æ˙ |……{…h… B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ E÷Ú±… =i{……n¢ {…Æ˙…®…∂…« ∫…‰¥……B∆ §™……V… +…ËÆ˙ EÚÆ˙ E‰Ú {…Ω˛±…‰ ±……¶… 4,926.12 (770.37) 439.34 1,361.36 3,979.09 9,935.53 x™…⁄x… : §™……V… 1,799.57 x™…⁄x… : +x™… + ¥… x…v……x…“™… ¥™…™… 4,492.44 {…⁄¥…« +¥… v… ®…n¢ (15.81) V……‰b˜ : +x™… + ¥… x…v……x…“™… ¥™…™… 0.00 EÚÆ˙ E‰Ú {…⁄¥…« ±……¶… 3,627.71 M…¶…« x…Æ˙…‰v…EÚ ∫¥……∫l™… Æ˙I…… ¥™……{……Æ˙ |……{…h… B¥…∆ `‰ˆEÚ… ∫…‰¥……B∆ E÷Ú±… x…™…÷HÚ {…⁄ƒV…“ =i{……n¢ {…Æ˙…®…∂…« ∫…‰¥……B∆ +…§…∆ ]ıi… +S…±… {… Æ˙∫…∆{… k…™……ƒ (EÚ) 12,707.12 10,300.34 44.66 923.87 0.94 23,976.92 +…§…∆ ]ıi… S……±…⁄ {… Æ˙∫…∆{… k…™……ƒ (J…) 28,270.55 28,661.31 4,025.68 9,755.91 11,386.74 82,100.19 (EÚ + J…) 40,977.67 38,961.65 4,070.34 10,679.77 11,387.681,06,077.11 +…§…∆ ]ıi… S……±…⁄ n‰˘™…i……Bƒ 10,253.00 8,930.19 1,799.61 3,341.20 6,675.23 30,999.23 x…™…÷HÚ {…⁄ƒV…“ +…§…∆]ıx… 30,724.67 30,031.46 2,270.73 7,338.58 4,712.45 75,077.88 x…™…÷HÚ {…⁄ƒV…“ E‰Ú + ¥… x…v……x…“™… +∆∂… (28,480.59) E÷Ú±… x…™…÷HÚ {…⁄ƒV…“ 46,597.29 2. ∫…‰EÚxb˜Æ˙“ J…∆b˜ ∫…⁄S…x…… - ¶……ËM……‰ ±…EÚ Æ˙…V…∫¥… ¶……Æi… 82,651.12 ¶……Æi… E‰Ú §……Ω˛Æ˙ 13,396.34 96,047.46 x…™…÷HÚ {…⁄ƒV…“ 41.132.39 ¶……Æ˙i… 5,464.90 ¶……Æ˙i… E‰Ú §……Ω˛Æ˙ 46,597.29 ®…∆b˜±… EÚ“ i…Æ˙°Ú ∫…‰ <∫…“ i……Æ˙“J… EÚ“ Ω˛®……Æ˙“ Æ˙{……‰]«ı ∫…∆±…Mx… Ω˲* EfiÚi…‰ B•…Ω˛…®… V……‰∫… ∫…x…n˘“ ±…‰J……EÚ…Æ& °Ú®…« x…∆. 000010B∫… ˙b˜…Ï. B®….+™™…{{…x… +…Æ˙˙.{…“. J…hb‰˜±…¥……±… {…“. ∏…“E÷Ú®……Æ˙ ∫…“B. V……‰∫… {……‰]¬ı]ı…‰EÚ…Æ˙x… +v™…I… B¥…∆ x…n‰˘∂…EÚ ( ¥…k…) E∆Ú{…x…“ ∫… S…¥… B¥…∆ ∫……Z…‰n˘…Æ˙ |…§…∆v… x…n‰˘∂…EÚ ={……v™…I…Ú ( ¥…k…) ∫…n˘∫™… ∫…∆. 012056 i…Ø˚¥…x…∆i…{…÷Æ˙®… 05.07.2014 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 302 ANNEXURE 2 - Referred to in Consolidated Notes No. C.5 Disclosures Under Accounting Standard-17-CONSOLIDATED SEGMENT REPORTING Particulars ` lacs 1. Primary Segment Information Segment Revenue Contraceptives Health Care Trading Procurement Contract Total Products and Services Consultancy Services Net Sales & Services 40,496.88 16.361.74 16,297.36 3,681.04 17,948.86 94,785.88 Other Unallocable Revenue - - - - - 1,261.58 Total - - - - - 96,047.46 Capital Employed Contraceptives Health Care Trading Procurement Contract Total Products and Services Consultancy Services Profit before Interest & Tax 4,926.12 (770.37) 439.34 1,361.36 3,979.09 9,935.53 Less: Interest - - - - - 1,799.57 Less :Other Unallocable Expenditure - - - - - 4,492.44 Prior period items - - - - - (15.81) Add : Unallocable Income - - - - - 0.00 Profit before tax - - - - - 3,627.71 Contraceptives Health Care Trading Procurement Contract Total Products and Services Capital Employed Consultancy Services Allocated Fixed Assets (a) 12,707.12 10,300.34 44.66 923.87 0.94 23,976.92 Allocated Current Assets (b) 28,270.55 28,661.31 4,025.68 9,755.91 11,386.74 82,100.19 a+b 40,977.67 38,961.65 4,070.34 10,679.77 11,387.68 1,06,077.11 Allocated Current Liabilities 10,253.00 8,930.19 1,799.61 3,341.20 6,675.23 30,999.23 Capital Employed Allocation 30,724.67 30,031.46 2,270.73 7,338.58 4,712.45 75,077.88 Unallocable portion of Capital Employed (28,480.59) Total Capital Employed 46,597.29 2. Secondary Segment Information - Geographical Revenue India 82,651.12 Outside India 13,396.34 96,047.46 Captial Employed India 41,132.39 Outside India 5,464.90 46,597.29 For and on behalf of the Board Vide our report of even date attached For M/s. Abraham & Jose Chartered Accountants Firm No. 000010S Dr. M. Ayyappan R.P. Khandelwal P. Sreekumar CA. Jose Pottokaran Chairman Director (Finance) Company Secretary Partner & Managing Director & VP (F) Membership No : 012056 Trivandrum 05.07.2014 Annual Report 2013-2014 303 {…∆V…“EfiÚi… B¥…∆ x…M… ®…i… EÚ…™……«±…™… BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜˜˜ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb˜˜ ®…x…‰∫…Æ˙ ™…⁄ x…]ı {…∆V…“EfiÚi… B¥…∆ x…M… ®…i… EÚ…™……«±…™… {±……Ï]ı x…∆o 71, ∫…‰C]ıÆ˙ 7, BS…B±…B±… ¶…¥…x…, {…⁄V…{{…÷Æ˙…, M…÷b˜M……¥…, Ω˛ Æ˙™……x……-122 050 i…Ø˚¥…x…∆i…{…÷Æ˙®… n⁄˘Æ˙¶……π… ∫…∆o : 0124- 4030949 E‰ÚÆ˙±…, ¶……Æ˙i… 695 012 °ËÚC∫… ∫…o : 0124 - 4030949 n⁄˘Æ˙¶……π… ∫…∆o: 91-471-2354949 (5 ±…… ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 304 REGISTERED & CORPORATE OFFICE HLL Lifecare Limited Manesar Unit HLL Lifecare Limited Plot No.71, Sector 7 Registered & Corporate Office Gurgaon, Haryana - 122050 HLL Bhavan, Poojappura Tel.No.0124 – 4030949 Thiruvananthapuram Fax No.0124– 4030949 Kerala, India 695 012 Tele: 91-471-2354949 ( 5 lines) HLL Indore Plant, Grams ROLATEX Sector-E, Sanver Road Fax 91-471-2356739 Industrial Area E mail : enquiry@ lifecarehll.com Indore - M.P. Website: www.lifecarehll.com Tel: (0731) 3259458 / 4011740 FACTORIES REGIONAL OFFICE: HLL Lifecare Limited Peroorkada Factory NOIDA Peroorkada. Thiruvananthapuram 695 005 Marketing office: Tel: 91-471-2437270/2433602/2433459/ HLL Lifecare Limited 2432880/2432292 No.B-14A, Sector-62 Fax: 91-471-2435013 Noida (U.P.) – 201 301 Tel: 0120-4071500, 0120-4071609 (Mktg.) HLL Lifecare Limited Fax No. 0120-4071513/4071627 Akkulam Factory Akkulam, Thiruvananthapuram-695017 KOLKATTA Tel : 91-471 - 2441384, 2442641, 2442642, HLL Lifecare Limited, 2442692, 2442697 Suite No: 901, 9th Floor Fax : 91-471-241383 Krishna Building, 224A, A.J.C.Bose Road HLL Lifecare Limited Kolkata - 700017 Kanagala Factory, Belgaum West Bengal Kanagala, Belgaum – 591225 Tel: 033 22905275/74 Tele: 08333-279206, 279207, 279244, 279245, 279239 Fax : 08333-321443 HLL Lifecare Limited Cochin Special Economic Zone Division, Plot No.16A/1 Kakkanad, Cochin – 682 037 Tele: 0484 – 2413332,2413293 Fax: 0484 - 2413293 Annual Report 2013-2014 305 ®…÷®§…<« Ω˲n˘Æ˙…§……n˘ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb, 201, u˘i…“™… i…±…, 3-5-816, ¥…“h…… v……Æ˙“ EÚ…Ï®{±…‰C∫…, {…÷ V…i… {±……W……, {±……Ï]ı x…∆.67 4¥……ƒ i…±…, ÀEÚRÛ EÚ…‰i…“ Æ˙…‰b˜, ∫…‰C]ıÆ˙-11, ∫…“ §…“ b˜“ §…‰±……{…÷Æ˙ Ω˲n˘Æ˙M…÷b˜…, Ω˲n˘Æ˙…§……n˘ - 560029 x…¥…“ ®…÷∆§…<« - 400 614 n⁄˘Æ˙¶……π… & °ËÚC∫… ∫…∆o : 040-23210041 n⁄˘Æ˙¶……π… ∫…∆o : 022-67715000/01 ±…J…x……> °ËÚC∫… ∫…o∆ : 022-25209950 <«-®…˱… : [email protected] BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb 9/316, ¥…EÚ…∫… x…M…Æ˙ S…‰z…Ë ±…J…x……> - 226 022 BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb (∫…“ §…“ b˜“/BS… ∫…“ b˜“) n⁄˘Æ˙¶……π… ∫…∆o : 0522 - 2330945, 2320592 x…∆o 185, {±……Ï]ı x…∆o 1, À±…M……¥…±… ]ı¥…Æ˙, °ËÚC∫… ∫…∆o : 0522- 2738947/2330945 100 °Ú“]ı §…Ë {……∫… Æ˙…‰c˜, ¥…V…™…… x…M…Æ˙, <«-®…˱… : [email protected] ¥…‰±……S…‰Æ˙“, S…‰z…Ë - 600 042 n⁄˘Æ˙¶……π… ∫…∆o: 044 - 22453478/22551860/ 22551868/22441727 °ËÚC∫… ∫…∆o: 044-22550764 <«-®…˱… : [email protected] BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb (b˜Œ§±…™…÷ BS… b˜“) x…o 12, 100 °Ú“] Æ˙…‰c˜, ¥…‰±……S…‰Æ˙“ i……Æ˙…®… h… Æ˙…‰c˜, EËÚx…Æ˙… §…ÈEÚ E‰Ú {……∫…, ¥…‰±……S…‰Æ˙“, S…‰z…Ë - 600 042. n⁄˘Æ˙¶……π… ∫…o: 044 - 22435604, 22435607, 22433306 §…ÈM…±…⁄Æ˙ BS…B±…B±… ±……<¢ÚE‰Ú™…Æ˙ ±… ®…]‰ıb #2, 4 ¥……ƒ GÚ…Ï∫… BC∫…-∫…¥…‘∫…®…‰x… Eڅϱ…x…“, §……x…∫…¥……b˜“, §…ÈM…±…⁄Æ˙ - 560 043 n⁄˘Æ˙¶……π… : 080 - 25424530 °ËÚC∫… ∫…∆o: 080 - 25424531 ¥……Ãπ…EÚ |… i…¥…‰n˘x… 2013-2014 306 MUMBAI HYDERABAD HLL Lifecare Limited HLL Lifecare Limited 201, Second Floor 3-5-816,Veena Dhari Complex, Pujith Plaza, Plot No 67 4th Floor, King Koti Road, Sector 11, CBD Belapur Hyderguda, Hyderabad - 560029. Navi Mumbai – 400614. Phone & Fax No.040-23210041 Tel: 022-67715000/01 Fax No. 022-25209950 LUCKNOW E-mail: [email protected] HLL Lifecare Limited, CHENNAI 9/316, Vikas Nagar Lucknow-226 022. HLL Lifecare Limited (CBD/HCD) Phone No: 0522-2330945, 2320592 No.185, Plot No.1, Lingavel tower Fax: 0522-2738947/2330945 100 ft. Bye Pass Road, Vijayanagar E-mail: [email protected] Velachery Chennai – 600 042. Tel: 044-22453478/22551860/ 22551868/22441727 Fax No. 044-22550764 E-mail: [email protected] HLL Lifecare Limited (WHD) No.12, 100 Feet Road, Velacherry Taramani Road, Near Canara Bank, Velacherry, Chennai – 600042 Phone : 044 -22435604, 22435607, 22433306 BANGALORE HLL Lifecare Limited #2, 4th Cross Ex-Servicemen Colony Banaswadi Bangalore - 560 043 Phone:080 25424530 Fax ; 080 25424531 Annual Report 2013-2014 307 HLL’s Corporate Headquarters at Thiruvananthapuram, Kerala Annual Report 2013-2014 Report Annual CIN : U25193KL1966GOI002621